data_2cpz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2cpz _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.491 ' O ' ' CB ' ' A' ' 429' ' ' SER . 26.6 mtpp . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.726 0.298 . . . . 0.0 110.966 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -144.52 165.69 27.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.816 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -88.55 -146.43 12.49 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.448 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.44 154.1 40.22 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.647 2.231 . . . . 0.0 112.307 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -52.0 124.64 13.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.916 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 113.53 -27.28 9.48 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.505 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . 0.496 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.94 127.11 43.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.82 0.343 . . . . 0.0 111.11 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.7 OUTLIER -159.05 163.17 36.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . 0.405 ' CD2' HD11 ' A' ' 459' ' ' ILE . 24.1 mt -159.36 122.37 3.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.922 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . 0.615 ' CZ ' ' CD1' ' A' ' 446' ' ' PHE . 41.4 m-85 -129.78 114.81 16.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 406' ' ' TYR . 3.8 mp -90.9 134.0 30.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.1 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . 0.444 ' CD2' ' HD3' ' A' ' 473' ' ' LYS . 71.9 m-85 -129.4 166.36 19.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.902 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 59.0 50.5 8.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.83 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 32.8 mt -91.24 149.21 39.37 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.657 0.741 . . . . 0.0 110.935 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -78.31 169.86 19.45 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.634 2.223 . . . . 0.0 112.342 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -73.59 -31.14 63.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.43 -38.55 91.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.866 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.557 ' CE1' HD12 ' A' ' 467' ' ' ILE . 4.3 m-85 -70.22 148.01 49.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.826 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -135.25 -133.56 3.27 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.493 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -87.76 -61.9 1.61 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.753 0.311 . . . . 0.0 110.867 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . 0.415 ' O ' ' C ' ' A' ' 416' ' ' ASP . 11.5 mm-40 -54.33 -54.3 42.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.928 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 415' ' ' GLN . 67.0 m-20 -36.91 -60.94 0.58 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.774 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 24.2 tp -46.52 -45.24 18.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.859 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 27.1 tp -59.62 -54.99 40.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.939 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -68.41 -9.93 51.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.845 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -85.57 -30.57 23.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.859 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . 0.424 ' C ' ' HD2' ' A' ' 423' ' ' PRO . 4.0 m-85 -100.35 -20.9 15.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.864 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' MET . . . . . 0.569 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 3.6 mtt -48.85 -46.6 73.78 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.523 0.678 . . . . 0.0 110.787 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 422' ' ' MET . 64.3 Cg_exo -47.97 -38.49 31.45 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.663 2.242 . . . . 0.0 112.354 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . 0.513 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 82.0 m-85 -73.93 -31.91 63.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.909 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 171.6 -177.25 44.52 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.47 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -77.47 94.91 4.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.913 0.387 . . . . 0.0 110.913 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 86.5 t -64.57 127.96 26.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.148 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 79.5 t -78.84 -45.39 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.159 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 8.5 p -128.99 144.7 51.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.89 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -160.72 107.53 1.5 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.113 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . 0.482 ' CG ' ' N ' ' A' ' 432' ' ' VAL . 52.2 tttt -145.16 162.74 36.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.887 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.482 ' N ' ' CG ' ' A' ' 431' ' ' LYS . 18.5 t -124.52 148.12 28.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.138 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . 0.637 ' CG ' ' CE1' ' A' ' 444' ' ' PHE . 4.5 m-85 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.849 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 22.6 m . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.869 0.366 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . 0.637 ' CE1' ' CG ' ' A' ' 433' ' ' PHE . 2.6 p90 -161.78 141.6 10.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.926 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -135.98 164.93 24.98 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.492 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . 0.615 ' CD1' ' CZ ' ' A' ' 404' ' ' PHE . 33.8 t80 -103.76 153.35 20.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.873 0.368 . . . . 0.0 110.913 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . 0.459 HG12 ' N ' ' A' ' 448' ' ' SER . 60.5 t -158.87 152.76 6.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.129 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 448' ' ' SER . . . . . 0.459 ' N ' HG12 ' A' ' 447' ' ' VAL . 10.1 m -153.86 150.74 28.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -113.07 -175.14 2.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.862 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -80.61 -13.05 59.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.856 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -161.37 159.36 23.72 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.596 0.713 . . . . 0.0 110.817 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . 0.449 ' N ' ' HB2' ' A' ' 401' ' ' ALA . 61.1 Cg_endo -75.86 -7.11 18.15 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.67 2.247 . . . . 0.0 112.362 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 58.9 t -81.3 -39.39 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.125 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 6.4 m -82.97 -40.7 19.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.89 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -53.1 -31.9 44.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.132 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -69.41 -43.72 72.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.951 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -43.84 -41.26 4.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.081 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . 0.513 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -64.29 -67.91 0.39 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.085 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . 0.409 ' O ' ' C ' ' A' ' 460' ' ' GLN . 87.1 mt -43.66 -45.95 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.114 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 459' ' ' ILE . 35.3 mt-30 -37.38 -47.42 0.85 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.869 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 2.8 m -101.58 -53.71 2.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.864 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 462' ' ' MET . . . . . 0.459 ' SD ' ' CE1' ' A' ' 424' ' ' PHE . 84.3 mmm -44.85 -47.77 11.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.92 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -45.27 104.34 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 86.22 25.35 37.16 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.48 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . 0.413 ' N ' ' O ' ' A' ' 462' ' ' MET . 21.7 t80 -69.87 108.69 4.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.795 0.331 . . . . 0.0 110.931 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -65.8 104.17 1.03 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.863 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . 0.557 HD12 ' CE1' ' A' ' 412' ' ' PHE . 19.8 tt -111.62 135.33 51.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.13 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 58.19 -93.01 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.463 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 59.9 mtp -133.57 -0.58 3.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.813 0.339 . . . . 0.0 110.875 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -127.88 -178.18 4.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.936 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 54.2 mtt85 -112.73 159.91 18.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.897 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . 0.401 ' CD2' HG23 ' A' ' 467' ' ' ILE . 87.3 mt -103.0 157.54 16.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.894 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . 0.444 ' HD3' ' CD2' ' A' ' 406' ' ' TYR . 13.3 tttt -132.26 104.67 6.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.923 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 2.8 t -113.55 135.82 51.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.138 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -157.1 137.92 13.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.836 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . 0.443 ' CB ' ' O ' ' A' ' 402' ' ' ASN . 1.6 pp -83.66 128.38 34.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 476' ' ' LEU . 10.7 tptm . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.748 0.309 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -131.41 -178.3 4.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.868 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -98.14 -145.89 19.67 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.561 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.52 151.08 52.61 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.697 2.265 . . . . 0.0 112.333 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -54.16 97.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.937 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 135.16 -22.95 3.53 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.462 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . 0.494 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -99.98 127.43 46.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.709 0.29 . . . . 0.0 111.166 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 18.6 m-80 -158.47 165.5 34.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.876 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . 0.466 HD11 ' CE1' ' A' ' 449' ' ' TYR . 22.4 mt -160.12 110.38 1.85 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.921 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . 0.566 ' CE1' ' HB2' ' A' ' 477' ' ' LYS . 26.2 m-85 -115.37 115.62 26.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.899 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . 0.454 HG21 ' CD1' ' A' ' 408' ' ' LEU . 4.0 mp -90.81 136.19 24.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.132 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . 0.52 ' CZ ' ' HB3' ' A' ' 404' ' ' PHE . 26.9 m-85 -130.49 167.53 18.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.945 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 59.79 50.14 7.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.858 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . 0.454 ' CD1' HG21 ' A' ' 405' ' ' ILE . 38.3 mt -97.25 145.93 30.48 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.58 0.705 . . . . 0.0 110.957 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.458 ' HG2' ' CD1' ' A' ' 412' ' ' PHE . 61.5 Cg_endo -76.42 -177.51 3.77 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.713 2.275 . . . . 0.0 112.308 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -84.44 -35.58 22.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.938 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -58.64 -33.39 70.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.938 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.486 ' CE1' HD12 ' A' ' 467' ' ' ILE . 3.4 m-85 -64.98 155.05 35.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.977 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -145.32 -148.08 4.75 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.493 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.35 -60.33 2.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.707 0.289 . . . . 0.0 110.805 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . 0.434 ' O ' ' C ' ' A' ' 416' ' ' ASP . 21.1 mp0 -54.27 -59.29 4.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.984 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 415' ' ' GLN . 35.3 m-20 -34.6 -61.19 0.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.831 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 19.5 tp -47.84 -47.67 31.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 18.4 tp -62.38 -44.09 97.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -74.25 -17.42 60.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.878 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 2.5 ttt -83.94 -28.85 27.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.863 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . 0.426 ' C ' ' HD2' ' A' ' 423' ' ' PRO . 5.3 m-85 -102.93 -19.83 14.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.883 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' MET . . . . . 0.584 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 0.2 OUTLIER -49.97 -46.05 81.33 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.517 0.675 . . . . 0.0 110.827 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 422' ' ' MET . 66.7 Cg_exo -48.03 -48.97 14.93 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.69 2.26 . . . . 0.0 112.299 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . 0.502 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 81.5 m-85 -62.18 -31.79 72.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 175.35 173.58 41.22 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.52 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -76.18 91.78 3.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.942 0.401 . . . . 0.0 110.886 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 72.4 t -56.33 128.62 16.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.127 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . 0.419 HG21 ' C ' ' A' ' 449' ' ' TYR . 31.3 t -73.16 -50.98 28.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.162 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 38.8 m -144.43 132.16 21.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.865 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -140.78 129.86 23.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.097 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . 0.418 ' C ' ' HD3' ' A' ' 431' ' ' LYS . 0.2 OUTLIER -159.83 137.75 10.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.868 -180.0 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 72.2 t -93.7 151.37 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.128 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.912 -179.992 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 19.0 p . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.798 0.333 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 7.0 p90 -162.1 141.9 9.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.908 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -139.25 179.08 19.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.475 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . 0.492 ' CE1' ' CE1' ' A' ' 404' ' ' PHE . 27.2 t80 -117.41 150.31 39.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.825 0.345 . . . . 0.0 110.958 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . 0.445 HG12 ' N ' ' A' ' 448' ' ' SER . 96.6 t -155.32 144.61 12.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.127 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 448' ' ' SER . . . . . 0.445 ' N ' HG12 ' A' ' 447' ' ' VAL . 51.6 p -139.81 146.34 39.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.838 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . 0.466 ' CE1' HD11 ' A' ' 403' ' ' LEU . 3.7 m-85 -111.86 174.67 5.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.87 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.63 -18.65 62.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.864 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . 0.482 ' OD1' ' N ' ' A' ' 451' ' ' ASN . 3.9 p-10 -152.01 155.1 33.36 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.642 0.734 . . . . 0.0 110.869 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.41 -15.1 20.04 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.644 2.23 . . . . 0.0 112.347 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 85.7 t -77.72 -38.1 24.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.025 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 1.5 t -80.21 -35.86 35.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.762 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -56.43 -39.53 73.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.128 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -61.97 -42.59 99.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -42.63 -43.76 3.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.148 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . 0.502 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -64.02 -70.52 0.22 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.156 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . 0.462 ' CD1' ' CD2' ' A' ' 403' ' ' LEU . 84.6 mt -41.9 -44.78 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.161 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -39.54 -47.22 1.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 2.4 m -97.58 -54.31 3.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.863 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 462' ' ' MET . . . . . 0.476 ' O ' ' N ' ' A' ' 465' ' ' PHE . 80.8 mmm -44.69 -57.39 3.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.847 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 462' ' ' MET . 9.8 t-20 -35.98 99.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.822 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 90.32 31.11 10.96 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.524 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . 0.476 ' N ' ' O ' ' A' ' 462' ' ' MET . 40.2 t80 -76.26 115.71 16.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.759 0.314 . . . . 0.0 110.883 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -63.54 103.28 0.51 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.894 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . 0.486 HD12 ' CE1' ' A' ' 412' ' ' PHE . 18.8 tt -114.01 138.9 42.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.151 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 48.17 -96.87 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.457 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 27.3 mmm -125.14 -9.33 7.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.873 0.368 . . . . 0.0 110.861 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 14.6 pttm -121.03 178.98 4.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.894 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 62.0 mtm180 -110.42 151.61 27.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.888 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 68.5 mt -94.22 158.08 15.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.874 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -137.43 108.53 6.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 2.9 t -110.02 140.34 29.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.129 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -157.17 141.01 16.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.907 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . 0.468 ' O ' ' CD1' ' A' ' 476' ' ' LEU . 1.5 pp -85.19 125.65 33.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.939 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.566 ' HB2' ' CE1' ' A' ' 404' ' ' PHE . 32.9 ttpt . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.874 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 33.3 mtmt . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.765 0.316 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -130.73 -178.33 4.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.84 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -96.41 -155.09 30.62 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.5 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.25 151.73 43.88 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.618 2.212 . . . . 0.0 112.395 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -48.45 113.56 0.78 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.88 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 121.57 -28.53 5.94 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.512 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . 0.496 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.81 127.4 43.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.8 0.333 . . . . 0.0 111.127 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.7 OUTLIER -158.42 161.96 37.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.947 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . 0.421 ' CD1' ' CE1' ' A' ' 449' ' ' TYR . 19.8 mt -155.67 120.28 4.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.915 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . 0.51 ' CE1' ' HB2' ' A' ' 477' ' ' LYS . 25.3 m-85 -127.61 110.74 12.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.945 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . 0.458 ' CG2' HD13 ' A' ' 408' ' ' LEU . 3.5 mp -91.84 136.31 24.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.127 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -127.28 174.63 8.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 51.04 50.29 19.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.919 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . 0.458 HD13 ' CG2' ' A' ' 405' ' ' ILE . 19.7 mt -98.27 140.18 21.69 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.549 0.69 . . . . 0.0 110.982 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.411 ' O ' ' O ' ' A' ' 408' ' ' LEU . 73.1 Cg_exo -50.46 -171.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.651 2.234 . . . . 0.0 112.411 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -100.01 -24.77 14.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.97 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.11 -32.17 59.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.873 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -58.19 130.85 48.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.869 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -118.47 -144.88 7.65 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.51 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.86 -60.22 2.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.794 0.331 . . . . 0.0 110.847 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -53.84 -55.1 29.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -42.23 -65.01 0.51 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.889 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 22.5 tp -42.86 -41.37 3.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.94 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 30.6 tp -65.35 -50.94 63.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.919 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -67.5 -9.0 38.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.925 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -86.43 -27.91 23.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.902 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . 0.597 ' CZ ' ' SD ' ' A' ' 462' ' ' MET . 10.6 m-85 -104.75 -12.48 16.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.909 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' MET . . . . . 0.575 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 6.1 mtt -54.22 -45.73 99.08 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.565 0.698 . . . . 0.0 110.877 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.0 Cg_exo -47.95 -40.79 33.08 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.611 2.207 . . . . 0.0 112.392 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . 0.557 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 86.7 m-85 -67.61 -36.01 80.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.806 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 178.34 -169.06 40.6 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.464 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -85.32 100.47 11.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.874 0.369 . . . . 0.0 110.911 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 74.7 t -65.15 135.95 27.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.152 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 25.2 t -84.87 -41.02 15.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.18 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 39.7 m -158.91 140.07 13.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.902 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -149.36 132.11 15.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.122 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -157.28 135.3 10.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.933 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 85.3 t -91.98 146.85 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.124 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.889 -179.975 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 27.8 p . . . . . 0 C--O 1.231 0.132 0 CA-C-O 120.892 0.377 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -161.99 150.74 15.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.919 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -141.98 176.27 22.15 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.544 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . 0.494 ' O ' ' CG2' ' A' ' 447' ' ' VAL . 39.8 t80 -117.03 156.81 26.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.948 0.404 . . . . 0.0 110.847 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . 0.494 ' CG2' ' O ' ' A' ' 446' ' ' PHE . 76.2 t -161.03 153.9 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.109 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 3.2 m -151.57 142.39 22.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.865 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . 0.421 ' CE1' ' CD1' ' A' ' 403' ' ' LEU . 3.2 m-85 -107.01 -177.66 3.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.66 -17.19 56.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.838 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . 0.474 ' OD1' ' N ' ' A' ' 451' ' ' ASN . 3.7 p-10 -154.34 156.9 32.15 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.595 0.712 . . . . 0.0 110.852 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.52 -9.29 18.63 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.635 2.224 . . . . 0.0 112.323 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 99.6 t -83.14 -33.76 10.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.099 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 61.3 m -83.6 -38.71 21.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -54.92 -29.13 55.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.112 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 41.3 mm-40 -66.81 -49.99 64.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.911 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -38.93 -40.45 0.65 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.047 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . 0.557 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -70.32 -61.91 1.59 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.152 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . 0.437 ' O ' ' CB ' ' A' ' 463' ' ' ASN . 88.6 mt -42.2 -42.3 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 50.6 mm-40 -42.84 -66.33 0.38 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.917 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 30.2 t -79.63 -54.68 5.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.848 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 462' ' ' MET . . . . . 0.597 ' SD ' ' CZ ' ' A' ' 421' ' ' PHE . 6.9 mmt -40.85 -48.21 3.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.849 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . 0.437 ' CB ' ' O ' ' A' ' 459' ' ' ILE . 36.4 t-20 -55.97 107.56 0.36 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.843 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 87.65 22.8 41.74 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.48 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -69.03 114.15 7.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.753 0.311 . . . . 0.0 110.906 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 6.0 tm0? -72.14 104.63 3.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.935 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . 0.401 ' O ' ' CG2' ' A' ' 467' ' ' ILE . 17.3 tt -112.08 122.73 66.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.121 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 66.94 -94.38 0.24 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.488 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.12 -3.17 4.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.917 0.389 . . . . 0.0 110.948 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -125.48 -178.99 4.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.922 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -112.88 163.99 13.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.854 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 82.1 mt -109.33 155.75 20.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.916 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 26.6 ttmt -129.27 113.25 14.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.912 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 11.4 t -120.54 135.73 59.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.146 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 -156.99 140.33 15.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.875 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . 0.426 ' CB ' ' O ' ' A' ' 402' ' ' ASN . 1.6 pp -80.96 125.35 30.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.938 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.51 ' HB2' ' CE1' ' A' ' 404' ' ' PHE . 15.3 ttmm . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.902 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.468 ' O ' ' CB ' ' A' ' 429' ' ' SER . 6.6 ptmm? . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.754 0.311 . . . . 0.0 110.91 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -132.01 -177.68 4.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -100.77 -147.2 20.49 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.501 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.77 161.18 36.85 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.669 2.246 . . . . 0.0 112.435 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -59.01 123.1 15.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 113.04 -27.57 9.49 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.576 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . 0.487 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.84 127.06 43.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.823 0.344 . . . . 0.0 111.112 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . 0.487 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.7 OUTLIER -159.02 159.94 35.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.934 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . 0.547 HD11 ' CE1' ' A' ' 449' ' ' TYR . 17.6 mt -156.11 122.66 5.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.904 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . 0.482 ' CE1' ' CE1' ' A' ' 446' ' ' PHE . 22.8 m-85 -130.23 110.86 11.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . 0.46 HG23 ' CG ' ' A' ' 408' ' ' LEU . 3.5 mp -91.1 134.13 30.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.176 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . 0.448 ' CD2' ' HD3' ' A' ' 473' ' ' LYS . 84.2 m-85 -126.19 -176.23 3.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.957 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 42.17 53.9 4.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . 0.46 ' CG ' HG23 ' A' ' 405' ' ' ILE . 28.1 mt -98.38 143.07 25.64 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.591 0.71 . . . . 0.0 110.937 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.5 164.42 32.47 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.668 2.245 . . . . 0.0 112.397 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -62.78 -37.64 87.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.918 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -58.23 -35.04 71.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.833 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.536 ' CZ ' ' HE3' ' A' ' 420' ' ' MET . 5.2 m-85 -77.94 115.57 17.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.848 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -109.16 -138.79 8.36 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.474 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 414' ' ' ASP . 0.1 OUTLIER -79.17 -53.72 6.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.761 0.315 . . . . 0.0 110.856 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . 0.417 ' O ' ' C ' ' A' ' 416' ' ' ASP . 16.0 mp0 -60.98 -57.82 11.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 415' ' ' GLN . 70.9 m-20 -36.16 -50.52 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.855 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 36.3 tp -57.74 -50.12 74.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.925 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 39.3 tp -56.73 -43.38 80.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -80.71 -10.76 59.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.936 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' MET . . . . . 0.536 ' HE3' ' CZ ' ' A' ' 412' ' ' PHE . 0.3 OUTLIER -82.29 -27.44 32.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.867 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . 0.417 ' C ' ' HD2' ' A' ' 423' ' ' PRO . 4.0 m-85 -107.14 -20.32 13.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.855 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' MET . . . . . 0.575 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 0.4 OUTLIER -49.44 -46.3 77.96 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.56 0.695 . . . . 0.0 110.883 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 422' ' ' MET . 64.9 Cg_exo -47.96 -41.63 32.56 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.704 2.269 . . . . 0.0 112.376 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . 0.424 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 88.0 m-85 -67.27 -35.97 80.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.92 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 173.6 177.9 43.16 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.499 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -66.03 115.26 5.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.846 0.355 . . . . 0.0 110.877 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 87.4 t -85.12 131.08 35.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.073 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . 0.411 HG22 ' C ' ' A' ' 449' ' ' TYR . 53.6 t -83.83 -34.6 10.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.15 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 0.8 OUTLIER -149.2 143.86 26.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -160.91 119.49 2.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.066 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . 0.492 ' CG ' ' N ' ' A' ' 432' ' ' VAL . 32.7 tttp -159.47 163.17 35.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.939 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.492 ' N ' ' CG ' ' A' ' 431' ' ' LYS . 55.8 t -114.76 154.44 16.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.136 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . 0.564 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.1 m-85 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.819 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 16.2 m . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.904 0.383 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . 0.564 ' CE1' ' HB2' ' A' ' 433' ' ' PHE . 1.8 p90 -161.94 139.67 8.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.93 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -133.7 172.07 21.76 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.512 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . 0.482 ' CE1' ' CE1' ' A' ' 404' ' ' PHE . 23.6 t80 -109.88 153.86 23.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.908 0.385 . . . . 0.0 110.894 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 75.3 t -157.31 153.97 6.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.12 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 2.9 m -154.45 154.97 34.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.928 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . 0.547 ' CE1' HD11 ' A' ' 403' ' ' LEU . 4.7 m-85 -118.9 -175.17 2.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -85.05 -8.87 58.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.877 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -160.2 155.11 20.96 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.634 0.731 . . . . 0.0 110.942 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.78 -8.23 19.02 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.648 2.232 . . . . 0.0 112.41 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 60.0 t -82.14 -36.92 14.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.086 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 1.4 t -82.1 -42.01 19.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.855 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -52.36 -41.33 62.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.118 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -58.32 -46.57 85.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.942 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -43.47 -41.21 4.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.112 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . 0.424 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -62.99 -68.25 0.35 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . 0.406 ' O ' ' C ' ' A' ' 460' ' ' GLN . 77.5 mt -48.01 -43.28 10.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.086 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' ' 459' ' ' ILE . 23.6 mt-30 -37.76 -42.46 0.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 1.9 m -103.78 -56.3 2.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.852 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 462' ' ' MET . . . . . 0.458 ' O ' ' N ' ' A' ' 465' ' ' PHE . 86.2 mmm -42.66 -42.84 3.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.96 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -42.55 100.26 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 83.24 31.35 28.43 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.488 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . 0.458 ' N ' ' O ' ' A' ' 462' ' ' MET . 58.3 t80 -64.79 117.12 7.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.787 0.327 . . . . 0.0 110.923 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 44.4 tp60 -74.26 105.39 5.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . 0.442 ' O ' ' CG2' ' A' ' 467' ' ' ILE . 16.4 tt -116.69 113.45 43.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.106 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 71.34 -104.12 1.37 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.465 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 469' ' ' MET . . . . . 0.4 ' O ' ' SD ' ' A' ' 469' ' ' MET . 5.8 tmm? -121.43 5.72 10.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.857 0.36 . . . . 0.0 110.846 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.73 -176.92 4.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.985 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -123.28 164.65 18.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.807 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 60.2 mt -106.56 163.82 12.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.918 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . 0.448 ' HD3' ' CD2' ' A' ' 406' ' ' TYR . 11.8 tttt -138.43 104.99 5.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.934 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 5.3 t -110.78 139.07 36.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.092 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -157.22 145.89 19.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.876 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . 0.495 ' O ' ' CD1' ' A' ' 476' ' ' LEU . 1.5 pp -92.08 123.99 35.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.471 ' N ' ' HB2' ' A' ' 402' ' ' ASN . 27.9 tttp . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.844 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.707 0.289 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -127.95 177.65 6.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.901 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -104.36 -147.31 16.85 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.535 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.57 151.61 32.81 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.709 2.273 . . . . 0.0 112.313 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -53.41 102.51 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.943 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 135.94 -28.71 2.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.466 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . 0.494 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.95 126.7 43.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.779 0.323 . . . . 0.0 111.106 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.5 OUTLIER -159.04 161.55 36.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.912 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . 0.573 HD12 ' CE1' ' A' ' 449' ' ' TYR . 17.9 mt -159.95 117.66 2.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.929 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . 0.73 ' CZ ' ' CD1' ' A' ' 446' ' ' PHE . 44.4 m-85 -126.39 115.42 19.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.887 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . 0.588 ' CD1' ' N ' ' A' ' 405' ' ' ILE . 1.2 mp -93.82 127.09 46.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.119 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . 0.465 ' CZ ' ' HB3' ' A' ' 404' ' ' PHE . 37.9 m-85 -120.19 151.99 38.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.964 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . 0.482 ' N ' ' O ' ' A' ' 443' ' ' CYS . 15.5 m-70 73.47 54.44 0.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.885 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 26.0 mt -101.58 136.05 19.67 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.6 0.714 . . . . 0.0 110.966 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -47.73 -179.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.729 2.286 . . . . 0.0 112.329 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 35.7 tp60 -91.9 -38.79 12.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.933 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 25.0 pm0 -65.15 -13.19 57.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.881 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -80.29 135.49 36.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.901 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -116.41 -151.86 9.69 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.451 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.18 -56.53 4.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.736 0.303 . . . . 0.0 110.873 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . 0.453 ' O ' ' C ' ' A' ' 416' ' ' ASP . 9.2 mm-40 -56.88 -55.98 27.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.9 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 415' ' ' GLN . 63.6 m-20 -34.41 -59.06 0.46 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.845 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . 0.555 HD13 ' CE1' ' A' ' 421' ' ' PHE . 39.1 tp -46.64 -49.02 19.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . 0.464 ' HB3' ' NE2' ' A' ' 419' ' ' GLN . 52.2 tp -55.27 -55.33 32.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.916 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . 0.464 ' NE2' ' HB3' ' A' ' 418' ' ' LEU . 6.9 mp0 -60.45 -17.6 45.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.923 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 3.8 ttm -86.55 -26.48 24.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . 0.555 ' CE1' HD13 ' A' ' 417' ' ' LEU . 10.8 m-85 -105.93 -10.14 16.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.9 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' MET . . . . . 0.592 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 4.3 mtt -59.64 -45.59 98.6 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.581 0.705 . . . . 0.0 110.923 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.9 Cg_exo -47.98 -37.9 30.51 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.628 2.219 . . . . 0.0 112.362 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . 0.496 ' CE2' ' HA ' ' A' ' 458' ' ' ALA . 86.8 m-85 -67.19 -34.94 78.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.934 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 171.67 -156.82 26.66 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.488 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -92.0 92.77 8.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.841 0.353 . . . . 0.0 110.886 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.505 HG22 ' CZ ' ' A' ' 449' ' ' TYR . 54.3 t -65.67 116.93 5.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.1 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 71.2 t -64.5 -43.18 96.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.126 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' SER . . . . . 0.435 ' O ' ' CG1' ' A' ' 427' ' ' VAL . 93.2 p -137.34 146.83 45.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.82 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -161.3 110.29 1.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.076 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . 0.412 ' C ' ' HD2' ' A' ' 431' ' ' LYS . 1.1 tmmm? -157.36 144.4 18.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.924 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 52.7 t -96.25 137.01 25.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.147 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . 0.401 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.2 m-85 . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . 0.482 ' O ' ' N ' ' A' ' 407' ' ' HIS . 31.4 p . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.832 0.349 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . 0.401 ' CE1' ' HB2' ' A' ' 433' ' ' PHE . 12.0 p90 -162.2 141.5 9.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.852 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -132.65 171.16 21.73 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.454 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . 0.73 ' CD1' ' CZ ' ' A' ' 404' ' ' PHE . 30.6 t80 -111.24 153.16 26.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.911 0.386 . . . . 0.0 110.822 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . 0.459 ' CG2' HD21 ' A' ' 417' ' ' LEU . 59.5 t -159.06 146.64 7.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.099 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 1.2 t -148.74 148.89 30.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.835 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . 0.573 ' CE1' HD12 ' A' ' 403' ' ' LEU . 8.6 m-85 -112.11 -174.9 2.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.98 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -80.58 -21.21 41.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.904 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -152.99 155.73 32.25 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.613 0.72 . . . . 0.0 110.943 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . 0.423 ' N ' ' HB2' ' A' ' 401' ' ' ALA . 60.5 Cg_endo -74.28 -2.27 12.12 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.731 2.287 . . . . 0.0 112.356 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 93.2 t -86.19 -34.25 7.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.08 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 14.0 m -87.39 -39.65 15.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.823 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -52.99 -30.72 36.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.041 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -64.48 -45.95 85.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.876 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -40.31 -44.32 1.9 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.164 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . 0.496 ' HA ' ' CE2' ' A' ' 424' ' ' PHE . . . -61.36 -68.55 0.3 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.108 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . 0.428 ' O ' ' CB ' ' A' ' 463' ' ' ASN . 86.9 mt -43.04 -45.75 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.174 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 24.3 mm100 -39.34 -46.51 1.61 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.933 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 32.5 t -103.19 -56.56 2.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.883 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 462' ' ' MET . . . . . 0.465 ' SD ' ' CZ ' ' A' ' 424' ' ' PHE . 86.6 mmm -42.65 -43.26 3.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.892 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' A' ' 459' ' ' ILE . 14.4 t30 -44.74 110.19 0.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.866 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 74.38 33.33 56.62 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.59 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . 0.414 ' CD1' HD12 ' A' ' 472' ' ' LEU . 9.9 t80 -67.51 113.22 5.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.753 0.311 . . . . 0.0 110.913 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -70.36 109.18 4.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.904 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.7 tt -125.01 134.94 65.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.087 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 58.6 -102.33 0.26 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.434 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -124.33 -9.24 7.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.821 0.344 . . . . 0.0 110.878 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 8.9 pttm -120.57 179.2 4.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.88 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -112.09 164.37 13.24 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.909 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . 0.414 ' CD2' ' O ' ' A' ' 407' ' ' HIS . 78.5 mt -107.0 158.39 17.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.886 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -131.97 102.52 5.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.825 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 15.3 t -110.18 125.54 67.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.138 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 39.9 tp60 -152.11 144.67 24.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . 0.475 ' O ' ' C ' ' A' ' 477' ' ' LYS . 1.6 pp -84.98 129.11 34.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.869 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.475 ' C ' ' O ' ' A' ' 476' ' ' LEU . 4.4 tptm . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.892 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.497 ' O ' ' CB ' ' A' ' 429' ' ' SER . 26.6 mtpt . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.783 0.325 . . . . 0.0 110.854 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -142.79 179.44 7.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.946 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -98.54 -147.37 22.04 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.53 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.56 155.77 40.43 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.672 2.248 . . . . 0.0 112.323 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -58.52 100.51 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 136.25 -28.75 2.88 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.479 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . 0.468 ' HB2' ' N ' ' A' ' 452' ' ' PRO . . . -97.88 127.25 43.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.774 0.321 . . . . 0.0 111.151 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . 0.493 ' O ' ' CB ' ' A' ' 476' ' ' LEU . 16.9 m-80 -158.64 165.43 34.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.94 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . 0.549 HD13 ' CE1' ' A' ' 449' ' ' TYR . 50.7 mt -159.29 108.0 1.84 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.912 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . 0.515 ' CE1' ' HB2' ' A' ' 477' ' ' LYS . 26.8 m-85 -109.94 120.32 42.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.87 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . 0.553 HD11 ' CE2' ' A' ' 421' ' ' PHE . 1.8 mm -91.04 133.92 31.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.074 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . 0.467 ' CZ ' ' HB3' ' A' ' 404' ' ' PHE . 13.9 m-85 -129.75 147.43 51.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.887 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . 0.461 ' O ' ' CD2' ' A' ' 472' ' ' LEU . 31.7 m-70 70.0 52.13 0.4 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.876 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . 0.461 ' CD2' HG21 ' A' ' 405' ' ' ILE . 32.7 mt -93.65 139.65 22.85 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.585 0.707 . . . . 0.0 110.897 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -47.39 -179.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.64 2.227 . . . . 0.0 112.331 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -98.92 -24.84 14.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.949 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 7.7 pm0 -82.37 -12.75 57.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.4 ' CZ ' HD11 ' A' ' 467' ' ' ILE . 6.3 m-85 -76.55 147.55 37.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.893 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -127.03 -148.7 7.04 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.482 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -81.85 -54.72 5.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.816 0.341 . . . . 0.0 110.903 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . 0.466 ' O ' ' N ' ' A' ' 418' ' ' LEU . 7.3 mm100 -58.16 -58.53 8.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.935 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 415' ' ' GLN . 24.2 m-20 -37.3 -56.46 0.96 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.833 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . 0.426 HD13 ' CE1' ' A' ' 421' ' ' PHE . 48.5 tp -51.99 -37.24 52.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.943 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' A' ' 415' ' ' GLN . 23.9 tp -70.78 -50.77 32.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -63.88 -13.89 48.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.855 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 2.1 ttm -89.58 -32.79 16.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.943 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . 0.553 ' CE2' HD11 ' A' ' 405' ' ' ILE . 6.2 m-85 -93.18 -17.8 23.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.873 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' MET . . . . . 0.58 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 0.4 OUTLIER -57.28 -45.61 99.89 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.503 0.668 . . . . 0.0 110.825 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 422' ' ' MET . 64.7 Cg_exo -47.94 -37.79 29.95 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.68 2.253 . . . . 0.0 112.351 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -71.33 -35.56 71.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.901 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 176.06 -178.62 47.48 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.459 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -76.93 89.33 3.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.839 0.352 . . . . 0.0 110.945 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 70.3 t -56.69 143.57 10.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.112 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . 0.418 ' CG2' ' C ' ' A' ' 449' ' ' TYR . 99.4 t -95.25 -38.39 8.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.149 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 3.5 p -140.76 145.09 35.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.928 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -161.03 113.71 1.93 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.14 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.03 142.75 17.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.919 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.404 HG12 ' N ' ' A' ' 433' ' ' PHE . 86.8 t -98.99 143.74 12.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.143 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . 0.534 ' CG ' ' CE1' ' A' ' 444' ' ' PHE . 3.1 m-85 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 24.5 p . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.807 0.337 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . 0.534 ' CE1' ' CG ' ' A' ' 433' ' ' PHE . 4.6 p90 -162.15 143.48 10.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.829 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -137.22 179.07 18.46 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.539 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . 0.469 ' CD1' ' CZ ' ' A' ' 404' ' ' PHE . 66.0 t80 -122.89 141.1 52.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.906 0.384 . . . . 0.0 110.871 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . 0.423 HG22 ' C ' ' A' ' 446' ' ' PHE . 84.5 t -146.12 149.44 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.102 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 448' ' ' SER . . . . . 0.403 ' N ' HG11 ' A' ' 447' ' ' VAL . 1.3 t -147.95 144.94 28.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.83 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . 0.549 ' CE1' HD13 ' A' ' 403' ' ' LEU . 4.1 m-85 -104.84 -174.83 2.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.874 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -79.63 -22.48 43.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.797 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -147.37 155.46 46.07 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.596 0.712 . . . . 0.0 110.875 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . 0.468 ' N ' ' HB2' ' A' ' 401' ' ' ALA . 59.7 Cg_endo -73.03 -0.36 8.95 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.713 2.275 . . . . 0.0 112.399 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 95.5 t -94.23 -37.05 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.149 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 50.6 m -78.63 -37.69 41.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.8 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -52.13 -30.13 25.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.054 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' A' ' 457' ' ' ALA . 42.1 mm-40 -67.59 -51.59 48.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.855 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 456' ' ' GLN . . . -36.64 -42.35 0.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.124 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -69.0 -48.23 63.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.119 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . 0.443 ' O ' ' CB ' ' A' ' 463' ' ' ASN . 70.5 mt -55.39 -42.85 69.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.148 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -40.97 -53.08 3.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.925 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 27.8 t -93.08 -55.27 3.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.856 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 462' ' ' MET . . . . . 0.45 ' SD ' ' CE1' ' A' ' 421' ' ' PHE . 6.3 mmt -43.53 -49.7 7.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.905 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' A' ' 459' ' ' ILE . 18.8 t-20 -48.45 114.7 1.01 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.878 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 65.88 33.86 86.93 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.492 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -75.9 109.04 9.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.795 0.331 . . . . 0.0 110.834 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -62.96 105.88 0.74 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.928 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . 0.41 ' O ' ' CG2' ' A' ' 467' ' ' ILE . 19.2 tt -111.05 116.99 53.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.189 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 65.85 -96.98 0.28 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.537 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 4.0 ttt -123.17 -13.0 7.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.792 0.329 . . . . 0.0 110.806 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 15.3 pttm -117.59 168.65 10.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.887 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -111.29 153.52 25.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.864 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . 0.461 ' CD2' ' O ' ' A' ' 407' ' ' HIS . 14.8 mt -104.21 161.61 13.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.977 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -134.57 104.74 6.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.928 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . 0.468 ' CG2' HD12 ' A' ' 405' ' ' ILE . 30.8 t -109.09 128.33 65.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.135 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -151.84 142.96 23.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.917 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . 0.493 ' CB ' ' O ' ' A' ' 402' ' ' ASN . 1.6 pp -80.13 135.24 36.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.973 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.515 ' HB2' ' CE1' ' A' ' 404' ' ' PHE . 22.8 ttpp . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.477 ' O ' ' CB ' ' A' ' 429' ' ' SER . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.737 0.303 . . . . 0.0 110.906 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -137.2 179.31 6.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.935 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -94.81 -154.77 31.15 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.546 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.09 151.29 61.31 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.7 2.267 . . . . 0.0 112.294 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -49.58 97.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.913 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 136.43 -24.74 3.19 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.48 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . 0.481 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -98.18 126.93 43.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.843 0.354 . . . . 0.0 111.053 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . 0.481 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 22.1 m-80 -158.97 161.87 36.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . 0.566 HD11 ' CD1' ' A' ' 449' ' ' TYR . 47.5 mt -159.24 108.56 1.89 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.931 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . 0.489 ' CE1' ' CE1' ' A' ' 446' ' ' PHE . 20.1 m-85 -113.14 112.42 23.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.923 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . 0.504 HG12 ' CZ ' ' A' ' 421' ' ' PHE . 3.0 mp -90.83 137.44 21.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.093 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . 0.435 ' CD1' ' HB2' ' A' ' 444' ' ' PHE . 93.6 m-85 -129.47 169.74 14.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . 0.469 ' N ' ' O ' ' A' ' 443' ' ' CYS . 20.3 m-70 53.95 51.69 14.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.874 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . 0.453 ' CG ' HG22 ' A' ' 405' ' ' ILE . 25.5 mt -93.9 134.35 26.31 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.594 0.711 . . . . 0.0 110.925 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -48.87 -175.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.659 2.24 . . . . 0.0 112.307 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -88.85 -41.43 12.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.957 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -62.5 -37.4 85.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.898 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -55.35 117.18 3.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.843 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -103.17 -138.45 9.91 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.552 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -89.98 -44.07 10.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.763 0.316 . . . . 0.0 110.871 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . 0.423 ' O ' ' N ' ' A' ' 418' ' ' LEU . 22.5 mp0 -70.06 -57.2 5.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 415' ' ' GLN . 32.9 m-20 -37.36 -56.77 0.95 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.838 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 61.7 tp -52.33 -40.5 61.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.933 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' A' ' 415' ' ' GLN . 24.6 tp -69.61 -38.63 77.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -73.23 -17.51 61.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 4.8 ttp -88.9 -12.67 41.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.826 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . 0.504 ' CZ ' HG12 ' A' ' 405' ' ' ILE . 5.8 m-85 -111.79 -0.01 16.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.868 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' MET . . . . . 0.576 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 4.5 mtt -71.82 -45.92 12.17 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.549 0.69 . . . . 0.0 110.848 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.1 Cg_exo -48.02 -36.84 28.81 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.762 2.308 . . . . 0.0 112.327 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . 0.498 ' CD1' ' HA ' ' A' ' 458' ' ' ALA . 97.2 m-85 -69.51 -36.02 76.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.833 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 171.7 -161.65 33.87 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.53 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -86.07 105.01 16.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.943 0.401 . . . . 0.0 110.896 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 93.8 t -74.13 130.0 36.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.126 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 76.2 t -85.99 -46.82 16.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.115 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 13.7 t -130.69 144.67 51.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.841 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -161.05 117.72 2.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.097 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . 0.416 ' C ' ' HD2' ' A' ' 431' ' ' LYS . 2.0 tmmm? -161.06 151.44 17.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.452 HG13 ' N ' ' A' ' 433' ' ' PHE . 82.0 t -108.62 137.96 37.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.138 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . 0.55 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.1 m-85 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . 0.469 ' O ' ' N ' ' A' ' 407' ' ' HIS . 23.0 p . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.867 0.365 . . . . 0.0 110.914 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . 0.55 ' CE1' ' HB2' ' A' ' 433' ' ' PHE . 6.0 p90 -161.97 138.42 8.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.88 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -136.2 175.46 20.9 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.475 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . 0.489 ' CE1' ' CE1' ' A' ' 404' ' ' PHE . 32.9 t80 -116.03 145.53 42.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.895 0.379 . . . . 0.0 110.857 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 69.3 t -151.44 151.31 12.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.117 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 3.8 m -148.0 153.53 39.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.866 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . 0.566 ' CD1' HD11 ' A' ' 403' ' ' LEU . 4.5 m-85 -115.01 -174.83 2.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.903 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -81.72 -17.54 47.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.869 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -156.44 154.71 27.64 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.672 0.748 . . . . 0.0 110.857 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.44 -6.14 18.29 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.723 2.282 . . . . 0.0 112.343 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 86.1 t -85.25 -33.39 7.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.063 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 61.7 m -85.76 -35.87 20.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.812 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -57.29 -23.8 50.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.095 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -67.33 -53.54 28.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.955 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -40.23 -43.29 1.66 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.152 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . 0.498 ' HA ' ' CD1' ' A' ' 424' ' ' PHE . . . -62.52 -52.29 64.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.124 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 55.5 mt -57.14 -44.16 82.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.132 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -40.94 -55.85 2.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 1.9 m -89.04 -56.1 3.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 462' ' ' MET . . . . . 0.448 ' O ' ' N ' ' A' ' 465' ' ' PHE . 11.1 mmt -40.96 -63.7 0.64 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.86 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . 0.438 ' C ' ' O ' ' A' ' 462' ' ' MET . 37.9 t-20 -35.6 110.92 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.87 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 472' ' ' LEU . . . 67.86 38.43 89.19 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.504 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . 0.448 ' N ' ' O ' ' A' ' 462' ' ' MET . 25.0 t80 -78.59 116.06 18.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.826 0.346 . . . . 0.0 110.919 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 18.7 tp60 -63.07 104.28 0.55 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.874 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 20.0 tt -116.7 118.78 59.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.12 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 64.38 -106.37 1.42 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.449 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -113.31 -11.63 13.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.878 0.37 . . . . 0.0 110.857 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.64 178.41 5.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.864 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -110.1 170.28 8.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.91 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . 0.41 ' O ' ' N ' ' A' ' 464' ' ' GLY . 65.6 mt -114.09 150.07 34.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.88 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -124.61 107.93 11.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 33.0 t -119.05 137.14 54.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.149 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 48.0 tp60 -157.04 145.73 19.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.907 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . 0.452 ' O ' ' C ' ' A' ' 477' ' ' LYS . 1.5 pp -86.0 127.04 34.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.911 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 476' ' ' LEU . 25.5 ttpt . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.853 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.418 ' O ' ' CB ' ' A' ' 429' ' ' SER . 6.6 ptmm? . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.835 0.35 . . . . 0.0 110.881 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . 0.413 ' CD ' ' O ' ' A' ' 397' ' ' GLY . 2.6 pp20? -126.72 -178.33 4.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.868 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . 0.413 ' O ' ' CD ' ' A' ' 396' ' ' GLU . . . -94.06 -146.42 20.14 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.511 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.71 152.05 37.09 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 122.747 2.298 . . . . 0.0 112.368 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -52.83 113.76 1.19 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.905 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 125.76 -28.19 5.0 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.529 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . 0.499 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.93 127.16 43.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.84 0.352 . . . . 0.0 111.09 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.7 OUTLIER -158.6 160.76 36.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.852 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . 0.565 HD13 ' CE1' ' A' ' 449' ' ' TYR . 15.8 mt -156.29 117.76 3.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.909 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . 0.463 ' CE1' ' HB2' ' A' ' 477' ' ' LYS . 12.8 m-85 -125.6 113.04 16.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . 0.501 ' CD1' ' N ' ' A' ' 405' ' ' ILE . 1.8 mp -90.77 136.13 24.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.178 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . 0.426 ' N ' HG22 ' A' ' 405' ' ' ILE . 83.6 m-85 -128.24 169.18 14.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.905 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . 0.43 ' N ' ' O ' ' A' ' 443' ' ' CYS . 30.2 m-70 54.23 53.44 10.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.874 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . 0.434 ' CG ' HG21 ' A' ' 405' ' ' ILE . 35.4 mt -94.1 143.62 26.72 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.608 0.718 . . . . 0.0 110.929 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.568 ' HG2' ' CD1' ' A' ' 412' ' ' PHE . 61.4 Cg_endo -78.21 155.73 29.33 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.674 2.249 . . . . 0.0 112.309 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -60.03 -37.22 79.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.919 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -60.19 -19.87 56.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.865 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.568 ' CD1' ' HG2' ' A' ' 409' ' ' PRO . 4.2 m-85 -89.84 125.88 35.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.828 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -114.55 -141.86 7.75 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.475 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.78 -59.02 2.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.75 0.31 . . . . 0.0 110.892 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . 0.424 ' O ' ' C ' ' A' ' 416' ' ' ASP . 52.3 mm-40 -57.78 -56.49 21.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.906 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 415' ' ' GLN . 62.0 m-20 -36.42 -39.4 0.19 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.855 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 24.2 tp -71.33 -53.58 13.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.947 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . 0.466 ' O ' ' CG ' ' A' ' 422' ' ' MET . 29.6 tp -54.62 -41.19 69.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.878 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -79.78 -9.95 59.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.01 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -85.19 -35.91 21.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.874 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . 0.573 ' CE1' ' SD ' ' A' ' 462' ' ' MET . 5.3 m-85 -98.38 -22.28 16.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' MET . . . . . 0.579 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 0.7 OUTLIER -50.35 -45.84 83.75 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.581 0.705 . . . . 0.0 110.889 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.4 Cg_exo -47.99 -41.79 32.62 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.627 2.218 . . . . 0.0 112.344 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -67.15 -34.39 77.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.902 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 170.5 -178.98 42.87 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.444 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -66.51 124.75 23.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.83 0.347 . . . . 0.0 110.877 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 58.7 t -98.08 118.53 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.143 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 40.5 t -61.98 -51.68 69.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.194 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 3.3 m -143.77 148.76 36.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.825 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -156.82 131.26 8.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.07 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . 0.476 ' CG ' ' N ' ' A' ' 432' ' ' VAL . 14.9 tttm -159.06 162.42 36.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.476 ' N ' ' CG ' ' A' ' 431' ' ' LYS . 69.6 t -121.32 144.41 30.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.145 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . 0.646 ' CG ' ' CE1' ' A' ' 444' ' ' PHE . 4.4 m-85 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.917 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . 0.43 ' O ' ' N ' ' A' ' 407' ' ' HIS . 60.7 m . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.812 0.339 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . 0.646 ' CE1' ' CG ' ' A' ' 433' ' ' PHE . 12.0 p90 -162.13 148.34 13.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -143.77 178.44 21.85 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.485 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . 0.503 ' O ' ' CG2' ' A' ' 447' ' ' VAL . 26.1 t80 -117.45 155.01 30.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.949 0.404 . . . . 0.0 110.83 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . 0.503 ' CG2' ' O ' ' A' ' 446' ' ' PHE . 71.4 t -161.35 150.57 4.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.126 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 84.6 p -149.69 141.81 24.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . 0.565 ' CE1' HD13 ' A' ' 403' ' ' LEU . 4.7 m-85 -106.07 -176.01 2.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.917 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.75 -10.57 59.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.883 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . 0.415 ' C ' ' HB2' ' A' ' 401' ' ' ALA . 0.9 OUTLIER -166.91 160.36 11.23 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.592 0.71 . . . . 0.0 110.897 -179.85 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . 0.449 ' N ' ' HB2' ' A' ' 401' ' ' ALA . 60.4 Cg_endo -74.76 -2.12 12.06 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.724 2.282 . . . . 0.0 112.316 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 92.8 t -85.11 -44.03 17.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.112 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 7.4 t -78.57 -34.8 46.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.838 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -59.35 -20.1 51.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.111 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' A' ' 457' ' ' ALA . 35.2 mm-40 -77.82 -53.92 6.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.936 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 456' ' ' GLN . . . -37.74 -44.42 0.73 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.11 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -64.58 -52.41 57.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.093 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 91.2 mt -52.8 -45.81 50.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.106 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -38.49 -58.52 1.02 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.863 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 30.0 t -87.71 -55.69 3.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 462' ' ' MET . . . . . 0.573 ' SD ' ' CE1' ' A' ' 421' ' ' PHE . 8.6 mmt -39.02 -57.54 1.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.876 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -47.1 114.26 0.82 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 75.93 29.69 58.66 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.493 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -73.47 126.45 30.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.837 0.351 . . . . 0.0 110.886 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 25.3 tm0? -69.96 104.67 2.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.928 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 16.8 tt -119.98 138.41 50.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.148 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 46.68 -95.48 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.518 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 8.8 ptp -134.21 5.03 3.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.903 0.382 . . . . 0.0 110.932 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 15.4 pttm -130.7 174.36 10.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.958 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 42.6 mtm-85 -106.73 145.6 31.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.892 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 27.2 mt -89.26 149.43 23.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.925 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 27.6 ttpt -125.63 103.8 8.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.858 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 2.8 t -110.04 137.63 41.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.141 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -157.05 145.74 19.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.93 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . 0.484 ' O ' ' CD1' ' A' ' 476' ' ' LEU . 1.5 pp -91.41 124.84 35.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.942 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.463 ' HB2' ' CE1' ' A' ' 404' ' ' PHE . 13.9 tttm . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.948 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.758 0.314 . . . . 0.0 110.933 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -136.29 -176.64 4.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -107.03 -143.17 10.96 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.459 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.13 151.89 44.74 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.666 2.244 . . . . 0.0 112.282 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -55.7 100.71 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.964 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 135.92 -25.78 3.19 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.486 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . 0.485 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -98.75 127.05 44.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.806 0.336 . . . . 0.0 111.103 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . 0.485 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 19.2 m-80 -158.86 167.89 28.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.93 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . 0.447 HD13 ' CE1' ' A' ' 449' ' ' TYR . 53.0 mt -158.66 124.6 4.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -130.07 111.02 12.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.911 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . 0.518 HG12 ' CZ ' ' A' ' 421' ' ' PHE . 3.2 mp -91.68 132.31 36.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.131 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -122.21 158.1 30.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.903 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . 0.491 ' O ' ' CD2' ' A' ' 472' ' ' LEU . 53.8 m-70 67.06 55.03 0.72 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.848 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 37.4 mt -100.97 129.9 26.26 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.691 0.757 . . . . 0.0 110.898 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -48.11 -178.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.681 2.254 . . . . 0.0 112.32 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -87.74 -41.93 12.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.935 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -59.9 -36.27 76.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.927 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -57.56 128.98 39.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.88 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . 0.406 ' O ' ' CG2' ' A' ' 432' ' ' VAL . . . -116.08 -138.11 6.29 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.515 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -90.54 -59.22 2.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.732 0.301 . . . . 0.0 110.746 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -51.46 -53.25 39.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.821 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -42.46 -61.74 1.14 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.86 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 33.2 tp -42.44 -49.78 5.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.934 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 52.9 tp -55.19 -58.67 6.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.949 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . 0.49 ' N ' ' OE1' ' A' ' 419' ' ' GLN . 0.8 OUTLIER -57.75 -21.36 40.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.913 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 4.2 ttm -82.21 -29.47 31.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.857 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . 0.518 ' CZ ' HG12 ' A' ' 405' ' ' ILE . 3.8 m-85 -106.9 4.29 27.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.856 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' MET . . . . . 0.588 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 17.5 mtt -73.14 -45.64 8.13 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.588 0.709 . . . . 0.0 110.946 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.7 Cg_exo -47.97 -45.72 24.08 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.673 2.249 . . . . 0.0 112.36 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -61.46 -25.32 67.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 160.21 -177.61 36.59 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.469 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -73.78 100.12 3.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.874 0.369 . . . . 0.0 110.867 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 54.2 t -67.0 122.82 18.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.142 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 76.7 t -75.25 -35.97 35.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.103 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -144.74 143.91 30.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.828 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -161.08 114.77 2.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.064 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . 0.415 ' C ' ' HD2' ' A' ' 431' ' ' LYS . 3.8 tmmm? -160.92 141.54 11.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 413' ' ' GLY . 58.6 t -90.8 139.5 17.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.192 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 -179.972 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . 0.434 ' O ' ' N ' ' A' ' 407' ' ' HIS . 27.3 p . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.805 0.336 . . . . 0.0 110.917 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -162.07 147.03 12.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.86 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -135.35 178.71 18.39 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.525 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . 0.425 ' O ' ' CG2' ' A' ' 447' ' ' VAL . 28.4 t80 -117.33 154.57 31.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.863 0.363 . . . . 0.0 110.883 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . 0.425 ' CG2' ' O ' ' A' ' 446' ' ' PHE . 72.2 t -158.53 155.96 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.116 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 448' ' ' SER . . . . . 0.412 ' N ' ' CG1' ' A' ' 447' ' ' VAL . 3.8 m -154.38 154.06 32.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.828 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . 0.447 ' CE1' HD13 ' A' ' 403' ' ' LEU . 4.4 m-85 -118.43 -175.25 2.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.899 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.25 -12.53 59.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.86 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -157.61 156.36 28.59 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-O 121.659 0.742 . . . . 0.0 110.846 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . 0.464 ' CA ' ' HB1' ' A' ' 401' ' ' ALA . 61.1 Cg_endo -75.45 0.21 9.36 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.648 2.232 . . . . 0.0 112.332 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 99.2 t -90.04 -38.84 11.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.134 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 31.2 m -79.34 -38.5 34.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.828 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -51.15 -42.92 61.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.069 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . 0.414 ' O ' ' C ' ' A' ' 457' ' ' ALA . 23.3 mm-40 -59.73 -51.27 70.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.917 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 456' ' ' GLN . . . -36.52 -41.94 0.32 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.083 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -64.43 -69.75 0.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.057 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 82.5 mt -43.55 -42.56 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.119 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -39.68 -45.73 1.73 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 30.0 t -100.71 -56.29 2.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 87.9 mmm -43.36 -33.15 0.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.881 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -53.01 103.14 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.873 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 83.49 30.77 29.26 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.565 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -67.67 110.4 3.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.783 0.325 . . . . 0.0 110.886 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 9.8 tm0? -66.03 107.16 1.8 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.908 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 17.0 tt -120.52 138.04 52.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.056 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 53.29 -96.44 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.449 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 2.4 ttt -131.89 -1.09 3.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.883 0.373 . . . . 0.0 110.895 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.35 174.68 8.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.891 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 54.5 mtm180 -105.22 172.64 6.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.84 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . 0.491 ' CD2' ' O ' ' A' ' 407' ' ' HIS . 82.2 mt -121.24 156.09 33.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.95 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -134.13 108.45 8.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.863 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 8.6 t -110.04 133.84 54.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.165 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -156.97 139.1 14.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.946 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . 0.446 ' O ' ' C ' ' A' ' 477' ' ' LYS . 1.6 pp -81.1 136.92 35.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.925 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 476' ' ' LEU . 21.7 tptt . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm . . . . . 0 N--CA 1.458 -0.056 0 CA-C-O 120.818 0.342 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.42 -176.76 3.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.946 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -110.73 -154.42 13.73 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.47 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -48.06 176.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.717 2.278 . . . . 0.0 112.263 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . 0.441 ' CD ' ' O ' ' A' ' 399' ' ' GLU . 0.2 OUTLIER -83.24 83.58 7.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.926 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 144.65 -14.77 2.0 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.468 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . 0.471 ' HB1' ' N ' ' A' ' 452' ' ' PRO . . . -98.2 126.5 43.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.815 0.34 . . . . 0.0 111.145 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . 0.437 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 29.3 m-80 -159.41 162.45 35.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . 0.573 HD12 ' CE1' ' A' ' 449' ' ' TYR . 28.6 mt -159.78 109.18 1.82 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . 0.432 ' CE1' ' CD1' ' A' ' 446' ' ' PHE . 19.2 m-85 -112.63 114.81 27.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . 0.444 ' CG1' ' CZ ' ' A' ' 421' ' ' PHE . 3.9 mp -90.87 135.72 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.113 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . 0.41 ' CD1' ' HB2' ' A' ' 444' ' ' PHE . 89.9 m-85 -130.22 168.25 17.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.952 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 32.6 m-70 61.4 48.68 5.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 38.0 mt -95.71 148.32 34.39 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.592 0.71 . . . . 0.0 110.914 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.566 ' HG2' ' CD1' ' A' ' 412' ' ' PHE . 59.9 Cg_endo -73.35 -169.77 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.699 2.266 . . . . 0.0 112.329 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -95.21 -38.01 10.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.932 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . 0.416 ' OE1' ' C ' ' A' ' 411' ' ' GLU . 0.3 OUTLIER -58.37 -32.45 68.58 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.922 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.566 ' CD1' ' HG2' ' A' ' 409' ' ' PRO . 4.1 m-85 -62.01 158.81 15.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -142.82 -140.74 3.76 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.547 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -88.65 -48.83 7.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.738 0.304 . . . . 0.0 110.876 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . 0.463 ' O ' ' N ' ' A' ' 418' ' ' LEU . 19.9 mp0 -64.43 -58.23 7.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.963 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 415' ' ' GLN . 35.9 m-20 -34.43 -56.6 0.52 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.899 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 24.3 tp -53.34 -43.42 67.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . 0.463 ' N ' ' O ' ' A' ' 415' ' ' GLN . 11.1 tp -65.04 -51.56 60.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.962 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -69.48 -9.85 55.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.951 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 2.8 ttm -89.79 -25.55 21.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.902 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . 0.444 ' CZ ' ' CG1' ' A' ' 405' ' ' ILE . 5.2 m-85 -104.57 -12.16 16.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.937 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' MET . . . . . 0.577 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 7.6 mtt -57.38 -46.12 99.83 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.56 0.695 . . . . 0.0 110.823 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 422' ' ' MET . 64.5 Cg_exo -47.94 -39.63 32.48 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.71 2.273 . . . . 0.0 112.31 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . 0.569 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 73.4 m-85 -68.23 -35.67 78.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.905 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 172.16 -173.84 45.29 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.487 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.94 114.56 12.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.86 0.362 . . . . 0.0 110.905 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 98.2 t -84.79 124.4 39.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.153 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . 0.416 HG23 ' C ' ' A' ' 449' ' ' TYR . 17.1 t -70.93 -54.05 19.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.08 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 14.6 m -148.63 136.57 20.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.859 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -144.35 134.46 24.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.132 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . 0.423 ' CG ' ' N ' ' A' ' 432' ' ' VAL . 20.6 tttt -159.97 159.29 32.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.888 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.431 HG12 ' N ' ' A' ' 433' ' ' PHE . 38.8 t -111.03 144.64 18.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.165 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . 0.558 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 7.5 m-85 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . 0.407 ' O ' ' SG ' ' A' ' 443' ' ' CYS . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.714 0.292 . . . . 0.0 110.819 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . 0.584 ' CD1' ' C ' ' A' ' 444' ' ' PHE . 1.1 p90 -161.71 145.65 12.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.876 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -139.25 179.16 18.94 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.534 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . 0.432 ' CD1' ' CE1' ' A' ' 404' ' ' PHE . 26.7 t80 -116.93 150.59 38.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.888 0.375 . . . . 0.0 110.875 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . 0.403 HG13 ' N ' ' A' ' 448' ' ' SER . 21.0 t -153.91 143.15 13.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.117 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 448' ' ' SER . . . . . 0.403 ' N ' HG13 ' A' ' 447' ' ' VAL . 99.8 p -139.05 141.85 38.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.865 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . 0.573 ' CE1' HD12 ' A' ' 403' ' ' LEU . 3.2 m-85 -108.92 175.18 5.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.912 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -69.59 -20.21 63.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.821 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -153.95 155.69 31.39 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.687 0.756 . . . . 0.0 110.836 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . 0.471 ' N ' ' HB1' ' A' ' 401' ' ' ALA . 59.6 Cg_endo -72.91 -15.65 26.28 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.686 2.258 . . . . 0.0 112.319 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 97.3 t -74.74 -43.09 47.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.134 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 1.9 t -75.61 -41.95 53.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.886 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -47.76 -42.78 26.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.153 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -59.16 -46.44 88.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.925 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -37.75 -44.34 0.72 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.1 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . 0.569 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -64.28 -69.73 0.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.157 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . 0.405 ' O ' ' C ' ' A' ' 460' ' ' GLN . 93.9 mt -40.33 -47.43 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.167 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 459' ' ' ILE . 40.7 mt-30 -38.04 -51.7 1.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.89 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 17.4 t -93.94 -54.87 3.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.839 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 462' ' ' MET . . . . . 0.463 ' O ' ' N ' ' A' ' 465' ' ' PHE . 77.5 mmm -43.7 -51.46 7.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.872 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 462' ' ' MET . 36.7 t-20 -38.17 105.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.921 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 472' ' ' LEU . . . 78.92 33.59 36.55 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.508 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . 0.463 ' N ' ' O ' ' A' ' 462' ' ' MET . 83.2 t80 -73.92 117.97 16.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.81 0.338 . . . . 0.0 110.907 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 5.2 tm0? -66.32 104.55 1.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.953 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 12.4 tt -117.65 139.33 45.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.114 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 49.54 -95.93 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.472 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 6.5 ptp -131.43 0.42 4.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.853 0.359 . . . . 0.0 110.914 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.7 172.93 11.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 48.2 mtt85 -100.91 167.32 10.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.887 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . 0.435 ' O ' ' N ' ' A' ' 464' ' ' GLY . 58.5 mt -114.81 152.98 31.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.005 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -130.69 106.62 8.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 15.6 t -112.44 131.88 62.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.121 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -154.4 137.77 15.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 477' ' ' LYS . 1.6 pp -79.5 132.84 36.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.856 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 476' ' ' LEU . 55.7 tttt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.886 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.497 ' O ' ' CB ' ' A' ' 429' ' ' SER . 9.8 ptmt . . . . . 0 N--CA 1.458 -0.032 0 CA-C-O 120.727 0.299 . . . . 0.0 110.905 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -128.67 -175.73 3.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -100.48 -146.38 19.25 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.468 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.53 151.41 41.99 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.698 2.265 . . . . 0.0 112.314 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -51.46 104.01 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 130.58 -24.85 4.32 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.445 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . 0.494 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -98.02 126.98 43.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.341 . . . . 0.0 111.098 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 16.6 m-80 -158.98 164.29 35.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.874 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . 0.562 HD13 ' CE1' ' A' ' 449' ' ' TYR . 34.5 mt -158.05 124.83 4.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.917 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . 0.493 ' CZ ' ' CD1' ' A' ' 446' ' ' PHE . 35.5 m-85 -130.96 113.32 13.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.846 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . 0.459 HG23 ' CG ' ' A' ' 408' ' ' LEU . 3.2 mp -90.75 136.09 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.122 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . 0.407 ' N ' HG21 ' A' ' 405' ' ' ILE . 62.4 m-85 -127.74 159.77 33.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 28.8 m-70 60.14 54.99 3.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.855 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . 0.459 ' CG ' HG23 ' A' ' 405' ' ' ILE . 19.3 mt -93.8 140.73 23.1 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.534 0.683 . . . . 0.0 110.943 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.565 ' HG2' ' CE1' ' A' ' 412' ' ' PHE . 77.6 Cg_exo -49.83 -173.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.67 2.247 . . . . 0.0 112.334 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -96.3 -35.62 11.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.953 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 25.3 pm0 -76.16 -13.77 60.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.858 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.565 ' CE1' ' HG2' ' A' ' 409' ' ' PRO . 5.3 m-85 -71.81 129.05 37.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -120.31 -152.93 9.04 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.44 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.48 -57.88 3.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.743 0.306 . . . . 0.0 110.886 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -54.9 -51.97 64.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.886 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -42.29 -58.57 2.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.833 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 44.8 tp -54.19 -45.8 72.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.927 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 18.2 tp -54.72 -55.39 30.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.865 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -72.89 -9.29 58.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.882 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -82.68 -20.85 35.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -115.18 -12.22 11.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.878 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 422' ' ' MET . . . . . 0.579 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 18.0 mtt -54.05 -45.84 98.9 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.611 0.719 . . . . 0.0 110.882 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.2 Cg_exo -48.05 -35.14 25.0 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.613 2.208 . . . . 0.0 112.335 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . 0.536 ' CZ ' ' SD ' ' A' ' 462' ' ' MET . 72.2 m-85 -73.89 -30.18 62.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 167.63 -171.87 42.3 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.502 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -77.91 98.77 5.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.888 0.375 . . . . 0.0 110.878 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 90.6 t -67.98 114.97 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.12 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . 0.425 HG23 ' C ' ' A' ' 449' ' ' TYR . 17.8 t -66.18 -45.54 89.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.121 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 429' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 30.8 t -135.87 144.58 45.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.821 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -157.17 106.36 2.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.075 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . 0.421 ' C ' ' HD3' ' A' ' 431' ' ' LYS . 1.1 tmtp? -142.5 143.98 32.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.895 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 66.2 t -113.75 148.59 16.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.102 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.934 -179.985 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 30.4 p . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.818 0.342 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -161.29 151.93 18.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.879 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -152.57 176.82 30.62 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.495 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . 0.493 ' CD1' ' CZ ' ' A' ' 404' ' ' PHE . 56.5 t80 -115.96 155.84 27.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.905 0.383 . . . . 0.0 110.885 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 446' ' ' PHE . 53.5 t -158.69 152.43 6.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.18 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 29.6 p -151.06 152.23 33.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.856 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . 0.562 ' CE1' HD13 ' A' ' 403' ' ' LEU . 4.5 m-85 -117.82 -177.51 3.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.895 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.48 -12.73 60.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . 0.459 ' OD1' ' N ' ' A' ' 451' ' ' ASN . 0.5 OUTLIER -159.25 159.99 28.66 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.627 0.727 . . . . 0.0 110.902 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . 0.458 ' N ' ' HB1' ' A' ' 401' ' ' ALA . 61.1 Cg_endo -75.23 -19.69 17.14 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.67 2.247 . . . . 0.0 112.379 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 60.3 t -72.94 -43.38 59.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.09 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 16.2 m -75.8 -44.7 39.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.873 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -52.25 -34.88 48.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.152 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -63.82 -44.35 93.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.904 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -41.8 -40.19 1.99 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.088 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . 0.477 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -62.39 -68.5 0.32 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.089 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . 0.444 ' O ' ' CB ' ' A' ' 463' ' ' ASN . 66.8 mt -45.71 -46.02 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.188 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -38.82 -50.48 1.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 2.8 m -97.12 -56.84 2.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.892 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 462' ' ' MET . . . . . 0.536 ' SD ' ' CZ ' ' A' ' 424' ' ' PHE . 81.1 mmm -42.64 -45.44 4.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.853 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . 0.444 ' CB ' ' O ' ' A' ' 459' ' ' ILE . 9.5 t30 -43.89 108.19 0.11 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.869 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 78.32 30.49 49.85 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.466 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -68.11 115.37 7.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.817 0.341 . . . . 0.0 110.894 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 18.6 tm0? -67.25 107.96 2.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.943 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 19.2 tt -126.22 126.31 69.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.108 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 64.26 -103.68 0.77 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.514 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 56.7 mtp -124.12 0.87 8.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.842 0.353 . . . . 0.0 110.9 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -131.18 -179.82 5.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.894 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 39.2 mtt-85 -112.68 164.39 13.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.881 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 65.8 mt -103.09 152.34 21.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.9 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 17.9 tttm -130.31 99.94 5.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.885 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 3.2 t -108.82 140.63 26.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.169 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -157.07 147.48 21.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.921 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . 0.48 ' O ' ' CD1' ' A' ' 476' ' ' LEU . 1.3 pp -94.25 127.21 39.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.923 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 476' ' ' LEU . 31.9 tttm . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.698 0.285 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -138.95 174.67 10.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.864 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -98.0 -145.27 18.6 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.51 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.57 153.33 43.99 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.736 2.291 . . . . 0.0 112.358 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 15.1 tm-20 -54.98 110.64 0.69 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.899 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 129.22 -27.7 4.2 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.474 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . 0.491 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.94 126.77 43.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.774 0.321 . . . . 0.0 111.086 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.6 OUTLIER -158.99 160.32 35.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.861 -179.918 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . 0.43 HD11 ' CD1' ' A' ' 449' ' ' TYR . 38.7 mt -159.61 114.24 2.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.902 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . 0.641 ' CZ ' ' CD1' ' A' ' 446' ' ' PHE . 42.6 m-85 -122.23 111.91 17.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.9 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . 0.494 HG12 ' CZ ' ' A' ' 421' ' ' PHE . 3.6 mp -91.65 134.99 28.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.152 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -124.56 169.29 12.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.922 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 57.47 44.43 21.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.832 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 30.4 mt -91.09 134.55 29.83 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.625 0.726 . . . . 0.0 110.886 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -48.77 -179.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.683 2.255 . . . . 0.0 112.377 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -85.16 -46.06 11.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.9 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -58.88 -36.04 73.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.925 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -55.4 116.91 3.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.844 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -107.48 -151.88 17.44 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.436 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.96 -44.22 40.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.779 0.323 . . . . 0.0 110.877 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . 0.407 ' O ' ' C ' ' A' ' 416' ' ' ASP . 3.4 mp0 -62.88 -56.88 13.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.923 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . 0.407 ' C ' ' O ' ' A' ' 415' ' ' GLN . 36.3 m-20 -36.99 -64.92 0.33 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 17.5 tp -42.73 -46.5 5.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.958 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . 0.453 ' O ' ' CG ' ' A' ' 422' ' ' MET . 14.9 tp -63.69 -37.41 87.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.913 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -80.44 -16.04 55.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.885 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 2.7 tpp -87.17 -30.43 21.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.881 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . 0.598 ' CE1' ' SD ' ' A' ' 462' ' ' MET . 4.6 m-85 -98.44 -25.55 14.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 422' ' ' MET . . . . . 0.546 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 0.3 OUTLIER -45.23 -47.94 33.17 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.541 0.686 . . . . 0.0 110.926 179.948 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . 0.546 ' CD ' ' N ' ' A' ' 422' ' ' MET . 63.9 Cg_exo -47.95 -46.12 22.84 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.722 2.281 . . . . 0.0 112.408 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . 0.436 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 90.1 m-85 -64.57 -33.96 77.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.854 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 169.03 163.58 23.31 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.541 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -56.46 118.47 4.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.863 0.363 . . . . 0.0 110.906 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 41.7 t -88.19 123.98 41.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.171 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 65.1 t -75.8 -36.11 32.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.09 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.39 143.14 32.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.859 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -160.82 111.68 1.8 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.151 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -157.48 143.5 17.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.952 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.442 HG13 ' N ' ' A' ' 433' ' ' PHE . 78.5 t -94.12 146.48 6.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.166 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . 0.461 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.4 m-30 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.798 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 26.8 p . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.865 0.364 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . 0.461 ' CE1' ' HB2' ' A' ' 433' ' ' PHE . 8.9 p90 -162.07 144.24 11.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.92 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -135.16 168.29 23.79 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.491 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . 0.641 ' CD1' ' CZ ' ' A' ' 404' ' ' PHE . 26.7 t80 -109.3 151.64 26.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.919 0.39 . . . . 0.0 110.913 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . 0.47 HG13 ' N ' ' A' ' 448' ' ' SER . 23.0 t -155.42 144.81 12.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.104 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 448' ' ' SER . . . . . 0.47 ' N ' HG13 ' A' ' 447' ' ' VAL . 1.8 m -143.22 141.06 30.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.896 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . 0.43 ' CD1' HD11 ' A' ' 403' ' ' LEU . 6.1 m-85 -107.43 176.61 5.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.913 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -72.01 -29.65 64.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.882 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -140.98 153.52 67.37 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.71 0.766 . . . . 0.0 110.871 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.39 0.12 8.46 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.716 2.277 . . . . 0.0 112.376 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 87.7 t -88.76 -37.66 10.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.131 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 22.9 t -78.88 -41.5 29.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.819 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -49.1 -37.0 20.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.177 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -62.25 -52.22 64.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.969 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -37.82 -45.67 0.86 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.106 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . 0.436 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -62.92 -62.96 1.37 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.108 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . 0.436 ' O ' ' C ' ' A' ' 460' ' ' GLN . 70.0 mt -47.43 -48.01 9.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.163 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . 0.436 ' C ' ' O ' ' A' ' 459' ' ' ILE . 49.7 mt-30 -34.35 -45.6 0.23 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.841 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 1.9 m -103.46 -56.27 2.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.882 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 462' ' ' MET . . . . . 0.598 ' SD ' ' CE1' ' A' ' 421' ' ' PHE . 5.7 mmt -38.93 -45.74 1.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -59.8 89.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.904 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 114.16 -10.39 22.52 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.517 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -43.53 110.32 0.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.741 0.305 . . . . 0.0 110.945 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -63.22 105.75 0.77 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.863 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . 0.405 ' O ' ' CG2' ' A' ' 467' ' ' ILE . 15.4 tt -110.9 122.35 65.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.103 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 61.96 -100.42 0.29 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.568 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 9.7 mtt -120.13 -14.52 8.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.885 0.374 . . . . 0.0 110.842 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 31.2 pttt -117.16 179.47 4.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.933 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 50.1 mtt180 -107.23 173.44 6.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.863 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 94.4 mt -113.45 154.14 27.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -129.68 104.84 7.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.899 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 23.8 t -114.28 135.94 52.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.128 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 28.6 tp60 -157.06 143.63 18.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . 0.471 ' CB ' ' O ' ' A' ' 402' ' ' ASN . 1.5 pp -86.9 125.37 33.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.916 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 476' ' ' LEU . 26.0 tttm . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.912 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.414 ' O ' ' CB ' ' A' ' 429' ' ' SER . 18.8 mtpp . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.774 0.321 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -121.53 -177.44 3.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.85 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -103.74 -163.31 25.09 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.518 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -49.45 157.84 2.0 Allowed 'Trans proline' 0 C--N 1.34 0.128 0 C-N-CA 122.683 2.255 . . . . 0.0 112.312 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -66.37 82.15 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.847 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 148.18 -18.2 1.36 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.495 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . 0.511 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -106.93 126.75 52.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.751 0.31 . . . . 0.0 111.08 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.3 OUTLIER -158.14 169.41 24.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.895 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . 0.541 HD13 ' CE1' ' A' ' 449' ' ' TYR . 16.3 mt -159.97 115.79 2.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.904 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . 0.545 ' CE1' ' CE1' ' A' ' 446' ' ' PHE . 25.3 m-85 -120.0 111.5 17.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.833 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . 0.48 HG12 ' CZ ' ' A' ' 421' ' ' PHE . 2.9 mp -91.01 136.01 25.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.16 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . 0.401 ' N ' HG22 ' A' ' 405' ' ' ILE . 8.8 m-85 -124.41 177.81 5.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.834 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . 0.462 ' N ' ' CD2' ' A' ' 407' ' ' HIS . 4.2 m170 47.74 54.2 10.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.885 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . 0.404 ' O ' ' O ' ' A' ' 409' ' ' PRO . 30.5 mt -96.62 140.86 22.38 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.575 0.703 . . . . 0.0 110.929 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.562 ' HG2' ' CE1' ' A' ' 412' ' ' PHE . 77.0 Cg_exo -49.81 -173.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.691 2.261 . . . . 0.0 112.32 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -95.52 -29.58 14.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -78.67 -20.29 50.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.949 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.562 ' CE1' ' HG2' ' A' ' 409' ' ' PRO . 5.4 m-85 -64.91 128.49 35.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.799 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . 0.426 ' O ' ' CG2' ' A' ' 432' ' ' VAL . . . -117.68 -139.93 6.42 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.507 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -88.01 -36.82 16.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.833 0.349 . . . . 0.0 110.898 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . 0.437 ' O ' ' N ' ' A' ' 418' ' ' LEU . 19.8 mm-40 -71.36 -58.26 3.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.913 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -37.96 -49.38 1.25 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.882 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 53.0 tp -58.59 -40.96 84.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.914 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 415' ' ' GLN . 20.7 tp -64.93 -58.15 6.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.897 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -66.77 -8.95 31.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.925 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -87.69 -27.36 22.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.833 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . 0.48 ' CZ ' HG12 ' A' ' 405' ' ' ILE . 3.4 m-85 -110.32 6.61 22.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.827 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 422' ' ' MET . . . . . 0.582 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 13.5 mtt -73.4 -45.76 7.66 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.549 0.69 . . . . 0.0 110.876 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 422' ' ' MET . 63.9 Cg_exo -47.96 -28.8 10.77 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.674 2.249 . . . . 0.0 112.418 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . 0.41 ' CE2' ' HA ' ' A' ' 458' ' ' ALA . 81.7 m-85 -76.7 -34.06 58.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.924 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 164.35 -163.63 36.21 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.488 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -72.68 134.77 45.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.889 0.376 . . . . 0.0 110.855 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 18.7 t -107.97 116.84 52.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.17 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 31.4 t -68.22 -55.34 16.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.181 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 429' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 0.9 OUTLIER -136.75 148.61 47.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.854 -179.864 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -161.06 120.1 2.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.117 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -161.09 141.88 11.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.92 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.426 ' CG2' ' O ' ' A' ' 413' ' ' GLY . 84.0 t -86.99 153.91 3.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.159 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . 0.558 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.3 m-30 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.934 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 31.3 p . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.785 0.326 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . 0.558 ' CE1' ' HB2' ' A' ' 433' ' ' PHE . 4.9 p90 -160.07 143.16 13.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -129.83 177.39 18.15 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.503 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . 0.545 ' CE1' ' CE1' ' A' ' 404' ' ' PHE . 20.2 t80 -119.35 152.67 36.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.956 0.408 . . . . 0.0 110.899 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 446' ' ' PHE . 77.9 t -159.03 153.75 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.063 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 79.0 p -151.53 144.35 24.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.857 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . 0.541 ' CE1' HD13 ' A' ' 403' ' ' LEU . 15.3 m-85 -107.84 -176.02 2.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.936 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.75 -16.72 55.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.937 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -150.93 155.15 35.12 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.608 0.718 . . . . 0.0 110.863 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . 0.48 ' N ' ' HB2' ' A' ' 401' ' ' ALA . 60.3 Cg_endo -73.95 -13.87 23.9 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.733 2.289 . . . . 0.0 112.378 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 37.2 t -78.89 -37.52 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.087 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 11.4 p -74.88 -50.95 15.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.887 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -40.84 -39.74 1.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.062 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . 0.4 ' O ' ' C ' ' A' ' 457' ' ' ALA . 45.6 mm-40 -56.66 -50.74 71.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.897 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 456' ' ' GLN . . . -36.91 -43.68 0.46 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.139 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . 0.41 ' HA ' ' CE2' ' A' ' 424' ' ' PHE . . . -62.81 -66.1 0.59 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.144 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . 0.443 ' O ' ' CB ' ' A' ' 463' ' ' ASN . 73.7 mt -46.94 -41.92 5.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.082 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -44.18 -49.14 9.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.9 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 45.2 t -98.12 -57.02 2.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.826 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 462' ' ' MET . . . . . 0.404 ' O ' ' N ' ' A' ' 465' ' ' PHE . 91.8 mmm -40.9 -47.6 2.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.882 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' A' ' 459' ' ' ILE . 26.5 t-20 -44.78 106.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.914 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 82.74 27.06 43.5 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.477 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . 0.404 ' N ' ' O ' ' A' ' 462' ' ' MET . 10.9 t80 -66.59 117.59 8.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.81 0.338 . . . . 0.0 110.844 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 11.6 tm0? -64.8 118.09 8.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.911 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . 0.459 ' O ' ' CG2' ' A' ' 467' ' ' ILE . 14.4 tt -140.58 120.71 13.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.097 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 69.07 -104.26 1.23 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.487 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 24.6 ttp -131.25 12.53 5.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.841 0.353 . . . . 0.0 110.875 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -138.81 -179.15 5.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.89 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 57.9 mtm180 -108.48 163.13 13.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 53.7 mt -109.85 148.99 30.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -124.46 128.28 48.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.871 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 32.5 t -133.95 133.81 56.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.09 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -157.13 136.34 11.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.905 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . 0.45 ' CB ' ' O ' ' A' ' 402' ' ' ASN . 1.5 pp -79.19 128.61 33.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.937 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 476' ' ' LEU . 46.7 tttm . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.915 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.747 0.308 . . . . 0.0 110.919 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -142.74 -177.59 5.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.922 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -83.49 -147.01 7.2 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.521 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.9 151.53 40.14 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.721 2.28 . . . . 0.0 112.309 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -52.37 107.83 0.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.932 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 131.32 -28.57 3.6 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.463 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . 0.495 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.86 126.83 43.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.749 0.309 . . . . 0.0 111.07 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . 0.496 ' O ' ' CB ' ' A' ' 476' ' ' LEU . 0.6 OUTLIER -158.83 163.72 36.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.82 -179.932 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . 0.557 HD12 ' CE1' ' A' ' 449' ' ' TYR . 23.7 mt -160.35 108.03 1.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.899 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . 0.554 ' CE1' ' HB2' ' A' ' 477' ' ' LYS . 5.3 m-85 -111.83 117.41 32.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.871 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . 0.558 HD12 ' CZ ' ' A' ' 421' ' ' PHE . 1.4 mm -90.88 135.49 26.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.103 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . 0.452 ' C ' ' CD2' ' A' ' 407' ' ' HIS . 81.6 m-85 -126.57 148.89 49.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.932 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . 0.494 ' N ' ' O ' ' A' ' 443' ' ' CYS . 12.6 m-70 71.66 54.66 0.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.872 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 31.6 mt -100.38 132.49 22.42 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.637 0.732 . . . . 0.0 110.932 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -47.84 178.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.722 2.282 . . . . 0.0 112.376 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 18.9 tp60 -88.16 -39.09 14.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.938 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -60.18 -36.96 78.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -53.98 150.79 7.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -138.24 -145.34 4.82 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.494 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -79.72 -59.65 2.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.761 0.315 . . . . 0.0 110.934 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 -58.0 -53.76 54.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -38.89 -49.8 1.68 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.858 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 40.8 tp -59.47 -49.41 77.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.903 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 54.9 tp -56.92 -56.01 27.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.925 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -60.24 -12.07 7.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.983 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 4.9 ttm -92.94 -23.59 18.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.904 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . 0.558 ' CZ ' HD12 ' A' ' 405' ' ' ILE . 7.0 m-85 -109.97 6.6 23.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 422' ' ' MET . . . . . 0.586 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 4.6 mtt -75.55 -45.78 4.29 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.622 0.725 . . . . 0.0 110.879 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.0 Cg_exo -47.97 -46.68 21.22 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.7 2.267 . . . . 0.0 112.325 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -59.4 -35.73 74.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.838 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 172.75 -171.9 44.67 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.501 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -81.53 102.59 10.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.842 0.353 . . . . 0.0 110.925 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 62.0 t -72.77 134.15 30.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.158 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . 0.419 HG23 ' C ' ' A' ' 449' ' ' TYR . 17.9 t -79.05 -48.5 21.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.107 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 1.3 m -146.69 143.44 28.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.842 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -153.86 116.95 4.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.172 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -150.61 137.93 19.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.896 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 57.8 t -87.3 155.25 3.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.105 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . 0.539 ' CG ' ' CE1' ' A' ' 444' ' ' PHE . 3.1 m-85 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . 0.494 ' O ' ' N ' ' A' ' 407' ' ' HIS . 26.6 p . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.843 0.354 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . 0.539 ' CE1' ' CG ' ' A' ' 433' ' ' PHE . 11.1 p90 -160.53 145.7 14.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.851 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -133.16 176.39 19.6 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.521 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -121.23 141.45 50.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.963 0.411 . . . . 0.0 110.818 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 54.7 t -148.69 147.41 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.169 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 51.7 p -142.53 149.99 39.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.93 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . 0.557 ' CE1' HD12 ' A' ' 403' ' ' LEU . 3.3 m-85 -113.11 -174.87 2.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.945 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -81.32 -19.23 43.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.939 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -154.41 154.95 30.29 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.608 0.718 . . . . 0.0 110.898 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . 0.437 ' N ' ' HB3' ' A' ' 401' ' ' ALA . 61.4 Cg_endo -75.72 -10.12 19.98 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.721 2.281 . . . . 0.0 112.359 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 97.8 t -82.63 -29.28 8.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.154 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 68.1 m -90.86 -35.44 14.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.791 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -57.14 -35.22 69.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.041 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -61.1 -38.93 88.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.911 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -47.81 -39.39 18.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.12 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -64.38 -68.4 0.36 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.081 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . 0.463 ' O ' ' CB ' ' A' ' 463' ' ' ASN . 95.2 mt -42.5 -45.32 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.206 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 -41.87 -45.28 3.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 2.9 t -101.47 -57.01 2.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.855 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 462' ' ' MET . . . . . 0.41 ' O ' ' N ' ' A' ' 465' ' ' PHE . 91.8 mmm -43.77 -44.68 6.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.911 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 459' ' ' ILE . 19.4 t-20 -44.95 108.0 0.11 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 82.1 25.45 52.02 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.444 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . 0.41 ' N ' ' O ' ' A' ' 462' ' ' MET . 18.0 t80 -64.34 109.25 1.85 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.809 0.337 . . . . 0.0 110.882 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 7.4 tm0? -63.12 114.79 3.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.875 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 17.9 tt -127.59 126.48 67.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.179 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 61.11 -96.79 0.11 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.467 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 33.0 ttp -129.44 -5.4 4.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.879 0.371 . . . . 0.0 110.896 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 15.6 pttm -121.45 176.23 5.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.871 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 28.1 mtm180 -108.56 169.3 8.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.925 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . 0.401 HD13 ' CD1' ' A' ' 465' ' ' PHE . 93.3 mt -115.54 158.32 22.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.904 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 33.8 tttp -137.76 107.54 6.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.928 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . 0.47 HG13 ' CD1' ' A' ' 405' ' ' ILE . 61.5 t -109.51 135.04 49.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.074 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -156.38 139.81 15.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . 0.496 ' CB ' ' O ' ' A' ' 402' ' ' ASN . 1.6 pp -83.5 129.91 34.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.554 ' HB2' ' CE1' ' A' ' 404' ' ' PHE . 59.2 tttt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.933 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.421 ' O ' ' CB ' ' A' ' 429' ' ' SER . 13.8 ptpt . . . . . 0 N--CA 1.458 -0.064 0 CA-C-O 120.794 0.331 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . 0.465 ' HA ' ' CB ' ' A' ' 448' ' ' SER . 15.2 pt-20 -131.48 -176.44 4.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.916 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -99.82 -146.87 20.6 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.52 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.07 150.85 49.01 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.722 2.281 . . . . 0.0 112.358 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -50.89 97.93 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.874 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 137.61 -25.24 2.99 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.432 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . 0.486 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -98.21 126.84 43.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.836 0.35 . . . . 0.0 111.131 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 22.0 m-80 -159.17 161.29 36.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.903 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . 0.564 HD12 ' CE1' ' A' ' 449' ' ' TYR . 27.7 mt -159.76 113.8 2.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.944 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . 0.766 ' CZ ' ' CD1' ' A' ' 446' ' ' PHE . 46.6 m-85 -123.02 113.68 19.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 4.6 mp -90.97 136.89 22.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.097 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . 0.442 ' CD2' ' O ' ' A' ' 473' ' ' LYS . 10.9 m-85 -127.69 153.69 46.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.962 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 69.29 52.64 0.47 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.856 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 19.4 mt -96.13 131.85 27.99 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.594 0.712 . . . . 0.0 110.918 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -48.16 167.9 0.1 OUTLIER 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.678 2.252 . . . . 0.0 112.362 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -70.26 -44.06 69.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.977 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -61.46 -39.65 91.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -54.32 112.42 0.98 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.862 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -104.67 -140.15 10.3 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.475 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.51 -60.76 2.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.808 0.337 . . . . 0.0 110.897 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . 0.469 ' O ' ' N ' ' A' ' 418' ' ' LEU . 1.6 mp0 -53.72 -61.59 2.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 415' ' ' GLN . 35.3 m-20 -34.47 -58.76 0.48 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.841 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 66.2 tp -51.53 -41.83 61.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.9 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' A' ' 415' ' ' GLN . 12.7 tp -67.64 -56.03 10.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.939 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -56.74 -13.14 2.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.971 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 3.0 tpp -86.23 -31.18 21.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . 0.43 ' C ' ' HD2' ' A' ' 423' ' ' PRO . 5.2 m-85 -95.38 -26.66 15.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.838 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 422' ' ' MET . . . . . 0.547 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 0.2 OUTLIER -46.14 -47.66 43.93 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.531 0.681 . . . . 0.0 110.846 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . 0.547 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.2 Cg_exo -47.96 -42.99 31.12 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.717 2.278 . . . . 0.0 112.315 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . 0.404 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 64.6 m-85 -67.54 -35.06 78.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.878 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 172.08 -169.35 42.46 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.49 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -75.99 122.25 23.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.803 0.335 . . . . 0.0 110.921 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . 0.425 HG13 ' CG1' ' A' ' 447' ' ' VAL . 84.1 t -95.15 115.23 33.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.191 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . 0.402 HG23 ' C ' ' A' ' 449' ' ' TYR . 54.1 t -69.4 -43.29 81.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.132 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 429' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 1.5 t -134.53 144.07 47.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -161.07 107.11 1.41 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.139 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . 0.413 ' C ' ' HD2' ' A' ' 431' ' ' LYS . 0.1 OUTLIER -153.29 149.72 28.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 72.9 t -103.76 142.1 18.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.097 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . 0.51 ' CG ' ' CE1' ' A' ' 444' ' ' PHE . 3.1 m-85 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.875 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 72.0 m . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.876 0.37 . . . . 0.0 110.822 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . 0.51 ' CE1' ' CG ' ' A' ' 433' ' ' PHE . 5.4 p90 -162.18 137.62 7.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.842 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -131.73 169.67 21.88 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.498 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . 0.766 ' CD1' ' CZ ' ' A' ' 404' ' ' PHE . 22.2 t80 -111.54 150.01 30.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.859 0.361 . . . . 0.0 110.918 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . 0.425 ' CG1' HG13 ' A' ' 427' ' ' VAL . 85.5 t -155.14 145.21 13.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.121 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 448' ' ' SER . . . . . 0.465 ' CB ' ' HA ' ' A' ' 396' ' ' GLU . 1.9 m -144.42 140.85 29.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.91 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . 0.564 ' CE1' HD12 ' A' ' 403' ' ' LEU . 3.6 m-85 -102.94 179.79 4.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.942 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -75.82 -25.88 56.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.938 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -147.05 158.56 44.68 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.558 0.694 . . . . 0.0 110.912 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.65 -12.69 20.25 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.713 2.275 . . . . 0.0 112.3 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 92.4 t -77.37 -38.56 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.147 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 1.5 t -83.37 -39.61 20.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.882 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -53.1 -43.23 66.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.076 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -59.08 -42.48 90.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.934 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -43.08 -38.84 2.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.126 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . 0.404 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -66.7 -61.74 1.81 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.121 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 67.1 mt -47.53 -45.45 10.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.115 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -37.68 -47.77 1.0 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 2.8 m -103.03 -56.98 2.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.899 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 88.4 mmm -39.72 -44.56 1.57 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.844 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -46.18 110.3 0.26 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.872 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 74.12 35.28 53.73 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.516 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . 0.417 ' CD1' ' C ' ' A' ' 465' ' ' PHE . 9.5 t80 -68.72 117.4 10.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.818 0.342 . . . . 0.0 110.905 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 11.2 tm0? -63.77 115.19 4.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.91 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 14.6 tt -138.11 132.94 43.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.094 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 51.25 -108.52 0.58 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.474 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 26.0 mtt -127.26 24.82 6.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.829 0.347 . . . . 0.0 110.844 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 7.8 pttt -142.43 -178.43 5.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.894 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 33.3 mtm-85 -125.13 121.91 35.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.911 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 45.0 mt -65.7 152.06 45.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.952 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . 0.442 ' O ' ' CD2' ' A' ' 406' ' ' TYR . 18.5 ttmm -132.6 100.49 4.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.88 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 21.1 t -107.56 136.75 41.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.203 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -156.52 145.89 20.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.87 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . 0.476 ' O ' ' CD1' ' A' ' 476' ' ' LEU . 1.4 pp -91.04 126.2 36.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 476' ' ' LEU . 16.9 ttpp . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.892 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.5 ' O ' ' CB ' ' A' ' 429' ' ' SER . 17.8 ptpt . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.778 0.323 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -109.71 -178.9 3.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.865 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -105.16 -155.45 22.52 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.555 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.13 157.58 8.25 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.729 2.286 . . . . 0.0 112.374 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -65.85 78.43 0.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.919 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 153.83 -16.69 0.63 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.456 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . 0.505 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -106.49 126.7 52.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.765 0.316 . . . . 0.0 111.111 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . 0.505 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.2 OUTLIER -158.15 168.91 25.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.884 -179.901 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . 0.569 HD12 ' CE1' ' A' ' 449' ' ' TYR . 27.7 mt -160.06 119.84 2.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.864 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . 0.527 ' CE1' ' HB2' ' A' ' 477' ' ' LYS . 15.0 m-85 -124.42 113.45 18.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.4 mp -91.15 133.95 31.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.151 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -125.75 162.27 25.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.935 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . 0.491 ' N ' ' O ' ' A' ' 443' ' ' CYS . 25.0 m-70 61.01 54.61 3.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.908 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 30.3 mt -99.87 144.91 29.24 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.668 0.747 . . . . 0.0 110.838 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.55 ' HG2' ' CD1' ' A' ' 412' ' ' PHE . 61.5 Cg_endo -76.47 164.96 29.92 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.711 2.274 . . . . 0.0 112.274 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -69.35 -38.63 78.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.918 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -54.46 -36.48 64.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.55 ' CD1' ' HG2' ' A' ' 409' ' ' PRO . 4.7 m-85 -67.65 138.64 56.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.934 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -123.48 -137.0 4.88 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.474 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -87.81 -56.97 3.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.772 0.32 . . . . 0.0 110.909 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . 0.444 ' O ' ' N ' ' A' ' 418' ' ' LEU . 26.9 mm-40 -58.4 -57.03 14.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.95 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' A' ' 415' ' ' GLN . 53.0 m-20 -34.87 -59.23 0.49 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.866 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 51.5 tp -51.29 -42.63 61.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.906 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 415' ' ' GLN . 10.8 tp -65.84 -46.33 78.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.904 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -68.18 -16.24 63.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.973 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 2.0 ttt -85.35 -35.01 21.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.917 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . 0.468 ' CE1' ' SD ' ' A' ' 462' ' ' MET . 3.8 m-85 -92.69 -22.72 19.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.839 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 422' ' ' MET . . . . . 0.574 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 0.3 OUTLIER -50.87 -45.62 87.24 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.563 0.697 . . . . 0.0 110.96 179.951 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.4 Cg_exo -47.98 -38.84 32.17 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.662 2.242 . . . . 0.0 112.372 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . 0.503 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 78.1 m-85 -70.88 -35.28 72.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.898 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 164.58 -178.96 39.59 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.523 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 -61.86 135.11 57.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.812 0.339 . . . . 0.0 110.834 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 24.2 t -111.47 124.83 68.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.117 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 19.1 t -69.64 -50.35 50.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.209 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 429' ' ' SER . . . . . 0.5 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 4.5 t -137.69 148.7 45.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.826 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -160.59 107.74 1.55 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.106 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -150.96 143.81 24.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 99.3 t -94.43 152.49 3.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.048 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . 0.412 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.5 m-30 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.931 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . 0.491 ' O ' ' N ' ' A' ' 407' ' ' HIS . 30.3 p . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.806 0.336 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . 0.412 ' CE1' ' HB2' ' A' ' 433' ' ' PHE . 8.2 p90 -161.89 147.55 13.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.939 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -138.36 179.07 18.78 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.524 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . 0.503 ' O ' ' CG2' ' A' ' 447' ' ' VAL . 55.6 t80 -118.79 153.71 34.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.831 0.348 . . . . 0.0 110.936 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . 0.503 ' CG2' ' O ' ' A' ' 446' ' ' PHE . 94.3 t -161.02 153.56 4.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.176 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 448' ' ' SER . . . . . 0.464 ' N ' HG11 ' A' ' 447' ' ' VAL . 65.7 p -153.12 148.39 26.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.876 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . 0.569 ' CE1' HD12 ' A' ' 403' ' ' LEU . 5.9 m-85 -110.43 -174.93 2.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.966 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -78.22 -25.55 47.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.817 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -146.87 158.28 45.73 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.66 0.743 . . . . 0.0 110.898 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . 0.468 ' CA ' ' HB3' ' A' ' 401' ' ' ALA . 61.2 Cg_endo -75.5 0.24 9.33 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.714 2.276 . . . . 0.0 112.317 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 75.5 t -88.5 -36.03 8.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.146 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 71.3 m -83.63 -39.94 19.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.88 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -50.66 -33.31 21.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.1 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -69.15 -45.55 69.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -41.6 -44.49 3.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.089 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . 0.503 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -63.85 -64.3 0.93 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.086 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . 0.41 ' O ' ' C ' ' A' ' 460' ' ' GLN . 65.9 mt -41.46 -47.15 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.171 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 459' ' ' ILE . 14.4 mm100 -36.89 -60.33 0.63 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.94 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 13.3 t -87.0 -52.93 5.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.884 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 462' ' ' MET . . . . . 0.468 ' SD ' ' CE1' ' A' ' 421' ' ' PHE . 7.5 mmt -40.43 -56.86 1.93 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -42.45 107.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.912 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 80.12 32.92 34.13 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.507 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -75.77 110.96 10.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.775 0.322 . . . . 0.0 110.891 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 12.6 tm0? -63.08 102.9 0.41 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.918 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . 0.449 HD13 ' CE1' ' A' ' 412' ' ' PHE . 16.1 tt -115.27 144.52 22.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.154 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 46.68 -95.94 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.498 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 4.6 tpt -130.22 -3.47 4.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.791 0.329 . . . . 0.0 110.869 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 11.7 pttm -125.26 -178.53 4.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.88 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 66.9 mtm-85 -108.25 172.38 6.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.843 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 82.8 mt -120.52 156.92 30.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.952 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 32.4 tttp -136.15 105.03 5.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.898 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 12.1 t -113.76 133.2 60.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.171 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -155.23 138.2 15.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . 0.455 ' O ' ' C ' ' A' ' 477' ' ' LYS . 1.6 pp -79.03 129.14 34.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.527 ' HB2' ' CE1' ' A' ' 404' ' ' PHE . 31.8 tttt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.909 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 4.1 ptmm? . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.821 0.343 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -148.18 179.01 8.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -98.47 -146.0 19.76 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.491 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.19 155.05 46.99 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.648 2.232 . . . . 0.0 112.317 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -55.12 118.75 4.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.87 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 120.21 -27.4 6.7 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.527 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . 0.493 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.97 126.95 43.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.769 0.318 . . . . 0.0 111.06 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . 0.493 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.7 OUTLIER -158.87 165.02 35.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . 0.567 HD13 ' CE1' ' A' ' 449' ' ' TYR . 15.5 mt -159.34 122.04 3.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.941 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . 0.465 ' CE1' ' CD1' ' A' ' 446' ' ' PHE . 29.1 m-85 -128.94 111.56 13.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . 0.424 HG23 ' CD2' ' A' ' 408' ' ' LEU . 3.9 mp -91.17 135.2 27.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.155 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . 0.407 ' CD1' ' HB2' ' A' ' 444' ' ' PHE . 89.5 m-85 -125.74 163.25 23.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.986 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . 0.421 ' N ' ' O ' ' A' ' 443' ' ' CYS . 29.2 m-70 61.48 52.98 3.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.843 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . 0.424 ' CD2' HG23 ' A' ' 405' ' ' ILE . 65.0 mt -92.24 128.92 43.13 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.571 0.7 . . . . 0.0 110.922 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -48.35 179.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.466 -0.126 0 C-N-CA 122.684 2.256 . . . . 0.0 112.33 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 23.8 tm0? -82.56 -41.28 19.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.899 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -65.75 -32.66 74.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.874 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.458 ' CE1' HD13 ' A' ' 467' ' ' ILE . 6.5 m-85 -59.88 138.72 57.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.899 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -137.05 -138.19 3.73 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.47 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -81.13 -61.09 2.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.704 0.288 . . . . 0.0 110.881 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -52.85 -53.72 44.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.954 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -41.36 -52.25 3.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.839 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 25.1 tp -55.44 -54.96 37.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.89 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . 0.41 ' O ' ' CG ' ' A' ' 422' ' ' MET . 55.8 tp -50.3 -45.3 54.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.924 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -77.89 -9.06 58.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 1.5 tpt -87.88 -27.35 22.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.796 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -110.1 -18.57 13.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.849 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 422' ' ' MET . . . . . 0.576 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 0.2 OUTLIER -52.18 -46.14 93.8 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.599 0.714 . . . . 0.0 110.901 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 422' ' ' MET . 64.1 Cg_exo -47.97 -37.24 29.26 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.654 2.236 . . . . 0.0 112.39 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . 0.46 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 69.5 m-85 -71.41 -35.8 71.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.859 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 174.06 -171.47 44.55 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.426 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -75.27 116.26 15.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.818 0.342 . . . . 0.0 110.874 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 88.0 t -87.44 120.56 36.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.117 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . 0.417 HG21 ' C ' ' A' ' 449' ' ' TYR . 60.5 t -78.16 -43.6 27.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.127 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -132.73 139.17 47.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.833 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -157.8 120.49 3.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.105 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . 0.45 ' CG ' ' N ' ' A' ' 432' ' ' VAL . 20.0 tttm -161.02 160.53 30.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.806 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.45 ' N ' ' CG ' ' A' ' 431' ' ' LYS . 41.0 t -119.18 140.2 43.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.172 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . 0.564 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.1 m-85 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . 0.421 ' O ' ' N ' ' A' ' 407' ' ' HIS . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.781 0.324 . . . . 0.0 110.918 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . 0.597 ' CD1' ' C ' ' A' ' 444' ' ' PHE . 0.9 OUTLIER -162.56 141.4 8.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.884 -179.854 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -135.6 175.66 20.62 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.48 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . 0.465 ' CD1' ' CE1' ' A' ' 404' ' ' PHE . 26.0 t80 -114.21 153.37 29.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.896 0.379 . . . . 0.0 110.873 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 446' ' ' PHE . 79.0 t -158.1 154.83 5.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.086 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 2.1 m -153.69 145.12 23.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.867 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . 0.567 ' CE1' HD13 ' A' ' 403' ' ' LEU . 4.2 m-85 -108.48 -174.72 2.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.934 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -78.5 -15.69 58.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.78 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . 0.451 ' OD1' ' N ' ' A' ' 451' ' ' ASN . 0.7 OUTLIER -158.69 160.17 29.41 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.598 0.713 . . . . 0.0 110.928 -179.918 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.87 -18.13 19.34 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.674 2.249 . . . . 0.0 112.354 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 62.4 t -72.16 -42.78 66.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.105 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 41.8 m -80.8 -41.42 23.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.851 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -50.51 -35.42 29.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.078 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' A' ' 457' ' ' ALA . 14.1 mm-40 -66.73 -44.75 80.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.918 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 456' ' ' GLN . . . -37.48 -43.18 0.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.085 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . 0.46 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -61.43 -69.44 0.24 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.147 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . 0.448 ' O ' ' C ' ' A' ' 460' ' ' GLN . 79.6 mt -44.13 -48.76 2.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.171 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 459' ' ' ILE . 35.9 mm-40 -34.62 -42.79 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.895 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 2.1 m -103.93 -56.53 2.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.848 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 462' ' ' MET . . . . . 0.443 ' O ' ' N ' ' A' ' 465' ' ' PHE . 82.8 mmm -43.22 -46.51 6.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.881 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -41.56 104.19 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.903 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 80.22 31.61 37.77 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.502 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . 0.443 ' N ' ' O ' ' A' ' 462' ' ' MET . 66.2 t80 -71.93 117.24 13.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.862 0.363 . . . . 0.0 110.823 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 12.3 tm0? -66.01 107.04 1.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.883 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . 0.458 HD13 ' CE1' ' A' ' 412' ' ' PHE . 20.1 tt -116.66 145.31 22.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.166 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 40.45 -95.56 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.49 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 469' ' ' MET . . . . . 0.43 ' N ' ' O ' ' A' ' 467' ' ' ILE . 12.8 tmm? -126.77 -9.89 6.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.905 0.383 . . . . 0.0 110.874 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.68 174.97 6.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 40.1 mtt180 -104.79 167.65 9.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.915 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 65.1 mt -111.2 155.39 23.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.913 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -132.95 104.66 6.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.836 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 4.3 t -109.9 138.34 38.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.216 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -156.86 139.77 15.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.98 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . 0.442 ' O ' ' CD1' ' A' ' 476' ' ' LEU . 1.5 pp -85.79 126.59 34.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.846 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 476' ' ' LEU . 11.3 tptm . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.912 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.498 ' O ' ' CB ' ' A' ' 429' ' ' SER . 7.8 mtpt . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.773 0.321 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -140.14 168.44 19.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.832 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -84.18 -152.93 16.05 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.444 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.05 157.76 46.42 Favored 'Trans proline' 0 N--CA 1.465 -0.188 0 C-N-CA 122.714 2.276 . . . . 0.0 112.39 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -55.42 110.46 0.7 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.858 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 127.77 -28.37 4.43 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.53 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . 0.501 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.94 127.14 43.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.781 0.324 . . . . 0.0 111.081 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . 0.501 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.6 OUTLIER -158.75 164.04 36.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.921 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . 0.557 HD11 ' CE1' ' A' ' 449' ' ' TYR . 20.1 mt -159.71 120.97 3.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . 0.538 ' CZ ' ' CD1' ' A' ' 446' ' ' PHE . 35.8 m-85 -126.59 111.16 14.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.939 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . 0.443 ' CG1' ' CZ ' ' A' ' 421' ' ' PHE . 4.0 mp -91.23 128.22 43.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.116 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . 0.413 ' C ' ' CD2' ' A' ' 407' ' ' HIS . 78.2 m-85 -122.11 151.84 40.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.94 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . 0.48 ' O ' ' CD2' ' A' ' 472' ' ' LEU . 15.8 m-70 72.9 47.8 0.2 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.85 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . 0.432 ' CD2' HG21 ' A' ' 405' ' ' ILE . 31.2 mt -91.39 137.73 25.88 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.643 0.735 . . . . 0.0 110.924 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -47.91 177.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.662 2.241 . . . . 0.0 112.344 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -85.92 -46.13 10.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.916 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . 0.409 ' HG3' ' N ' ' A' ' 412' ' ' PHE . 12.7 pt-20 -58.54 -40.1 82.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.409 ' N ' ' HG3' ' A' ' 411' ' ' GLU . 7.9 m-85 -50.35 146.59 5.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -132.75 -139.21 4.22 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.444 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -86.12 -51.48 6.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.708 0.289 . . . . 0.0 110.795 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -61.79 -52.42 64.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.942 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -39.69 -59.92 1.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . 0.413 HD12 ' CE1' ' A' ' 421' ' ' PHE . 56.1 tp -49.67 -45.13 48.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.966 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 22.2 tp -62.95 -44.24 96.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.851 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -72.18 -9.73 58.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.87 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 6.2 ttm -93.89 -27.75 16.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.83 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . 0.443 ' CZ ' ' CG1' ' A' ' 405' ' ' ILE . 5.4 m-85 -101.25 -20.35 15.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.866 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 422' ' ' MET . . . . . 0.579 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 3.1 mtt -49.7 -46.19 79.61 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.613 0.72 . . . . 0.0 110.911 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.3 Cg_exo -47.96 -45.68 24.17 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.705 2.27 . . . . 0.0 112.356 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . 0.537 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 86.6 m-85 -64.03 -30.17 71.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.933 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 168.71 170.05 32.88 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.519 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -66.31 94.02 0.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.841 0.353 . . . . 0.0 110.862 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 92.4 t -62.29 133.86 27.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.133 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 75.7 t -79.88 -48.17 20.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.159 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 429' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 44.5 t -136.45 148.3 47.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -161.21 114.01 1.91 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.116 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . 0.415 ' C ' ' HD2' ' A' ' 431' ' ' LYS . 2.0 tmmm? -154.99 142.47 19.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.925 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 87.4 t -93.43 137.95 21.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.119 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . 0.466 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.3 m-85 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.884 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 83.6 m . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.797 0.332 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . 0.466 ' CE1' ' HB2' ' A' ' 433' ' ' PHE . 4.6 p90 -162.07 138.84 8.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.859 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -132.55 169.31 22.39 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.509 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . 0.538 ' CD1' ' CZ ' ' A' ' 404' ' ' PHE . 61.4 t80 -106.33 154.26 21.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.925 0.393 . . . . 0.0 110.831 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . 0.448 HG13 ' N ' ' A' ' 448' ' ' SER . 64.1 t -158.13 152.91 6.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.097 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 448' ' ' SER . . . . . 0.448 ' N ' HG13 ' A' ' 447' ' ' VAL . 60.6 p -150.39 152.8 34.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.876 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . 0.557 ' CE1' HD11 ' A' ' 403' ' ' LEU . 5.1 m-85 -116.89 179.57 3.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.933 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . 0.446 ' CG ' ' OD1' ' A' ' 451' ' ' ASN . 0.6 OUTLIER -71.89 -28.91 63.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.868 179.858 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . 0.446 ' OD1' ' CG ' ' A' ' 450' ' ' ASP . 0.9 OUTLIER -146.64 155.92 48.72 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.659 0.742 . . . . 0.0 110.878 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.0 -12.6 28.41 Favored 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.71 2.273 . . . . 0.0 112.414 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 95.5 t -79.64 -33.13 14.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.187 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 78.3 p -84.0 -40.63 18.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.89 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -51.73 -40.4 60.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.159 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 53.0 mm-40 -57.08 -48.96 77.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.949 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -38.69 -40.58 0.62 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.119 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . 0.537 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -67.57 -63.99 0.95 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.1 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . 0.487 ' O ' ' CB ' ' A' ' 463' ' ' ASN . 81.0 mt -46.68 -44.24 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.17 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -41.63 -49.2 4.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.929 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 1.8 m -98.02 -57.13 2.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.82 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 85.2 mmm -42.93 -38.55 2.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.825 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . 0.487 ' CB ' ' O ' ' A' ' 459' ' ' ILE . 15.1 t30 -49.12 106.0 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.904 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 78.3 32.16 44.13 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.5 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -70.79 105.26 3.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.796 0.332 . . . . 0.0 110.88 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -63.62 103.24 0.52 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 16.9 tt -113.0 122.26 66.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.175 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 70.56 -96.9 0.59 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.488 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 41.2 mtt -133.25 8.61 4.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.859 0.361 . . . . 0.0 110.881 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.3 175.46 9.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.856 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 71.6 mtt-85 -108.98 170.45 8.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.827 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . 0.48 ' CD2' ' O ' ' A' ' 407' ' ' HIS . 72.4 mt -121.97 157.87 30.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.925 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 33.5 tttp -128.56 101.36 6.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.911 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 16.6 t -106.49 127.4 61.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.111 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -151.86 147.16 26.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.923 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . 0.449 ' CB ' ' O ' ' A' ' 402' ' ' ASN . 1.6 pp -91.18 129.34 37.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.917 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 476' ' ' LEU . 38.3 tttt . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.91 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 429' ' ' SER . 22.4 ptmt . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.77 0.319 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . 0.605 ' OE2' ' CE2' ' A' ' 446' ' ' PHE . 6.1 mm-40 -129.87 179.72 5.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -117.2 -148.59 8.83 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.515 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -76.02 151.47 35.11 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.781 2.32 . . . . 0.0 112.32 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -56.44 108.89 0.53 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.902 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 128.61 -28.39 4.22 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.509 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . 0.505 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.86 126.98 43.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.826 0.346 . . . . 0.0 111.074 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . 0.505 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.6 OUTLIER -158.7 161.85 37.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.873 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . 0.581 HD12 ' CE1' ' A' ' 449' ' ' TYR . 38.4 mt -154.57 125.84 7.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.903 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . 0.559 ' CE1' ' HB2' ' A' ' 477' ' ' LYS . 27.8 m-85 -133.83 114.64 13.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . 0.433 ' CD1' ' N ' ' A' ' 405' ' ' ILE . 3.0 mp -90.85 131.55 37.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.121 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . 0.453 ' CZ ' ' HB3' ' A' ' 404' ' ' PHE . 47.3 m-85 -125.31 171.12 10.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.976 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 45.8 m-70 53.67 50.98 15.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.869 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . 0.404 ' CD1' HG21 ' A' ' 405' ' ' ILE . 46.6 mt -100.24 151.71 37.61 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.636 0.731 . . . . 0.0 110.928 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.475 ' HG2' ' CD1' ' A' ' 412' ' ' PHE . 57.4 Cg_endo -70.54 -168.31 0.3 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.689 2.259 . . . . 0.0 112.322 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -98.51 -37.91 9.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.872 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . 0.444 ' OE1' ' C ' ' A' ' 411' ' ' GLU . 0.2 OUTLIER -57.88 -38.33 75.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 -179.881 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . 0.475 ' CD1' ' HG2' ' A' ' 409' ' ' PRO . 6.5 m-85 -58.97 140.94 55.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.93 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -126.58 -134.19 3.98 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.471 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -87.99 -54.96 3.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.757 0.313 . . . . 0.0 110.837 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . 0.442 ' O ' ' C ' ' A' ' 416' ' ' ASP . 43.2 mm-40 -59.86 -60.64 3.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.852 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 415' ' ' GLN . 45.7 m-20 -34.47 -57.7 0.5 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.925 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 67.6 tp -53.71 -44.35 69.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.838 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' A' ' 415' ' ' GLN . 29.7 tp -66.55 -61.67 1.86 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.87 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -51.84 -17.21 0.88 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 3.3 ttm -84.21 -35.91 23.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.825 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . 0.412 ' C ' ' HD2' ' A' ' 423' ' ' PRO . 4.0 m-85 -92.2 -17.86 24.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.88 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 422' ' ' MET . . . . . 0.581 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 4.2 mtt -51.12 -45.81 88.71 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.54 0.686 . . . . 0.0 110.842 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 422' ' ' MET . 66.2 Cg_exo -48.03 -46.77 21.13 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.596 2.197 . . . . 0.0 112.34 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . 0.558 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 56.0 m-85 -60.14 -36.03 76.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.81 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 170.18 -179.57 42.32 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.476 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -69.17 109.72 4.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.88 0.371 . . . . 0.0 110.903 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 91.1 t -79.3 131.37 34.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.106 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . 0.441 HG23 ' N ' ' A' ' 450' ' ' ASP . 55.2 t -84.36 -47.68 17.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.152 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 429' ' ' SER . . . . . 0.492 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 23.3 t -129.57 144.4 51.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.814 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -160.44 111.09 1.83 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.118 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -159.04 135.1 8.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.856 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.455 HG13 ' N ' ' A' ' 433' ' ' PHE . 80.0 t -90.05 142.5 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.162 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . 0.54 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.0 m-85 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 98.9 m . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.871 0.367 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . 0.54 ' CE1' ' HB2' ' A' ' 433' ' ' PHE . 3.7 p90 -162.28 139.93 8.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.868 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -131.09 175.86 19.31 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.503 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . 0.605 ' CE2' ' OE2' ' A' ' 396' ' ' GLU . 35.0 t80 -116.01 153.76 31.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.908 0.385 . . . . 0.0 110.857 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 65.5 t -154.69 150.13 11.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.102 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 6.1 p -147.1 141.35 26.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . 0.581 ' CE1' HD12 ' A' ' 403' ' ' LEU . 3.8 m-85 -111.42 170.46 8.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.867 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . 0.441 ' N ' HG23 ' A' ' 428' ' ' VAL . 2.7 m-20 -67.09 -25.65 66.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.803 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . 0.405 ' OD1' ' N ' ' A' ' 451' ' ' ASN . 2.0 p-10 -143.32 156.98 60.64 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.611 0.72 . . . . 0.0 110.896 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.39 -22.12 14.46 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.653 2.235 . . . . 0.0 112.377 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 98.3 t -72.82 -40.9 61.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.109 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 1.8 m -73.08 -42.65 62.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.81 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -52.83 -42.67 65.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.097 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -53.76 -44.86 70.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.867 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -43.63 -43.02 5.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.11 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . 0.558 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -58.18 -66.37 0.49 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.185 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . 0.454 ' O ' ' C ' ' A' ' 460' ' ' GLN . 58.8 mt -50.1 -48.94 23.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.121 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . 0.454 ' C ' ' O ' ' A' ' 459' ' ' ILE . 36.3 mt-30 -33.91 -43.24 0.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.93 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 34.1 t -102.55 -56.91 2.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 462' ' ' MET . . . . . 0.427 ' O ' ' N ' ' A' ' 465' ' ' PHE . 80.6 mmm -44.36 -47.83 9.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.819 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -40.35 100.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.854 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 80.99 37.22 19.57 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.477 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . 0.427 ' N ' ' O ' ' A' ' 462' ' ' MET . 64.9 t80 -77.79 115.36 17.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.816 0.341 . . . . 0.0 110.899 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -64.28 102.88 0.57 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.952 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 19.4 tt -112.94 144.95 19.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.153 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 42.45 -96.94 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.457 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 54.4 mtm -125.1 -7.77 7.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.863 0.363 . . . . 0.0 110.877 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.91 -177.96 3.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.907 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 68.0 mtt85 -112.2 168.4 9.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.867 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 56.7 mt -111.22 158.35 19.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.912 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 21.4 ttmt -134.5 99.96 4.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 11.4 t -105.84 138.2 32.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.14 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -156.98 138.2 13.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.834 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . 0.44 ' O ' ' CD1' ' A' ' 476' ' ' LEU . 1.6 pp -78.93 124.37 28.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.886 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.559 ' HB2' ' CE1' ' A' ' 404' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.85 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 395' ' ' LYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 429' ' ' SER . 14.7 ptmt . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.786 0.327 . . . . 0.0 110.928 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -143.34 -178.38 5.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.901 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -100.08 -154.7 27.73 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.468 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.57 159.24 46.41 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.715 2.276 . . . . 0.0 112.349 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -54.51 116.38 2.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 120.33 -27.74 6.54 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.499 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 401' ' ' ALA . . . . . 0.488 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.91 127.18 43.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.858 0.361 . . . . 0.0 111.063 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 402' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.6 OUTLIER -158.73 160.0 35.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 -179.917 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 403' ' ' LEU . . . . . 0.561 HD13 ' CE1' ' A' ' 449' ' ' TYR . 23.1 mt -156.0 122.25 5.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.924 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 404' ' ' PHE . . . . . 0.502 ' CE1' ' HD3' ' A' ' 477' ' ' LYS . 36.6 m-85 -131.33 110.85 11.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.834 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 405' ' ' ILE . . . . . 0.443 ' CD1' ' N ' ' A' ' 405' ' ' ILE . 3.0 mp -91.18 136.76 23.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.116 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 406' ' ' TYR . . . . . 0.402 ' N ' HG22 ' A' ' 405' ' ' ILE . 88.3 m-85 -131.2 165.69 22.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.956 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 407' ' ' HIS . . . . . 0.454 ' N ' ' O ' ' A' ' 443' ' ' CYS . 22.0 m-70 58.96 53.22 5.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.891 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 408' ' ' LEU . . . . . 0.4 ' O ' ' O ' ' A' ' 409' ' ' PRO . 21.1 mt -94.83 138.35 22.17 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.613 0.721 . . . . 0.0 110.915 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 409' ' ' PRO . . . . . 0.4 ' O ' ' O ' ' A' ' 408' ' ' LEU . 76.1 Cg_exo -50.02 -172.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.671 2.247 . . . . 0.0 112.384 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -90.93 -43.03 10.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.876 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -62.52 -36.99 84.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -51.57 132.03 30.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.903 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -127.16 -130.91 3.42 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.536 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.56 -62.84 1.37 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.761 0.315 . . . . 0.0 110.836 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 415' ' ' GLN . . . . . 0.42 ' O ' ' C ' ' A' ' 416' ' ' ASP . 35.0 mm-40 -47.06 -58.03 4.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.948 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 416' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 415' ' ' GLN . 71.2 m-20 -36.0 -71.87 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 417' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 416' ' ' ASP . 26.2 tp -37.53 -53.26 1.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.966 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 27.5 tp -54.99 -46.61 75.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.944 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -75.33 -11.83 60.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.924 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 2.9 tpp -86.68 -28.3 23.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 421' ' ' PHE . . . . . 0.443 ' CE1' ' SD ' ' A' ' 462' ' ' MET . 6.0 m-85 -106.56 -11.27 15.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.936 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 422' ' ' MET . . . . . 0.583 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 1.6 mmt -60.59 -45.71 97.18 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.543 0.687 . . . . 0.0 110.852 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 423' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 422' ' ' MET . 66.5 Cg_exo -47.97 -48.44 16.31 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.706 2.271 . . . . 0.0 112.311 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -60.21 -35.15 74.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.865 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 175.79 -171.94 44.98 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.495 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -79.34 105.75 10.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.917 0.389 . . . . 0.0 110.919 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 95.9 t -71.82 126.59 32.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.109 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 428' ' ' VAL . . . . . 0.41 HG21 ' C ' ' A' ' 449' ' ' TYR . 95.2 t -84.27 -38.31 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.081 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 429' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 1.0 OUTLIER -137.72 140.54 40.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.849 -179.841 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -160.22 114.55 2.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.087 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -159.5 133.85 7.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 432' ' ' VAL . . . . . 0.417 HG13 ' N ' ' A' ' 433' ' ' PHE . 88.0 t -88.6 153.93 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.153 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 433' ' ' PHE . . . . . 0.417 ' N ' HG13 ' A' ' 432' ' ' VAL . 3.8 m-30 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.863 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 443' ' ' CYS . . . . . 0.454 ' O ' ' N ' ' A' ' 407' ' ' HIS . 26.7 p . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.799 0.333 . . . . 0.0 110.839 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -159.91 145.92 15.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -142.96 175.8 22.9 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.479 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 446' ' ' PHE . . . . . 0.494 ' CD1' ' CZ ' ' A' ' 404' ' ' PHE . 25.2 t80 -112.62 154.93 25.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.911 0.386 . . . . 0.0 110.92 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 447' ' ' VAL . . . . . 0.48 ' CG2' ' O ' ' A' ' 446' ' ' PHE . 72.3 t -160.86 156.01 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.134 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 448' ' ' SER . . . . . 0.427 ' N ' HG11 ' A' ' 447' ' ' VAL . 2.4 m -155.89 152.68 28.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.864 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 449' ' ' TYR . . . . . 0.561 ' CE1' HD13 ' A' ' 403' ' ' LEU . 3.7 m-85 -115.63 -175.01 2.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.935 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -79.1 -24.0 43.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.817 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -147.98 158.34 42.16 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.627 0.727 . . . . 0.0 110.844 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.56 -2.13 12.01 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.645 2.23 . . . . 0.0 112.303 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 96.6 t -89.82 -39.85 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.089 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 10.6 t -74.76 -40.14 61.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.876 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -50.64 -32.97 20.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.172 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 456' ' ' GLN . . . . . 0.505 ' O ' ' N ' ' A' ' 458' ' ' ALA . 34.1 mm-40 -61.57 -60.34 3.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.918 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 457' ' ' ALA . . . . . 0.457 ' C ' ' HG2' ' A' ' 460' ' ' GLN . . . -35.89 -30.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.117 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 458' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 456' ' ' GLN . . . -81.53 -44.98 16.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.092 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 459' ' ' ILE . . . . . 0.488 ' N ' ' O ' ' A' ' 456' ' ' GLN . 26.0 mt -70.1 -48.42 62.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.113 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 460' ' ' GLN . . . . . 0.485 ' HG3' ' N ' ' A' ' 461' ' ' SER . 3.8 pt20 -37.01 -45.05 0.55 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.875 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 461' ' ' SER . . . . . 0.485 ' N ' ' HG3' ' A' ' 460' ' ' GLN . 2.0 m -93.94 -54.18 3.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.82 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 462' ' ' MET . . . . . 0.496 ' O ' ' N ' ' A' ' 465' ' ' PHE . 9.6 mmt -44.38 -57.49 3.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.85 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -38.16 97.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 464' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 462' ' ' MET . . . 84.43 34.82 15.65 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.517 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 465' ' ' PHE . . . . . 0.496 ' N ' ' O ' ' A' ' 462' ' ' MET . 48.6 t80 -71.98 125.92 28.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.823 0.344 . . . . 0.0 110.856 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 14.6 tm0? -70.73 117.18 11.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.945 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.6 tt -139.03 133.1 40.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.151 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 50.91 -103.0 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.465 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 11.4 mmm -132.53 25.58 4.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.805 0.336 . . . . 0.0 110.846 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -145.85 179.64 7.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.891 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 -120.32 122.3 40.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.877 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 52.8 mt -64.48 158.07 24.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.852 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -133.25 111.72 11.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.899 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 20.9 t -122.22 136.95 57.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.119 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 33.1 tp60 -157.14 141.6 16.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 476' ' ' LEU . . . . . 0.465 ' O ' ' CD1' ' A' ' 476' ' ' LEU . 1.5 pp -85.01 125.05 32.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.961 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 477' ' ' LYS . . . . . 0.502 ' HD3' ' CE1' ' A' ' 404' ' ' PHE . 7.8 tptm . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.932 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.556 -0.217 . . . . 0.0 112.556 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 73.3 m 60.27 42.43 15.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.906 0.384 . . . . 0.0 110.861 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 66.4 m -81.22 146.76 30.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.791 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -146.88 169.66 27.95 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.451 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 3.1 m -152.83 133.53 13.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.862 0.363 . . . . 0.0 110.863 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 94.2 p -101.64 41.95 1.17 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.825 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -63.74 119.33 15.98 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.468 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -47.12 109.48 0.21 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.879 0.371 . . . . 0.0 110.914 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 24.5 m -118.65 138.78 52.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.094 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -93.91 41.29 1.08 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.918 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -103.37 93.71 5.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.923 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 26.8 t -110.7 95.0 5.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 33.5 mt -108.31 -54.75 5.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.123 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 92.78 60.54 1.2 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.466 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -112.56 -33.02 6.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.79 0.329 . . . . 0.0 111.068 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -48.18 110.01 0.29 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.108 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 85.7 57.13 2.23 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.491 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 75.3 m -147.58 130.7 16.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.834 0.349 . . . . 0.0 110.851 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -88.57 36.47 0.8 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.911 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.491 ' O ' ' CB ' ' A' ' 429' ' ' SER . 26.6 mtpp -88.28 163.05 16.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.966 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -144.52 165.69 27.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.816 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -88.55 -146.43 12.49 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.448 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.44 154.1 40.22 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.647 2.231 . . . . 0.0 112.307 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -52.0 124.64 13.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.916 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 113.53 -27.28 9.48 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.505 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . 0.496 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.94 127.11 43.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.82 0.343 . . . . 0.0 111.11 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.7 OUTLIER -159.05 163.17 36.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . 0.405 ' CD2' HD11 ' A' ' 459' ' ' ILE . 24.1 mt -159.36 122.37 3.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.922 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . 0.615 ' CZ ' ' CD1' ' A' ' 446' ' ' PHE . 41.4 m-85 -129.78 114.81 16.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . 0.402 HG22 ' N ' ' A' ' 406' ' ' TYR . 3.8 mp -90.9 134.0 30.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.1 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . 0.444 ' CD2' ' HD3' ' A' ' 473' ' ' LYS . 71.9 m-85 -129.4 166.36 19.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.902 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 59.0 50.5 8.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.83 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 32.8 mt -91.24 149.21 39.37 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.657 0.741 . . . . 0.0 110.935 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -78.31 169.86 19.45 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.634 2.223 . . . . 0.0 112.342 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -73.59 -31.14 63.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.43 -38.55 91.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.866 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.557 ' CE1' HD12 ' A' ' 467' ' ' ILE . 4.3 m-85 -70.22 148.01 49.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.826 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -135.25 -133.56 3.27 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.493 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -87.76 -61.9 1.61 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.753 0.311 . . . . 0.0 110.867 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . 0.415 ' O ' ' C ' ' A' ' 416' ' ' ASP . 11.5 mm-40 -54.33 -54.3 42.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.928 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 415' ' ' GLN . 67.0 m-20 -36.91 -60.94 0.58 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.774 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 24.2 tp -46.52 -45.24 18.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.859 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 27.1 tp -59.62 -54.99 40.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.939 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -68.41 -9.93 51.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.845 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -85.57 -30.57 23.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.859 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . 0.424 ' C ' ' HD2' ' A' ' 423' ' ' PRO . 4.0 m-85 -100.35 -20.9 15.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.864 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' MET . . . . . 0.569 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 3.6 mtt -48.85 -46.6 73.78 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.523 0.678 . . . . 0.0 110.787 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 422' ' ' MET . 64.3 Cg_exo -47.97 -38.49 31.45 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.663 2.242 . . . . 0.0 112.354 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . 0.513 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 82.0 m-85 -73.93 -31.91 63.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.909 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 171.6 -177.25 44.52 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.47 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -77.47 94.91 4.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.913 0.387 . . . . 0.0 110.913 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 86.5 t -64.57 127.96 26.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.148 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 79.5 t -78.84 -45.39 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.159 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 8.5 p -128.99 144.7 51.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.89 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -160.72 107.53 1.5 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.113 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . 0.482 ' CG ' ' N ' ' A' ' 432' ' ' VAL . 52.2 tttt -145.16 162.74 36.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.887 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.482 ' N ' ' CG ' ' A' ' 431' ' ' LYS . 18.5 t -124.52 148.12 28.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.138 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . 0.637 ' CG ' ' CE1' ' A' ' 444' ' ' PHE . 4.5 m-85 -92.61 153.75 18.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.849 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 19.7 mm -125.43 140.76 47.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.119 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -67.46 148.93 50.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.866 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.65 3.19 54.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.915 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -119.2 -46.03 2.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.964 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 38.8 p -96.66 0.36 49.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.136 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 45.51 32.73 1.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.93 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.415 ' O ' ' C ' ' A' ' 441' ' ' SER . 57.4 mt -128.57 152.12 48.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.918 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 440' ' ' LEU . 7.4 t -35.9 136.75 0.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.863 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.555 ' HB3' ' CE2' ' A' ' 444' ' ' PHE . 67.5 mttt -77.47 8.6 4.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.948 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 22.6 m 67.0 26.76 8.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . 0.637 ' CE1' ' CG ' ' A' ' 433' ' ' PHE . 2.6 p90 -161.78 141.6 10.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.926 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -135.98 164.93 24.98 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.492 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . 0.615 ' CD1' ' CZ ' ' A' ' 404' ' ' PHE . 33.8 t80 -103.76 153.35 20.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.873 0.368 . . . . 0.0 110.913 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . 0.459 HG12 ' N ' ' A' ' 448' ' ' SER . 60.5 t -158.87 152.76 6.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.129 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 448' ' ' SER . . . . . 0.459 ' N ' HG12 ' A' ' 447' ' ' VAL . 10.1 m -153.86 150.74 28.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 -179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -113.07 -175.14 2.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.862 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -80.61 -13.05 59.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.856 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -161.37 159.36 23.72 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.596 0.713 . . . . 0.0 110.817 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . 0.449 ' N ' ' HB2' ' A' ' 401' ' ' ALA . 61.1 Cg_endo -75.86 -7.11 18.15 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.67 2.247 . . . . 0.0 112.362 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 58.9 t -81.3 -39.39 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.125 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 6.4 m -82.97 -40.7 19.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.89 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -53.1 -31.9 44.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.132 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -69.41 -43.72 72.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.951 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -43.84 -41.26 4.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.081 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . 0.513 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -64.29 -67.91 0.39 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.085 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . 0.409 ' O ' ' C ' ' A' ' 460' ' ' GLN . 87.1 mt -43.66 -45.95 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.114 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 459' ' ' ILE . 35.3 mt-30 -37.38 -47.42 0.85 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.869 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 2.8 m -101.58 -53.71 2.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.864 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 462' ' ' MET . . . . . 0.459 ' SD ' ' CE1' ' A' ' 424' ' ' PHE . 84.3 mmm -44.85 -47.77 11.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.92 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -45.27 104.34 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 86.22 25.35 37.16 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.48 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . 0.413 ' N ' ' O ' ' A' ' 462' ' ' MET . 21.7 t80 -69.87 108.69 4.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.795 0.331 . . . . 0.0 110.931 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -65.8 104.17 1.03 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.863 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . 0.557 HD12 ' CE1' ' A' ' 412' ' ' PHE . 19.8 tt -111.62 135.33 51.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.13 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 58.19 -93.01 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.463 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 59.9 mtp -133.57 -0.58 3.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.813 0.339 . . . . 0.0 110.875 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -127.88 -178.18 4.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.936 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 54.2 mtt85 -112.73 159.91 18.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.897 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . 0.401 ' CD2' HG23 ' A' ' 467' ' ' ILE . 87.3 mt -103.0 157.54 16.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.894 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . 0.444 ' HD3' ' CD2' ' A' ' 406' ' ' TYR . 13.3 tttt -132.26 104.67 6.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.923 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 2.8 t -113.55 135.82 51.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.138 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -157.1 137.92 13.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.836 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . 0.443 ' CB ' ' O ' ' A' ' 402' ' ' ASN . 1.6 pp -83.66 128.38 34.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 476' ' ' LEU . 10.7 tptm -34.37 112.79 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 71.2 ttt-85 -48.69 158.53 0.29 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 62.8 m -141.16 117.1 10.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.859 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 28.7 mtpt -69.83 -62.21 1.48 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.879 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -110.88 113.24 25.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.862 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -119.47 105.42 11.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.84 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 27.4 m -96.89 99.3 10.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.897 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -100.38 97.54 8.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.883 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 37.8 p -64.42 83.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.819 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -87.33 -147.1 11.56 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.498 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -76.35 131.16 12.52 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.697 2.265 . . . . 0.0 112.348 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 19.0 m -121.59 171.5 8.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.842 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 74.2 p 39.08 41.66 0.61 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.906 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.456 -179.992 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.423 -0.271 . . . . 0.0 112.423 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 2.5 t -114.52 115.07 26.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.892 0.377 . . . . 0.0 110.828 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 9.2 t -102.7 124.41 48.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.852 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -134.79 -126.4 2.62 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.469 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 6.1 t -146.78 147.56 31.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.843 0.354 . . . . 0.0 110.888 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 13.5 t -106.3 156.8 18.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.829 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 137.9 177.72 15.45 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.459 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 6.9 tt -99.94 -58.22 1.96 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.863 0.363 . . . . 0.0 110.921 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 89.7 m -107.32 124.09 49.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.15 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . 0.426 ' O ' ' C ' ' A' ' 386' ' ' GLN . 36.9 mm-40 -81.01 -46.51 14.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.907 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 385' ' ' GLN . 41.2 tt0 -35.19 -57.73 0.57 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 77.6 p -71.76 118.33 14.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.85 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 17.8 mt -117.49 -50.77 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.192 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 58.39 63.97 4.75 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.499 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -109.76 -35.56 6.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.857 0.36 . . . . 0.0 111.124 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -54.57 98.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.148 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 107.3 -39.17 2.99 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.518 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 61.2 m -43.38 121.84 2.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.81 0.338 . . . . 0.0 110.848 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -96.04 33.79 1.66 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.956 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt -95.93 171.86 8.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.841 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -131.41 -178.3 4.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.868 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -98.14 -145.89 19.67 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.561 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.52 151.08 52.61 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.697 2.265 . . . . 0.0 112.333 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -54.16 97.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.937 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 135.16 -22.95 3.53 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.462 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . 0.494 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -99.98 127.43 46.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.709 0.29 . . . . 0.0 111.166 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 18.6 m-80 -158.47 165.5 34.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.876 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . 0.466 HD11 ' CE1' ' A' ' 449' ' ' TYR . 22.4 mt -160.12 110.38 1.85 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.921 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . 0.566 ' CE1' ' HB2' ' A' ' 477' ' ' LYS . 26.2 m-85 -115.37 115.62 26.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.899 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . 0.454 HG21 ' CD1' ' A' ' 408' ' ' LEU . 4.0 mp -90.81 136.19 24.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.132 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . 0.52 ' CZ ' ' HB3' ' A' ' 404' ' ' PHE . 26.9 m-85 -130.49 167.53 18.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.945 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 59.79 50.14 7.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.858 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . 0.454 ' CD1' HG21 ' A' ' 405' ' ' ILE . 38.3 mt -97.25 145.93 30.48 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.58 0.705 . . . . 0.0 110.957 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.458 ' HG2' ' CD1' ' A' ' 412' ' ' PHE . 61.5 Cg_endo -76.42 -177.51 3.77 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.713 2.275 . . . . 0.0 112.308 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -84.44 -35.58 22.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.938 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -58.64 -33.39 70.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.938 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.486 ' CE1' HD12 ' A' ' 467' ' ' ILE . 3.4 m-85 -64.98 155.05 35.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.977 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -145.32 -148.08 4.75 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.493 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.35 -60.33 2.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.707 0.289 . . . . 0.0 110.805 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . 0.434 ' O ' ' C ' ' A' ' 416' ' ' ASP . 21.1 mp0 -54.27 -59.29 4.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.984 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 415' ' ' GLN . 35.3 m-20 -34.6 -61.19 0.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.831 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 19.5 tp -47.84 -47.67 31.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 18.4 tp -62.38 -44.09 97.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -74.25 -17.42 60.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.878 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 2.5 ttt -83.94 -28.85 27.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.863 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . 0.426 ' C ' ' HD2' ' A' ' 423' ' ' PRO . 5.3 m-85 -102.93 -19.83 14.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.883 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' MET . . . . . 0.584 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 0.2 OUTLIER -49.97 -46.05 81.33 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.517 0.675 . . . . 0.0 110.827 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 422' ' ' MET . 66.7 Cg_exo -48.03 -48.97 14.93 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.69 2.26 . . . . 0.0 112.299 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . 0.502 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 81.5 m-85 -62.18 -31.79 72.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 175.35 173.58 41.22 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.52 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -76.18 91.78 3.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.942 0.401 . . . . 0.0 110.886 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 72.4 t -56.33 128.62 16.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.127 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . 0.419 HG21 ' C ' ' A' ' 449' ' ' TYR . 31.3 t -73.16 -50.98 28.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.162 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 38.8 m -144.43 132.16 21.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.865 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -140.78 129.86 23.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.097 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . 0.418 ' C ' ' HD3' ' A' ' 431' ' ' LYS . 0.2 OUTLIER -159.83 137.75 10.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.868 -180.0 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 72.2 t -93.7 151.37 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.128 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -82.55 153.46 25.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.912 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 22.7 mm -131.8 158.77 43.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.081 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -103.87 149.63 24.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.856 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -92.91 -15.97 25.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.946 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -91.35 -45.08 8.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.889 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 30.8 p -95.02 -39.68 10.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.122 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 68.98 39.92 1.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.888 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 19.7 mt -128.49 134.28 48.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.886 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 8.4 p -38.37 105.87 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.874 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.577 ' HD3' ' CE1' ' A' ' 444' ' ' PHE . 17.9 mttm -52.02 -174.49 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.86 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 19.0 p -108.67 31.15 5.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.828 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . 0.577 ' CE1' ' HD3' ' A' ' 442' ' ' LYS . 7.0 p90 -162.1 141.9 9.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.908 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -139.25 179.08 19.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.475 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . 0.492 ' CE1' ' CE1' ' A' ' 404' ' ' PHE . 27.2 t80 -117.41 150.31 39.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.825 0.345 . . . . 0.0 110.958 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . 0.445 HG12 ' N ' ' A' ' 448' ' ' SER . 96.6 t -155.32 144.61 12.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.127 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 448' ' ' SER . . . . . 0.445 ' N ' HG12 ' A' ' 447' ' ' VAL . 51.6 p -139.81 146.34 39.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.838 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . 0.466 ' CE1' HD11 ' A' ' 403' ' ' LEU . 3.7 m-85 -111.86 174.67 5.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.87 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.63 -18.65 62.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.864 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . 0.482 ' OD1' ' N ' ' A' ' 451' ' ' ASN . 3.9 p-10 -152.01 155.1 33.36 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.642 0.734 . . . . 0.0 110.869 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -75.41 -15.1 20.04 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.644 2.23 . . . . 0.0 112.347 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 85.7 t -77.72 -38.1 24.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.025 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 1.5 t -80.21 -35.86 35.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.762 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -56.43 -39.53 73.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.128 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -61.97 -42.59 99.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -42.63 -43.76 3.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.148 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . 0.502 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -64.02 -70.52 0.22 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.156 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . 0.462 ' CD1' ' CD2' ' A' ' 403' ' ' LEU . 84.6 mt -41.9 -44.78 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.161 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -39.54 -47.22 1.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 2.4 m -97.58 -54.31 3.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.863 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 462' ' ' MET . . . . . 0.476 ' O ' ' N ' ' A' ' 465' ' ' PHE . 80.8 mmm -44.69 -57.39 3.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.847 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 462' ' ' MET . 9.8 t-20 -35.98 99.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.822 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 90.32 31.11 10.96 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.524 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . 0.476 ' N ' ' O ' ' A' ' 462' ' ' MET . 40.2 t80 -76.26 115.71 16.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.759 0.314 . . . . 0.0 110.883 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -63.54 103.28 0.51 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.894 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . 0.486 HD12 ' CE1' ' A' ' 412' ' ' PHE . 18.8 tt -114.01 138.9 42.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.151 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 48.17 -96.87 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.457 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 27.3 mmm -125.14 -9.33 7.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.873 0.368 . . . . 0.0 110.861 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 14.6 pttm -121.03 178.98 4.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.894 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 62.0 mtm180 -110.42 151.61 27.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.888 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 68.5 mt -94.22 158.08 15.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.874 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -137.43 108.53 6.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 2.9 t -110.02 140.34 29.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.129 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -157.17 141.01 16.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.907 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . 0.468 ' O ' ' CD1' ' A' ' 476' ' ' LEU . 1.5 pp -85.19 125.65 33.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.939 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.566 ' HB2' ' CE1' ' A' ' 404' ' ' PHE . 32.9 ttpt -44.4 116.46 1.04 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.874 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 25.4 ttt180 -74.85 127.39 33.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.871 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 26.3 p -112.96 123.15 49.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.911 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.4 119.05 8.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.856 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -82.75 133.52 35.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.918 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -112.7 126.29 55.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.854 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 29.6 t -85.23 -61.47 1.76 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.829 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 30.1 mtmt -102.55 153.45 20.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.852 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 31.0 t -91.76 -57.22 2.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.918 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 74.75 74.37 0.88 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.549 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -79.96 29.54 0.5 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.677 2.252 . . . . 0.0 112.339 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 83.1 p -132.86 177.66 7.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 3.9 m -45.86 -52.45 11.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.84 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.205 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.395 -179.934 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 N-CA-C 112.437 -0.265 . . . . 0.0 112.437 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 28.5 t 64.81 41.27 5.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.836 0.35 . . . . 0.0 110.848 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 4.4 t -117.12 103.75 10.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.827 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 129.28 45.28 0.18 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.498 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 15.9 m -95.0 95.21 8.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.907 0.384 . . . . 0.0 110.923 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 23.1 t -103.68 130.66 51.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.89 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -159.53 51.91 0.38 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.472 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 24.2 mt -100.32 85.36 2.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.87 0.367 . . . . 0.0 110.944 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 21.3 p -100.55 155.83 17.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.19 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.18 -48.93 2.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.965 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -144.1 118.15 9.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.895 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 2.1 t -103.4 105.57 15.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.855 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.419 ' N ' HD13 ' A' ' 388' ' ' ILE . 4.9 mp -107.04 133.35 51.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.151 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . 0.413 ' N ' HG23 ' A' ' 388' ' ' ILE . . . -135.16 59.07 0.67 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.528 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -102.11 78.25 1.76 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.817 0.341 . . . . 0.0 111.109 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -129.29 120.78 26.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.161 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 93.99 -25.48 21.62 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.539 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 2.6 m -55.95 117.16 3.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.902 0.382 . . . . 0.0 110.801 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -86.2 30.82 0.66 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.97 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 33.3 mtmt -90.63 162.24 15.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.937 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -130.73 -178.33 4.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.84 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -96.41 -155.09 30.62 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.5 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.25 151.73 43.88 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.618 2.212 . . . . 0.0 112.395 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -48.45 113.56 0.78 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.88 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 121.57 -28.53 5.94 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.512 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . 0.496 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.81 127.4 43.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.8 0.333 . . . . 0.0 111.127 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.7 OUTLIER -158.42 161.96 37.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.947 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . 0.421 ' CD1' ' CE1' ' A' ' 449' ' ' TYR . 19.8 mt -155.67 120.28 4.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.915 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . 0.51 ' CE1' ' HB2' ' A' ' 477' ' ' LYS . 25.3 m-85 -127.61 110.74 12.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.945 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . 0.458 ' CG2' HD13 ' A' ' 408' ' ' LEU . 3.5 mp -91.84 136.31 24.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.127 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -127.28 174.63 8.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 51.04 50.29 19.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.919 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . 0.458 HD13 ' CG2' ' A' ' 405' ' ' ILE . 19.7 mt -98.27 140.18 21.69 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.549 0.69 . . . . 0.0 110.982 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.411 ' O ' ' O ' ' A' ' 408' ' ' LEU . 73.1 Cg_exo -50.46 -171.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.651 2.234 . . . . 0.0 112.411 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -100.01 -24.77 14.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.97 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.11 -32.17 59.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.873 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -58.19 130.85 48.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.869 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -118.47 -144.88 7.65 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.51 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.86 -60.22 2.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.794 0.331 . . . . 0.0 110.847 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -53.84 -55.1 29.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -42.23 -65.01 0.51 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.889 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 22.5 tp -42.86 -41.37 3.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.94 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 30.6 tp -65.35 -50.94 63.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.919 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -67.5 -9.0 38.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.925 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -86.43 -27.91 23.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.902 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . 0.597 ' CZ ' ' SD ' ' A' ' 462' ' ' MET . 10.6 m-85 -104.75 -12.48 16.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.909 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' MET . . . . . 0.575 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 6.1 mtt -54.22 -45.73 99.08 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.565 0.698 . . . . 0.0 110.877 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.0 Cg_exo -47.95 -40.79 33.08 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.611 2.207 . . . . 0.0 112.392 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . 0.557 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 86.7 m-85 -67.61 -36.01 80.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.806 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 178.34 -169.06 40.6 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.464 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -85.32 100.47 11.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.874 0.369 . . . . 0.0 110.911 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 74.7 t -65.15 135.95 27.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.152 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 25.2 t -84.87 -41.02 15.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.18 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 39.7 m -158.91 140.07 13.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.902 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -149.36 132.11 15.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.122 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -157.28 135.3 10.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.933 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 85.3 t -91.98 146.85 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.124 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -75.85 142.26 42.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.889 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . 0.408 ' C ' ' HE2' ' A' ' 442' ' ' LYS . 41.4 mt -132.01 148.8 32.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.137 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -83.11 144.03 30.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.891 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 40.8 mttp -95.38 5.79 50.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -113.18 -45.23 3.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.87 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 76.9 p -99.27 -28.32 13.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.137 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 52.8 t30 72.66 33.79 1.3 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.919 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 17.0 mt -116.67 114.42 24.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -42.65 117.46 1.04 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.912 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.454 ' HG2' ' CZ ' ' A' ' 444' ' ' PHE . 0.5 OUTLIER -53.72 -175.49 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 27.8 p -101.91 36.39 2.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.913 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . 0.454 ' CZ ' ' HG2' ' A' ' 442' ' ' LYS . 1.2 p90 -161.99 150.74 15.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.919 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -141.98 176.27 22.15 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.544 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . 0.494 ' O ' ' CG2' ' A' ' 447' ' ' VAL . 39.8 t80 -117.03 156.81 26.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.948 0.404 . . . . 0.0 110.847 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . 0.494 ' CG2' ' O ' ' A' ' 446' ' ' PHE . 76.2 t -161.03 153.9 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.109 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 3.2 m -151.57 142.39 22.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.865 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . 0.421 ' CE1' ' CD1' ' A' ' 403' ' ' LEU . 3.2 m-85 -107.01 -177.66 3.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.66 -17.19 56.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.838 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . 0.474 ' OD1' ' N ' ' A' ' 451' ' ' ASN . 3.7 p-10 -154.34 156.9 32.15 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.595 0.712 . . . . 0.0 110.852 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.52 -9.29 18.63 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.635 2.224 . . . . 0.0 112.323 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 99.6 t -83.14 -33.76 10.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.099 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 61.3 m -83.6 -38.71 21.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -54.92 -29.13 55.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.112 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 41.3 mm-40 -66.81 -49.99 64.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.911 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -38.93 -40.45 0.65 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.047 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . 0.557 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -70.32 -61.91 1.59 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.152 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . 0.437 ' O ' ' CB ' ' A' ' 463' ' ' ASN . 88.6 mt -42.2 -42.3 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 50.6 mm-40 -42.84 -66.33 0.38 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.917 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 30.2 t -79.63 -54.68 5.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.848 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 462' ' ' MET . . . . . 0.597 ' SD ' ' CZ ' ' A' ' 421' ' ' PHE . 6.9 mmt -40.85 -48.21 3.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.849 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . 0.437 ' CB ' ' O ' ' A' ' 459' ' ' ILE . 36.4 t-20 -55.97 107.56 0.36 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.843 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 87.65 22.8 41.74 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.48 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -69.03 114.15 7.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.753 0.311 . . . . 0.0 110.906 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 6.0 tm0? -72.14 104.63 3.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.935 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . 0.401 ' O ' ' CG2' ' A' ' 467' ' ' ILE . 17.3 tt -112.08 122.73 66.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.121 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 66.94 -94.38 0.24 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.488 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.12 -3.17 4.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.917 0.389 . . . . 0.0 110.948 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -125.48 -178.99 4.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.922 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -112.88 163.99 13.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.854 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 82.1 mt -109.33 155.75 20.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.916 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 26.6 ttmt -129.27 113.25 14.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.912 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 11.4 t -120.54 135.73 59.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.146 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 -156.99 140.33 15.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.875 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . 0.426 ' CB ' ' O ' ' A' ' 402' ' ' ASN . 1.6 pp -80.96 125.35 30.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.938 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.51 ' HB2' ' CE1' ' A' ' 404' ' ' PHE . 15.3 ttmm -39.54 104.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.902 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -119.53 49.03 1.41 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.812 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 8.0 t -81.6 -45.0 16.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 5.0 ptpt -84.59 44.77 1.07 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.914 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -57.0 -61.87 2.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.907 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -170.48 129.06 0.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 9.6 t -116.73 158.11 24.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.857 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -98.6 176.83 5.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.87 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 3.1 m -85.7 48.55 1.61 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -102.72 -95.21 2.3 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.428 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -46.09 104.32 0.06 OUTLIER 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.736 2.29 . . . . 0.0 112.295 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 21.3 m -95.91 148.09 22.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.908 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 1.9 m -170.47 151.15 3.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.81 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.467 179.985 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.461 -0.255 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 74.2 m -123.86 145.2 49.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.84 0.352 . . . . 0.0 110.874 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 50.5 m -145.3 157.04 44.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.851 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 72.63 82.04 0.33 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.504 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 3.2 t -104.56 159.58 15.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.891 0.377 . . . . 0.0 110.875 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 32.3 t -168.57 121.99 0.86 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.888 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 127.13 114.18 1.85 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.475 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -56.76 141.35 44.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.87 0.367 . . . . 0.0 110.902 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 1.4 m -144.35 137.51 27.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.114 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 17.3 tp60 -72.93 -51.45 18.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.884 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 57.21 52.17 9.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.902 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 4.2 m -104.79 81.16 1.73 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.785 -179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.431 ' N ' HD13 ' A' ' 388' ' ' ILE . 3.4 mp -115.48 -38.81 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.108 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 38.91 80.03 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.504 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -104.94 78.84 1.45 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.87 0.367 . . . . 0.0 111.114 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -121.28 147.92 45.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.105 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 49.91 33.49 20.8 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.485 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.4 t -106.96 154.02 21.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.918 0.39 . . . . 0.0 110.823 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -122.46 47.72 1.88 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.9 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.468 ' O ' ' CB ' ' A' ' 429' ' ' SER . 6.6 ptmm? -120.66 163.81 17.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.91 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -132.01 -177.68 4.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -100.77 -147.2 20.49 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.501 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.77 161.18 36.85 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.669 2.246 . . . . 0.0 112.435 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -59.01 123.1 15.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 113.04 -27.57 9.49 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.576 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . 0.487 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.84 127.06 43.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.823 0.344 . . . . 0.0 111.112 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . 0.487 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.7 OUTLIER -159.02 159.94 35.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.934 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . 0.547 HD11 ' CE1' ' A' ' 449' ' ' TYR . 17.6 mt -156.11 122.66 5.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.904 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . 0.482 ' CE1' ' CE1' ' A' ' 446' ' ' PHE . 22.8 m-85 -130.23 110.86 11.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . 0.46 HG23 ' CG ' ' A' ' 408' ' ' LEU . 3.5 mp -91.1 134.13 30.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.176 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . 0.448 ' CD2' ' HD3' ' A' ' 473' ' ' LYS . 84.2 m-85 -126.19 -176.23 3.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.957 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 42.17 53.9 4.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . 0.46 ' CG ' HG23 ' A' ' 405' ' ' ILE . 28.1 mt -98.38 143.07 25.64 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.591 0.71 . . . . 0.0 110.937 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.5 164.42 32.47 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.668 2.245 . . . . 0.0 112.397 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -62.78 -37.64 87.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.918 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -58.23 -35.04 71.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.833 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.536 ' CZ ' ' HE3' ' A' ' 420' ' ' MET . 5.2 m-85 -77.94 115.57 17.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.848 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -109.16 -138.79 8.36 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.474 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 414' ' ' ASP . 0.1 OUTLIER -79.17 -53.72 6.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.761 0.315 . . . . 0.0 110.856 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . 0.417 ' O ' ' C ' ' A' ' 416' ' ' ASP . 16.0 mp0 -60.98 -57.82 11.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 415' ' ' GLN . 70.9 m-20 -36.16 -50.52 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.855 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 36.3 tp -57.74 -50.12 74.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.925 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 39.3 tp -56.73 -43.38 80.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -80.71 -10.76 59.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.936 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' MET . . . . . 0.536 ' HE3' ' CZ ' ' A' ' 412' ' ' PHE . 0.3 OUTLIER -82.29 -27.44 32.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.867 179.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . 0.417 ' C ' ' HD2' ' A' ' 423' ' ' PRO . 4.0 m-85 -107.14 -20.32 13.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.855 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' MET . . . . . 0.575 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 0.4 OUTLIER -49.44 -46.3 77.96 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.56 0.695 . . . . 0.0 110.883 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 422' ' ' MET . 64.9 Cg_exo -47.96 -41.63 32.56 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.704 2.269 . . . . 0.0 112.376 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . 0.424 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 88.0 m-85 -67.27 -35.97 80.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.92 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 173.6 177.9 43.16 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.499 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -66.03 115.26 5.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.846 0.355 . . . . 0.0 110.877 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 87.4 t -85.12 131.08 35.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.073 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . 0.411 HG22 ' C ' ' A' ' 449' ' ' TYR . 53.6 t -83.83 -34.6 10.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.15 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 0.8 OUTLIER -149.2 143.86 26.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -160.91 119.49 2.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.066 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . 0.492 ' CG ' ' N ' ' A' ' 432' ' ' VAL . 32.7 tttp -159.47 163.17 35.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.939 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.492 ' N ' ' CG ' ' A' ' 431' ' ' LYS . 55.8 t -114.76 154.44 16.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.136 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . 0.564 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.1 m-85 -99.8 143.72 29.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.819 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 21.5 mt -137.85 144.7 30.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.142 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -78.35 133.41 37.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.936 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.59 -6.79 46.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.946 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -98.1 -55.93 2.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.921 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 59.6 p -81.09 -27.11 35.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.152 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 63.61 41.43 7.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.895 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 7.9 mt -140.54 141.32 35.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.927 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 48.6 m -44.25 134.22 5.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.549 ' HB3' ' CE2' ' A' ' 444' ' ' PHE . 36.0 mttt -78.09 9.55 3.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.953 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 16.2 m 68.07 29.61 6.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.879 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . 0.564 ' CE1' ' HB2' ' A' ' 433' ' ' PHE . 1.8 p90 -161.94 139.67 8.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.93 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -133.7 172.07 21.76 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.512 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . 0.482 ' CE1' ' CE1' ' A' ' 404' ' ' PHE . 23.6 t80 -109.88 153.86 23.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.908 0.385 . . . . 0.0 110.894 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 75.3 t -157.31 153.97 6.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.12 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 2.9 m -154.45 154.97 34.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.928 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . 0.547 ' CE1' HD11 ' A' ' 403' ' ' LEU . 4.7 m-85 -118.9 -175.17 2.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -85.05 -8.87 58.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.877 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -160.2 155.11 20.96 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.634 0.731 . . . . 0.0 110.942 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.78 -8.23 19.02 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.648 2.232 . . . . 0.0 112.41 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 60.0 t -82.14 -36.92 14.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.086 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 1.4 t -82.1 -42.01 19.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.855 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -52.36 -41.33 62.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.118 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -58.32 -46.57 85.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.942 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -43.47 -41.21 4.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.112 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . 0.424 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -62.99 -68.25 0.35 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . 0.406 ' O ' ' C ' ' A' ' 460' ' ' GLN . 77.5 mt -48.01 -43.28 10.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.086 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' ' 459' ' ' ILE . 23.6 mt-30 -37.76 -42.46 0.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 1.9 m -103.78 -56.3 2.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.852 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 462' ' ' MET . . . . . 0.458 ' O ' ' N ' ' A' ' 465' ' ' PHE . 86.2 mmm -42.66 -42.84 3.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.96 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -42.55 100.26 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 83.24 31.35 28.43 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.488 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . 0.458 ' N ' ' O ' ' A' ' 462' ' ' MET . 58.3 t80 -64.79 117.12 7.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.787 0.327 . . . . 0.0 110.923 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 44.4 tp60 -74.26 105.39 5.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . 0.442 ' O ' ' CG2' ' A' ' 467' ' ' ILE . 16.4 tt -116.69 113.45 43.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.106 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 71.34 -104.12 1.37 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.465 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 469' ' ' MET . . . . . 0.4 ' O ' ' SD ' ' A' ' 469' ' ' MET . 5.8 tmm? -121.43 5.72 10.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.857 0.36 . . . . 0.0 110.846 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.73 -176.92 4.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.985 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -123.28 164.65 18.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.807 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 60.2 mt -106.56 163.82 12.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.918 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . 0.448 ' HD3' ' CD2' ' A' ' 406' ' ' TYR . 11.8 tttt -138.43 104.99 5.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.934 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 5.3 t -110.78 139.07 36.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.092 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -157.22 145.89 19.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.876 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . 0.495 ' O ' ' CD1' ' A' ' 476' ' ' LEU . 1.5 pp -92.08 123.99 35.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.471 ' N ' ' HB2' ' A' ' 402' ' ' ASN . 27.9 tttp -40.66 111.73 0.23 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.844 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -132.0 75.18 1.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 19.1 m -121.01 81.13 1.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.891 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.1 42.17 1.25 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.878 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -63.9 -46.1 86.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.86 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -117.92 136.31 53.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 27.6 m -69.06 -45.36 70.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.849 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 31.3 tttm -84.39 155.0 22.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.907 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 67.0 m -80.41 -48.35 13.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.885 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 135.09 146.15 5.29 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.416 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -77.7 97.65 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.694 2.263 . . . . 0.0 112.325 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 488' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 489' ' ' SER . 1.9 t -152.59 159.72 43.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.844 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 489' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 488' ' ' SER . 2.4 m 35.31 50.0 0.5 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.835 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.497 179.986 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 73.9 p -140.98 130.79 24.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.827 0.346 . . . . 0.0 110.78 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 22.9 t -69.75 140.36 53.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.85 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -87.35 91.06 1.71 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.55 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 3.5 t -117.51 134.07 55.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.886 0.374 . . . . 0.0 110.862 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 19.6 m -57.21 -47.12 82.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.868 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 53.25 62.05 6.36 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.472 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -58.44 169.77 0.84 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.853 0.359 . . . . 0.0 110.936 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 25.6 m -144.28 105.58 4.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.125 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -66.37 -24.21 66.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.952 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -94.05 105.65 17.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.924 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 75.4 m -93.76 81.27 4.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.944 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.412 HG23 ' N ' ' A' ' 389' ' ' GLY . 49.6 mm -72.87 135.7 27.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.153 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . 0.412 ' N ' HG23 ' A' ' 388' ' ' ILE . . . -69.97 110.91 3.53 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.502 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . 0.405 ' N ' HD23 ' A' ' 418' ' ' LEU . . . -73.07 77.47 1.22 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.772 0.32 . . . . 0.0 111.058 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -123.05 141.87 51.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.106 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 40.59 37.66 1.3 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.508 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.4 t -89.62 -25.95 21.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.761 0.315 . . . . 0.0 110.812 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 50.25 43.58 26.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.93 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt -121.68 164.54 17.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.95 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -127.95 177.65 6.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.901 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -104.36 -147.31 16.85 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.535 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.57 151.61 32.81 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.709 2.273 . . . . 0.0 112.313 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -53.41 102.51 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.943 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 135.94 -28.71 2.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.466 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . 0.494 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.95 126.7 43.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.779 0.323 . . . . 0.0 111.106 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.5 OUTLIER -159.04 161.55 36.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.912 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . 0.573 HD12 ' CE1' ' A' ' 449' ' ' TYR . 17.9 mt -159.95 117.66 2.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.929 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . 0.73 ' CZ ' ' CD1' ' A' ' 446' ' ' PHE . 44.4 m-85 -126.39 115.42 19.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.887 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . 0.588 ' CD1' ' N ' ' A' ' 405' ' ' ILE . 1.2 mp -93.82 127.09 46.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.119 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . 0.465 ' CZ ' ' HB3' ' A' ' 404' ' ' PHE . 37.9 m-85 -120.19 151.99 38.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.964 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . 0.482 ' N ' ' O ' ' A' ' 443' ' ' CYS . 15.5 m-70 73.47 54.44 0.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.885 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 26.0 mt -101.58 136.05 19.67 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.6 0.714 . . . . 0.0 110.966 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -47.73 -179.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.729 2.286 . . . . 0.0 112.329 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 35.7 tp60 -91.9 -38.79 12.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.933 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 25.0 pm0 -65.15 -13.19 57.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.881 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -80.29 135.49 36.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.901 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -116.41 -151.86 9.69 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.451 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.18 -56.53 4.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.736 0.303 . . . . 0.0 110.873 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . 0.453 ' O ' ' C ' ' A' ' 416' ' ' ASP . 9.2 mm-40 -56.88 -55.98 27.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.9 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 415' ' ' GLN . 63.6 m-20 -34.41 -59.06 0.46 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.845 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . 0.555 HD13 ' CE1' ' A' ' 421' ' ' PHE . 39.1 tp -46.64 -49.02 19.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . 0.464 ' HB3' ' NE2' ' A' ' 419' ' ' GLN . 52.2 tp -55.27 -55.33 32.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.916 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . 0.464 ' NE2' ' HB3' ' A' ' 418' ' ' LEU . 6.9 mp0 -60.45 -17.6 45.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.923 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 3.8 ttm -86.55 -26.48 24.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . 0.555 ' CE1' HD13 ' A' ' 417' ' ' LEU . 10.8 m-85 -105.93 -10.14 16.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.9 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' MET . . . . . 0.592 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 4.3 mtt -59.64 -45.59 98.6 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.581 0.705 . . . . 0.0 110.923 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.9 Cg_exo -47.98 -37.9 30.51 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.628 2.219 . . . . 0.0 112.362 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . 0.496 ' CE2' ' HA ' ' A' ' 458' ' ' ALA . 86.8 m-85 -67.19 -34.94 78.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.934 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 171.67 -156.82 26.66 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.488 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -92.0 92.77 8.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.841 0.353 . . . . 0.0 110.886 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.505 HG22 ' CZ ' ' A' ' 449' ' ' TYR . 54.3 t -65.67 116.93 5.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.1 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 71.2 t -64.5 -43.18 96.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.126 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' SER . . . . . 0.435 ' O ' ' CG1' ' A' ' 427' ' ' VAL . 93.2 p -137.34 146.83 45.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.82 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -161.3 110.29 1.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.076 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . 0.412 ' C ' ' HD2' ' A' ' 431' ' ' LYS . 1.1 tmmm? -157.36 144.4 18.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.924 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 52.7 t -96.25 137.01 25.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.147 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . 0.401 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.2 m-85 -77.82 151.47 33.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . 0.422 ' C ' ' HD2' ' A' ' 442' ' ' LYS . 45.8 mt -123.36 152.36 28.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.168 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -84.73 132.2 34.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.937 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt -75.01 -11.82 60.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.92 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 6.1 mm100 -95.59 -55.39 3.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.842 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 22.1 p -79.61 -32.13 41.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.125 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 38.2 t30 71.66 31.96 2.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.857 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 10.1 mt -129.84 141.34 50.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 8.8 m -42.73 110.97 0.21 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.84 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.565 ' HD3' ' CE2' ' A' ' 444' ' ' PHE . 15.8 mttm -55.36 -174.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.902 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . 0.482 ' O ' ' N ' ' A' ' 407' ' ' HIS . 31.4 p -103.03 35.52 2.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.973 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . 0.565 ' CE2' ' HD3' ' A' ' 442' ' ' LYS . 12.0 p90 -162.2 141.5 9.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.852 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -132.65 171.16 21.73 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.454 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . 0.73 ' CD1' ' CZ ' ' A' ' 404' ' ' PHE . 30.6 t80 -111.24 153.16 26.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.911 0.386 . . . . 0.0 110.822 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . 0.459 ' CG2' HD21 ' A' ' 417' ' ' LEU . 59.5 t -159.06 146.64 7.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.099 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 1.2 t -148.74 148.89 30.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.835 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . 0.573 ' CE1' HD12 ' A' ' 403' ' ' LEU . 8.6 m-85 -112.11 -174.9 2.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.98 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -80.58 -21.21 41.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.904 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -152.99 155.73 32.25 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.613 0.72 . . . . 0.0 110.943 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . 0.423 ' N ' ' HB2' ' A' ' 401' ' ' ALA . 60.5 Cg_endo -74.28 -2.27 12.12 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.731 2.287 . . . . 0.0 112.356 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 93.2 t -86.19 -34.25 7.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.08 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 14.0 m -87.39 -39.65 15.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.823 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -52.99 -30.72 36.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.041 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -64.48 -45.95 85.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.876 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -40.31 -44.32 1.9 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.164 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . 0.496 ' HA ' ' CE2' ' A' ' 424' ' ' PHE . . . -61.36 -68.55 0.3 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.108 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . 0.428 ' O ' ' CB ' ' A' ' 463' ' ' ASN . 86.9 mt -43.04 -45.75 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.174 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 24.3 mm100 -39.34 -46.51 1.61 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.933 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 32.5 t -103.19 -56.56 2.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.883 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 462' ' ' MET . . . . . 0.465 ' SD ' ' CZ ' ' A' ' 424' ' ' PHE . 86.6 mmm -42.65 -43.26 3.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.892 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' A' ' 459' ' ' ILE . 14.4 t30 -44.74 110.19 0.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.866 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 74.38 33.33 56.62 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.59 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . 0.414 ' CD1' HD12 ' A' ' 472' ' ' LEU . 9.9 t80 -67.51 113.22 5.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.753 0.311 . . . . 0.0 110.913 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -70.36 109.18 4.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.904 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.7 tt -125.01 134.94 65.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.087 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 58.6 -102.33 0.26 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.434 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -124.33 -9.24 7.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.821 0.344 . . . . 0.0 110.878 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 8.9 pttm -120.57 179.2 4.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.88 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -112.09 164.37 13.24 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.909 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . 0.414 ' CD2' ' O ' ' A' ' 407' ' ' HIS . 78.5 mt -107.0 158.39 17.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.886 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -131.97 102.52 5.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.825 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 15.3 t -110.18 125.54 67.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.138 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 39.9 tp60 -152.11 144.67 24.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . 0.533 ' CD1' ' C ' ' A' ' 478' ' ' ARG . 1.6 pp -84.98 129.11 34.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.869 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.475 ' C ' ' O ' ' A' ' 476' ' ' LEU . 4.4 tptm -32.38 -70.82 0.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.892 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . 0.533 ' C ' ' CD1' ' A' ' 476' ' ' LEU . 0.4 OUTLIER -151.23 142.1 22.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.878 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 57.9 p -101.48 -52.81 3.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.875 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 31.1 pttt -125.57 93.03 3.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.955 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -143.91 109.86 5.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.922 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -170.88 130.56 0.8 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.86 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 4.6 t -54.7 170.34 0.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.929 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 14.2 tptp -124.64 -54.5 1.65 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 49.4 m 64.04 42.55 5.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.872 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -144.47 68.58 0.42 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.499 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.15 -3.52 13.82 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.63 2.22 . . . . 0.0 112.286 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 33.4 m -108.8 106.05 15.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.843 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 2.5 m -89.36 82.06 6.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.861 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.455 179.933 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 37.9 m -146.58 176.83 9.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.905 0.383 . . . . 0.0 110.845 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 31.6 p -127.2 90.84 3.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.885 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 52.04 90.18 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.51 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 88.9 p -67.98 104.22 1.68 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.924 0.392 . . . . 0.0 110.856 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 80.0 p -46.2 165.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.904 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 53.28 82.73 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.475 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 4.3 pp -62.49 158.13 18.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.934 0.397 . . . . 0.0 110.848 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 54.7 p -127.71 100.62 6.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.099 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -85.67 41.06 0.88 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -117.33 39.93 3.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.898 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 4.6 m -82.25 43.5 0.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.839 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . 0.401 HG21 ' N ' ' A' ' 389' ' ' GLY . 60.2 mt -39.27 133.65 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.109 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . 0.401 ' N ' HG21 ' A' ' 388' ' ' ILE . . . -130.87 47.46 1.02 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.45 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -98.46 -56.87 2.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.835 0.35 . . . . 0.0 111.108 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -38.77 127.52 1.55 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.075 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 86.98 -39.78 3.09 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.493 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 10.7 t -53.93 120.69 6.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.779 0.323 . . . . 0.0 110.901 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -92.11 26.46 2.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.883 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.497 ' O ' ' CB ' ' A' ' 429' ' ' SER . 26.6 mtpt -72.96 172.53 10.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.854 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -142.79 179.44 7.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.946 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -98.54 -147.37 22.04 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.53 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.56 155.77 40.43 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.672 2.248 . . . . 0.0 112.323 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -58.52 100.51 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 136.25 -28.75 2.88 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.479 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . 0.468 ' HB2' ' N ' ' A' ' 452' ' ' PRO . . . -97.88 127.25 43.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.774 0.321 . . . . 0.0 111.151 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . 0.493 ' O ' ' CB ' ' A' ' 476' ' ' LEU . 16.9 m-80 -158.64 165.43 34.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.94 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . 0.549 HD13 ' CE1' ' A' ' 449' ' ' TYR . 50.7 mt -159.29 108.0 1.84 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.912 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . 0.515 ' CE1' ' HB2' ' A' ' 477' ' ' LYS . 26.8 m-85 -109.94 120.32 42.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.87 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . 0.553 HD11 ' CE2' ' A' ' 421' ' ' PHE . 1.8 mm -91.04 133.92 31.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.074 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . 0.467 ' CZ ' ' HB3' ' A' ' 404' ' ' PHE . 13.9 m-85 -129.75 147.43 51.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.887 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . 0.461 ' O ' ' CD2' ' A' ' 472' ' ' LEU . 31.7 m-70 70.0 52.13 0.4 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.876 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . 0.461 ' CD2' HG21 ' A' ' 405' ' ' ILE . 32.7 mt -93.65 139.65 22.85 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.585 0.707 . . . . 0.0 110.897 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -47.39 -179.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.64 2.227 . . . . 0.0 112.331 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -98.92 -24.84 14.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.949 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 7.7 pm0 -82.37 -12.75 57.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.4 ' CZ ' HD11 ' A' ' 467' ' ' ILE . 6.3 m-85 -76.55 147.55 37.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.893 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -127.03 -148.7 7.04 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.482 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -81.85 -54.72 5.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.816 0.341 . . . . 0.0 110.903 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . 0.466 ' O ' ' N ' ' A' ' 418' ' ' LEU . 7.3 mm100 -58.16 -58.53 8.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.935 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 415' ' ' GLN . 24.2 m-20 -37.3 -56.46 0.96 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.833 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . 0.426 HD13 ' CE1' ' A' ' 421' ' ' PHE . 48.5 tp -51.99 -37.24 52.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.943 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' A' ' 415' ' ' GLN . 23.9 tp -70.78 -50.77 32.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -63.88 -13.89 48.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.855 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 2.1 ttm -89.58 -32.79 16.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.943 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . 0.553 ' CE2' HD11 ' A' ' 405' ' ' ILE . 6.2 m-85 -93.18 -17.8 23.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.873 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' MET . . . . . 0.58 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 0.4 OUTLIER -57.28 -45.61 99.89 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.503 0.668 . . . . 0.0 110.825 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 422' ' ' MET . 64.7 Cg_exo -47.94 -37.79 29.95 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.68 2.253 . . . . 0.0 112.351 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -71.33 -35.56 71.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.901 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 176.06 -178.62 47.48 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.459 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -76.93 89.33 3.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.839 0.352 . . . . 0.0 110.945 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 70.3 t -56.69 143.57 10.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.112 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . 0.418 ' CG2' ' C ' ' A' ' 449' ' ' TYR . 99.4 t -95.25 -38.39 8.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.149 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 3.5 p -140.76 145.09 35.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.928 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -161.03 113.71 1.93 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.14 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.03 142.75 17.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.919 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.404 HG12 ' N ' ' A' ' 433' ' ' PHE . 86.8 t -98.99 143.74 12.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.143 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . 0.534 ' CG ' ' CE1' ' A' ' 444' ' ' PHE . 3.1 m-85 -84.42 153.7 23.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . 0.475 ' CG2' ' N ' ' A' ' 435' ' ' ASP . 69.3 mt -130.18 164.74 32.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.128 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . 0.475 ' N ' ' CG2' ' A' ' 434' ' ' ILE . 3.5 m-20 -102.45 151.47 22.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.88 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 16.3 mttp -89.6 -18.42 26.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.928 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -94.3 -52.65 4.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.917 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 438' ' ' THR . . . . . 0.463 ' O ' ' ND2' ' A' ' 439' ' ' ASN . 58.2 p -82.1 -22.03 36.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.115 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . 0.463 ' ND2' ' O ' ' A' ' 438' ' ' THR . 10.6 p30 49.14 38.32 12.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.87 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.444 ' O ' ' C ' ' A' ' 441' ' ' SER . 57.5 mt -129.22 127.39 41.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.953 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 441' ' ' SER . . . . . 0.444 ' C ' ' O ' ' A' ' 440' ' ' LEU . 7.9 t -34.35 107.29 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.57 ' HD3' ' CE2' ' A' ' 444' ' ' PHE . 39.6 mttt -51.54 -174.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.908 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 24.5 p -110.13 37.91 2.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.903 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . 0.57 ' CE2' ' HD3' ' A' ' 442' ' ' LYS . 4.6 p90 -162.15 143.48 10.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.829 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -137.22 179.07 18.46 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.539 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . 0.469 ' CD1' ' CZ ' ' A' ' 404' ' ' PHE . 66.0 t80 -122.89 141.1 52.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.906 0.384 . . . . 0.0 110.871 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . 0.423 HG22 ' C ' ' A' ' 446' ' ' PHE . 84.5 t -146.12 149.44 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.102 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 448' ' ' SER . . . . . 0.403 ' N ' HG11 ' A' ' 447' ' ' VAL . 1.3 t -147.95 144.94 28.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.83 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . 0.549 ' CE1' HD13 ' A' ' 403' ' ' LEU . 4.1 m-85 -104.84 -174.83 2.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.874 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -79.63 -22.48 43.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.797 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -147.37 155.46 46.07 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.596 0.712 . . . . 0.0 110.875 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . 0.468 ' N ' ' HB2' ' A' ' 401' ' ' ALA . 59.7 Cg_endo -73.03 -0.36 8.95 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.713 2.275 . . . . 0.0 112.399 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 95.5 t -94.23 -37.05 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.149 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 50.6 m -78.63 -37.69 41.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.8 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -52.13 -30.13 25.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.054 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' A' ' 457' ' ' ALA . 42.1 mm-40 -67.59 -51.59 48.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.855 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 456' ' ' GLN . . . -36.64 -42.35 0.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.124 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -69.0 -48.23 63.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.119 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . 0.443 ' O ' ' CB ' ' A' ' 463' ' ' ASN . 70.5 mt -55.39 -42.85 69.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.148 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -40.97 -53.08 3.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.925 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 27.8 t -93.08 -55.27 3.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.856 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 462' ' ' MET . . . . . 0.45 ' SD ' ' CE1' ' A' ' 421' ' ' PHE . 6.3 mmt -43.53 -49.7 7.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.905 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' A' ' 459' ' ' ILE . 18.8 t-20 -48.45 114.7 1.01 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.878 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 65.88 33.86 86.93 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.492 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -75.9 109.04 9.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.795 0.331 . . . . 0.0 110.834 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -62.96 105.88 0.74 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.928 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . 0.41 ' O ' ' CG2' ' A' ' 467' ' ' ILE . 19.2 tt -111.05 116.99 53.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.189 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 65.85 -96.98 0.28 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.537 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 4.0 ttt -123.17 -13.0 7.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.792 0.329 . . . . 0.0 110.806 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 15.3 pttm -117.59 168.65 10.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.887 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -111.29 153.52 25.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.864 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . 0.461 ' CD2' ' O ' ' A' ' 407' ' ' HIS . 14.8 mt -104.21 161.61 13.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.977 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -134.57 104.74 6.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.928 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . 0.468 ' CG2' HD12 ' A' ' 405' ' ' ILE . 30.8 t -109.09 128.33 65.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.135 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -151.84 142.96 23.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.917 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . 0.493 ' CB ' ' O ' ' A' ' 402' ' ' ASN . 1.6 pp -80.13 135.24 36.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.973 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.515 ' HB2' ' CE1' ' A' ' 404' ' ' PHE . 22.8 ttpp -44.81 111.51 0.32 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 26.4 ttm-85 -90.34 86.8 6.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 11.8 t -82.1 104.3 12.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.824 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 12.8 pttp -103.22 40.77 1.34 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.875 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -107.1 87.07 2.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.843 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -117.79 83.73 2.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.907 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 15.1 m -85.2 96.81 9.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.786 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 9.8 tppt? -133.0 117.95 18.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.886 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 91.6 p -60.0 107.03 0.57 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.846 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 96.81 170.68 34.09 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.451 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.99 -42.01 0.34 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.773 2.315 . . . . 0.0 112.323 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 3.7 m 44.03 42.25 4.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.886 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 4.7 m -38.37 154.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.829 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.48 179.988 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 3.4 m -52.48 155.49 2.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.786 0.327 . . . . 0.0 110.906 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 19.9 m -118.02 98.01 6.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.84 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -157.19 87.24 0.12 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.484 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 3.2 t -147.11 123.82 11.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.852 0.358 . . . . 0.0 110.904 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 13.1 t -99.96 89.16 3.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -173.08 92.81 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.494 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 43.8 mt -94.99 115.09 26.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.914 0.388 . . . . 0.0 110.875 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 95.5 m -58.6 -67.17 0.38 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.157 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -130.67 167.09 19.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 40.4 tp60 -116.54 -46.31 2.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.882 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 4.4 t -123.35 94.48 4.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.769 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 5.1 mp -74.54 -54.87 13.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 44.14 90.02 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.451 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -100.78 -49.02 4.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.713 0.292 . . . . 0.0 111.06 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -40.47 130.38 2.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.139 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 393' ' ' SER . . . 79.13 -50.2 3.66 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.487 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 392' ' ' GLY . 1.8 t -36.32 152.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.806 0.336 . . . . 0.0 110.897 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -124.33 48.97 1.85 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.874 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.477 ' O ' ' CB ' ' A' ' 429' ' ' SER . 0.1 OUTLIER -107.07 171.16 7.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.906 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -137.2 179.31 6.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.935 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -94.81 -154.77 31.15 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.546 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.09 151.29 61.31 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.7 2.267 . . . . 0.0 112.294 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -49.58 97.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.913 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 136.43 -24.74 3.19 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.48 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . 0.481 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -98.18 126.93 43.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.843 0.354 . . . . 0.0 111.053 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . 0.481 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 22.1 m-80 -158.97 161.87 36.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . 0.566 HD11 ' CD1' ' A' ' 449' ' ' TYR . 47.5 mt -159.24 108.56 1.89 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.931 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . 0.489 ' CE1' ' CE1' ' A' ' 446' ' ' PHE . 20.1 m-85 -113.14 112.42 23.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.923 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . 0.504 HG12 ' CZ ' ' A' ' 421' ' ' PHE . 3.0 mp -90.83 137.44 21.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.093 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . 0.435 ' CD1' ' HB2' ' A' ' 444' ' ' PHE . 93.6 m-85 -129.47 169.74 14.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . 0.469 ' N ' ' O ' ' A' ' 443' ' ' CYS . 20.3 m-70 53.95 51.69 14.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.874 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . 0.453 ' CG ' HG22 ' A' ' 405' ' ' ILE . 25.5 mt -93.9 134.35 26.31 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.594 0.711 . . . . 0.0 110.925 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -48.87 -175.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.659 2.24 . . . . 0.0 112.307 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -88.85 -41.43 12.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.957 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -62.5 -37.4 85.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.898 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -55.35 117.18 3.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.843 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -103.17 -138.45 9.91 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.552 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -89.98 -44.07 10.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.763 0.316 . . . . 0.0 110.871 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . 0.423 ' O ' ' N ' ' A' ' 418' ' ' LEU . 22.5 mp0 -70.06 -57.2 5.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 415' ' ' GLN . 32.9 m-20 -37.36 -56.77 0.95 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.838 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 61.7 tp -52.33 -40.5 61.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.933 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' A' ' 415' ' ' GLN . 24.6 tp -69.61 -38.63 77.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -73.23 -17.51 61.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 4.8 ttp -88.9 -12.67 41.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.826 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . 0.504 ' CZ ' HG12 ' A' ' 405' ' ' ILE . 5.8 m-85 -111.79 -0.01 16.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.868 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' MET . . . . . 0.576 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 4.5 mtt -71.82 -45.92 12.17 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.549 0.69 . . . . 0.0 110.848 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.1 Cg_exo -48.02 -36.84 28.81 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.762 2.308 . . . . 0.0 112.327 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . 0.498 ' CD1' ' HA ' ' A' ' 458' ' ' ALA . 97.2 m-85 -69.51 -36.02 76.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.833 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 171.7 -161.65 33.87 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.53 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -86.07 105.01 16.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.943 0.401 . . . . 0.0 110.896 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 93.8 t -74.13 130.0 36.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.126 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 76.2 t -85.99 -46.82 16.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.115 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 13.7 t -130.69 144.67 51.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.841 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -161.05 117.72 2.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.097 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . 0.416 ' C ' ' HD2' ' A' ' 431' ' ' LYS . 2.0 tmmm? -161.06 151.44 17.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.452 HG13 ' N ' ' A' ' 433' ' ' PHE . 82.0 t -108.62 137.96 37.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.138 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . 0.55 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.1 m-85 -79.51 153.0 29.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . 0.452 ' CA ' ' HD2' ' A' ' 442' ' ' LYS . 73.0 mt -131.11 159.91 42.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.152 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . 0.416 ' N ' ' CG2' ' A' ' 434' ' ' ILE . 4.1 m-20 -92.34 150.82 20.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.872 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -95.81 -17.17 21.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.95 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -95.39 -40.52 9.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 73.3 p -96.3 -25.54 15.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.126 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 31.3 m120 55.1 42.26 30.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.878 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' A' ' 441' ' ' SER . 15.3 mt -128.99 123.55 32.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.925 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 441' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 440' ' ' LEU . 4.9 p -34.88 103.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.858 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.567 ' HD3' ' CE2' ' A' ' 444' ' ' PHE . 34.6 mttt -51.92 -174.9 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.844 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . 0.469 ' O ' ' N ' ' A' ' 407' ' ' HIS . 23.0 p -112.93 40.62 2.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.914 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . 0.567 ' CE2' ' HD3' ' A' ' 442' ' ' LYS . 6.0 p90 -161.97 138.42 8.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.88 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -136.2 175.46 20.9 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.475 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . 0.489 ' CE1' ' CE1' ' A' ' 404' ' ' PHE . 32.9 t80 -116.03 145.53 42.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.895 0.379 . . . . 0.0 110.857 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 69.3 t -151.44 151.31 12.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.117 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 3.8 m -148.0 153.53 39.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.866 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . 0.566 ' CD1' HD11 ' A' ' 403' ' ' LEU . 4.5 m-85 -115.01 -174.83 2.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.903 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -81.72 -17.54 47.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.869 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -156.44 154.71 27.64 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.672 0.748 . . . . 0.0 110.857 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.44 -6.14 18.29 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.723 2.282 . . . . 0.0 112.343 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 86.1 t -85.25 -33.39 7.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.063 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 61.7 m -85.76 -35.87 20.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.812 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -57.29 -23.8 50.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.095 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -67.33 -53.54 28.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.955 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -40.23 -43.29 1.66 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.152 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . 0.498 ' HA ' ' CD1' ' A' ' 424' ' ' PHE . . . -62.52 -52.29 64.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.124 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 55.5 mt -57.14 -44.16 82.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.132 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -40.94 -55.85 2.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 1.9 m -89.04 -56.1 3.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 462' ' ' MET . . . . . 0.448 ' O ' ' N ' ' A' ' 465' ' ' PHE . 11.1 mmt -40.96 -63.7 0.64 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.86 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . 0.438 ' C ' ' O ' ' A' ' 462' ' ' MET . 37.9 t-20 -35.6 110.92 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.87 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 472' ' ' LEU . . . 67.86 38.43 89.19 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.504 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . 0.448 ' N ' ' O ' ' A' ' 462' ' ' MET . 25.0 t80 -78.59 116.06 18.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.826 0.346 . . . . 0.0 110.919 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 18.7 tp60 -63.07 104.28 0.55 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.874 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 20.0 tt -116.7 118.78 59.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.12 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 64.38 -106.37 1.42 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.449 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -113.31 -11.63 13.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.878 0.37 . . . . 0.0 110.857 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.64 178.41 5.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.864 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -110.1 170.28 8.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.91 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . 0.41 ' O ' ' N ' ' A' ' 464' ' ' GLY . 65.6 mt -114.09 150.07 34.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.88 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -124.61 107.93 11.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 33.0 t -119.05 137.14 54.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.149 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 48.0 tp60 -157.04 145.73 19.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.907 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . 0.486 ' CD1' ' C ' ' A' ' 478' ' ' ARG . 1.5 pp -86.0 127.04 34.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.911 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 476' ' ' LEU . 25.5 ttpt -33.79 -72.39 0.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.853 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . 0.486 ' C ' ' CD1' ' A' ' 476' ' ' LEU . 8.2 mmt180 -146.35 151.03 36.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.821 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 3.8 t -125.39 76.37 1.55 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.828 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -46.43 -67.06 0.31 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.951 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -166.55 161.2 15.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -61.81 128.16 34.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.838 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 92.5 p -67.69 168.86 10.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.923 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.29 -56.86 3.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.927 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 9.4 t 46.08 40.76 7.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.871 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -76.18 -146.06 1.78 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.469 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -79.73 23.97 0.64 Allowed 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.716 2.277 . . . . 0.0 112.405 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 488' ' ' SER . . . . . 0.449 ' O ' ' C ' ' A' ' 489' ' ' SER . 67.0 m -135.56 138.64 43.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.864 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 489' ' ' SER . . . . . 0.449 ' C ' ' O ' ' A' ' 488' ' ' SER . 68.3 p -34.85 -44.45 0.22 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.828 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.496 -179.97 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.377 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 33.0 m -87.51 145.33 26.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.881 0.372 . . . . 0.0 110.874 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 97.3 p -94.05 42.66 1.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.832 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 87.22 -75.68 2.14 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.417 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 36.3 t -46.49 135.1 8.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.877 0.37 . . . . 0.0 110.789 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 95.0 p -92.07 124.98 36.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.85 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -99.65 -62.1 0.83 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.476 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -107.29 84.1 1.92 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.896 0.379 . . . . 0.0 110.911 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 15.0 t -118.78 37.83 3.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.143 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -41.94 101.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.892 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -118.72 87.78 2.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.914 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 80.1 p -94.79 89.61 5.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.882 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 41.3 mm -125.27 135.83 62.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.062 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -67.8 86.11 0.16 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.529 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -61.65 -44.31 97.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.808 0.337 . . . . 0.0 111.16 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -44.24 115.32 0.82 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.099 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 111.33 -47.76 1.01 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.474 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 2.2 m -45.81 130.15 9.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.842 0.353 . . . . 0.0 110.828 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -101.41 -12.66 18.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.877 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.418 ' O ' ' CB ' ' A' ' 429' ' ' SER . 6.6 ptmm? -55.48 161.61 1.9 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . 0.413 ' CD ' ' O ' ' A' ' 397' ' ' GLY . 2.6 pp20? -126.72 -178.33 4.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.868 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . 0.413 ' O ' ' CD ' ' A' ' 396' ' ' GLU . . . -94.06 -146.42 20.14 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.511 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.71 152.05 37.09 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 122.747 2.298 . . . . 0.0 112.368 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -52.83 113.76 1.19 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.905 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 125.76 -28.19 5.0 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.529 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . 0.499 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.93 127.16 43.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.84 0.352 . . . . 0.0 111.09 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.7 OUTLIER -158.6 160.76 36.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.852 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . 0.565 HD13 ' CE1' ' A' ' 449' ' ' TYR . 15.8 mt -156.29 117.76 3.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.909 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . 0.463 ' CE1' ' HB2' ' A' ' 477' ' ' LYS . 12.8 m-85 -125.6 113.04 16.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . 0.501 ' CD1' ' N ' ' A' ' 405' ' ' ILE . 1.8 mp -90.77 136.13 24.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.178 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . 0.426 ' N ' HG22 ' A' ' 405' ' ' ILE . 83.6 m-85 -128.24 169.18 14.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.905 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . 0.43 ' N ' ' O ' ' A' ' 443' ' ' CYS . 30.2 m-70 54.23 53.44 10.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.874 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . 0.434 ' CG ' HG21 ' A' ' 405' ' ' ILE . 35.4 mt -94.1 143.62 26.72 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.608 0.718 . . . . 0.0 110.929 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.568 ' HG2' ' CD1' ' A' ' 412' ' ' PHE . 61.4 Cg_endo -78.21 155.73 29.33 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.674 2.249 . . . . 0.0 112.309 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -60.03 -37.22 79.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.919 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -60.19 -19.87 56.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.865 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.568 ' CD1' ' HG2' ' A' ' 409' ' ' PRO . 4.2 m-85 -89.84 125.88 35.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.828 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -114.55 -141.86 7.75 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.475 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.78 -59.02 2.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.75 0.31 . . . . 0.0 110.892 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . 0.424 ' O ' ' C ' ' A' ' 416' ' ' ASP . 52.3 mm-40 -57.78 -56.49 21.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.906 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 415' ' ' GLN . 62.0 m-20 -36.42 -39.4 0.19 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.855 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 24.2 tp -71.33 -53.58 13.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.947 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . 0.466 ' O ' ' CG ' ' A' ' 422' ' ' MET . 29.6 tp -54.62 -41.19 69.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.878 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -79.78 -9.95 59.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.01 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -85.19 -35.91 21.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.874 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . 0.573 ' CE1' ' SD ' ' A' ' 462' ' ' MET . 5.3 m-85 -98.38 -22.28 16.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' MET . . . . . 0.579 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 0.7 OUTLIER -50.35 -45.84 83.75 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.581 0.705 . . . . 0.0 110.889 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.4 Cg_exo -47.99 -41.79 32.62 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.627 2.218 . . . . 0.0 112.344 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -67.15 -34.39 77.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.902 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 170.5 -178.98 42.87 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.444 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -66.51 124.75 23.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.83 0.347 . . . . 0.0 110.877 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 58.7 t -98.08 118.53 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.143 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 40.5 t -61.98 -51.68 69.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.194 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 3.3 m -143.77 148.76 36.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.825 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -156.82 131.26 8.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.07 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . 0.476 ' CG ' ' N ' ' A' ' 432' ' ' VAL . 14.9 tttm -159.06 162.42 36.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.476 ' N ' ' CG ' ' A' ' 431' ' ' LYS . 69.6 t -121.32 144.41 30.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.145 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . 0.646 ' CG ' ' CE1' ' A' ' 444' ' ' PHE . 4.4 m-85 -86.36 147.89 25.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.917 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . 0.402 HG23 ' N ' ' A' ' 435' ' ' ASP . 76.1 mt -119.3 138.22 50.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.116 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . 0.493 ' O ' ' N ' ' A' ' 439' ' ' ASN . 9.3 t0 -83.34 101.36 11.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . 0.42 ' HG3' ' N ' ' A' ' 437' ' ' GLN . 0.0 OUTLIER -50.8 -33.16 22.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.857 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . 0.42 ' N ' ' HG3' ' A' ' 436' ' ' LYS . 19.9 mm-40 -51.24 -42.12 60.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 438' ' ' THR . . . . . 0.404 ' O ' ' C ' ' A' ' 439' ' ' ASN . 17.8 p -129.27 18.33 5.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.181 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 435' ' ' ASP . 2.3 m-80 37.71 38.54 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 20.4 mt -118.5 130.14 55.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.859 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 8.6 t -41.42 116.89 0.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.556 ' HD3' ' CE2' ' A' ' 444' ' ' PHE . 26.4 mttt -59.3 -174.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . 0.43 ' O ' ' N ' ' A' ' 407' ' ' HIS . 60.7 m -106.83 37.99 2.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.843 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . 0.646 ' CE1' ' CG ' ' A' ' 433' ' ' PHE . 12.0 p90 -162.13 148.34 13.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -143.77 178.44 21.85 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.485 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . 0.503 ' O ' ' CG2' ' A' ' 447' ' ' VAL . 26.1 t80 -117.45 155.01 30.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.949 0.404 . . . . 0.0 110.83 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . 0.503 ' CG2' ' O ' ' A' ' 446' ' ' PHE . 71.4 t -161.35 150.57 4.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.126 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 84.6 p -149.69 141.81 24.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . 0.565 ' CE1' HD13 ' A' ' 403' ' ' LEU . 4.7 m-85 -106.07 -176.01 2.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.917 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.75 -10.57 59.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.883 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . 0.415 ' C ' ' HB2' ' A' ' 401' ' ' ALA . 0.9 OUTLIER -166.91 160.36 11.23 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.592 0.71 . . . . 0.0 110.897 -179.85 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . 0.449 ' N ' ' HB2' ' A' ' 401' ' ' ALA . 60.4 Cg_endo -74.76 -2.12 12.06 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.724 2.282 . . . . 0.0 112.316 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 92.8 t -85.11 -44.03 17.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.112 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 7.4 t -78.57 -34.8 46.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.838 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -59.35 -20.1 51.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.111 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' A' ' 457' ' ' ALA . 35.2 mm-40 -77.82 -53.92 6.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.936 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 456' ' ' GLN . . . -37.74 -44.42 0.73 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.11 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -64.58 -52.41 57.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.093 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 91.2 mt -52.8 -45.81 50.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.106 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -38.49 -58.52 1.02 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.863 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 30.0 t -87.71 -55.69 3.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 462' ' ' MET . . . . . 0.573 ' SD ' ' CE1' ' A' ' 421' ' ' PHE . 8.6 mmt -39.02 -57.54 1.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.876 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -47.1 114.26 0.82 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 75.93 29.69 58.66 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.493 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -73.47 126.45 30.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.837 0.351 . . . . 0.0 110.886 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 25.3 tm0? -69.96 104.67 2.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.928 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 16.8 tt -119.98 138.41 50.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.148 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 46.68 -95.48 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.518 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 8.8 ptp -134.21 5.03 3.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.903 0.382 . . . . 0.0 110.932 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 15.4 pttm -130.7 174.36 10.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.958 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 42.6 mtm-85 -106.73 145.6 31.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.892 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 27.2 mt -89.26 149.43 23.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.925 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 27.6 ttpt -125.63 103.8 8.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.858 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 2.8 t -110.04 137.63 41.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.141 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -157.05 145.74 19.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.93 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . 0.484 ' O ' ' CD1' ' A' ' 476' ' ' LEU . 1.5 pp -91.41 124.84 35.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.942 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.463 ' HB2' ' CE1' ' A' ' 404' ' ' PHE . 13.9 tttm -34.97 105.18 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.948 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -90.07 148.98 22.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 51.7 m -136.89 162.57 32.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.828 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 36.1 tttm -63.46 -60.48 3.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.86 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -106.88 88.5 2.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.932 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -109.06 -53.06 2.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.867 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 3.6 t -97.92 -49.88 4.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.829 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -72.43 174.55 7.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.873 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 88.4 p -123.76 148.2 46.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.844 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -170.42 76.52 0.1 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.504 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -45.57 162.22 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.651 2.234 . . . . 0.0 112.403 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 5.7 t -50.22 124.52 10.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.831 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 74.5 p -73.26 141.11 47.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.888 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.451 -179.97 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.506 -0.237 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 26.3 p -83.39 121.76 27.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.96 0.409 . . . . 0.0 110.843 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 12.4 t -104.58 85.92 2.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.818 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 82.25 -130.33 9.63 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.453 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 1.6 t 58.78 40.86 22.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.837 0.351 . . . . 0.0 110.846 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 73.7 m -118.67 121.26 39.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.832 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 108.98 91.6 2.17 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.468 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -72.44 159.46 33.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.867 0.365 . . . . 0.0 110.896 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 9.0 t -170.77 132.45 0.9 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.195 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -148.76 152.81 37.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.936 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . 0.418 ' N ' ' CD ' ' A' ' 386' ' ' GLN . 2.9 mp0 -65.04 110.28 2.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.941 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 32.8 p -83.06 40.58 0.71 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.856 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 31.0 mt -108.99 99.91 9.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.117 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -71.08 117.74 7.01 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.477 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -90.15 -26.6 20.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.821 0.343 . . . . 0.0 111.089 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -43.62 119.27 1.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.052 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 393' ' ' SER . . . 94.63 -45.07 2.19 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.505 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 392' ' ' GLY . 5.3 p -35.87 126.42 0.71 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.866 0.365 . . . . 0.0 110.856 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -107.36 50.78 0.76 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.886 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.43 177.12 4.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.933 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -136.29 -176.64 4.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -107.03 -143.17 10.96 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.459 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.13 151.89 44.74 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.666 2.244 . . . . 0.0 112.282 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -55.7 100.71 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.964 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 135.92 -25.78 3.19 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.486 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . 0.485 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -98.75 127.05 44.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.806 0.336 . . . . 0.0 111.103 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . 0.485 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 19.2 m-80 -158.86 167.89 28.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.93 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . 0.447 HD13 ' CE1' ' A' ' 449' ' ' TYR . 53.0 mt -158.66 124.6 4.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -130.07 111.02 12.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.911 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . 0.518 HG12 ' CZ ' ' A' ' 421' ' ' PHE . 3.2 mp -91.68 132.31 36.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.131 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -122.21 158.1 30.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.903 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . 0.491 ' O ' ' CD2' ' A' ' 472' ' ' LEU . 53.8 m-70 67.06 55.03 0.72 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.848 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 37.4 mt -100.97 129.9 26.26 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.691 0.757 . . . . 0.0 110.898 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -48.11 -178.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.681 2.254 . . . . 0.0 112.32 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -87.74 -41.93 12.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.935 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -59.9 -36.27 76.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.927 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -57.56 128.98 39.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.88 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . 0.406 ' O ' ' CG2' ' A' ' 432' ' ' VAL . . . -116.08 -138.11 6.29 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.515 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -90.54 -59.22 2.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.732 0.301 . . . . 0.0 110.746 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -51.46 -53.25 39.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.821 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -42.46 -61.74 1.14 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.86 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 33.2 tp -42.44 -49.78 5.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.934 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 52.9 tp -55.19 -58.67 6.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.949 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . 0.49 ' N ' ' OE1' ' A' ' 419' ' ' GLN . 0.8 OUTLIER -57.75 -21.36 40.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.913 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 4.2 ttm -82.21 -29.47 31.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.857 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . 0.518 ' CZ ' HG12 ' A' ' 405' ' ' ILE . 3.8 m-85 -106.9 4.29 27.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.856 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' MET . . . . . 0.588 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 17.5 mtt -73.14 -45.64 8.13 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.588 0.709 . . . . 0.0 110.946 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.7 Cg_exo -47.97 -45.72 24.08 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.673 2.249 . . . . 0.0 112.36 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -61.46 -25.32 67.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 160.21 -177.61 36.59 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.469 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -73.78 100.12 3.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.874 0.369 . . . . 0.0 110.867 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 54.2 t -67.0 122.82 18.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.142 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 76.7 t -75.25 -35.97 35.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.103 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -144.74 143.91 30.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.828 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -161.08 114.77 2.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.064 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . 0.415 ' C ' ' HD2' ' A' ' 431' ' ' LYS . 3.8 tmmm? -160.92 141.54 11.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 413' ' ' GLY . 58.6 t -90.8 139.5 17.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.192 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -82.43 153.21 25.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . 0.488 ' CG2' ' N ' ' A' ' 435' ' ' ASP . 67.1 mt -128.01 164.48 29.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.141 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . 0.488 ' N ' ' CG2' ' A' ' 434' ' ' ILE . 5.1 m-20 -98.09 152.1 19.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.91 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.08 -16.73 22.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.855 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 35.6 tp60 -96.04 -41.95 8.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.928 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 70.1 p -95.26 -25.36 16.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.105 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 34.8 m-20 56.76 33.6 23.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.86 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.436 ' O ' ' C ' ' A' ' 441' ' ' SER . 23.7 mt -121.01 126.67 50.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.944 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 441' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 440' ' ' LEU . 1.5 m -35.39 102.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.839 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.565 ' HD3' ' CE2' ' A' ' 444' ' ' PHE . 25.2 mttm -47.38 174.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.837 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . 0.434 ' O ' ' N ' ' A' ' 407' ' ' HIS . 27.3 p -100.28 34.99 2.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.917 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . 0.565 ' CE2' ' HD3' ' A' ' 442' ' ' LYS . 7.4 p90 -162.07 147.03 12.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.86 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -135.35 178.71 18.39 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.525 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . 0.425 ' O ' ' CG2' ' A' ' 447' ' ' VAL . 28.4 t80 -117.33 154.57 31.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.863 0.363 . . . . 0.0 110.883 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . 0.425 ' CG2' ' O ' ' A' ' 446' ' ' PHE . 72.2 t -158.53 155.96 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.116 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 448' ' ' SER . . . . . 0.412 ' N ' ' CG1' ' A' ' 447' ' ' VAL . 3.8 m -154.38 154.06 32.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.828 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . 0.447 ' CE1' HD13 ' A' ' 403' ' ' LEU . 4.4 m-85 -118.43 -175.25 2.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.899 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.25 -12.53 59.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.86 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -157.61 156.36 28.59 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-O 121.659 0.742 . . . . 0.0 110.846 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . 0.464 ' CA ' ' HB1' ' A' ' 401' ' ' ALA . 61.1 Cg_endo -75.45 0.21 9.36 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.648 2.232 . . . . 0.0 112.332 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 99.2 t -90.04 -38.84 11.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.134 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 31.2 m -79.34 -38.5 34.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.828 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -51.15 -42.92 61.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.069 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . 0.414 ' O ' ' C ' ' A' ' 457' ' ' ALA . 23.3 mm-40 -59.73 -51.27 70.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.917 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 456' ' ' GLN . . . -36.52 -41.94 0.32 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.083 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -64.43 -69.75 0.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.057 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 82.5 mt -43.55 -42.56 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.119 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -39.68 -45.73 1.73 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 30.0 t -100.71 -56.29 2.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 87.9 mmm -43.36 -33.15 0.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.881 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -53.01 103.14 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.873 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 83.49 30.77 29.26 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.565 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -67.67 110.4 3.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.783 0.325 . . . . 0.0 110.886 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 9.8 tm0? -66.03 107.16 1.8 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.908 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 17.0 tt -120.52 138.04 52.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.056 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 53.29 -96.44 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.449 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 2.4 ttt -131.89 -1.09 3.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.883 0.373 . . . . 0.0 110.895 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.35 174.68 8.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.891 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 54.5 mtm180 -105.22 172.64 6.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.84 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . 0.491 ' CD2' ' O ' ' A' ' 407' ' ' HIS . 82.2 mt -121.24 156.09 33.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.95 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -134.13 108.45 8.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.863 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 8.6 t -110.04 133.84 54.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.165 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -156.97 139.1 14.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.946 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . 0.446 ' O ' ' C ' ' A' ' 477' ' ' LYS . 1.6 pp -81.1 136.92 35.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.925 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 476' ' ' LEU . 21.7 tptt -34.01 107.48 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -97.3 179.34 4.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 45.4 m 59.27 48.69 9.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -72.52 89.64 1.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.978 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -61.81 138.71 58.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.934 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 11.5 t70 66.62 45.19 2.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.895 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 77.4 p -89.74 -42.49 11.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.882 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 45.4 pttt -112.85 136.74 52.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.95 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 2.9 m -131.7 130.48 42.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.835 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -176.21 97.45 0.11 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.431 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -43.31 167.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.666 2.244 . . . . 0.0 112.349 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 3.5 m -55.23 -66.39 0.42 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 4.1 p -131.86 65.84 1.56 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.837 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.388 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.507 179.96 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 11.2 m -82.0 169.69 16.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.844 0.354 . . . . 0.0 110.875 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 29.3 m -47.46 168.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -164.61 57.44 0.26 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.445 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 27.4 m -116.45 102.5 9.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.894 0.378 . . . . 0.0 110.836 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 3.3 m -98.4 138.07 36.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.903 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -104.8 106.88 2.79 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.492 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 6.5 mp -121.53 126.64 49.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.938 0.399 . . . . 0.0 110.871 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 45.8 p -133.42 172.39 12.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.165 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -77.91 -57.79 3.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.987 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -141.92 124.09 15.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.959 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 7.0 m -122.05 45.59 2.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.864 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 64.6 mt -108.65 -47.28 7.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.124 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 43.9 67.94 0.95 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.513 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -72.69 -49.82 28.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.834 0.35 . . . . 0.0 111.141 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -39.92 119.93 1.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.091 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 81.13 53.95 3.74 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.51 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 3.2 m -140.16 135.97 33.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.817 0.341 . . . . 0.0 110.874 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -103.46 33.73 3.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.001 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm -98.27 160.4 14.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.42 -176.76 3.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.946 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -110.73 -154.42 13.73 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.47 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -48.06 176.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.717 2.278 . . . . 0.0 112.263 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . 0.441 ' CD ' ' O ' ' A' ' 399' ' ' GLU . 0.2 OUTLIER -83.24 83.58 7.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.926 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 144.65 -14.77 2.0 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.468 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . 0.471 ' HB1' ' N ' ' A' ' 452' ' ' PRO . . . -98.2 126.5 43.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.815 0.34 . . . . 0.0 111.145 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . 0.437 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 29.3 m-80 -159.41 162.45 35.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . 0.573 HD12 ' CE1' ' A' ' 449' ' ' TYR . 28.6 mt -159.78 109.18 1.82 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . 0.432 ' CE1' ' CD1' ' A' ' 446' ' ' PHE . 19.2 m-85 -112.63 114.81 27.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . 0.444 ' CG1' ' CZ ' ' A' ' 421' ' ' PHE . 3.9 mp -90.87 135.72 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.113 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . 0.41 ' CD1' ' HB2' ' A' ' 444' ' ' PHE . 89.9 m-85 -130.22 168.25 17.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.952 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 32.6 m-70 61.4 48.68 5.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 38.0 mt -95.71 148.32 34.39 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.592 0.71 . . . . 0.0 110.914 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.566 ' HG2' ' CD1' ' A' ' 412' ' ' PHE . 59.9 Cg_endo -73.35 -169.77 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.699 2.266 . . . . 0.0 112.329 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -95.21 -38.01 10.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.932 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . 0.416 ' OE1' ' C ' ' A' ' 411' ' ' GLU . 0.3 OUTLIER -58.37 -32.45 68.58 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.922 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.566 ' CD1' ' HG2' ' A' ' 409' ' ' PRO . 4.1 m-85 -62.01 158.81 15.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -142.82 -140.74 3.76 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.547 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -88.65 -48.83 7.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.738 0.304 . . . . 0.0 110.876 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . 0.463 ' O ' ' N ' ' A' ' 418' ' ' LEU . 19.9 mp0 -64.43 -58.23 7.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.963 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 415' ' ' GLN . 35.9 m-20 -34.43 -56.6 0.52 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.899 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 24.3 tp -53.34 -43.42 67.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . 0.463 ' N ' ' O ' ' A' ' 415' ' ' GLN . 11.1 tp -65.04 -51.56 60.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.962 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -69.48 -9.85 55.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.951 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 2.8 ttm -89.79 -25.55 21.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.902 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . 0.444 ' CZ ' ' CG1' ' A' ' 405' ' ' ILE . 5.2 m-85 -104.57 -12.16 16.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.937 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' MET . . . . . 0.577 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 7.6 mtt -57.38 -46.12 99.83 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.56 0.695 . . . . 0.0 110.823 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 422' ' ' MET . 64.5 Cg_exo -47.94 -39.63 32.48 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.71 2.273 . . . . 0.0 112.31 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . 0.569 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 73.4 m-85 -68.23 -35.67 78.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.905 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 172.16 -173.84 45.29 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.487 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.94 114.56 12.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.86 0.362 . . . . 0.0 110.905 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 98.2 t -84.79 124.4 39.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.153 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . 0.416 HG23 ' C ' ' A' ' 449' ' ' TYR . 17.1 t -70.93 -54.05 19.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.08 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 14.6 m -148.63 136.57 20.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.859 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -144.35 134.46 24.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.132 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . 0.423 ' CG ' ' N ' ' A' ' 432' ' ' VAL . 20.6 tttt -159.97 159.29 32.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.888 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.431 HG12 ' N ' ' A' ' 433' ' ' PHE . 38.8 t -111.03 144.64 18.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.165 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . 0.558 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 7.5 m-85 -91.98 152.46 20.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . 0.467 ' CA ' ' HG3' ' A' ' 442' ' ' LYS . 64.2 mt -137.6 144.27 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.132 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . 0.401 ' O ' ' N ' ' A' ' 439' ' ' ASN . 1.5 t70 -84.16 137.18 33.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.867 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.32 -30.0 61.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.881 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -73.28 -49.54 27.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 25.6 p -85.65 -35.13 21.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.172 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . 0.401 ' N ' ' O ' ' A' ' 435' ' ' ASP . 3.2 t30 71.85 31.02 2.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.824 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.421 ' O ' ' C ' ' A' ' 441' ' ' SER . 8.6 mt -135.95 153.08 51.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.893 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 441' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 440' ' ' LEU . 1.5 t -36.81 139.58 0.19 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.845 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.574 ' HB3' ' CE2' ' A' ' 444' ' ' PHE . 16.3 mtpt -86.56 20.29 2.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.852 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . 0.41 ' SG ' ' O ' ' A' ' 442' ' ' LYS . 0.9 OUTLIER 52.42 25.13 3.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.819 179.933 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . 0.584 ' CD1' ' C ' ' A' ' 444' ' ' PHE . 1.1 p90 -161.71 145.65 12.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.876 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -139.25 179.16 18.94 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.534 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . 0.432 ' CD1' ' CE1' ' A' ' 404' ' ' PHE . 26.7 t80 -116.93 150.59 38.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.888 0.375 . . . . 0.0 110.875 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . 0.403 HG13 ' N ' ' A' ' 448' ' ' SER . 21.0 t -153.91 143.15 13.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.117 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 448' ' ' SER . . . . . 0.403 ' N ' HG13 ' A' ' 447' ' ' VAL . 99.8 p -139.05 141.85 38.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.865 -179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . 0.573 ' CE1' HD12 ' A' ' 403' ' ' LEU . 3.2 m-85 -108.92 175.18 5.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.912 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -69.59 -20.21 63.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.821 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -153.95 155.69 31.39 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.687 0.756 . . . . 0.0 110.836 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . 0.471 ' N ' ' HB1' ' A' ' 401' ' ' ALA . 59.6 Cg_endo -72.91 -15.65 26.28 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.686 2.258 . . . . 0.0 112.319 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 97.3 t -74.74 -43.09 47.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.134 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 1.9 t -75.61 -41.95 53.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.886 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -47.76 -42.78 26.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.153 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -59.16 -46.44 88.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.925 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -37.75 -44.34 0.72 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.1 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . 0.569 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -64.28 -69.73 0.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.157 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . 0.405 ' O ' ' C ' ' A' ' 460' ' ' GLN . 93.9 mt -40.33 -47.43 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.167 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 459' ' ' ILE . 40.7 mt-30 -38.04 -51.7 1.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.89 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 17.4 t -93.94 -54.87 3.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.839 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 462' ' ' MET . . . . . 0.463 ' O ' ' N ' ' A' ' 465' ' ' PHE . 77.5 mmm -43.7 -51.46 7.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.872 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 462' ' ' MET . 36.7 t-20 -38.17 105.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.921 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 472' ' ' LEU . . . 78.92 33.59 36.55 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.508 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . 0.463 ' N ' ' O ' ' A' ' 462' ' ' MET . 83.2 t80 -73.92 117.97 16.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.81 0.338 . . . . 0.0 110.907 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 5.2 tm0? -66.32 104.55 1.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.953 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 12.4 tt -117.65 139.33 45.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.114 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 49.54 -95.93 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.472 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 6.5 ptp -131.43 0.42 4.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.853 0.359 . . . . 0.0 110.914 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.7 172.93 11.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 48.2 mtt85 -100.91 167.32 10.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.887 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . 0.435 ' O ' ' N ' ' A' ' 464' ' ' GLY . 58.5 mt -114.81 152.98 31.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.005 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -130.69 106.62 8.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 15.6 t -112.44 131.88 62.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.121 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -154.4 137.77 15.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' A' ' 477' ' ' LYS . 1.6 pp -79.5 132.84 36.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.856 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 476' ' ' LEU . 55.7 tttt -35.92 102.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.886 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 32.8 ttt-85 -118.25 100.45 7.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.9 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 84.3 p -41.88 146.44 0.27 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.875 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -55.77 -51.87 65.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.861 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -108.87 114.78 28.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.916 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . 0.418 ' OD1' ' C ' ' A' ' 482' ' ' ASP . 0.0 OUTLIER -93.03 -49.21 6.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.831 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 2.9 m -134.29 99.61 4.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.773 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 7.2 ptmm? -59.07 121.85 12.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.913 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 29.2 t -129.21 81.49 2.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.87 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 63.32 146.07 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.501 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -46.68 120.87 4.3 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.63 2.22 . . . . 0.0 112.379 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 64.2 p -73.28 145.72 45.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 41.2 p -89.06 123.0 32.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.832 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.261 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.44 -179.957 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.547 -0.221 . . . . 0.0 112.547 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 8.8 t -77.49 129.54 35.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.857 0.36 . . . . 0.0 110.85 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 24.8 p -146.85 140.42 25.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.866 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -125.15 135.19 9.23 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.52 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 5.8 m -115.89 97.71 6.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.834 0.35 . . . . 0.0 110.857 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 8.5 t -104.17 41.08 1.35 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.902 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 383' ' ' LEU . . . 161.24 -106.28 0.28 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.444 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . 0.425 ' C ' ' O ' ' A' ' 382' ' ' GLY . 69.4 mt 36.04 39.37 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.929 0.395 . . . . 0.0 110.982 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 15.1 t -90.83 157.96 17.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.2 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -84.57 127.22 33.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.903 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -84.33 178.3 7.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.889 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 78.1 p -105.31 123.02 47.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.844 -179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 3.2 mp -117.62 101.94 12.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.096 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -100.34 48.58 1.18 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.498 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -91.92 -28.43 17.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.812 0.339 . . . . 0.0 111.147 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -56.58 103.44 0.11 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.149 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 98.98 -39.34 2.77 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.442 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 14.9 m -46.92 123.06 4.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.827 0.346 . . . . 0.0 110.841 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -93.57 25.81 3.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.907 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.497 ' O ' ' CB ' ' A' ' 429' ' ' SER . 9.8 ptmt -82.64 163.23 21.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -128.67 -175.73 3.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -100.48 -146.38 19.25 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.468 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.53 151.41 41.99 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.698 2.265 . . . . 0.0 112.314 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -51.46 104.01 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 130.58 -24.85 4.32 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.445 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . 0.494 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -98.02 126.98 43.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.341 . . . . 0.0 111.098 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 16.6 m-80 -158.98 164.29 35.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.874 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . 0.562 HD13 ' CE1' ' A' ' 449' ' ' TYR . 34.5 mt -158.05 124.83 4.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.917 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . 0.493 ' CZ ' ' CD1' ' A' ' 446' ' ' PHE . 35.5 m-85 -130.96 113.32 13.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.846 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . 0.459 HG23 ' CG ' ' A' ' 408' ' ' LEU . 3.2 mp -90.75 136.09 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.122 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . 0.407 ' N ' HG21 ' A' ' 405' ' ' ILE . 62.4 m-85 -127.74 159.77 33.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 28.8 m-70 60.14 54.99 3.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.855 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . 0.459 ' CG ' HG23 ' A' ' 405' ' ' ILE . 19.3 mt -93.8 140.73 23.1 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.534 0.683 . . . . 0.0 110.943 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.565 ' HG2' ' CE1' ' A' ' 412' ' ' PHE . 77.6 Cg_exo -49.83 -173.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.67 2.247 . . . . 0.0 112.334 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -96.3 -35.62 11.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.953 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 25.3 pm0 -76.16 -13.77 60.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.858 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.565 ' CE1' ' HG2' ' A' ' 409' ' ' PRO . 5.3 m-85 -71.81 129.05 37.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -120.31 -152.93 9.04 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.44 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.48 -57.88 3.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.743 0.306 . . . . 0.0 110.886 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -54.9 -51.97 64.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.886 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -42.29 -58.57 2.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.833 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 44.8 tp -54.19 -45.8 72.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.927 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 18.2 tp -54.72 -55.39 30.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.865 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -72.89 -9.29 58.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.882 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -82.68 -20.85 35.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -115.18 -12.22 11.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.878 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 422' ' ' MET . . . . . 0.579 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 18.0 mtt -54.05 -45.84 98.9 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.611 0.719 . . . . 0.0 110.882 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.2 Cg_exo -48.05 -35.14 25.0 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.613 2.208 . . . . 0.0 112.335 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . 0.536 ' CZ ' ' SD ' ' A' ' 462' ' ' MET . 72.2 m-85 -73.89 -30.18 62.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 167.63 -171.87 42.3 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.502 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -77.91 98.77 5.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.888 0.375 . . . . 0.0 110.878 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 90.6 t -67.98 114.97 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.12 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . 0.425 HG23 ' C ' ' A' ' 449' ' ' TYR . 17.8 t -66.18 -45.54 89.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.121 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 429' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 30.8 t -135.87 144.58 45.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.821 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -157.17 106.36 2.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.075 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . 0.421 ' C ' ' HD3' ' A' ' 431' ' ' LYS . 1.1 tmtp? -142.5 143.98 32.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.895 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 66.2 t -113.75 148.59 16.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.102 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . 0.434 ' C ' ' HG3' ' A' ' 442' ' ' LYS . 2.9 m-85 -84.11 144.51 28.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.934 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . 0.414 ' CG2' ' N ' ' A' ' 435' ' ' ASP . 14.7 mt -129.09 165.66 28.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . 0.425 ' N ' ' HE3' ' A' ' 442' ' ' LYS . 5.9 t0 -106.52 131.53 53.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.83 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 14.7 ttmt -86.73 33.26 0.65 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.872 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -125.19 -42.27 2.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 438' ' ' THR . . . . . 0.405 ' O ' ' CG ' ' A' ' 439' ' ' ASN . 51.1 p -128.85 14.29 6.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.069 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . 0.405 ' CG ' ' O ' ' A' ' 438' ' ' THR . 1.5 p-10 45.75 30.65 0.86 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.933 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 31.8 mt -96.81 120.8 37.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.878 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 1.9 m -52.37 122.2 8.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.434 ' HG3' ' C ' ' A' ' 433' ' ' PHE . 4.7 mmtp -53.04 -174.85 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.898 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 30.4 p -112.96 32.3 5.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.879 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -161.29 151.93 18.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.879 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -152.57 176.82 30.62 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.495 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . 0.493 ' CD1' ' CZ ' ' A' ' 404' ' ' PHE . 56.5 t80 -115.96 155.84 27.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.905 0.383 . . . . 0.0 110.885 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . 0.404 ' CG2' ' O ' ' A' ' 446' ' ' PHE . 53.5 t -158.69 152.43 6.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.18 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 29.6 p -151.06 152.23 33.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.856 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . 0.562 ' CE1' HD13 ' A' ' 403' ' ' LEU . 4.5 m-85 -117.82 -177.51 3.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.895 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.48 -12.73 60.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . 0.459 ' OD1' ' N ' ' A' ' 451' ' ' ASN . 0.5 OUTLIER -159.25 159.99 28.66 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.627 0.727 . . . . 0.0 110.902 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . 0.458 ' N ' ' HB1' ' A' ' 401' ' ' ALA . 61.1 Cg_endo -75.23 -19.69 17.14 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.67 2.247 . . . . 0.0 112.379 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 60.3 t -72.94 -43.38 59.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.09 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 16.2 m -75.8 -44.7 39.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.873 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -52.25 -34.88 48.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.152 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 14.7 mm-40 -63.82 -44.35 93.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.904 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -41.8 -40.19 1.99 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.088 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . 0.477 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -62.39 -68.5 0.32 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.089 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . 0.444 ' O ' ' CB ' ' A' ' 463' ' ' ASN . 66.8 mt -45.71 -46.02 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.188 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -38.82 -50.48 1.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 2.8 m -97.12 -56.84 2.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.892 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 462' ' ' MET . . . . . 0.536 ' SD ' ' CZ ' ' A' ' 424' ' ' PHE . 81.1 mmm -42.64 -45.44 4.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.853 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . 0.444 ' CB ' ' O ' ' A' ' 459' ' ' ILE . 9.5 t30 -43.89 108.19 0.11 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.869 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 78.32 30.49 49.85 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.466 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -68.11 115.37 7.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.817 0.341 . . . . 0.0 110.894 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 18.6 tm0? -67.25 107.96 2.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.943 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 19.2 tt -126.22 126.31 69.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.108 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 64.26 -103.68 0.77 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.514 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 56.7 mtp -124.12 0.87 8.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.842 0.353 . . . . 0.0 110.9 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -131.18 -179.82 5.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.894 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 39.2 mtt-85 -112.68 164.39 13.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.881 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 65.8 mt -103.09 152.34 21.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.9 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 17.9 tttm -130.31 99.94 5.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.885 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 3.2 t -108.82 140.63 26.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.169 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -157.07 147.48 21.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.921 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . 0.48 ' O ' ' CD1' ' A' ' 476' ' ' LEU . 1.3 pp -94.25 127.21 39.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.923 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 476' ' ' LEU . 31.9 tttm -35.25 110.6 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 12.4 ttt180 -114.63 -46.16 2.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.857 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 70.5 m -61.43 133.83 56.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.826 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -63.26 149.42 45.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.899 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -50.61 -47.33 58.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.904 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.79 143.9 45.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.825 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 2.7 m -53.6 108.09 0.31 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.916 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 33.6 tttm -64.92 89.79 0.08 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.92 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 20.2 m -146.04 133.5 20.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -172.14 166.0 38.76 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.555 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.06 -49.3 0.11 Allowed 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 122.674 2.25 . . . . 0.0 112.34 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 92.6 p -101.77 169.89 8.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 10.3 t -108.11 83.48 1.79 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.444 179.956 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 4.3 m -160.26 132.51 6.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.925 0.393 . . . . 0.0 110.845 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 21.8 t -91.31 98.08 11.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.883 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -51.17 120.95 10.27 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.437 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 15.2 t -95.37 -55.19 3.13 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.882 0.373 . . . . 0.0 110.839 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 12.2 t -61.89 130.81 47.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.792 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -151.82 119.15 0.95 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.471 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 4.2 pp -85.53 31.5 0.59 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.903 0.383 . . . . 0.0 110.891 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 50.5 m -120.51 108.83 14.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.065 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -90.73 -59.09 2.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.902 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -117.03 125.5 51.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 12.8 t -119.57 113.63 21.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.883 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 5.3 mp -102.02 103.58 15.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.135 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -37.29 118.13 0.53 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.491 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -118.69 38.47 3.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.749 0.309 . . . . 0.0 111.048 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -107.87 105.14 14.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.075 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 99.99 38.45 3.6 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.465 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.1 t -129.35 129.38 44.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.777 0.323 . . . . 0.0 110.843 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -93.32 53.76 1.97 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.861 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -111.7 166.59 11.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.931 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -138.95 174.67 10.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.864 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -98.0 -145.27 18.6 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.51 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.57 153.33 43.99 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.736 2.291 . . . . 0.0 112.358 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 15.1 tm-20 -54.98 110.64 0.69 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.899 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 129.22 -27.7 4.2 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.474 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . 0.491 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.94 126.77 43.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.774 0.321 . . . . 0.0 111.086 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.6 OUTLIER -158.99 160.32 35.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.861 -179.918 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . 0.43 HD11 ' CD1' ' A' ' 449' ' ' TYR . 38.7 mt -159.61 114.24 2.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.902 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . 0.641 ' CZ ' ' CD1' ' A' ' 446' ' ' PHE . 42.6 m-85 -122.23 111.91 17.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.9 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . 0.494 HG12 ' CZ ' ' A' ' 421' ' ' PHE . 3.6 mp -91.65 134.99 28.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.152 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -124.56 169.29 12.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.922 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 57.47 44.43 21.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.832 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 30.4 mt -91.09 134.55 29.83 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.625 0.726 . . . . 0.0 110.886 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -48.77 -179.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.683 2.255 . . . . 0.0 112.377 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -85.16 -46.06 11.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.9 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -58.88 -36.04 73.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.925 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -55.4 116.91 3.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.844 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -107.48 -151.88 17.44 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.436 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.96 -44.22 40.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.779 0.323 . . . . 0.0 110.877 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . 0.407 ' O ' ' C ' ' A' ' 416' ' ' ASP . 3.4 mp0 -62.88 -56.88 13.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.923 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . 0.407 ' C ' ' O ' ' A' ' 415' ' ' GLN . 36.3 m-20 -36.99 -64.92 0.33 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 17.5 tp -42.73 -46.5 5.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.958 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . 0.453 ' O ' ' CG ' ' A' ' 422' ' ' MET . 14.9 tp -63.69 -37.41 87.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.913 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -80.44 -16.04 55.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.885 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 2.7 tpp -87.17 -30.43 21.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.881 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . 0.598 ' CE1' ' SD ' ' A' ' 462' ' ' MET . 4.6 m-85 -98.44 -25.55 14.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 422' ' ' MET . . . . . 0.546 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 0.3 OUTLIER -45.23 -47.94 33.17 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.541 0.686 . . . . 0.0 110.926 179.948 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . 0.546 ' CD ' ' N ' ' A' ' 422' ' ' MET . 63.9 Cg_exo -47.95 -46.12 22.84 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.722 2.281 . . . . 0.0 112.408 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . 0.436 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 90.1 m-85 -64.57 -33.96 77.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.854 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 169.03 163.58 23.31 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.541 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -56.46 118.47 4.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.863 0.363 . . . . 0.0 110.906 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 41.7 t -88.19 123.98 41.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.171 179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 65.1 t -75.8 -36.11 32.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.09 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.39 143.14 32.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.859 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -160.82 111.68 1.8 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.151 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -157.48 143.5 17.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.952 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.442 HG13 ' N ' ' A' ' 433' ' ' PHE . 78.5 t -94.12 146.48 6.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.166 179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . 0.461 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.4 m-30 -87.72 154.05 20.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.798 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 46.4 mt -128.39 156.08 40.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.177 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -91.22 144.72 25.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 13.6 ttmm -89.62 -10.2 46.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -94.57 -45.4 7.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.849 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 70.5 p -94.8 -36.46 11.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.129 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 72.98 39.18 0.65 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.899 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.441 ' O ' ' C ' ' A' ' 441' ' ' SER . 21.2 mt -130.99 127.5 38.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.936 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 441' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 440' ' ' LEU . 15.0 m -34.53 106.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.561 ' HD3' ' CE2' ' A' ' 444' ' ' PHE . 17.1 mttm -51.61 -174.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.942 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 26.8 p -107.15 38.21 2.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.929 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . 0.561 ' CE2' ' HD3' ' A' ' 442' ' ' LYS . 8.9 p90 -162.07 144.24 11.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.92 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -135.16 168.29 23.79 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.491 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . 0.641 ' CD1' ' CZ ' ' A' ' 404' ' ' PHE . 26.7 t80 -109.3 151.64 26.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.919 0.39 . . . . 0.0 110.913 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . 0.47 HG13 ' N ' ' A' ' 448' ' ' SER . 23.0 t -155.42 144.81 12.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.104 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 448' ' ' SER . . . . . 0.47 ' N ' HG13 ' A' ' 447' ' ' VAL . 1.8 m -143.22 141.06 30.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.896 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . 0.43 ' CD1' HD11 ' A' ' 403' ' ' LEU . 6.1 m-85 -107.43 176.61 5.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.913 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -72.01 -29.65 64.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.882 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -140.98 153.52 67.37 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.71 0.766 . . . . 0.0 110.871 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.39 0.12 8.46 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.716 2.277 . . . . 0.0 112.376 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 87.7 t -88.76 -37.66 10.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.131 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 22.9 t -78.88 -41.5 29.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.819 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -49.1 -37.0 20.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.177 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -62.25 -52.22 64.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.969 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -37.82 -45.67 0.86 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.106 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . 0.436 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -62.92 -62.96 1.37 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.108 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . 0.436 ' O ' ' C ' ' A' ' 460' ' ' GLN . 70.0 mt -47.43 -48.01 9.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.163 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . 0.436 ' C ' ' O ' ' A' ' 459' ' ' ILE . 49.7 mt-30 -34.35 -45.6 0.23 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.841 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 1.9 m -103.46 -56.27 2.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.882 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 462' ' ' MET . . . . . 0.598 ' SD ' ' CE1' ' A' ' 421' ' ' PHE . 5.7 mmt -38.93 -45.74 1.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -59.8 89.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.904 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 114.16 -10.39 22.52 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.517 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -43.53 110.32 0.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.741 0.305 . . . . 0.0 110.945 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -63.22 105.75 0.77 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.863 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . 0.405 ' O ' ' CG2' ' A' ' 467' ' ' ILE . 15.4 tt -110.9 122.35 65.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.103 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 61.96 -100.42 0.29 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.568 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 9.7 mtt -120.13 -14.52 8.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.885 0.374 . . . . 0.0 110.842 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 31.2 pttt -117.16 179.47 4.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.933 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 50.1 mtt180 -107.23 173.44 6.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.863 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 94.4 mt -113.45 154.14 27.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -129.68 104.84 7.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.899 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 23.8 t -114.28 135.94 52.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.128 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . 0.477 ' NE2' ' NH2' ' A' ' 478' ' ' ARG . 28.6 tp60 -157.06 143.63 18.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . 0.471 ' CB ' ' O ' ' A' ' 402' ' ' ASN . 1.5 pp -86.9 125.37 33.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.916 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 476' ' ' LEU . 26.0 tttm -34.09 116.78 0.31 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.912 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . 0.477 ' NH2' ' NE2' ' A' ' 475' ' ' GLN . 32.1 mtt85 -81.4 122.92 28.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.823 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 83.9 p -105.42 150.75 24.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.825 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -121.57 148.61 44.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.868 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -135.66 133.34 38.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.867 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -119.13 127.25 53.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.833 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 1.3 t -171.83 166.65 6.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.804 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 16.8 ttmm -160.68 137.44 8.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.926 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 3.3 m -100.47 114.1 27.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.893 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -130.11 95.48 0.35 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.476 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -45.08 136.86 10.22 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.74 2.294 . . . . 0.0 112.357 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 44.2 m -82.75 -46.99 12.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.818 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 8.5 m -73.06 111.89 8.59 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.879 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.251 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.492 -180.0 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 63.1 m -114.01 106.24 14.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.883 0.373 . . . . 0.0 110.892 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 3.6 m -93.1 115.02 27.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.843 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -178.19 44.13 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.493 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 83.7 p -67.11 135.21 53.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.928 0.394 . . . . 0.0 110.843 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 10.5 t -128.63 147.19 50.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.94 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 81.28 84.11 0.75 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.516 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . 0.438 HD22 ' N ' ' A' ' 383' ' ' LEU . 4.2 mm? -115.25 107.99 15.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.893 0.378 . . . . 0.0 110.954 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' THR . . . . . 0.433 ' O ' ' C ' ' A' ' 385' ' ' GLN . 26.0 m -90.67 89.2 7.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.161 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . 0.433 ' C ' ' O ' ' A' ' 384' ' ' THR . 7.4 pt20 35.32 42.52 0.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.913 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 7.5 mm100 -88.31 85.7 6.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.826 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 42.7 p -121.02 95.32 4.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.89 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 4.5 mp -96.59 98.09 7.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.154 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -79.04 72.87 2.41 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.518 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -101.24 84.25 2.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.854 0.359 . . . . 0.0 111.101 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -133.7 120.39 20.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.099 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.408 ' CA ' ' HB2' ' A' ' 431' ' ' LYS . . . 97.07 -45.62 1.78 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.493 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 19.1 m -39.29 114.75 0.43 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.845 0.355 . . . . 0.0 110.904 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . 0.432 ' CD ' ' O ' ' A' ' 394' ' ' GLN . 11.2 tm0? -88.25 28.29 1.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.956 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.414 ' O ' ' CB ' ' A' ' 429' ' ' SER . 18.8 mtpp -88.84 165.42 14.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.896 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -121.53 -177.44 3.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.85 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -103.74 -163.31 25.09 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.518 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -49.45 157.84 2.0 Allowed 'Trans proline' 0 C--N 1.34 0.128 0 C-N-CA 122.683 2.255 . . . . 0.0 112.312 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -66.37 82.15 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.847 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 148.18 -18.2 1.36 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.495 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . 0.511 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -106.93 126.75 52.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.751 0.31 . . . . 0.0 111.08 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.3 OUTLIER -158.14 169.41 24.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.895 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . 0.541 HD13 ' CE1' ' A' ' 449' ' ' TYR . 16.3 mt -159.97 115.79 2.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.904 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . 0.545 ' CE1' ' CE1' ' A' ' 446' ' ' PHE . 25.3 m-85 -120.0 111.5 17.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.833 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . 0.48 HG12 ' CZ ' ' A' ' 421' ' ' PHE . 2.9 mp -91.01 136.01 25.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.16 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . 0.401 ' N ' HG22 ' A' ' 405' ' ' ILE . 8.8 m-85 -124.41 177.81 5.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.834 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . 0.462 ' N ' ' CD2' ' A' ' 407' ' ' HIS . 4.2 m170 47.74 54.2 10.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.885 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . 0.404 ' O ' ' O ' ' A' ' 409' ' ' PRO . 30.5 mt -96.62 140.86 22.38 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.575 0.703 . . . . 0.0 110.929 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.562 ' HG2' ' CE1' ' A' ' 412' ' ' PHE . 77.0 Cg_exo -49.81 -173.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.691 2.261 . . . . 0.0 112.32 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -95.52 -29.58 14.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -78.67 -20.29 50.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.949 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.562 ' CE1' ' HG2' ' A' ' 409' ' ' PRO . 5.4 m-85 -64.91 128.49 35.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.799 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . 0.426 ' O ' ' CG2' ' A' ' 432' ' ' VAL . . . -117.68 -139.93 6.42 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.507 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -88.01 -36.82 16.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.833 0.349 . . . . 0.0 110.898 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . 0.437 ' O ' ' N ' ' A' ' 418' ' ' LEU . 19.8 mm-40 -71.36 -58.26 3.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.913 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -37.96 -49.38 1.25 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.882 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 53.0 tp -58.59 -40.96 84.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.914 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 415' ' ' GLN . 20.7 tp -64.93 -58.15 6.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.897 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -66.77 -8.95 31.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.925 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -87.69 -27.36 22.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.833 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . 0.48 ' CZ ' HG12 ' A' ' 405' ' ' ILE . 3.4 m-85 -110.32 6.61 22.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.827 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 422' ' ' MET . . . . . 0.582 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 13.5 mtt -73.4 -45.76 7.66 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.549 0.69 . . . . 0.0 110.876 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 422' ' ' MET . 63.9 Cg_exo -47.96 -28.8 10.77 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.674 2.249 . . . . 0.0 112.418 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . 0.41 ' CE2' ' HA ' ' A' ' 458' ' ' ALA . 81.7 m-85 -76.7 -34.06 58.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.924 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 164.35 -163.63 36.21 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.488 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -72.68 134.77 45.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.889 0.376 . . . . 0.0 110.855 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 18.7 t -107.97 116.84 52.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.17 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 31.4 t -68.22 -55.34 16.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.181 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 429' ' ' SER . . . . . 0.414 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 0.9 OUTLIER -136.75 148.61 47.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.854 -179.864 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -161.06 120.1 2.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.117 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . 0.408 ' HB2' ' CA ' ' A' ' 392' ' ' GLY . 0.4 OUTLIER -161.09 141.88 11.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.92 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.426 ' CG2' ' O ' ' A' ' 413' ' ' GLY . 84.0 t -86.99 153.91 3.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.159 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . 0.558 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.3 m-30 -97.53 150.77 20.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.934 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . 0.411 ' C ' ' HD2' ' A' ' 442' ' ' LYS . 43.0 mt -124.67 158.7 31.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.149 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -96.31 129.84 43.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 25.0 tptt -77.52 6.66 6.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.909 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 11.1 tm0? -107.9 -51.86 2.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.89 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 16.2 p -91.61 -24.86 19.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.168 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 34.3 m120 65.25 36.98 6.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.855 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.437 ' O ' ' C ' ' A' ' 441' ' ' SER . 9.1 mt -130.94 125.92 34.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.953 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 441' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 440' ' ' LEU . 12.4 p -34.49 110.91 0.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.853 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.563 ' HD3' ' CE2' ' A' ' 444' ' ' PHE . 28.5 mttt -54.36 -174.81 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.917 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 31.3 p -106.22 36.66 2.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.866 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . 0.563 ' CE2' ' HD3' ' A' ' 442' ' ' LYS . 4.9 p90 -160.07 143.16 13.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -129.83 177.39 18.15 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.503 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . 0.545 ' CE1' ' CE1' ' A' ' 404' ' ' PHE . 20.2 t80 -119.35 152.67 36.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.956 0.408 . . . . 0.0 110.899 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 446' ' ' PHE . 77.9 t -159.03 153.75 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.063 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 79.0 p -151.53 144.35 24.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.857 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . 0.541 ' CE1' HD13 ' A' ' 403' ' ' LEU . 15.3 m-85 -107.84 -176.02 2.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.936 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -79.75 -16.72 55.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.937 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -150.93 155.15 35.12 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.608 0.718 . . . . 0.0 110.863 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . 0.48 ' N ' ' HB2' ' A' ' 401' ' ' ALA . 60.3 Cg_endo -73.95 -13.87 23.9 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.733 2.289 . . . . 0.0 112.378 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 37.2 t -78.89 -37.52 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.087 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 11.4 p -74.88 -50.95 15.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.887 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -40.84 -39.74 1.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.062 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . 0.4 ' O ' ' C ' ' A' ' 457' ' ' ALA . 45.6 mm-40 -56.66 -50.74 71.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.897 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 456' ' ' GLN . . . -36.91 -43.68 0.46 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.139 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . 0.41 ' HA ' ' CE2' ' A' ' 424' ' ' PHE . . . -62.81 -66.1 0.59 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.144 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . 0.443 ' O ' ' CB ' ' A' ' 463' ' ' ASN . 73.7 mt -46.94 -41.92 5.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.082 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -44.18 -49.14 9.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.9 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 45.2 t -98.12 -57.02 2.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.826 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 462' ' ' MET . . . . . 0.404 ' O ' ' N ' ' A' ' 465' ' ' PHE . 91.8 mmm -40.9 -47.6 2.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.882 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' A' ' 459' ' ' ILE . 26.5 t-20 -44.78 106.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.914 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 82.74 27.06 43.5 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.477 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . 0.404 ' N ' ' O ' ' A' ' 462' ' ' MET . 10.9 t80 -66.59 117.59 8.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.81 0.338 . . . . 0.0 110.844 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 11.6 tm0? -64.8 118.09 8.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.911 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . 0.459 ' O ' ' CG2' ' A' ' 467' ' ' ILE . 14.4 tt -140.58 120.71 13.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.097 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 69.07 -104.26 1.23 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.487 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 24.6 ttp -131.25 12.53 5.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.841 0.353 . . . . 0.0 110.875 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -138.81 -179.15 5.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.89 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 57.9 mtm180 -108.48 163.13 13.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 53.7 mt -109.85 148.99 30.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.879 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -124.46 128.28 48.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.871 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 32.5 t -133.95 133.81 56.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.09 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -157.13 136.34 11.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.905 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . 0.45 ' CB ' ' O ' ' A' ' 402' ' ' ASN . 1.5 pp -79.19 128.61 33.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.937 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 476' ' ' LEU . 46.7 tttm -34.67 109.28 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.915 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . 0.47 ' HG3' ' N ' ' A' ' 479' ' ' SER . 14.6 tpp180 -41.36 150.19 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.834 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 479' ' ' SER . . . . . 0.47 ' N ' ' HG3' ' A' ' 478' ' ' ARG . 5.0 t -147.38 157.3 43.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.821 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 481' ' ' ASN . 24.9 mttp -98.23 -51.77 3.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 480' ' ' LYS . 16.7 m120 -37.12 115.63 0.4 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.91 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -79.21 -55.05 5.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 4.9 t -174.81 109.52 0.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.845 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -143.91 126.33 15.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.879 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 3.2 t -166.62 166.46 16.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.847 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 132.97 152.29 6.88 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.539 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.16 139.54 19.05 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.597 2.198 . . . . 0.0 112.403 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 91.6 p -79.68 117.28 20.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.831 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 73.0 p -74.55 91.36 2.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.847 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.515 -179.926 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.427 -0.269 . . . . 0.0 112.427 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 53.8 p -149.73 153.09 36.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.898 0.38 . . . . 0.0 110.876 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 20.4 m -112.06 157.92 20.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.877 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -68.41 113.5 5.37 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.44 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 48.3 m -155.36 169.2 24.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 110.819 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 2.6 m -134.18 164.34 27.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.911 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 137.53 72.51 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.553 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . 0.408 HD11 ' C ' ' A' ' 383' ' ' LEU . 3.5 pp -53.27 -33.04 51.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.837 0.351 . . . . 0.0 110.88 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 15.2 t -105.17 153.19 21.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.133 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -129.86 165.92 21.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.951 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -134.54 134.85 41.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.933 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 39.7 m -106.22 44.27 1.06 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.866 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 54.7 mt -98.92 119.27 46.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.166 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -89.04 108.9 3.51 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.471 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -101.1 70.88 1.37 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.805 0.336 . . . . 0.0 111.119 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -106.47 -44.24 4.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.034 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -120.41 39.38 2.46 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.521 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 52.3 m -97.34 125.03 41.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.825 0.345 . . . . 0.0 110.857 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -91.24 -9.88 43.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.848 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.21 170.7 8.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.919 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -142.74 -177.59 5.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.922 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -83.49 -147.01 7.2 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.521 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.9 151.53 40.14 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.721 2.28 . . . . 0.0 112.309 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -52.37 107.83 0.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.932 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 131.32 -28.57 3.6 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.463 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . 0.495 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.86 126.83 43.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.749 0.309 . . . . 0.0 111.07 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . 0.496 ' O ' ' CB ' ' A' ' 476' ' ' LEU . 0.6 OUTLIER -158.83 163.72 36.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.82 -179.932 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . 0.557 HD12 ' CE1' ' A' ' 449' ' ' TYR . 23.7 mt -160.35 108.03 1.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.899 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . 0.554 ' CE1' ' HB2' ' A' ' 477' ' ' LYS . 5.3 m-85 -111.83 117.41 32.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.871 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . 0.558 HD12 ' CZ ' ' A' ' 421' ' ' PHE . 1.4 mm -90.88 135.49 26.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.103 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . 0.452 ' C ' ' CD2' ' A' ' 407' ' ' HIS . 81.6 m-85 -126.57 148.89 49.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.932 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . 0.494 ' N ' ' O ' ' A' ' 443' ' ' CYS . 12.6 m-70 71.66 54.66 0.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.872 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 31.6 mt -100.38 132.49 22.42 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.637 0.732 . . . . 0.0 110.932 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -47.84 178.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.722 2.282 . . . . 0.0 112.376 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . 0.435 ' NE2' ' HB3' ' A' ' 440' ' ' LEU . 18.9 tp60 -88.16 -39.09 14.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.938 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -60.18 -36.96 78.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -53.98 150.79 7.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -138.24 -145.34 4.82 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.494 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -79.72 -59.65 2.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.761 0.315 . . . . 0.0 110.934 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 -58.0 -53.76 54.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -38.89 -49.8 1.68 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.858 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 40.8 tp -59.47 -49.41 77.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.903 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 54.9 tp -56.92 -56.01 27.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.925 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -60.24 -12.07 7.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.983 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 4.9 ttm -92.94 -23.59 18.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.904 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . 0.558 ' CZ ' HD12 ' A' ' 405' ' ' ILE . 7.0 m-85 -109.97 6.6 23.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 422' ' ' MET . . . . . 0.586 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 4.6 mtt -75.55 -45.78 4.29 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.622 0.725 . . . . 0.0 110.879 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.0 Cg_exo -47.97 -46.68 21.22 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.7 2.267 . . . . 0.0 112.325 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -59.4 -35.73 74.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.838 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 172.75 -171.9 44.67 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.501 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -81.53 102.59 10.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.842 0.353 . . . . 0.0 110.925 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 62.0 t -72.77 134.15 30.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.158 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . 0.419 HG23 ' C ' ' A' ' 449' ' ' TYR . 17.9 t -79.05 -48.5 21.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.107 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 1.3 m -146.69 143.44 28.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.842 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -153.86 116.95 4.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.172 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -150.61 137.93 19.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.896 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 57.8 t -87.3 155.25 3.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.105 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . 0.539 ' CG ' ' CE1' ' A' ' 444' ' ' PHE . 3.1 m-85 -95.75 148.03 23.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 30.7 mt -121.74 161.04 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.071 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -102.75 133.07 48.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.813 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? -80.07 0.16 33.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.963 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -99.23 -42.47 7.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.875 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 68.0 p -104.28 -21.84 13.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.183 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 64.45 39.25 7.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.938 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.435 ' HB3' ' NE2' ' A' ' 410' ' ' GLN . 22.4 mt -134.54 135.12 42.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.945 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 52.0 p -40.34 111.77 0.23 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.556 ' HD3' ' CE2' ' A' ' 444' ' ' PHE . 15.7 mttm -51.8 -175.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.876 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . 0.494 ' O ' ' N ' ' A' ' 407' ' ' HIS . 26.6 p -101.55 33.86 2.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . 0.556 ' CE2' ' HD3' ' A' ' 442' ' ' LYS . 11.1 p90 -160.53 145.7 14.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.851 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -133.16 176.39 19.6 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.521 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -121.23 141.45 50.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.963 0.411 . . . . 0.0 110.818 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 54.7 t -148.69 147.41 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.169 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 51.7 p -142.53 149.99 39.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.93 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . 0.557 ' CE1' HD12 ' A' ' 403' ' ' LEU . 3.3 m-85 -113.11 -174.87 2.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.945 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -81.32 -19.23 43.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.939 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -154.41 154.95 30.29 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.608 0.718 . . . . 0.0 110.898 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . 0.437 ' N ' ' HB3' ' A' ' 401' ' ' ALA . 61.4 Cg_endo -75.72 -10.12 19.98 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.721 2.281 . . . . 0.0 112.359 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 97.8 t -82.63 -29.28 8.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.154 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 68.1 m -90.86 -35.44 14.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.791 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -57.14 -35.22 69.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.041 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -61.1 -38.93 88.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.911 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -47.81 -39.39 18.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.12 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -64.38 -68.4 0.36 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.081 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . 0.463 ' O ' ' CB ' ' A' ' 463' ' ' ASN . 95.2 mt -42.5 -45.32 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.206 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 -41.87 -45.28 3.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 2.9 t -101.47 -57.01 2.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.855 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 462' ' ' MET . . . . . 0.41 ' O ' ' N ' ' A' ' 465' ' ' PHE . 91.8 mmm -43.77 -44.68 6.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.911 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 459' ' ' ILE . 19.4 t-20 -44.95 108.0 0.11 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 82.1 25.45 52.02 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.444 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . 0.41 ' N ' ' O ' ' A' ' 462' ' ' MET . 18.0 t80 -64.34 109.25 1.85 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.809 0.337 . . . . 0.0 110.882 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 7.4 tm0? -63.12 114.79 3.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.875 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 17.9 tt -127.59 126.48 67.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.179 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 61.11 -96.79 0.11 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.467 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 33.0 ttp -129.44 -5.4 4.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.879 0.371 . . . . 0.0 110.896 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 15.6 pttm -121.45 176.23 5.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.871 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 28.1 mtm180 -108.56 169.3 8.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.925 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . 0.401 HD13 ' CD1' ' A' ' 465' ' ' PHE . 93.3 mt -115.54 158.32 22.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.904 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 33.8 tttp -137.76 107.54 6.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.928 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . 0.47 HG13 ' CD1' ' A' ' 405' ' ' ILE . 61.5 t -109.51 135.04 49.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.074 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -156.38 139.81 15.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . 0.496 ' CB ' ' O ' ' A' ' 402' ' ' ASN . 1.6 pp -83.5 129.91 34.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.554 ' HB2' ' CE1' ' A' ' 404' ' ' PHE . 59.2 tttt -33.72 111.5 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.933 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . 0.452 ' O ' ' C ' ' A' ' 479' ' ' SER . 16.4 mmt180 -103.69 83.05 2.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.813 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 479' ' ' SER . . . . . 0.452 ' C ' ' O ' ' A' ' 478' ' ' ARG . 23.0 m -34.53 -46.06 0.26 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.72 95.28 5.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.921 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -75.62 -52.66 10.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.943 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -59.05 -178.83 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.883 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 38.5 t -175.02 127.73 0.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.871 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 36.9 tttm -162.9 152.61 15.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 17.9 p -157.11 170.75 21.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.913 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -156.38 144.07 10.41 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.49 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -47.09 135.27 18.68 Favored 'Trans proline' 0 C--O 1.231 0.126 0 C-N-CA 122.631 2.22 . . . . 0.0 112.375 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 46.5 m -71.51 94.1 1.25 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.887 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 78.1 p -151.46 120.09 6.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.861 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.493 -179.971 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 112.469 -0.253 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 68.1 m -147.61 137.66 22.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.8 0.333 . . . . 0.0 110.912 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 88.4 p -120.85 160.5 23.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.791 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -111.49 -101.54 2.6 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.545 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 77.8 p -148.94 122.09 8.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.844 0.354 . . . . 0.0 110.851 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 15.7 m -102.65 160.39 14.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 39.51 -110.03 0.14 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.56 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 11.7 mt 46.88 48.64 15.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.901 0.382 . . . . 0.0 110.897 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 74.9 p -121.11 115.77 23.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.129 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -82.58 -58.55 2.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.009 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 20.6 mp0 -117.66 101.97 8.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.917 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 3.6 t -88.4 51.35 2.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.845 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 41.6 mm -55.18 127.57 14.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.161 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -120.47 81.55 0.34 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.458 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . 0.422 ' O ' ' C ' ' A' ' 391' ' ' ALA . . . -64.33 -54.86 26.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.828 0.346 . . . . 0.0 111.17 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . 0.437 ' CB ' ' OE1' ' A' ' 415' ' ' GLN . . . -35.9 120.61 0.62 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.131 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 83.52 52.22 3.81 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.455 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 56.6 m -137.91 129.51 28.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.764 0.316 . . . . 0.0 110.901 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.59 72.13 1.37 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.882 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.421 ' O ' ' CB ' ' A' ' 429' ' ' SER . 13.8 ptpt -141.07 163.64 32.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.9 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . 0.465 ' HA ' ' CB ' ' A' ' 448' ' ' SER . 15.2 pt-20 -131.48 -176.44 4.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.916 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -99.82 -146.87 20.6 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.52 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.07 150.85 49.01 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.722 2.281 . . . . 0.0 112.358 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -50.89 97.93 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.874 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 137.61 -25.24 2.99 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.432 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . 0.486 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -98.21 126.84 43.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.836 0.35 . . . . 0.0 111.131 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 22.0 m-80 -159.17 161.29 36.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.903 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . 0.564 HD12 ' CE1' ' A' ' 449' ' ' TYR . 27.7 mt -159.76 113.8 2.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.944 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . 0.766 ' CZ ' ' CD1' ' A' ' 446' ' ' PHE . 46.6 m-85 -123.02 113.68 19.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 4.6 mp -90.97 136.89 22.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.097 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . 0.442 ' CD2' ' O ' ' A' ' 473' ' ' LYS . 10.9 m-85 -127.69 153.69 46.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.962 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 69.29 52.64 0.47 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.856 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 19.4 mt -96.13 131.85 27.99 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.594 0.712 . . . . 0.0 110.918 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -48.16 167.9 0.1 OUTLIER 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.678 2.252 . . . . 0.0 112.362 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -70.26 -44.06 69.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.977 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -61.46 -39.65 91.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -54.32 112.42 0.98 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.862 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -104.67 -140.15 10.3 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.475 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.51 -60.76 2.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.808 0.337 . . . . 0.0 110.897 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . 0.469 ' O ' ' N ' ' A' ' 418' ' ' LEU . 1.6 mp0 -53.72 -61.59 2.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 415' ' ' GLN . 35.3 m-20 -34.47 -58.76 0.48 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.841 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 66.2 tp -51.53 -41.83 61.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.9 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' A' ' 415' ' ' GLN . 12.7 tp -67.64 -56.03 10.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.939 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -56.74 -13.14 2.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.971 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 3.0 tpp -86.23 -31.18 21.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . 0.43 ' C ' ' HD2' ' A' ' 423' ' ' PRO . 5.2 m-85 -95.38 -26.66 15.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.838 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 422' ' ' MET . . . . . 0.547 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 0.2 OUTLIER -46.14 -47.66 43.93 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.531 0.681 . . . . 0.0 110.846 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . 0.547 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.2 Cg_exo -47.96 -42.99 31.12 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.717 2.278 . . . . 0.0 112.315 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . 0.404 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 64.6 m-85 -67.54 -35.06 78.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.878 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 172.08 -169.35 42.46 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.49 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -75.99 122.25 23.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.803 0.335 . . . . 0.0 110.921 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . 0.425 HG13 ' CG1' ' A' ' 447' ' ' VAL . 84.1 t -95.15 115.23 33.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.191 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . 0.402 HG23 ' C ' ' A' ' 449' ' ' TYR . 54.1 t -69.4 -43.29 81.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.132 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 429' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 1.5 t -134.53 144.07 47.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -161.07 107.11 1.41 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.139 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . 0.413 ' C ' ' HD2' ' A' ' 431' ' ' LYS . 0.1 OUTLIER -153.29 149.72 28.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 72.9 t -103.76 142.1 18.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.097 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . 0.51 ' CG ' ' CE1' ' A' ' 444' ' ' PHE . 3.1 m-85 -81.88 153.0 26.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.875 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . 0.471 ' N ' ' HD2' ' A' ' 442' ' ' LYS . 69.4 mt -128.1 155.53 39.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.062 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -87.54 152.1 22.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.881 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.58 -23.73 15.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -88.14 -28.13 21.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.958 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 75.5 p -109.22 -34.88 6.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.135 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 67.75 42.32 2.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.934 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 441' ' ' SER . 10.1 mt -132.17 127.17 35.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 441' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 440' ' ' LEU . 36.6 p -34.87 106.03 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.852 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.555 ' HD3' ' CE2' ' A' ' 444' ' ' PHE . 19.3 mttm -51.69 -174.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.836 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 72.0 m -110.43 38.15 2.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.822 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . 0.555 ' CE2' ' HD3' ' A' ' 442' ' ' LYS . 5.4 p90 -162.18 137.62 7.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.842 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -131.73 169.67 21.88 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.498 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . 0.766 ' CD1' ' CZ ' ' A' ' 404' ' ' PHE . 22.2 t80 -111.54 150.01 30.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.859 0.361 . . . . 0.0 110.918 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . 0.425 ' CG1' HG13 ' A' ' 427' ' ' VAL . 85.5 t -155.14 145.21 13.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.121 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 448' ' ' SER . . . . . 0.465 ' CB ' ' HA ' ' A' ' 396' ' ' GLU . 1.9 m -144.42 140.85 29.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.91 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . 0.564 ' CE1' HD12 ' A' ' 403' ' ' LEU . 3.6 m-85 -102.94 179.79 4.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.942 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -75.82 -25.88 56.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.938 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -147.05 158.56 44.68 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.558 0.694 . . . . 0.0 110.912 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.65 -12.69 20.25 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.713 2.275 . . . . 0.0 112.3 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 92.4 t -77.37 -38.56 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.147 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 1.5 t -83.37 -39.61 20.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.882 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -53.1 -43.23 66.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.076 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -59.08 -42.48 90.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.934 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -43.08 -38.84 2.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.126 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . 0.404 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -66.7 -61.74 1.81 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.121 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 67.1 mt -47.53 -45.45 10.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.115 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -37.68 -47.77 1.0 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 2.8 m -103.03 -56.98 2.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.899 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 88.4 mmm -39.72 -44.56 1.57 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.844 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -46.18 110.3 0.26 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.872 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 74.12 35.28 53.73 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.516 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . 0.417 ' CD1' ' C ' ' A' ' 465' ' ' PHE . 9.5 t80 -68.72 117.4 10.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.818 0.342 . . . . 0.0 110.905 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 11.2 tm0? -63.77 115.19 4.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.91 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 14.6 tt -138.11 132.94 43.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.094 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 51.25 -108.52 0.58 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.474 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 26.0 mtt -127.26 24.82 6.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.829 0.347 . . . . 0.0 110.844 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 7.8 pttt -142.43 -178.43 5.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.894 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 33.3 mtm-85 -125.13 121.91 35.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.911 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 45.0 mt -65.7 152.06 45.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.952 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . 0.442 ' O ' ' CD2' ' A' ' 406' ' ' TYR . 18.5 ttmm -132.6 100.49 4.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.88 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 21.1 t -107.56 136.75 41.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.203 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -156.52 145.89 20.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.87 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . 0.476 ' O ' ' CD1' ' A' ' 476' ' ' LEU . 1.4 pp -91.04 126.2 36.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 476' ' ' LEU . 16.9 ttpp -34.47 115.53 0.26 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.892 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . 0.448 ' HD2' ' CB ' ' A' ' 481' ' ' ASN . 13.5 tpp180 -81.15 94.47 6.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.854 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 65.3 m -111.72 109.88 19.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt 40.69 41.47 1.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.875 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . 0.448 ' CB ' ' HD2' ' A' ' 478' ' ' ARG . 20.6 t-20 -52.98 -59.2 4.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.873 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -99.41 97.83 8.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 57.5 p -85.31 116.77 23.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.877 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 15.2 ttmm -161.01 124.42 3.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.978 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 90.3 p -107.54 130.28 54.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.913 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -85.27 147.78 22.64 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.449 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -45.61 121.22 3.85 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.662 2.241 . . . . 0.0 112.358 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 6.2 t -68.59 168.68 12.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.827 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 69.7 m -93.42 -44.0 8.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.854 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.506 -179.959 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 53.7 m -105.88 -58.23 1.94 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.875 0.369 . . . . 0.0 110.882 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 82.7 p -65.97 143.55 57.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.801 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 162.4 -73.21 0.2 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.475 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 59.7 p -174.07 151.28 1.69 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.814 0.34 . . . . 0.0 110.923 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 12.2 p -116.66 -28.14 6.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.814 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 78.6 135.22 0.97 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.506 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 7.4 mp -109.6 -63.09 1.41 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.913 0.387 . . . . 0.0 110.945 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 13.8 m 52.77 44.36 30.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.09 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 14.3 tp60 -90.84 -46.01 8.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.886 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -103.08 123.15 46.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.92 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 74.1 m -115.33 46.24 1.51 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.796 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 68.5 mt -116.74 102.78 14.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.129 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -108.51 114.0 3.97 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.529 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -81.96 88.5 6.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.731 0.3 . . . . 0.0 111.099 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -136.69 115.51 12.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.142 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.448 ' O ' ' C ' ' A' ' 393' ' ' SER . . . 98.77 -49.45 1.28 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.464 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' SER . . . . . 0.448 ' C ' ' O ' ' A' ' 392' ' ' GLY . 3.3 m -34.72 145.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.759 0.314 . . . . 0.0 110.914 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -123.75 38.34 4.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.912 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.5 ' O ' ' CB ' ' A' ' 429' ' ' SER . 17.8 ptpt -103.66 157.31 17.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.856 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -109.71 -178.9 3.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.865 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -105.16 -155.45 22.52 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.555 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.13 157.58 8.25 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.729 2.286 . . . . 0.0 112.374 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -65.85 78.43 0.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.919 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 153.83 -16.69 0.63 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.456 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . 0.505 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -106.49 126.7 52.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.765 0.316 . . . . 0.0 111.111 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . 0.505 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.2 OUTLIER -158.15 168.91 25.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.884 -179.901 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . 0.569 HD12 ' CE1' ' A' ' 449' ' ' TYR . 27.7 mt -160.06 119.84 2.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.864 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . 0.527 ' CE1' ' HB2' ' A' ' 477' ' ' LYS . 15.0 m-85 -124.42 113.45 18.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . . . . . . . . . 3.4 mp -91.15 133.95 31.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.151 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -125.75 162.27 25.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.935 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . 0.491 ' N ' ' O ' ' A' ' 443' ' ' CYS . 25.0 m-70 61.01 54.61 3.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.908 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 30.3 mt -99.87 144.91 29.24 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.668 0.747 . . . . 0.0 110.838 -179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.55 ' HG2' ' CD1' ' A' ' 412' ' ' PHE . 61.5 Cg_endo -76.47 164.96 29.92 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.711 2.274 . . . . 0.0 112.274 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -69.35 -38.63 78.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.918 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -54.46 -36.48 64.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.55 ' CD1' ' HG2' ' A' ' 409' ' ' PRO . 4.7 m-85 -67.65 138.64 56.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.934 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -123.48 -137.0 4.88 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.474 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -87.81 -56.97 3.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.772 0.32 . . . . 0.0 110.909 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . 0.444 ' O ' ' N ' ' A' ' 418' ' ' LEU . 26.9 mm-40 -58.4 -57.03 14.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.95 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' A' ' 415' ' ' GLN . 53.0 m-20 -34.87 -59.23 0.49 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.866 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 51.5 tp -51.29 -42.63 61.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.906 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 415' ' ' GLN . 10.8 tp -65.84 -46.33 78.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.904 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -68.18 -16.24 63.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.973 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 2.0 ttt -85.35 -35.01 21.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.917 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . 0.468 ' CE1' ' SD ' ' A' ' 462' ' ' MET . 3.8 m-85 -92.69 -22.72 19.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.839 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 422' ' ' MET . . . . . 0.574 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 0.3 OUTLIER -50.87 -45.62 87.24 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.563 0.697 . . . . 0.0 110.96 179.951 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.4 Cg_exo -47.98 -38.84 32.17 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.662 2.242 . . . . 0.0 112.372 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . 0.503 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 78.1 m-85 -70.88 -35.28 72.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.898 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 164.58 -178.96 39.59 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.523 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 -61.86 135.11 57.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.812 0.339 . . . . 0.0 110.834 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 24.2 t -111.47 124.83 68.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.117 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 19.1 t -69.64 -50.35 50.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.209 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 429' ' ' SER . . . . . 0.5 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 4.5 t -137.69 148.7 45.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.826 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -160.59 107.74 1.55 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.106 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -150.96 143.81 24.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 99.3 t -94.43 152.49 3.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.048 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . 0.412 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.5 m-30 -89.68 154.06 20.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.931 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . 0.466 ' N ' ' HD2' ' A' ' 442' ' ' LYS . 71.4 mt -136.48 152.0 28.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.15 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -86.35 144.51 27.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.861 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 43.0 mttt -94.4 -8.4 38.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.85 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -99.98 -28.79 12.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.896 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 46.0 p -112.74 -28.87 7.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.162 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 66.28 31.37 8.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 47.9 mt -116.7 124.58 50.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.959 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 5.8 p -37.85 110.06 0.12 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.564 ' HD3' ' CE1' ' A' ' 444' ' ' PHE . 37.1 mttt -52.21 -174.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.942 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . 0.491 ' O ' ' N ' ' A' ' 407' ' ' HIS . 30.3 p -110.13 33.72 4.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.943 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . 0.564 ' CE1' ' HD3' ' A' ' 442' ' ' LYS . 8.2 p90 -161.89 147.55 13.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.939 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -138.36 179.07 18.78 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.524 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . 0.503 ' O ' ' CG2' ' A' ' 447' ' ' VAL . 55.6 t80 -118.79 153.71 34.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.831 0.348 . . . . 0.0 110.936 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . 0.503 ' CG2' ' O ' ' A' ' 446' ' ' PHE . 94.3 t -161.02 153.56 4.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.176 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 448' ' ' SER . . . . . 0.464 ' N ' HG11 ' A' ' 447' ' ' VAL . 65.7 p -153.12 148.39 26.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.876 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . 0.569 ' CE1' HD12 ' A' ' 403' ' ' LEU . 5.9 m-85 -110.43 -174.93 2.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.966 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -78.22 -25.55 47.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.817 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -146.87 158.28 45.73 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.66 0.743 . . . . 0.0 110.898 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . 0.468 ' CA ' ' HB3' ' A' ' 401' ' ' ALA . 61.2 Cg_endo -75.5 0.24 9.33 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.714 2.276 . . . . 0.0 112.317 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 75.5 t -88.5 -36.03 8.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.146 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 71.3 m -83.63 -39.94 19.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.88 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -50.66 -33.31 21.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.1 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -69.15 -45.55 69.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -41.6 -44.49 3.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.089 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . 0.503 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -63.85 -64.3 0.93 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.086 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . 0.41 ' O ' ' C ' ' A' ' 460' ' ' GLN . 65.9 mt -41.46 -47.15 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.171 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 459' ' ' ILE . 14.4 mm100 -36.89 -60.33 0.63 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.94 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 13.3 t -87.0 -52.93 5.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.884 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 462' ' ' MET . . . . . 0.468 ' SD ' ' CE1' ' A' ' 421' ' ' PHE . 7.5 mmt -40.43 -56.86 1.93 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -42.45 107.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.912 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 80.12 32.92 34.13 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.507 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -75.77 110.96 10.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.775 0.322 . . . . 0.0 110.891 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 12.6 tm0? -63.08 102.9 0.41 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.918 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . 0.449 HD13 ' CE1' ' A' ' 412' ' ' PHE . 16.1 tt -115.27 144.52 22.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.154 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 46.68 -95.94 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.498 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 4.6 tpt -130.22 -3.47 4.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.791 0.329 . . . . 0.0 110.869 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 11.7 pttm -125.26 -178.53 4.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.88 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 66.9 mtm-85 -108.25 172.38 6.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.843 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 82.8 mt -120.52 156.92 30.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.952 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 32.4 tttp -136.15 105.03 5.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.898 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 12.1 t -113.76 133.2 60.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.171 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -155.23 138.2 15.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . 0.455 ' O ' ' C ' ' A' ' 477' ' ' LYS . 1.6 pp -79.03 129.14 34.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.527 ' HB2' ' CE1' ' A' ' 404' ' ' PHE . 31.8 tttt -34.04 99.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.909 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 28.1 ttm-85 -97.62 139.35 33.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.866 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 16.8 m -105.92 -61.89 1.44 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.797 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -115.46 157.43 24.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -125.63 -47.92 1.68 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.823 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 24.8 p-10 -92.64 165.75 12.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.897 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 483' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 484' ' ' LYS . 2.7 t 40.96 40.18 0.97 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 483' ' ' SER . 8.6 tptm -36.54 -53.88 0.87 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.884 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 70.3 m -144.9 145.79 31.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.885 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -144.16 147.57 18.9 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.588 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.58 109.63 0.2 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.704 2.269 . . . . 0.0 112.365 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 44.5 m -71.37 165.54 23.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.811 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 55.9 p -164.37 155.44 15.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.519 179.995 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 15.2 m -142.05 159.47 42.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.896 0.379 . . . . 0.0 110.884 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 80.3 p -158.22 140.28 14.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -166.31 66.36 0.2 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.393 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 2.0 t -115.64 118.46 33.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.792 0.329 . . . . 0.0 110.849 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 62.0 p -102.65 80.03 1.87 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.823 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 49.03 -177.83 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.478 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -85.37 176.79 8.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.91 0.386 . . . . 0.0 110.903 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 6.9 t -108.76 -39.33 5.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.155 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -155.09 128.74 8.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.861 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 21.7 tm0? -61.0 -53.35 58.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.944 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 5.0 m -103.36 125.18 49.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.868 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 5.3 mp -98.2 119.13 45.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.172 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -60.33 96.94 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.476 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -122.77 -49.61 1.98 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.778 0.323 . . . . 0.0 111.1 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -45.43 101.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.13 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 85.89 35.0 11.86 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.5 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 2.2 t -121.68 121.58 37.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.849 0.357 . . . . 0.0 110.828 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -89.22 60.2 5.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.905 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 4.1 ptmm? -126.12 176.24 7.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.861 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -148.18 179.01 8.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -98.47 -146.0 19.76 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.491 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.19 155.05 46.99 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.648 2.232 . . . . 0.0 112.317 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -55.12 118.75 4.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.87 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 120.21 -27.4 6.7 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.527 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . 0.493 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.97 126.95 43.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.769 0.318 . . . . 0.0 111.06 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . 0.493 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.7 OUTLIER -158.87 165.02 35.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . 0.567 HD13 ' CE1' ' A' ' 449' ' ' TYR . 15.5 mt -159.34 122.04 3.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.941 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . 0.465 ' CE1' ' CD1' ' A' ' 446' ' ' PHE . 29.1 m-85 -128.94 111.56 13.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . 0.424 HG23 ' CD2' ' A' ' 408' ' ' LEU . 3.9 mp -91.17 135.2 27.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.155 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . 0.407 ' CD1' ' HB2' ' A' ' 444' ' ' PHE . 89.5 m-85 -125.74 163.25 23.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.986 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . 0.421 ' N ' ' O ' ' A' ' 443' ' ' CYS . 29.2 m-70 61.48 52.98 3.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.843 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . 0.424 ' CD2' HG23 ' A' ' 405' ' ' ILE . 65.0 mt -92.24 128.92 43.13 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.571 0.7 . . . . 0.0 110.922 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -48.35 179.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.466 -0.126 0 C-N-CA 122.684 2.256 . . . . 0.0 112.33 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 23.8 tm0? -82.56 -41.28 19.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.899 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -65.75 -32.66 74.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.874 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.458 ' CE1' HD13 ' A' ' 467' ' ' ILE . 6.5 m-85 -59.88 138.72 57.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.899 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -137.05 -138.19 3.73 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.47 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -81.13 -61.09 2.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.704 0.288 . . . . 0.0 110.881 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -52.85 -53.72 44.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.954 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -41.36 -52.25 3.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.839 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 25.1 tp -55.44 -54.96 37.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.89 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . 0.41 ' O ' ' CG ' ' A' ' 422' ' ' MET . 55.8 tp -50.3 -45.3 54.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.924 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -77.89 -9.06 58.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 1.5 tpt -87.88 -27.35 22.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.796 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -110.1 -18.57 13.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.849 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 422' ' ' MET . . . . . 0.576 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 0.2 OUTLIER -52.18 -46.14 93.8 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.599 0.714 . . . . 0.0 110.901 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 422' ' ' MET . 64.1 Cg_exo -47.97 -37.24 29.26 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.654 2.236 . . . . 0.0 112.39 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . 0.46 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 69.5 m-85 -71.41 -35.8 71.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.859 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 174.06 -171.47 44.55 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.426 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -75.27 116.26 15.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.818 0.342 . . . . 0.0 110.874 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 88.0 t -87.44 120.56 36.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.117 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . 0.417 HG21 ' C ' ' A' ' 449' ' ' TYR . 60.5 t -78.16 -43.6 27.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.127 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -132.73 139.17 47.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.833 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -157.8 120.49 3.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.105 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . 0.45 ' CG ' ' N ' ' A' ' 432' ' ' VAL . 20.0 tttm -161.02 160.53 30.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.806 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.45 ' N ' ' CG ' ' A' ' 431' ' ' LYS . 41.0 t -119.18 140.2 43.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.172 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . 0.564 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.1 m-85 -83.27 151.78 25.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 84.3 mt -138.14 150.97 24.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.042 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -90.62 128.66 36.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.888 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -72.08 -3.75 24.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.906 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -99.66 -47.43 5.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.89 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 27.5 p -92.4 -20.57 20.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.102 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 60.18 33.38 21.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.996 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 441' ' ' SER . 10.0 mt -135.22 145.37 47.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.925 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 441' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 440' ' ' LEU . 24.3 p -36.91 140.53 0.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.586 ' HB3' ' CE2' ' A' ' 444' ' ' PHE . 18.6 mttp -84.24 21.85 1.33 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.912 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . 0.422 ' SG ' ' O ' ' A' ' 442' ' ' LYS . 0.8 OUTLIER 53.56 25.03 4.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.918 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . 0.597 ' CD1' ' C ' ' A' ' 444' ' ' PHE . 0.9 OUTLIER -162.56 141.4 8.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.884 -179.854 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -135.6 175.66 20.62 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.48 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . 0.465 ' CD1' ' CE1' ' A' ' 404' ' ' PHE . 26.0 t80 -114.21 153.37 29.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.896 0.379 . . . . 0.0 110.873 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . 0.406 ' CG2' ' O ' ' A' ' 446' ' ' PHE . 79.0 t -158.1 154.83 5.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.086 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 2.1 m -153.69 145.12 23.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.867 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . 0.567 ' CE1' HD13 ' A' ' 403' ' ' LEU . 4.2 m-85 -108.48 -174.72 2.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.934 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -78.5 -15.69 58.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.78 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . 0.451 ' OD1' ' N ' ' A' ' 451' ' ' ASN . 0.7 OUTLIER -158.69 160.17 29.41 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.598 0.713 . . . . 0.0 110.928 -179.918 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -74.87 -18.13 19.34 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.674 2.249 . . . . 0.0 112.354 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 62.4 t -72.16 -42.78 66.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.105 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 41.8 m -80.8 -41.42 23.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.851 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -50.51 -35.42 29.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.078 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' A' ' 457' ' ' ALA . 14.1 mm-40 -66.73 -44.75 80.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.918 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 456' ' ' GLN . . . -37.48 -43.18 0.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.085 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . 0.46 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -61.43 -69.44 0.24 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.147 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . 0.448 ' O ' ' C ' ' A' ' 460' ' ' GLN . 79.6 mt -44.13 -48.76 2.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.171 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 459' ' ' ILE . 35.9 mm-40 -34.62 -42.79 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.895 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 2.1 m -103.93 -56.53 2.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.848 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 462' ' ' MET . . . . . 0.443 ' O ' ' N ' ' A' ' 465' ' ' PHE . 82.8 mmm -43.22 -46.51 6.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.881 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -41.56 104.19 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.903 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 80.22 31.61 37.77 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.502 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . 0.443 ' N ' ' O ' ' A' ' 462' ' ' MET . 66.2 t80 -71.93 117.24 13.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.862 0.363 . . . . 0.0 110.823 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 12.3 tm0? -66.01 107.04 1.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.883 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . 0.458 HD13 ' CE1' ' A' ' 412' ' ' PHE . 20.1 tt -116.66 145.31 22.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.166 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 40.45 -95.56 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.49 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 469' ' ' MET . . . . . 0.43 ' N ' ' O ' ' A' ' 467' ' ' ILE . 12.8 tmm? -126.77 -9.89 6.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.905 0.383 . . . . 0.0 110.874 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.68 174.97 6.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 40.1 mtt180 -104.79 167.65 9.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.915 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 65.1 mt -111.2 155.39 23.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.913 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -132.95 104.66 6.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.836 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 4.3 t -109.9 138.34 38.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.216 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . 0.431 ' NE2' ' HD2' ' A' ' 478' ' ' ARG . 11.6 tt0 -156.86 139.77 15.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.98 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . 0.442 ' O ' ' CD1' ' A' ' 476' ' ' LEU . 1.5 pp -85.79 126.59 34.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.846 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 476' ' ' LEU . 11.3 tptm -34.14 133.76 0.21 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.912 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . 0.431 ' HD2' ' NE2' ' A' ' 475' ' ' GLN . 0.0 OUTLIER -126.32 151.84 47.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.861 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 2.2 m -160.73 154.55 22.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.882 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -115.91 79.68 1.34 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.935 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -136.07 115.34 12.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.964 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -166.36 115.64 0.93 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.895 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 2.4 p -116.4 -9.84 11.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.55 -70.03 0.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.894 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 2.0 m -160.42 169.21 23.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.849 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -130.43 96.88 0.37 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.486 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.18 90.74 0.97 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.649 2.233 . . . . 0.0 112.367 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 3.0 t -97.32 97.73 9.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.853 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 31.1 p -166.27 160.95 16.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.906 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.477 179.998 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.391 0 N-CA-C 112.494 -0.242 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 59.5 m -109.91 158.66 17.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.893 0.378 . . . . 0.0 110.856 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 58.3 m -99.98 164.31 12.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.875 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -138.46 -109.62 0.89 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.538 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 3.1 m -130.03 116.13 18.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.863 0.363 . . . . 0.0 110.863 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 70.5 p -136.17 168.36 19.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.845 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 84.06 108.9 0.58 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.469 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 16.7 tp -80.51 91.02 5.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.887 0.375 . . . . 0.0 110.914 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 36.3 p -108.38 158.55 17.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.181 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -104.5 122.39 45.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.947 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -95.68 103.97 15.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 56.7 m -124.95 41.46 3.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.867 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 5.1 mp -75.88 133.98 30.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.119 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -114.73 101.53 1.08 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.533 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -84.44 -30.96 24.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.785 0.326 . . . . 0.0 111.113 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -51.72 135.27 29.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.157 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 393' ' ' SER . . . 81.66 -51.71 4.46 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.483 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 392' ' ' GLY . 27.8 m -37.32 124.62 0.99 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.819 0.342 . . . . 0.0 110.878 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -101.65 27.29 6.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.903 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.498 ' O ' ' CB ' ' A' ' 429' ' ' SER . 7.8 mtpt -81.49 170.46 15.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.9 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -140.14 168.44 19.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.832 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -84.18 -152.93 16.05 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.444 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.05 157.76 46.42 Favored 'Trans proline' 0 N--CA 1.465 -0.188 0 C-N-CA 122.714 2.276 . . . . 0.0 112.39 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -55.42 110.46 0.7 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.858 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 127.77 -28.37 4.43 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.53 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . 0.501 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.94 127.14 43.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.781 0.324 . . . . 0.0 111.081 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . 0.501 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.6 OUTLIER -158.75 164.04 36.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.921 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . 0.557 HD11 ' CE1' ' A' ' 449' ' ' TYR . 20.1 mt -159.71 120.97 3.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . 0.538 ' CZ ' ' CD1' ' A' ' 446' ' ' PHE . 35.8 m-85 -126.59 111.16 14.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.939 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . 0.443 ' CG1' ' CZ ' ' A' ' 421' ' ' PHE . 4.0 mp -91.23 128.22 43.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.116 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . 0.413 ' C ' ' CD2' ' A' ' 407' ' ' HIS . 78.2 m-85 -122.11 151.84 40.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.94 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . 0.48 ' O ' ' CD2' ' A' ' 472' ' ' LEU . 15.8 m-70 72.9 47.8 0.2 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.85 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . 0.432 ' CD2' HG21 ' A' ' 405' ' ' ILE . 31.2 mt -91.39 137.73 25.88 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.643 0.735 . . . . 0.0 110.924 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -47.91 177.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.662 2.241 . . . . 0.0 112.344 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -85.92 -46.13 10.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.916 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . 0.409 ' HG3' ' N ' ' A' ' 412' ' ' PHE . 12.7 pt-20 -58.54 -40.1 82.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.409 ' N ' ' HG3' ' A' ' 411' ' ' GLU . 7.9 m-85 -50.35 146.59 5.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -132.75 -139.21 4.22 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.444 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -86.12 -51.48 6.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.708 0.289 . . . . 0.0 110.795 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -61.79 -52.42 64.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.942 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -39.69 -59.92 1.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . 0.413 HD12 ' CE1' ' A' ' 421' ' ' PHE . 56.1 tp -49.67 -45.13 48.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.966 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 22.2 tp -62.95 -44.24 96.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.851 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -72.18 -9.73 58.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.87 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 6.2 ttm -93.89 -27.75 16.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.83 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . 0.443 ' CZ ' ' CG1' ' A' ' 405' ' ' ILE . 5.4 m-85 -101.25 -20.35 15.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.866 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 422' ' ' MET . . . . . 0.579 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 3.1 mtt -49.7 -46.19 79.61 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.613 0.72 . . . . 0.0 110.911 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.3 Cg_exo -47.96 -45.68 24.17 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.705 2.27 . . . . 0.0 112.356 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . 0.537 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 86.6 m-85 -64.03 -30.17 71.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.933 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 168.71 170.05 32.88 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.519 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -66.31 94.02 0.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.841 0.353 . . . . 0.0 110.862 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 92.4 t -62.29 133.86 27.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.133 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 75.7 t -79.88 -48.17 20.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.159 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 429' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 44.5 t -136.45 148.3 47.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -161.21 114.01 1.91 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.116 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . 0.415 ' C ' ' HD2' ' A' ' 431' ' ' LYS . 2.0 tmmm? -154.99 142.47 19.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.925 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 87.4 t -93.43 137.95 21.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.119 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . 0.466 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.3 m-85 -79.22 153.97 29.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.884 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . 0.434 ' CG2' ' N ' ' A' ' 435' ' ' ASP . 77.2 mt -123.81 158.49 29.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.098 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . 0.434 ' N ' ' CG2' ' A' ' 434' ' ' ILE . 7.0 t0 -87.94 138.89 31.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.782 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.04 -2.48 58.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.903 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -106.95 -52.4 2.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.893 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 30.8 p -88.38 -20.55 25.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.124 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 59.96 38.55 20.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.827 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 74.7 mt -127.87 132.17 49.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.965 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 49.2 p -39.92 107.28 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.882 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.55 ' HD3' ' CE2' ' A' ' 444' ' ' PHE . 14.5 mttm -52.78 -176.21 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 83.6 m -106.83 37.99 2.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.865 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . 0.55 ' CE2' ' HD3' ' A' ' 442' ' ' LYS . 4.6 p90 -162.07 138.84 8.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.859 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -132.55 169.31 22.39 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.509 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . 0.538 ' CD1' ' CZ ' ' A' ' 404' ' ' PHE . 61.4 t80 -106.33 154.26 21.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.925 0.393 . . . . 0.0 110.831 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . 0.448 HG13 ' N ' ' A' ' 448' ' ' SER . 64.1 t -158.13 152.91 6.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.097 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 448' ' ' SER . . . . . 0.448 ' N ' HG13 ' A' ' 447' ' ' VAL . 60.6 p -150.39 152.8 34.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.876 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . 0.557 ' CE1' HD11 ' A' ' 403' ' ' LEU . 5.1 m-85 -116.89 179.57 3.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.933 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . 0.446 ' CG ' ' OD1' ' A' ' 451' ' ' ASN . 0.6 OUTLIER -71.89 -28.91 63.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.868 179.858 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . 0.446 ' OD1' ' CG ' ' A' ' 450' ' ' ASP . 0.9 OUTLIER -146.64 155.92 48.72 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.659 0.742 . . . . 0.0 110.878 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.0 -12.6 28.41 Favored 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.71 2.273 . . . . 0.0 112.414 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 95.5 t -79.64 -33.13 14.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.187 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 78.3 p -84.0 -40.63 18.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.89 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -51.73 -40.4 60.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.159 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 53.0 mm-40 -57.08 -48.96 77.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.949 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -38.69 -40.58 0.62 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.119 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . 0.537 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -67.57 -63.99 0.95 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.1 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . 0.487 ' O ' ' CB ' ' A' ' 463' ' ' ASN . 81.0 mt -46.68 -44.24 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.17 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -41.63 -49.2 4.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.929 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 1.8 m -98.02 -57.13 2.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.82 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 85.2 mmm -42.93 -38.55 2.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.825 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . 0.487 ' CB ' ' O ' ' A' ' 459' ' ' ILE . 15.1 t30 -49.12 106.0 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.904 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 78.3 32.16 44.13 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.5 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -70.79 105.26 3.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.796 0.332 . . . . 0.0 110.88 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -63.62 103.24 0.52 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 16.9 tt -113.0 122.26 66.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.175 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 70.56 -96.9 0.59 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.488 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 41.2 mtt -133.25 8.61 4.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.859 0.361 . . . . 0.0 110.881 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.3 175.46 9.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.856 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 71.6 mtt-85 -108.98 170.45 8.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.827 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . 0.48 ' CD2' ' O ' ' A' ' 407' ' ' HIS . 72.4 mt -121.97 157.87 30.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.925 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 33.5 tttp -128.56 101.36 6.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.911 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 16.6 t -106.49 127.4 61.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.111 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -151.86 147.16 26.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.923 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . 0.449 ' CB ' ' O ' ' A' ' 402' ' ' ASN . 1.6 pp -91.18 129.34 37.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.917 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 476' ' ' LEU . 38.3 tttt -34.34 121.33 0.48 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.91 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -119.01 170.28 9.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.924 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 5.7 t 58.97 42.34 19.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.999 0.428 . . . . 0.0 110.872 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 21.2 tttt -98.67 -51.47 3.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.948 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -124.84 130.04 51.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.932 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.55 146.32 43.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.858 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 7.7 t -103.48 152.31 21.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.822 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.0 163.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.95 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 18.5 m -143.05 121.82 12.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.865 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 136.69 138.73 3.83 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.528 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -79.17 118.83 4.09 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.751 2.301 . . . . 0.0 112.334 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 27.5 t -77.82 -59.92 2.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.839 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 7.6 t -110.33 -57.28 2.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.869 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.428 -179.979 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.373 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 88.3 p -172.78 157.79 3.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.878 0.37 . . . . 0.0 110.854 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 13.8 t -122.7 120.34 33.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -163.69 164.15 36.16 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.461 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 30.9 t -75.76 93.13 3.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.885 0.374 . . . . 0.0 110.873 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 68.3 m -89.99 96.49 10.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.882 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 59.46 -148.46 41.19 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.501 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 5.0 mp 58.42 43.58 19.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.88 0.372 . . . . 0.0 110.874 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 92.4 m -97.37 133.15 42.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.137 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -113.26 -46.84 3.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.921 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -93.54 126.54 38.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.932 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 23.0 t -128.81 85.03 2.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.777 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 5.1 mp -66.34 140.54 19.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.094 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -54.24 113.24 3.17 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.498 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -111.31 -37.73 5.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.733 0.301 . . . . 0.0 111.072 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -59.42 112.08 1.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.069 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 393' ' ' SER . . . 96.95 -30.21 9.36 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.453 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 392' ' ' GLY . 46.9 t -34.85 -47.98 0.37 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.834 0.349 . . . . 0.0 110.913 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.84 44.33 1.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.947 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 429' ' ' SER . 22.4 ptmt -105.71 174.18 5.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.892 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . 0.605 ' OE2' ' CE2' ' A' ' 446' ' ' PHE . 6.1 mm-40 -129.87 179.72 5.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -117.2 -148.59 8.83 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.515 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -76.02 151.47 35.11 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.781 2.32 . . . . 0.0 112.32 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -56.44 108.89 0.53 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.902 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 128.61 -28.39 4.22 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.509 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . 0.505 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.86 126.98 43.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.826 0.346 . . . . 0.0 111.074 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . 0.505 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.6 OUTLIER -158.7 161.85 37.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.873 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . 0.581 HD12 ' CE1' ' A' ' 449' ' ' TYR . 38.4 mt -154.57 125.84 7.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.903 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . 0.559 ' CE1' ' HB2' ' A' ' 477' ' ' LYS . 27.8 m-85 -133.83 114.64 13.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . 0.433 ' CD1' ' N ' ' A' ' 405' ' ' ILE . 3.0 mp -90.85 131.55 37.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.121 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . 0.453 ' CZ ' ' HB3' ' A' ' 404' ' ' PHE . 47.3 m-85 -125.31 171.12 10.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.976 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 45.8 m-70 53.67 50.98 15.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.869 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . 0.404 ' CD1' HG21 ' A' ' 405' ' ' ILE . 46.6 mt -100.24 151.71 37.61 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.636 0.731 . . . . 0.0 110.928 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.475 ' HG2' ' CD1' ' A' ' 412' ' ' PHE . 57.4 Cg_endo -70.54 -168.31 0.3 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.689 2.259 . . . . 0.0 112.322 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -98.51 -37.91 9.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.872 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . 0.444 ' OE1' ' C ' ' A' ' 411' ' ' GLU . 0.2 OUTLIER -57.88 -38.33 75.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 -179.881 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . 0.475 ' CD1' ' HG2' ' A' ' 409' ' ' PRO . 6.5 m-85 -58.97 140.94 55.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.93 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -126.58 -134.19 3.98 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.471 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -87.99 -54.96 3.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.757 0.313 . . . . 0.0 110.837 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . 0.442 ' O ' ' C ' ' A' ' 416' ' ' ASP . 43.2 mm-40 -59.86 -60.64 3.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.852 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 415' ' ' GLN . 45.7 m-20 -34.47 -57.7 0.5 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.925 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 67.6 tp -53.71 -44.35 69.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.838 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' A' ' 415' ' ' GLN . 29.7 tp -66.55 -61.67 1.86 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.87 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -51.84 -17.21 0.88 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 3.3 ttm -84.21 -35.91 23.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.825 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . 0.412 ' C ' ' HD2' ' A' ' 423' ' ' PRO . 4.0 m-85 -92.2 -17.86 24.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.88 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 422' ' ' MET . . . . . 0.581 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 4.2 mtt -51.12 -45.81 88.71 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.54 0.686 . . . . 0.0 110.842 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 422' ' ' MET . 66.2 Cg_exo -48.03 -46.77 21.13 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.596 2.197 . . . . 0.0 112.34 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . 0.558 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 56.0 m-85 -60.14 -36.03 76.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.81 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 170.18 -179.57 42.32 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.476 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -69.17 109.72 4.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.88 0.371 . . . . 0.0 110.903 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 91.1 t -79.3 131.37 34.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.106 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . 0.441 HG23 ' N ' ' A' ' 450' ' ' ASP . 55.2 t -84.36 -47.68 17.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.152 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 429' ' ' SER . . . . . 0.492 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 23.3 t -129.57 144.4 51.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.814 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -160.44 111.09 1.83 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.118 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -159.04 135.1 8.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.856 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.455 HG13 ' N ' ' A' ' 433' ' ' PHE . 80.0 t -90.05 142.5 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.162 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . 0.54 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.0 m-85 -83.84 144.48 29.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . 0.409 ' C ' ' HE3' ' A' ' 442' ' ' LYS . 21.0 mt -138.08 149.89 24.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.12 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -82.48 151.94 26.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.83 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -82.05 -30.96 31.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -77.57 -58.98 2.97 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.88 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 44.3 p -72.05 -42.86 65.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.205 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 5.6 t30 74.97 36.1 0.57 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . 0.444 ' O ' ' C ' ' A' ' 441' ' ' SER . 5.7 mt -139.27 138.39 36.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.921 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 441' ' ' SER . . . . . 0.444 ' C ' ' O ' ' A' ' 440' ' ' LEU . 52.7 m -34.35 137.29 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.863 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.487 ' CB ' ' CE2' ' A' ' 444' ' ' PHE . 84.8 mttt -83.41 20.62 1.3 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.884 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 98.9 m 62.76 27.41 16.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.884 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . 0.54 ' CE1' ' HB2' ' A' ' 433' ' ' PHE . 3.7 p90 -162.28 139.93 8.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.868 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -131.09 175.86 19.31 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.503 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . 0.605 ' CE2' ' OE2' ' A' ' 396' ' ' GLU . 35.0 t80 -116.01 153.76 31.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.908 0.385 . . . . 0.0 110.857 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 65.5 t -154.69 150.13 11.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.102 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 6.1 p -147.1 141.35 26.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . 0.581 ' CE1' HD12 ' A' ' 403' ' ' LEU . 3.8 m-85 -111.42 170.46 8.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.867 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . 0.441 ' N ' HG23 ' A' ' 428' ' ' VAL . 2.7 m-20 -67.09 -25.65 66.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.803 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . 0.405 ' OD1' ' N ' ' A' ' 451' ' ' ASN . 2.0 p-10 -143.32 156.98 60.64 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.611 0.72 . . . . 0.0 110.896 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.39 -22.12 14.46 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.653 2.235 . . . . 0.0 112.377 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 98.3 t -72.82 -40.9 61.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.109 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 1.8 m -73.08 -42.65 62.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.81 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -52.83 -42.67 65.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.097 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 25.5 mm-40 -53.76 -44.86 70.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.867 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -43.63 -43.02 5.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.11 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . 0.558 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -58.18 -66.37 0.49 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.185 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . 0.454 ' O ' ' C ' ' A' ' 460' ' ' GLN . 58.8 mt -50.1 -48.94 23.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.121 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . 0.454 ' C ' ' O ' ' A' ' 459' ' ' ILE . 36.3 mt-30 -33.91 -43.24 0.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.93 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 34.1 t -102.55 -56.91 2.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 462' ' ' MET . . . . . 0.427 ' O ' ' N ' ' A' ' 465' ' ' PHE . 80.6 mmm -44.36 -47.83 9.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.819 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -40.35 100.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.854 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 80.99 37.22 19.57 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.477 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . 0.427 ' N ' ' O ' ' A' ' 462' ' ' MET . 64.9 t80 -77.79 115.36 17.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.816 0.341 . . . . 0.0 110.899 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -64.28 102.88 0.57 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.952 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 19.4 tt -112.94 144.95 19.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.153 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 42.45 -96.94 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.457 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 54.4 mtm -125.1 -7.77 7.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.863 0.363 . . . . 0.0 110.877 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.91 -177.96 3.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.907 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 68.0 mtt85 -112.2 168.4 9.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.867 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 56.7 mt -111.22 158.35 19.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.912 -179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 21.4 ttmt -134.5 99.96 4.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 11.4 t -105.84 138.2 32.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.14 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . 0.446 ' OE1' ' NH1' ' A' ' 478' ' ' ARG . 37.5 tt0 -156.98 138.2 13.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.834 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . 0.44 ' O ' ' CD1' ' A' ' 476' ' ' LEU . 1.6 pp -78.93 124.37 28.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.886 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.559 ' HB2' ' CE1' ' A' ' 404' ' ' PHE . 0.3 OUTLIER -61.26 117.21 5.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.85 179.828 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . 0.446 ' NH1' ' OE1' ' A' ' 475' ' ' GLN . 4.0 mpt_? -74.23 139.46 44.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 95.1 p -50.1 135.1 21.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.11 176.86 11.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.932 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -135.97 137.09 40.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.894 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -129.72 -56.53 1.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.868 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 94.0 p -166.0 112.55 0.88 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.79 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 5.3 tmtm? -121.1 125.82 48.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.87 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 43.5 t -141.65 156.45 45.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -96.56 134.25 11.73 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.471 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -78.06 120.93 5.16 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.741 2.294 . . . . 0.0 112.341 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 80.6 p -93.52 89.26 6.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.789 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 25.0 p 44.02 41.98 4.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.843 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.459 179.993 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.256 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 44.8 p -94.18 138.82 31.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.848 0.356 . . . . 0.0 110.891 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 55.5 p -73.33 175.42 6.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.874 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -161.83 148.23 15.43 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.547 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 25.4 t -116.63 91.96 3.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.926 0.394 . . . . 0.0 110.8 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 19.6 m -96.96 99.59 11.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.862 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 47.17 -127.53 11.88 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.499 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 1.8 tt 64.01 41.29 6.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.855 0.36 . . . . 0.0 110.956 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 70.0 p -136.83 157.28 47.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.139 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -102.37 116.11 31.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.923 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -151.74 136.02 16.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.925 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 17.7 m -122.85 91.75 3.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.842 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 4.0 mp -119.74 135.01 61.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.115 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -61.51 118.09 13.69 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.498 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -110.74 31.54 5.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.839 0.352 . . . . 0.0 111.145 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -90.98 132.83 35.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.05 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 83.83 -41.12 2.93 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.459 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 11.4 m -43.98 114.2 0.63 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.837 0.351 . . . . 0.0 110.916 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -87.15 42.64 1.04 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.936 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' LYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 429' ' ' SER . 14.7 ptmt -102.38 176.76 5.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.928 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -143.34 -178.38 5.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.901 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -100.08 -154.7 27.73 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.468 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.57 159.24 46.41 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.715 2.276 . . . . 0.0 112.349 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -54.51 116.38 2.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 120.33 -27.74 6.54 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.499 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' ALA . . . . . 0.488 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.91 127.18 43.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.858 0.361 . . . . 0.0 111.063 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 402' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.6 OUTLIER -158.73 160.0 35.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 -179.917 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 403' ' ' LEU . . . . . 0.561 HD13 ' CE1' ' A' ' 449' ' ' TYR . 23.1 mt -156.0 122.25 5.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.924 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 404' ' ' PHE . . . . . 0.502 ' CE1' ' HD3' ' A' ' 477' ' ' LYS . 36.6 m-85 -131.33 110.85 11.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.834 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 405' ' ' ILE . . . . . 0.443 ' CD1' ' N ' ' A' ' 405' ' ' ILE . 3.0 mp -91.18 136.76 23.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.116 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 406' ' ' TYR . . . . . 0.402 ' N ' HG22 ' A' ' 405' ' ' ILE . 88.3 m-85 -131.2 165.69 22.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.956 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 407' ' ' HIS . . . . . 0.454 ' N ' ' O ' ' A' ' 443' ' ' CYS . 22.0 m-70 58.96 53.22 5.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.891 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 408' ' ' LEU . . . . . 0.4 ' O ' ' O ' ' A' ' 409' ' ' PRO . 21.1 mt -94.83 138.35 22.17 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.613 0.721 . . . . 0.0 110.915 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 409' ' ' PRO . . . . . 0.4 ' O ' ' O ' ' A' ' 408' ' ' LEU . 76.1 Cg_exo -50.02 -172.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.671 2.247 . . . . 0.0 112.384 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -90.93 -43.03 10.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.876 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -62.52 -36.99 84.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -51.57 132.03 30.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.903 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -127.16 -130.91 3.42 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.536 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.56 -62.84 1.37 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.761 0.315 . . . . 0.0 110.836 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 415' ' ' GLN . . . . . 0.42 ' O ' ' C ' ' A' ' 416' ' ' ASP . 35.0 mm-40 -47.06 -58.03 4.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.948 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 416' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 415' ' ' GLN . 71.2 m-20 -36.0 -71.87 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 417' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 416' ' ' ASP . 26.2 tp -37.53 -53.26 1.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.966 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 27.5 tp -54.99 -46.61 75.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.944 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -75.33 -11.83 60.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.924 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 2.9 tpp -86.68 -28.3 23.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 421' ' ' PHE . . . . . 0.443 ' CE1' ' SD ' ' A' ' 462' ' ' MET . 6.0 m-85 -106.56 -11.27 15.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.936 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 422' ' ' MET . . . . . 0.583 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 1.6 mmt -60.59 -45.71 97.18 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.543 0.687 . . . . 0.0 110.852 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 423' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 422' ' ' MET . 66.5 Cg_exo -47.97 -48.44 16.31 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.706 2.271 . . . . 0.0 112.311 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -60.21 -35.15 74.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.865 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 175.79 -171.94 44.98 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.495 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -79.34 105.75 10.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.917 0.389 . . . . 0.0 110.919 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 95.9 t -71.82 126.59 32.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.109 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 428' ' ' VAL . . . . . 0.41 HG21 ' C ' ' A' ' 449' ' ' TYR . 95.2 t -84.27 -38.31 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.081 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 429' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 1.0 OUTLIER -137.72 140.54 40.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.849 -179.841 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -160.22 114.55 2.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.087 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -159.5 133.85 7.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 432' ' ' VAL . . . . . 0.417 HG13 ' N ' ' A' ' 433' ' ' PHE . 88.0 t -88.6 153.93 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.153 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 433' ' ' PHE . . . . . 0.417 ' N ' HG13 ' A' ' 432' ' ' VAL . 3.8 m-30 -88.01 153.98 20.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.863 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 434' ' ' ILE . . . . . 0.468 ' CA ' ' HD2' ' A' ' 442' ' ' LYS . 21.3 mm -132.98 141.89 43.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.122 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -85.33 147.88 26.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.92 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 18.2 tptp -92.13 -5.24 53.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -98.37 -46.21 5.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.865 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 30.4 p -97.21 -21.59 17.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.128 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 58.1 t30 55.06 44.88 27.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.865 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 55.3 mt -130.36 160.41 34.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.897 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 441' ' ' SER . . . . . 0.439 ' HA ' ' CD1' ' A' ' 434' ' ' ILE . 10.3 p -61.94 104.86 0.5 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.913 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 442' ' ' LYS . . . . . 0.568 ' HD3' ' CE1' ' A' ' 444' ' ' PHE . 20.6 mttt -52.46 -174.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.834 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 443' ' ' CYS . . . . . 0.454 ' O ' ' N ' ' A' ' 407' ' ' HIS . 26.7 p -110.27 30.63 6.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.839 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 444' ' ' PHE . . . . . 0.568 ' CE1' ' HD3' ' A' ' 442' ' ' LYS . 7.4 p90 -159.91 145.92 15.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -142.96 175.8 22.9 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.479 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 446' ' ' PHE . . . . . 0.494 ' CD1' ' CZ ' ' A' ' 404' ' ' PHE . 25.2 t80 -112.62 154.93 25.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.911 0.386 . . . . 0.0 110.92 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 447' ' ' VAL . . . . . 0.48 ' CG2' ' O ' ' A' ' 446' ' ' PHE . 72.3 t -160.86 156.01 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.134 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 448' ' ' SER . . . . . 0.427 ' N ' HG11 ' A' ' 447' ' ' VAL . 2.4 m -155.89 152.68 28.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.864 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 449' ' ' TYR . . . . . 0.561 ' CE1' HD13 ' A' ' 403' ' ' LEU . 3.7 m-85 -115.63 -175.01 2.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.935 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -79.1 -24.0 43.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.817 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -147.98 158.34 42.16 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.627 0.727 . . . . 0.0 110.844 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.56 -2.13 12.01 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.645 2.23 . . . . 0.0 112.303 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 96.6 t -89.82 -39.85 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.089 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 10.6 t -74.76 -40.14 61.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.876 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -50.64 -32.97 20.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.172 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 456' ' ' GLN . . . . . 0.505 ' O ' ' N ' ' A' ' 458' ' ' ALA . 34.1 mm-40 -61.57 -60.34 3.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.918 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 457' ' ' ALA . . . . . 0.457 ' C ' ' HG2' ' A' ' 460' ' ' GLN . . . -35.89 -30.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.117 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 458' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 456' ' ' GLN . . . -81.53 -44.98 16.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.092 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 459' ' ' ILE . . . . . 0.488 ' N ' ' O ' ' A' ' 456' ' ' GLN . 26.0 mt -70.1 -48.42 62.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.113 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 460' ' ' GLN . . . . . 0.485 ' HG3' ' N ' ' A' ' 461' ' ' SER . 3.8 pt20 -37.01 -45.05 0.55 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.875 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 461' ' ' SER . . . . . 0.485 ' N ' ' HG3' ' A' ' 460' ' ' GLN . 2.0 m -93.94 -54.18 3.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.82 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 462' ' ' MET . . . . . 0.496 ' O ' ' N ' ' A' ' 465' ' ' PHE . 9.6 mmt -44.38 -57.49 3.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.85 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -38.16 97.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 464' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 462' ' ' MET . . . 84.43 34.82 15.65 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.517 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 465' ' ' PHE . . . . . 0.496 ' N ' ' O ' ' A' ' 462' ' ' MET . 48.6 t80 -71.98 125.92 28.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.823 0.344 . . . . 0.0 110.856 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 14.6 tm0? -70.73 117.18 11.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.945 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.6 tt -139.03 133.1 40.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.151 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 50.91 -103.0 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.465 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 11.4 mmm -132.53 25.58 4.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.805 0.336 . . . . 0.0 110.846 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -145.85 179.64 7.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.891 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 -120.32 122.3 40.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.877 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 52.8 mt -64.48 158.07 24.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.852 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -133.25 111.72 11.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.899 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 20.9 t -122.22 136.95 57.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.119 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 33.1 tp60 -157.14 141.6 16.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 476' ' ' LEU . . . . . 0.465 ' O ' ' CD1' ' A' ' 476' ' ' LEU . 1.5 pp -85.01 125.05 32.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.961 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 477' ' ' LYS . . . . . 0.502 ' HD3' ' CE1' ' A' ' 404' ' ' PHE . 7.8 tptm -34.18 109.07 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.932 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 46.3 mtt180 -74.4 98.82 3.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.922 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 80.8 p -112.45 110.71 21.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.887 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -99.26 40.78 1.19 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -84.57 42.19 0.89 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -83.81 86.45 7.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.878 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 22.5 t -115.15 42.85 2.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.813 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -132.2 95.33 3.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.833 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 19.3 m -83.48 102.37 12.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.801 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 113.91 96.46 2.18 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.483 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.62 136.01 20.65 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.66 2.24 . . . . 0.0 112.337 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 14.9 t -108.14 109.73 21.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.871 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 7.0 t -108.59 89.1 2.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.882 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.526 -179.936 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.491 ' O ' ' CB ' ' A' ' 429' ' ' SER . 26.6 mtpp . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.726 0.298 . . . . 0.0 110.966 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -144.52 165.69 27.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.816 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -88.55 -146.43 12.49 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.448 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.44 154.1 40.22 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.647 2.231 . . . . 0.0 112.307 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -52.0 124.64 13.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.916 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 113.53 -27.28 9.48 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.505 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 401' ' ' ALA . . . . . 0.496 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.94 127.11 43.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.82 0.343 . . . . 0.0 111.11 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 402' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.7 OUTLIER -159.05 163.17 36.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 403' ' ' LEU . . . . . 0.493 HD12 ' CE1' ' A' ' 449' ' ' TYR . 24.1 mt -159.36 122.37 3.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.922 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 404' ' ' PHE . . . . . 0.615 ' CZ ' ' CD1' ' A' ' 446' ' ' PHE . 41.4 m-85 -129.78 114.81 16.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 405' ' ' ILE . . . . . 0.62 HG12 HD11 ' A' ' 417' ' ' LEU . 3.8 mp -90.9 134.0 30.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.1 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 406' ' ' TYR . . . . . 0.446 ' CD2' ' HD3' ' A' ' 473' ' ' LYS . 71.9 m-85 -129.4 166.36 19.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.902 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 23.3 m80 59.0 50.5 8.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.83 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.493 HD21 HG21 ' A' ' 405' ' ' ILE . 32.8 mt -91.24 149.21 39.37 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.657 0.741 . . . . 0.0 110.935 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -78.31 169.86 19.45 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.634 2.223 . . . . 0.0 112.342 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -73.59 -31.14 63.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.43 -38.55 91.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.866 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.581 ' CE1' HD11 ' A' ' 467' ' ' ILE . 4.3 m-85 -70.22 148.01 49.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.826 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 413' ' ' GLY . . . . . 0.525 ' O ' HG21 ' A' ' 432' ' ' VAL . . . -135.25 -133.56 3.27 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.493 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -87.76 -61.9 1.61 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.753 0.311 . . . . 0.0 110.867 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 415' ' ' GLN . . . . . 0.415 ' O ' ' C ' ' A' ' 416' ' ' ASP . 11.5 mm-40 -54.33 -54.3 42.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.928 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 416' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 415' ' ' GLN . 67.0 m-20 -36.91 -60.94 0.58 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.774 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 417' ' ' LEU . . . . . 0.62 HD11 HG12 ' A' ' 405' ' ' ILE . 24.2 tp -46.52 -45.24 18.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.859 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 418' ' ' LEU . . . . . 0.451 HD13 ' HB3' ' A' ' 430' ' ' ALA . 27.1 tp -59.62 -54.99 40.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.939 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -68.41 -9.93 51.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.845 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -85.57 -30.57 23.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.859 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 421' ' ' PHE . . . . . 0.432 ' C ' ' HD2' ' A' ' 423' ' ' PRO . 4.0 m-85 -100.35 -20.9 15.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.864 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 422' ' ' MET . . . . . 0.569 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 3.6 mtt -48.85 -46.6 73.78 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.523 0.678 . . . . 0.0 110.787 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 422' ' ' MET . 64.3 Cg_exo -47.97 -38.49 31.45 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.663 2.242 . . . . 0.0 112.354 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 424' ' ' PHE . . . . . 0.517 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 82.0 m-85 -73.93 -31.91 63.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.909 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 171.6 -177.25 44.52 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.47 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -77.47 94.91 4.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.913 0.387 . . . . 0.0 110.913 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.425 HG22 ' CE1' ' A' ' 449' ' ' TYR . 86.5 t -64.57 127.96 26.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.148 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 79.5 t -78.84 -45.39 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.159 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 429' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 8.5 p -128.99 144.7 51.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.89 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 430' ' ' ALA . . . . . 0.451 ' HB3' HD13 ' A' ' 418' ' ' LEU . . . -160.72 107.53 1.5 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.113 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 431' ' ' LYS . . . . . 0.482 ' CG ' ' N ' ' A' ' 432' ' ' VAL . 52.2 tttt -145.16 162.74 36.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.887 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.525 HG21 ' O ' ' A' ' 413' ' ' GLY . 18.5 t -124.52 148.12 28.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.138 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 433' ' ' PHE . . . . . 0.637 ' CG ' ' CE1' ' A' ' 444' ' ' PHE . 4.5 m-85 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.849 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 22.6 m . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.869 0.366 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 444' ' ' PHE . . . . . 0.637 ' CE1' ' CG ' ' A' ' 433' ' ' PHE . 2.6 p90 -161.78 141.6 10.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.926 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -135.98 164.93 24.98 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.492 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 446' ' ' PHE . . . . . 0.615 ' CD1' ' CZ ' ' A' ' 404' ' ' PHE . 33.8 t80 -103.76 153.35 20.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.873 0.368 . . . . 0.0 110.913 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 447' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 446' ' ' PHE . 60.5 t -158.87 152.76 6.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.129 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 10.1 m -153.86 150.74 28.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 449' ' ' TYR . . . . . 0.493 ' CE1' HD12 ' A' ' 403' ' ' LEU . 3.9 m-85 -113.07 -175.14 2.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.862 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -80.61 -13.05 59.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.856 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -161.37 159.36 23.72 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.596 0.713 . . . . 0.0 110.817 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 452' ' ' PRO . . . . . 0.466 ' N ' ' HB2' ' A' ' 401' ' ' ALA . 61.1 Cg_endo -75.86 -7.11 18.15 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.67 2.247 . . . . 0.0 112.362 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 58.9 t -81.3 -39.39 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.125 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 6.4 m -82.97 -40.7 19.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.89 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -53.1 -31.9 44.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.132 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -69.41 -43.72 72.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.951 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -43.84 -41.26 4.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.081 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 458' ' ' ALA . . . . . 0.517 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -64.29 -67.91 0.39 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.085 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 459' ' ' ILE . . . . . 0.527 HG23 ' HB2' ' A' ' 463' ' ' ASN . 87.1 mt -43.66 -45.95 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.114 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 460' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 459' ' ' ILE . 35.3 mt-30 -37.38 -47.42 0.85 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.869 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 2.8 m -101.58 -53.71 2.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.864 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 462' ' ' MET . . . . . 0.459 ' SD ' ' CE1' ' A' ' 424' ' ' PHE . 84.3 mmm -44.85 -47.77 11.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.92 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 463' ' ' ASN . . . . . 0.527 ' HB2' HG23 ' A' ' 459' ' ' ILE . 27.2 t-20 -45.27 104.34 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 86.22 25.35 37.16 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.48 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 465' ' ' PHE . . . . . 0.413 ' N ' ' O ' ' A' ' 462' ' ' MET . 21.7 t80 -69.87 108.69 4.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.795 0.331 . . . . 0.0 110.931 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -65.8 104.17 1.03 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.863 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 467' ' ' ILE . . . . . 0.581 HD11 ' CE1' ' A' ' 412' ' ' PHE . 19.8 tt -111.62 135.33 51.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.13 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 58.19 -93.01 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.463 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 59.9 mtp -133.57 -0.58 3.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.813 0.339 . . . . 0.0 110.875 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -127.88 -178.18 4.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.936 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 54.2 mtt85 -112.73 159.91 18.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.897 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 87.3 mt -103.0 157.54 16.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.894 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 473' ' ' LYS . . . . . 0.446 ' HD3' ' CD2' ' A' ' 406' ' ' TYR . 13.3 tttt -132.26 104.67 6.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.923 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 2.8 t -113.55 135.82 51.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.138 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -157.1 137.92 13.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.836 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 476' ' ' LEU . . . . . 0.666 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.6 pp -83.66 128.38 34.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 476' ' ' LEU . 10.7 tptm . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.748 0.309 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -131.41 -178.3 4.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.868 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -98.14 -145.89 19.67 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.561 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.52 151.08 52.61 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.697 2.265 . . . . 0.0 112.333 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -54.16 97.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.937 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 135.16 -22.95 3.53 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.462 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 401' ' ' ALA . . . . . 0.448 ' HB2' ' N ' ' A' ' 452' ' ' PRO . . . -99.98 127.43 46.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.709 0.29 . . . . 0.0 111.166 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -158.47 165.5 34.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.876 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 403' ' ' LEU . . . . . 0.716 HD23 HD11 ' A' ' 459' ' ' ILE . 22.4 mt -160.12 110.38 1.85 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.921 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 404' ' ' PHE . . . . . 0.584 ' CE1' ' HB2' ' A' ' 477' ' ' LYS . 26.2 m-85 -115.37 115.62 26.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.899 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 405' ' ' ILE . . . . . 0.572 HG21 HD21 ' A' ' 408' ' ' LEU . 4.0 mp -90.81 136.19 24.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.132 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 406' ' ' TYR . . . . . 0.54 ' CZ ' ' HB3' ' A' ' 404' ' ' PHE . 26.9 m-85 -130.49 167.53 18.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.945 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 6.0 m80 59.79 50.14 7.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.858 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.572 HD21 HG21 ' A' ' 405' ' ' ILE . 38.3 mt -97.25 145.93 30.48 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.58 0.705 . . . . 0.0 110.957 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.487 ' HG2' ' CD1' ' A' ' 412' ' ' PHE . 61.5 Cg_endo -76.42 -177.51 3.77 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.713 2.275 . . . . 0.0 112.308 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -84.44 -35.58 22.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.938 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -58.64 -33.39 70.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.938 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.517 ' CE1' HD11 ' A' ' 467' ' ' ILE . 3.4 m-85 -64.98 155.05 35.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.977 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -145.32 -148.08 4.75 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.493 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.35 -60.33 2.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.707 0.289 . . . . 0.0 110.805 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 415' ' ' GLN . . . . . 0.434 ' O ' ' C ' ' A' ' 416' ' ' ASP . 21.1 mp0 -54.27 -59.29 4.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.984 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 416' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 415' ' ' GLN . 35.3 m-20 -34.6 -61.19 0.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.831 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 417' ' ' LEU . . . . . 0.423 HD11 HD13 ' A' ' 405' ' ' ILE . 19.5 tp -47.84 -47.67 31.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 18.4 tp -62.38 -44.09 97.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -74.25 -17.42 60.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.878 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 2.5 ttt -83.94 -28.85 27.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.863 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 421' ' ' PHE . . . . . 0.438 ' C ' ' HD2' ' A' ' 423' ' ' PRO . 5.3 m-85 -102.93 -19.83 14.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.883 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 422' ' ' MET . . . . . 0.584 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 0.2 OUTLIER -49.97 -46.05 81.33 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.517 0.675 . . . . 0.0 110.827 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 422' ' ' MET . 66.7 Cg_exo -48.03 -48.97 14.93 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.69 2.26 . . . . 0.0 112.299 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 424' ' ' PHE . . . . . 0.503 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 81.5 m-85 -62.18 -31.79 72.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 175.35 173.58 41.22 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.52 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -76.18 91.78 3.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.942 0.401 . . . . 0.0 110.886 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.518 HG11 ' HB2' ' A' ' 430' ' ' ALA . 72.4 t -56.33 128.62 16.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.127 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 31.3 t -73.16 -50.98 28.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.162 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 38.8 m -144.43 132.16 21.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.865 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 430' ' ' ALA . . . . . 0.518 ' HB2' HG11 ' A' ' 427' ' ' VAL . . . -140.78 129.86 23.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.097 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 431' ' ' LYS . . . . . 0.419 ' HD3' ' C ' ' A' ' 431' ' ' LYS . 0.2 OUTLIER -159.83 137.75 10.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.868 -180.0 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 72.2 t -93.7 151.37 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.128 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 433' ' ' PHE . . . . . 0.405 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 4.1 m-30 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.912 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 19.0 p . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.798 0.333 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 444' ' ' PHE . . . . . 0.405 ' CE1' ' HB2' ' A' ' 433' ' ' PHE . 7.0 p90 -162.1 141.9 9.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.908 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -139.25 179.08 19.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.475 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 446' ' ' PHE . . . . . 0.492 ' CE1' ' CE1' ' A' ' 404' ' ' PHE . 27.2 t80 -117.41 150.31 39.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.825 0.345 . . . . 0.0 110.958 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 96.6 t -155.32 144.61 12.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.127 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 51.6 p -139.81 146.34 39.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.838 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 449' ' ' TYR . . . . . 0.706 ' CE1' HD12 ' A' ' 403' ' ' LEU . 3.7 m-85 -111.86 174.67 5.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.87 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.63 -18.65 62.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.864 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 451' ' ' ASN . . . . . 0.482 ' N ' ' OD1' ' A' ' 451' ' ' ASN . 3.9 p-10 -152.01 155.1 33.36 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.642 0.734 . . . . 0.0 110.869 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 452' ' ' PRO . . . . . 0.448 ' N ' ' HB2' ' A' ' 401' ' ' ALA . 60.9 Cg_endo -75.41 -15.1 20.04 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.644 2.23 . . . . 0.0 112.347 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 85.7 t -77.72 -38.1 24.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.025 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 1.5 t -80.21 -35.86 35.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.762 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -56.43 -39.53 73.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.128 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -61.97 -42.59 99.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -42.63 -43.76 3.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.148 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 458' ' ' ALA . . . . . 0.503 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -64.02 -70.52 0.22 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.156 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 459' ' ' ILE . . . . . 0.716 HD11 HD23 ' A' ' 403' ' ' LEU . 84.6 mt -41.9 -44.78 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.161 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -39.54 -47.22 1.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 2.4 m -97.58 -54.31 3.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.863 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 462' ' ' MET . . . . . 0.476 ' O ' ' N ' ' A' ' 465' ' ' PHE . 80.8 mmm -44.69 -57.39 3.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.847 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 463' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 462' ' ' MET . 9.8 t-20 -35.98 99.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.822 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 90.32 31.11 10.96 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.524 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 465' ' ' PHE . . . . . 0.476 ' N ' ' O ' ' A' ' 462' ' ' MET . 40.2 t80 -76.26 115.71 16.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.759 0.314 . . . . 0.0 110.883 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -63.54 103.28 0.51 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.894 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 467' ' ' ILE . . . . . 0.517 HD11 ' CE1' ' A' ' 412' ' ' PHE . 18.8 tt -114.01 138.9 42.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.151 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 48.17 -96.87 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.457 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 27.3 mmm -125.14 -9.33 7.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.873 0.368 . . . . 0.0 110.861 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 14.6 pttm -121.03 178.98 4.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.894 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 62.0 mtm180 -110.42 151.61 27.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.888 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 68.5 mt -94.22 158.08 15.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.874 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -137.43 108.53 6.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 474' ' ' VAL . . . . . 0.423 HG21 ' HB3' ' A' ' 462' ' ' MET . 2.9 t -110.02 140.34 29.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.129 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -157.17 141.01 16.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.907 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 476' ' ' LEU . . . . . 0.759 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.5 pp -85.19 125.65 33.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.939 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.584 ' HB2' ' CE1' ' A' ' 404' ' ' PHE . 32.9 ttpt . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.874 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 33.3 mtmt . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.765 0.316 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -130.73 -178.33 4.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.84 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -96.41 -155.09 30.62 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.5 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.25 151.73 43.88 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.618 2.212 . . . . 0.0 112.395 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -48.45 113.56 0.78 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.88 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 121.57 -28.53 5.94 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.512 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 401' ' ' ALA . . . . . 0.496 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.81 127.4 43.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.8 0.333 . . . . 0.0 111.127 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 402' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.7 OUTLIER -158.42 161.96 37.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.947 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 403' ' ' LEU . . . . . 0.495 HD12 ' CE1' ' A' ' 449' ' ' TYR . 19.8 mt -155.67 120.28 4.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.915 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 404' ' ' PHE . . . . . 0.529 ' CE1' ' HB2' ' A' ' 477' ' ' LYS . 25.3 m-85 -127.61 110.74 12.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.945 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 405' ' ' ILE . . . . . 0.635 ' N ' HD12 ' A' ' 405' ' ' ILE . 3.5 mp -91.84 136.31 24.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.127 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -127.28 174.63 8.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 407' ' ' HIS . . . . . 0.535 ' O ' HD23 ' A' ' 472' ' ' LEU . 21.3 m80 51.04 50.29 19.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.919 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.424 HD11 ' CG2' ' A' ' 405' ' ' ILE . 19.7 mt -98.27 140.18 21.69 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.549 0.69 . . . . 0.0 110.982 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.411 ' O ' ' O ' ' A' ' 408' ' ' LEU . 73.1 Cg_exo -50.46 -171.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.651 2.234 . . . . 0.0 112.411 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -100.01 -24.77 14.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.97 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.11 -32.17 59.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.873 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -58.19 130.85 48.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.869 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -118.47 -144.88 7.65 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.51 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.86 -60.22 2.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.794 0.331 . . . . 0.0 110.847 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -53.84 -55.1 29.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -42.23 -65.01 0.51 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.889 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 22.5 tp -42.86 -41.37 3.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.94 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 418' ' ' LEU . . . . . 0.612 HD13 ' HB3' ' A' ' 430' ' ' ALA . 30.6 tp -65.35 -50.94 63.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.919 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -67.5 -9.0 38.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.925 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -86.43 -27.91 23.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.902 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 421' ' ' PHE . . . . . 0.597 ' CZ ' ' SD ' ' A' ' 462' ' ' MET . 10.6 m-85 -104.75 -12.48 16.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.909 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 422' ' ' MET . . . . . 0.575 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 6.1 mtt -54.22 -45.73 99.08 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.565 0.698 . . . . 0.0 110.877 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.0 Cg_exo -47.95 -40.79 33.08 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.611 2.207 . . . . 0.0 112.392 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 424' ' ' PHE . . . . . 0.559 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 86.7 m-85 -67.61 -36.01 80.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.806 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 178.34 -169.06 40.6 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.464 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -85.32 100.47 11.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.874 0.369 . . . . 0.0 110.911 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.551 HG11 HD12 ' A' ' 418' ' ' LEU . 74.7 t -65.15 135.95 27.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.152 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 25.2 t -84.87 -41.02 15.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.18 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 39.7 m -158.91 140.07 13.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.902 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 430' ' ' ALA . . . . . 0.612 ' HB3' HD13 ' A' ' 418' ' ' LEU . . . -149.36 132.11 15.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.122 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -157.28 135.3 10.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.933 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 85.3 t -91.98 146.85 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.124 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.889 -179.975 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 27.8 p . . . . . 0 C--O 1.231 0.132 0 CA-C-O 120.892 0.377 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -161.99 150.74 15.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.919 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -141.98 176.27 22.15 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.544 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 446' ' ' PHE . . . . . 0.521 ' O ' HG23 ' A' ' 447' ' ' VAL . 39.8 t80 -117.03 156.81 26.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.948 0.404 . . . . 0.0 110.847 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 447' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 446' ' ' PHE . 76.2 t -161.03 153.9 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.109 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 448' ' ' SER . . . . . 0.418 ' N ' HG12 ' A' ' 447' ' ' VAL . 3.2 m -151.57 142.39 22.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.865 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 449' ' ' TYR . . . . . 0.495 ' CE1' HD12 ' A' ' 403' ' ' LEU . 3.2 m-85 -107.01 -177.66 3.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.66 -17.19 56.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.838 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 451' ' ' ASN . . . . . 0.474 ' N ' ' OD1' ' A' ' 451' ' ' ASN . 3.7 p-10 -154.34 156.9 32.15 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.595 0.712 . . . . 0.0 110.852 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.52 -9.29 18.63 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.635 2.224 . . . . 0.0 112.323 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 99.6 t -83.14 -33.76 10.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.099 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 61.3 m -83.6 -38.71 21.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -54.92 -29.13 55.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.112 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -66.81 -49.99 64.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.911 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -38.93 -40.45 0.65 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.047 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 458' ' ' ALA . . . . . 0.559 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -70.32 -61.91 1.59 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.152 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 459' ' ' ILE . . . . . 0.437 ' O ' ' CB ' ' A' ' 463' ' ' ASN . 88.6 mt -42.2 -42.3 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 50.6 mm-40 -42.84 -66.33 0.38 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.917 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 30.2 t -79.63 -54.68 5.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.848 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 462' ' ' MET . . . . . 0.709 ' HB3' HG21 ' A' ' 474' ' ' VAL . 6.9 mmt -40.85 -48.21 3.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.849 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 463' ' ' ASN . . . . . 0.437 ' CB ' ' O ' ' A' ' 459' ' ' ILE . 36.4 t-20 -55.97 107.56 0.36 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.843 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 87.65 22.8 41.74 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.48 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -69.03 114.15 7.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.753 0.311 . . . . 0.0 110.906 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 6.0 tm0? -72.14 104.63 3.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.935 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 467' ' ' ILE . . . . . 0.538 HG23 ' O ' ' A' ' 467' ' ' ILE . 17.3 tt -112.08 122.73 66.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.121 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 66.94 -94.38 0.24 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.488 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.12 -3.17 4.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.917 0.389 . . . . 0.0 110.948 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -125.48 -178.99 4.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.922 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -112.88 163.99 13.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.854 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 472' ' ' LEU . . . . . 0.535 HD23 ' O ' ' A' ' 407' ' ' HIS . 82.1 mt -109.33 155.75 20.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.916 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 26.6 ttmt -129.27 113.25 14.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.912 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 474' ' ' VAL . . . . . 0.709 HG21 ' HB3' ' A' ' 462' ' ' MET . 11.4 t -120.54 135.73 59.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.146 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 -156.99 140.33 15.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.875 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 476' ' ' LEU . . . . . 0.69 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.6 pp -80.96 125.35 30.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.938 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.529 ' HB2' ' CE1' ' A' ' 404' ' ' PHE . 15.3 ttmm . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.902 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.468 ' O ' ' CB ' ' A' ' 429' ' ' SER . 6.6 ptmm? . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.754 0.311 . . . . 0.0 110.91 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -132.01 -177.68 4.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -100.77 -147.2 20.49 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.501 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.77 161.18 36.85 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.669 2.246 . . . . 0.0 112.435 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -59.01 123.1 15.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 113.04 -27.57 9.49 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.576 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 401' ' ' ALA . . . . . 0.487 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.84 127.06 43.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.823 0.344 . . . . 0.0 111.112 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 402' ' ' ASN . . . . . 0.488 ' HB2' ' N ' ' A' ' 477' ' ' LYS . 0.7 OUTLIER -159.02 159.94 35.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.934 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 403' ' ' LEU . . . . . 0.567 HD23 HD11 ' A' ' 459' ' ' ILE . 17.6 mt -156.11 122.66 5.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.904 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 404' ' ' PHE . . . . . 0.482 ' CE1' ' CE1' ' A' ' 446' ' ' PHE . 22.8 m-85 -130.23 110.86 11.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 405' ' ' ILE . . . . . 0.625 ' N ' HD12 ' A' ' 405' ' ' ILE . 3.5 mp -91.1 134.13 30.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.176 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 406' ' ' TYR . . . . . 0.458 ' CD2' ' HD3' ' A' ' 473' ' ' LYS . 84.2 m-85 -126.19 -176.23 3.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.957 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 6.5 m80 42.17 53.9 4.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.411 HD21 HG21 ' A' ' 405' ' ' ILE . 28.1 mt -98.38 143.07 25.64 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.591 0.71 . . . . 0.0 110.937 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.5 164.42 32.47 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.668 2.245 . . . . 0.0 112.397 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -62.78 -37.64 87.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.918 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -58.23 -35.04 71.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.833 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.472 ' CE1' HD11 ' A' ' 467' ' ' ILE . 5.2 m-85 -77.94 115.57 17.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.848 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -109.16 -138.79 8.36 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.474 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 414' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 414' ' ' ASP . 0.1 OUTLIER -79.17 -53.72 6.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.761 0.315 . . . . 0.0 110.856 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 415' ' ' GLN . . . . . 0.417 ' O ' ' C ' ' A' ' 416' ' ' ASP . 16.0 mp0 -60.98 -57.82 11.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 416' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 415' ' ' GLN . 70.9 m-20 -36.16 -50.52 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.855 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 417' ' ' LEU . . . . . 0.461 HD11 HG12 ' A' ' 405' ' ' ILE . 36.3 tp -57.74 -50.12 74.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.925 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 39.3 tp -56.73 -43.38 80.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -80.71 -10.76 59.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.936 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -82.29 -27.44 32.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.867 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 421' ' ' PHE . . . . . 0.425 ' C ' ' HD2' ' A' ' 423' ' ' PRO . 4.0 m-85 -107.14 -20.32 13.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.855 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 422' ' ' MET . . . . . 0.575 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 0.4 OUTLIER -49.44 -46.3 77.96 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.56 0.695 . . . . 0.0 110.883 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 422' ' ' MET . 64.9 Cg_exo -47.96 -41.63 32.56 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.704 2.269 . . . . 0.0 112.376 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 424' ' ' PHE . . . . . 0.431 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 88.0 m-85 -67.27 -35.97 80.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.92 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 173.6 177.9 43.16 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.499 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -66.03 115.26 5.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.846 0.355 . . . . 0.0 110.877 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 87.4 t -85.12 131.08 35.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.073 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 53.6 t -83.83 -34.6 10.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.15 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 429' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 0.8 OUTLIER -149.2 143.86 26.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -160.91 119.49 2.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.066 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 431' ' ' LYS . . . . . 0.492 ' CG ' ' N ' ' A' ' 432' ' ' VAL . 32.7 tttp -159.47 163.17 35.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.939 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.492 ' N ' ' CG ' ' A' ' 431' ' ' LYS . 55.8 t -114.76 154.44 16.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.136 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 433' ' ' PHE . . . . . 0.563 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.1 m-85 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.819 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 16.2 m . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.904 0.383 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 444' ' ' PHE . . . . . 0.563 ' CE1' ' HB2' ' A' ' 433' ' ' PHE . 1.8 p90 -161.94 139.67 8.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.93 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -133.7 172.07 21.76 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.512 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 446' ' ' PHE . . . . . 0.482 ' CE1' ' CE1' ' A' ' 404' ' ' PHE . 23.6 t80 -109.88 153.86 23.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.908 0.385 . . . . 0.0 110.894 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 447' ' ' VAL . . . . . 0.423 HG12 ' N ' ' A' ' 448' ' ' SER . 75.3 t -157.31 153.97 6.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.12 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 448' ' ' SER . . . . . 0.423 ' N ' HG12 ' A' ' 447' ' ' VAL . 2.9 m -154.45 154.97 34.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.928 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 449' ' ' TYR . . . . . 0.46 ' CE1' HD12 ' A' ' 403' ' ' LEU . 4.7 m-85 -118.9 -175.17 2.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -85.05 -8.87 58.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.877 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -160.2 155.11 20.96 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.634 0.731 . . . . 0.0 110.942 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.78 -8.23 19.02 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.648 2.232 . . . . 0.0 112.41 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 60.0 t -82.14 -36.92 14.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.086 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 1.4 t -82.1 -42.01 19.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.855 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -52.36 -41.33 62.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.118 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -58.32 -46.57 85.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.942 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -43.47 -41.21 4.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.112 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 458' ' ' ALA . . . . . 0.431 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -62.99 -68.25 0.35 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 459' ' ' ILE . . . . . 0.567 HD11 HD23 ' A' ' 403' ' ' LEU . 77.5 mt -48.01 -43.28 10.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.086 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 460' ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' ' 459' ' ' ILE . 23.6 mt-30 -37.76 -42.46 0.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 1.9 m -103.78 -56.3 2.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.852 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 462' ' ' MET . . . . . 0.521 ' HB3' HG21 ' A' ' 474' ' ' VAL . 86.2 mmm -42.66 -42.84 3.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.96 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -42.55 100.26 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 83.24 31.35 28.43 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.488 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 465' ' ' PHE . . . . . 0.458 ' N ' ' O ' ' A' ' 462' ' ' MET . 58.3 t80 -64.79 117.12 7.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.787 0.327 . . . . 0.0 110.923 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 44.4 tp60 -74.26 105.39 5.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 467' ' ' ILE . . . . . 0.646 HG23 ' O ' ' A' ' 467' ' ' ILE . 16.4 tt -116.69 113.45 43.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.106 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 71.34 -104.12 1.37 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.465 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 469' ' ' MET . . . . . 0.4 ' O ' ' SD ' ' A' ' 469' ' ' MET . 5.8 tmm? -121.43 5.72 10.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.857 0.36 . . . . 0.0 110.846 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.73 -176.92 4.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.985 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -123.28 164.65 18.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.807 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 472' ' ' LEU . . . . . 0.458 HD12 ' HB3' ' A' ' 465' ' ' PHE . 60.2 mt -106.56 163.82 12.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.918 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 473' ' ' LYS . . . . . 0.458 ' HD3' ' CD2' ' A' ' 406' ' ' TYR . 11.8 tttt -138.43 104.99 5.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.934 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 474' ' ' VAL . . . . . 0.521 HG21 ' HB3' ' A' ' 462' ' ' MET . 5.3 t -110.78 139.07 36.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.092 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -157.22 145.89 19.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.876 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 476' ' ' LEU . . . . . 0.787 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.5 pp -92.08 123.99 35.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.488 ' N ' ' HB2' ' A' ' 402' ' ' ASN . 27.9 tttp . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.844 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.707 0.289 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -127.95 177.65 6.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.901 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -104.36 -147.31 16.85 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.535 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.57 151.61 32.81 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.709 2.273 . . . . 0.0 112.313 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -53.41 102.51 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.943 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 135.94 -28.71 2.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.466 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 401' ' ' ALA . . . . . 0.494 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.95 126.7 43.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.779 0.323 . . . . 0.0 111.106 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 402' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.5 OUTLIER -159.04 161.55 36.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.912 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 403' ' ' LEU . . . . . 0.562 HD12 ' CE1' ' A' ' 449' ' ' TYR . 17.9 mt -159.95 117.66 2.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.929 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 404' ' ' PHE . . . . . 0.73 ' CZ ' ' CD1' ' A' ' 446' ' ' PHE . 44.4 m-85 -126.39 115.42 19.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.887 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 405' ' ' ILE . . . . . 0.834 ' N ' HD12 ' A' ' 405' ' ' ILE . 1.2 mp -93.82 127.09 46.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.119 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 406' ' ' TYR . . . . . 0.484 ' CZ ' ' HB3' ' A' ' 404' ' ' PHE . 37.9 m-85 -120.19 151.99 38.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.964 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 407' ' ' HIS . . . . . 0.646 ' O ' HD23 ' A' ' 472' ' ' LEU . 10.6 m80 73.47 54.44 0.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.885 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 26.0 mt -101.58 136.05 19.67 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.6 0.714 . . . . 0.0 110.966 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -47.73 -179.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.729 2.286 . . . . 0.0 112.329 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 35.7 tp60 -91.9 -38.79 12.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.933 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 25.0 pm0 -65.15 -13.19 57.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.881 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -80.29 135.49 36.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.901 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -116.41 -151.86 9.69 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.451 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.18 -56.53 4.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.736 0.303 . . . . 0.0 110.873 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 415' ' ' GLN . . . . . 0.453 ' O ' ' C ' ' A' ' 416' ' ' ASP . 9.2 mm-40 -56.88 -55.98 27.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.9 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 416' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 415' ' ' GLN . 63.6 m-20 -34.41 -59.06 0.46 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.845 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 417' ' ' LEU . . . . . 0.402 HD11 HG12 ' A' ' 405' ' ' ILE . 39.1 tp -46.64 -49.02 19.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 418' ' ' LEU . . . . . 0.464 ' HB3' ' NE2' ' A' ' 419' ' ' GLN . 52.2 tp -55.27 -55.33 32.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.916 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 419' ' ' GLN . . . . . 0.464 ' NE2' ' HB3' ' A' ' 418' ' ' LEU . 6.9 mp0 -60.45 -17.6 45.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.923 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 3.8 ttm -86.55 -26.48 24.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 421' ' ' PHE . . . . . 0.55 ' CZ ' HG12 ' A' ' 405' ' ' ILE . 10.8 m-85 -105.93 -10.14 16.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.9 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 422' ' ' MET . . . . . 0.592 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 4.3 mtt -59.64 -45.59 98.6 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.581 0.705 . . . . 0.0 110.923 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.9 Cg_exo -47.98 -37.9 30.51 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.628 2.219 . . . . 0.0 112.362 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 424' ' ' PHE . . . . . 0.507 ' CE2' ' HA ' ' A' ' 458' ' ' ALA . 86.8 m-85 -67.19 -34.94 78.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.934 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 171.67 -156.82 26.66 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.488 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -92.0 92.77 8.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.841 0.353 . . . . 0.0 110.886 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.518 HG11 ' HB2' ' A' ' 430' ' ' ALA . 54.3 t -65.67 116.93 5.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.1 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 71.2 t -64.5 -43.18 96.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.126 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 429' ' ' SER . . . . . 0.435 ' O ' ' CG1' ' A' ' 427' ' ' VAL . 93.2 p -137.34 146.83 45.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.82 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 430' ' ' ALA . . . . . 0.518 ' HB2' HG11 ' A' ' 427' ' ' VAL . . . -161.3 110.29 1.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.076 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 431' ' ' LYS . . . . . 0.418 ' C ' ' HD2' ' A' ' 431' ' ' LYS . 1.1 tmmm? -157.36 144.4 18.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.924 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 52.7 t -96.25 137.01 25.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.147 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 433' ' ' PHE . . . . . 0.403 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.2 m-85 . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 443' ' ' CYS . . . . . 0.482 ' O ' ' N ' ' A' ' 407' ' ' HIS . 31.4 p . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.832 0.349 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 444' ' ' PHE . . . . . 0.403 ' CE1' ' HB2' ' A' ' 433' ' ' PHE . 12.0 p90 -162.2 141.5 9.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.852 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -132.65 171.16 21.73 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.454 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 446' ' ' PHE . . . . . 0.73 ' CD1' ' CZ ' ' A' ' 404' ' ' PHE . 30.6 t80 -111.24 153.16 26.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.911 0.386 . . . . 0.0 110.822 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 447' ' ' VAL . . . . . 0.467 HG13 ' CG1' ' A' ' 427' ' ' VAL . 59.5 t -159.06 146.64 7.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.099 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 1.2 t -148.74 148.89 30.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.835 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 449' ' ' TYR . . . . . 0.562 ' CE1' HD12 ' A' ' 403' ' ' LEU . 8.6 m-85 -112.11 -174.9 2.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.98 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -80.58 -21.21 41.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.904 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -152.99 155.73 32.25 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.613 0.72 . . . . 0.0 110.943 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 452' ' ' PRO . . . . . 0.452 ' N ' ' HB2' ' A' ' 401' ' ' ALA . 60.5 Cg_endo -74.28 -2.27 12.12 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.731 2.287 . . . . 0.0 112.356 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 93.2 t -86.19 -34.25 7.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.08 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 14.0 m -87.39 -39.65 15.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.823 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -52.99 -30.72 36.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.041 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -64.48 -45.95 85.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.876 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -40.31 -44.32 1.9 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.164 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 458' ' ' ALA . . . . . 0.507 ' HA ' ' CE2' ' A' ' 424' ' ' PHE . . . -61.36 -68.55 0.3 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.108 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 459' ' ' ILE . . . . . 0.428 ' O ' ' CB ' ' A' ' 463' ' ' ASN . 86.9 mt -43.04 -45.75 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.174 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 24.3 mm100 -39.34 -46.51 1.61 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.933 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 32.5 t -103.19 -56.56 2.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.883 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 462' ' ' MET . . . . . 0.501 ' HB3' HG21 ' A' ' 474' ' ' VAL . 86.6 mmm -42.65 -43.26 3.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.892 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 463' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' A' ' 459' ' ' ILE . 14.4 t30 -44.74 110.19 0.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.866 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 74.38 33.33 56.62 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.59 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 465' ' ' PHE . . . . . 0.593 ' HB3' HD12 ' A' ' 472' ' ' LEU . 9.9 t80 -67.51 113.22 5.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.753 0.311 . . . . 0.0 110.913 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -70.36 109.18 4.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.904 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.7 tt -125.01 134.94 65.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.087 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 58.6 -102.33 0.26 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.434 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -124.33 -9.24 7.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.821 0.344 . . . . 0.0 110.878 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 8.9 pttm -120.57 179.2 4.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.88 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -112.09 164.37 13.24 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.909 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 472' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 407' ' ' HIS . 78.5 mt -107.0 158.39 17.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.886 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -131.97 102.52 5.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.825 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 474' ' ' VAL . . . . . 0.501 HG21 ' HB3' ' A' ' 462' ' ' MET . 15.3 t -110.18 125.54 67.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.138 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 39.9 tp60 -152.11 144.67 24.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 476' ' ' LEU . . . . . 0.617 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.6 pp -84.98 129.11 34.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.869 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.475 ' C ' ' O ' ' A' ' 476' ' ' LEU . 4.4 tptm . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.892 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.497 ' O ' ' CB ' ' A' ' 429' ' ' SER . 26.6 mtpt . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.783 0.325 . . . . 0.0 110.854 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -142.79 179.44 7.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.946 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -98.54 -147.37 22.04 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.53 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.56 155.77 40.43 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.672 2.248 . . . . 0.0 112.323 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -58.52 100.51 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 136.25 -28.75 2.88 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.479 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 401' ' ' ALA . . . . . 0.669 ' HB2' ' CA ' ' A' ' 452' ' ' PRO . . . -97.88 127.25 43.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.774 0.321 . . . . 0.0 111.151 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 402' ' ' ASN . . . . . 0.493 ' O ' ' CB ' ' A' ' 476' ' ' LEU . 16.9 m-80 -158.64 165.43 34.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.94 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 403' ' ' LEU . . . . . 0.523 HD12 ' CE1' ' A' ' 449' ' ' TYR . 50.7 mt -159.29 108.0 1.84 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.912 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 404' ' ' PHE . . . . . 0.535 ' C ' HD13 ' A' ' 405' ' ' ILE . 26.8 m-85 -109.94 120.32 42.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.87 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 405' ' ' ILE . . . . . 0.773 HD12 HG22 ' A' ' 474' ' ' VAL . 1.8 mm -91.04 133.92 31.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.074 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 406' ' ' TYR . . . . . 0.489 ' CZ ' ' HB3' ' A' ' 404' ' ' PHE . 13.9 m-85 -129.75 147.43 51.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.887 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 407' ' ' HIS . . . . . 0.66 ' O ' HD23 ' A' ' 472' ' ' LEU . 20.2 m80 70.0 52.13 0.4 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.876 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.692 HD21 HG21 ' A' ' 405' ' ' ILE . 32.7 mt -93.65 139.65 22.85 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.585 0.707 . . . . 0.0 110.897 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -47.39 -179.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.64 2.227 . . . . 0.0 112.331 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -98.92 -24.84 14.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.949 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 7.7 pm0 -82.37 -12.75 57.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.461 ' CZ ' HD11 ' A' ' 467' ' ' ILE . 6.3 m-85 -76.55 147.55 37.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.893 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -127.03 -148.7 7.04 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.482 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -81.85 -54.72 5.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.816 0.341 . . . . 0.0 110.903 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 415' ' ' GLN . . . . . 0.466 ' O ' ' N ' ' A' ' 418' ' ' LEU . 7.3 mm100 -58.16 -58.53 8.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.935 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 416' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 415' ' ' GLN . 24.2 m-20 -37.3 -56.46 0.96 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.833 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 417' ' ' LEU . . . . . 0.548 HD11 HG13 ' A' ' 405' ' ' ILE . 48.5 tp -51.99 -37.24 52.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.943 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 418' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' A' ' 415' ' ' GLN . 23.9 tp -70.78 -50.77 32.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -63.88 -13.89 48.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.855 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 2.1 ttm -89.58 -32.79 16.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.943 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 421' ' ' PHE . . . . . 0.45 ' CE1' ' SD ' ' A' ' 462' ' ' MET . 6.2 m-85 -93.18 -17.8 23.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.873 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 422' ' ' MET . . . . . 0.58 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 0.4 OUTLIER -57.28 -45.61 99.89 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.503 0.668 . . . . 0.0 110.825 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 422' ' ' MET . 64.7 Cg_exo -47.94 -37.79 29.95 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.68 2.253 . . . . 0.0 112.351 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -71.33 -35.56 71.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.901 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 176.06 -178.62 47.48 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.459 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -76.93 89.33 3.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.839 0.352 . . . . 0.0 110.945 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 70.3 t -56.69 143.57 10.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.112 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 428' ' ' VAL . . . . . 0.418 ' CG2' ' C ' ' A' ' 449' ' ' TYR . 99.4 t -95.25 -38.39 8.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.149 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 429' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 3.5 p -140.76 145.09 35.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.928 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -161.03 113.71 1.93 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.14 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.03 142.75 17.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.919 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 86.8 t -98.99 143.74 12.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.143 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 433' ' ' PHE . . . . . 0.534 ' CG ' ' CE1' ' A' ' 444' ' ' PHE . 3.1 m-85 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 24.5 p . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.807 0.337 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 444' ' ' PHE . . . . . 0.534 ' CE1' ' CG ' ' A' ' 433' ' ' PHE . 4.6 p90 -162.15 143.48 10.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.829 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -137.22 179.07 18.46 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.539 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 446' ' ' PHE . . . . . 0.469 ' CD1' ' CZ ' ' A' ' 404' ' ' PHE . 66.0 t80 -122.89 141.1 52.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.906 0.384 . . . . 0.0 110.871 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 447' ' ' VAL . . . . . 0.42 HG13 ' O ' ' A' ' 429' ' ' SER . 84.5 t -146.12 149.44 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.102 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 1.3 t -147.95 144.94 28.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.83 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 449' ' ' TYR . . . . . 0.523 ' CE1' HD12 ' A' ' 403' ' ' LEU . 4.1 m-85 -104.84 -174.83 2.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.874 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -79.63 -22.48 43.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.797 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -147.37 155.46 46.07 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.596 0.712 . . . . 0.0 110.875 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 452' ' ' PRO . . . . . 0.669 ' CA ' ' HB2' ' A' ' 401' ' ' ALA . 59.7 Cg_endo -73.03 -0.36 8.95 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.713 2.275 . . . . 0.0 112.399 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 95.5 t -94.23 -37.05 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.149 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 50.6 m -78.63 -37.69 41.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.8 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -52.13 -30.13 25.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.054 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 456' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' A' ' 457' ' ' ALA . 11.0 mm100 -67.59 -51.59 48.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.855 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 457' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 456' ' ' GLN . . . -36.64 -42.35 0.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.124 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -69.0 -48.23 63.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.119 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 459' ' ' ILE . . . . . 0.443 ' O ' ' CB ' ' A' ' 463' ' ' ASN . 70.5 mt -55.39 -42.85 69.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.148 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -40.97 -53.08 3.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.925 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 27.8 t -93.08 -55.27 3.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.856 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 462' ' ' MET . . . . . 0.573 ' HB3' HG21 ' A' ' 474' ' ' VAL . 6.3 mmt -43.53 -49.7 7.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.905 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 463' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' A' ' 459' ' ' ILE . 18.8 t-20 -48.45 114.7 1.01 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.878 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 65.88 33.86 86.93 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.492 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -75.9 109.04 9.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.795 0.331 . . . . 0.0 110.834 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -62.96 105.88 0.74 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.928 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 467' ' ' ILE . . . . . 0.588 HG23 ' O ' ' A' ' 467' ' ' ILE . 19.2 tt -111.05 116.99 53.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.189 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 65.85 -96.98 0.28 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.537 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 4.0 ttt -123.17 -13.0 7.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.792 0.329 . . . . 0.0 110.806 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 15.3 pttm -117.59 168.65 10.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.887 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -111.29 153.52 25.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.864 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 472' ' ' LEU . . . . . 0.66 HD23 ' O ' ' A' ' 407' ' ' HIS . 14.8 mt -104.21 161.61 13.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.977 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -134.57 104.74 6.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.928 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 474' ' ' VAL . . . . . 0.773 HG22 HD12 ' A' ' 405' ' ' ILE . 30.8 t -109.09 128.33 65.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.135 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -151.84 142.96 23.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.917 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 476' ' ' LEU . . . . . 0.615 ' C ' HD12 ' A' ' 476' ' ' LEU . 1.6 pp -80.13 135.24 36.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.973 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.53 ' HB2' ' CE1' ' A' ' 404' ' ' PHE . 22.8 ttpp . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.477 ' O ' ' CB ' ' A' ' 429' ' ' SER . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.737 0.303 . . . . 0.0 110.906 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -137.2 179.31 6.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.935 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -94.81 -154.77 31.15 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.546 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.09 151.29 61.31 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.7 2.267 . . . . 0.0 112.294 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -49.58 97.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.913 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 136.43 -24.74 3.19 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.48 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -98.18 126.93 43.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.843 0.354 . . . . 0.0 111.053 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 402' ' ' ASN . . . . . 0.409 ' O ' ' CB ' ' A' ' 476' ' ' LEU . 9.5 m120 -158.97 161.87 36.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 403' ' ' LEU . . . . . 0.637 HD12 ' CE1' ' A' ' 449' ' ' TYR . 47.5 mt -159.24 108.56 1.89 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.931 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 404' ' ' PHE . . . . . 0.489 ' CE1' ' CE1' ' A' ' 446' ' ' PHE . 20.1 m-85 -113.14 112.42 23.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.923 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 405' ' ' ILE . . . . . 0.689 ' N ' HD12 ' A' ' 405' ' ' ILE . 3.0 mp -90.83 137.44 21.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.093 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 406' ' ' TYR . . . . . 0.453 ' CD1' ' HB2' ' A' ' 444' ' ' PHE . 93.6 m-85 -129.47 169.74 14.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 407' ' ' HIS . . . . . 0.469 ' N ' ' O ' ' A' ' 443' ' ' CYS . 22.1 m80 53.95 51.69 14.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.874 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.423 HD21 HG21 ' A' ' 405' ' ' ILE . 25.5 mt -93.9 134.35 26.31 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.594 0.711 . . . . 0.0 110.925 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -48.87 -175.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.659 2.24 . . . . 0.0 112.307 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -88.85 -41.43 12.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.957 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -62.5 -37.4 85.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.898 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -55.35 117.18 3.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.843 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 413' ' ' GLY . . . . . 0.461 ' O ' HG21 ' A' ' 432' ' ' VAL . . . -103.17 -138.45 9.91 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.552 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -89.98 -44.07 10.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.763 0.316 . . . . 0.0 110.871 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 415' ' ' GLN . . . . . 0.423 ' O ' ' N ' ' A' ' 418' ' ' LEU . 22.5 mp0 -70.06 -57.2 5.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 416' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 415' ' ' GLN . 32.9 m-20 -37.36 -56.77 0.95 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.838 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 417' ' ' LEU . . . . . 0.413 HD11 HG12 ' A' ' 405' ' ' ILE . 61.7 tp -52.33 -40.5 61.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.933 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 418' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' A' ' 415' ' ' GLN . 24.6 tp -69.61 -38.63 77.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -73.23 -17.51 61.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 4.8 ttp -88.9 -12.67 41.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.826 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 421' ' ' PHE . . . . . 0.517 ' CZ ' HG12 ' A' ' 405' ' ' ILE . 5.8 m-85 -111.79 -0.01 16.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.868 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 422' ' ' MET . . . . . 0.576 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 4.5 mtt -71.82 -45.92 12.17 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.549 0.69 . . . . 0.0 110.848 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.1 Cg_exo -48.02 -36.84 28.81 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.762 2.308 . . . . 0.0 112.327 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 424' ' ' PHE . . . . . 0.501 ' CD1' ' HA ' ' A' ' 458' ' ' ALA . 97.2 m-85 -69.51 -36.02 76.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.833 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 171.7 -161.65 33.87 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.53 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -86.07 105.01 16.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.943 0.401 . . . . 0.0 110.896 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 93.8 t -74.13 130.0 36.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.126 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 76.2 t -85.99 -46.82 16.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.115 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 429' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 13.7 t -130.69 144.67 51.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.841 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -161.05 117.72 2.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.097 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 431' ' ' LYS . . . . . 0.425 ' C ' ' HD2' ' A' ' 431' ' ' LYS . 2.0 tmmm? -161.06 151.44 17.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.461 HG21 ' O ' ' A' ' 413' ' ' GLY . 82.0 t -108.62 137.96 37.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.138 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 433' ' ' PHE . . . . . 0.547 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.1 m-85 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 443' ' ' CYS . . . . . 0.469 ' O ' ' N ' ' A' ' 407' ' ' HIS . 23.0 p . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.867 0.365 . . . . 0.0 110.914 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 444' ' ' PHE . . . . . 0.547 ' CE1' ' HB2' ' A' ' 433' ' ' PHE . 6.0 p90 -161.97 138.42 8.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.88 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -136.2 175.46 20.9 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.475 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 446' ' ' PHE . . . . . 0.489 ' CE1' ' CE1' ' A' ' 404' ' ' PHE . 32.9 t80 -116.03 145.53 42.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.895 0.379 . . . . 0.0 110.857 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 69.3 t -151.44 151.31 12.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.117 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 3.8 m -148.0 153.53 39.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.866 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 449' ' ' TYR . . . . . 0.637 ' CE1' HD12 ' A' ' 403' ' ' LEU . 4.5 m-85 -115.01 -174.83 2.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.903 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -81.72 -17.54 47.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.869 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -156.44 154.71 27.64 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.672 0.748 . . . . 0.0 110.857 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.44 -6.14 18.29 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.723 2.282 . . . . 0.0 112.343 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 86.1 t -85.25 -33.39 7.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.063 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 61.7 m -85.76 -35.87 20.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.812 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -57.29 -23.8 50.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.095 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -67.33 -53.54 28.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.955 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -40.23 -43.29 1.66 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.152 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 458' ' ' ALA . . . . . 0.501 ' HA ' ' CD1' ' A' ' 424' ' ' PHE . . . -62.52 -52.29 64.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.124 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 55.5 mt -57.14 -44.16 82.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.132 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -40.94 -55.85 2.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 1.9 m -89.04 -56.1 3.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 462' ' ' MET . . . . . 0.448 ' O ' ' N ' ' A' ' 465' ' ' PHE . 11.1 mmt -40.96 -63.7 0.64 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.86 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 463' ' ' ASN . . . . . 0.438 ' C ' ' O ' ' A' ' 462' ' ' MET . 37.9 t-20 -35.6 110.92 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.87 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 464' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 472' ' ' LEU . . . 67.86 38.43 89.19 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.504 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 465' ' ' PHE . . . . . 0.448 ' N ' ' O ' ' A' ' 462' ' ' MET . 25.0 t80 -78.59 116.06 18.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.826 0.346 . . . . 0.0 110.919 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 18.7 tp60 -63.07 104.28 0.55 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.874 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 467' ' ' ILE . . . . . 0.559 HG23 ' O ' ' A' ' 467' ' ' ILE . 20.0 tt -116.7 118.78 59.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.12 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 64.38 -106.37 1.42 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.449 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -113.31 -11.63 13.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.878 0.37 . . . . 0.0 110.857 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.64 178.41 5.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.864 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -110.1 170.28 8.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.91 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 472' ' ' LEU . . . . . 0.41 ' O ' ' N ' ' A' ' 464' ' ' GLY . 65.6 mt -114.09 150.07 34.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.88 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -124.61 107.93 11.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 33.0 t -119.05 137.14 54.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.149 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 48.0 tp60 -157.04 145.73 19.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.907 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 476' ' ' LEU . . . . . 0.709 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.5 pp -86.0 127.04 34.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.911 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.457 ' HB2' ' CE1' ' A' ' 404' ' ' PHE . 25.5 ttpt . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.853 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.418 ' O ' ' CB ' ' A' ' 429' ' ' SER . 6.6 ptmm? . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.835 0.35 . . . . 0.0 110.881 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 396' ' ' GLU . . . . . 0.413 ' CD ' ' O ' ' A' ' 397' ' ' GLY . 2.6 pp20? -126.72 -178.33 4.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.868 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 397' ' ' GLY . . . . . 0.413 ' O ' ' CD ' ' A' ' 396' ' ' GLU . . . -94.06 -146.42 20.14 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.511 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.71 152.05 37.09 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 122.747 2.298 . . . . 0.0 112.368 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -52.83 113.76 1.19 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.905 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 125.76 -28.19 5.0 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.529 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 401' ' ' ALA . . . . . 0.527 ' HB2' ' N ' ' A' ' 452' ' ' PRO . . . -97.93 127.16 43.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.84 0.352 . . . . 0.0 111.09 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 402' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.7 OUTLIER -158.6 160.76 36.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.852 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 403' ' ' LEU . . . . . 0.609 HD12 ' CE1' ' A' ' 449' ' ' TYR . 15.8 mt -156.29 117.76 3.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.909 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 404' ' ' PHE . . . . . 0.467 ' CE1' ' HB2' ' A' ' 477' ' ' LYS . 12.8 m-85 -125.6 113.04 16.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 405' ' ' ILE . . . . . 0.726 ' N ' HD12 ' A' ' 405' ' ' ILE . 1.8 mp -90.77 136.13 24.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.178 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -128.24 169.18 14.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.905 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 407' ' ' HIS . . . . . 0.43 ' N ' ' O ' ' A' ' 443' ' ' CYS . 34.5 m80 54.23 53.44 10.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.874 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.601 HD21 HG21 ' A' ' 405' ' ' ILE . 35.4 mt -94.1 143.62 26.72 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.608 0.718 . . . . 0.0 110.929 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.601 ' HG2' ' CD1' ' A' ' 412' ' ' PHE . 61.4 Cg_endo -78.21 155.73 29.33 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.674 2.249 . . . . 0.0 112.309 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -60.03 -37.22 79.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.919 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -60.19 -19.87 56.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.865 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.601 ' CD1' ' HG2' ' A' ' 409' ' ' PRO . 4.2 m-85 -89.84 125.88 35.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.828 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -114.55 -141.86 7.75 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.475 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.78 -59.02 2.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.75 0.31 . . . . 0.0 110.892 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 415' ' ' GLN . . . . . 0.424 ' O ' ' C ' ' A' ' 416' ' ' ASP . 52.3 mm-40 -57.78 -56.49 21.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.906 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 416' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 415' ' ' GLN . 62.0 m-20 -36.42 -39.4 0.19 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.855 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 24.2 tp -71.33 -53.58 13.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.947 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 418' ' ' LEU . . . . . 0.466 ' O ' ' CG ' ' A' ' 422' ' ' MET . 29.6 tp -54.62 -41.19 69.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.878 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -79.78 -9.95 59.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.01 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -85.19 -35.91 21.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.874 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 421' ' ' PHE . . . . . 0.573 ' CE1' ' SD ' ' A' ' 462' ' ' MET . 5.3 m-85 -98.38 -22.28 16.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 422' ' ' MET . . . . . 0.579 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 0.7 OUTLIER -50.35 -45.84 83.75 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.581 0.705 . . . . 0.0 110.889 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.4 Cg_exo -47.99 -41.79 32.62 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.627 2.218 . . . . 0.0 112.344 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -67.15 -34.39 77.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.902 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 170.5 -178.98 42.87 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.444 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -66.51 124.75 23.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.83 0.347 . . . . 0.0 110.877 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 58.7 t -98.08 118.53 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.143 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 40.5 t -61.98 -51.68 69.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.194 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 429' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 3.3 m -143.77 148.76 36.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.825 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -156.82 131.26 8.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.07 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 431' ' ' LYS . . . . . 0.476 ' CG ' ' N ' ' A' ' 432' ' ' VAL . 14.9 tttm -159.06 162.42 36.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.476 ' N ' ' CG ' ' A' ' 431' ' ' LYS . 69.6 t -121.32 144.41 30.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.145 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 433' ' ' PHE . . . . . 0.646 ' CG ' ' CE1' ' A' ' 444' ' ' PHE . 4.4 m-85 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.917 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 443' ' ' CYS . . . . . 0.43 ' O ' ' N ' ' A' ' 407' ' ' HIS . 60.7 m . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.812 0.339 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 444' ' ' PHE . . . . . 0.646 ' CE1' ' CG ' ' A' ' 433' ' ' PHE . 12.0 p90 -162.13 148.34 13.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -143.77 178.44 21.85 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.485 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 446' ' ' PHE . . . . . 0.543 ' O ' HG23 ' A' ' 447' ' ' VAL . 26.1 t80 -117.45 155.01 30.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.949 0.404 . . . . 0.0 110.83 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 447' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 446' ' ' PHE . 71.4 t -161.35 150.57 4.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.126 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 84.6 p -149.69 141.81 24.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 449' ' ' TYR . . . . . 0.609 ' CE1' HD12 ' A' ' 403' ' ' LEU . 4.7 m-85 -106.07 -176.01 2.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.917 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.75 -10.57 59.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.883 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -166.91 160.36 11.23 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.592 0.71 . . . . 0.0 110.897 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 452' ' ' PRO . . . . . 0.527 ' N ' ' HB2' ' A' ' 401' ' ' ALA . 60.4 Cg_endo -74.76 -2.12 12.06 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.724 2.282 . . . . 0.0 112.316 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 92.8 t -85.11 -44.03 17.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.112 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 7.4 t -78.57 -34.8 46.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.838 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -59.35 -20.1 51.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.111 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 456' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' A' ' 457' ' ' ALA . 35.2 mm-40 -77.82 -53.92 6.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.936 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 457' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 456' ' ' GLN . . . -37.74 -44.42 0.73 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.11 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -64.58 -52.41 57.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.093 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 91.2 mt -52.8 -45.81 50.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.106 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -38.49 -58.52 1.02 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.863 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 30.0 t -87.71 -55.69 3.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 462' ' ' MET . . . . . 0.746 ' HB3' HG21 ' A' ' 474' ' ' VAL . 8.6 mmt -39.02 -57.54 1.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.876 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -47.1 114.26 0.82 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 75.93 29.69 58.66 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.493 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -73.47 126.45 30.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.837 0.351 . . . . 0.0 110.886 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 25.3 tm0? -69.96 104.67 2.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.928 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 16.8 tt -119.98 138.41 50.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.148 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 46.68 -95.48 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.518 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 8.8 ptp -134.21 5.03 3.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.903 0.382 . . . . 0.0 110.932 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 15.4 pttm -130.7 174.36 10.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.958 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 42.6 mtm-85 -106.73 145.6 31.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.892 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 27.2 mt -89.26 149.43 23.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.925 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 27.6 ttpt -125.63 103.8 8.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.858 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 474' ' ' VAL . . . . . 0.746 HG21 ' HB3' ' A' ' 462' ' ' MET . 2.8 t -110.04 137.63 41.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.141 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -157.05 145.74 19.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.93 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 476' ' ' LEU . . . . . 0.784 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.5 pp -91.41 124.84 35.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.942 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.467 ' HB2' ' CE1' ' A' ' 404' ' ' PHE . 13.9 tttm . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.948 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.758 0.314 . . . . 0.0 110.933 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -136.29 -176.64 4.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -107.03 -143.17 10.96 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.459 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.13 151.89 44.74 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.666 2.244 . . . . 0.0 112.282 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -55.7 100.71 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.964 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 135.92 -25.78 3.19 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.486 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 401' ' ' ALA . . . . . 0.423 ' HB2' ' N ' ' A' ' 452' ' ' PRO . . . -98.75 127.05 44.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.806 0.336 . . . . 0.0 111.103 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -158.86 167.89 28.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.93 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 403' ' ' LEU . . . . . 0.416 ' CD1' ' CE1' ' A' ' 449' ' ' TYR . 53.0 mt -158.66 124.6 4.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 404' ' ' PHE . . . . . 0.421 ' CZ ' ' HD3' ' A' ' 477' ' ' LYS . 28.8 m-85 -130.07 111.02 12.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.911 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 405' ' ' ILE . . . . . 0.627 ' N ' HD12 ' A' ' 405' ' ' ILE . 3.2 mp -91.68 132.31 36.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.131 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -122.21 158.1 30.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.903 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 407' ' ' HIS . . . . . 0.491 ' O ' ' CD2' ' A' ' 472' ' ' LEU . 53.8 m-70 67.06 55.03 0.72 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.848 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 37.4 mt -100.97 129.9 26.26 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.691 0.757 . . . . 0.0 110.898 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -48.11 -178.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.681 2.254 . . . . 0.0 112.32 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -87.74 -41.93 12.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.935 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -59.9 -36.27 76.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.927 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -57.56 128.98 39.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.88 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 413' ' ' GLY . . . . . 0.455 ' O ' HG21 ' A' ' 432' ' ' VAL . . . -116.08 -138.11 6.29 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.515 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -90.54 -59.22 2.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.732 0.301 . . . . 0.0 110.746 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -51.46 -53.25 39.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.821 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -42.46 -61.74 1.14 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.86 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 33.2 tp -42.44 -49.78 5.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.934 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 418' ' ' LEU . . . . . 0.408 ' CD1' ' HB ' ' A' ' 427' ' ' VAL . 52.9 tp -55.19 -58.67 6.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.949 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 419' ' ' GLN . . . . . 0.49 ' OE1' ' N ' ' A' ' 419' ' ' GLN . 0.8 OUTLIER -57.75 -21.36 40.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.913 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 4.2 ttm -82.21 -29.47 31.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.857 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 421' ' ' PHE . . . . . 0.528 ' CZ ' HG12 ' A' ' 405' ' ' ILE . 3.8 m-85 -106.9 4.29 27.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.856 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 422' ' ' MET . . . . . 0.588 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 17.5 mtt -73.14 -45.64 8.13 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.588 0.709 . . . . 0.0 110.946 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.7 Cg_exo -47.97 -45.72 24.08 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.673 2.249 . . . . 0.0 112.36 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -61.46 -25.32 67.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 160.21 -177.61 36.59 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.469 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -73.78 100.12 3.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.874 0.369 . . . . 0.0 110.867 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.554 HG11 ' HB2' ' A' ' 430' ' ' ALA . 54.2 t -67.0 122.82 18.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.142 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 76.7 t -75.25 -35.97 35.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.103 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -144.74 143.91 30.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.828 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 430' ' ' ALA . . . . . 0.554 ' HB2' HG11 ' A' ' 427' ' ' VAL . . . -161.08 114.77 2.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.064 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 431' ' ' LYS . . . . . 0.419 ' C ' ' HD2' ' A' ' 431' ' ' LYS . 3.8 tmmm? -160.92 141.54 11.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.455 HG21 ' O ' ' A' ' 413' ' ' GLY . 58.6 t -90.8 139.5 17.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.192 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 -179.972 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 443' ' ' CYS . . . . . 0.434 ' O ' ' N ' ' A' ' 407' ' ' HIS . 27.3 p . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.805 0.336 . . . . 0.0 110.917 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -162.07 147.03 12.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.86 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -135.35 178.71 18.39 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.525 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 446' ' ' PHE . . . . . 0.437 ' O ' HG23 ' A' ' 447' ' ' VAL . 28.4 t80 -117.33 154.57 31.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.863 0.363 . . . . 0.0 110.883 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 447' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 448' ' ' SER . 72.2 t -158.53 155.96 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.116 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 448' ' ' SER . . . . . 0.467 ' N ' HG12 ' A' ' 447' ' ' VAL . 3.8 m -154.38 154.06 32.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.828 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 449' ' ' TYR . . . . . 0.416 ' CE1' ' CD1' ' A' ' 403' ' ' LEU . 4.4 m-85 -118.43 -175.25 2.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.899 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.25 -12.53 59.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.86 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -157.61 156.36 28.59 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-O 121.659 0.742 . . . . 0.0 110.846 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 452' ' ' PRO . . . . . 0.423 ' N ' ' HB2' ' A' ' 401' ' ' ALA . 61.1 Cg_endo -75.45 0.21 9.36 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.648 2.232 . . . . 0.0 112.332 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 99.2 t -90.04 -38.84 11.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.134 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 31.2 m -79.34 -38.5 34.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.828 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -51.15 -42.92 61.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.069 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 456' ' ' GLN . . . . . 0.414 ' O ' ' C ' ' A' ' 457' ' ' ALA . 11.6 mm100 -59.73 -51.27 70.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.917 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 457' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 456' ' ' GLN . . . -36.52 -41.94 0.32 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.083 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -64.43 -69.75 0.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.057 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 459' ' ' ILE . . . . . 0.548 HG12 HG12 ' A' ' 474' ' ' VAL . 82.5 mt -43.55 -42.56 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.119 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -39.68 -45.73 1.73 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 30.0 t -100.71 -56.29 2.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 462' ' ' MET . . . . . 0.52 ' HB3' HG21 ' A' ' 474' ' ' VAL . 87.9 mmm -43.36 -33.15 0.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.881 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -53.01 103.14 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.873 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 83.49 30.77 29.26 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.565 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 465' ' ' PHE . . . . . 0.578 ' HB3' HD12 ' A' ' 472' ' ' LEU . 26.5 t80 -67.67 110.4 3.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.783 0.325 . . . . 0.0 110.886 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 9.8 tm0? -66.03 107.16 1.8 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.908 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 467' ' ' ILE . . . . . 0.432 HG21 HD21 ' A' ' 472' ' ' LEU . 17.0 tt -120.52 138.04 52.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.056 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 53.29 -96.44 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.449 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 2.4 ttt -131.89 -1.09 3.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.883 0.373 . . . . 0.0 110.895 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.35 174.68 8.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.891 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 54.5 mtm180 -105.22 172.64 6.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.84 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 472' ' ' LEU . . . . . 0.578 HD12 ' HB3' ' A' ' 465' ' ' PHE . 82.2 mt -121.24 156.09 33.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.95 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -134.13 108.45 8.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.863 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 474' ' ' VAL . . . . . 0.548 HG12 HG12 ' A' ' 459' ' ' ILE . 8.6 t -110.04 133.84 54.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.165 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 475' ' ' GLN . . . . . 0.444 ' HA ' HD13 ' A' ' 459' ' ' ILE . 26.1 mt-30 -156.97 139.1 14.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.946 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 476' ' ' LEU . . . . . 0.625 ' C ' HD12 ' A' ' 476' ' ' LEU . 1.6 pp -81.1 136.92 35.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.925 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.462 ' O ' HD12 ' A' ' 476' ' ' LEU . 21.7 tptt . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm . . . . . 0 N--CA 1.458 -0.056 0 CA-C-O 120.818 0.342 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.42 -176.76 3.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.946 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -110.73 -154.42 13.73 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.47 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -48.06 176.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.717 2.278 . . . . 0.0 112.263 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 399' ' ' GLU . . . . . 0.441 ' CD ' ' O ' ' A' ' 399' ' ' GLU . 0.2 OUTLIER -83.24 83.58 7.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.926 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 144.65 -14.77 2.0 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.468 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -98.2 126.5 43.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.815 0.34 . . . . 0.0 111.145 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 402' ' ' ASN . . . . . 0.404 ' O ' ' CB ' ' A' ' 476' ' ' LEU . 10.9 m120 -159.41 162.45 35.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 403' ' ' LEU . . . . . 0.595 HD23 HD11 ' A' ' 459' ' ' ILE . 28.6 mt -159.78 109.18 1.82 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 404' ' ' PHE . . . . . 0.432 ' CE1' ' CD1' ' A' ' 446' ' ' PHE . 19.2 m-85 -112.63 114.81 27.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 405' ' ' ILE . . . . . 0.805 HG21 HD21 ' A' ' 408' ' ' LEU . 3.9 mp -90.87 135.72 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.113 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 406' ' ' TYR . . . . . 0.426 ' CD1' ' HB2' ' A' ' 444' ' ' PHE . 89.9 m-85 -130.22 168.25 17.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.952 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 32.6 m-70 61.4 48.68 5.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.805 HD21 HG21 ' A' ' 405' ' ' ILE . 38.0 mt -95.71 148.32 34.39 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.592 0.71 . . . . 0.0 110.914 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.598 ' HG2' ' CD1' ' A' ' 412' ' ' PHE . 59.9 Cg_endo -73.35 -169.77 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.699 2.266 . . . . 0.0 112.329 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -95.21 -38.01 10.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.932 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 411' ' ' GLU . . . . . 0.416 ' C ' ' OE1' ' A' ' 411' ' ' GLU . 0.3 OUTLIER -58.37 -32.45 68.58 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.922 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.598 ' CD1' ' HG2' ' A' ' 409' ' ' PRO . 4.1 m-85 -62.01 158.81 15.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -142.82 -140.74 3.76 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.547 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -88.65 -48.83 7.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.738 0.304 . . . . 0.0 110.876 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 415' ' ' GLN . . . . . 0.463 ' O ' ' N ' ' A' ' 418' ' ' LEU . 19.9 mp0 -64.43 -58.23 7.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.963 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 416' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 415' ' ' GLN . 35.9 m-20 -34.43 -56.6 0.52 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.899 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 24.3 tp -53.34 -43.42 67.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 418' ' ' LEU . . . . . 0.463 ' N ' ' O ' ' A' ' 415' ' ' GLN . 11.1 tp -65.04 -51.56 60.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.962 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -69.48 -9.85 55.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.951 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 2.8 ttm -89.79 -25.55 21.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.902 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 421' ' ' PHE . . . . . 0.444 ' CZ ' ' CG1' ' A' ' 405' ' ' ILE . 5.2 m-85 -104.57 -12.16 16.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.937 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 422' ' ' MET . . . . . 0.577 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 7.6 mtt -57.38 -46.12 99.83 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.56 0.695 . . . . 0.0 110.823 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 422' ' ' MET . 64.5 Cg_exo -47.94 -39.63 32.48 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.71 2.273 . . . . 0.0 112.31 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 424' ' ' PHE . . . . . 0.574 ' CE2' ' HA ' ' A' ' 458' ' ' ALA . 73.4 m-85 -68.23 -35.67 78.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.905 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 172.16 -173.84 45.29 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.487 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.94 114.56 12.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.86 0.362 . . . . 0.0 110.905 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 98.2 t -84.79 124.4 39.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.153 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 17.1 t -70.93 -54.05 19.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.08 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 14.6 m -148.63 136.57 20.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.859 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -144.35 134.46 24.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.132 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 431' ' ' LYS . . . . . 0.423 ' CG ' ' N ' ' A' ' 432' ' ' VAL . 20.6 tttt -159.97 159.29 32.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.888 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.423 ' N ' ' CG ' ' A' ' 431' ' ' LYS . 38.8 t -111.03 144.64 18.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.165 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 433' ' ' PHE . . . . . 0.554 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 7.5 m-85 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 443' ' ' CYS . . . . . 0.407 ' O ' ' SG ' ' A' ' 443' ' ' CYS . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.714 0.292 . . . . 0.0 110.819 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 444' ' ' PHE . . . . . 0.584 ' C ' ' CD1' ' A' ' 444' ' ' PHE . 1.1 p90 -161.71 145.65 12.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.876 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -139.25 179.16 18.94 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.534 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 446' ' ' PHE . . . . . 0.432 ' CD1' ' CE1' ' A' ' 404' ' ' PHE . 26.7 t80 -116.93 150.59 38.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.888 0.375 . . . . 0.0 110.875 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 21.0 t -153.91 143.15 13.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.117 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 99.8 p -139.05 141.85 38.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.865 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 449' ' ' TYR . . . . . 0.537 ' CE1' HD12 ' A' ' 403' ' ' LEU . 3.2 m-85 -108.92 175.18 5.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.912 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -69.59 -20.21 63.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.821 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -153.95 155.69 31.39 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.687 0.756 . . . . 0.0 110.836 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.91 -15.65 26.28 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.686 2.258 . . . . 0.0 112.319 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 97.3 t -74.74 -43.09 47.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.134 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 1.9 t -75.61 -41.95 53.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.886 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -47.76 -42.78 26.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.153 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -59.16 -46.44 88.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.925 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -37.75 -44.34 0.72 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.1 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 458' ' ' ALA . . . . . 0.574 ' HA ' ' CE2' ' A' ' 424' ' ' PHE . . . -64.28 -69.73 0.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.157 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 459' ' ' ILE . . . . . 0.595 HD11 HD23 ' A' ' 403' ' ' LEU . 93.9 mt -40.33 -47.43 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.167 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 460' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 459' ' ' ILE . 40.7 mt-30 -38.04 -51.7 1.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.89 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 17.4 t -93.94 -54.87 3.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.839 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 462' ' ' MET . . . . . 0.463 ' O ' ' N ' ' A' ' 465' ' ' PHE . 77.5 mmm -43.7 -51.46 7.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.872 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 463' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 462' ' ' MET . 36.7 t-20 -38.17 105.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.921 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 464' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 472' ' ' LEU . . . 78.92 33.59 36.55 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.508 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 465' ' ' PHE . . . . . 0.463 ' N ' ' O ' ' A' ' 462' ' ' MET . 83.2 t80 -73.92 117.97 16.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.81 0.338 . . . . 0.0 110.907 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 5.2 tm0? -66.32 104.55 1.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.953 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 12.4 tt -117.65 139.33 45.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.114 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 49.54 -95.93 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.472 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 6.5 ptp -131.43 0.42 4.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.853 0.359 . . . . 0.0 110.914 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.7 172.93 11.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 48.2 mtt85 -100.91 167.32 10.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.887 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 472' ' ' LEU . . . . . 0.435 ' O ' ' N ' ' A' ' 464' ' ' GLY . 58.5 mt -114.81 152.98 31.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.005 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -130.69 106.62 8.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 474' ' ' VAL . . . . . 0.488 HG12 HG12 ' A' ' 459' ' ' ILE . 15.6 t -112.44 131.88 62.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.121 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -154.4 137.77 15.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 476' ' ' LEU . . . . . 0.626 ' C ' HD12 ' A' ' 476' ' ' LEU . 1.6 pp -79.5 132.84 36.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.856 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 476' ' ' LEU . 55.7 tttt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.886 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.497 ' O ' ' CB ' ' A' ' 429' ' ' SER . 9.8 ptmt . . . . . 0 N--CA 1.458 -0.032 0 CA-C-O 120.727 0.299 . . . . 0.0 110.905 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -128.67 -175.73 3.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -100.48 -146.38 19.25 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.468 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.53 151.41 41.99 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.698 2.265 . . . . 0.0 112.314 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -51.46 104.01 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 130.58 -24.85 4.32 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.445 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 401' ' ' ALA . . . . . 0.405 ' HB2' ' N ' ' A' ' 452' ' ' PRO . . . -98.02 126.98 43.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.341 . . . . 0.0 111.098 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -158.98 164.29 35.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.874 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 403' ' ' LEU . . . . . 0.449 HD12 ' CE1' ' A' ' 449' ' ' TYR . 34.5 mt -158.05 124.83 4.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.917 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 404' ' ' PHE . . . . . 0.493 ' CZ ' ' CD1' ' A' ' 446' ' ' PHE . 35.5 m-85 -130.96 113.32 13.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.846 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 405' ' ' ILE . . . . . 0.657 ' N ' HD12 ' A' ' 405' ' ' ILE . 3.2 mp -90.75 136.09 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.122 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -127.74 159.77 33.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 24.8 m80 60.14 54.99 3.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.855 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.526 HD21 HG21 ' A' ' 405' ' ' ILE . 19.3 mt -93.8 140.73 23.1 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.534 0.683 . . . . 0.0 110.943 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.565 ' HG2' ' CE1' ' A' ' 412' ' ' PHE . 77.6 Cg_exo -49.83 -173.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.67 2.247 . . . . 0.0 112.334 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -96.3 -35.62 11.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.953 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 25.3 pm0 -76.16 -13.77 60.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.858 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.565 ' CE1' ' HG2' ' A' ' 409' ' ' PRO . 5.3 m-85 -71.81 129.05 37.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -120.31 -152.93 9.04 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.44 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.48 -57.88 3.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.743 0.306 . . . . 0.0 110.886 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -54.9 -51.97 64.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.886 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -42.29 -58.57 2.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.833 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 417' ' ' LEU . . . . . 0.503 HD11 HG12 ' A' ' 405' ' ' ILE . 44.8 tp -54.19 -45.8 72.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.927 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 18.2 tp -54.72 -55.39 30.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.865 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -72.89 -9.29 58.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.882 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -82.68 -20.85 35.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -115.18 -12.22 11.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.878 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 422' ' ' MET . . . . . 0.579 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 18.0 mtt -54.05 -45.84 98.9 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.611 0.719 . . . . 0.0 110.882 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.2 Cg_exo -48.05 -35.14 25.0 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.613 2.208 . . . . 0.0 112.335 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 424' ' ' PHE . . . . . 0.536 ' CZ ' ' SD ' ' A' ' 462' ' ' MET . 72.2 m-85 -73.89 -30.18 62.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 167.63 -171.87 42.3 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.502 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -77.91 98.77 5.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.888 0.375 . . . . 0.0 110.878 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.501 HG13 HG13 ' A' ' 447' ' ' VAL . 90.6 t -67.98 114.97 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.12 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 17.8 t -66.18 -45.54 89.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.121 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 429' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 30.8 t -135.87 144.58 45.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.821 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 430' ' ' ALA . . . . . 0.454 ' HB2' HG11 ' A' ' 427' ' ' VAL . . . -157.17 106.36 2.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.075 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 431' ' ' LYS . . . . . 0.42 ' HD3' ' C ' ' A' ' 431' ' ' LYS . 1.1 tmtp? -142.5 143.98 32.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.895 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 66.2 t -113.75 148.59 16.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.102 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 433' ' ' PHE . . . . . 0.41 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 2.9 m-85 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.934 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 30.4 p . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.818 0.342 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 444' ' ' PHE . . . . . 0.41 ' CE1' ' HB2' ' A' ' 433' ' ' PHE . 2.0 p90 -161.29 151.93 18.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.879 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -152.57 176.82 30.62 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.495 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 446' ' ' PHE . . . . . 0.502 ' O ' HG23 ' A' ' 447' ' ' VAL . 56.5 t80 -115.96 155.84 27.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.905 0.383 . . . . 0.0 110.885 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 447' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 446' ' ' PHE . 53.5 t -158.69 152.43 6.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.18 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 29.6 p -151.06 152.23 33.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.856 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 449' ' ' TYR . . . . . 0.544 ' HB2' ' HB2' ' A' ' 455' ' ' ALA . 4.5 m-85 -117.82 -177.51 3.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.895 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.48 -12.73 60.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 451' ' ' ASN . . . . . 0.459 ' N ' ' OD1' ' A' ' 451' ' ' ASN . 0.5 OUTLIER -159.25 159.99 28.66 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.627 0.727 . . . . 0.0 110.902 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 452' ' ' PRO . . . . . 0.405 ' N ' ' HB2' ' A' ' 401' ' ' ALA . 61.1 Cg_endo -75.23 -19.69 17.14 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.67 2.247 . . . . 0.0 112.379 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 60.3 t -72.94 -43.38 59.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.09 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 16.2 m -75.8 -44.7 39.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.873 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 455' ' ' ALA . . . . . 0.544 ' HB2' ' HB2' ' A' ' 449' ' ' TYR . . . -52.25 -34.88 48.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.152 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -63.82 -44.35 93.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.904 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -41.8 -40.19 1.99 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.088 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 458' ' ' ALA . . . . . 0.478 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -62.39 -68.5 0.32 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.089 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 459' ' ' ILE . . . . . 0.444 ' O ' ' CB ' ' A' ' 463' ' ' ASN . 66.8 mt -45.71 -46.02 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.188 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -38.82 -50.48 1.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 2.8 m -97.12 -56.84 2.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.892 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 462' ' ' MET . . . . . 0.536 ' SD ' ' CZ ' ' A' ' 424' ' ' PHE . 81.1 mmm -42.64 -45.44 4.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.853 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 463' ' ' ASN . . . . . 0.444 ' CB ' ' O ' ' A' ' 459' ' ' ILE . 9.5 t30 -43.89 108.19 0.11 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.869 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 78.32 30.49 49.85 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.466 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 465' ' ' PHE . . . . . 0.514 ' HB3' HD12 ' A' ' 472' ' ' LEU . 55.2 t80 -68.11 115.37 7.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.817 0.341 . . . . 0.0 110.894 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 18.6 tm0? -67.25 107.96 2.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.943 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 467' ' ' ILE . . . . . 0.469 HG23 ' O ' ' A' ' 467' ' ' ILE . 19.2 tt -126.22 126.31 69.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.108 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 64.26 -103.68 0.77 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.514 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 56.7 mtp -124.12 0.87 8.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.842 0.353 . . . . 0.0 110.9 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -131.18 -179.82 5.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.894 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 39.2 mtt-85 -112.68 164.39 13.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.881 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 472' ' ' LEU . . . . . 0.514 HD12 ' HB3' ' A' ' 465' ' ' PHE . 65.8 mt -103.09 152.34 21.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.9 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 17.9 tttm -130.31 99.94 5.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.885 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 3.2 t -108.82 140.63 26.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.169 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -157.07 147.48 21.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.921 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 476' ' ' LEU . . . . . 0.806 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.3 pp -94.25 127.21 39.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.923 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 476' ' ' LEU . 31.9 tttm . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.698 0.285 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -138.95 174.67 10.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.864 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -98.0 -145.27 18.6 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.51 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.57 153.33 43.99 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.736 2.291 . . . . 0.0 112.358 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 15.1 tm-20 -54.98 110.64 0.69 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.899 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 129.22 -27.7 4.2 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.474 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 401' ' ' ALA . . . . . 0.491 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.94 126.77 43.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.774 0.321 . . . . 0.0 111.086 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 402' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.6 OUTLIER -158.99 160.32 35.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.861 -179.918 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 403' ' ' LEU . . . . . 0.622 HD23 HD11 ' A' ' 459' ' ' ILE . 38.7 mt -159.61 114.24 2.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.902 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 404' ' ' PHE . . . . . 0.641 ' CZ ' ' CD1' ' A' ' 446' ' ' PHE . 42.6 m-85 -122.23 111.91 17.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.9 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 405' ' ' ILE . . . . . 0.623 ' N ' HD12 ' A' ' 405' ' ' ILE . 3.6 mp -91.65 134.99 28.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.152 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -124.56 169.29 12.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.922 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 8.0 m80 57.47 44.43 21.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.832 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.445 HD21 HG21 ' A' ' 405' ' ' ILE . 30.4 mt -91.09 134.55 29.83 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.625 0.726 . . . . 0.0 110.886 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -48.77 -179.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.683 2.255 . . . . 0.0 112.377 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -85.16 -46.06 11.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.9 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -58.88 -36.04 73.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.925 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.472 ' CZ ' HD11 ' A' ' 467' ' ' ILE . 7.9 m-85 -55.4 116.91 3.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.844 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -107.48 -151.88 17.44 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.436 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.96 -44.22 40.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.779 0.323 . . . . 0.0 110.877 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 415' ' ' GLN . . . . . 0.407 ' O ' ' C ' ' A' ' 416' ' ' ASP . 3.4 mp0 -62.88 -56.88 13.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.923 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 416' ' ' ASP . . . . . 0.407 ' C ' ' O ' ' A' ' 415' ' ' GLN . 36.3 m-20 -36.99 -64.92 0.33 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 417' ' ' LEU . . . . . 0.43 HD21 HD13 ' A' ' 405' ' ' ILE . 17.5 tp -42.73 -46.5 5.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.958 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 418' ' ' LEU . . . . . 0.453 ' O ' ' CG ' ' A' ' 422' ' ' MET . 14.9 tp -63.69 -37.41 87.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.913 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -80.44 -16.04 55.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.885 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 2.7 tpp -87.17 -30.43 21.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.881 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 421' ' ' PHE . . . . . 0.598 ' CE1' ' SD ' ' A' ' 462' ' ' MET . 4.6 m-85 -98.44 -25.55 14.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 422' ' ' MET . . . . . 0.546 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 0.3 OUTLIER -45.23 -47.94 33.17 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.541 0.686 . . . . 0.0 110.926 179.948 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.546 ' CD ' ' N ' ' A' ' 422' ' ' MET . 63.9 Cg_exo -47.95 -46.12 22.84 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.722 2.281 . . . . 0.0 112.408 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 424' ' ' PHE . . . . . 0.44 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 90.1 m-85 -64.57 -33.96 77.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.854 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 169.03 163.58 23.31 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.541 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -56.46 118.47 4.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.863 0.363 . . . . 0.0 110.906 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.563 HG11 ' HB2' ' A' ' 430' ' ' ALA . 41.7 t -88.19 123.98 41.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.171 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 65.1 t -75.8 -36.11 32.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.09 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 429' ' ' SER . . . . . 0.445 ' O ' HG13 ' A' ' 447' ' ' VAL . 0.7 OUTLIER -142.39 143.14 32.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.859 -179.856 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 430' ' ' ALA . . . . . 0.563 ' HB2' HG11 ' A' ' 427' ' ' VAL . . . -160.82 111.68 1.8 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.151 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -157.48 143.5 17.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.952 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 78.5 t -94.12 146.48 6.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.166 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 433' ' ' PHE . . . . . 0.456 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.4 m-30 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.798 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 26.8 p . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.865 0.364 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 444' ' ' PHE . . . . . 0.456 ' CE1' ' HB2' ' A' ' 433' ' ' PHE . 8.9 p90 -162.07 144.24 11.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.92 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -135.16 168.29 23.79 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.491 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 446' ' ' PHE . . . . . 0.641 ' CD1' ' CZ ' ' A' ' 404' ' ' PHE . 26.7 t80 -109.3 151.64 26.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.919 0.39 . . . . 0.0 110.913 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 447' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 429' ' ' SER . 23.0 t -155.42 144.81 12.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.104 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 1.8 m -143.22 141.06 30.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.896 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 449' ' ' TYR . . . . . 0.599 ' CE1' HD12 ' A' ' 403' ' ' LEU . 6.1 m-85 -107.43 176.61 5.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.913 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -72.01 -29.65 64.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.882 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -140.98 153.52 67.37 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.71 0.766 . . . . 0.0 110.871 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.39 0.12 8.46 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.716 2.277 . . . . 0.0 112.376 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 87.7 t -88.76 -37.66 10.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.131 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 22.9 t -78.88 -41.5 29.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.819 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -49.1 -37.0 20.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.177 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -62.25 -52.22 64.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.969 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -37.82 -45.67 0.86 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.106 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 458' ' ' ALA . . . . . 0.44 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -62.92 -62.96 1.37 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.108 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 459' ' ' ILE . . . . . 0.622 HD11 HD23 ' A' ' 403' ' ' LEU . 70.0 mt -47.43 -48.01 9.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.163 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 460' ' ' GLN . . . . . 0.436 ' C ' ' O ' ' A' ' 459' ' ' ILE . 49.7 mt-30 -34.35 -45.6 0.23 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.841 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 1.9 m -103.46 -56.27 2.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.882 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 462' ' ' MET . . . . . 0.666 ' HB3' HG21 ' A' ' 474' ' ' VAL . 5.7 mmt -38.93 -45.74 1.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 463' ' ' ASN . . . . . 0.403 ' HB2' HG23 ' A' ' 459' ' ' ILE . 28.6 t-20 -59.8 89.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.904 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 114.16 -10.39 22.52 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.517 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -43.53 110.32 0.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.741 0.305 . . . . 0.0 110.945 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -63.22 105.75 0.77 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.863 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 467' ' ' ILE . . . . . 0.526 HG23 ' O ' ' A' ' 467' ' ' ILE . 15.4 tt -110.9 122.35 65.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.103 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 61.96 -100.42 0.29 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.568 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 9.7 mtt -120.13 -14.52 8.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.885 0.374 . . . . 0.0 110.842 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 31.2 pttt -117.16 179.47 4.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.933 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 50.1 mtt180 -107.23 173.44 6.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.863 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 94.4 mt -113.45 154.14 27.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -129.68 104.84 7.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.899 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 474' ' ' VAL . . . . . 0.666 HG21 ' HB3' ' A' ' 462' ' ' MET . 23.8 t -114.28 135.94 52.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.128 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 28.6 tp60 -157.06 143.63 18.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 476' ' ' LEU . . . . . 0.728 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.5 pp -86.9 125.37 33.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.916 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.467 ' O ' HD12 ' A' ' 476' ' ' LEU . 26.0 tttm . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.912 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.414 ' O ' ' CB ' ' A' ' 429' ' ' SER . 18.8 mtpp . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.774 0.321 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -121.53 -177.44 3.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.85 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -103.74 -163.31 25.09 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.518 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 398' ' ' PRO . . . . . 0.401 ' HG2' ' O ' ' A' ' 450' ' ' ASP . 53.5 Cg_exo -49.45 157.84 2.0 Allowed 'Trans proline' 0 C--N 1.34 0.128 0 C-N-CA 122.683 2.255 . . . . 0.0 112.312 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -66.37 82.15 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.847 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 148.18 -18.2 1.36 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.495 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 401' ' ' ALA . . . . . 0.57 ' HB2' ' CA ' ' A' ' 452' ' ' PRO . . . -106.93 126.75 52.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.751 0.31 . . . . 0.0 111.08 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 402' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.3 OUTLIER -158.14 169.41 24.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.895 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 403' ' ' LEU . . . . . 0.578 HD12 ' CE1' ' A' ' 449' ' ' TYR . 16.3 mt -159.97 115.79 2.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.904 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 404' ' ' PHE . . . . . 0.545 ' CE1' ' CE1' ' A' ' 446' ' ' PHE . 25.3 m-85 -120.0 111.5 17.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.833 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 405' ' ' ILE . . . . . 0.676 ' N ' HD12 ' A' ' 405' ' ' ILE . 2.9 mp -91.01 136.01 25.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.16 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -124.41 177.81 5.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.834 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 407' ' ' HIS . . . . . 0.422 ' O ' HD23 ' A' ' 472' ' ' LEU . 0.2 OUTLIER 47.74 54.2 10.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.885 179.912 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 409' ' ' PRO . 30.5 mt -96.62 140.86 22.38 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.575 0.703 . . . . 0.0 110.929 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.561 ' HG2' ' CE1' ' A' ' 412' ' ' PHE . 77.0 Cg_exo -49.81 -173.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.691 2.261 . . . . 0.0 112.32 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -95.52 -29.58 14.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -78.67 -20.29 50.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.949 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.561 ' CE1' ' HG2' ' A' ' 409' ' ' PRO . 5.4 m-85 -64.91 128.49 35.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.799 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 413' ' ' GLY . . . . . 0.471 ' O ' HG21 ' A' ' 432' ' ' VAL . . . -117.68 -139.93 6.42 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.507 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -88.01 -36.82 16.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.833 0.349 . . . . 0.0 110.898 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 415' ' ' GLN . . . . . 0.437 ' O ' ' N ' ' A' ' 418' ' ' LEU . 19.8 mm-40 -71.36 -58.26 3.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.913 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -37.96 -49.38 1.25 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.882 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 53.0 tp -58.59 -40.96 84.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.914 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 418' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 415' ' ' GLN . 20.7 tp -64.93 -58.15 6.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.897 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -66.77 -8.95 31.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.925 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -87.69 -27.36 22.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.833 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 421' ' ' PHE . . . . . 0.492 ' CZ ' HG12 ' A' ' 405' ' ' ILE . 3.4 m-85 -110.32 6.61 22.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.827 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 422' ' ' MET . . . . . 0.582 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 13.5 mtt -73.4 -45.76 7.66 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.549 0.69 . . . . 0.0 110.876 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 422' ' ' MET . 63.9 Cg_exo -47.96 -28.8 10.77 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.674 2.249 . . . . 0.0 112.418 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 424' ' ' PHE . . . . . 0.422 ' CE2' ' HA ' ' A' ' 458' ' ' ALA . 81.7 m-85 -76.7 -34.06 58.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.924 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 164.35 -163.63 36.21 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.488 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -72.68 134.77 45.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.889 0.376 . . . . 0.0 110.855 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 18.7 t -107.97 116.84 52.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.17 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 428' ' ' VAL . . . . . 0.526 HG12 ' OG ' ' A' ' 429' ' ' SER . 31.4 t -68.22 -55.34 16.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.181 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 429' ' ' SER . . . . . 0.526 ' OG ' HG12 ' A' ' 428' ' ' VAL . 0.9 OUTLIER -136.75 148.61 47.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.854 -179.864 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -161.06 120.1 2.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.117 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -161.09 141.88 11.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.92 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.471 HG21 ' O ' ' A' ' 413' ' ' GLY . 84.0 t -86.99 153.91 3.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.159 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 433' ' ' PHE . . . . . 0.556 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.3 m-30 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.934 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 31.3 p . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.785 0.326 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 444' ' ' PHE . . . . . 0.556 ' CE1' ' HB2' ' A' ' 433' ' ' PHE . 4.9 p90 -160.07 143.16 13.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -129.83 177.39 18.15 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.503 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 446' ' ' PHE . . . . . 0.545 ' CE1' ' CE1' ' A' ' 404' ' ' PHE . 20.2 t80 -119.35 152.67 36.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.956 0.408 . . . . 0.0 110.899 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 447' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 446' ' ' PHE . 77.9 t -159.03 153.75 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.063 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 448' ' ' SER . . . . . 0.416 ' N ' HG12 ' A' ' 447' ' ' VAL . 79.0 p -151.53 144.35 24.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.857 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 449' ' ' TYR . . . . . 0.578 ' CE1' HD12 ' A' ' 403' ' ' LEU . 15.3 m-85 -107.84 -176.02 2.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.936 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 450' ' ' ASP . . . . . 0.401 ' O ' ' HG2' ' A' ' 398' ' ' PRO . 0.4 OUTLIER -79.75 -16.72 55.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.937 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -150.93 155.15 35.12 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.608 0.718 . . . . 0.0 110.863 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 452' ' ' PRO . . . . . 0.57 ' CA ' ' HB2' ' A' ' 401' ' ' ALA . 60.3 Cg_endo -73.95 -13.87 23.9 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.733 2.289 . . . . 0.0 112.378 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 37.2 t -78.89 -37.52 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.087 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 11.4 p -74.88 -50.95 15.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.887 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -40.84 -39.74 1.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.062 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 456' ' ' GLN . . . . . 0.4 ' O ' ' C ' ' A' ' 457' ' ' ALA . 45.6 mm-40 -56.66 -50.74 71.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.897 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 457' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 456' ' ' GLN . . . -36.91 -43.68 0.46 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.139 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 458' ' ' ALA . . . . . 0.422 ' HA ' ' CE2' ' A' ' 424' ' ' PHE . . . -62.81 -66.1 0.59 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.144 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 459' ' ' ILE . . . . . 0.443 ' O ' ' CB ' ' A' ' 463' ' ' ASN . 73.7 mt -46.94 -41.92 5.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.082 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -44.18 -49.14 9.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.9 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 45.2 t -98.12 -57.02 2.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.826 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 462' ' ' MET . . . . . 0.404 ' O ' ' N ' ' A' ' 465' ' ' PHE . 91.8 mmm -40.9 -47.6 2.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.882 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 463' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' A' ' 459' ' ' ILE . 26.5 t-20 -44.78 106.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.914 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 82.74 27.06 43.5 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.477 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 465' ' ' PHE . . . . . 0.404 ' N ' ' O ' ' A' ' 462' ' ' MET . 10.9 t80 -66.59 117.59 8.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.81 0.338 . . . . 0.0 110.844 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 11.6 tm0? -64.8 118.09 8.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.911 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 467' ' ' ILE . . . . . 0.556 HG23 ' O ' ' A' ' 467' ' ' ILE . 14.4 tt -140.58 120.71 13.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.097 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 69.07 -104.26 1.23 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.487 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 24.6 ttp -131.25 12.53 5.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.841 0.353 . . . . 0.0 110.875 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -138.81 -179.15 5.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.89 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 57.9 mtm180 -108.48 163.13 13.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 472' ' ' LEU . . . . . 0.422 HD23 ' O ' ' A' ' 407' ' ' HIS . 53.7 mt -109.85 148.99 30.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.879 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -124.46 128.28 48.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.871 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 474' ' ' VAL . . . . . 0.429 HG12 HG12 ' A' ' 459' ' ' ILE . 32.5 t -133.95 133.81 56.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.09 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -157.13 136.34 11.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.905 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 476' ' ' LEU . . . . . 0.676 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.5 pp -79.19 128.61 33.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.937 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 476' ' ' LEU . 46.7 tttm . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.915 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.406 ' HB2' ' NZ ' ' A' ' 395' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.747 0.308 . . . . 0.0 110.919 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -142.74 -177.59 5.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.922 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -83.49 -147.01 7.2 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.521 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.9 151.53 40.14 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.721 2.28 . . . . 0.0 112.309 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -52.37 107.83 0.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.932 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 131.32 -28.57 3.6 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.463 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 401' ' ' ALA . . . . . 0.495 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.86 126.83 43.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.749 0.309 . . . . 0.0 111.07 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 402' ' ' ASN . . . . . 0.496 ' O ' ' CB ' ' A' ' 476' ' ' LEU . 0.6 OUTLIER -158.83 163.72 36.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.82 -179.932 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 403' ' ' LEU . . . . . 0.553 HD12 ' CE1' ' A' ' 449' ' ' TYR . 23.7 mt -160.35 108.03 1.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.899 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 404' ' ' PHE . . . . . 0.571 ' C ' HD13 ' A' ' 405' ' ' ILE . 5.3 m-85 -111.83 117.41 32.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.871 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 405' ' ' ILE . . . . . 0.826 HD12 HG22 ' A' ' 474' ' ' VAL . 1.4 mm -90.88 135.49 26.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.103 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -126.57 148.89 49.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.932 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 407' ' ' HIS . . . . . 0.474 ' N ' ' O ' ' A' ' 443' ' ' CYS . 8.8 m80 71.66 54.66 0.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.872 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 31.6 mt -100.38 132.49 22.42 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.637 0.732 . . . . 0.0 110.932 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -47.84 178.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.722 2.282 . . . . 0.0 112.376 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 18.9 tp60 -88.16 -39.09 14.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.938 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -60.18 -36.96 78.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -53.98 150.79 7.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -138.24 -145.34 4.82 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.494 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -79.72 -59.65 2.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.761 0.315 . . . . 0.0 110.934 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 -58.0 -53.76 54.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -38.89 -49.8 1.68 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.858 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 417' ' ' LEU . . . . . 0.4 HD21 ' CG2' ' A' ' 447' ' ' VAL . 40.8 tp -59.47 -49.41 77.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.903 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 54.9 tp -56.92 -56.01 27.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.925 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -60.24 -12.07 7.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.983 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 4.9 ttm -92.94 -23.59 18.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.904 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -109.97 6.6 23.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 422' ' ' MET . . . . . 0.586 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 4.6 mtt -75.55 -45.78 4.29 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.622 0.725 . . . . 0.0 110.879 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.0 Cg_exo -47.97 -46.68 21.22 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.7 2.267 . . . . 0.0 112.325 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -59.4 -35.73 74.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.838 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 172.75 -171.9 44.67 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.501 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -81.53 102.59 10.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.842 0.353 . . . . 0.0 110.925 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 62.0 t -72.77 134.15 30.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.158 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 428' ' ' VAL . . . . . 0.562 HG12 ' OG ' ' A' ' 429' ' ' SER . 17.9 t -79.05 -48.5 21.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.107 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 429' ' ' SER . . . . . 0.562 ' OG ' HG12 ' A' ' 428' ' ' VAL . 1.3 m -146.69 143.44 28.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.842 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -153.86 116.95 4.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.172 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -150.61 137.93 19.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.896 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.451 HG12 ' N ' ' A' ' 433' ' ' PHE . 57.8 t -87.3 155.25 3.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.105 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 433' ' ' PHE . . . . . 0.539 ' CG ' ' CE1' ' A' ' 444' ' ' PHE . 3.1 m-85 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 443' ' ' CYS . . . . . 0.474 ' O ' ' N ' ' A' ' 407' ' ' HIS . 26.6 p . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.843 0.354 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 444' ' ' PHE . . . . . 0.539 ' CE1' ' CG ' ' A' ' 433' ' ' PHE . 11.1 p90 -160.53 145.7 14.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.851 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -133.16 176.39 19.6 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.521 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -121.23 141.45 50.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.963 0.411 . . . . 0.0 110.818 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 447' ' ' VAL . . . . . 0.4 ' CG2' HD21 ' A' ' 417' ' ' LEU . 54.7 t -148.69 147.41 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.169 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 51.7 p -142.53 149.99 39.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.93 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 449' ' ' TYR . . . . . 0.553 ' CE1' HD12 ' A' ' 403' ' ' LEU . 3.3 m-85 -113.11 -174.87 2.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.945 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -81.32 -19.23 43.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.939 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -154.41 154.95 30.29 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.608 0.718 . . . . 0.0 110.898 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 452' ' ' PRO . . . . . 0.456 ' N ' ' HB2' ' A' ' 401' ' ' ALA . 61.4 Cg_endo -75.72 -10.12 19.98 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.721 2.281 . . . . 0.0 112.359 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 97.8 t -82.63 -29.28 8.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.154 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 68.1 m -90.86 -35.44 14.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.791 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -57.14 -35.22 69.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.041 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -61.1 -38.93 88.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.911 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -47.81 -39.39 18.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.12 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -64.38 -68.4 0.36 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.081 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 459' ' ' ILE . . . . . 0.52 HG12 HG12 ' A' ' 474' ' ' VAL . 95.2 mt -42.5 -45.32 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.206 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 -41.87 -45.28 3.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 2.9 t -101.47 -57.01 2.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.855 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 462' ' ' MET . . . . . 0.41 ' O ' ' N ' ' A' ' 465' ' ' PHE . 91.8 mmm -43.77 -44.68 6.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.911 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 463' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 459' ' ' ILE . 19.4 t-20 -44.95 108.0 0.11 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 82.1 25.45 52.02 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.444 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 465' ' ' PHE . . . . . 0.507 ' HB3' HD12 ' A' ' 472' ' ' LEU . 18.0 t80 -64.34 109.25 1.85 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.809 0.337 . . . . 0.0 110.882 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 7.4 tm0? -63.12 114.79 3.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.875 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 467' ' ' ILE . . . . . 0.478 HG23 ' O ' ' A' ' 467' ' ' ILE . 17.9 tt -127.59 126.48 67.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.179 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 61.11 -96.79 0.11 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.467 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 33.0 ttp -129.44 -5.4 4.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.879 0.371 . . . . 0.0 110.896 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 15.6 pttm -121.45 176.23 5.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.871 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 28.1 mtm180 -108.56 169.3 8.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.925 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 472' ' ' LEU . . . . . 0.507 HD12 ' HB3' ' A' ' 465' ' ' PHE . 93.3 mt -115.54 158.32 22.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.904 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 33.8 tttp -137.76 107.54 6.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.928 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 474' ' ' VAL . . . . . 0.826 HG22 HD12 ' A' ' 405' ' ' ILE . 61.5 t -109.51 135.04 49.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.074 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -156.38 139.81 15.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 476' ' ' LEU . . . . . 0.631 ' C ' HD12 ' A' ' 476' ' ' LEU . 1.6 pp -83.5 129.91 34.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.563 ' HB2' ' CE1' ' A' ' 404' ' ' PHE . 59.2 tttt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.933 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.421 ' O ' ' CB ' ' A' ' 429' ' ' SER . 13.8 ptpt . . . . . 0 N--CA 1.458 -0.064 0 CA-C-O 120.794 0.331 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 396' ' ' GLU . . . . . 0.474 ' HA ' ' CB ' ' A' ' 448' ' ' SER . 15.2 pt-20 -131.48 -176.44 4.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.916 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -99.82 -146.87 20.6 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.52 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.07 150.85 49.01 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.722 2.281 . . . . 0.0 112.358 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -50.89 97.93 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.874 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 137.61 -25.24 2.99 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.432 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -98.21 126.84 43.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.836 0.35 . . . . 0.0 111.131 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 402' ' ' ASN . . . . . 0.439 ' O ' ' CB ' ' A' ' 476' ' ' LEU . 9.9 m120 -159.17 161.29 36.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.903 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 403' ' ' LEU . . . . . 0.608 HD12 ' CE1' ' A' ' 449' ' ' TYR . 27.7 mt -159.76 113.8 2.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.944 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 404' ' ' PHE . . . . . 0.766 ' CZ ' ' CD1' ' A' ' 446' ' ' PHE . 46.6 m-85 -123.02 113.68 19.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 405' ' ' ILE . . . . . 0.645 HD11 ' CZ ' ' A' ' 421' ' ' PHE . 4.6 mp -90.97 136.89 22.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.097 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 406' ' ' TYR . . . . . 0.442 ' CD2' ' O ' ' A' ' 473' ' ' LYS . 10.9 m-85 -127.69 153.69 46.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.962 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 27.6 m80 69.29 52.64 0.47 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.856 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 19.4 mt -96.13 131.85 27.99 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.594 0.712 . . . . 0.0 110.918 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -48.16 167.9 0.1 OUTLIER 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.678 2.252 . . . . 0.0 112.362 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -70.26 -44.06 69.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.977 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -61.46 -39.65 91.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -54.32 112.42 0.98 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.862 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -104.67 -140.15 10.3 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.475 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.51 -60.76 2.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.808 0.337 . . . . 0.0 110.897 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 415' ' ' GLN . . . . . 0.469 ' O ' ' N ' ' A' ' 418' ' ' LEU . 1.6 mp0 -53.72 -61.59 2.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 416' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 415' ' ' GLN . 35.3 m-20 -34.47 -58.76 0.48 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.841 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 66.2 tp -51.53 -41.83 61.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.9 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 418' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' A' ' 415' ' ' GLN . 12.7 tp -67.64 -56.03 10.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.939 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -56.74 -13.14 2.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.971 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 3.0 tpp -86.23 -31.18 21.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 421' ' ' PHE . . . . . 0.645 ' CZ ' HD11 ' A' ' 405' ' ' ILE . 5.2 m-85 -95.38 -26.66 15.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.838 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 422' ' ' MET . . . . . 0.547 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 0.2 OUTLIER -46.14 -47.66 43.93 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.531 0.681 . . . . 0.0 110.846 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.547 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.2 Cg_exo -47.96 -42.99 31.12 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.717 2.278 . . . . 0.0 112.315 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 424' ' ' PHE . . . . . 0.408 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 64.6 m-85 -67.54 -35.06 78.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.878 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 172.08 -169.35 42.46 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.49 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -75.99 122.25 23.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.803 0.335 . . . . 0.0 110.921 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.495 HG11 ' HB2' ' A' ' 430' ' ' ALA . 84.1 t -95.15 115.23 33.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.191 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.4 -43.29 81.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.132 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 429' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 1.5 t -134.53 144.07 47.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 430' ' ' ALA . . . . . 0.495 ' HB2' HG11 ' A' ' 427' ' ' VAL . . . -161.07 107.11 1.41 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.139 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 431' ' ' LYS . . . . . 0.421 ' C ' ' HD2' ' A' ' 431' ' ' LYS . 0.1 OUTLIER -153.29 149.72 28.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 72.9 t -103.76 142.1 18.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.097 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 433' ' ' PHE . . . . . 0.51 ' CG ' ' CE1' ' A' ' 444' ' ' PHE . 3.1 m-85 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.875 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 72.0 m . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.876 0.37 . . . . 0.0 110.822 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 444' ' ' PHE . . . . . 0.51 ' CE1' ' CG ' ' A' ' 433' ' ' PHE . 5.4 p90 -162.18 137.62 7.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.842 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -131.73 169.67 21.88 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.498 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 446' ' ' PHE . . . . . 0.766 ' CD1' ' CZ ' ' A' ' 404' ' ' PHE . 22.2 t80 -111.54 150.01 30.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.859 0.361 . . . . 0.0 110.918 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 447' ' ' VAL . . . . . 0.468 HG13 HG13 ' A' ' 427' ' ' VAL . 85.5 t -155.14 145.21 13.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.121 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 448' ' ' SER . . . . . 0.474 ' CB ' ' HA ' ' A' ' 396' ' ' GLU . 1.9 m -144.42 140.85 29.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.91 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 449' ' ' TYR . . . . . 0.608 ' CE1' HD12 ' A' ' 403' ' ' LEU . 3.6 m-85 -102.94 179.79 4.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.942 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -75.82 -25.88 56.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.938 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -147.05 158.56 44.68 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.558 0.694 . . . . 0.0 110.912 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.65 -12.69 20.25 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.713 2.275 . . . . 0.0 112.3 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 92.4 t -77.37 -38.56 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.147 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 1.5 t -83.37 -39.61 20.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.882 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 455' ' ' ALA . . . . . 0.459 ' HB2' ' HB2' ' A' ' 449' ' ' TYR . . . -53.1 -43.23 66.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.076 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -59.08 -42.48 90.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.934 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -43.08 -38.84 2.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.126 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 458' ' ' ALA . . . . . 0.408 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -66.7 -61.74 1.81 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.121 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 67.1 mt -47.53 -45.45 10.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.115 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -37.68 -47.77 1.0 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 2.8 m -103.03 -56.98 2.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.899 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 88.4 mmm -39.72 -44.56 1.57 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.844 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -46.18 110.3 0.26 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.872 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 74.12 35.28 53.73 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.516 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 465' ' ' PHE . . . . . 0.417 ' CD1' ' C ' ' A' ' 465' ' ' PHE . 9.5 t80 -68.72 117.4 10.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.818 0.342 . . . . 0.0 110.905 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 11.2 tm0? -63.77 115.19 4.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.91 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 14.6 tt -138.11 132.94 43.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.094 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 51.25 -108.52 0.58 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.474 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 26.0 mtt -127.26 24.82 6.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.829 0.347 . . . . 0.0 110.844 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 7.8 pttt -142.43 -178.43 5.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.894 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 33.3 mtm-85 -125.13 121.91 35.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.911 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 45.0 mt -65.7 152.06 45.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.952 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 473' ' ' LYS . . . . . 0.442 ' O ' ' CD2' ' A' ' 406' ' ' TYR . 18.5 ttmm -132.6 100.49 4.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.88 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 474' ' ' VAL . . . . . 0.556 HG22 HG13 ' A' ' 405' ' ' ILE . 21.1 t -107.56 136.75 41.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.203 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -156.52 145.89 20.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.87 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 476' ' ' LEU . . . . . 0.786 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.4 pp -91.04 126.2 36.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 476' ' ' LEU . 16.9 ttpp . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.892 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.5 ' O ' ' CB ' ' A' ' 429' ' ' SER . 17.8 ptpt . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.778 0.323 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -109.71 -178.9 3.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.865 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -105.16 -155.45 22.52 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.555 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.13 157.58 8.25 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.729 2.286 . . . . 0.0 112.374 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -65.85 78.43 0.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.919 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 153.83 -16.69 0.63 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.456 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 401' ' ' ALA . . . . . 0.505 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -106.49 126.7 52.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.765 0.316 . . . . 0.0 111.111 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 402' ' ' ASN . . . . . 0.505 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.2 OUTLIER -158.15 168.91 25.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.884 -179.901 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 403' ' ' LEU . . . . . 0.497 HD12 ' CE1' ' A' ' 449' ' ' TYR . 27.7 mt -160.06 119.84 2.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.864 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 404' ' ' PHE . . . . . 0.535 ' CE1' ' HB2' ' A' ' 477' ' ' LYS . 15.0 m-85 -124.42 113.45 18.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 405' ' ' ILE . . . . . 0.567 ' N ' HD12 ' A' ' 405' ' ' ILE . 3.4 mp -91.15 133.95 31.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.151 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -125.75 162.27 25.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.935 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 407' ' ' HIS . . . . . 0.491 ' N ' ' O ' ' A' ' 443' ' ' CYS . 16.6 m80 61.01 54.61 3.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.908 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.534 HD21 HG21 ' A' ' 405' ' ' ILE . 30.3 mt -99.87 144.91 29.24 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.668 0.747 . . . . 0.0 110.838 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.578 ' HG2' ' CD1' ' A' ' 412' ' ' PHE . 61.5 Cg_endo -76.47 164.96 29.92 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.711 2.274 . . . . 0.0 112.274 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -69.35 -38.63 78.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.918 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -54.46 -36.48 64.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.578 ' CD1' ' HG2' ' A' ' 409' ' ' PRO . 4.7 m-85 -67.65 138.64 56.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.934 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -123.48 -137.0 4.88 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.474 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -87.81 -56.97 3.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.772 0.32 . . . . 0.0 110.909 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 415' ' ' GLN . . . . . 0.444 ' O ' ' N ' ' A' ' 418' ' ' LEU . 26.9 mm-40 -58.4 -57.03 14.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.95 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 416' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' A' ' 415' ' ' GLN . 53.0 m-20 -34.87 -59.23 0.49 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.866 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 417' ' ' LEU . . . . . 0.403 HD11 HG12 ' A' ' 405' ' ' ILE . 51.5 tp -51.29 -42.63 61.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.906 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 418' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 415' ' ' GLN . 10.8 tp -65.84 -46.33 78.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.904 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -68.18 -16.24 63.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.973 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 2.0 ttt -85.35 -35.01 21.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.917 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 421' ' ' PHE . . . . . 0.468 ' CE1' ' SD ' ' A' ' 462' ' ' MET . 3.8 m-85 -92.69 -22.72 19.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.839 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 422' ' ' MET . . . . . 0.574 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 0.3 OUTLIER -50.87 -45.62 87.24 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.563 0.697 . . . . 0.0 110.96 179.951 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.4 Cg_exo -47.98 -38.84 32.17 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.662 2.242 . . . . 0.0 112.372 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 424' ' ' PHE . . . . . 0.503 ' CE2' ' HA ' ' A' ' 458' ' ' ALA . 78.1 m-85 -70.88 -35.28 72.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.898 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 164.58 -178.96 39.59 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.523 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 -61.86 135.11 57.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.812 0.339 . . . . 0.0 110.834 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.436 HG11 ' HB2' ' A' ' 430' ' ' ALA . 24.2 t -111.47 124.83 68.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.117 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 19.1 t -69.64 -50.35 50.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.209 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 429' ' ' SER . . . . . 0.5 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 4.5 t -137.69 148.7 45.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.826 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 430' ' ' ALA . . . . . 0.436 ' HB2' HG11 ' A' ' 427' ' ' VAL . . . -160.59 107.74 1.55 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.106 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -150.96 143.81 24.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 433' ' ' PHE . 99.3 t -94.43 152.49 3.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.048 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 433' ' ' PHE . . . . . 0.426 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.5 m-30 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.931 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 443' ' ' CYS . . . . . 0.491 ' O ' ' N ' ' A' ' 407' ' ' HIS . 30.3 p . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.806 0.336 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 444' ' ' PHE . . . . . 0.426 ' CE1' ' HB2' ' A' ' 433' ' ' PHE . 8.2 p90 -161.89 147.55 13.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.939 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -138.36 179.07 18.78 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.524 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 446' ' ' PHE . . . . . 0.503 ' O ' ' CG2' ' A' ' 447' ' ' VAL . 55.6 t80 -118.79 153.71 34.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.831 0.348 . . . . 0.0 110.936 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 447' ' ' VAL . . . . . 0.503 ' CG2' ' O ' ' A' ' 446' ' ' PHE . 94.3 t -161.02 153.56 4.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.176 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 448' ' ' SER . . . . . 0.417 ' N ' HG12 ' A' ' 447' ' ' VAL . 65.7 p -153.12 148.39 26.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.876 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 449' ' ' TYR . . . . . 0.497 ' CE1' HD12 ' A' ' 403' ' ' LEU . 5.9 m-85 -110.43 -174.93 2.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.966 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -78.22 -25.55 47.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.817 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -146.87 158.28 45.73 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.66 0.743 . . . . 0.0 110.898 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 452' ' ' PRO . . . . . 0.414 ' N ' ' HB2' ' A' ' 401' ' ' ALA . 61.2 Cg_endo -75.5 0.24 9.33 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.714 2.276 . . . . 0.0 112.317 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 75.5 t -88.5 -36.03 8.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.146 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 71.3 m -83.63 -39.94 19.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.88 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -50.66 -33.31 21.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.1 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -69.15 -45.55 69.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -41.6 -44.49 3.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.089 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 458' ' ' ALA . . . . . 0.503 ' HA ' ' CE2' ' A' ' 424' ' ' PHE . . . -63.85 -64.3 0.93 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.086 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 459' ' ' ILE . . . . . 0.41 ' O ' ' C ' ' A' ' 460' ' ' GLN . 65.9 mt -41.46 -47.15 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.171 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 460' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 459' ' ' ILE . 14.4 mm100 -36.89 -60.33 0.63 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.94 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 13.3 t -87.0 -52.93 5.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.884 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 462' ' ' MET . . . . . 0.468 ' SD ' ' CE1' ' A' ' 421' ' ' PHE . 7.5 mmt -40.43 -56.86 1.93 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -42.45 107.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.912 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 80.12 32.92 34.13 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.507 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -75.77 110.96 10.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.775 0.322 . . . . 0.0 110.891 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 12.6 tm0? -63.08 102.9 0.41 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.918 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 467' ' ' ILE . . . . . 0.521 HD11 ' CE1' ' A' ' 412' ' ' PHE . 16.1 tt -115.27 144.52 22.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.154 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 46.68 -95.94 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.498 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 4.6 tpt -130.22 -3.47 4.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.791 0.329 . . . . 0.0 110.869 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 11.7 pttm -125.26 -178.53 4.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.88 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 66.9 mtm-85 -108.25 172.38 6.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.843 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 82.8 mt -120.52 156.92 30.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.952 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 32.4 tttp -136.15 105.03 5.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.898 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 474' ' ' VAL . . . . . 0.433 HG22 HG13 ' A' ' 405' ' ' ILE . 12.1 t -113.76 133.2 60.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.171 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -155.23 138.2 15.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 476' ' ' LEU . . . . . 0.635 ' C ' HD12 ' A' ' 476' ' ' LEU . 1.6 pp -79.03 129.14 34.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.535 ' HB2' ' CE1' ' A' ' 404' ' ' PHE . 31.8 tttt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.909 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 4.1 ptmm? . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.821 0.343 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -148.18 179.01 8.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -98.47 -146.0 19.76 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.491 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.19 155.05 46.99 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.648 2.232 . . . . 0.0 112.317 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -55.12 118.75 4.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.87 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 120.21 -27.4 6.7 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.527 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 401' ' ' ALA . . . . . 0.493 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.97 126.95 43.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.769 0.318 . . . . 0.0 111.06 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 402' ' ' ASN . . . . . 0.493 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.7 OUTLIER -158.87 165.02 35.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 403' ' ' LEU . . . . . 0.5 HD12 ' CE1' ' A' ' 449' ' ' TYR . 15.5 mt -159.34 122.04 3.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.941 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 404' ' ' PHE . . . . . 0.465 ' CE1' ' CD1' ' A' ' 446' ' ' PHE . 29.1 m-85 -128.94 111.56 13.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 405' ' ' ILE . . . . . 0.736 HG21 HD21 ' A' ' 408' ' ' LEU . 3.9 mp -91.17 135.2 27.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.155 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 406' ' ' TYR . . . . . 0.424 ' CD1' ' HB2' ' A' ' 444' ' ' PHE . 89.5 m-85 -125.74 163.25 23.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.986 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 407' ' ' HIS . . . . . 0.421 ' N ' ' O ' ' A' ' 443' ' ' CYS . 31.9 m80 61.48 52.98 3.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.843 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.736 HD21 HG21 ' A' ' 405' ' ' ILE . 65.0 mt -92.24 128.92 43.13 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.571 0.7 . . . . 0.0 110.922 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -48.35 179.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.466 -0.126 0 C-N-CA 122.684 2.256 . . . . 0.0 112.33 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 23.8 tm0? -82.56 -41.28 19.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.899 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -65.75 -32.66 74.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.874 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.507 ' CE1' HD11 ' A' ' 467' ' ' ILE . 6.5 m-85 -59.88 138.72 57.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.899 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -137.05 -138.19 3.73 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.47 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -81.13 -61.09 2.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.704 0.288 . . . . 0.0 110.881 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -52.85 -53.72 44.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.954 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -41.36 -52.25 3.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.839 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 25.1 tp -55.44 -54.96 37.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.89 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 418' ' ' LEU . . . . . 0.41 ' O ' ' CG ' ' A' ' 422' ' ' MET . 55.8 tp -50.3 -45.3 54.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.924 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -77.89 -9.06 58.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 1.5 tpt -87.88 -27.35 22.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.796 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -110.1 -18.57 13.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.849 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 422' ' ' MET . . . . . 0.576 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 0.2 OUTLIER -52.18 -46.14 93.8 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.599 0.714 . . . . 0.0 110.901 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 422' ' ' MET . 64.1 Cg_exo -47.97 -37.24 29.26 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.654 2.236 . . . . 0.0 112.39 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 424' ' ' PHE . . . . . 0.464 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 69.5 m-85 -71.41 -35.8 71.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.859 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 174.06 -171.47 44.55 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.426 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -75.27 116.26 15.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.818 0.342 . . . . 0.0 110.874 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.473 HG11 ' HB2' ' A' ' 430' ' ' ALA . 88.0 t -87.44 120.56 36.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.117 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 60.5 t -78.16 -43.6 27.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.127 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -132.73 139.17 47.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.833 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 430' ' ' ALA . . . . . 0.473 ' HB2' HG11 ' A' ' 427' ' ' VAL . . . -157.8 120.49 3.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.105 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 431' ' ' LYS . . . . . 0.45 ' CG ' ' N ' ' A' ' 432' ' ' VAL . 20.0 tttm -161.02 160.53 30.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.806 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.45 ' N ' ' CG ' ' A' ' 431' ' ' LYS . 41.0 t -119.18 140.2 43.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.172 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 433' ' ' PHE . . . . . 0.56 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.1 m-85 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 443' ' ' CYS . . . . . 0.421 ' O ' ' N ' ' A' ' 407' ' ' HIS . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.781 0.324 . . . . 0.0 110.918 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 444' ' ' PHE . . . . . 0.597 ' C ' ' CD1' ' A' ' 444' ' ' PHE . 0.9 OUTLIER -162.56 141.4 8.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.884 -179.854 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -135.6 175.66 20.62 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.48 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 446' ' ' PHE . . . . . 0.465 ' CD1' ' CE1' ' A' ' 404' ' ' PHE . 26.0 t80 -114.21 153.37 29.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.896 0.379 . . . . 0.0 110.873 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 447' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 446' ' ' PHE . 79.0 t -158.1 154.83 5.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.086 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 448' ' ' SER . . . . . 0.431 ' N ' HG12 ' A' ' 447' ' ' VAL . 2.1 m -153.69 145.12 23.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.867 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 449' ' ' TYR . . . . . 0.5 ' CE1' HD12 ' A' ' 403' ' ' LEU . 4.2 m-85 -108.48 -174.72 2.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.934 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -78.5 -15.69 58.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.78 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 451' ' ' ASN . . . . . 0.451 ' OD1' ' N ' ' A' ' 451' ' ' ASN . 0.7 OUTLIER -158.69 160.17 29.41 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.598 0.713 . . . . 0.0 110.928 -179.918 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 452' ' ' PRO . . . . . 0.449 ' N ' ' HB2' ' A' ' 401' ' ' ALA . 60.9 Cg_endo -74.87 -18.13 19.34 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.674 2.249 . . . . 0.0 112.354 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 62.4 t -72.16 -42.78 66.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.105 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 41.8 m -80.8 -41.42 23.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.851 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 455' ' ' ALA . . . . . 0.458 ' HB2' ' HB2' ' A' ' 449' ' ' TYR . . . -50.51 -35.42 29.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.078 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 456' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' A' ' 457' ' ' ALA . 14.1 mm-40 -66.73 -44.75 80.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.918 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 457' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 456' ' ' GLN . . . -37.48 -43.18 0.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.085 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 458' ' ' ALA . . . . . 0.464 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -61.43 -69.44 0.24 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.147 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 459' ' ' ILE . . . . . 0.448 ' O ' ' C ' ' A' ' 460' ' ' GLN . 79.6 mt -44.13 -48.76 2.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.171 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 460' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 459' ' ' ILE . 35.9 mm-40 -34.62 -42.79 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.895 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 2.1 m -103.93 -56.53 2.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.848 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 462' ' ' MET . . . . . 0.443 ' O ' ' N ' ' A' ' 465' ' ' PHE . 82.8 mmm -43.22 -46.51 6.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.881 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -41.56 104.19 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.903 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 80.22 31.61 37.77 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.502 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 465' ' ' PHE . . . . . 0.443 ' N ' ' O ' ' A' ' 462' ' ' MET . 66.2 t80 -71.93 117.24 13.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.862 0.363 . . . . 0.0 110.823 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 12.3 tm0? -66.01 107.04 1.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.883 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 467' ' ' ILE . . . . . 0.507 HD11 ' CE1' ' A' ' 412' ' ' PHE . 20.1 tt -116.66 145.31 22.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.166 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 40.45 -95.56 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.49 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 469' ' ' MET . . . . . 0.43 ' N ' ' O ' ' A' ' 467' ' ' ILE . 12.8 tmm? -126.77 -9.89 6.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.905 0.383 . . . . 0.0 110.874 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.68 174.97 6.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 40.1 mtt180 -104.79 167.65 9.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.915 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 65.1 mt -111.2 155.39 23.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.913 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -132.95 104.66 6.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.836 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 4.3 t -109.9 138.34 38.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.216 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -156.86 139.77 15.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.98 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 476' ' ' LEU . . . . . 0.77 HD12 ' O ' ' A' ' 477' ' ' LYS . 1.5 pp -85.79 126.59 34.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.846 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.77 ' O ' HD12 ' A' ' 476' ' ' LEU . 11.3 tptm . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.912 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.498 ' O ' ' CB ' ' A' ' 429' ' ' SER . 7.8 mtpt . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.773 0.321 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -140.14 168.44 19.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.832 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -84.18 -152.93 16.05 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.444 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.05 157.76 46.42 Favored 'Trans proline' 0 N--CA 1.465 -0.188 0 C-N-CA 122.714 2.276 . . . . 0.0 112.39 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -55.42 110.46 0.7 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.858 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 127.77 -28.37 4.43 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.53 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 401' ' ' ALA . . . . . 0.501 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.94 127.14 43.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.781 0.324 . . . . 0.0 111.081 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 402' ' ' ASN . . . . . 0.501 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.6 OUTLIER -158.75 164.04 36.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.921 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 403' ' ' LEU . . . . . 0.595 HD12 ' CE1' ' A' ' 449' ' ' TYR . 20.1 mt -159.71 120.97 3.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 404' ' ' PHE . . . . . 0.538 ' CZ ' ' CD1' ' A' ' 446' ' ' PHE . 35.8 m-85 -126.59 111.16 14.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.939 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 405' ' ' ILE . . . . . 0.553 ' N ' HD12 ' A' ' 405' ' ' ILE . 4.0 mp -91.23 128.22 43.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.116 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -122.11 151.84 40.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.94 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 407' ' ' HIS . . . . . 0.48 ' O ' ' CD2' ' A' ' 472' ' ' LEU . 10.8 m80 72.9 47.8 0.2 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.85 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.536 HD21 HG21 ' A' ' 405' ' ' ILE . 31.2 mt -91.39 137.73 25.88 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.643 0.735 . . . . 0.0 110.924 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -47.91 177.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.662 2.241 . . . . 0.0 112.344 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -85.92 -46.13 10.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.916 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 411' ' ' GLU . . . . . 0.42 ' HG3' ' N ' ' A' ' 412' ' ' PHE . 12.7 pt-20 -58.54 -40.1 82.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.42 ' N ' ' HG3' ' A' ' 411' ' ' GLU . 7.9 m-85 -50.35 146.59 5.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 413' ' ' GLY . . . . . 0.401 ' O ' HG21 ' A' ' 432' ' ' VAL . . . -132.75 -139.21 4.22 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.444 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -86.12 -51.48 6.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.708 0.289 . . . . 0.0 110.795 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -61.79 -52.42 64.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.942 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -39.69 -59.92 1.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 417' ' ' LEU . . . . . 0.449 HD11 HG12 ' A' ' 405' ' ' ILE . 56.1 tp -49.67 -45.13 48.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.966 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 22.2 tp -62.95 -44.24 96.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.851 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -72.18 -9.73 58.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.87 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 6.2 ttm -93.89 -27.75 16.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.83 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 421' ' ' PHE . . . . . 0.443 ' CZ ' ' CG1' ' A' ' 405' ' ' ILE . 5.4 m-85 -101.25 -20.35 15.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.866 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 422' ' ' MET . . . . . 0.579 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 3.1 mtt -49.7 -46.19 79.61 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.613 0.72 . . . . 0.0 110.911 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.3 Cg_exo -47.96 -45.68 24.17 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.705 2.27 . . . . 0.0 112.356 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 424' ' ' PHE . . . . . 0.538 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 86.6 m-85 -64.03 -30.17 71.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.933 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 168.71 170.05 32.88 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.519 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -66.31 94.02 0.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.841 0.353 . . . . 0.0 110.862 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 92.4 t -62.29 133.86 27.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.133 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 75.7 t -79.88 -48.17 20.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.159 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 429' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 44.5 t -136.45 148.3 47.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -161.21 114.01 1.91 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.116 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 431' ' ' LYS . . . . . 0.417 ' C ' ' HD2' ' A' ' 431' ' ' LYS . 2.0 tmmm? -154.99 142.47 19.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.925 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.401 HG21 ' O ' ' A' ' 413' ' ' GLY . 87.4 t -93.43 137.95 21.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.119 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 433' ' ' PHE . . . . . 0.463 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.3 m-85 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.884 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 83.6 m . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.797 0.332 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 444' ' ' PHE . . . . . 0.463 ' CE1' ' HB2' ' A' ' 433' ' ' PHE . 4.6 p90 -162.07 138.84 8.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.859 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -132.55 169.31 22.39 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.509 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 446' ' ' PHE . . . . . 0.538 ' CD1' ' CZ ' ' A' ' 404' ' ' PHE . 61.4 t80 -106.33 154.26 21.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.925 0.393 . . . . 0.0 110.831 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 447' ' ' VAL . . . . . 0.425 HG23 ' C ' ' A' ' 446' ' ' PHE . 64.1 t -158.13 152.91 6.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.097 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 448' ' ' SER . . . . . 0.416 ' N ' HG12 ' A' ' 447' ' ' VAL . 60.6 p -150.39 152.8 34.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.876 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 449' ' ' TYR . . . . . 0.595 ' CE1' HD12 ' A' ' 403' ' ' LEU . 5.1 m-85 -116.89 179.57 3.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.933 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 450' ' ' ASP . . . . . 0.446 ' CG ' ' OD1' ' A' ' 451' ' ' ASN . 0.6 OUTLIER -71.89 -28.91 63.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.868 179.858 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 451' ' ' ASN . . . . . 0.446 ' OD1' ' CG ' ' A' ' 450' ' ' ASP . 0.9 OUTLIER -146.64 155.92 48.72 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.659 0.742 . . . . 0.0 110.878 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.0 -12.6 28.41 Favored 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.71 2.273 . . . . 0.0 112.414 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 95.5 t -79.64 -33.13 14.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.187 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 78.3 p -84.0 -40.63 18.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.89 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -51.73 -40.4 60.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.159 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 53.0 mm-40 -57.08 -48.96 77.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.949 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -38.69 -40.58 0.62 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.119 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 458' ' ' ALA . . . . . 0.538 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -67.57 -63.99 0.95 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.1 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 459' ' ' ILE . . . . . 0.487 ' O ' ' CB ' ' A' ' 463' ' ' ASN . 81.0 mt -46.68 -44.24 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.17 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -41.63 -49.2 4.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.929 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 1.8 m -98.02 -57.13 2.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.82 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 462' ' ' MET . . . . . 0.447 ' HB3' HG21 ' A' ' 474' ' ' VAL . 85.2 mmm -42.93 -38.55 2.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.825 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 463' ' ' ASN . . . . . 0.487 ' CB ' ' O ' ' A' ' 459' ' ' ILE . 15.1 t30 -49.12 106.0 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.904 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 78.3 32.16 44.13 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.5 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -70.79 105.26 3.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.796 0.332 . . . . 0.0 110.88 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -63.62 103.24 0.52 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 467' ' ' ILE . . . . . 0.486 HG23 ' O ' ' A' ' 467' ' ' ILE . 16.9 tt -113.0 122.26 66.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.175 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 70.56 -96.9 0.59 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.488 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 41.2 mtt -133.25 8.61 4.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.859 0.361 . . . . 0.0 110.881 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.3 175.46 9.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.856 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 71.6 mtt-85 -108.98 170.45 8.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.827 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 472' ' ' LEU . . . . . 0.48 ' CD2' ' O ' ' A' ' 407' ' ' HIS . 72.4 mt -121.97 157.87 30.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.925 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 33.5 tttp -128.56 101.36 6.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.911 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 474' ' ' VAL . . . . . 0.447 HG21 ' HB3' ' A' ' 462' ' ' MET . 16.6 t -106.49 127.4 61.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.111 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -151.86 147.16 26.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.923 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 476' ' ' LEU . . . . . 0.632 ' C ' HD12 ' A' ' 476' ' ' LEU . 1.6 pp -91.18 129.34 37.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.917 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.601 ' O ' HD12 ' A' ' 476' ' ' LEU . 38.3 tttt . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.91 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 429' ' ' SER . 22.4 ptmt . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.77 0.319 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 396' ' ' GLU . . . . . 0.605 ' OE2' ' CE2' ' A' ' 446' ' ' PHE . 6.1 mm-40 -129.87 179.72 5.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -117.2 -148.59 8.83 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.515 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -76.02 151.47 35.11 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.781 2.32 . . . . 0.0 112.32 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -56.44 108.89 0.53 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.902 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 128.61 -28.39 4.22 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.509 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 401' ' ' ALA . . . . . 0.563 ' HB2' ' CA ' ' A' ' 452' ' ' PRO . . . -97.86 126.98 43.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.826 0.346 . . . . 0.0 111.074 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 402' ' ' ASN . . . . . 0.505 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.6 OUTLIER -158.7 161.85 37.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.873 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 403' ' ' LEU . . . . . 0.54 HD12 ' CE1' ' A' ' 449' ' ' TYR . 38.4 mt -154.57 125.84 7.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.903 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 404' ' ' PHE . . . . . 0.58 ' CE1' ' HB2' ' A' ' 477' ' ' LYS . 27.8 m-85 -133.83 114.64 13.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 405' ' ' ILE . . . . . 0.673 HG12 HD11 ' A' ' 417' ' ' LEU . 3.0 mp -90.85 131.55 37.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.121 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 406' ' ' TYR . . . . . 0.472 ' CZ ' ' HB3' ' A' ' 404' ' ' PHE . 47.3 m-85 -125.31 171.12 10.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.976 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 45.8 m-70 53.67 50.98 15.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.869 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.636 HD11 ' CG2' ' A' ' 405' ' ' ILE . 46.6 mt -100.24 151.71 37.61 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.636 0.731 . . . . 0.0 110.928 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.512 ' HG2' ' CD1' ' A' ' 412' ' ' PHE . 57.4 Cg_endo -70.54 -168.31 0.3 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.689 2.259 . . . . 0.0 112.322 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -98.51 -37.91 9.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.872 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 411' ' ' GLU . . . . . 0.444 ' C ' ' OE1' ' A' ' 411' ' ' GLU . 0.2 OUTLIER -57.88 -38.33 75.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 -179.881 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 412' ' ' PHE . . . . . 0.512 ' CD1' ' HG2' ' A' ' 409' ' ' PRO . 6.5 m-85 -58.97 140.94 55.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.93 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -126.58 -134.19 3.98 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.471 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -87.99 -54.96 3.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.757 0.313 . . . . 0.0 110.837 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 415' ' ' GLN . . . . . 0.442 ' O ' ' C ' ' A' ' 416' ' ' ASP . 43.2 mm-40 -59.86 -60.64 3.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.852 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 416' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 415' ' ' GLN . 45.7 m-20 -34.47 -57.7 0.5 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.925 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 417' ' ' LEU . . . . . 0.673 HD11 HG12 ' A' ' 405' ' ' ILE . 67.6 tp -53.71 -44.35 69.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.838 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 418' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' A' ' 415' ' ' GLN . 29.7 tp -66.55 -61.67 1.86 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.87 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -51.84 -17.21 0.88 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 3.3 ttm -84.21 -35.91 23.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.825 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 421' ' ' PHE . . . . . 0.425 ' C ' ' HD2' ' A' ' 423' ' ' PRO . 4.0 m-85 -92.2 -17.86 24.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.88 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 422' ' ' MET . . . . . 0.581 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 4.2 mtt -51.12 -45.81 88.71 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.54 0.686 . . . . 0.0 110.842 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 422' ' ' MET . 66.2 Cg_exo -48.03 -46.77 21.13 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.596 2.197 . . . . 0.0 112.34 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 424' ' ' PHE . . . . . 0.564 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 56.0 m-85 -60.14 -36.03 76.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.81 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 170.18 -179.57 42.32 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.476 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -69.17 109.72 4.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.88 0.371 . . . . 0.0 110.903 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 91.1 t -79.3 131.37 34.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.106 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 428' ' ' VAL . . . . . 0.442 HG12 ' HG3' ' A' ' 395' ' ' LYS . 55.2 t -84.36 -47.68 17.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.152 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 429' ' ' SER . . . . . 0.492 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 23.3 t -129.57 144.4 51.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.814 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -160.44 111.09 1.83 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.118 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -159.04 135.1 8.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.856 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 80.0 t -90.05 142.5 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.162 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 433' ' ' PHE . . . . . 0.54 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.0 m-85 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 98.9 m . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.871 0.367 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 444' ' ' PHE . . . . . 0.54 ' CE1' ' HB2' ' A' ' 433' ' ' PHE . 3.7 p90 -162.28 139.93 8.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.868 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -131.09 175.86 19.31 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.503 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 446' ' ' PHE . . . . . 0.605 ' CE2' ' OE2' ' A' ' 396' ' ' GLU . 35.0 t80 -116.01 153.76 31.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.908 0.385 . . . . 0.0 110.857 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 447' ' ' VAL . . . . . 0.406 ' HB ' ' CB ' ' A' ' 403' ' ' LEU . 65.5 t -154.69 150.13 11.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.102 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 6.1 p -147.1 141.35 26.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 449' ' ' TYR . . . . . 0.54 ' CE1' HD12 ' A' ' 403' ' ' LEU . 3.8 m-85 -111.42 170.46 8.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.867 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -67.09 -25.65 66.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.803 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 451' ' ' ASN . . . . . 0.405 ' OD1' ' N ' ' A' ' 451' ' ' ASN . 2.0 p-10 -143.32 156.98 60.64 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.611 0.72 . . . . 0.0 110.896 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 452' ' ' PRO . . . . . 0.563 ' CA ' ' HB2' ' A' ' 401' ' ' ALA . 61.2 Cg_endo -75.39 -22.12 14.46 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.653 2.235 . . . . 0.0 112.377 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 98.3 t -72.82 -40.9 61.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.109 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 1.8 m -73.08 -42.65 62.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.81 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 455' ' ' ALA . . . . . 0.4 ' HB2' ' HB2' ' A' ' 449' ' ' TYR . . . -52.83 -42.67 65.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.097 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -53.76 -44.86 70.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.867 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -43.63 -43.02 5.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.11 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 458' ' ' ALA . . . . . 0.564 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -58.18 -66.37 0.49 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.185 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 459' ' ' ILE . . . . . 0.454 ' O ' ' C ' ' A' ' 460' ' ' GLN . 58.8 mt -50.1 -48.94 23.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.121 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 460' ' ' GLN . . . . . 0.454 ' C ' ' O ' ' A' ' 459' ' ' ILE . 23.1 mt-30 -33.91 -43.24 0.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.93 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 34.1 t -102.55 -56.91 2.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 462' ' ' MET . . . . . 0.427 ' O ' ' N ' ' A' ' 465' ' ' PHE . 80.6 mmm -44.36 -47.83 9.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.819 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -40.35 100.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.854 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 80.99 37.22 19.57 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.477 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 465' ' ' PHE . . . . . 0.427 ' N ' ' O ' ' A' ' 462' ' ' MET . 64.9 t80 -77.79 115.36 17.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.816 0.341 . . . . 0.0 110.899 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -64.28 102.88 0.57 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.952 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 467' ' ' ILE . . . . . 0.484 HG21 HD21 ' A' ' 472' ' ' LEU . 19.4 tt -112.94 144.95 19.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.153 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 42.45 -96.94 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.457 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 54.4 mtm -125.1 -7.77 7.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.863 0.363 . . . . 0.0 110.877 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.91 -177.96 3.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.907 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 68.0 mtt85 -112.2 168.4 9.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.867 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 472' ' ' LEU . . . . . 0.484 HD21 HG21 ' A' ' 467' ' ' ILE . 56.7 mt -111.22 158.35 19.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.912 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 21.4 ttmt -134.5 99.96 4.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 11.4 t -105.84 138.2 32.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.14 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -156.98 138.2 13.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.834 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 476' ' ' LEU . . . . . 0.697 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.6 pp -78.93 124.37 28.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.886 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.58 ' HB2' ' CE1' ' A' ' 404' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.85 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 395' ' ' LYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 429' ' ' SER . 14.7 ptmt . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.786 0.327 . . . . 0.0 110.928 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -143.34 -178.38 5.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.901 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -100.08 -154.7 27.73 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.468 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.57 159.24 46.41 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.715 2.276 . . . . 0.0 112.349 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -54.51 116.38 2.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 120.33 -27.74 6.54 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.499 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 401' ' ' ALA . . . . . 0.488 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.91 127.18 43.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.858 0.361 . . . . 0.0 111.063 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 402' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.6 OUTLIER -158.73 160.0 35.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 -179.917 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 403' ' ' LEU . . . . . 0.467 HD12 ' CE1' ' A' ' 449' ' ' TYR . 23.1 mt -156.0 122.25 5.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.924 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 404' ' ' PHE . . . . . 0.522 ' CE1' ' HD3' ' A' ' 477' ' ' LYS . 36.6 m-85 -131.33 110.85 11.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.834 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 405' ' ' ILE . . . . . 0.682 ' N ' HD12 ' A' ' 405' ' ' ILE . 3.0 mp -91.18 136.76 23.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.116 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -131.2 165.69 22.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.956 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 407' ' ' HIS . . . . . 0.463 ' O ' HD23 ' A' ' 472' ' ' LEU . 24.5 m80 58.96 53.22 5.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.891 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 408' ' ' LEU . . . . . 0.4 ' O ' ' O ' ' A' ' 409' ' ' PRO . 21.1 mt -94.83 138.35 22.17 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.613 0.721 . . . . 0.0 110.915 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 409' ' ' PRO . . . . . 0.4 ' O ' ' O ' ' A' ' 408' ' ' LEU . 76.1 Cg_exo -50.02 -172.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.671 2.247 . . . . 0.0 112.384 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -90.93 -43.03 10.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.876 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -62.52 -36.99 84.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -51.57 132.03 30.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.903 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 413' ' ' GLY . . . . . 0.511 ' O ' HG21 ' A' ' 432' ' ' VAL . . . -127.16 -130.91 3.42 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.536 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.56 -62.84 1.37 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.761 0.315 . . . . 0.0 110.836 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 415' ' ' GLN . . . . . 0.42 ' O ' ' C ' ' A' ' 416' ' ' ASP . 35.0 mm-40 -47.06 -58.03 4.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.948 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 416' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 415' ' ' GLN . 71.2 m-20 -36.0 -71.87 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 417' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 416' ' ' ASP . 26.2 tp -37.53 -53.26 1.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.966 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 27.5 tp -54.99 -46.61 75.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.944 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -75.33 -11.83 60.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.924 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 2.9 tpp -86.68 -28.3 23.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 421' ' ' PHE . . . . . 0.443 ' CE1' ' SD ' ' A' ' 462' ' ' MET . 6.0 m-85 -106.56 -11.27 15.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.936 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 422' ' ' MET . . . . . 0.583 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 1.6 mmt -60.59 -45.71 97.18 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.543 0.687 . . . . 0.0 110.852 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 423' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 422' ' ' MET . 66.5 Cg_exo -47.97 -48.44 16.31 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.706 2.271 . . . . 0.0 112.311 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -60.21 -35.15 74.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.865 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 175.79 -171.94 44.98 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.495 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -79.34 105.75 10.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.917 0.389 . . . . 0.0 110.919 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 427' ' ' VAL . . . . . 0.44 HG11 ' HB2' ' A' ' 430' ' ' ALA . 95.9 t -71.82 126.59 32.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.109 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 95.2 t -84.27 -38.31 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.081 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 429' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 1.0 OUTLIER -137.72 140.54 40.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.849 -179.841 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 430' ' ' ALA . . . . . 0.44 ' HB2' HG11 ' A' ' 427' ' ' VAL . . . -160.22 114.55 2.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.087 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -159.5 133.85 7.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 432' ' ' VAL . . . . . 0.511 HG21 ' O ' ' A' ' 413' ' ' GLY . 88.0 t -88.6 153.93 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.153 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 433' ' ' PHE . . . . . 0.436 ' N ' HG12 ' A' ' 432' ' ' VAL . 3.8 m-30 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.863 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 443' ' ' CYS . . . . . 0.454 ' O ' ' N ' ' A' ' 407' ' ' HIS . 26.7 p . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.799 0.333 . . . . 0.0 110.839 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 444' ' ' PHE . . . . . 0.411 ' CE1' ' HB2' ' A' ' 433' ' ' PHE . 7.4 p90 -159.91 145.92 15.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -142.96 175.8 22.9 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.479 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 446' ' ' PHE . . . . . 0.549 ' O ' HG23 ' A' ' 447' ' ' VAL . 25.2 t80 -112.62 154.93 25.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.911 0.386 . . . . 0.0 110.92 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 447' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 446' ' ' PHE . 72.3 t -160.86 156.01 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.134 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 448' ' ' SER . . . . . 0.452 ' N ' HG12 ' A' ' 447' ' ' VAL . 2.4 m -155.89 152.68 28.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.864 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 449' ' ' TYR . . . . . 0.467 ' CE1' HD12 ' A' ' 403' ' ' LEU . 3.7 m-85 -115.63 -175.01 2.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.935 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -79.1 -24.0 43.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.817 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -147.98 158.34 42.16 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.627 0.727 . . . . 0.0 110.844 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.56 -2.13 12.01 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.645 2.23 . . . . 0.0 112.303 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 96.6 t -89.82 -39.85 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.089 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 10.6 t -74.76 -40.14 61.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.876 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -50.64 -32.97 20.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.172 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 456' ' ' GLN . . . . . 0.505 ' O ' ' N ' ' A' ' 458' ' ' ALA . 34.1 mm-40 -61.57 -60.34 3.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.918 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 457' ' ' ALA . . . . . 0.47 ' C ' ' HG2' ' A' ' 460' ' ' GLN . . . -35.89 -30.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.117 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 458' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 456' ' ' GLN . . . -81.53 -44.98 16.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.092 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 459' ' ' ILE . . . . . 0.488 ' N ' ' O ' ' A' ' 456' ' ' GLN . 26.0 mt -70.1 -48.42 62.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.113 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 460' ' ' GLN . . . . . 0.495 ' HG3' ' N ' ' A' ' 461' ' ' SER . 3.8 pt20 -37.01 -45.05 0.55 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.875 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 461' ' ' SER . . . . . 0.495 ' N ' ' HG3' ' A' ' 460' ' ' GLN . 2.0 m -93.94 -54.18 3.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.82 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 462' ' ' MET . . . . . 0.601 ' HB3' HG21 ' A' ' 474' ' ' VAL . 9.6 mmt -44.38 -57.49 3.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.85 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -38.16 97.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 464' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 462' ' ' MET . . . 84.43 34.82 15.65 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.517 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 465' ' ' PHE . . . . . 0.496 ' N ' ' O ' ' A' ' 462' ' ' MET . 48.6 t80 -71.98 125.92 28.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.823 0.344 . . . . 0.0 110.856 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 14.6 tm0? -70.73 117.18 11.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.945 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.6 tt -139.03 133.1 40.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.151 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 50.91 -103.0 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.465 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 11.4 mmm -132.53 25.58 4.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.805 0.336 . . . . 0.0 110.846 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -145.85 179.64 7.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.891 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 -120.32 122.3 40.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.877 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 472' ' ' LEU . . . . . 0.463 HD23 ' O ' ' A' ' 407' ' ' HIS . 52.8 mt -64.48 158.07 24.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.852 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -133.25 111.72 11.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.899 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 474' ' ' VAL . . . . . 0.601 HG21 ' HB3' ' A' ' 462' ' ' MET . 20.9 t -122.22 136.95 57.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.119 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 33.1 tp60 -157.14 141.6 16.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 476' ' ' LEU . . . . . 0.757 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.5 pp -85.01 125.05 32.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.961 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 477' ' ' LYS . . . . . 0.522 ' HD3' ' CE1' ' A' ' 404' ' ' PHE . 7.8 tptm . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.932 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.556 -0.217 . . . . 0.0 112.556 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 73.3 m 60.27 42.43 15.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.906 0.384 . . . . 0.0 110.861 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 66.4 m -81.22 146.76 30.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.791 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -146.88 169.66 27.95 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.451 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 3.1 m -152.83 133.53 13.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.862 0.363 . . . . 0.0 110.863 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 94.2 p -101.64 41.95 1.17 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.825 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -63.74 119.33 15.98 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.468 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 383' ' ' LEU . . . . . 0.443 HD22 ' HA ' ' A' ' 383' ' ' LEU . 0.6 OUTLIER -47.12 109.48 0.21 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.879 0.371 . . . . 0.0 110.914 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 384' ' ' THR . . . . . 0.425 HG22 ' HG3' ' A' ' 386' ' ' GLN . 24.5 m -118.65 138.78 52.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.094 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -93.91 41.29 1.08 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.918 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 386' ' ' GLN . . . . . 0.425 ' HG3' HG22 ' A' ' 384' ' ' THR . 72.3 mt-30 -103.37 93.71 5.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.923 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 26.8 t -110.7 95.0 5.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 33.5 mt -108.31 -54.75 5.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.123 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 92.78 60.54 1.2 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.466 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -112.56 -33.02 6.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.79 0.329 . . . . 0.0 111.068 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -48.18 110.01 0.29 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.108 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 85.7 57.13 2.23 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.491 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 75.3 m -147.58 130.7 16.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.834 0.349 . . . . 0.0 110.851 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -88.57 36.47 0.8 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.911 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.491 ' O ' ' CB ' ' A' ' 429' ' ' SER . 26.6 mtpp -88.28 163.05 16.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.966 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -144.52 165.69 27.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.816 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -88.55 -146.43 12.49 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.448 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.44 154.1 40.22 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.647 2.231 . . . . 0.0 112.307 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -52.0 124.64 13.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.916 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 113.53 -27.28 9.48 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.505 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 401' ' ' ALA . . . . . 0.496 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.94 127.11 43.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.82 0.343 . . . . 0.0 111.11 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 402' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.7 OUTLIER -159.05 163.17 36.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 403' ' ' LEU . . . . . 0.493 HD12 ' CE1' ' A' ' 449' ' ' TYR . 24.1 mt -159.36 122.37 3.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.922 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 404' ' ' PHE . . . . . 0.615 ' CZ ' ' CD1' ' A' ' 446' ' ' PHE . 41.4 m-85 -129.78 114.81 16.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 405' ' ' ILE . . . . . 0.62 HG12 HD11 ' A' ' 417' ' ' LEU . 3.8 mp -90.9 134.0 30.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.1 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 406' ' ' TYR . . . . . 0.446 ' CD2' ' HD3' ' A' ' 473' ' ' LYS . 71.9 m-85 -129.4 166.36 19.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.902 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 23.3 m80 59.0 50.5 8.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.83 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.493 HD21 HG21 ' A' ' 405' ' ' ILE . 32.8 mt -91.24 149.21 39.37 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.657 0.741 . . . . 0.0 110.935 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -78.31 169.86 19.45 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.634 2.223 . . . . 0.0 112.342 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -73.59 -31.14 63.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.43 -38.55 91.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.866 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.581 ' CE1' HD11 ' A' ' 467' ' ' ILE . 4.3 m-85 -70.22 148.01 49.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.826 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 413' ' ' GLY . . . . . 0.525 ' O ' HG21 ' A' ' 432' ' ' VAL . . . -135.25 -133.56 3.27 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.493 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -87.76 -61.9 1.61 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.753 0.311 . . . . 0.0 110.867 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 415' ' ' GLN . . . . . 0.415 ' O ' ' C ' ' A' ' 416' ' ' ASP . 11.5 mm-40 -54.33 -54.3 42.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.928 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 416' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 415' ' ' GLN . 67.0 m-20 -36.91 -60.94 0.58 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.774 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 417' ' ' LEU . . . . . 0.62 HD11 HG12 ' A' ' 405' ' ' ILE . 24.2 tp -46.52 -45.24 18.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.859 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 418' ' ' LEU . . . . . 0.451 HD13 ' HB3' ' A' ' 430' ' ' ALA . 27.1 tp -59.62 -54.99 40.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.939 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -68.41 -9.93 51.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.845 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -85.57 -30.57 23.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.859 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 421' ' ' PHE . . . . . 0.432 ' C ' ' HD2' ' A' ' 423' ' ' PRO . 4.0 m-85 -100.35 -20.9 15.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.864 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.569 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 3.6 mtt -48.85 -46.6 73.78 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.523 0.678 . . . . 0.0 110.787 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 422' ' ' MET . 64.3 Cg_exo -47.97 -38.49 31.45 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.663 2.242 . . . . 0.0 112.354 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 424' ' ' PHE . . . . . 0.517 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 82.0 m-85 -73.93 -31.91 63.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.909 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 171.6 -177.25 44.52 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.47 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -77.47 94.91 4.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.913 0.387 . . . . 0.0 110.913 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.425 HG22 ' CE1' ' A' ' 449' ' ' TYR . 86.5 t -64.57 127.96 26.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.148 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 79.5 t -78.84 -45.39 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.159 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 429' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 8.5 p -128.99 144.7 51.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.89 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 430' ' ' ALA . . . . . 0.451 ' HB3' HD13 ' A' ' 418' ' ' LEU . . . -160.72 107.53 1.5 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.113 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 431' ' ' LYS . . . . . 0.482 ' CG ' ' N ' ' A' ' 432' ' ' VAL . 52.2 tttt -145.16 162.74 36.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.887 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.525 HG21 ' O ' ' A' ' 413' ' ' GLY . 18.5 t -124.52 148.12 28.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.138 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 433' ' ' PHE . . . . . 0.637 ' CG ' ' CE1' ' A' ' 444' ' ' PHE . 4.5 m-85 -92.61 153.75 18.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.849 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.7 HD13 ' HA ' ' A' ' 441' ' ' SER . 19.7 mm -125.43 140.76 47.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.119 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -67.46 148.93 50.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.866 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.65 3.19 54.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.915 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -119.2 -46.03 2.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.964 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 38.8 p -96.66 0.36 49.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.136 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 45.51 32.73 1.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.93 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.415 ' O ' ' C ' ' A' ' 441' ' ' SER . 57.4 mt -128.57 152.12 48.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.918 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 441' ' ' SER . . . . . 0.7 ' HA ' HD13 ' A' ' 434' ' ' ILE . 7.4 t -35.9 136.75 0.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.863 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.574 ' HB3' ' CE2' ' A' ' 444' ' ' PHE . 67.5 mttt -77.47 8.6 4.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.948 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 22.6 m 67.0 26.76 8.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 444' ' ' PHE . . . . . 0.637 ' CE1' ' CG ' ' A' ' 433' ' ' PHE . 2.6 p90 -161.78 141.6 10.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.926 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -135.98 164.93 24.98 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.492 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 446' ' ' PHE . . . . . 0.615 ' CD1' ' CZ ' ' A' ' 404' ' ' PHE . 33.8 t80 -103.76 153.35 20.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.873 0.368 . . . . 0.0 110.913 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 447' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 446' ' ' PHE . 60.5 t -158.87 152.76 6.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.129 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 10.1 m -153.86 150.74 28.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 449' ' ' TYR . . . . . 0.493 ' CE1' HD12 ' A' ' 403' ' ' LEU . 3.9 m-85 -113.07 -175.14 2.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.862 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -80.61 -13.05 59.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.856 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -161.37 159.36 23.72 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.596 0.713 . . . . 0.0 110.817 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 452' ' ' PRO . . . . . 0.466 ' N ' ' HB2' ' A' ' 401' ' ' ALA . 61.1 Cg_endo -75.86 -7.11 18.15 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.67 2.247 . . . . 0.0 112.362 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 58.9 t -81.3 -39.39 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.125 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 6.4 m -82.97 -40.7 19.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.89 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -53.1 -31.9 44.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.132 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -69.41 -43.72 72.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.951 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -43.84 -41.26 4.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.081 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 458' ' ' ALA . . . . . 0.517 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -64.29 -67.91 0.39 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.085 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 459' ' ' ILE . . . . . 0.527 HG23 ' HB2' ' A' ' 463' ' ' ASN . 87.1 mt -43.66 -45.95 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.114 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 460' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 459' ' ' ILE . 35.3 mt-30 -37.38 -47.42 0.85 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.869 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 2.8 m -101.58 -53.71 2.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.864 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 462' ' ' MET . . . . . 0.459 ' SD ' ' CE1' ' A' ' 424' ' ' PHE . 84.3 mmm -44.85 -47.77 11.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.92 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 463' ' ' ASN . . . . . 0.527 ' HB2' HG23 ' A' ' 459' ' ' ILE . 27.2 t-20 -45.27 104.34 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 86.22 25.35 37.16 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.48 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 465' ' ' PHE . . . . . 0.413 ' N ' ' O ' ' A' ' 462' ' ' MET . 21.7 t80 -69.87 108.69 4.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.795 0.331 . . . . 0.0 110.931 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -65.8 104.17 1.03 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.863 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 467' ' ' ILE . . . . . 0.581 HD11 ' CE1' ' A' ' 412' ' ' PHE . 19.8 tt -111.62 135.33 51.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.13 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 58.19 -93.01 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.463 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 59.9 mtp -133.57 -0.58 3.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.813 0.339 . . . . 0.0 110.875 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -127.88 -178.18 4.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.936 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 54.2 mtt85 -112.73 159.91 18.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.897 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 87.3 mt -103.0 157.54 16.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.894 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 473' ' ' LYS . . . . . 0.446 ' HD3' ' CD2' ' A' ' 406' ' ' TYR . 13.3 tttt -132.26 104.67 6.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.923 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 2.8 t -113.55 135.82 51.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.138 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -157.1 137.92 13.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.836 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 476' ' ' LEU . . . . . 0.666 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.6 pp -83.66 128.38 34.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 476' ' ' LEU . 10.7 tptm -34.37 112.79 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 71.2 ttt-85 -48.69 158.53 0.29 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 62.8 m -141.16 117.1 10.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.859 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 28.7 mtpt -69.83 -62.21 1.48 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.879 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -110.88 113.24 25.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.862 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -119.47 105.42 11.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.84 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 27.4 m -96.89 99.3 10.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.897 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -100.38 97.54 8.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.883 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 37.8 p -64.42 83.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.819 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -87.33 -147.1 11.56 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.498 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -76.35 131.16 12.52 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.697 2.265 . . . . 0.0 112.348 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 19.0 m -121.59 171.5 8.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.842 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 74.2 p 39.08 41.66 0.61 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.906 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.456 -179.992 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.423 -0.271 . . . . 0.0 112.423 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 2.5 t -114.52 115.07 26.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.892 0.377 . . . . 0.0 110.828 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 9.2 t -102.7 124.41 48.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.852 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -134.79 -126.4 2.62 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.469 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 6.1 t -146.78 147.56 31.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.843 0.354 . . . . 0.0 110.888 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 13.5 t -106.3 156.8 18.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.829 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 137.9 177.72 15.45 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.459 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 383' ' ' LEU . . . . . 0.504 HD23 ' C ' ' A' ' 383' ' ' LEU . 6.9 tt -99.94 -58.22 1.96 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.863 0.363 . . . . 0.0 110.921 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 89.7 m -107.32 124.09 49.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.15 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 385' ' ' GLN . . . . . 0.426 ' O ' ' C ' ' A' ' 386' ' ' GLN . 36.9 mm-40 -81.01 -46.51 14.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.907 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 386' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 385' ' ' GLN . 41.2 tt0 -35.19 -57.73 0.57 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 77.6 p -71.76 118.33 14.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.85 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 17.8 mt -117.49 -50.77 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.192 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 58.39 63.97 4.75 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.499 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -109.76 -35.56 6.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.857 0.36 . . . . 0.0 111.124 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -54.57 98.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.148 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 107.3 -39.17 2.99 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.518 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 61.2 m -43.38 121.84 2.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.81 0.338 . . . . 0.0 110.848 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -96.04 33.79 1.66 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.956 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt -95.93 171.86 8.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.841 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -131.41 -178.3 4.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.868 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -98.14 -145.89 19.67 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.561 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.52 151.08 52.61 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.697 2.265 . . . . 0.0 112.333 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -54.16 97.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.937 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 135.16 -22.95 3.53 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.462 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 401' ' ' ALA . . . . . 0.448 ' HB2' ' N ' ' A' ' 452' ' ' PRO . . . -99.98 127.43 46.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.709 0.29 . . . . 0.0 111.166 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -158.47 165.5 34.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.876 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 403' ' ' LEU . . . . . 0.716 HD23 HD11 ' A' ' 459' ' ' ILE . 22.4 mt -160.12 110.38 1.85 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.921 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 404' ' ' PHE . . . . . 0.584 ' CE1' ' HB2' ' A' ' 477' ' ' LYS . 26.2 m-85 -115.37 115.62 26.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.899 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 405' ' ' ILE . . . . . 0.572 HG21 HD21 ' A' ' 408' ' ' LEU . 4.0 mp -90.81 136.19 24.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.132 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 406' ' ' TYR . . . . . 0.54 ' CZ ' ' HB3' ' A' ' 404' ' ' PHE . 26.9 m-85 -130.49 167.53 18.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.945 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 6.0 m80 59.79 50.14 7.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.858 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.572 HD21 HG21 ' A' ' 405' ' ' ILE . 38.3 mt -97.25 145.93 30.48 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.58 0.705 . . . . 0.0 110.957 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.487 ' HG2' ' CD1' ' A' ' 412' ' ' PHE . 61.5 Cg_endo -76.42 -177.51 3.77 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.713 2.275 . . . . 0.0 112.308 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -84.44 -35.58 22.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.938 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -58.64 -33.39 70.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.938 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.517 ' CE1' HD11 ' A' ' 467' ' ' ILE . 3.4 m-85 -64.98 155.05 35.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.977 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -145.32 -148.08 4.75 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.493 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.35 -60.33 2.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.707 0.289 . . . . 0.0 110.805 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 415' ' ' GLN . . . . . 0.434 ' O ' ' C ' ' A' ' 416' ' ' ASP . 21.1 mp0 -54.27 -59.29 4.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.984 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 416' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 415' ' ' GLN . 35.3 m-20 -34.6 -61.19 0.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.831 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 417' ' ' LEU . . . . . 0.423 HD11 HD13 ' A' ' 405' ' ' ILE . 19.5 tp -47.84 -47.67 31.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 18.4 tp -62.38 -44.09 97.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -74.25 -17.42 60.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.878 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 2.5 ttt -83.94 -28.85 27.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.863 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 421' ' ' PHE . . . . . 0.438 ' C ' ' HD2' ' A' ' 423' ' ' PRO . 5.3 m-85 -102.93 -19.83 14.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.883 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.584 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 0.2 OUTLIER -49.97 -46.05 81.33 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.517 0.675 . . . . 0.0 110.827 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 422' ' ' MET . 66.7 Cg_exo -48.03 -48.97 14.93 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.69 2.26 . . . . 0.0 112.299 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 424' ' ' PHE . . . . . 0.503 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 81.5 m-85 -62.18 -31.79 72.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 175.35 173.58 41.22 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.52 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -76.18 91.78 3.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.942 0.401 . . . . 0.0 110.886 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.518 HG11 ' HB2' ' A' ' 430' ' ' ALA . 72.4 t -56.33 128.62 16.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.127 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 31.3 t -73.16 -50.98 28.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.162 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 38.8 m -144.43 132.16 21.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.865 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 430' ' ' ALA . . . . . 0.518 ' HB2' HG11 ' A' ' 427' ' ' VAL . . . -140.78 129.86 23.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.097 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 431' ' ' LYS . . . . . 0.419 ' HD3' ' C ' ' A' ' 431' ' ' LYS . 0.2 OUTLIER -159.83 137.75 10.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.868 -180.0 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 72.2 t -93.7 151.37 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.128 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 433' ' ' PHE . . . . . 0.405 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 4.1 m-30 -82.55 153.46 25.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.912 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.508 HG22 ' N ' ' A' ' 435' ' ' ASP . 22.7 mm -131.8 158.77 43.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.081 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 435' ' ' ASP . . . . . 0.508 ' N ' HG22 ' A' ' 434' ' ' ILE . 22.1 t0 -103.87 149.63 24.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.856 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -92.91 -15.97 25.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.946 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -91.35 -45.08 8.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.889 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 30.8 p -95.02 -39.68 10.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.122 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 68.98 39.92 1.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.888 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 19.7 mt -128.49 134.28 48.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.886 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 8.4 p -38.37 105.87 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.874 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.584 ' HD3' ' CE1' ' A' ' 444' ' ' PHE . 17.9 mttm -52.02 -174.49 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.86 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 19.0 p -108.67 31.15 5.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.828 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 444' ' ' PHE . . . . . 0.584 ' CE1' ' HD3' ' A' ' 442' ' ' LYS . 7.0 p90 -162.1 141.9 9.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.908 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -139.25 179.08 19.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.475 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 446' ' ' PHE . . . . . 0.492 ' CE1' ' CE1' ' A' ' 404' ' ' PHE . 27.2 t80 -117.41 150.31 39.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.825 0.345 . . . . 0.0 110.958 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 96.6 t -155.32 144.61 12.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.127 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 51.6 p -139.81 146.34 39.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.838 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 449' ' ' TYR . . . . . 0.706 ' CE1' HD12 ' A' ' 403' ' ' LEU . 3.7 m-85 -111.86 174.67 5.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.87 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.63 -18.65 62.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.864 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 451' ' ' ASN . . . . . 0.482 ' N ' ' OD1' ' A' ' 451' ' ' ASN . 3.9 p-10 -152.01 155.1 33.36 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.642 0.734 . . . . 0.0 110.869 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 452' ' ' PRO . . . . . 0.448 ' N ' ' HB2' ' A' ' 401' ' ' ALA . 60.9 Cg_endo -75.41 -15.1 20.04 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.644 2.23 . . . . 0.0 112.347 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 85.7 t -77.72 -38.1 24.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.025 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 1.5 t -80.21 -35.86 35.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.762 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -56.43 -39.53 73.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.128 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -61.97 -42.59 99.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -42.63 -43.76 3.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.148 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 458' ' ' ALA . . . . . 0.503 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -64.02 -70.52 0.22 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.156 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 459' ' ' ILE . . . . . 0.716 HD11 HD23 ' A' ' 403' ' ' LEU . 84.6 mt -41.9 -44.78 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.161 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -39.54 -47.22 1.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 2.4 m -97.58 -54.31 3.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.863 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 462' ' ' MET . . . . . 0.476 ' O ' ' N ' ' A' ' 465' ' ' PHE . 80.8 mmm -44.69 -57.39 3.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.847 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 463' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 462' ' ' MET . 9.8 t-20 -35.98 99.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.822 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 90.32 31.11 10.96 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.524 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 465' ' ' PHE . . . . . 0.476 ' N ' ' O ' ' A' ' 462' ' ' MET . 40.2 t80 -76.26 115.71 16.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.759 0.314 . . . . 0.0 110.883 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -63.54 103.28 0.51 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.894 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 467' ' ' ILE . . . . . 0.517 HD11 ' CE1' ' A' ' 412' ' ' PHE . 18.8 tt -114.01 138.9 42.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.151 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 48.17 -96.87 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.457 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 27.3 mmm -125.14 -9.33 7.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.873 0.368 . . . . 0.0 110.861 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 14.6 pttm -121.03 178.98 4.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.894 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 62.0 mtm180 -110.42 151.61 27.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.888 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 68.5 mt -94.22 158.08 15.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.874 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -137.43 108.53 6.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 474' ' ' VAL . . . . . 0.423 HG21 ' HB3' ' A' ' 462' ' ' MET . 2.9 t -110.02 140.34 29.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.129 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -157.17 141.01 16.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.907 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 476' ' ' LEU . . . . . 0.759 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.5 pp -85.19 125.65 33.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.939 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.584 ' HB2' ' CE1' ' A' ' 404' ' ' PHE . 32.9 ttpt -44.4 116.46 1.04 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.874 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 25.4 ttt180 -74.85 127.39 33.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.871 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 26.3 p -112.96 123.15 49.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.911 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.4 119.05 8.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.856 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -82.75 133.52 35.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.918 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -112.7 126.29 55.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.854 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 29.6 t -85.23 -61.47 1.76 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.829 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 30.1 mtmt -102.55 153.45 20.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.852 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 31.0 t -91.76 -57.22 2.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.918 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 74.75 74.37 0.88 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.549 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -79.96 29.54 0.5 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.677 2.252 . . . . 0.0 112.339 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 83.1 p -132.86 177.66 7.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 3.9 m -45.86 -52.45 11.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.84 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.205 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.395 -179.934 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 N-CA-C 112.437 -0.265 . . . . 0.0 112.437 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 28.5 t 64.81 41.27 5.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.836 0.35 . . . . 0.0 110.848 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 4.4 t -117.12 103.75 10.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.827 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 129.28 45.28 0.18 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.498 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 15.9 m -95.0 95.21 8.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.907 0.384 . . . . 0.0 110.923 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 23.1 t -103.68 130.66 51.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.89 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -159.53 51.91 0.38 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.472 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 24.2 mt -100.32 85.36 2.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.87 0.367 . . . . 0.0 110.944 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 21.3 p -100.55 155.83 17.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.19 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.18 -48.93 2.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.965 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -144.1 118.15 9.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.895 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 2.1 t -103.4 105.57 15.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.855 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.408 ' N ' HD12 ' A' ' 388' ' ' ILE . 4.9 mp -107.04 133.35 51.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.151 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -135.16 59.07 0.67 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.528 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 390' ' ' ALA . . . . . 0.63 ' O ' HD22 ' A' ' 418' ' ' LEU . . . -102.11 78.25 1.76 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.817 0.341 . . . . 0.0 111.109 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -129.29 120.78 26.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.161 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 93.99 -25.48 21.62 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.539 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 2.6 m -55.95 117.16 3.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.902 0.382 . . . . 0.0 110.801 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -86.2 30.82 0.66 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.97 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 33.3 mtmt -90.63 162.24 15.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.937 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -130.73 -178.33 4.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.84 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -96.41 -155.09 30.62 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.5 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.25 151.73 43.88 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.618 2.212 . . . . 0.0 112.395 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -48.45 113.56 0.78 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.88 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 121.57 -28.53 5.94 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.512 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 401' ' ' ALA . . . . . 0.496 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.81 127.4 43.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.8 0.333 . . . . 0.0 111.127 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 402' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.7 OUTLIER -158.42 161.96 37.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.947 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 403' ' ' LEU . . . . . 0.495 HD12 ' CE1' ' A' ' 449' ' ' TYR . 19.8 mt -155.67 120.28 4.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.915 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 404' ' ' PHE . . . . . 0.529 ' CE1' ' HB2' ' A' ' 477' ' ' LYS . 25.3 m-85 -127.61 110.74 12.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.945 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 405' ' ' ILE . . . . . 0.635 ' N ' HD12 ' A' ' 405' ' ' ILE . 3.5 mp -91.84 136.31 24.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.127 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -127.28 174.63 8.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 407' ' ' HIS . . . . . 0.535 ' O ' HD23 ' A' ' 472' ' ' LEU . 21.3 m80 51.04 50.29 19.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.919 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.424 HD11 ' CG2' ' A' ' 405' ' ' ILE . 19.7 mt -98.27 140.18 21.69 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.549 0.69 . . . . 0.0 110.982 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.411 ' O ' ' O ' ' A' ' 408' ' ' LEU . 73.1 Cg_exo -50.46 -171.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.651 2.234 . . . . 0.0 112.411 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -100.01 -24.77 14.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.97 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.11 -32.17 59.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.873 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -58.19 130.85 48.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.869 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -118.47 -144.88 7.65 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.51 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.86 -60.22 2.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.794 0.331 . . . . 0.0 110.847 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -53.84 -55.1 29.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -42.23 -65.01 0.51 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.889 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 22.5 tp -42.86 -41.37 3.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.94 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 418' ' ' LEU . . . . . 0.63 HD22 ' O ' ' A' ' 390' ' ' ALA . 30.6 tp -65.35 -50.94 63.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.919 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -67.5 -9.0 38.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.925 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -86.43 -27.91 23.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.902 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 421' ' ' PHE . . . . . 0.597 ' CZ ' ' SD ' ' A' ' 462' ' ' MET . 10.6 m-85 -104.75 -12.48 16.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.909 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.575 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 6.1 mtt -54.22 -45.73 99.08 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.565 0.698 . . . . 0.0 110.877 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.0 Cg_exo -47.95 -40.79 33.08 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.611 2.207 . . . . 0.0 112.392 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 424' ' ' PHE . . . . . 0.559 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 86.7 m-85 -67.61 -36.01 80.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.806 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 178.34 -169.06 40.6 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.464 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -85.32 100.47 11.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.874 0.369 . . . . 0.0 110.911 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.551 HG11 HD12 ' A' ' 418' ' ' LEU . 74.7 t -65.15 135.95 27.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.152 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 25.2 t -84.87 -41.02 15.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.18 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 39.7 m -158.91 140.07 13.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.902 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 430' ' ' ALA . . . . . 0.612 ' HB3' HD13 ' A' ' 418' ' ' LEU . . . -149.36 132.11 15.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.122 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -157.28 135.3 10.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.933 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 85.3 t -91.98 146.85 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.124 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -75.85 142.26 42.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.889 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.403 ' C ' ' HE2' ' A' ' 442' ' ' LYS . 41.4 mt -132.01 148.8 32.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.137 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -83.11 144.03 30.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.891 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 40.8 mttp -95.38 5.79 50.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -113.18 -45.23 3.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.87 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 76.9 p -99.27 -28.32 13.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.137 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 52.8 t30 72.66 33.79 1.3 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.919 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 17.0 mt -116.67 114.42 24.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -42.65 117.46 1.04 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.912 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.452 ' HG2' ' CZ ' ' A' ' 444' ' ' PHE . 0.5 OUTLIER -53.72 -175.49 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 27.8 p -101.91 36.39 2.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.913 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 444' ' ' PHE . . . . . 0.452 ' CZ ' ' HG2' ' A' ' 442' ' ' LYS . 1.2 p90 -161.99 150.74 15.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.919 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -141.98 176.27 22.15 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.544 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 446' ' ' PHE . . . . . 0.521 ' O ' HG23 ' A' ' 447' ' ' VAL . 39.8 t80 -117.03 156.81 26.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.948 0.404 . . . . 0.0 110.847 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 447' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 446' ' ' PHE . 76.2 t -161.03 153.9 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.109 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 448' ' ' SER . . . . . 0.418 ' N ' HG12 ' A' ' 447' ' ' VAL . 3.2 m -151.57 142.39 22.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.865 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 449' ' ' TYR . . . . . 0.495 ' CE1' HD12 ' A' ' 403' ' ' LEU . 3.2 m-85 -107.01 -177.66 3.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.66 -17.19 56.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.838 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 451' ' ' ASN . . . . . 0.474 ' N ' ' OD1' ' A' ' 451' ' ' ASN . 3.7 p-10 -154.34 156.9 32.15 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.595 0.712 . . . . 0.0 110.852 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.52 -9.29 18.63 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.635 2.224 . . . . 0.0 112.323 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 99.6 t -83.14 -33.76 10.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.099 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 61.3 m -83.6 -38.71 21.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -54.92 -29.13 55.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.112 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -66.81 -49.99 64.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.911 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -38.93 -40.45 0.65 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.047 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 458' ' ' ALA . . . . . 0.559 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -70.32 -61.91 1.59 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.152 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 459' ' ' ILE . . . . . 0.437 ' O ' ' CB ' ' A' ' 463' ' ' ASN . 88.6 mt -42.2 -42.3 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 50.6 mm-40 -42.84 -66.33 0.38 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.917 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 30.2 t -79.63 -54.68 5.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.848 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 462' ' ' MET . . . . . 0.709 ' HB3' HG21 ' A' ' 474' ' ' VAL . 6.9 mmt -40.85 -48.21 3.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.849 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 463' ' ' ASN . . . . . 0.437 ' CB ' ' O ' ' A' ' 459' ' ' ILE . 36.4 t-20 -55.97 107.56 0.36 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.843 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 87.65 22.8 41.74 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.48 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -69.03 114.15 7.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.753 0.311 . . . . 0.0 110.906 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 6.0 tm0? -72.14 104.63 3.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.935 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 467' ' ' ILE . . . . . 0.538 HG23 ' O ' ' A' ' 467' ' ' ILE . 17.3 tt -112.08 122.73 66.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.121 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 66.94 -94.38 0.24 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.488 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.12 -3.17 4.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.917 0.389 . . . . 0.0 110.948 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -125.48 -178.99 4.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.922 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -112.88 163.99 13.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.854 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 472' ' ' LEU . . . . . 0.535 HD23 ' O ' ' A' ' 407' ' ' HIS . 82.1 mt -109.33 155.75 20.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.916 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 26.6 ttmt -129.27 113.25 14.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.912 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 474' ' ' VAL . . . . . 0.709 HG21 ' HB3' ' A' ' 462' ' ' MET . 11.4 t -120.54 135.73 59.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.146 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 -156.99 140.33 15.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.875 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 476' ' ' LEU . . . . . 0.69 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.6 pp -80.96 125.35 30.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.938 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.529 ' HB2' ' CE1' ' A' ' 404' ' ' PHE . 15.3 ttmm -39.54 104.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.902 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 478' ' ' ARG . . . . . 0.488 ' HD3' HD11 ' A' ' 476' ' ' LEU . 9.2 tpt180 -119.53 49.03 1.41 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.812 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 8.0 t -81.6 -45.0 16.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 5.0 ptpt -84.59 44.77 1.07 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.914 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -57.0 -61.87 2.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.907 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -170.48 129.06 0.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 9.6 t -116.73 158.11 24.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.857 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -98.6 176.83 5.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.87 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 3.1 m -85.7 48.55 1.61 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -102.72 -95.21 2.3 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.428 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -46.09 104.32 0.06 OUTLIER 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.736 2.29 . . . . 0.0 112.295 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 21.3 m -95.91 148.09 22.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.908 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 1.9 m -170.47 151.15 3.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.81 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.467 179.985 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.461 -0.255 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 74.2 m -123.86 145.2 49.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.84 0.352 . . . . 0.0 110.874 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 50.5 m -145.3 157.04 44.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.851 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 72.63 82.04 0.33 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.504 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 3.2 t -104.56 159.58 15.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.891 0.377 . . . . 0.0 110.875 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 32.3 t -168.57 121.99 0.86 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.888 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 127.13 114.18 1.85 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.475 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 383' ' ' LEU . . . . . 0.401 HD23 ' H ' ' A' ' 383' ' ' LEU . 1.6 pt? -56.76 141.35 44.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.87 0.367 . . . . 0.0 110.902 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 1.4 m -144.35 137.51 27.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.114 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 17.3 tp60 -72.93 -51.45 18.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.884 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 57.21 52.17 9.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.902 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 387' ' ' SER . . . . . 0.404 ' C ' HD12 ' A' ' 388' ' ' ILE . 4.2 m -104.79 81.16 1.73 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.785 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.568 HG21 ' O ' ' A' ' 427' ' ' VAL . 3.4 mp -115.48 -38.81 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.108 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 38.91 80.03 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.504 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 390' ' ' ALA . . . . . 0.615 ' O ' ' HB3' ' A' ' 430' ' ' ALA . . . -104.94 78.84 1.45 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.87 0.367 . . . . 0.0 111.114 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -121.28 147.92 45.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.105 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 49.91 33.49 20.8 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.485 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.4 t -106.96 154.02 21.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.918 0.39 . . . . 0.0 110.823 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -122.46 47.72 1.88 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.9 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.468 ' O ' ' CB ' ' A' ' 429' ' ' SER . 6.6 ptmm? -120.66 163.81 17.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.91 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -132.01 -177.68 4.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -100.77 -147.2 20.49 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.501 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.77 161.18 36.85 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.669 2.246 . . . . 0.0 112.435 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -59.01 123.1 15.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 113.04 -27.57 9.49 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.576 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 401' ' ' ALA . . . . . 0.487 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.84 127.06 43.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.823 0.344 . . . . 0.0 111.112 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 402' ' ' ASN . . . . . 0.488 ' HB2' ' N ' ' A' ' 477' ' ' LYS . 0.7 OUTLIER -159.02 159.94 35.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.934 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 403' ' ' LEU . . . . . 0.567 HD23 HD11 ' A' ' 459' ' ' ILE . 17.6 mt -156.11 122.66 5.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.904 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 404' ' ' PHE . . . . . 0.482 ' CE1' ' CE1' ' A' ' 446' ' ' PHE . 22.8 m-85 -130.23 110.86 11.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 405' ' ' ILE . . . . . 0.625 ' N ' HD12 ' A' ' 405' ' ' ILE . 3.5 mp -91.1 134.13 30.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.176 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 406' ' ' TYR . . . . . 0.458 ' CD2' ' HD3' ' A' ' 473' ' ' LYS . 84.2 m-85 -126.19 -176.23 3.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.957 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 6.5 m80 42.17 53.9 4.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.411 HD21 HG21 ' A' ' 405' ' ' ILE . 28.1 mt -98.38 143.07 25.64 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.591 0.71 . . . . 0.0 110.937 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.5 164.42 32.47 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.668 2.245 . . . . 0.0 112.397 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -62.78 -37.64 87.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.918 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -58.23 -35.04 71.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.833 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.472 ' CE1' HD11 ' A' ' 467' ' ' ILE . 5.2 m-85 -77.94 115.57 17.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.848 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -109.16 -138.79 8.36 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.474 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 414' ' ' ASP . 0.1 OUTLIER -79.17 -53.72 6.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.761 0.315 . . . . 0.0 110.856 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 415' ' ' GLN . . . . . 0.417 ' O ' ' C ' ' A' ' 416' ' ' ASP . 16.0 mp0 -60.98 -57.82 11.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 416' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 415' ' ' GLN . 70.9 m-20 -36.16 -50.52 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.855 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 417' ' ' LEU . . . . . 0.461 HD11 HG12 ' A' ' 405' ' ' ILE . 36.3 tp -57.74 -50.12 74.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.925 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 418' ' ' LEU . . . . . 0.401 HD13 ' HB3' ' A' ' 390' ' ' ALA . 39.3 tp -56.73 -43.38 80.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -80.71 -10.76 59.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.936 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -82.29 -27.44 32.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.867 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 421' ' ' PHE . . . . . 0.425 ' C ' ' HD2' ' A' ' 423' ' ' PRO . 4.0 m-85 -107.14 -20.32 13.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.855 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.575 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 0.4 OUTLIER -49.44 -46.3 77.96 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.56 0.695 . . . . 0.0 110.883 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 422' ' ' MET . 64.9 Cg_exo -47.96 -41.63 32.56 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.704 2.269 . . . . 0.0 112.376 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 424' ' ' PHE . . . . . 0.431 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 88.0 m-85 -67.27 -35.97 80.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.92 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 173.6 177.9 43.16 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.499 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -66.03 115.26 5.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.846 0.355 . . . . 0.0 110.877 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.568 ' O ' HG21 ' A' ' 388' ' ' ILE . 87.4 t -85.12 131.08 35.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.073 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 53.6 t -83.83 -34.6 10.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.15 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 429' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 0.8 OUTLIER -149.2 143.86 26.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 430' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 390' ' ' ALA . . . -160.91 119.49 2.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.066 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 431' ' ' LYS . . . . . 0.492 ' CG ' ' N ' ' A' ' 432' ' ' VAL . 32.7 tttp -159.47 163.17 35.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.939 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.492 ' N ' ' CG ' ' A' ' 431' ' ' LYS . 55.8 t -114.76 154.44 16.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.136 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 433' ' ' PHE . . . . . 0.563 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.1 m-85 -99.8 143.72 29.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.819 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 21.5 mt -137.85 144.7 30.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.142 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -78.35 133.41 37.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.936 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.59 -6.79 46.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.946 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -98.1 -55.93 2.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.921 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 59.6 p -81.09 -27.11 35.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.152 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 63.61 41.43 7.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.895 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 7.9 mt -140.54 141.32 35.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.927 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 48.6 m -44.25 134.22 5.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.565 ' HB3' ' CE2' ' A' ' 444' ' ' PHE . 36.0 mttt -78.09 9.55 3.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.953 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 16.2 m 68.07 29.61 6.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.879 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 444' ' ' PHE . . . . . 0.565 ' CE2' ' HB3' ' A' ' 442' ' ' LYS . 1.8 p90 -161.94 139.67 8.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.93 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -133.7 172.07 21.76 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.512 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 446' ' ' PHE . . . . . 0.482 ' CE1' ' CE1' ' A' ' 404' ' ' PHE . 23.6 t80 -109.88 153.86 23.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.908 0.385 . . . . 0.0 110.894 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 447' ' ' VAL . . . . . 0.423 HG12 ' N ' ' A' ' 448' ' ' SER . 75.3 t -157.31 153.97 6.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.12 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 448' ' ' SER . . . . . 0.423 ' N ' HG12 ' A' ' 447' ' ' VAL . 2.9 m -154.45 154.97 34.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.928 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 449' ' ' TYR . . . . . 0.46 ' CE1' HD12 ' A' ' 403' ' ' LEU . 4.7 m-85 -118.9 -175.17 2.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -85.05 -8.87 58.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.877 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -160.2 155.11 20.96 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.634 0.731 . . . . 0.0 110.942 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.78 -8.23 19.02 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.648 2.232 . . . . 0.0 112.41 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 60.0 t -82.14 -36.92 14.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.086 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 1.4 t -82.1 -42.01 19.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.855 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -52.36 -41.33 62.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.118 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 9.2 mm100 -58.32 -46.57 85.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.942 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -43.47 -41.21 4.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.112 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 458' ' ' ALA . . . . . 0.431 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -62.99 -68.25 0.35 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 459' ' ' ILE . . . . . 0.567 HD11 HD23 ' A' ' 403' ' ' LEU . 77.5 mt -48.01 -43.28 10.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.086 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 460' ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' ' 459' ' ' ILE . 23.6 mt-30 -37.76 -42.46 0.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 1.9 m -103.78 -56.3 2.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.852 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 462' ' ' MET . . . . . 0.521 ' HB3' HG21 ' A' ' 474' ' ' VAL . 86.2 mmm -42.66 -42.84 3.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.96 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -42.55 100.26 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 83.24 31.35 28.43 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.488 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 465' ' ' PHE . . . . . 0.458 ' N ' ' O ' ' A' ' 462' ' ' MET . 58.3 t80 -64.79 117.12 7.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.787 0.327 . . . . 0.0 110.923 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 44.4 tp60 -74.26 105.39 5.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 467' ' ' ILE . . . . . 0.646 HG23 ' O ' ' A' ' 467' ' ' ILE . 16.4 tt -116.69 113.45 43.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.106 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 71.34 -104.12 1.37 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.465 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 469' ' ' MET . . . . . 0.4 ' O ' ' SD ' ' A' ' 469' ' ' MET . 5.8 tmm? -121.43 5.72 10.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.857 0.36 . . . . 0.0 110.846 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.73 -176.92 4.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.985 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -123.28 164.65 18.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.807 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 472' ' ' LEU . . . . . 0.458 HD12 ' HB3' ' A' ' 465' ' ' PHE . 60.2 mt -106.56 163.82 12.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.918 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 473' ' ' LYS . . . . . 0.458 ' HD3' ' CD2' ' A' ' 406' ' ' TYR . 11.8 tttt -138.43 104.99 5.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.934 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 474' ' ' VAL . . . . . 0.521 HG21 ' HB3' ' A' ' 462' ' ' MET . 5.3 t -110.78 139.07 36.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.092 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -157.22 145.89 19.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.876 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 476' ' ' LEU . . . . . 0.787 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.5 pp -92.08 123.99 35.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.488 ' N ' ' HB2' ' A' ' 402' ' ' ASN . 27.9 tttp -40.66 111.73 0.23 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.844 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -132.0 75.18 1.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 19.1 m -121.01 81.13 1.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.891 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.1 42.17 1.25 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.878 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -63.9 -46.1 86.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.86 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -117.92 136.31 53.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 27.6 m -69.06 -45.36 70.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.849 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 31.3 tttm -84.39 155.0 22.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.907 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 67.0 m -80.41 -48.35 13.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.885 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 135.09 146.15 5.29 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.416 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -77.7 97.65 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.694 2.263 . . . . 0.0 112.325 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 488' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 489' ' ' SER . 1.9 t -152.59 159.72 43.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.844 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 489' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 488' ' ' SER . 2.4 m 35.31 50.0 0.5 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.835 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.497 179.986 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 73.9 p -140.98 130.79 24.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.827 0.346 . . . . 0.0 110.78 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 22.9 t -69.75 140.36 53.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.85 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -87.35 91.06 1.71 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.55 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 3.5 t -117.51 134.07 55.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.886 0.374 . . . . 0.0 110.862 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 19.6 m -57.21 -47.12 82.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.868 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 53.25 62.05 6.36 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.472 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -58.44 169.77 0.84 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.853 0.359 . . . . 0.0 110.936 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 25.6 m -144.28 105.58 4.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.125 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -66.37 -24.21 66.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.952 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -94.05 105.65 17.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.924 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 75.4 m -93.76 81.27 4.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.944 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 49.6 mm -72.87 135.7 27.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.153 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -69.97 110.91 3.53 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.502 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 390' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' A' ' 430' ' ' ALA . . . -73.07 77.47 1.22 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.772 0.32 . . . . 0.0 111.058 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -123.05 141.87 51.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.106 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 40.59 37.66 1.3 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.508 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.4 t -89.62 -25.95 21.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.761 0.315 . . . . 0.0 110.812 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 50.25 43.58 26.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.93 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt -121.68 164.54 17.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.95 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -127.95 177.65 6.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.901 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -104.36 -147.31 16.85 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.535 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.57 151.61 32.81 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.709 2.273 . . . . 0.0 112.313 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -53.41 102.51 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.943 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 135.94 -28.71 2.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.466 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 401' ' ' ALA . . . . . 0.494 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.95 126.7 43.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.779 0.323 . . . . 0.0 111.106 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 402' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.5 OUTLIER -159.04 161.55 36.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.912 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 403' ' ' LEU . . . . . 0.562 HD12 ' CE1' ' A' ' 449' ' ' TYR . 17.9 mt -159.95 117.66 2.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.929 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 404' ' ' PHE . . . . . 0.73 ' CZ ' ' CD1' ' A' ' 446' ' ' PHE . 44.4 m-85 -126.39 115.42 19.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.887 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 405' ' ' ILE . . . . . 0.834 ' N ' HD12 ' A' ' 405' ' ' ILE . 1.2 mp -93.82 127.09 46.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.119 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 406' ' ' TYR . . . . . 0.484 ' CZ ' ' HB3' ' A' ' 404' ' ' PHE . 37.9 m-85 -120.19 151.99 38.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.964 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 407' ' ' HIS . . . . . 0.646 ' O ' HD23 ' A' ' 472' ' ' LEU . 10.6 m80 73.47 54.44 0.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.885 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 26.0 mt -101.58 136.05 19.67 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.6 0.714 . . . . 0.0 110.966 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -47.73 -179.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.729 2.286 . . . . 0.0 112.329 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 35.7 tp60 -91.9 -38.79 12.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.933 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 25.0 pm0 -65.15 -13.19 57.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.881 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -80.29 135.49 36.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.901 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -116.41 -151.86 9.69 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.451 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.18 -56.53 4.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.736 0.303 . . . . 0.0 110.873 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 415' ' ' GLN . . . . . 0.453 ' O ' ' C ' ' A' ' 416' ' ' ASP . 9.2 mm-40 -56.88 -55.98 27.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.9 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 416' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 415' ' ' GLN . 63.6 m-20 -34.41 -59.06 0.46 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.845 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 417' ' ' LEU . . . . . 0.402 HD11 HG12 ' A' ' 405' ' ' ILE . 39.1 tp -46.64 -49.02 19.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 418' ' ' LEU . . . . . 0.464 ' HB3' ' NE2' ' A' ' 419' ' ' GLN . 52.2 tp -55.27 -55.33 32.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.916 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 419' ' ' GLN . . . . . 0.464 ' NE2' ' HB3' ' A' ' 418' ' ' LEU . 6.9 mp0 -60.45 -17.6 45.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.923 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 3.8 ttm -86.55 -26.48 24.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 421' ' ' PHE . . . . . 0.55 ' CZ ' HG12 ' A' ' 405' ' ' ILE . 10.8 m-85 -105.93 -10.14 16.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.9 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.592 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 4.3 mtt -59.64 -45.59 98.6 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.581 0.705 . . . . 0.0 110.923 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.9 Cg_exo -47.98 -37.9 30.51 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.628 2.219 . . . . 0.0 112.362 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 424' ' ' PHE . . . . . 0.507 ' CE2' ' HA ' ' A' ' 458' ' ' ALA . 86.8 m-85 -67.19 -34.94 78.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.934 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 171.67 -156.82 26.66 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.488 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -92.0 92.77 8.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.841 0.353 . . . . 0.0 110.886 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.518 HG11 ' HB2' ' A' ' 430' ' ' ALA . 54.3 t -65.67 116.93 5.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.1 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 71.2 t -64.5 -43.18 96.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.126 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 429' ' ' SER . . . . . 0.435 ' O ' ' CG1' ' A' ' 427' ' ' VAL . 93.2 p -137.34 146.83 45.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.82 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 430' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 390' ' ' ALA . . . -161.3 110.29 1.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.076 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 431' ' ' LYS . . . . . 0.418 ' C ' ' HD2' ' A' ' 431' ' ' LYS . 1.1 tmmm? -157.36 144.4 18.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.924 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 52.7 t -96.25 137.01 25.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.147 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 433' ' ' PHE . . . . . 0.403 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.2 m-85 -77.82 151.47 33.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.46 HG23 ' C ' ' A' ' 440' ' ' LEU . 45.8 mt -123.36 152.36 28.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.168 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -84.73 132.2 34.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.937 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt -75.01 -11.82 60.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.92 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 6.1 mm100 -95.59 -55.39 3.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.842 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 22.1 p -79.61 -32.13 41.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.125 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 38.2 t30 71.66 31.96 2.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.857 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.46 ' C ' HG23 ' A' ' 434' ' ' ILE . 10.1 mt -129.84 141.34 50.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 8.8 m -42.73 110.97 0.21 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.84 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.563 ' HD3' ' CE2' ' A' ' 444' ' ' PHE . 15.8 mttm -55.36 -174.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.902 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 443' ' ' CYS . . . . . 0.482 ' O ' ' N ' ' A' ' 407' ' ' HIS . 31.4 p -103.03 35.52 2.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.973 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 444' ' ' PHE . . . . . 0.563 ' CE2' ' HD3' ' A' ' 442' ' ' LYS . 12.0 p90 -162.2 141.5 9.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.852 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -132.65 171.16 21.73 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.454 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 446' ' ' PHE . . . . . 0.73 ' CD1' ' CZ ' ' A' ' 404' ' ' PHE . 30.6 t80 -111.24 153.16 26.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.911 0.386 . . . . 0.0 110.822 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 447' ' ' VAL . . . . . 0.467 HG13 ' CG1' ' A' ' 427' ' ' VAL . 59.5 t -159.06 146.64 7.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.099 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 1.2 t -148.74 148.89 30.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.835 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 449' ' ' TYR . . . . . 0.562 ' CE1' HD12 ' A' ' 403' ' ' LEU . 8.6 m-85 -112.11 -174.9 2.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.98 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -80.58 -21.21 41.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.904 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -152.99 155.73 32.25 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.613 0.72 . . . . 0.0 110.943 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 452' ' ' PRO . . . . . 0.452 ' N ' ' HB2' ' A' ' 401' ' ' ALA . 60.5 Cg_endo -74.28 -2.27 12.12 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.731 2.287 . . . . 0.0 112.356 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 93.2 t -86.19 -34.25 7.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.08 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 14.0 m -87.39 -39.65 15.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.823 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -52.99 -30.72 36.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.041 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -64.48 -45.95 85.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.876 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -40.31 -44.32 1.9 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.164 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 458' ' ' ALA . . . . . 0.507 ' HA ' ' CE2' ' A' ' 424' ' ' PHE . . . -61.36 -68.55 0.3 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.108 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 459' ' ' ILE . . . . . 0.428 ' O ' ' CB ' ' A' ' 463' ' ' ASN . 86.9 mt -43.04 -45.75 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.174 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 24.3 mm100 -39.34 -46.51 1.61 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.933 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 32.5 t -103.19 -56.56 2.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.883 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 462' ' ' MET . . . . . 0.501 ' HB3' HG21 ' A' ' 474' ' ' VAL . 86.6 mmm -42.65 -43.26 3.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.892 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 463' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' A' ' 459' ' ' ILE . 14.4 t30 -44.74 110.19 0.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.866 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 74.38 33.33 56.62 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.59 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 465' ' ' PHE . . . . . 0.593 ' HB3' HD12 ' A' ' 472' ' ' LEU . 9.9 t80 -67.51 113.22 5.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.753 0.311 . . . . 0.0 110.913 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -70.36 109.18 4.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.904 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.7 tt -125.01 134.94 65.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.087 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 58.6 -102.33 0.26 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.434 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -124.33 -9.24 7.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.821 0.344 . . . . 0.0 110.878 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 8.9 pttm -120.57 179.2 4.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.88 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -112.09 164.37 13.24 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.909 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 472' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 407' ' ' HIS . 78.5 mt -107.0 158.39 17.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.886 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -131.97 102.52 5.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.825 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 474' ' ' VAL . . . . . 0.501 HG21 ' HB3' ' A' ' 462' ' ' MET . 15.3 t -110.18 125.54 67.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.138 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 39.9 tp60 -152.11 144.67 24.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 476' ' ' LEU . . . . . 0.617 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.6 pp -84.98 129.11 34.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.869 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.475 ' C ' ' O ' ' A' ' 476' ' ' LEU . 4.4 tptm -32.38 -70.82 0.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.892 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 478' ' ' ARG . . . . . 0.585 ' N ' HD12 ' A' ' 476' ' ' LEU . 0.4 OUTLIER -151.23 142.1 22.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.878 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 479' ' ' SER . . . . . 0.443 ' N ' HD11 ' A' ' 476' ' ' LEU . 57.9 p -101.48 -52.81 3.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.875 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 31.1 pttt -125.57 93.03 3.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.955 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -143.91 109.86 5.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.922 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -170.88 130.56 0.8 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.86 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 4.6 t -54.7 170.34 0.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.929 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 14.2 tptp -124.64 -54.5 1.65 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 49.4 m 64.04 42.55 5.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.872 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -144.47 68.58 0.42 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.499 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.15 -3.52 13.82 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.63 2.22 . . . . 0.0 112.286 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 33.4 m -108.8 106.05 15.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.843 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 2.5 m -89.36 82.06 6.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.861 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.455 179.933 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 37.9 m -146.58 176.83 9.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.905 0.383 . . . . 0.0 110.845 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 31.6 p -127.2 90.84 3.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.885 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 52.04 90.18 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.51 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 88.9 p -67.98 104.22 1.68 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.924 0.392 . . . . 0.0 110.856 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 80.0 p -46.2 165.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.904 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 53.28 82.73 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.475 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 4.3 pp -62.49 158.13 18.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.934 0.397 . . . . 0.0 110.848 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 54.7 p -127.71 100.62 6.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.099 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -85.67 41.06 0.88 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -117.33 39.93 3.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.898 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 4.6 m -82.25 43.5 0.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.839 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 60.2 mt -39.27 133.65 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.109 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -130.87 47.46 1.02 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.45 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -98.46 -56.87 2.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.835 0.35 . . . . 0.0 111.108 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -38.77 127.52 1.55 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.075 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 86.98 -39.78 3.09 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.493 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 10.7 t -53.93 120.69 6.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.779 0.323 . . . . 0.0 110.901 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -92.11 26.46 2.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.883 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.497 ' O ' ' CB ' ' A' ' 429' ' ' SER . 26.6 mtpt -72.96 172.53 10.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.854 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -142.79 179.44 7.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.946 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -98.54 -147.37 22.04 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.53 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.56 155.77 40.43 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.672 2.248 . . . . 0.0 112.323 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -58.52 100.51 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 136.25 -28.75 2.88 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.479 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 401' ' ' ALA . . . . . 0.669 ' HB2' ' CA ' ' A' ' 452' ' ' PRO . . . -97.88 127.25 43.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.774 0.321 . . . . 0.0 111.151 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 402' ' ' ASN . . . . . 0.493 ' O ' ' CB ' ' A' ' 476' ' ' LEU . 16.9 m-80 -158.64 165.43 34.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.94 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 403' ' ' LEU . . . . . 0.523 HD12 ' CE1' ' A' ' 449' ' ' TYR . 50.7 mt -159.29 108.0 1.84 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.912 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 404' ' ' PHE . . . . . 0.535 ' C ' HD13 ' A' ' 405' ' ' ILE . 26.8 m-85 -109.94 120.32 42.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.87 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 405' ' ' ILE . . . . . 0.773 HD12 HG22 ' A' ' 474' ' ' VAL . 1.8 mm -91.04 133.92 31.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.074 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 406' ' ' TYR . . . . . 0.489 ' CZ ' ' HB3' ' A' ' 404' ' ' PHE . 13.9 m-85 -129.75 147.43 51.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.887 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 407' ' ' HIS . . . . . 0.66 ' O ' HD23 ' A' ' 472' ' ' LEU . 20.2 m80 70.0 52.13 0.4 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.876 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.692 HD21 HG21 ' A' ' 405' ' ' ILE . 32.7 mt -93.65 139.65 22.85 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.585 0.707 . . . . 0.0 110.897 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -47.39 -179.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.64 2.227 . . . . 0.0 112.331 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -98.92 -24.84 14.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.949 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 7.7 pm0 -82.37 -12.75 57.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.461 ' CZ ' HD11 ' A' ' 467' ' ' ILE . 6.3 m-85 -76.55 147.55 37.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.893 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -127.03 -148.7 7.04 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.482 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -81.85 -54.72 5.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.816 0.341 . . . . 0.0 110.903 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 415' ' ' GLN . . . . . 0.466 ' O ' ' N ' ' A' ' 418' ' ' LEU . 7.3 mm100 -58.16 -58.53 8.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.935 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 416' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 415' ' ' GLN . 24.2 m-20 -37.3 -56.46 0.96 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.833 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 417' ' ' LEU . . . . . 0.548 HD11 HG13 ' A' ' 405' ' ' ILE . 48.5 tp -51.99 -37.24 52.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.943 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 418' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' A' ' 415' ' ' GLN . 23.9 tp -70.78 -50.77 32.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -63.88 -13.89 48.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.855 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 2.1 ttm -89.58 -32.79 16.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.943 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 421' ' ' PHE . . . . . 0.45 ' CE1' ' SD ' ' A' ' 462' ' ' MET . 6.2 m-85 -93.18 -17.8 23.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.873 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.58 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 0.4 OUTLIER -57.28 -45.61 99.89 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.503 0.668 . . . . 0.0 110.825 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 422' ' ' MET . 64.7 Cg_exo -47.94 -37.79 29.95 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.68 2.253 . . . . 0.0 112.351 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -71.33 -35.56 71.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.901 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 176.06 -178.62 47.48 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.459 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -76.93 89.33 3.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.839 0.352 . . . . 0.0 110.945 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 70.3 t -56.69 143.57 10.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.112 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 428' ' ' VAL . . . . . 0.418 ' CG2' ' C ' ' A' ' 449' ' ' TYR . 99.4 t -95.25 -38.39 8.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.149 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 429' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 3.5 p -140.76 145.09 35.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.928 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -161.03 113.71 1.93 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.14 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.03 142.75 17.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.919 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 86.8 t -98.99 143.74 12.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.143 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 433' ' ' PHE . . . . . 0.534 ' CG ' ' CE1' ' A' ' 444' ' ' PHE . 3.1 m-85 -84.42 153.7 23.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.634 HG22 ' N ' ' A' ' 435' ' ' ASP . 69.3 mt -130.18 164.74 32.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.128 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 435' ' ' ASP . . . . . 0.634 ' N ' HG22 ' A' ' 434' ' ' ILE . 3.5 m-20 -102.45 151.47 22.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.88 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 16.3 mttp -89.6 -18.42 26.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.928 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -94.3 -52.65 4.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.917 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 438' ' ' THR . . . . . 0.446 ' O ' ' CG ' ' A' ' 439' ' ' ASN . 58.2 p -82.1 -22.03 36.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.115 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 439' ' ' ASN . . . . . 0.465 ' ND2' ' O ' ' A' ' 439' ' ' ASN . 2.2 p-10 49.14 38.32 12.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.87 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.444 ' O ' ' C ' ' A' ' 441' ' ' SER . 57.5 mt -129.22 127.39 41.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.953 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 441' ' ' SER . . . . . 0.444 ' C ' ' O ' ' A' ' 440' ' ' LEU . 7.9 t -34.35 107.29 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.568 ' HD3' ' CE2' ' A' ' 444' ' ' PHE . 39.6 mttt -51.54 -174.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.908 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 24.5 p -110.13 37.91 2.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.903 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 444' ' ' PHE . . . . . 0.568 ' CE2' ' HD3' ' A' ' 442' ' ' LYS . 4.6 p90 -162.15 143.48 10.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.829 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -137.22 179.07 18.46 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.539 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 446' ' ' PHE . . . . . 0.469 ' CD1' ' CZ ' ' A' ' 404' ' ' PHE . 66.0 t80 -122.89 141.1 52.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.906 0.384 . . . . 0.0 110.871 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 447' ' ' VAL . . . . . 0.42 HG13 ' O ' ' A' ' 429' ' ' SER . 84.5 t -146.12 149.44 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.102 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 1.3 t -147.95 144.94 28.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.83 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 449' ' ' TYR . . . . . 0.523 ' CE1' HD12 ' A' ' 403' ' ' LEU . 4.1 m-85 -104.84 -174.83 2.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.874 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -79.63 -22.48 43.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.797 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -147.37 155.46 46.07 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.596 0.712 . . . . 0.0 110.875 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 452' ' ' PRO . . . . . 0.669 ' CA ' ' HB2' ' A' ' 401' ' ' ALA . 59.7 Cg_endo -73.03 -0.36 8.95 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.713 2.275 . . . . 0.0 112.399 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 95.5 t -94.23 -37.05 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.149 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 50.6 m -78.63 -37.69 41.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.8 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -52.13 -30.13 25.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.054 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 456' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' A' ' 457' ' ' ALA . 11.0 mm100 -67.59 -51.59 48.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.855 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 457' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 456' ' ' GLN . . . -36.64 -42.35 0.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.124 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -69.0 -48.23 63.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.119 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 459' ' ' ILE . . . . . 0.443 ' O ' ' CB ' ' A' ' 463' ' ' ASN . 70.5 mt -55.39 -42.85 69.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.148 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -40.97 -53.08 3.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.925 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 27.8 t -93.08 -55.27 3.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.856 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 462' ' ' MET . . . . . 0.573 ' HB3' HG21 ' A' ' 474' ' ' VAL . 6.3 mmt -43.53 -49.7 7.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.905 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 463' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' A' ' 459' ' ' ILE . 18.8 t-20 -48.45 114.7 1.01 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.878 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 65.88 33.86 86.93 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.492 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -75.9 109.04 9.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.795 0.331 . . . . 0.0 110.834 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -62.96 105.88 0.74 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.928 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 467' ' ' ILE . . . . . 0.588 HG23 ' O ' ' A' ' 467' ' ' ILE . 19.2 tt -111.05 116.99 53.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.189 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 65.85 -96.98 0.28 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.537 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 4.0 ttt -123.17 -13.0 7.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.792 0.329 . . . . 0.0 110.806 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 15.3 pttm -117.59 168.65 10.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.887 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -111.29 153.52 25.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.864 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 472' ' ' LEU . . . . . 0.66 HD23 ' O ' ' A' ' 407' ' ' HIS . 14.8 mt -104.21 161.61 13.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.977 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -134.57 104.74 6.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.928 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 474' ' ' VAL . . . . . 0.773 HG22 HD12 ' A' ' 405' ' ' ILE . 30.8 t -109.09 128.33 65.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.135 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -151.84 142.96 23.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.917 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 476' ' ' LEU . . . . . 0.615 ' C ' HD12 ' A' ' 476' ' ' LEU . 1.6 pp -80.13 135.24 36.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.973 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.53 ' HB2' ' CE1' ' A' ' 404' ' ' PHE . 22.8 ttpp -44.81 111.51 0.32 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 26.4 ttm-85 -90.34 86.8 6.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 11.8 t -82.1 104.3 12.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.824 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 12.8 pttp -103.22 40.77 1.34 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.875 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -107.1 87.07 2.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.843 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -117.79 83.73 2.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.907 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 15.1 m -85.2 96.81 9.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.786 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 9.8 tppt? -133.0 117.95 18.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.886 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 91.6 p -60.0 107.03 0.57 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.846 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 96.81 170.68 34.09 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.451 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.99 -42.01 0.34 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.773 2.315 . . . . 0.0 112.323 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 3.7 m 44.03 42.25 4.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.886 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 4.7 m -38.37 154.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.829 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.48 179.988 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 3.4 m -52.48 155.49 2.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.786 0.327 . . . . 0.0 110.906 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 19.9 m -118.02 98.01 6.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.84 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -157.19 87.24 0.12 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.484 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 3.2 t -147.11 123.82 11.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.852 0.358 . . . . 0.0 110.904 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 13.1 t -99.96 89.16 3.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -173.08 92.81 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.494 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 43.8 mt -94.99 115.09 26.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.914 0.388 . . . . 0.0 110.875 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 95.5 m -58.6 -67.17 0.38 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.157 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -130.67 167.09 19.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 40.4 tp60 -116.54 -46.31 2.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.882 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 4.4 t -123.35 94.48 4.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.769 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.593 ' H ' HD12 ' A' ' 388' ' ' ILE . 5.1 mp -74.54 -54.87 13.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 44.14 90.02 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.451 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -100.78 -49.02 4.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.713 0.292 . . . . 0.0 111.06 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -40.47 130.38 2.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.139 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 393' ' ' SER . . . 79.13 -50.2 3.66 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.487 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 393' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 392' ' ' GLY . 1.8 t -36.32 152.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.806 0.336 . . . . 0.0 110.897 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -124.33 48.97 1.85 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.874 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.477 ' O ' ' CB ' ' A' ' 429' ' ' SER . 0.1 OUTLIER -107.07 171.16 7.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.906 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -137.2 179.31 6.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.935 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -94.81 -154.77 31.15 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.546 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.09 151.29 61.31 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.7 2.267 . . . . 0.0 112.294 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -49.58 97.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.913 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 136.43 -24.74 3.19 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.48 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -98.18 126.93 43.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.843 0.354 . . . . 0.0 111.053 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 402' ' ' ASN . . . . . 0.409 ' O ' ' CB ' ' A' ' 476' ' ' LEU . 9.5 m120 -158.97 161.87 36.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 403' ' ' LEU . . . . . 0.637 HD12 ' CE1' ' A' ' 449' ' ' TYR . 47.5 mt -159.24 108.56 1.89 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.931 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 404' ' ' PHE . . . . . 0.489 ' CE1' ' CE1' ' A' ' 446' ' ' PHE . 20.1 m-85 -113.14 112.42 23.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.923 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 405' ' ' ILE . . . . . 0.689 ' N ' HD12 ' A' ' 405' ' ' ILE . 3.0 mp -90.83 137.44 21.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.093 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 406' ' ' TYR . . . . . 0.453 ' CD1' ' HB2' ' A' ' 444' ' ' PHE . 93.6 m-85 -129.47 169.74 14.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 407' ' ' HIS . . . . . 0.469 ' N ' ' O ' ' A' ' 443' ' ' CYS . 22.1 m80 53.95 51.69 14.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.874 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.423 HD21 HG21 ' A' ' 405' ' ' ILE . 25.5 mt -93.9 134.35 26.31 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.594 0.711 . . . . 0.0 110.925 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -48.87 -175.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.659 2.24 . . . . 0.0 112.307 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -88.85 -41.43 12.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.957 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -62.5 -37.4 85.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.898 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -55.35 117.18 3.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.843 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 413' ' ' GLY . . . . . 0.461 ' O ' HG21 ' A' ' 432' ' ' VAL . . . -103.17 -138.45 9.91 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.552 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -89.98 -44.07 10.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.763 0.316 . . . . 0.0 110.871 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 415' ' ' GLN . . . . . 0.423 ' O ' ' N ' ' A' ' 418' ' ' LEU . 22.5 mp0 -70.06 -57.2 5.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 416' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 415' ' ' GLN . 32.9 m-20 -37.36 -56.77 0.95 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.838 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 417' ' ' LEU . . . . . 0.413 HD11 HG12 ' A' ' 405' ' ' ILE . 61.7 tp -52.33 -40.5 61.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.933 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 418' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' A' ' 415' ' ' GLN . 24.6 tp -69.61 -38.63 77.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -73.23 -17.51 61.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 4.8 ttp -88.9 -12.67 41.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.826 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 421' ' ' PHE . . . . . 0.517 ' CZ ' HG12 ' A' ' 405' ' ' ILE . 5.8 m-85 -111.79 -0.01 16.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.868 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.576 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 4.5 mtt -71.82 -45.92 12.17 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.549 0.69 . . . . 0.0 110.848 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.1 Cg_exo -48.02 -36.84 28.81 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.762 2.308 . . . . 0.0 112.327 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 424' ' ' PHE . . . . . 0.501 ' CD1' ' HA ' ' A' ' 458' ' ' ALA . 97.2 m-85 -69.51 -36.02 76.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.833 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 171.7 -161.65 33.87 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.53 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -86.07 105.01 16.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.943 0.401 . . . . 0.0 110.896 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 93.8 t -74.13 130.0 36.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.126 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 76.2 t -85.99 -46.82 16.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.115 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 429' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 13.7 t -130.69 144.67 51.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.841 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -161.05 117.72 2.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.097 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 431' ' ' LYS . . . . . 0.425 ' C ' ' HD2' ' A' ' 431' ' ' LYS . 2.0 tmmm? -161.06 151.44 17.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.461 HG21 ' O ' ' A' ' 413' ' ' GLY . 82.0 t -108.62 137.96 37.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.138 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 433' ' ' PHE . . . . . 0.547 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.1 m-85 -79.51 153.0 29.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.544 HG22 ' N ' ' A' ' 435' ' ' ASP . 73.0 mt -131.11 159.91 42.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.152 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 435' ' ' ASP . . . . . 0.544 ' N ' HG22 ' A' ' 434' ' ' ILE . 4.1 m-20 -92.34 150.82 20.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.872 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -95.81 -17.17 21.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.95 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -95.39 -40.52 9.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 438' ' ' THR . . . . . 0.47 ' HB ' HD12 ' A' ' 440' ' ' LEU . 73.3 p -96.3 -25.54 15.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.126 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 31.3 m120 55.1 42.26 30.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.878 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.47 HD12 ' HB ' ' A' ' 438' ' ' THR . 15.3 mt -128.99 123.55 32.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.925 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 441' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 440' ' ' LEU . 4.9 p -34.88 103.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.858 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.566 ' HD3' ' CE2' ' A' ' 444' ' ' PHE . 34.6 mttt -51.92 -174.9 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.844 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 443' ' ' CYS . . . . . 0.469 ' O ' ' N ' ' A' ' 407' ' ' HIS . 23.0 p -112.93 40.62 2.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.914 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 444' ' ' PHE . . . . . 0.566 ' CE2' ' HD3' ' A' ' 442' ' ' LYS . 6.0 p90 -161.97 138.42 8.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.88 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -136.2 175.46 20.9 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.475 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 446' ' ' PHE . . . . . 0.489 ' CE1' ' CE1' ' A' ' 404' ' ' PHE . 32.9 t80 -116.03 145.53 42.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.895 0.379 . . . . 0.0 110.857 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 69.3 t -151.44 151.31 12.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.117 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 3.8 m -148.0 153.53 39.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.866 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 449' ' ' TYR . . . . . 0.637 ' CE1' HD12 ' A' ' 403' ' ' LEU . 4.5 m-85 -115.01 -174.83 2.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.903 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -81.72 -17.54 47.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.869 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -156.44 154.71 27.64 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.672 0.748 . . . . 0.0 110.857 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.44 -6.14 18.29 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.723 2.282 . . . . 0.0 112.343 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 86.1 t -85.25 -33.39 7.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.063 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 61.7 m -85.76 -35.87 20.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.812 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -57.29 -23.8 50.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.095 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -67.33 -53.54 28.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.955 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -40.23 -43.29 1.66 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.152 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 458' ' ' ALA . . . . . 0.501 ' HA ' ' CD1' ' A' ' 424' ' ' PHE . . . -62.52 -52.29 64.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.124 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 55.5 mt -57.14 -44.16 82.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.132 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -40.94 -55.85 2.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 1.9 m -89.04 -56.1 3.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 462' ' ' MET . . . . . 0.448 ' O ' ' N ' ' A' ' 465' ' ' PHE . 11.1 mmt -40.96 -63.7 0.64 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.86 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 463' ' ' ASN . . . . . 0.438 ' C ' ' O ' ' A' ' 462' ' ' MET . 37.9 t-20 -35.6 110.92 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.87 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 464' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 472' ' ' LEU . . . 67.86 38.43 89.19 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.504 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 465' ' ' PHE . . . . . 0.448 ' N ' ' O ' ' A' ' 462' ' ' MET . 25.0 t80 -78.59 116.06 18.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.826 0.346 . . . . 0.0 110.919 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 18.7 tp60 -63.07 104.28 0.55 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.874 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 467' ' ' ILE . . . . . 0.559 HG23 ' O ' ' A' ' 467' ' ' ILE . 20.0 tt -116.7 118.78 59.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.12 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 64.38 -106.37 1.42 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.449 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -113.31 -11.63 13.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.878 0.37 . . . . 0.0 110.857 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.64 178.41 5.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.864 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -110.1 170.28 8.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.91 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 472' ' ' LEU . . . . . 0.41 ' O ' ' N ' ' A' ' 464' ' ' GLY . 65.6 mt -114.09 150.07 34.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.88 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -124.61 107.93 11.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 33.0 t -119.05 137.14 54.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.149 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 48.0 tp60 -157.04 145.73 19.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.907 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 476' ' ' LEU . . . . . 0.709 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.5 pp -86.0 127.04 34.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.911 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.457 ' HB2' ' CE1' ' A' ' 404' ' ' PHE . 25.5 ttpt -33.79 -72.39 0.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.853 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 478' ' ' ARG . . . . . 0.486 ' C ' ' CD1' ' A' ' 476' ' ' LEU . 8.2 mmt180 -146.35 151.03 36.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.821 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 3.8 t -125.39 76.37 1.55 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.828 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -46.43 -67.06 0.31 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.951 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -166.55 161.2 15.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -61.81 128.16 34.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.838 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 92.5 p -67.69 168.86 10.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.923 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.29 -56.86 3.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.927 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 9.4 t 46.08 40.76 7.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.871 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -76.18 -146.06 1.78 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.469 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -79.73 23.97 0.64 Allowed 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.716 2.277 . . . . 0.0 112.405 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 488' ' ' SER . . . . . 0.449 ' O ' ' C ' ' A' ' 489' ' ' SER . 67.0 m -135.56 138.64 43.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.864 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 489' ' ' SER . . . . . 0.449 ' C ' ' O ' ' A' ' 488' ' ' SER . 68.3 p -34.85 -44.45 0.22 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.828 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.496 -179.97 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.377 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 33.0 m -87.51 145.33 26.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.881 0.372 . . . . 0.0 110.874 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 97.3 p -94.05 42.66 1.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.832 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 87.22 -75.68 2.14 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.417 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 36.3 t -46.49 135.1 8.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.877 0.37 . . . . 0.0 110.789 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 95.0 p -92.07 124.98 36.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.85 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -99.65 -62.1 0.83 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.476 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 383' ' ' LEU . . . . . 0.496 HD13 ' HA ' ' A' ' 383' ' ' LEU . 2.5 mm? -107.29 84.1 1.92 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.896 0.379 . . . . 0.0 110.911 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 15.0 t -118.78 37.83 3.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.143 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -41.94 101.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.892 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -118.72 87.78 2.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.914 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 80.1 p -94.79 89.61 5.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.882 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 41.3 mm -125.27 135.83 62.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.062 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -67.8 86.11 0.16 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.529 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -61.65 -44.31 97.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.808 0.337 . . . . 0.0 111.16 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -44.24 115.32 0.82 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.099 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 111.33 -47.76 1.01 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.474 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 2.2 m -45.81 130.15 9.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.842 0.353 . . . . 0.0 110.828 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -101.41 -12.66 18.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.877 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.418 ' O ' ' CB ' ' A' ' 429' ' ' SER . 6.6 ptmm? -55.48 161.61 1.9 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 396' ' ' GLU . . . . . 0.413 ' CD ' ' O ' ' A' ' 397' ' ' GLY . 2.6 pp20? -126.72 -178.33 4.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.868 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 397' ' ' GLY . . . . . 0.413 ' O ' ' CD ' ' A' ' 396' ' ' GLU . . . -94.06 -146.42 20.14 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.511 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.71 152.05 37.09 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 122.747 2.298 . . . . 0.0 112.368 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -52.83 113.76 1.19 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.905 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 125.76 -28.19 5.0 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.529 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 401' ' ' ALA . . . . . 0.527 ' HB2' ' N ' ' A' ' 452' ' ' PRO . . . -97.93 127.16 43.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.84 0.352 . . . . 0.0 111.09 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 402' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.7 OUTLIER -158.6 160.76 36.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.852 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 403' ' ' LEU . . . . . 0.609 HD12 ' CE1' ' A' ' 449' ' ' TYR . 15.8 mt -156.29 117.76 3.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.909 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 404' ' ' PHE . . . . . 0.467 ' CE1' ' HB2' ' A' ' 477' ' ' LYS . 12.8 m-85 -125.6 113.04 16.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 405' ' ' ILE . . . . . 0.726 ' N ' HD12 ' A' ' 405' ' ' ILE . 1.8 mp -90.77 136.13 24.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.178 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -128.24 169.18 14.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.905 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 407' ' ' HIS . . . . . 0.43 ' N ' ' O ' ' A' ' 443' ' ' CYS . 34.5 m80 54.23 53.44 10.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.874 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.601 HD21 HG21 ' A' ' 405' ' ' ILE . 35.4 mt -94.1 143.62 26.72 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.608 0.718 . . . . 0.0 110.929 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.601 ' HG2' ' CD1' ' A' ' 412' ' ' PHE . 61.4 Cg_endo -78.21 155.73 29.33 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.674 2.249 . . . . 0.0 112.309 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -60.03 -37.22 79.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.919 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -60.19 -19.87 56.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.865 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.601 ' CD1' ' HG2' ' A' ' 409' ' ' PRO . 4.2 m-85 -89.84 125.88 35.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.828 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -114.55 -141.86 7.75 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.475 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.78 -59.02 2.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.75 0.31 . . . . 0.0 110.892 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 415' ' ' GLN . . . . . 0.424 ' O ' ' C ' ' A' ' 416' ' ' ASP . 52.3 mm-40 -57.78 -56.49 21.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.906 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 416' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 415' ' ' GLN . 62.0 m-20 -36.42 -39.4 0.19 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.855 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 24.2 tp -71.33 -53.58 13.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.947 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 418' ' ' LEU . . . . . 0.466 ' O ' ' CG ' ' A' ' 422' ' ' MET . 29.6 tp -54.62 -41.19 69.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.878 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -79.78 -9.95 59.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.01 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -85.19 -35.91 21.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.874 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 421' ' ' PHE . . . . . 0.573 ' CE1' ' SD ' ' A' ' 462' ' ' MET . 5.3 m-85 -98.38 -22.28 16.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.579 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 0.7 OUTLIER -50.35 -45.84 83.75 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.581 0.705 . . . . 0.0 110.889 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.4 Cg_exo -47.99 -41.79 32.62 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.627 2.218 . . . . 0.0 112.344 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -67.15 -34.39 77.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.902 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 170.5 -178.98 42.87 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.444 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -66.51 124.75 23.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.83 0.347 . . . . 0.0 110.877 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 58.7 t -98.08 118.53 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.143 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 40.5 t -61.98 -51.68 69.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.194 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 429' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 3.3 m -143.77 148.76 36.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.825 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -156.82 131.26 8.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.07 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 431' ' ' LYS . . . . . 0.476 ' CG ' ' N ' ' A' ' 432' ' ' VAL . 14.9 tttm -159.06 162.42 36.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.476 ' N ' ' CG ' ' A' ' 431' ' ' LYS . 69.6 t -121.32 144.41 30.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.145 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 433' ' ' PHE . . . . . 0.646 ' CG ' ' CE1' ' A' ' 444' ' ' PHE . 4.4 m-85 -86.36 147.89 25.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.917 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 76.1 mt -119.3 138.22 50.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.116 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 435' ' ' ASP . . . . . 0.493 ' O ' ' N ' ' A' ' 439' ' ' ASN . 9.3 t0 -83.34 101.36 11.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 436' ' ' LYS . . . . . 0.405 ' HG3' ' N ' ' A' ' 437' ' ' GLN . 0.0 OUTLIER -50.8 -33.16 22.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.857 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 437' ' ' GLN . . . . . 0.405 ' N ' ' HG3' ' A' ' 436' ' ' LYS . 19.9 mm-40 -51.24 -42.12 60.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 438' ' ' THR . . . . . 0.404 ' O ' ' C ' ' A' ' 439' ' ' ASN . 17.8 p -129.27 18.33 5.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.181 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 439' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 435' ' ' ASP . 6.2 m120 37.71 38.54 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 20.4 mt -118.5 130.14 55.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.859 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 8.6 t -41.42 116.89 0.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.548 ' HD3' ' CE2' ' A' ' 444' ' ' PHE . 26.4 mttt -59.3 -174.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 443' ' ' CYS . . . . . 0.43 ' O ' ' N ' ' A' ' 407' ' ' HIS . 60.7 m -106.83 37.99 2.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.843 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 444' ' ' PHE . . . . . 0.646 ' CE1' ' CG ' ' A' ' 433' ' ' PHE . 12.0 p90 -162.13 148.34 13.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -143.77 178.44 21.85 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.485 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 446' ' ' PHE . . . . . 0.543 ' O ' HG23 ' A' ' 447' ' ' VAL . 26.1 t80 -117.45 155.01 30.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.949 0.404 . . . . 0.0 110.83 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 447' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 446' ' ' PHE . 71.4 t -161.35 150.57 4.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.126 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 84.6 p -149.69 141.81 24.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 449' ' ' TYR . . . . . 0.609 ' CE1' HD12 ' A' ' 403' ' ' LEU . 4.7 m-85 -106.07 -176.01 2.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.917 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.75 -10.57 59.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.883 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -166.91 160.36 11.23 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.592 0.71 . . . . 0.0 110.897 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 452' ' ' PRO . . . . . 0.527 ' N ' ' HB2' ' A' ' 401' ' ' ALA . 60.4 Cg_endo -74.76 -2.12 12.06 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.724 2.282 . . . . 0.0 112.316 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 92.8 t -85.11 -44.03 17.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.112 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 7.4 t -78.57 -34.8 46.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.838 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -59.35 -20.1 51.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.111 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 456' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' A' ' 457' ' ' ALA . 35.2 mm-40 -77.82 -53.92 6.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.936 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 457' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 456' ' ' GLN . . . -37.74 -44.42 0.73 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.11 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -64.58 -52.41 57.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.093 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 91.2 mt -52.8 -45.81 50.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.106 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -38.49 -58.52 1.02 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.863 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 30.0 t -87.71 -55.69 3.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 462' ' ' MET . . . . . 0.746 ' HB3' HG21 ' A' ' 474' ' ' VAL . 8.6 mmt -39.02 -57.54 1.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.876 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -47.1 114.26 0.82 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 75.93 29.69 58.66 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.493 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -73.47 126.45 30.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.837 0.351 . . . . 0.0 110.886 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 25.3 tm0? -69.96 104.67 2.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.928 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 16.8 tt -119.98 138.41 50.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.148 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 46.68 -95.48 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.518 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 8.8 ptp -134.21 5.03 3.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.903 0.382 . . . . 0.0 110.932 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 15.4 pttm -130.7 174.36 10.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.958 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 42.6 mtm-85 -106.73 145.6 31.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.892 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 27.2 mt -89.26 149.43 23.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.925 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 27.6 ttpt -125.63 103.8 8.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.858 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 474' ' ' VAL . . . . . 0.746 HG21 ' HB3' ' A' ' 462' ' ' MET . 2.8 t -110.04 137.63 41.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.141 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -157.05 145.74 19.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.93 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 476' ' ' LEU . . . . . 0.784 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.5 pp -91.41 124.84 35.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.942 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.467 ' HB2' ' CE1' ' A' ' 404' ' ' PHE . 13.9 tttm -34.97 105.18 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.948 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -90.07 148.98 22.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 51.7 m -136.89 162.57 32.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.828 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 36.1 tttm -63.46 -60.48 3.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.86 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -106.88 88.5 2.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.932 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -109.06 -53.06 2.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.867 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 3.6 t -97.92 -49.88 4.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.829 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -72.43 174.55 7.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.873 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 88.4 p -123.76 148.2 46.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.844 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -170.42 76.52 0.1 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.504 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -45.57 162.22 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.651 2.234 . . . . 0.0 112.403 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 5.7 t -50.22 124.52 10.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.831 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 74.5 p -73.26 141.11 47.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.888 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.451 -179.97 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.506 -0.237 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 26.3 p -83.39 121.76 27.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.96 0.409 . . . . 0.0 110.843 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 12.4 t -104.58 85.92 2.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.818 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 82.25 -130.33 9.63 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.453 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 1.6 t 58.78 40.86 22.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.837 0.351 . . . . 0.0 110.846 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 73.7 m -118.67 121.26 39.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.832 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 108.98 91.6 2.17 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.468 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 383' ' ' LEU . . . . . 0.641 HD23 ' H ' ' A' ' 383' ' ' LEU . 1.4 pt? -72.44 159.46 33.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.867 0.365 . . . . 0.0 110.896 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 9.0 t -170.77 132.45 0.9 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.195 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -148.76 152.81 37.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.936 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 386' ' ' GLN . . . . . 0.418 ' CD ' ' N ' ' A' ' 386' ' ' GLN . 2.9 mp0 -65.04 110.28 2.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.941 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 32.8 p -83.06 40.58 0.71 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.856 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 31.0 mt -108.99 99.91 9.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.117 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -71.08 117.74 7.01 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.477 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -90.15 -26.6 20.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.821 0.343 . . . . 0.0 111.089 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -43.62 119.27 1.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.052 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 393' ' ' SER . . . 94.63 -45.07 2.19 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.505 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 393' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 392' ' ' GLY . 5.3 p -35.87 126.42 0.71 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.866 0.365 . . . . 0.0 110.856 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -107.36 50.78 0.76 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.886 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.43 177.12 4.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.933 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -136.29 -176.64 4.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -107.03 -143.17 10.96 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.459 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.13 151.89 44.74 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.666 2.244 . . . . 0.0 112.282 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -55.7 100.71 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.964 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 135.92 -25.78 3.19 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.486 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 401' ' ' ALA . . . . . 0.423 ' HB2' ' N ' ' A' ' 452' ' ' PRO . . . -98.75 127.05 44.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.806 0.336 . . . . 0.0 111.103 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -158.86 167.89 28.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.93 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 403' ' ' LEU . . . . . 0.416 ' CD1' ' CE1' ' A' ' 449' ' ' TYR . 53.0 mt -158.66 124.6 4.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 404' ' ' PHE . . . . . 0.421 ' CZ ' ' HD3' ' A' ' 477' ' ' LYS . 28.8 m-85 -130.07 111.02 12.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.911 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 405' ' ' ILE . . . . . 0.627 ' N ' HD12 ' A' ' 405' ' ' ILE . 3.2 mp -91.68 132.31 36.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.131 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -122.21 158.1 30.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.903 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 407' ' ' HIS . . . . . 0.491 ' O ' ' CD2' ' A' ' 472' ' ' LEU . 53.8 m-70 67.06 55.03 0.72 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.848 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 37.4 mt -100.97 129.9 26.26 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.691 0.757 . . . . 0.0 110.898 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -48.11 -178.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.681 2.254 . . . . 0.0 112.32 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -87.74 -41.93 12.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.935 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -59.9 -36.27 76.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.927 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -57.56 128.98 39.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.88 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 413' ' ' GLY . . . . . 0.455 ' O ' HG21 ' A' ' 432' ' ' VAL . . . -116.08 -138.11 6.29 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.515 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -90.54 -59.22 2.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.732 0.301 . . . . 0.0 110.746 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -51.46 -53.25 39.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.821 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -42.46 -61.74 1.14 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.86 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 33.2 tp -42.44 -49.78 5.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.934 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 418' ' ' LEU . . . . . 0.408 ' CD1' ' HB ' ' A' ' 427' ' ' VAL . 52.9 tp -55.19 -58.67 6.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.949 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 419' ' ' GLN . . . . . 0.49 ' OE1' ' N ' ' A' ' 419' ' ' GLN . 0.8 OUTLIER -57.75 -21.36 40.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.913 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 4.2 ttm -82.21 -29.47 31.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.857 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 421' ' ' PHE . . . . . 0.528 ' CZ ' HG12 ' A' ' 405' ' ' ILE . 3.8 m-85 -106.9 4.29 27.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.856 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.588 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 17.5 mtt -73.14 -45.64 8.13 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.588 0.709 . . . . 0.0 110.946 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.7 Cg_exo -47.97 -45.72 24.08 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.673 2.249 . . . . 0.0 112.36 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -61.46 -25.32 67.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 160.21 -177.61 36.59 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.469 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -73.78 100.12 3.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.874 0.369 . . . . 0.0 110.867 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.554 HG11 ' HB2' ' A' ' 430' ' ' ALA . 54.2 t -67.0 122.82 18.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.142 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 76.7 t -75.25 -35.97 35.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.103 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -144.74 143.91 30.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.828 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 430' ' ' ALA . . . . . 0.554 ' HB2' HG11 ' A' ' 427' ' ' VAL . . . -161.08 114.77 2.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.064 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 431' ' ' LYS . . . . . 0.419 ' C ' ' HD2' ' A' ' 431' ' ' LYS . 3.8 tmmm? -160.92 141.54 11.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.455 HG21 ' O ' ' A' ' 413' ' ' GLY . 58.6 t -90.8 139.5 17.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.192 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -82.43 153.21 25.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.636 HG22 ' N ' ' A' ' 435' ' ' ASP . 67.1 mt -128.01 164.48 29.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.141 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 435' ' ' ASP . . . . . 0.636 ' N ' HG22 ' A' ' 434' ' ' ILE . 5.1 m-20 -98.09 152.1 19.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.91 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.08 -16.73 22.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.855 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 35.6 tp60 -96.04 -41.95 8.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.928 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 70.1 p -95.26 -25.36 16.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.105 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 34.8 m-20 56.76 33.6 23.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.86 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.436 ' O ' ' C ' ' A' ' 441' ' ' SER . 23.7 mt -121.01 126.67 50.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.944 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 441' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 440' ' ' LEU . 1.5 m -35.39 102.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.839 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.563 ' HD3' ' CE2' ' A' ' 444' ' ' PHE . 25.2 mttm -47.38 174.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.837 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 443' ' ' CYS . . . . . 0.434 ' O ' ' N ' ' A' ' 407' ' ' HIS . 27.3 p -100.28 34.99 2.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.917 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 444' ' ' PHE . . . . . 0.563 ' CE2' ' HD3' ' A' ' 442' ' ' LYS . 7.4 p90 -162.07 147.03 12.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.86 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -135.35 178.71 18.39 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.525 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 446' ' ' PHE . . . . . 0.437 ' O ' HG23 ' A' ' 447' ' ' VAL . 28.4 t80 -117.33 154.57 31.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.863 0.363 . . . . 0.0 110.883 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 447' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 448' ' ' SER . 72.2 t -158.53 155.96 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.116 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 448' ' ' SER . . . . . 0.467 ' N ' HG12 ' A' ' 447' ' ' VAL . 3.8 m -154.38 154.06 32.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.828 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 449' ' ' TYR . . . . . 0.416 ' CE1' ' CD1' ' A' ' 403' ' ' LEU . 4.4 m-85 -118.43 -175.25 2.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.899 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.25 -12.53 59.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.86 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -157.61 156.36 28.59 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-O 121.659 0.742 . . . . 0.0 110.846 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 452' ' ' PRO . . . . . 0.423 ' N ' ' HB2' ' A' ' 401' ' ' ALA . 61.1 Cg_endo -75.45 0.21 9.36 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.648 2.232 . . . . 0.0 112.332 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 99.2 t -90.04 -38.84 11.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.134 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 31.2 m -79.34 -38.5 34.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.828 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -51.15 -42.92 61.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.069 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 456' ' ' GLN . . . . . 0.414 ' O ' ' C ' ' A' ' 457' ' ' ALA . 11.6 mm100 -59.73 -51.27 70.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.917 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 457' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 456' ' ' GLN . . . -36.52 -41.94 0.32 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.083 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -64.43 -69.75 0.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.057 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 459' ' ' ILE . . . . . 0.548 HG12 HG12 ' A' ' 474' ' ' VAL . 82.5 mt -43.55 -42.56 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.119 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -39.68 -45.73 1.73 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 30.0 t -100.71 -56.29 2.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 462' ' ' MET . . . . . 0.52 ' HB3' HG21 ' A' ' 474' ' ' VAL . 87.9 mmm -43.36 -33.15 0.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.881 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -53.01 103.14 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.873 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 83.49 30.77 29.26 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.565 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 465' ' ' PHE . . . . . 0.578 ' HB3' HD12 ' A' ' 472' ' ' LEU . 26.5 t80 -67.67 110.4 3.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.783 0.325 . . . . 0.0 110.886 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 9.8 tm0? -66.03 107.16 1.8 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.908 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 467' ' ' ILE . . . . . 0.432 HG21 HD21 ' A' ' 472' ' ' LEU . 17.0 tt -120.52 138.04 52.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.056 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 53.29 -96.44 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.449 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 2.4 ttt -131.89 -1.09 3.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.883 0.373 . . . . 0.0 110.895 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.35 174.68 8.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.891 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 54.5 mtm180 -105.22 172.64 6.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.84 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 472' ' ' LEU . . . . . 0.578 HD12 ' HB3' ' A' ' 465' ' ' PHE . 82.2 mt -121.24 156.09 33.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.95 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -134.13 108.45 8.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.863 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 474' ' ' VAL . . . . . 0.548 HG12 HG12 ' A' ' 459' ' ' ILE . 8.6 t -110.04 133.84 54.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.165 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 475' ' ' GLN . . . . . 0.444 ' HA ' HD13 ' A' ' 459' ' ' ILE . 26.1 mt-30 -156.97 139.1 14.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.946 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 476' ' ' LEU . . . . . 0.625 ' C ' HD12 ' A' ' 476' ' ' LEU . 1.6 pp -81.1 136.92 35.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.925 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.462 ' O ' HD12 ' A' ' 476' ' ' LEU . 21.7 tptt -34.01 107.48 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -97.3 179.34 4.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 45.4 m 59.27 48.69 9.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -72.52 89.64 1.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.978 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -61.81 138.71 58.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.934 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 11.5 t70 66.62 45.19 2.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.895 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 77.4 p -89.74 -42.49 11.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.882 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 45.4 pttt -112.85 136.74 52.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.95 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 2.9 m -131.7 130.48 42.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.835 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -176.21 97.45 0.11 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.431 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -43.31 167.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.666 2.244 . . . . 0.0 112.349 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 3.5 m -55.23 -66.39 0.42 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 4.1 p -131.86 65.84 1.56 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.837 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.388 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.507 179.96 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 11.2 m -82.0 169.69 16.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.844 0.354 . . . . 0.0 110.875 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 29.3 m -47.46 168.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -164.61 57.44 0.26 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.445 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 27.4 m -116.45 102.5 9.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.894 0.378 . . . . 0.0 110.836 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 3.3 m -98.4 138.07 36.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.903 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -104.8 106.88 2.79 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.492 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 6.5 mp -121.53 126.64 49.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.938 0.399 . . . . 0.0 110.871 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 45.8 p -133.42 172.39 12.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.165 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -77.91 -57.79 3.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.987 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -141.92 124.09 15.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.959 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 7.0 m -122.05 45.59 2.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.864 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 64.6 mt -108.65 -47.28 7.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.124 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 43.9 67.94 0.95 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.513 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -72.69 -49.82 28.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.834 0.35 . . . . 0.0 111.141 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -39.92 119.93 1.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.091 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 81.13 53.95 3.74 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.51 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 3.2 m -140.16 135.97 33.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.817 0.341 . . . . 0.0 110.874 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -103.46 33.73 3.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.001 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm -98.27 160.4 14.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.42 -176.76 3.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.946 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -110.73 -154.42 13.73 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.47 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -48.06 176.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.717 2.278 . . . . 0.0 112.263 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 399' ' ' GLU . . . . . 0.441 ' CD ' ' O ' ' A' ' 399' ' ' GLU . 0.2 OUTLIER -83.24 83.58 7.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.926 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 144.65 -14.77 2.0 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.468 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -98.2 126.5 43.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.815 0.34 . . . . 0.0 111.145 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 402' ' ' ASN . . . . . 0.404 ' O ' ' CB ' ' A' ' 476' ' ' LEU . 10.9 m120 -159.41 162.45 35.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 403' ' ' LEU . . . . . 0.595 HD23 HD11 ' A' ' 459' ' ' ILE . 28.6 mt -159.78 109.18 1.82 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 404' ' ' PHE . . . . . 0.432 ' CE1' ' CD1' ' A' ' 446' ' ' PHE . 19.2 m-85 -112.63 114.81 27.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 405' ' ' ILE . . . . . 0.805 HG21 HD21 ' A' ' 408' ' ' LEU . 3.9 mp -90.87 135.72 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.113 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 406' ' ' TYR . . . . . 0.426 ' CD1' ' HB2' ' A' ' 444' ' ' PHE . 89.9 m-85 -130.22 168.25 17.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.952 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 32.6 m-70 61.4 48.68 5.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.805 HD21 HG21 ' A' ' 405' ' ' ILE . 38.0 mt -95.71 148.32 34.39 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.592 0.71 . . . . 0.0 110.914 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.598 ' HG2' ' CD1' ' A' ' 412' ' ' PHE . 59.9 Cg_endo -73.35 -169.77 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.699 2.266 . . . . 0.0 112.329 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -95.21 -38.01 10.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.932 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 411' ' ' GLU . . . . . 0.416 ' C ' ' OE1' ' A' ' 411' ' ' GLU . 0.3 OUTLIER -58.37 -32.45 68.58 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.922 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.598 ' CD1' ' HG2' ' A' ' 409' ' ' PRO . 4.1 m-85 -62.01 158.81 15.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -142.82 -140.74 3.76 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.547 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -88.65 -48.83 7.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.738 0.304 . . . . 0.0 110.876 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 415' ' ' GLN . . . . . 0.463 ' O ' ' N ' ' A' ' 418' ' ' LEU . 19.9 mp0 -64.43 -58.23 7.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.963 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 416' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 415' ' ' GLN . 35.9 m-20 -34.43 -56.6 0.52 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.899 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 24.3 tp -53.34 -43.42 67.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 418' ' ' LEU . . . . . 0.463 ' N ' ' O ' ' A' ' 415' ' ' GLN . 11.1 tp -65.04 -51.56 60.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.962 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -69.48 -9.85 55.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.951 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 2.8 ttm -89.79 -25.55 21.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.902 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 421' ' ' PHE . . . . . 0.444 ' CZ ' ' CG1' ' A' ' 405' ' ' ILE . 5.2 m-85 -104.57 -12.16 16.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.937 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.577 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 7.6 mtt -57.38 -46.12 99.83 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.56 0.695 . . . . 0.0 110.823 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 422' ' ' MET . 64.5 Cg_exo -47.94 -39.63 32.48 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.71 2.273 . . . . 0.0 112.31 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 424' ' ' PHE . . . . . 0.574 ' CE2' ' HA ' ' A' ' 458' ' ' ALA . 73.4 m-85 -68.23 -35.67 78.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.905 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 172.16 -173.84 45.29 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.487 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.94 114.56 12.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.86 0.362 . . . . 0.0 110.905 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 98.2 t -84.79 124.4 39.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.153 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 17.1 t -70.93 -54.05 19.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.08 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 14.6 m -148.63 136.57 20.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.859 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -144.35 134.46 24.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.132 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 431' ' ' LYS . . . . . 0.423 ' CG ' ' N ' ' A' ' 432' ' ' VAL . 20.6 tttt -159.97 159.29 32.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.888 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.423 ' N ' ' CG ' ' A' ' 431' ' ' LYS . 38.8 t -111.03 144.64 18.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.165 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 433' ' ' PHE . . . . . 0.554 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 7.5 m-85 -91.98 152.46 20.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.5 HG23 ' C ' ' A' ' 440' ' ' LEU . 64.2 mt -137.6 144.27 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.132 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -84.16 137.18 33.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.867 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.32 -30.0 61.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.881 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -73.28 -49.54 27.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 25.6 p -85.65 -35.13 21.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.172 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 3.2 t30 71.85 31.02 2.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.824 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.5 ' C ' HG23 ' A' ' 434' ' ' ILE . 8.6 mt -135.95 153.08 51.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.893 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 441' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 440' ' ' LEU . 1.5 t -36.81 139.58 0.19 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.845 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.59 ' HB3' ' CE2' ' A' ' 444' ' ' PHE . 16.3 mtpt -86.56 20.29 2.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.852 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 443' ' ' CYS . . . . . 0.407 ' SG ' ' O ' ' A' ' 442' ' ' LYS . 0.9 OUTLIER 52.42 25.13 3.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.819 179.933 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 444' ' ' PHE . . . . . 0.59 ' CE2' ' HB3' ' A' ' 442' ' ' LYS . 1.1 p90 -161.71 145.65 12.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.876 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -139.25 179.16 18.94 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.534 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 446' ' ' PHE . . . . . 0.432 ' CD1' ' CE1' ' A' ' 404' ' ' PHE . 26.7 t80 -116.93 150.59 38.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.888 0.375 . . . . 0.0 110.875 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 21.0 t -153.91 143.15 13.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.117 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 99.8 p -139.05 141.85 38.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.865 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 449' ' ' TYR . . . . . 0.537 ' CE1' HD12 ' A' ' 403' ' ' LEU . 3.2 m-85 -108.92 175.18 5.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.912 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -69.59 -20.21 63.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.821 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -153.95 155.69 31.39 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.687 0.756 . . . . 0.0 110.836 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.91 -15.65 26.28 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.686 2.258 . . . . 0.0 112.319 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 97.3 t -74.74 -43.09 47.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.134 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 1.9 t -75.61 -41.95 53.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.886 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -47.76 -42.78 26.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.153 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -59.16 -46.44 88.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.925 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -37.75 -44.34 0.72 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.1 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 458' ' ' ALA . . . . . 0.574 ' HA ' ' CE2' ' A' ' 424' ' ' PHE . . . -64.28 -69.73 0.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.157 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 459' ' ' ILE . . . . . 0.595 HD11 HD23 ' A' ' 403' ' ' LEU . 93.9 mt -40.33 -47.43 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.167 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 460' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 459' ' ' ILE . 40.7 mt-30 -38.04 -51.7 1.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.89 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 17.4 t -93.94 -54.87 3.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.839 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 462' ' ' MET . . . . . 0.463 ' O ' ' N ' ' A' ' 465' ' ' PHE . 77.5 mmm -43.7 -51.46 7.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.872 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 463' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 462' ' ' MET . 36.7 t-20 -38.17 105.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.921 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 464' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 472' ' ' LEU . . . 78.92 33.59 36.55 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.508 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 465' ' ' PHE . . . . . 0.463 ' N ' ' O ' ' A' ' 462' ' ' MET . 83.2 t80 -73.92 117.97 16.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.81 0.338 . . . . 0.0 110.907 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 5.2 tm0? -66.32 104.55 1.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.953 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 12.4 tt -117.65 139.33 45.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.114 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 49.54 -95.93 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.472 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 6.5 ptp -131.43 0.42 4.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.853 0.359 . . . . 0.0 110.914 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.7 172.93 11.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 48.2 mtt85 -100.91 167.32 10.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.887 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 472' ' ' LEU . . . . . 0.435 ' O ' ' N ' ' A' ' 464' ' ' GLY . 58.5 mt -114.81 152.98 31.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.005 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -130.69 106.62 8.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 474' ' ' VAL . . . . . 0.488 HG12 HG12 ' A' ' 459' ' ' ILE . 15.6 t -112.44 131.88 62.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.121 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -154.4 137.77 15.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 476' ' ' LEU . . . . . 0.626 ' C ' HD12 ' A' ' 476' ' ' LEU . 1.6 pp -79.5 132.84 36.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.856 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 476' ' ' LEU . 55.7 tttt -35.92 102.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.886 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 32.8 ttt-85 -118.25 100.45 7.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.9 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 84.3 p -41.88 146.44 0.27 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.875 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -55.77 -51.87 65.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.861 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -108.87 114.78 28.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.916 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 482' ' ' ASP . . . . . 0.418 ' OD1' ' C ' ' A' ' 482' ' ' ASP . 0.0 OUTLIER -93.03 -49.21 6.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.831 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 2.9 m -134.29 99.61 4.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.773 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 7.2 ptmm? -59.07 121.85 12.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.913 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 29.2 t -129.21 81.49 2.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.87 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 63.32 146.07 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.501 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -46.68 120.87 4.3 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.63 2.22 . . . . 0.0 112.379 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 64.2 p -73.28 145.72 45.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 41.2 p -89.06 123.0 32.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.832 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.261 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.44 -179.957 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.547 -0.221 . . . . 0.0 112.547 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 8.8 t -77.49 129.54 35.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.857 0.36 . . . . 0.0 110.85 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 24.8 p -146.85 140.42 25.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.866 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -125.15 135.19 9.23 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.52 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 5.8 m -115.89 97.71 6.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.834 0.35 . . . . 0.0 110.857 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 8.5 t -104.17 41.08 1.35 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.902 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 382' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 383' ' ' LEU . . . 161.24 -106.28 0.28 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.444 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 383' ' ' LEU . . . . . 0.425 ' C ' ' O ' ' A' ' 382' ' ' GLY . 69.4 mt 36.04 39.37 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.929 0.395 . . . . 0.0 110.982 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 15.1 t -90.83 157.96 17.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.2 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -84.57 127.22 33.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.903 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -84.33 178.3 7.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.889 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 387' ' ' SER . . . . . 0.481 ' C ' HD12 ' A' ' 388' ' ' ILE . 78.1 p -105.31 123.02 47.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.844 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.541 ' N ' HD12 ' A' ' 388' ' ' ILE . 3.2 mp -117.62 101.94 12.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.096 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -100.34 48.58 1.18 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.498 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -91.92 -28.43 17.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.812 0.339 . . . . 0.0 111.147 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -56.58 103.44 0.11 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.149 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 98.98 -39.34 2.77 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.442 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 14.9 m -46.92 123.06 4.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.827 0.346 . . . . 0.0 110.841 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -93.57 25.81 3.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.907 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.497 ' O ' ' CB ' ' A' ' 429' ' ' SER . 9.8 ptmt -82.64 163.23 21.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -128.67 -175.73 3.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -100.48 -146.38 19.25 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.468 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.53 151.41 41.99 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.698 2.265 . . . . 0.0 112.314 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -51.46 104.01 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 130.58 -24.85 4.32 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.445 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 401' ' ' ALA . . . . . 0.405 ' HB2' ' N ' ' A' ' 452' ' ' PRO . . . -98.02 126.98 43.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.341 . . . . 0.0 111.098 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 402' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -158.98 164.29 35.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.874 -179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 403' ' ' LEU . . . . . 0.449 HD12 ' CE1' ' A' ' 449' ' ' TYR . 34.5 mt -158.05 124.83 4.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.917 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 404' ' ' PHE . . . . . 0.493 ' CZ ' ' CD1' ' A' ' 446' ' ' PHE . 35.5 m-85 -130.96 113.32 13.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.846 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 405' ' ' ILE . . . . . 0.657 ' N ' HD12 ' A' ' 405' ' ' ILE . 3.2 mp -90.75 136.09 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.122 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -127.74 159.77 33.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 24.8 m80 60.14 54.99 3.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.855 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.526 HD21 HG21 ' A' ' 405' ' ' ILE . 19.3 mt -93.8 140.73 23.1 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.534 0.683 . . . . 0.0 110.943 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.565 ' HG2' ' CE1' ' A' ' 412' ' ' PHE . 77.6 Cg_exo -49.83 -173.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.67 2.247 . . . . 0.0 112.334 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -96.3 -35.62 11.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.953 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 25.3 pm0 -76.16 -13.77 60.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.858 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.565 ' CE1' ' HG2' ' A' ' 409' ' ' PRO . 5.3 m-85 -71.81 129.05 37.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -120.31 -152.93 9.04 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.44 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.48 -57.88 3.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.743 0.306 . . . . 0.0 110.886 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -54.9 -51.97 64.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.886 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -42.29 -58.57 2.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.833 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 417' ' ' LEU . . . . . 0.503 HD11 HG12 ' A' ' 405' ' ' ILE . 44.8 tp -54.19 -45.8 72.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.927 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 18.2 tp -54.72 -55.39 30.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.865 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -72.89 -9.29 58.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.882 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -82.68 -20.85 35.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -115.18 -12.22 11.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.878 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.579 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 18.0 mtt -54.05 -45.84 98.9 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.611 0.719 . . . . 0.0 110.882 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.2 Cg_exo -48.05 -35.14 25.0 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.613 2.208 . . . . 0.0 112.335 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 424' ' ' PHE . . . . . 0.536 ' CZ ' ' SD ' ' A' ' 462' ' ' MET . 72.2 m-85 -73.89 -30.18 62.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 167.63 -171.87 42.3 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.502 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -77.91 98.77 5.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.888 0.375 . . . . 0.0 110.878 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.501 HG13 HG13 ' A' ' 447' ' ' VAL . 90.6 t -67.98 114.97 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.12 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 17.8 t -66.18 -45.54 89.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.121 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 429' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 30.8 t -135.87 144.58 45.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.821 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 430' ' ' ALA . . . . . 0.454 ' HB2' HG11 ' A' ' 427' ' ' VAL . . . -157.17 106.36 2.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.075 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 431' ' ' LYS . . . . . 0.42 ' HD3' ' C ' ' A' ' 431' ' ' LYS . 1.1 tmtp? -142.5 143.98 32.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.895 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 66.2 t -113.75 148.59 16.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.102 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 433' ' ' PHE . . . . . 0.453 ' C ' ' HG3' ' A' ' 442' ' ' LYS . 2.9 m-85 -84.11 144.51 28.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.934 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.605 HG22 ' N ' ' A' ' 435' ' ' ASP . 14.7 mt -129.09 165.66 28.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 435' ' ' ASP . . . . . 0.605 ' N ' HG22 ' A' ' 434' ' ' ILE . 5.9 t0 -106.52 131.53 53.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.83 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 14.7 ttmt -86.73 33.26 0.65 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.872 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -125.19 -42.27 2.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 438' ' ' THR . . . . . 0.405 ' O ' ' CG ' ' A' ' 439' ' ' ASN . 51.1 p -128.85 14.29 6.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.069 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 439' ' ' ASN . . . . . 0.405 ' CG ' ' O ' ' A' ' 438' ' ' THR . 1.5 p-10 45.75 30.65 0.86 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.933 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 31.8 mt -96.81 120.8 37.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.878 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 1.9 m -52.37 122.2 8.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.453 ' HG3' ' C ' ' A' ' 433' ' ' PHE . 4.7 mmtp -53.04 -174.85 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.898 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 30.4 p -112.96 32.3 5.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.879 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 444' ' ' PHE . . . . . 0.41 ' CE1' ' HB2' ' A' ' 433' ' ' PHE . 2.0 p90 -161.29 151.93 18.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.879 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -152.57 176.82 30.62 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.495 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 446' ' ' PHE . . . . . 0.502 ' O ' HG23 ' A' ' 447' ' ' VAL . 56.5 t80 -115.96 155.84 27.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.905 0.383 . . . . 0.0 110.885 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 447' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 446' ' ' PHE . 53.5 t -158.69 152.43 6.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.18 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 29.6 p -151.06 152.23 33.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.856 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 449' ' ' TYR . . . . . 0.544 ' HB2' ' HB2' ' A' ' 455' ' ' ALA . 4.5 m-85 -117.82 -177.51 3.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.895 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.48 -12.73 60.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 451' ' ' ASN . . . . . 0.459 ' N ' ' OD1' ' A' ' 451' ' ' ASN . 0.5 OUTLIER -159.25 159.99 28.66 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.627 0.727 . . . . 0.0 110.902 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 452' ' ' PRO . . . . . 0.405 ' N ' ' HB2' ' A' ' 401' ' ' ALA . 61.1 Cg_endo -75.23 -19.69 17.14 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.67 2.247 . . . . 0.0 112.379 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 60.3 t -72.94 -43.38 59.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.09 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 16.2 m -75.8 -44.7 39.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.873 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 455' ' ' ALA . . . . . 0.544 ' HB2' ' HB2' ' A' ' 449' ' ' TYR . . . -52.25 -34.88 48.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.152 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -63.82 -44.35 93.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.904 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -41.8 -40.19 1.99 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.088 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 458' ' ' ALA . . . . . 0.478 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -62.39 -68.5 0.32 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.089 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 459' ' ' ILE . . . . . 0.444 ' O ' ' CB ' ' A' ' 463' ' ' ASN . 66.8 mt -45.71 -46.02 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.188 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 25.4 mt-30 -38.82 -50.48 1.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 2.8 m -97.12 -56.84 2.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.892 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 462' ' ' MET . . . . . 0.536 ' SD ' ' CZ ' ' A' ' 424' ' ' PHE . 81.1 mmm -42.64 -45.44 4.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.853 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 463' ' ' ASN . . . . . 0.444 ' CB ' ' O ' ' A' ' 459' ' ' ILE . 9.5 t30 -43.89 108.19 0.11 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.869 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 78.32 30.49 49.85 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.466 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 465' ' ' PHE . . . . . 0.514 ' HB3' HD12 ' A' ' 472' ' ' LEU . 55.2 t80 -68.11 115.37 7.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.817 0.341 . . . . 0.0 110.894 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 18.6 tm0? -67.25 107.96 2.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.943 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 467' ' ' ILE . . . . . 0.469 HG23 ' O ' ' A' ' 467' ' ' ILE . 19.2 tt -126.22 126.31 69.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.108 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 64.26 -103.68 0.77 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.514 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 56.7 mtp -124.12 0.87 8.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.842 0.353 . . . . 0.0 110.9 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -131.18 -179.82 5.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.894 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 39.2 mtt-85 -112.68 164.39 13.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.881 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 472' ' ' LEU . . . . . 0.514 HD12 ' HB3' ' A' ' 465' ' ' PHE . 65.8 mt -103.09 152.34 21.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.9 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 17.9 tttm -130.31 99.94 5.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.885 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 3.2 t -108.82 140.63 26.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.169 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -157.07 147.48 21.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.921 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 476' ' ' LEU . . . . . 0.806 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.3 pp -94.25 127.21 39.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.923 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 476' ' ' LEU . 31.9 tttm -35.25 110.6 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 12.4 ttt180 -114.63 -46.16 2.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.857 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 70.5 m -61.43 133.83 56.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.826 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -63.26 149.42 45.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.899 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -50.61 -47.33 58.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.904 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.79 143.9 45.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.825 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 2.7 m -53.6 108.09 0.31 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.916 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 33.6 tttm -64.92 89.79 0.08 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.92 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 20.2 m -146.04 133.5 20.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -172.14 166.0 38.76 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.555 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.06 -49.3 0.11 Allowed 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 122.674 2.25 . . . . 0.0 112.34 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 92.6 p -101.77 169.89 8.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 10.3 t -108.11 83.48 1.79 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.444 179.956 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 4.3 m -160.26 132.51 6.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.925 0.393 . . . . 0.0 110.845 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 21.8 t -91.31 98.08 11.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.883 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -51.17 120.95 10.27 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.437 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 15.2 t -95.37 -55.19 3.13 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.882 0.373 . . . . 0.0 110.839 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 12.2 t -61.89 130.81 47.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.792 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -151.82 119.15 0.95 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.471 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 383' ' ' LEU . . . . . 0.637 HD12 ' O ' ' A' ' 383' ' ' LEU . 4.2 pp -85.53 31.5 0.59 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.903 0.383 . . . . 0.0 110.891 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 50.5 m -120.51 108.83 14.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.065 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -90.73 -59.09 2.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.902 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -117.03 125.5 51.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 12.8 t -119.57 113.63 21.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.883 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 5.3 mp -102.02 103.58 15.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.135 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -37.29 118.13 0.53 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.491 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -118.69 38.47 3.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.749 0.309 . . . . 0.0 111.048 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -107.87 105.14 14.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.075 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 99.99 38.45 3.6 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.465 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.1 t -129.35 129.38 44.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.777 0.323 . . . . 0.0 110.843 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -93.32 53.76 1.97 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.861 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -111.7 166.59 11.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.931 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -138.95 174.67 10.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.864 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -98.0 -145.27 18.6 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.51 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.57 153.33 43.99 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.736 2.291 . . . . 0.0 112.358 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 15.1 tm-20 -54.98 110.64 0.69 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.899 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 129.22 -27.7 4.2 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.474 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 401' ' ' ALA . . . . . 0.491 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.94 126.77 43.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.774 0.321 . . . . 0.0 111.086 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 402' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.6 OUTLIER -158.99 160.32 35.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.861 -179.918 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 403' ' ' LEU . . . . . 0.622 HD23 HD11 ' A' ' 459' ' ' ILE . 38.7 mt -159.61 114.24 2.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.902 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 404' ' ' PHE . . . . . 0.641 ' CZ ' ' CD1' ' A' ' 446' ' ' PHE . 42.6 m-85 -122.23 111.91 17.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.9 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 405' ' ' ILE . . . . . 0.623 ' N ' HD12 ' A' ' 405' ' ' ILE . 3.6 mp -91.65 134.99 28.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.152 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -124.56 169.29 12.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.922 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 8.0 m80 57.47 44.43 21.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.832 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.445 HD21 HG21 ' A' ' 405' ' ' ILE . 30.4 mt -91.09 134.55 29.83 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.625 0.726 . . . . 0.0 110.886 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -48.77 -179.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.683 2.255 . . . . 0.0 112.377 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -85.16 -46.06 11.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.9 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -58.88 -36.04 73.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.925 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.472 ' CZ ' HD11 ' A' ' 467' ' ' ILE . 7.9 m-85 -55.4 116.91 3.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.844 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -107.48 -151.88 17.44 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.436 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.96 -44.22 40.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.779 0.323 . . . . 0.0 110.877 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 415' ' ' GLN . . . . . 0.407 ' O ' ' C ' ' A' ' 416' ' ' ASP . 3.4 mp0 -62.88 -56.88 13.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.923 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 416' ' ' ASP . . . . . 0.407 ' C ' ' O ' ' A' ' 415' ' ' GLN . 36.3 m-20 -36.99 -64.92 0.33 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 417' ' ' LEU . . . . . 0.43 HD21 HD13 ' A' ' 405' ' ' ILE . 17.5 tp -42.73 -46.5 5.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.958 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 418' ' ' LEU . . . . . 0.453 ' O ' ' CG ' ' A' ' 422' ' ' MET . 14.9 tp -63.69 -37.41 87.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.913 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -80.44 -16.04 55.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.885 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 2.7 tpp -87.17 -30.43 21.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.881 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 421' ' ' PHE . . . . . 0.598 ' CE1' ' SD ' ' A' ' 462' ' ' MET . 4.6 m-85 -98.44 -25.55 14.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.546 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 0.3 OUTLIER -45.23 -47.94 33.17 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.541 0.686 . . . . 0.0 110.926 179.948 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.546 ' CD ' ' N ' ' A' ' 422' ' ' MET . 63.9 Cg_exo -47.95 -46.12 22.84 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.722 2.281 . . . . 0.0 112.408 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 424' ' ' PHE . . . . . 0.44 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 90.1 m-85 -64.57 -33.96 77.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.854 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 169.03 163.58 23.31 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.541 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -56.46 118.47 4.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.863 0.363 . . . . 0.0 110.906 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.563 HG11 ' HB2' ' A' ' 430' ' ' ALA . 41.7 t -88.19 123.98 41.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.171 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 65.1 t -75.8 -36.11 32.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.09 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 429' ' ' SER . . . . . 0.445 ' O ' HG13 ' A' ' 447' ' ' VAL . 0.7 OUTLIER -142.39 143.14 32.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.859 -179.856 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 430' ' ' ALA . . . . . 0.563 ' HB2' HG11 ' A' ' 427' ' ' VAL . . . -160.82 111.68 1.8 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.151 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -157.48 143.5 17.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.952 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 78.5 t -94.12 146.48 6.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.166 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 433' ' ' PHE . . . . . 0.456 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.4 m-30 -87.72 154.05 20.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.798 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.471 HG22 ' N ' ' A' ' 435' ' ' ASP . 46.4 mt -128.39 156.08 40.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.177 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 435' ' ' ASP . . . . . 0.471 ' N ' HG22 ' A' ' 434' ' ' ILE . 6.3 t0 -91.22 144.72 25.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 13.6 ttmm -89.62 -10.2 46.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -94.57 -45.4 7.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.849 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 70.5 p -94.8 -36.46 11.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.129 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 72.98 39.18 0.65 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.899 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.441 ' O ' ' C ' ' A' ' 441' ' ' SER . 21.2 mt -130.99 127.5 38.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.936 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 441' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 440' ' ' LEU . 15.0 m -34.53 106.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.561 ' HD3' ' CE2' ' A' ' 444' ' ' PHE . 17.1 mttm -51.61 -174.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.942 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 26.8 p -107.15 38.21 2.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.929 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 444' ' ' PHE . . . . . 0.561 ' CE2' ' HD3' ' A' ' 442' ' ' LYS . 8.9 p90 -162.07 144.24 11.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.92 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -135.16 168.29 23.79 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.491 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 446' ' ' PHE . . . . . 0.641 ' CD1' ' CZ ' ' A' ' 404' ' ' PHE . 26.7 t80 -109.3 151.64 26.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.919 0.39 . . . . 0.0 110.913 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 447' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 429' ' ' SER . 23.0 t -155.42 144.81 12.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.104 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 1.8 m -143.22 141.06 30.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.896 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 449' ' ' TYR . . . . . 0.599 ' CE1' HD12 ' A' ' 403' ' ' LEU . 6.1 m-85 -107.43 176.61 5.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.913 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -72.01 -29.65 64.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.882 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -140.98 153.52 67.37 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.71 0.766 . . . . 0.0 110.871 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.39 0.12 8.46 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.716 2.277 . . . . 0.0 112.376 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 87.7 t -88.76 -37.66 10.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.131 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 22.9 t -78.88 -41.5 29.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.819 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -49.1 -37.0 20.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.177 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -62.25 -52.22 64.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.969 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -37.82 -45.67 0.86 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.106 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 458' ' ' ALA . . . . . 0.44 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -62.92 -62.96 1.37 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.108 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 459' ' ' ILE . . . . . 0.622 HD11 HD23 ' A' ' 403' ' ' LEU . 70.0 mt -47.43 -48.01 9.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.163 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 460' ' ' GLN . . . . . 0.436 ' C ' ' O ' ' A' ' 459' ' ' ILE . 49.7 mt-30 -34.35 -45.6 0.23 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.841 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 1.9 m -103.46 -56.27 2.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.882 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 462' ' ' MET . . . . . 0.666 ' HB3' HG21 ' A' ' 474' ' ' VAL . 5.7 mmt -38.93 -45.74 1.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 463' ' ' ASN . . . . . 0.403 ' HB2' HG23 ' A' ' 459' ' ' ILE . 28.6 t-20 -59.8 89.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.904 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 114.16 -10.39 22.52 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.517 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -43.53 110.32 0.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.741 0.305 . . . . 0.0 110.945 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -63.22 105.75 0.77 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.863 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 467' ' ' ILE . . . . . 0.526 HG23 ' O ' ' A' ' 467' ' ' ILE . 15.4 tt -110.9 122.35 65.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.103 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 61.96 -100.42 0.29 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.568 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 9.7 mtt -120.13 -14.52 8.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.885 0.374 . . . . 0.0 110.842 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 31.2 pttt -117.16 179.47 4.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.933 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 50.1 mtt180 -107.23 173.44 6.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.863 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 94.4 mt -113.45 154.14 27.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -129.68 104.84 7.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.899 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 474' ' ' VAL . . . . . 0.666 HG21 ' HB3' ' A' ' 462' ' ' MET . 23.8 t -114.28 135.94 52.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.128 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 2.5 tp-100 -157.06 143.63 18.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 476' ' ' LEU . . . . . 0.728 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.5 pp -86.9 125.37 33.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.916 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.467 ' O ' HD12 ' A' ' 476' ' ' LEU . 26.0 tttm -34.09 116.78 0.31 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.912 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 32.1 mtt85 -81.4 122.92 28.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.823 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 83.9 p -105.42 150.75 24.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.825 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -121.57 148.61 44.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.868 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -135.66 133.34 38.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.867 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -119.13 127.25 53.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.833 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 1.3 t -171.83 166.65 6.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.804 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 16.8 ttmm -160.68 137.44 8.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.926 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 3.3 m -100.47 114.1 27.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.893 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -130.11 95.48 0.35 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.476 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -45.08 136.86 10.22 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.74 2.294 . . . . 0.0 112.357 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 44.2 m -82.75 -46.99 12.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.818 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 8.5 m -73.06 111.89 8.59 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.879 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.251 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.492 -180.0 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 63.1 m -114.01 106.24 14.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.883 0.373 . . . . 0.0 110.892 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 3.6 m -93.1 115.02 27.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.843 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -178.19 44.13 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.493 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 83.7 p -67.11 135.21 53.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.928 0.394 . . . . 0.0 110.843 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 10.5 t -128.63 147.19 50.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.94 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 81.28 84.11 0.75 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.516 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -115.25 107.99 15.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.893 0.378 . . . . 0.0 110.954 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 384' ' ' THR . . . . . 0.433 ' O ' ' C ' ' A' ' 385' ' ' GLN . 26.0 m -90.67 89.2 7.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.161 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 385' ' ' GLN . . . . . 0.433 ' C ' ' O ' ' A' ' 384' ' ' THR . 7.4 pt20 35.32 42.52 0.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.913 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 7.5 mm100 -88.31 85.7 6.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.826 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 42.7 p -121.02 95.32 4.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.89 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.509 ' N ' HD12 ' A' ' 388' ' ' ILE . 4.5 mp -96.59 98.09 7.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.154 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -79.04 72.87 2.41 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.518 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -101.24 84.25 2.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.854 0.359 . . . . 0.0 111.101 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -133.7 120.39 20.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.099 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.41 ' CA ' ' HB2' ' A' ' 431' ' ' LYS . . . 97.07 -45.62 1.78 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.493 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 19.1 m -39.29 114.75 0.43 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.845 0.355 . . . . 0.0 110.904 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.432 ' CD ' ' O ' ' A' ' 394' ' ' GLN . 11.2 tm0? -88.25 28.29 1.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.956 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.414 ' O ' ' CB ' ' A' ' 429' ' ' SER . 18.8 mtpp -88.84 165.42 14.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.896 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -121.53 -177.44 3.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.85 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -103.74 -163.31 25.09 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.518 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 398' ' ' PRO . . . . . 0.401 ' HG2' ' O ' ' A' ' 450' ' ' ASP . 53.5 Cg_exo -49.45 157.84 2.0 Allowed 'Trans proline' 0 C--N 1.34 0.128 0 C-N-CA 122.683 2.255 . . . . 0.0 112.312 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -66.37 82.15 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.847 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 148.18 -18.2 1.36 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.495 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 401' ' ' ALA . . . . . 0.57 ' HB2' ' CA ' ' A' ' 452' ' ' PRO . . . -106.93 126.75 52.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.751 0.31 . . . . 0.0 111.08 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 402' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.3 OUTLIER -158.14 169.41 24.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.895 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 403' ' ' LEU . . . . . 0.578 HD12 ' CE1' ' A' ' 449' ' ' TYR . 16.3 mt -159.97 115.79 2.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.904 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 404' ' ' PHE . . . . . 0.545 ' CE1' ' CE1' ' A' ' 446' ' ' PHE . 25.3 m-85 -120.0 111.5 17.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.833 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 405' ' ' ILE . . . . . 0.676 ' N ' HD12 ' A' ' 405' ' ' ILE . 2.9 mp -91.01 136.01 25.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.16 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -124.41 177.81 5.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.834 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 407' ' ' HIS . . . . . 0.422 ' O ' HD23 ' A' ' 472' ' ' LEU . 0.2 OUTLIER 47.74 54.2 10.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.885 179.912 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 409' ' ' PRO . 30.5 mt -96.62 140.86 22.38 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.575 0.703 . . . . 0.0 110.929 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.561 ' HG2' ' CE1' ' A' ' 412' ' ' PHE . 77.0 Cg_exo -49.81 -173.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.691 2.261 . . . . 0.0 112.32 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -95.52 -29.58 14.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -78.67 -20.29 50.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.949 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.561 ' CE1' ' HG2' ' A' ' 409' ' ' PRO . 5.4 m-85 -64.91 128.49 35.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.799 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 413' ' ' GLY . . . . . 0.471 ' O ' HG21 ' A' ' 432' ' ' VAL . . . -117.68 -139.93 6.42 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.507 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -88.01 -36.82 16.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.833 0.349 . . . . 0.0 110.898 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 415' ' ' GLN . . . . . 0.437 ' O ' ' N ' ' A' ' 418' ' ' LEU . 19.8 mm-40 -71.36 -58.26 3.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.913 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -37.96 -49.38 1.25 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.882 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 53.0 tp -58.59 -40.96 84.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.914 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 418' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 415' ' ' GLN . 20.7 tp -64.93 -58.15 6.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.897 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -66.77 -8.95 31.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.925 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -87.69 -27.36 22.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.833 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 421' ' ' PHE . . . . . 0.492 ' CZ ' HG12 ' A' ' 405' ' ' ILE . 3.4 m-85 -110.32 6.61 22.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.827 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.582 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 13.5 mtt -73.4 -45.76 7.66 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.549 0.69 . . . . 0.0 110.876 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 422' ' ' MET . 63.9 Cg_exo -47.96 -28.8 10.77 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.674 2.249 . . . . 0.0 112.418 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 424' ' ' PHE . . . . . 0.422 ' CE2' ' HA ' ' A' ' 458' ' ' ALA . 81.7 m-85 -76.7 -34.06 58.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.924 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 164.35 -163.63 36.21 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.488 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -72.68 134.77 45.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.889 0.376 . . . . 0.0 110.855 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 18.7 t -107.97 116.84 52.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.17 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 428' ' ' VAL . . . . . 0.526 HG12 ' OG ' ' A' ' 429' ' ' SER . 31.4 t -68.22 -55.34 16.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.181 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 429' ' ' SER . . . . . 0.526 ' OG ' HG12 ' A' ' 428' ' ' VAL . 0.9 OUTLIER -136.75 148.61 47.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.854 -179.864 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -161.06 120.1 2.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.117 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 431' ' ' LYS . . . . . 0.41 ' HB2' ' CA ' ' A' ' 392' ' ' GLY . 0.4 OUTLIER -161.09 141.88 11.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.92 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.471 HG21 ' O ' ' A' ' 413' ' ' GLY . 84.0 t -86.99 153.91 3.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.159 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 433' ' ' PHE . . . . . 0.556 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.3 m-30 -97.53 150.77 20.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.934 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.506 HG22 ' N ' ' A' ' 435' ' ' ASP . 43.0 mt -124.67 158.7 31.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.149 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 435' ' ' ASP . . . . . 0.506 ' N ' HG22 ' A' ' 434' ' ' ILE . 2.1 t70 -96.31 129.84 43.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 25.0 tptt -77.52 6.66 6.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.909 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 11.1 tm0? -107.9 -51.86 2.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.89 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 16.2 p -91.61 -24.86 19.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.168 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 34.3 m120 65.25 36.98 6.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.855 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.437 ' O ' ' C ' ' A' ' 441' ' ' SER . 9.1 mt -130.94 125.92 34.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.953 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 441' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 440' ' ' LEU . 12.4 p -34.49 110.91 0.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.853 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.559 ' HD3' ' CE2' ' A' ' 444' ' ' PHE . 28.5 mttt -54.36 -174.81 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.917 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 31.3 p -106.22 36.66 2.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.866 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 444' ' ' PHE . . . . . 0.559 ' CE2' ' HD3' ' A' ' 442' ' ' LYS . 4.9 p90 -160.07 143.16 13.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -129.83 177.39 18.15 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.503 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 446' ' ' PHE . . . . . 0.545 ' CE1' ' CE1' ' A' ' 404' ' ' PHE . 20.2 t80 -119.35 152.67 36.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.956 0.408 . . . . 0.0 110.899 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 447' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 446' ' ' PHE . 77.9 t -159.03 153.75 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.063 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 448' ' ' SER . . . . . 0.416 ' N ' HG12 ' A' ' 447' ' ' VAL . 79.0 p -151.53 144.35 24.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.857 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 449' ' ' TYR . . . . . 0.578 ' CE1' HD12 ' A' ' 403' ' ' LEU . 15.3 m-85 -107.84 -176.02 2.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.936 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 450' ' ' ASP . . . . . 0.401 ' O ' ' HG2' ' A' ' 398' ' ' PRO . 0.4 OUTLIER -79.75 -16.72 55.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.937 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -150.93 155.15 35.12 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.608 0.718 . . . . 0.0 110.863 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 452' ' ' PRO . . . . . 0.57 ' CA ' ' HB2' ' A' ' 401' ' ' ALA . 60.3 Cg_endo -73.95 -13.87 23.9 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.733 2.289 . . . . 0.0 112.378 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 37.2 t -78.89 -37.52 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.087 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 11.4 p -74.88 -50.95 15.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.887 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -40.84 -39.74 1.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.062 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 456' ' ' GLN . . . . . 0.4 ' O ' ' C ' ' A' ' 457' ' ' ALA . 45.6 mm-40 -56.66 -50.74 71.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.897 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 457' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 456' ' ' GLN . . . -36.91 -43.68 0.46 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.139 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 458' ' ' ALA . . . . . 0.422 ' HA ' ' CE2' ' A' ' 424' ' ' PHE . . . -62.81 -66.1 0.59 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.144 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 459' ' ' ILE . . . . . 0.443 ' O ' ' CB ' ' A' ' 463' ' ' ASN . 73.7 mt -46.94 -41.92 5.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.082 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -44.18 -49.14 9.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.9 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 45.2 t -98.12 -57.02 2.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.826 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 462' ' ' MET . . . . . 0.404 ' O ' ' N ' ' A' ' 465' ' ' PHE . 91.8 mmm -40.9 -47.6 2.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.882 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 463' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' A' ' 459' ' ' ILE . 26.5 t-20 -44.78 106.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.914 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 82.74 27.06 43.5 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.477 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 465' ' ' PHE . . . . . 0.404 ' N ' ' O ' ' A' ' 462' ' ' MET . 10.9 t80 -66.59 117.59 8.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.81 0.338 . . . . 0.0 110.844 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 11.6 tm0? -64.8 118.09 8.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.911 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 467' ' ' ILE . . . . . 0.556 HG23 ' O ' ' A' ' 467' ' ' ILE . 14.4 tt -140.58 120.71 13.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.097 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 69.07 -104.26 1.23 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.487 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 24.6 ttp -131.25 12.53 5.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.841 0.353 . . . . 0.0 110.875 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -138.81 -179.15 5.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.89 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 57.9 mtm180 -108.48 163.13 13.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 472' ' ' LEU . . . . . 0.422 HD23 ' O ' ' A' ' 407' ' ' HIS . 53.7 mt -109.85 148.99 30.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.879 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -124.46 128.28 48.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.871 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 474' ' ' VAL . . . . . 0.429 HG12 HG12 ' A' ' 459' ' ' ILE . 32.5 t -133.95 133.81 56.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.09 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -157.13 136.34 11.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.905 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 476' ' ' LEU . . . . . 0.676 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.5 pp -79.19 128.61 33.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.937 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 476' ' ' LEU . 46.7 tttm -34.67 109.28 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.915 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 478' ' ' ARG . . . . . 0.464 ' HG3' ' N ' ' A' ' 479' ' ' SER . 14.6 tpp180 -41.36 150.19 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.834 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 479' ' ' SER . . . . . 0.464 ' N ' ' HG3' ' A' ' 478' ' ' ARG . 5.0 t -147.38 157.3 43.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.821 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 480' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 481' ' ' ASN . 24.9 mttp -98.23 -51.77 3.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 481' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 480' ' ' LYS . 16.7 m120 -37.12 115.63 0.4 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.91 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -79.21 -55.05 5.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 4.9 t -174.81 109.52 0.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.845 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -143.91 126.33 15.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.879 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 3.2 t -166.62 166.46 16.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.847 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 132.97 152.29 6.88 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.539 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.16 139.54 19.05 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.597 2.198 . . . . 0.0 112.403 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 91.6 p -79.68 117.28 20.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.831 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 73.0 p -74.55 91.36 2.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.847 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.515 -179.926 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.427 -0.269 . . . . 0.0 112.427 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 53.8 p -149.73 153.09 36.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.898 0.38 . . . . 0.0 110.876 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 20.4 m -112.06 157.92 20.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.877 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -68.41 113.5 5.37 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.44 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 48.3 m -155.36 169.2 24.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 110.819 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 2.6 m -134.18 164.34 27.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.911 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 137.53 72.51 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.553 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 383' ' ' LEU . . . . . 0.438 ' C ' HD12 ' A' ' 383' ' ' LEU . 3.5 pp -53.27 -33.04 51.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.837 0.351 . . . . 0.0 110.88 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 15.2 t -105.17 153.19 21.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.133 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -129.86 165.92 21.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.951 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -134.54 134.85 41.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.933 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 39.7 m -106.22 44.27 1.06 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.866 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 54.7 mt -98.92 119.27 46.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.166 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -89.04 108.9 3.51 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.471 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 390' ' ' ALA . . . . . 0.474 ' HB1' ' HA ' ' A' ' 429' ' ' SER . . . -101.1 70.88 1.37 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.805 0.336 . . . . 0.0 111.119 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 391' ' ' ALA . . . . . 0.402 ' HB1' ' CB ' ' A' ' 414' ' ' ASP . . . -106.47 -44.24 4.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.034 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -120.41 39.38 2.46 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.521 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 52.3 m -97.34 125.03 41.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.825 0.345 . . . . 0.0 110.857 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -91.24 -9.88 43.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.848 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.406 ' HB2' ' NZ ' ' A' ' 395' ' ' LYS . 0.0 OUTLIER -68.21 170.7 8.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.919 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -142.74 -177.59 5.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.922 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -83.49 -147.01 7.2 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.521 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.9 151.53 40.14 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.721 2.28 . . . . 0.0 112.309 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -52.37 107.83 0.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.932 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 131.32 -28.57 3.6 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.463 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 401' ' ' ALA . . . . . 0.495 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.86 126.83 43.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.749 0.309 . . . . 0.0 111.07 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 402' ' ' ASN . . . . . 0.496 ' O ' ' CB ' ' A' ' 476' ' ' LEU . 0.6 OUTLIER -158.83 163.72 36.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.82 -179.932 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 403' ' ' LEU . . . . . 0.553 HD12 ' CE1' ' A' ' 449' ' ' TYR . 23.7 mt -160.35 108.03 1.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.899 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 404' ' ' PHE . . . . . 0.571 ' C ' HD13 ' A' ' 405' ' ' ILE . 5.3 m-85 -111.83 117.41 32.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.871 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 405' ' ' ILE . . . . . 0.826 HD12 HG22 ' A' ' 474' ' ' VAL . 1.4 mm -90.88 135.49 26.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.103 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -126.57 148.89 49.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.932 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 407' ' ' HIS . . . . . 0.474 ' N ' ' O ' ' A' ' 443' ' ' CYS . 8.8 m80 71.66 54.66 0.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.872 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 31.6 mt -100.38 132.49 22.42 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.637 0.732 . . . . 0.0 110.932 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -47.84 178.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.722 2.282 . . . . 0.0 112.376 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 410' ' ' GLN . . . . . 0.453 ' NE2' ' HB3' ' A' ' 440' ' ' LEU . 18.9 tp60 -88.16 -39.09 14.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.938 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -60.18 -36.96 78.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -53.98 150.79 7.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -138.24 -145.34 4.82 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.494 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 414' ' ' ASP . . . . . 0.402 ' CB ' ' HB1' ' A' ' 391' ' ' ALA . 16.4 m-20 -79.72 -59.65 2.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.761 0.315 . . . . 0.0 110.934 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 -58.0 -53.76 54.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -38.89 -49.8 1.68 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.858 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 417' ' ' LEU . . . . . 0.4 HD21 ' CG2' ' A' ' 447' ' ' VAL . 40.8 tp -59.47 -49.41 77.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.903 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 54.9 tp -56.92 -56.01 27.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.925 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -60.24 -12.07 7.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.983 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 4.9 ttm -92.94 -23.59 18.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.904 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -109.97 6.6 23.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.586 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 4.6 mtt -75.55 -45.78 4.29 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.622 0.725 . . . . 0.0 110.879 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.0 Cg_exo -47.97 -46.68 21.22 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.7 2.267 . . . . 0.0 112.325 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -59.4 -35.73 74.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.838 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 172.75 -171.9 44.67 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.501 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -81.53 102.59 10.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.842 0.353 . . . . 0.0 110.925 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 62.0 t -72.77 134.15 30.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.158 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 428' ' ' VAL . . . . . 0.562 HG12 ' OG ' ' A' ' 429' ' ' SER . 17.9 t -79.05 -48.5 21.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.107 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 429' ' ' SER . . . . . 0.562 ' OG ' HG12 ' A' ' 428' ' ' VAL . 1.3 m -146.69 143.44 28.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.842 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -153.86 116.95 4.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.172 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -150.61 137.93 19.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.896 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.451 HG12 ' N ' ' A' ' 433' ' ' PHE . 57.8 t -87.3 155.25 3.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.105 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 433' ' ' PHE . . . . . 0.539 ' CG ' ' CE1' ' A' ' 444' ' ' PHE . 3.1 m-85 -95.75 148.03 23.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.522 HG22 ' N ' ' A' ' 435' ' ' ASP . 30.7 mt -121.74 161.04 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.071 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 435' ' ' ASP . . . . . 0.522 ' N ' HG22 ' A' ' 434' ' ' ILE . 2.5 t70 -102.75 133.07 48.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.813 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? -80.07 0.16 33.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.963 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -99.23 -42.47 7.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.875 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 68.0 p -104.28 -21.84 13.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.183 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 64.45 39.25 7.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.938 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.453 ' HB3' ' NE2' ' A' ' 410' ' ' GLN . 22.4 mt -134.54 135.12 42.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.945 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 52.0 p -40.34 111.77 0.23 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.556 ' HD3' ' CE2' ' A' ' 444' ' ' PHE . 15.7 mttm -51.8 -175.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.876 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 443' ' ' CYS . . . . . 0.474 ' O ' ' N ' ' A' ' 407' ' ' HIS . 26.6 p -101.55 33.86 2.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 444' ' ' PHE . . . . . 0.556 ' CE2' ' HD3' ' A' ' 442' ' ' LYS . 11.1 p90 -160.53 145.7 14.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.851 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -133.16 176.39 19.6 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.521 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -121.23 141.45 50.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.963 0.411 . . . . 0.0 110.818 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 447' ' ' VAL . . . . . 0.4 ' CG2' HD21 ' A' ' 417' ' ' LEU . 54.7 t -148.69 147.41 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.169 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 51.7 p -142.53 149.99 39.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.93 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 449' ' ' TYR . . . . . 0.553 ' CE1' HD12 ' A' ' 403' ' ' LEU . 3.3 m-85 -113.11 -174.87 2.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.945 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -81.32 -19.23 43.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.939 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -154.41 154.95 30.29 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.608 0.718 . . . . 0.0 110.898 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 452' ' ' PRO . . . . . 0.456 ' N ' ' HB2' ' A' ' 401' ' ' ALA . 61.4 Cg_endo -75.72 -10.12 19.98 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.721 2.281 . . . . 0.0 112.359 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 97.8 t -82.63 -29.28 8.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.154 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 68.1 m -90.86 -35.44 14.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.791 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -57.14 -35.22 69.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.041 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -61.1 -38.93 88.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.911 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -47.81 -39.39 18.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.12 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -64.38 -68.4 0.36 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.081 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 459' ' ' ILE . . . . . 0.52 HG12 HG12 ' A' ' 474' ' ' VAL . 95.2 mt -42.5 -45.32 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.206 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 -41.87 -45.28 3.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 2.9 t -101.47 -57.01 2.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.855 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 462' ' ' MET . . . . . 0.41 ' O ' ' N ' ' A' ' 465' ' ' PHE . 91.8 mmm -43.77 -44.68 6.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.911 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 463' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 459' ' ' ILE . 19.4 t-20 -44.95 108.0 0.11 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 82.1 25.45 52.02 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.444 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 465' ' ' PHE . . . . . 0.507 ' HB3' HD12 ' A' ' 472' ' ' LEU . 18.0 t80 -64.34 109.25 1.85 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.809 0.337 . . . . 0.0 110.882 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 7.4 tm0? -63.12 114.79 3.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.875 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 467' ' ' ILE . . . . . 0.478 HG23 ' O ' ' A' ' 467' ' ' ILE . 17.9 tt -127.59 126.48 67.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.179 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 61.11 -96.79 0.11 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.467 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 33.0 ttp -129.44 -5.4 4.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.879 0.371 . . . . 0.0 110.896 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 15.6 pttm -121.45 176.23 5.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.871 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 28.1 mtm180 -108.56 169.3 8.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.925 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 472' ' ' LEU . . . . . 0.507 HD12 ' HB3' ' A' ' 465' ' ' PHE . 93.3 mt -115.54 158.32 22.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.904 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 33.8 tttp -137.76 107.54 6.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.928 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 474' ' ' VAL . . . . . 0.826 HG22 HD12 ' A' ' 405' ' ' ILE . 61.5 t -109.51 135.04 49.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.074 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -156.38 139.81 15.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 476' ' ' LEU . . . . . 0.631 ' C ' HD12 ' A' ' 476' ' ' LEU . 1.6 pp -83.5 129.91 34.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.563 ' HB2' ' CE1' ' A' ' 404' ' ' PHE . 59.2 tttt -33.72 111.5 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.933 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 478' ' ' ARG . . . . . 0.452 ' O ' ' C ' ' A' ' 479' ' ' SER . 16.4 mmt180 -103.69 83.05 2.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.813 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 479' ' ' SER . . . . . 0.452 ' C ' ' O ' ' A' ' 478' ' ' ARG . 23.0 m -34.53 -46.06 0.26 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.72 95.28 5.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.921 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -75.62 -52.66 10.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.943 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -59.05 -178.83 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.883 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 38.5 t -175.02 127.73 0.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.871 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 36.9 tttm -162.9 152.61 15.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 17.9 p -157.11 170.75 21.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.913 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -156.38 144.07 10.41 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.49 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -47.09 135.27 18.68 Favored 'Trans proline' 0 C--O 1.231 0.126 0 C-N-CA 122.631 2.22 . . . . 0.0 112.375 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 46.5 m -71.51 94.1 1.25 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.887 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 78.1 p -151.46 120.09 6.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.861 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.493 -179.971 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 112.469 -0.253 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 68.1 m -147.61 137.66 22.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.8 0.333 . . . . 0.0 110.912 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 88.4 p -120.85 160.5 23.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.791 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -111.49 -101.54 2.6 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.545 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 77.8 p -148.94 122.09 8.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.844 0.354 . . . . 0.0 110.851 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 15.7 m -102.65 160.39 14.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 382' ' ' GLY . . . . . 0.545 ' O ' HG23 ' A' ' 384' ' ' THR . . . 39.51 -110.03 0.14 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.56 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 11.7 mt 46.88 48.64 15.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.901 0.382 . . . . 0.0 110.897 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 384' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 382' ' ' GLY . 74.9 p -121.11 115.77 23.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.129 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -82.58 -58.55 2.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.009 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 20.6 mp0 -117.66 101.97 8.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.917 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 3.6 t -88.4 51.35 2.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.845 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 41.6 mm -55.18 127.57 14.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.161 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -120.47 81.55 0.34 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.458 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 390' ' ' ALA . . . . . 0.422 ' O ' ' C ' ' A' ' 391' ' ' ALA . . . -64.33 -54.86 26.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.828 0.346 . . . . 0.0 111.17 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 391' ' ' ALA . . . . . 0.437 ' CB ' ' OE1' ' A' ' 415' ' ' GLN . . . -35.9 120.61 0.62 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.131 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 83.52 52.22 3.81 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.455 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 56.6 m -137.91 129.51 28.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.764 0.316 . . . . 0.0 110.901 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 394' ' ' GLN . . . . . 0.405 ' HG2' ' HZ1' ' A' ' 431' ' ' LYS . 4.3 mm-40 -101.59 72.13 1.37 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.882 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.421 ' O ' ' CB ' ' A' ' 429' ' ' SER . 13.8 ptpt -141.07 163.64 32.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.9 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 396' ' ' GLU . . . . . 0.474 ' HA ' ' CB ' ' A' ' 448' ' ' SER . 15.2 pt-20 -131.48 -176.44 4.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.916 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -99.82 -146.87 20.6 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.52 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.07 150.85 49.01 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.722 2.281 . . . . 0.0 112.358 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -50.89 97.93 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.874 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 137.61 -25.24 2.99 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.432 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 401' ' ' ALA . . . . . . . . . . . . . . . -98.21 126.84 43.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.836 0.35 . . . . 0.0 111.131 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 402' ' ' ASN . . . . . 0.439 ' O ' ' CB ' ' A' ' 476' ' ' LEU . 9.9 m120 -159.17 161.29 36.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.903 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 403' ' ' LEU . . . . . 0.608 HD12 ' CE1' ' A' ' 449' ' ' TYR . 27.7 mt -159.76 113.8 2.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.944 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 404' ' ' PHE . . . . . 0.766 ' CZ ' ' CD1' ' A' ' 446' ' ' PHE . 46.6 m-85 -123.02 113.68 19.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 405' ' ' ILE . . . . . 0.645 HD11 ' CZ ' ' A' ' 421' ' ' PHE . 4.6 mp -90.97 136.89 22.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.097 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 406' ' ' TYR . . . . . 0.442 ' CD2' ' O ' ' A' ' 473' ' ' LYS . 10.9 m-85 -127.69 153.69 46.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.962 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 27.6 m80 69.29 52.64 0.47 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.856 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 19.4 mt -96.13 131.85 27.99 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.594 0.712 . . . . 0.0 110.918 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -48.16 167.9 0.1 OUTLIER 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.678 2.252 . . . . 0.0 112.362 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -70.26 -44.06 69.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.977 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -61.46 -39.65 91.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -54.32 112.42 0.98 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.862 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -104.67 -140.15 10.3 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.475 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.51 -60.76 2.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.808 0.337 . . . . 0.0 110.897 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 415' ' ' GLN . . . . . 0.469 ' O ' ' N ' ' A' ' 418' ' ' LEU . 1.6 mp0 -53.72 -61.59 2.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 416' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 415' ' ' GLN . 35.3 m-20 -34.47 -58.76 0.48 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.841 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 66.2 tp -51.53 -41.83 61.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.9 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 418' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' A' ' 415' ' ' GLN . 12.7 tp -67.64 -56.03 10.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.939 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -56.74 -13.14 2.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.971 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 3.0 tpp -86.23 -31.18 21.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 421' ' ' PHE . . . . . 0.645 ' CZ ' HD11 ' A' ' 405' ' ' ILE . 5.2 m-85 -95.38 -26.66 15.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.838 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.547 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 0.2 OUTLIER -46.14 -47.66 43.93 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.531 0.681 . . . . 0.0 110.846 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.547 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.2 Cg_exo -47.96 -42.99 31.12 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.717 2.278 . . . . 0.0 112.315 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 424' ' ' PHE . . . . . 0.408 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 64.6 m-85 -67.54 -35.06 78.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.878 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 172.08 -169.35 42.46 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.49 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -75.99 122.25 23.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.803 0.335 . . . . 0.0 110.921 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.495 HG11 ' HB2' ' A' ' 430' ' ' ALA . 84.1 t -95.15 115.23 33.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.191 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.4 -43.29 81.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.132 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 429' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 1.5 t -134.53 144.07 47.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 430' ' ' ALA . . . . . 0.495 ' HB2' HG11 ' A' ' 427' ' ' VAL . . . -161.07 107.11 1.41 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.139 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 431' ' ' LYS . . . . . 0.421 ' C ' ' HD2' ' A' ' 431' ' ' LYS . 0.1 OUTLIER -153.29 149.72 28.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 72.9 t -103.76 142.1 18.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.097 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 433' ' ' PHE . . . . . 0.51 ' CG ' ' CE1' ' A' ' 444' ' ' PHE . 3.1 m-85 -81.88 153.0 26.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.875 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.48 ' N ' ' HD2' ' A' ' 442' ' ' LYS . 69.4 mt -128.1 155.53 39.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.062 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 435' ' ' ASP . . . . . 0.461 ' N ' HG22 ' A' ' 434' ' ' ILE . 3.6 m-20 -87.54 152.1 22.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.881 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.58 -23.73 15.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -88.14 -28.13 21.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.958 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 438' ' ' THR . . . . . 0.425 ' HB ' HD12 ' A' ' 440' ' ' LEU . 75.5 p -109.22 -34.88 6.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.135 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 67.75 42.32 2.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.934 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 441' ' ' SER . 10.1 mt -132.17 127.17 35.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 441' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 440' ' ' LEU . 36.6 p -34.87 106.03 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.852 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.555 ' HD3' ' CE2' ' A' ' 444' ' ' PHE . 19.3 mttm -51.69 -174.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.836 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 72.0 m -110.43 38.15 2.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.822 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 444' ' ' PHE . . . . . 0.555 ' CE2' ' HD3' ' A' ' 442' ' ' LYS . 5.4 p90 -162.18 137.62 7.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.842 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -131.73 169.67 21.88 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.498 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 446' ' ' PHE . . . . . 0.766 ' CD1' ' CZ ' ' A' ' 404' ' ' PHE . 22.2 t80 -111.54 150.01 30.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.859 0.361 . . . . 0.0 110.918 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 447' ' ' VAL . . . . . 0.468 HG13 HG13 ' A' ' 427' ' ' VAL . 85.5 t -155.14 145.21 13.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.121 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 448' ' ' SER . . . . . 0.474 ' CB ' ' HA ' ' A' ' 396' ' ' GLU . 1.9 m -144.42 140.85 29.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.91 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 449' ' ' TYR . . . . . 0.608 ' CE1' HD12 ' A' ' 403' ' ' LEU . 3.6 m-85 -102.94 179.79 4.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.942 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -75.82 -25.88 56.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.938 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -147.05 158.56 44.68 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.558 0.694 . . . . 0.0 110.912 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.65 -12.69 20.25 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.713 2.275 . . . . 0.0 112.3 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 92.4 t -77.37 -38.56 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.147 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 1.5 t -83.37 -39.61 20.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.882 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 455' ' ' ALA . . . . . 0.459 ' HB2' ' HB2' ' A' ' 449' ' ' TYR . . . -53.1 -43.23 66.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.076 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -59.08 -42.48 90.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.934 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -43.08 -38.84 2.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.126 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 458' ' ' ALA . . . . . 0.408 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -66.7 -61.74 1.81 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.121 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 67.1 mt -47.53 -45.45 10.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.115 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -37.68 -47.77 1.0 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 2.8 m -103.03 -56.98 2.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.899 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 88.4 mmm -39.72 -44.56 1.57 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.844 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -46.18 110.3 0.26 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.872 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 74.12 35.28 53.73 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.516 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 465' ' ' PHE . . . . . 0.417 ' CD1' ' C ' ' A' ' 465' ' ' PHE . 9.5 t80 -68.72 117.4 10.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.818 0.342 . . . . 0.0 110.905 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 11.2 tm0? -63.77 115.19 4.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.91 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 14.6 tt -138.11 132.94 43.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.094 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 51.25 -108.52 0.58 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.474 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 26.0 mtt -127.26 24.82 6.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.829 0.347 . . . . 0.0 110.844 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 7.8 pttt -142.43 -178.43 5.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.894 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 33.3 mtm-85 -125.13 121.91 35.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.911 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 45.0 mt -65.7 152.06 45.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.952 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 473' ' ' LYS . . . . . 0.442 ' O ' ' CD2' ' A' ' 406' ' ' TYR . 18.5 ttmm -132.6 100.49 4.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.88 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 474' ' ' VAL . . . . . 0.556 HG22 HG13 ' A' ' 405' ' ' ILE . 21.1 t -107.56 136.75 41.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.203 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -156.52 145.89 20.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.87 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 476' ' ' LEU . . . . . 0.786 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.4 pp -91.04 126.2 36.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 476' ' ' LEU . 16.9 ttpp -34.47 115.53 0.26 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.892 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 478' ' ' ARG . . . . . 0.468 ' HD2' ' CB ' ' A' ' 481' ' ' ASN . 13.5 tpp180 -81.15 94.47 6.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.854 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 65.3 m -111.72 109.88 19.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt 40.69 41.47 1.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.875 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 481' ' ' ASN . . . . . 0.468 ' CB ' ' HD2' ' A' ' 478' ' ' ARG . 20.6 t-20 -52.98 -59.2 4.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.873 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -99.41 97.83 8.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 57.5 p -85.31 116.77 23.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.877 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 15.2 ttmm -161.01 124.42 3.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.978 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 90.3 p -107.54 130.28 54.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.913 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -85.27 147.78 22.64 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.449 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -45.61 121.22 3.85 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.662 2.241 . . . . 0.0 112.358 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 6.2 t -68.59 168.68 12.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.827 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 69.7 m -93.42 -44.0 8.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.854 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.506 -179.959 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 53.7 m -105.88 -58.23 1.94 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.875 0.369 . . . . 0.0 110.882 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 82.7 p -65.97 143.55 57.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.801 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 162.4 -73.21 0.2 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.475 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 59.7 p -174.07 151.28 1.69 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.814 0.34 . . . . 0.0 110.923 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 12.2 p -116.66 -28.14 6.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.814 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 78.6 135.22 0.97 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.506 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 7.4 mp -109.6 -63.09 1.41 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.913 0.387 . . . . 0.0 110.945 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 384' ' ' THR . . . . . 0.492 ' O ' HG22 ' A' ' 384' ' ' THR . 13.8 m 52.77 44.36 30.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.09 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 14.3 tp60 -90.84 -46.01 8.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.886 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -103.08 123.15 46.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.92 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 74.1 m -115.33 46.24 1.51 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.796 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 68.5 mt -116.74 102.78 14.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.129 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -108.51 114.0 3.97 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.529 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 390' ' ' ALA . . . . . 0.699 ' HB3' HD13 ' A' ' 418' ' ' LEU . . . -81.96 88.5 6.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.731 0.3 . . . . 0.0 111.099 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -136.69 115.51 12.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.142 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.448 ' O ' ' C ' ' A' ' 393' ' ' SER . . . 98.77 -49.45 1.28 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.464 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 393' ' ' SER . . . . . 0.448 ' C ' ' O ' ' A' ' 392' ' ' GLY . 3.3 m -34.72 145.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.759 0.314 . . . . 0.0 110.914 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -123.75 38.34 4.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.912 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.5 ' O ' ' CB ' ' A' ' 429' ' ' SER . 17.8 ptpt -103.66 157.31 17.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.856 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -109.71 -178.9 3.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.865 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -105.16 -155.45 22.52 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.555 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.13 157.58 8.25 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.729 2.286 . . . . 0.0 112.374 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -65.85 78.43 0.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.919 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 153.83 -16.69 0.63 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.456 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 401' ' ' ALA . . . . . 0.505 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -106.49 126.7 52.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.765 0.316 . . . . 0.0 111.111 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 402' ' ' ASN . . . . . 0.505 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.2 OUTLIER -158.15 168.91 25.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.884 -179.901 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 403' ' ' LEU . . . . . 0.497 HD12 ' CE1' ' A' ' 449' ' ' TYR . 27.7 mt -160.06 119.84 2.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.864 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 404' ' ' PHE . . . . . 0.535 ' CE1' ' HB2' ' A' ' 477' ' ' LYS . 15.0 m-85 -124.42 113.45 18.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 405' ' ' ILE . . . . . 0.567 ' N ' HD12 ' A' ' 405' ' ' ILE . 3.4 mp -91.15 133.95 31.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.151 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -125.75 162.27 25.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.935 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 407' ' ' HIS . . . . . 0.491 ' N ' ' O ' ' A' ' 443' ' ' CYS . 16.6 m80 61.01 54.61 3.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.908 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.534 HD21 HG21 ' A' ' 405' ' ' ILE . 30.3 mt -99.87 144.91 29.24 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.668 0.747 . . . . 0.0 110.838 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.578 ' HG2' ' CD1' ' A' ' 412' ' ' PHE . 61.5 Cg_endo -76.47 164.96 29.92 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.711 2.274 . . . . 0.0 112.274 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -69.35 -38.63 78.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.918 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -54.46 -36.48 64.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.578 ' CD1' ' HG2' ' A' ' 409' ' ' PRO . 4.7 m-85 -67.65 138.64 56.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.934 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -123.48 -137.0 4.88 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.474 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -87.81 -56.97 3.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.772 0.32 . . . . 0.0 110.909 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 415' ' ' GLN . . . . . 0.444 ' O ' ' N ' ' A' ' 418' ' ' LEU . 26.9 mm-40 -58.4 -57.03 14.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.95 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 416' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' A' ' 415' ' ' GLN . 53.0 m-20 -34.87 -59.23 0.49 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.866 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 417' ' ' LEU . . . . . 0.403 HD11 HG12 ' A' ' 405' ' ' ILE . 51.5 tp -51.29 -42.63 61.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.906 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 418' ' ' LEU . . . . . 0.699 HD13 ' HB3' ' A' ' 390' ' ' ALA . 10.8 tp -65.84 -46.33 78.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.904 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -68.18 -16.24 63.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.973 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 2.0 ttt -85.35 -35.01 21.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.917 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 421' ' ' PHE . . . . . 0.468 ' CE1' ' SD ' ' A' ' 462' ' ' MET . 3.8 m-85 -92.69 -22.72 19.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.839 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.574 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 0.3 OUTLIER -50.87 -45.62 87.24 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.563 0.697 . . . . 0.0 110.96 179.951 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.4 Cg_exo -47.98 -38.84 32.17 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.662 2.242 . . . . 0.0 112.372 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 424' ' ' PHE . . . . . 0.503 ' CE2' ' HA ' ' A' ' 458' ' ' ALA . 78.1 m-85 -70.88 -35.28 72.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.898 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 164.58 -178.96 39.59 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.523 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 -61.86 135.11 57.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.812 0.339 . . . . 0.0 110.834 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.436 HG11 ' HB2' ' A' ' 430' ' ' ALA . 24.2 t -111.47 124.83 68.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.117 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 19.1 t -69.64 -50.35 50.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.209 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 429' ' ' SER . . . . . 0.5 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 4.5 t -137.69 148.7 45.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.826 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 430' ' ' ALA . . . . . 0.436 ' HB2' HG11 ' A' ' 427' ' ' VAL . . . -160.59 107.74 1.55 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.106 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -150.96 143.81 24.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 433' ' ' PHE . 99.3 t -94.43 152.49 3.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.048 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 433' ' ' PHE . . . . . 0.426 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.5 m-30 -89.68 154.06 20.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.931 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.48 ' N ' ' HD2' ' A' ' 442' ' ' LYS . 71.4 mt -136.48 152.0 28.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.15 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 435' ' ' ASP . . . . . 0.402 ' N ' HG22 ' A' ' 434' ' ' ILE . 3.9 m-20 -86.35 144.51 27.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.861 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 43.0 mttt -94.4 -8.4 38.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.85 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -99.98 -28.79 12.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.896 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 46.0 p -112.74 -28.87 7.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.162 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 66.28 31.37 8.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 47.9 mt -116.7 124.58 50.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.959 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 5.8 p -37.85 110.06 0.12 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.562 ' HD3' ' CE1' ' A' ' 444' ' ' PHE . 37.1 mttt -52.21 -174.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.942 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 443' ' ' CYS . . . . . 0.491 ' O ' ' N ' ' A' ' 407' ' ' HIS . 30.3 p -110.13 33.72 4.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.943 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 444' ' ' PHE . . . . . 0.562 ' CE1' ' HD3' ' A' ' 442' ' ' LYS . 8.2 p90 -161.89 147.55 13.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.939 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -138.36 179.07 18.78 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.524 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 446' ' ' PHE . . . . . 0.503 ' O ' ' CG2' ' A' ' 447' ' ' VAL . 55.6 t80 -118.79 153.71 34.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.831 0.348 . . . . 0.0 110.936 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 447' ' ' VAL . . . . . 0.503 ' CG2' ' O ' ' A' ' 446' ' ' PHE . 94.3 t -161.02 153.56 4.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.176 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 448' ' ' SER . . . . . 0.417 ' N ' HG12 ' A' ' 447' ' ' VAL . 65.7 p -153.12 148.39 26.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.876 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 449' ' ' TYR . . . . . 0.497 ' CE1' HD12 ' A' ' 403' ' ' LEU . 5.9 m-85 -110.43 -174.93 2.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.966 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -78.22 -25.55 47.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.817 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -146.87 158.28 45.73 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.66 0.743 . . . . 0.0 110.898 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 452' ' ' PRO . . . . . 0.414 ' N ' ' HB2' ' A' ' 401' ' ' ALA . 61.2 Cg_endo -75.5 0.24 9.33 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.714 2.276 . . . . 0.0 112.317 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 75.5 t -88.5 -36.03 8.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.146 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 71.3 m -83.63 -39.94 19.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.88 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -50.66 -33.31 21.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.1 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -69.15 -45.55 69.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -41.6 -44.49 3.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.089 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 458' ' ' ALA . . . . . 0.503 ' HA ' ' CE2' ' A' ' 424' ' ' PHE . . . -63.85 -64.3 0.93 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.086 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 459' ' ' ILE . . . . . 0.41 ' O ' ' C ' ' A' ' 460' ' ' GLN . 65.9 mt -41.46 -47.15 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.171 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 460' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 459' ' ' ILE . 14.4 mm100 -36.89 -60.33 0.63 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.94 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 13.3 t -87.0 -52.93 5.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.884 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 462' ' ' MET . . . . . 0.468 ' SD ' ' CE1' ' A' ' 421' ' ' PHE . 7.5 mmt -40.43 -56.86 1.93 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -42.45 107.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.912 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 80.12 32.92 34.13 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.507 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -75.77 110.96 10.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.775 0.322 . . . . 0.0 110.891 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 12.6 tm0? -63.08 102.9 0.41 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.918 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 467' ' ' ILE . . . . . 0.521 HD11 ' CE1' ' A' ' 412' ' ' PHE . 16.1 tt -115.27 144.52 22.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.154 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 46.68 -95.94 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.498 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 4.6 tpt -130.22 -3.47 4.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.791 0.329 . . . . 0.0 110.869 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 11.7 pttm -125.26 -178.53 4.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.88 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 66.9 mtm-85 -108.25 172.38 6.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.843 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 82.8 mt -120.52 156.92 30.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.952 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 32.4 tttp -136.15 105.03 5.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.898 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 474' ' ' VAL . . . . . 0.433 HG22 HG13 ' A' ' 405' ' ' ILE . 12.1 t -113.76 133.2 60.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.171 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -155.23 138.2 15.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 476' ' ' LEU . . . . . 0.635 ' C ' HD12 ' A' ' 476' ' ' LEU . 1.6 pp -79.03 129.14 34.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.535 ' HB2' ' CE1' ' A' ' 404' ' ' PHE . 31.8 tttt -34.04 99.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.909 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 28.1 ttm-85 -97.62 139.35 33.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.866 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 16.8 m -105.92 -61.89 1.44 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.797 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -115.46 157.43 24.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -125.63 -47.92 1.68 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.823 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 24.8 p-10 -92.64 165.75 12.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.897 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 483' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 484' ' ' LYS . 2.7 t 40.96 40.18 0.97 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 484' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 483' ' ' SER . 8.6 tptm -36.54 -53.88 0.87 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.884 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 70.3 m -144.9 145.79 31.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.885 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -144.16 147.57 18.9 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.588 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.58 109.63 0.2 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.704 2.269 . . . . 0.0 112.365 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 44.5 m -71.37 165.54 23.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.811 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 55.9 p -164.37 155.44 15.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.519 179.995 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 15.2 m -142.05 159.47 42.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.896 0.379 . . . . 0.0 110.884 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 80.3 p -158.22 140.28 14.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -166.31 66.36 0.2 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.393 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 2.0 t -115.64 118.46 33.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.792 0.329 . . . . 0.0 110.849 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 62.0 p -102.65 80.03 1.87 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.823 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 49.03 -177.83 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.478 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -85.37 176.79 8.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.91 0.386 . . . . 0.0 110.903 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 6.9 t -108.76 -39.33 5.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.155 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -155.09 128.74 8.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.861 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 21.7 tm0? -61.0 -53.35 58.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.944 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 5.0 m -103.36 125.18 49.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.868 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 5.3 mp -98.2 119.13 45.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.172 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -60.33 96.94 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.476 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -122.77 -49.61 1.98 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.778 0.323 . . . . 0.0 111.1 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -45.43 101.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.13 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 85.89 35.0 11.86 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.5 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 2.2 t -121.68 121.58 37.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.849 0.357 . . . . 0.0 110.828 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -89.22 60.2 5.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.905 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 4.1 ptmm? -126.12 176.24 7.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.861 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -148.18 179.01 8.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -98.47 -146.0 19.76 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.491 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.19 155.05 46.99 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.648 2.232 . . . . 0.0 112.317 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -55.12 118.75 4.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.87 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 120.21 -27.4 6.7 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.527 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 401' ' ' ALA . . . . . 0.493 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.97 126.95 43.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.769 0.318 . . . . 0.0 111.06 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 402' ' ' ASN . . . . . 0.493 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.7 OUTLIER -158.87 165.02 35.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 403' ' ' LEU . . . . . 0.5 HD12 ' CE1' ' A' ' 449' ' ' TYR . 15.5 mt -159.34 122.04 3.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.941 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 404' ' ' PHE . . . . . 0.465 ' CE1' ' CD1' ' A' ' 446' ' ' PHE . 29.1 m-85 -128.94 111.56 13.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 405' ' ' ILE . . . . . 0.736 HG21 HD21 ' A' ' 408' ' ' LEU . 3.9 mp -91.17 135.2 27.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.155 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 406' ' ' TYR . . . . . 0.424 ' CD1' ' HB2' ' A' ' 444' ' ' PHE . 89.5 m-85 -125.74 163.25 23.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.986 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 407' ' ' HIS . . . . . 0.421 ' N ' ' O ' ' A' ' 443' ' ' CYS . 31.9 m80 61.48 52.98 3.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.843 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.736 HD21 HG21 ' A' ' 405' ' ' ILE . 65.0 mt -92.24 128.92 43.13 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.571 0.7 . . . . 0.0 110.922 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -48.35 179.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.466 -0.126 0 C-N-CA 122.684 2.256 . . . . 0.0 112.33 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 23.8 tm0? -82.56 -41.28 19.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.899 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -65.75 -32.66 74.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.874 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.507 ' CE1' HD11 ' A' ' 467' ' ' ILE . 6.5 m-85 -59.88 138.72 57.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.899 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -137.05 -138.19 3.73 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.47 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -81.13 -61.09 2.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.704 0.288 . . . . 0.0 110.881 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 4.5 mm100 -52.85 -53.72 44.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.954 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -41.36 -52.25 3.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.839 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 25.1 tp -55.44 -54.96 37.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.89 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 418' ' ' LEU . . . . . 0.41 ' O ' ' CG ' ' A' ' 422' ' ' MET . 55.8 tp -50.3 -45.3 54.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.924 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -77.89 -9.06 58.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 1.5 tpt -87.88 -27.35 22.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.796 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -110.1 -18.57 13.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.849 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.576 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 0.2 OUTLIER -52.18 -46.14 93.8 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.599 0.714 . . . . 0.0 110.901 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 422' ' ' MET . 64.1 Cg_exo -47.97 -37.24 29.26 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.654 2.236 . . . . 0.0 112.39 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 424' ' ' PHE . . . . . 0.464 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 69.5 m-85 -71.41 -35.8 71.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.859 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 174.06 -171.47 44.55 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.426 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -75.27 116.26 15.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.818 0.342 . . . . 0.0 110.874 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.473 HG11 ' HB2' ' A' ' 430' ' ' ALA . 88.0 t -87.44 120.56 36.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.117 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 60.5 t -78.16 -43.6 27.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.127 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -132.73 139.17 47.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.833 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 430' ' ' ALA . . . . . 0.473 ' HB2' HG11 ' A' ' 427' ' ' VAL . . . -157.8 120.49 3.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.105 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 431' ' ' LYS . . . . . 0.45 ' CG ' ' N ' ' A' ' 432' ' ' VAL . 20.0 tttm -161.02 160.53 30.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.806 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.45 ' N ' ' CG ' ' A' ' 431' ' ' LYS . 41.0 t -119.18 140.2 43.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.172 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 433' ' ' PHE . . . . . 0.56 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.1 m-85 -83.27 151.78 25.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 84.3 mt -138.14 150.97 24.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.042 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -90.62 128.66 36.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.888 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -72.08 -3.75 24.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.906 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -99.66 -47.43 5.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.89 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 27.5 p -92.4 -20.57 20.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.102 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 60.18 33.38 21.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.996 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 441' ' ' SER . 10.0 mt -135.22 145.37 47.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.925 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 441' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 440' ' ' LEU . 24.3 p -36.91 140.53 0.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.603 ' HB3' ' CE2' ' A' ' 444' ' ' PHE . 18.6 mttp -84.24 21.85 1.33 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.912 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 443' ' ' CYS . . . . . 0.421 ' O ' ' N ' ' A' ' 407' ' ' HIS . 0.8 OUTLIER 53.56 25.03 4.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.918 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 444' ' ' PHE . . . . . 0.603 ' CE2' ' HB3' ' A' ' 442' ' ' LYS . 0.9 OUTLIER -162.56 141.4 8.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.884 -179.854 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -135.6 175.66 20.62 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.48 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 446' ' ' PHE . . . . . 0.465 ' CD1' ' CE1' ' A' ' 404' ' ' PHE . 26.0 t80 -114.21 153.37 29.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.896 0.379 . . . . 0.0 110.873 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 447' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 446' ' ' PHE . 79.0 t -158.1 154.83 5.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.086 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 448' ' ' SER . . . . . 0.431 ' N ' HG12 ' A' ' 447' ' ' VAL . 2.1 m -153.69 145.12 23.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.867 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 449' ' ' TYR . . . . . 0.5 ' CE1' HD12 ' A' ' 403' ' ' LEU . 4.2 m-85 -108.48 -174.72 2.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.934 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -78.5 -15.69 58.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.78 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 451' ' ' ASN . . . . . 0.451 ' OD1' ' N ' ' A' ' 451' ' ' ASN . 0.7 OUTLIER -158.69 160.17 29.41 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.598 0.713 . . . . 0.0 110.928 -179.918 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 452' ' ' PRO . . . . . 0.449 ' N ' ' HB2' ' A' ' 401' ' ' ALA . 60.9 Cg_endo -74.87 -18.13 19.34 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.674 2.249 . . . . 0.0 112.354 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 62.4 t -72.16 -42.78 66.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.105 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 41.8 m -80.8 -41.42 23.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.851 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 455' ' ' ALA . . . . . 0.458 ' HB2' ' HB2' ' A' ' 449' ' ' TYR . . . -50.51 -35.42 29.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.078 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 456' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' A' ' 457' ' ' ALA . 14.1 mm-40 -66.73 -44.75 80.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.918 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 457' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 456' ' ' GLN . . . -37.48 -43.18 0.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.085 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 458' ' ' ALA . . . . . 0.464 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -61.43 -69.44 0.24 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.147 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 459' ' ' ILE . . . . . 0.448 ' O ' ' C ' ' A' ' 460' ' ' GLN . 79.6 mt -44.13 -48.76 2.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.171 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 460' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 459' ' ' ILE . 35.9 mm-40 -34.62 -42.79 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.895 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 2.1 m -103.93 -56.53 2.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.848 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 462' ' ' MET . . . . . 0.443 ' O ' ' N ' ' A' ' 465' ' ' PHE . 82.8 mmm -43.22 -46.51 6.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.881 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -41.56 104.19 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.903 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 80.22 31.61 37.77 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.502 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 465' ' ' PHE . . . . . 0.443 ' N ' ' O ' ' A' ' 462' ' ' MET . 66.2 t80 -71.93 117.24 13.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.862 0.363 . . . . 0.0 110.823 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 12.3 tm0? -66.01 107.04 1.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.883 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 467' ' ' ILE . . . . . 0.507 HD11 ' CE1' ' A' ' 412' ' ' PHE . 20.1 tt -116.66 145.31 22.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.166 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 40.45 -95.56 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.49 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 469' ' ' MET . . . . . 0.43 ' N ' ' O ' ' A' ' 467' ' ' ILE . 12.8 tmm? -126.77 -9.89 6.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.905 0.383 . . . . 0.0 110.874 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.68 174.97 6.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 40.1 mtt180 -104.79 167.65 9.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.915 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 65.1 mt -111.2 155.39 23.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.913 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -132.95 104.66 6.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.836 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 4.3 t -109.9 138.34 38.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.216 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -156.86 139.77 15.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.98 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 476' ' ' LEU . . . . . 0.77 HD12 ' O ' ' A' ' 477' ' ' LYS . 1.5 pp -85.79 126.59 34.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.846 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.77 ' O ' HD12 ' A' ' 476' ' ' LEU . 11.3 tptm -34.14 133.76 0.21 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.912 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.32 151.84 47.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.861 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 2.2 m -160.73 154.55 22.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.882 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -115.91 79.68 1.34 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.935 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -136.07 115.34 12.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.964 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -166.36 115.64 0.93 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.895 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 2.4 p -116.4 -9.84 11.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.55 -70.03 0.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.894 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 2.0 m -160.42 169.21 23.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.849 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -130.43 96.88 0.37 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.486 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.18 90.74 0.97 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.649 2.233 . . . . 0.0 112.367 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 3.0 t -97.32 97.73 9.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.853 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 31.1 p -166.27 160.95 16.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.906 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.477 179.998 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.391 0 N-CA-C 112.494 -0.242 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 59.5 m -109.91 158.66 17.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.893 0.378 . . . . 0.0 110.856 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 58.3 m -99.98 164.31 12.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.875 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -138.46 -109.62 0.89 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.538 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 3.1 m -130.03 116.13 18.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.863 0.363 . . . . 0.0 110.863 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 70.5 p -136.17 168.36 19.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.845 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 84.06 108.9 0.58 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.469 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 16.7 tp -80.51 91.02 5.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.887 0.375 . . . . 0.0 110.914 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 36.3 p -108.38 158.55 17.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.181 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -104.5 122.39 45.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.947 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -95.68 103.97 15.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 56.7 m -124.95 41.46 3.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.867 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.569 ' H ' HD12 ' A' ' 388' ' ' ILE . 5.1 mp -75.88 133.98 30.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.119 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -114.73 101.53 1.08 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.533 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -84.44 -30.96 24.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.785 0.326 . . . . 0.0 111.113 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -51.72 135.27 29.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.157 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 393' ' ' SER . . . 81.66 -51.71 4.46 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.483 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 393' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 392' ' ' GLY . 27.8 m -37.32 124.62 0.99 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.819 0.342 . . . . 0.0 110.878 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -101.65 27.29 6.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.903 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.498 ' O ' ' CB ' ' A' ' 429' ' ' SER . 7.8 mtpt -81.49 170.46 15.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.9 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -140.14 168.44 19.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.832 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -84.18 -152.93 16.05 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.444 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.05 157.76 46.42 Favored 'Trans proline' 0 N--CA 1.465 -0.188 0 C-N-CA 122.714 2.276 . . . . 0.0 112.39 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -55.42 110.46 0.7 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.858 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 127.77 -28.37 4.43 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.53 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 401' ' ' ALA . . . . . 0.501 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.94 127.14 43.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.781 0.324 . . . . 0.0 111.081 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 402' ' ' ASN . . . . . 0.501 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.6 OUTLIER -158.75 164.04 36.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.921 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 403' ' ' LEU . . . . . 0.595 HD12 ' CE1' ' A' ' 449' ' ' TYR . 20.1 mt -159.71 120.97 3.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 404' ' ' PHE . . . . . 0.538 ' CZ ' ' CD1' ' A' ' 446' ' ' PHE . 35.8 m-85 -126.59 111.16 14.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.939 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 405' ' ' ILE . . . . . 0.553 ' N ' HD12 ' A' ' 405' ' ' ILE . 4.0 mp -91.23 128.22 43.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.116 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -122.11 151.84 40.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.94 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 407' ' ' HIS . . . . . 0.48 ' O ' ' CD2' ' A' ' 472' ' ' LEU . 10.8 m80 72.9 47.8 0.2 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.85 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.536 HD21 HG21 ' A' ' 405' ' ' ILE . 31.2 mt -91.39 137.73 25.88 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.643 0.735 . . . . 0.0 110.924 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -47.91 177.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.662 2.241 . . . . 0.0 112.344 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -85.92 -46.13 10.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.916 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 411' ' ' GLU . . . . . 0.42 ' HG3' ' N ' ' A' ' 412' ' ' PHE . 12.7 pt-20 -58.54 -40.1 82.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.42 ' N ' ' HG3' ' A' ' 411' ' ' GLU . 7.9 m-85 -50.35 146.59 5.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 413' ' ' GLY . . . . . 0.401 ' O ' HG21 ' A' ' 432' ' ' VAL . . . -132.75 -139.21 4.22 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.444 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -86.12 -51.48 6.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.708 0.289 . . . . 0.0 110.795 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 2.4 mm100 -61.79 -52.42 64.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.942 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -39.69 -59.92 1.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 417' ' ' LEU . . . . . 0.449 HD11 HG12 ' A' ' 405' ' ' ILE . 56.1 tp -49.67 -45.13 48.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.966 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 22.2 tp -62.95 -44.24 96.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.851 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -72.18 -9.73 58.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.87 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 6.2 ttm -93.89 -27.75 16.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.83 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 421' ' ' PHE . . . . . 0.443 ' CZ ' ' CG1' ' A' ' 405' ' ' ILE . 5.4 m-85 -101.25 -20.35 15.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.866 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.579 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 3.1 mtt -49.7 -46.19 79.61 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.613 0.72 . . . . 0.0 110.911 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.3 Cg_exo -47.96 -45.68 24.17 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.705 2.27 . . . . 0.0 112.356 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 424' ' ' PHE . . . . . 0.538 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 86.6 m-85 -64.03 -30.17 71.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.933 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 168.71 170.05 32.88 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.519 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -66.31 94.02 0.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.841 0.353 . . . . 0.0 110.862 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 92.4 t -62.29 133.86 27.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.133 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 75.7 t -79.88 -48.17 20.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.159 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 429' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 44.5 t -136.45 148.3 47.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -161.21 114.01 1.91 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.116 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 431' ' ' LYS . . . . . 0.417 ' C ' ' HD2' ' A' ' 431' ' ' LYS . 2.0 tmmm? -154.99 142.47 19.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.925 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.401 HG21 ' O ' ' A' ' 413' ' ' GLY . 87.4 t -93.43 137.95 21.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.119 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 433' ' ' PHE . . . . . 0.463 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.3 m-85 -79.22 153.97 29.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.884 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.526 HG22 ' N ' ' A' ' 435' ' ' ASP . 77.2 mt -123.81 158.49 29.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.098 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 435' ' ' ASP . . . . . 0.526 ' N ' HG22 ' A' ' 434' ' ' ILE . 7.0 t0 -87.94 138.89 31.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.782 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.04 -2.48 58.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.903 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -106.95 -52.4 2.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.893 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 30.8 p -88.38 -20.55 25.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.124 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 59.96 38.55 20.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.827 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 74.7 mt -127.87 132.17 49.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.965 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 49.2 p -39.92 107.28 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.882 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.546 ' HD3' ' CE2' ' A' ' 444' ' ' PHE . 14.5 mttm -52.78 -176.21 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 83.6 m -106.83 37.99 2.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.865 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 444' ' ' PHE . . . . . 0.546 ' CE2' ' HD3' ' A' ' 442' ' ' LYS . 4.6 p90 -162.07 138.84 8.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.859 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -132.55 169.31 22.39 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.509 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 446' ' ' PHE . . . . . 0.538 ' CD1' ' CZ ' ' A' ' 404' ' ' PHE . 61.4 t80 -106.33 154.26 21.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.925 0.393 . . . . 0.0 110.831 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 447' ' ' VAL . . . . . 0.425 HG23 ' C ' ' A' ' 446' ' ' PHE . 64.1 t -158.13 152.91 6.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.097 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 448' ' ' SER . . . . . 0.416 ' N ' HG12 ' A' ' 447' ' ' VAL . 60.6 p -150.39 152.8 34.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.876 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 449' ' ' TYR . . . . . 0.595 ' CE1' HD12 ' A' ' 403' ' ' LEU . 5.1 m-85 -116.89 179.57 3.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.933 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 450' ' ' ASP . . . . . 0.446 ' CG ' ' OD1' ' A' ' 451' ' ' ASN . 0.6 OUTLIER -71.89 -28.91 63.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.868 179.858 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 451' ' ' ASN . . . . . 0.446 ' OD1' ' CG ' ' A' ' 450' ' ' ASP . 0.9 OUTLIER -146.64 155.92 48.72 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.659 0.742 . . . . 0.0 110.878 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.0 -12.6 28.41 Favored 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.71 2.273 . . . . 0.0 112.414 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 95.5 t -79.64 -33.13 14.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.187 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 78.3 p -84.0 -40.63 18.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.89 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -51.73 -40.4 60.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.159 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 53.0 mm-40 -57.08 -48.96 77.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.949 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -38.69 -40.58 0.62 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.119 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 458' ' ' ALA . . . . . 0.538 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -67.57 -63.99 0.95 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.1 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 459' ' ' ILE . . . . . 0.487 ' O ' ' CB ' ' A' ' 463' ' ' ASN . 81.0 mt -46.68 -44.24 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.17 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -41.63 -49.2 4.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.929 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 1.8 m -98.02 -57.13 2.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.82 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 462' ' ' MET . . . . . 0.447 ' HB3' HG21 ' A' ' 474' ' ' VAL . 85.2 mmm -42.93 -38.55 2.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.825 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 463' ' ' ASN . . . . . 0.487 ' CB ' ' O ' ' A' ' 459' ' ' ILE . 15.1 t30 -49.12 106.0 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.904 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 78.3 32.16 44.13 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.5 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -70.79 105.26 3.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.796 0.332 . . . . 0.0 110.88 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -63.62 103.24 0.52 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 467' ' ' ILE . . . . . 0.486 HG23 ' O ' ' A' ' 467' ' ' ILE . 16.9 tt -113.0 122.26 66.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.175 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 70.56 -96.9 0.59 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.488 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 41.2 mtt -133.25 8.61 4.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.859 0.361 . . . . 0.0 110.881 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.3 175.46 9.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.856 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 71.6 mtt-85 -108.98 170.45 8.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.827 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 472' ' ' LEU . . . . . 0.48 ' CD2' ' O ' ' A' ' 407' ' ' HIS . 72.4 mt -121.97 157.87 30.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.925 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 33.5 tttp -128.56 101.36 6.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.911 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 474' ' ' VAL . . . . . 0.447 HG21 ' HB3' ' A' ' 462' ' ' MET . 16.6 t -106.49 127.4 61.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.111 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -151.86 147.16 26.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.923 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 476' ' ' LEU . . . . . 0.632 ' C ' HD12 ' A' ' 476' ' ' LEU . 1.6 pp -91.18 129.34 37.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.917 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.601 ' O ' HD12 ' A' ' 476' ' ' LEU . 38.3 tttt -34.34 121.33 0.48 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.91 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -119.01 170.28 9.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.924 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 5.7 t 58.97 42.34 19.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.999 0.428 . . . . 0.0 110.872 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 21.2 tttt -98.67 -51.47 3.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.948 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -124.84 130.04 51.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.932 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.55 146.32 43.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.858 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 7.7 t -103.48 152.31 21.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.822 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.0 163.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.95 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 18.5 m -143.05 121.82 12.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.865 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 136.69 138.73 3.83 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.528 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -79.17 118.83 4.09 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.751 2.301 . . . . 0.0 112.334 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 27.5 t -77.82 -59.92 2.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.839 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 7.6 t -110.33 -57.28 2.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.869 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.428 -179.979 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.373 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 88.3 p -172.78 157.79 3.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.878 0.37 . . . . 0.0 110.854 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 13.8 t -122.7 120.34 33.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -163.69 164.15 36.16 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.461 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 30.9 t -75.76 93.13 3.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.885 0.374 . . . . 0.0 110.873 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 68.3 m -89.99 96.49 10.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.882 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 59.46 -148.46 41.19 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.501 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 5.0 mp 58.42 43.58 19.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.88 0.372 . . . . 0.0 110.874 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 92.4 m -97.37 133.15 42.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.137 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -113.26 -46.84 3.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.921 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -93.54 126.54 38.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.932 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 23.0 t -128.81 85.03 2.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.777 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.509 ' H ' HD12 ' A' ' 388' ' ' ILE . 5.1 mp -66.34 140.54 19.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.094 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -54.24 113.24 3.17 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.498 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -111.31 -37.73 5.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.733 0.301 . . . . 0.0 111.072 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -59.42 112.08 1.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.069 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 392' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 393' ' ' SER . . . 96.95 -30.21 9.36 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.453 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 393' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 392' ' ' GLY . 46.9 t -34.85 -47.98 0.37 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.834 0.349 . . . . 0.0 110.913 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.84 44.33 1.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.947 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 429' ' ' SER . 22.4 ptmt -105.71 174.18 5.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.892 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 396' ' ' GLU . . . . . 0.605 ' OE2' ' CE2' ' A' ' 446' ' ' PHE . 6.1 mm-40 -129.87 179.72 5.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -117.2 -148.59 8.83 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.515 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -76.02 151.47 35.11 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.781 2.32 . . . . 0.0 112.32 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -56.44 108.89 0.53 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.902 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 128.61 -28.39 4.22 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.509 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 401' ' ' ALA . . . . . 0.563 ' HB2' ' CA ' ' A' ' 452' ' ' PRO . . . -97.86 126.98 43.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.826 0.346 . . . . 0.0 111.074 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 402' ' ' ASN . . . . . 0.505 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.6 OUTLIER -158.7 161.85 37.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.873 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 403' ' ' LEU . . . . . 0.54 HD12 ' CE1' ' A' ' 449' ' ' TYR . 38.4 mt -154.57 125.84 7.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.903 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 404' ' ' PHE . . . . . 0.58 ' CE1' ' HB2' ' A' ' 477' ' ' LYS . 27.8 m-85 -133.83 114.64 13.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 405' ' ' ILE . . . . . 0.673 HG12 HD11 ' A' ' 417' ' ' LEU . 3.0 mp -90.85 131.55 37.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.121 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 406' ' ' TYR . . . . . 0.472 ' CZ ' ' HB3' ' A' ' 404' ' ' PHE . 47.3 m-85 -125.31 171.12 10.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.976 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 45.8 m-70 53.67 50.98 15.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.869 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.636 HD11 ' CG2' ' A' ' 405' ' ' ILE . 46.6 mt -100.24 151.71 37.61 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.636 0.731 . . . . 0.0 110.928 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.512 ' HG2' ' CD1' ' A' ' 412' ' ' PHE . 57.4 Cg_endo -70.54 -168.31 0.3 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.689 2.259 . . . . 0.0 112.322 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -98.51 -37.91 9.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.872 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 411' ' ' GLU . . . . . 0.444 ' C ' ' OE1' ' A' ' 411' ' ' GLU . 0.2 OUTLIER -57.88 -38.33 75.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 -179.881 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 412' ' ' PHE . . . . . 0.512 ' CD1' ' HG2' ' A' ' 409' ' ' PRO . 6.5 m-85 -58.97 140.94 55.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.93 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -126.58 -134.19 3.98 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.471 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -87.99 -54.96 3.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.757 0.313 . . . . 0.0 110.837 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 415' ' ' GLN . . . . . 0.442 ' O ' ' C ' ' A' ' 416' ' ' ASP . 43.2 mm-40 -59.86 -60.64 3.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.852 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 416' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 415' ' ' GLN . 45.7 m-20 -34.47 -57.7 0.5 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.925 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 417' ' ' LEU . . . . . 0.673 HD11 HG12 ' A' ' 405' ' ' ILE . 67.6 tp -53.71 -44.35 69.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.838 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 418' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' A' ' 415' ' ' GLN . 29.7 tp -66.55 -61.67 1.86 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.87 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -51.84 -17.21 0.88 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 3.3 ttm -84.21 -35.91 23.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.825 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 421' ' ' PHE . . . . . 0.425 ' C ' ' HD2' ' A' ' 423' ' ' PRO . 4.0 m-85 -92.2 -17.86 24.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.88 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.581 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 4.2 mtt -51.12 -45.81 88.71 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.54 0.686 . . . . 0.0 110.842 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 422' ' ' MET . 66.2 Cg_exo -48.03 -46.77 21.13 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.596 2.197 . . . . 0.0 112.34 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 424' ' ' PHE . . . . . 0.564 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 56.0 m-85 -60.14 -36.03 76.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.81 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 170.18 -179.57 42.32 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.476 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -69.17 109.72 4.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.88 0.371 . . . . 0.0 110.903 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 91.1 t -79.3 131.37 34.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.106 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 428' ' ' VAL . . . . . 0.442 HG12 ' HG3' ' A' ' 395' ' ' LYS . 55.2 t -84.36 -47.68 17.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.152 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 429' ' ' SER . . . . . 0.492 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 23.3 t -129.57 144.4 51.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.814 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -160.44 111.09 1.83 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.118 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -159.04 135.1 8.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.856 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 80.0 t -90.05 142.5 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.162 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 433' ' ' PHE . . . . . 0.54 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.0 m-85 -83.84 144.48 29.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.432 HG23 ' C ' ' A' ' 440' ' ' LEU . 21.0 mt -138.08 149.89 24.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.12 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -82.48 151.94 26.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.83 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -82.05 -30.96 31.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -77.57 -58.98 2.97 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.88 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 44.3 p -72.05 -42.86 65.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.205 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 5.6 t30 74.97 36.1 0.57 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 440' ' ' LEU . . . . . 0.444 ' O ' ' C ' ' A' ' 441' ' ' SER . 5.7 mt -139.27 138.39 36.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.921 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 441' ' ' SER . . . . . 0.444 ' C ' ' O ' ' A' ' 440' ' ' LEU . 52.7 m -34.35 137.29 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.863 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.487 ' CB ' ' CE2' ' A' ' 444' ' ' PHE . 84.8 mttt -83.41 20.62 1.3 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.884 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 98.9 m 62.76 27.41 16.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.884 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 444' ' ' PHE . . . . . 0.54 ' CE1' ' HB2' ' A' ' 433' ' ' PHE . 3.7 p90 -162.28 139.93 8.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.868 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -131.09 175.86 19.31 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.503 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 446' ' ' PHE . . . . . 0.605 ' CE2' ' OE2' ' A' ' 396' ' ' GLU . 35.0 t80 -116.01 153.76 31.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.908 0.385 . . . . 0.0 110.857 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 447' ' ' VAL . . . . . 0.406 ' HB ' ' CB ' ' A' ' 403' ' ' LEU . 65.5 t -154.69 150.13 11.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.102 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 6.1 p -147.1 141.35 26.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 449' ' ' TYR . . . . . 0.54 ' CE1' HD12 ' A' ' 403' ' ' LEU . 3.8 m-85 -111.42 170.46 8.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.867 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -67.09 -25.65 66.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.803 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 451' ' ' ASN . . . . . 0.405 ' OD1' ' N ' ' A' ' 451' ' ' ASN . 2.0 p-10 -143.32 156.98 60.64 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.611 0.72 . . . . 0.0 110.896 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 452' ' ' PRO . . . . . 0.563 ' CA ' ' HB2' ' A' ' 401' ' ' ALA . 61.2 Cg_endo -75.39 -22.12 14.46 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.653 2.235 . . . . 0.0 112.377 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 98.3 t -72.82 -40.9 61.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.109 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 1.8 m -73.08 -42.65 62.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.81 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 455' ' ' ALA . . . . . 0.4 ' HB2' ' HB2' ' A' ' 449' ' ' TYR . . . -52.83 -42.67 65.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.097 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 5.1 mm100 -53.76 -44.86 70.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.867 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -43.63 -43.02 5.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.11 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 458' ' ' ALA . . . . . 0.564 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -58.18 -66.37 0.49 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.185 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 459' ' ' ILE . . . . . 0.454 ' O ' ' C ' ' A' ' 460' ' ' GLN . 58.8 mt -50.1 -48.94 23.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.121 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 460' ' ' GLN . . . . . 0.454 ' C ' ' O ' ' A' ' 459' ' ' ILE . 23.1 mt-30 -33.91 -43.24 0.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.93 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 34.1 t -102.55 -56.91 2.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 462' ' ' MET . . . . . 0.427 ' O ' ' N ' ' A' ' 465' ' ' PHE . 80.6 mmm -44.36 -47.83 9.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.819 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -40.35 100.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.854 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 80.99 37.22 19.57 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.477 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 465' ' ' PHE . . . . . 0.427 ' N ' ' O ' ' A' ' 462' ' ' MET . 64.9 t80 -77.79 115.36 17.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.816 0.341 . . . . 0.0 110.899 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -64.28 102.88 0.57 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.952 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 467' ' ' ILE . . . . . 0.484 HG21 HD21 ' A' ' 472' ' ' LEU . 19.4 tt -112.94 144.95 19.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.153 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 42.45 -96.94 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.457 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 54.4 mtm -125.1 -7.77 7.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.863 0.363 . . . . 0.0 110.877 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.91 -177.96 3.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.907 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 68.0 mtt85 -112.2 168.4 9.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.867 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 472' ' ' LEU . . . . . 0.484 HD21 HG21 ' A' ' 467' ' ' ILE . 56.7 mt -111.22 158.35 19.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.912 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 21.4 ttmt -134.5 99.96 4.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 11.4 t -105.84 138.2 32.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.14 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 475' ' ' GLN . . . . . 0.446 ' OE1' ' NH1' ' A' ' 478' ' ' ARG . 37.5 tt0 -156.98 138.2 13.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.834 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 476' ' ' LEU . . . . . 0.697 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.6 pp -78.93 124.37 28.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.886 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.58 ' HB2' ' CE1' ' A' ' 404' ' ' PHE . 0.3 OUTLIER -61.26 117.21 5.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.85 179.828 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 478' ' ' ARG . . . . . 0.446 ' NH1' ' OE1' ' A' ' 475' ' ' GLN . 4.0 mpt_? -74.23 139.46 44.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 95.1 p -50.1 135.1 21.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.11 176.86 11.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.932 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -135.97 137.09 40.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.894 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -129.72 -56.53 1.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.868 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 94.0 p -166.0 112.55 0.88 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.79 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 5.3 tmtm? -121.1 125.82 48.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.87 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 43.5 t -141.65 156.45 45.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -96.56 134.25 11.73 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.471 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -78.06 120.93 5.16 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.741 2.294 . . . . 0.0 112.341 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 80.6 p -93.52 89.26 6.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.789 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 25.0 p 44.02 41.98 4.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.843 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.459 179.993 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.256 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 44.8 p -94.18 138.82 31.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.848 0.356 . . . . 0.0 110.891 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 55.5 p -73.33 175.42 6.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.874 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -161.83 148.23 15.43 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.547 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 25.4 t -116.63 91.96 3.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.926 0.394 . . . . 0.0 110.8 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 19.6 m -96.96 99.59 11.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.862 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 47.17 -127.53 11.88 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.499 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 383' ' ' LEU . . . . . 0.616 HD23 ' O ' ' A' ' 383' ' ' LEU . 1.8 tt 64.01 41.29 6.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.855 0.36 . . . . 0.0 110.956 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 70.0 p -136.83 157.28 47.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.139 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -102.37 116.11 31.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.923 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -151.74 136.02 16.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.925 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 17.7 m -122.85 91.75 3.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.842 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 388' ' ' ILE . . . . . 0.559 ' N ' HD12 ' A' ' 388' ' ' ILE . 4.0 mp -119.74 135.01 61.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.115 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -61.51 118.09 13.69 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.498 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -110.74 31.54 5.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.839 0.352 . . . . 0.0 111.145 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -90.98 132.83 35.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.05 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 83.83 -41.12 2.93 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.459 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 11.4 m -43.98 114.2 0.63 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.837 0.351 . . . . 0.0 110.916 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -87.15 42.64 1.04 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.936 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 395' ' ' LYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 429' ' ' SER . 14.7 ptmt -102.38 176.76 5.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.928 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -143.34 -178.38 5.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.901 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -100.08 -154.7 27.73 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.468 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.57 159.24 46.41 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.715 2.276 . . . . 0.0 112.349 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -54.51 116.38 2.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 120.33 -27.74 6.54 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.499 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 401' ' ' ALA . . . . . 0.488 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.91 127.18 43.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.858 0.361 . . . . 0.0 111.063 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 402' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.6 OUTLIER -158.73 160.0 35.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 -179.917 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 403' ' ' LEU . . . . . 0.467 HD12 ' CE1' ' A' ' 449' ' ' TYR . 23.1 mt -156.0 122.25 5.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.924 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 404' ' ' PHE . . . . . 0.522 ' CE1' ' HD3' ' A' ' 477' ' ' LYS . 36.6 m-85 -131.33 110.85 11.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.834 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 405' ' ' ILE . . . . . 0.682 ' N ' HD12 ' A' ' 405' ' ' ILE . 3.0 mp -91.18 136.76 23.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.116 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -131.2 165.69 22.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.956 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 407' ' ' HIS . . . . . 0.463 ' O ' HD23 ' A' ' 472' ' ' LEU . 24.5 m80 58.96 53.22 5.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.891 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 408' ' ' LEU . . . . . 0.4 ' O ' ' O ' ' A' ' 409' ' ' PRO . 21.1 mt -94.83 138.35 22.17 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.613 0.721 . . . . 0.0 110.915 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 409' ' ' PRO . . . . . 0.4 ' O ' ' O ' ' A' ' 408' ' ' LEU . 76.1 Cg_exo -50.02 -172.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.671 2.247 . . . . 0.0 112.384 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -90.93 -43.03 10.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.876 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -62.52 -36.99 84.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -51.57 132.03 30.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.903 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 413' ' ' GLY . . . . . 0.511 ' O ' HG21 ' A' ' 432' ' ' VAL . . . -127.16 -130.91 3.42 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.536 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.56 -62.84 1.37 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.761 0.315 . . . . 0.0 110.836 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 415' ' ' GLN . . . . . 0.42 ' O ' ' C ' ' A' ' 416' ' ' ASP . 35.0 mm-40 -47.06 -58.03 4.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.948 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 416' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 415' ' ' GLN . 71.2 m-20 -36.0 -71.87 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 417' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 416' ' ' ASP . 26.2 tp -37.53 -53.26 1.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.966 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 27.5 tp -54.99 -46.61 75.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.944 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -75.33 -11.83 60.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.924 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 2.9 tpp -86.68 -28.3 23.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 421' ' ' PHE . . . . . 0.443 ' CE1' ' SD ' ' A' ' 462' ' ' MET . 6.0 m-85 -106.56 -11.27 15.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.936 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 422' ' ' MET . . . . . 0.583 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 1.6 mmt -60.59 -45.71 97.18 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.543 0.687 . . . . 0.0 110.852 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 423' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 422' ' ' MET . 66.5 Cg_exo -47.97 -48.44 16.31 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.706 2.271 . . . . 0.0 112.311 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -60.21 -35.15 74.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.865 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 175.79 -171.94 44.98 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.495 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -79.34 105.75 10.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.917 0.389 . . . . 0.0 110.919 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 427' ' ' VAL . . . . . 0.44 HG11 ' HB2' ' A' ' 430' ' ' ALA . 95.9 t -71.82 126.59 32.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.109 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 95.2 t -84.27 -38.31 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.081 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 429' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 1.0 OUTLIER -137.72 140.54 40.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.849 -179.841 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 430' ' ' ALA . . . . . 0.44 ' HB2' HG11 ' A' ' 427' ' ' VAL . . . -160.22 114.55 2.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.087 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -159.5 133.85 7.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 432' ' ' VAL . . . . . 0.511 HG21 ' O ' ' A' ' 413' ' ' GLY . 88.0 t -88.6 153.93 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.153 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 433' ' ' PHE . . . . . 0.436 ' N ' HG12 ' A' ' 432' ' ' VAL . 3.8 m-30 -88.01 153.98 20.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.863 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 434' ' ' ILE . . . . . 0.476 HD13 ' HA ' ' A' ' 441' ' ' SER . 21.3 mm -132.98 141.89 43.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.122 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -85.33 147.88 26.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.92 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 18.2 tptp -92.13 -5.24 53.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -98.37 -46.21 5.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.865 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 30.4 p -97.21 -21.59 17.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.128 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 58.1 t30 55.06 44.88 27.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.865 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 55.3 mt -130.36 160.41 34.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.897 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 441' ' ' SER . . . . . 0.476 ' HA ' HD13 ' A' ' 434' ' ' ILE . 10.3 p -61.94 104.86 0.5 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.913 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 442' ' ' LYS . . . . . 0.562 ' HD3' ' CE1' ' A' ' 444' ' ' PHE . 20.6 mttt -52.46 -174.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.834 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 443' ' ' CYS . . . . . 0.454 ' O ' ' N ' ' A' ' 407' ' ' HIS . 26.7 p -110.27 30.63 6.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.839 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 444' ' ' PHE . . . . . 0.562 ' CE1' ' HD3' ' A' ' 442' ' ' LYS . 7.4 p90 -159.91 145.92 15.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -142.96 175.8 22.9 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.479 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 446' ' ' PHE . . . . . 0.549 ' O ' HG23 ' A' ' 447' ' ' VAL . 25.2 t80 -112.62 154.93 25.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.911 0.386 . . . . 0.0 110.92 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 447' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 446' ' ' PHE . 72.3 t -160.86 156.01 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.134 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 448' ' ' SER . . . . . 0.452 ' N ' HG12 ' A' ' 447' ' ' VAL . 2.4 m -155.89 152.68 28.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.864 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 449' ' ' TYR . . . . . 0.467 ' CE1' HD12 ' A' ' 403' ' ' LEU . 3.7 m-85 -115.63 -175.01 2.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.935 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -79.1 -24.0 43.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.817 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -147.98 158.34 42.16 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.627 0.727 . . . . 0.0 110.844 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.56 -2.13 12.01 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.645 2.23 . . . . 0.0 112.303 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 96.6 t -89.82 -39.85 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.089 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 10.6 t -74.76 -40.14 61.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.876 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -50.64 -32.97 20.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.172 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 456' ' ' GLN . . . . . 0.505 ' O ' ' N ' ' A' ' 458' ' ' ALA . 34.1 mm-40 -61.57 -60.34 3.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.918 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 457' ' ' ALA . . . . . 0.47 ' C ' ' HG2' ' A' ' 460' ' ' GLN . . . -35.89 -30.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.117 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 458' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 456' ' ' GLN . . . -81.53 -44.98 16.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.092 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 459' ' ' ILE . . . . . 0.488 ' N ' ' O ' ' A' ' 456' ' ' GLN . 26.0 mt -70.1 -48.42 62.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.113 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 460' ' ' GLN . . . . . 0.495 ' HG3' ' N ' ' A' ' 461' ' ' SER . 3.8 pt20 -37.01 -45.05 0.55 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.875 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 461' ' ' SER . . . . . 0.495 ' N ' ' HG3' ' A' ' 460' ' ' GLN . 2.0 m -93.94 -54.18 3.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.82 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 462' ' ' MET . . . . . 0.601 ' HB3' HG21 ' A' ' 474' ' ' VAL . 9.6 mmt -44.38 -57.49 3.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.85 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -38.16 97.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 464' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 462' ' ' MET . . . 84.43 34.82 15.65 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.517 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 465' ' ' PHE . . . . . 0.496 ' N ' ' O ' ' A' ' 462' ' ' MET . 48.6 t80 -71.98 125.92 28.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.823 0.344 . . . . 0.0 110.856 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 14.6 tm0? -70.73 117.18 11.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.945 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.6 tt -139.03 133.1 40.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.151 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 50.91 -103.0 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.465 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 11.4 mmm -132.53 25.58 4.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.805 0.336 . . . . 0.0 110.846 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -145.85 179.64 7.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.891 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 -120.32 122.3 40.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.877 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 472' ' ' LEU . . . . . 0.463 HD23 ' O ' ' A' ' 407' ' ' HIS . 52.8 mt -64.48 158.07 24.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.852 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -133.25 111.72 11.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.899 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 474' ' ' VAL . . . . . 0.601 HG21 ' HB3' ' A' ' 462' ' ' MET . 20.9 t -122.22 136.95 57.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.119 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 33.1 tp60 -157.14 141.6 16.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 476' ' ' LEU . . . . . 0.757 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.5 pp -85.01 125.05 32.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.961 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 477' ' ' LYS . . . . . 0.522 ' HD3' ' CE1' ' A' ' 404' ' ' PHE . 7.8 tptm -34.18 109.07 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.932 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 46.3 mtt180 -74.4 98.82 3.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.922 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 80.8 p -112.45 110.71 21.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.887 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -99.26 40.78 1.19 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -84.57 42.19 0.89 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -83.81 86.45 7.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.878 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 22.5 t -115.15 42.85 2.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.813 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -132.2 95.33 3.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.833 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 19.3 m -83.48 102.37 12.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.801 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 113.91 96.46 2.18 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.483 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.62 136.01 20.65 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.66 2.24 . . . . 0.0 112.337 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 14.9 t -108.14 109.73 21.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.871 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 7.0 t -108.59 89.1 2.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.882 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.526 -179.936 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.491 ' O ' ' CB ' ' A' ' 429' ' ' SER . 26.6 mtpp . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.726 0.298 . . . . 0.0 110.966 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -144.52 165.69 27.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.816 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -88.55 -146.43 12.49 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.448 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.44 154.1 40.22 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.647 2.231 . . . . 0.0 112.307 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -52.0 124.64 13.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.916 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 113.53 -27.28 9.48 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.505 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . 0.496 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.94 127.11 43.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.82 0.343 . . . . 0.0 111.11 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.7 OUTLIER -159.05 163.17 36.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . 0.493 HD12 ' CE1' ' A' ' 449' ' ' TYR . 24.1 mt -159.36 122.37 3.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.922 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . 0.615 ' CZ ' ' CD1' ' A' ' 446' ' ' PHE . 41.4 m-85 -129.78 114.81 16.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . 0.62 HG12 HD11 ' A' ' 417' ' ' LEU . 3.8 mp -90.9 134.0 30.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.1 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . 0.446 ' CD2' ' HD3' ' A' ' 473' ' ' LYS . 71.9 m-85 -129.4 166.36 19.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.902 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 59.0 50.5 8.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.83 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.493 HD21 HG21 ' A' ' 405' ' ' ILE . 32.8 mt -91.24 149.21 39.37 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.657 0.741 . . . . 0.0 110.935 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -78.31 169.86 19.45 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.634 2.223 . . . . 0.0 112.342 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -73.59 -31.14 63.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.43 -38.55 91.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.866 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.581 ' CE1' HD11 ' A' ' 467' ' ' ILE . 4.3 m-85 -70.22 148.01 49.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.826 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . 0.525 ' O ' HG21 ' A' ' 432' ' ' VAL . . . -135.25 -133.56 3.27 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.493 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -87.76 -61.9 1.61 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.753 0.311 . . . . 0.0 110.867 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . 0.415 ' O ' ' C ' ' A' ' 416' ' ' ASP . 11.5 mm-40 -54.33 -54.3 42.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.928 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 415' ' ' GLN . 67.0 m-20 -36.91 -60.94 0.58 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.774 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . 0.62 HD11 HG12 ' A' ' 405' ' ' ILE . 24.2 tp -46.52 -45.24 18.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.859 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . 0.451 HD13 ' HB3' ' A' ' 430' ' ' ALA . 27.1 tp -59.62 -54.99 40.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.939 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -68.41 -9.93 51.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.845 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -85.57 -30.57 23.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.859 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . 0.432 ' C ' ' HD2' ' A' ' 423' ' ' PRO . 4.0 m-85 -100.35 -20.9 15.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.864 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . 0.569 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 3.6 mtt -48.85 -46.6 73.78 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.523 0.678 . . . . 0.0 110.787 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 422' ' ' MET . 64.3 Cg_exo -47.97 -38.49 31.45 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.663 2.242 . . . . 0.0 112.354 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . 0.517 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 82.0 m-85 -73.93 -31.91 63.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.909 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 171.6 -177.25 44.52 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.47 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -77.47 94.91 4.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.913 0.387 . . . . 0.0 110.913 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.425 HG22 ' CE1' ' A' ' 449' ' ' TYR . 86.5 t -64.57 127.96 26.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.148 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 79.5 t -78.84 -45.39 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.159 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 8.5 p -128.99 144.7 51.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.89 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . 0.451 ' HB3' HD13 ' A' ' 418' ' ' LEU . . . -160.72 107.53 1.5 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.113 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . 0.482 ' CG ' ' N ' ' A' ' 432' ' ' VAL . 52.2 tttt -145.16 162.74 36.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.887 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.525 HG21 ' O ' ' A' ' 413' ' ' GLY . 18.5 t -124.52 148.12 28.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.138 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . 0.637 ' CG ' ' CE1' ' A' ' 444' ' ' PHE . 4.5 m-85 . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.849 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 22.6 m . . . . . 0 C--O 1.232 0.163 0 CA-C-O 120.869 0.366 . . . . 0.0 110.916 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . 0.637 ' CE1' ' CG ' ' A' ' 433' ' ' PHE . 2.6 p90 -161.78 141.6 10.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.926 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -135.98 164.93 24.98 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.492 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . 0.615 ' CD1' ' CZ ' ' A' ' 404' ' ' PHE . 33.8 t80 -103.76 153.35 20.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.873 0.368 . . . . 0.0 110.913 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 446' ' ' PHE . 60.5 t -158.87 152.76 6.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.129 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 10.1 m -153.86 150.74 28.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . 0.493 ' CE1' HD12 ' A' ' 403' ' ' LEU . 3.9 m-85 -113.07 -175.14 2.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.862 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -80.61 -13.05 59.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.856 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -161.37 159.36 23.72 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.596 0.713 . . . . 0.0 110.817 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . 0.466 ' N ' ' HB2' ' A' ' 401' ' ' ALA . 61.1 Cg_endo -75.86 -7.11 18.15 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.67 2.247 . . . . 0.0 112.362 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 58.9 t -81.3 -39.39 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.125 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 6.4 m -82.97 -40.7 19.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.89 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -53.1 -31.9 44.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.132 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -69.41 -43.72 72.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.951 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -43.84 -41.26 4.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.081 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . 0.517 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -64.29 -67.91 0.39 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.085 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . 0.527 HG23 ' HB2' ' A' ' 463' ' ' ASN . 87.1 mt -43.66 -45.95 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.114 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 459' ' ' ILE . 35.3 mt-30 -37.38 -47.42 0.85 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.869 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 2.8 m -101.58 -53.71 2.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.864 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . 0.459 ' SD ' ' CE1' ' A' ' 424' ' ' PHE . 84.3 mmm -44.85 -47.77 11.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.92 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . 0.527 ' HB2' HG23 ' A' ' 459' ' ' ILE . 27.2 t-20 -45.27 104.34 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 86.22 25.35 37.16 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.48 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . 0.413 ' N ' ' O ' ' A' ' 462' ' ' MET . 21.7 t80 -69.87 108.69 4.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.795 0.331 . . . . 0.0 110.931 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -65.8 104.17 1.03 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.863 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . 0.581 HD11 ' CE1' ' A' ' 412' ' ' PHE . 19.8 tt -111.62 135.33 51.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.13 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 58.19 -93.01 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.463 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 59.9 mtp -133.57 -0.58 3.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.813 0.339 . . . . 0.0 110.875 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -127.88 -178.18 4.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.936 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 54.2 mtt85 -112.73 159.91 18.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.897 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 87.3 mt -103.0 157.54 16.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.894 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . 0.446 ' HD3' ' CD2' ' A' ' 406' ' ' TYR . 13.3 tttt -132.26 104.67 6.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.923 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 2.8 t -113.55 135.82 51.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.138 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -157.1 137.92 13.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.836 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . 0.666 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.6 pp -83.66 128.38 34.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 476' ' ' LEU . 10.7 tptm . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.748 0.309 . . . . 0.0 110.841 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -131.41 -178.3 4.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.868 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -98.14 -145.89 19.67 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.561 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.52 151.08 52.61 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.697 2.265 . . . . 0.0 112.333 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -54.16 97.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.937 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 135.16 -22.95 3.53 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.462 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . 0.494 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -99.98 127.43 46.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.709 0.29 . . . . 0.0 111.166 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 18.6 m-80 -158.47 165.5 34.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.876 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . 0.716 HD23 HD11 ' A' ' 459' ' ' ILE . 22.4 mt -160.12 110.38 1.85 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.921 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . 0.584 ' CE1' ' HB2' ' A' ' 477' ' ' LYS . 26.2 m-85 -115.37 115.62 26.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.899 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . 0.572 HG21 HD21 ' A' ' 408' ' ' LEU . 4.0 mp -90.81 136.19 24.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.132 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . 0.54 ' CZ ' ' HB3' ' A' ' 404' ' ' PHE . 26.9 m-85 -130.49 167.53 18.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.945 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 59.79 50.14 7.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.858 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.572 HD21 HG21 ' A' ' 405' ' ' ILE . 38.3 mt -97.25 145.93 30.48 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.58 0.705 . . . . 0.0 110.957 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.487 ' HG2' ' CD1' ' A' ' 412' ' ' PHE . 61.5 Cg_endo -76.42 -177.51 3.77 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.713 2.275 . . . . 0.0 112.308 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -84.44 -35.58 22.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.938 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -58.64 -33.39 70.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.938 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.517 ' CE1' HD11 ' A' ' 467' ' ' ILE . 3.4 m-85 -64.98 155.05 35.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.977 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -145.32 -148.08 4.75 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.493 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.35 -60.33 2.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.707 0.289 . . . . 0.0 110.805 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . 0.434 ' O ' ' C ' ' A' ' 416' ' ' ASP . 21.1 mp0 -54.27 -59.29 4.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.984 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 415' ' ' GLN . 35.3 m-20 -34.6 -61.19 0.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.831 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . 0.423 HD11 HD13 ' A' ' 405' ' ' ILE . 19.5 tp -47.84 -47.67 31.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 18.4 tp -62.38 -44.09 97.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -74.25 -17.42 60.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.878 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 2.5 ttt -83.94 -28.85 27.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.863 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . 0.438 ' C ' ' HD2' ' A' ' 423' ' ' PRO . 5.3 m-85 -102.93 -19.83 14.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.883 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . 0.584 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 0.2 OUTLIER -49.97 -46.05 81.33 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.517 0.675 . . . . 0.0 110.827 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 422' ' ' MET . 66.7 Cg_exo -48.03 -48.97 14.93 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.69 2.26 . . . . 0.0 112.299 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . 0.503 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 81.5 m-85 -62.18 -31.79 72.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 175.35 173.58 41.22 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.52 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -76.18 91.78 3.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.942 0.401 . . . . 0.0 110.886 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.518 HG11 ' HB2' ' A' ' 430' ' ' ALA . 72.4 t -56.33 128.62 16.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.127 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 31.3 t -73.16 -50.98 28.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.162 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 38.8 m -144.43 132.16 21.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.865 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . 0.518 ' HB2' HG11 ' A' ' 427' ' ' VAL . . . -140.78 129.86 23.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.097 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . 0.419 ' C ' ' HD3' ' A' ' 431' ' ' LYS . 0.2 OUTLIER -159.83 137.75 10.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.868 -180.0 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 72.2 t -93.7 151.37 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.128 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . 0.405 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 4.1 m-30 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.912 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 19.0 p . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.798 0.333 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . 0.405 ' CE1' ' HB2' ' A' ' 433' ' ' PHE . 7.0 p90 -162.1 141.9 9.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.908 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -139.25 179.08 19.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.475 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . 0.492 ' CE1' ' CE1' ' A' ' 404' ' ' PHE . 27.2 t80 -117.41 150.31 39.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.825 0.345 . . . . 0.0 110.958 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 96.6 t -155.32 144.61 12.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.127 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 51.6 p -139.81 146.34 39.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.838 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . 0.706 ' CE1' HD12 ' A' ' 403' ' ' LEU . 3.7 m-85 -111.86 174.67 5.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.87 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.63 -18.65 62.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.864 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . 0.482 ' OD1' ' N ' ' A' ' 451' ' ' ASN . 3.9 p-10 -152.01 155.1 33.36 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.642 0.734 . . . . 0.0 110.869 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . 0.448 ' N ' ' HB2' ' A' ' 401' ' ' ALA . 60.9 Cg_endo -75.41 -15.1 20.04 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.644 2.23 . . . . 0.0 112.347 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 85.7 t -77.72 -38.1 24.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.025 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 1.5 t -80.21 -35.86 35.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.762 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -56.43 -39.53 73.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.128 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -61.97 -42.59 99.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -42.63 -43.76 3.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.148 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . 0.503 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -64.02 -70.52 0.22 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.156 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . 0.716 HD11 HD23 ' A' ' 403' ' ' LEU . 84.6 mt -41.9 -44.78 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.161 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -39.54 -47.22 1.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 2.4 m -97.58 -54.31 3.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.863 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . 0.476 ' O ' ' N ' ' A' ' 465' ' ' PHE . 80.8 mmm -44.69 -57.39 3.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.847 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 462' ' ' MET . 9.8 t-20 -35.98 99.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.822 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 90.32 31.11 10.96 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.524 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . 0.476 ' N ' ' O ' ' A' ' 462' ' ' MET . 40.2 t80 -76.26 115.71 16.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.759 0.314 . . . . 0.0 110.883 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -63.54 103.28 0.51 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.894 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . 0.517 HD11 ' CE1' ' A' ' 412' ' ' PHE . 18.8 tt -114.01 138.9 42.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.151 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 48.17 -96.87 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.457 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 27.3 mmm -125.14 -9.33 7.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.873 0.368 . . . . 0.0 110.861 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 14.6 pttm -121.03 178.98 4.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.894 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 62.0 mtm180 -110.42 151.61 27.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.888 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 68.5 mt -94.22 158.08 15.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.874 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -137.43 108.53 6.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . 0.423 HG21 ' HB3' ' A' ' 462' ' ' MET . 2.9 t -110.02 140.34 29.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.129 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -157.17 141.01 16.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.907 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . 0.759 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.5 pp -85.19 125.65 33.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.939 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.584 ' HB2' ' CE1' ' A' ' 404' ' ' PHE . 32.9 ttpt . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.874 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 33.3 mtmt . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.765 0.316 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -130.73 -178.33 4.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.84 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -96.41 -155.09 30.62 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.5 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.25 151.73 43.88 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.618 2.212 . . . . 0.0 112.395 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -48.45 113.56 0.78 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.88 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 121.57 -28.53 5.94 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.512 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . 0.496 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.81 127.4 43.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.8 0.333 . . . . 0.0 111.127 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.7 OUTLIER -158.42 161.96 37.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.947 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . 0.495 HD12 ' CE1' ' A' ' 449' ' ' TYR . 19.8 mt -155.67 120.28 4.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.915 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . 0.529 ' CE1' ' HB2' ' A' ' 477' ' ' LYS . 25.3 m-85 -127.61 110.74 12.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.945 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . 0.635 HD12 ' N ' ' A' ' 405' ' ' ILE . 3.5 mp -91.84 136.31 24.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.127 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -127.28 174.63 8.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . 0.535 ' O ' HD23 ' A' ' 472' ' ' LEU . 20.2 m-70 51.04 50.29 19.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.919 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.424 HD11 ' CG2' ' A' ' 405' ' ' ILE . 19.7 mt -98.27 140.18 21.69 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.549 0.69 . . . . 0.0 110.982 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.411 ' O ' ' O ' ' A' ' 408' ' ' LEU . 73.1 Cg_exo -50.46 -171.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.651 2.234 . . . . 0.0 112.411 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -100.01 -24.77 14.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.97 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.11 -32.17 59.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.873 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -58.19 130.85 48.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.869 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -118.47 -144.88 7.65 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.51 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.86 -60.22 2.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.794 0.331 . . . . 0.0 110.847 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -53.84 -55.1 29.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -42.23 -65.01 0.51 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.889 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 22.5 tp -42.86 -41.37 3.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.94 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . 0.612 HD13 ' HB3' ' A' ' 430' ' ' ALA . 30.6 tp -65.35 -50.94 63.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.919 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -67.5 -9.0 38.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.925 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -86.43 -27.91 23.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.902 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . 0.597 ' CZ ' ' SD ' ' A' ' 462' ' ' MET . 10.6 m-85 -104.75 -12.48 16.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.909 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . 0.575 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 6.1 mtt -54.22 -45.73 99.08 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.565 0.698 . . . . 0.0 110.877 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.0 Cg_exo -47.95 -40.79 33.08 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.611 2.207 . . . . 0.0 112.392 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . 0.559 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 86.7 m-85 -67.61 -36.01 80.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.806 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 178.34 -169.06 40.6 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.464 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -85.32 100.47 11.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.874 0.369 . . . . 0.0 110.911 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.551 HG11 HD12 ' A' ' 418' ' ' LEU . 74.7 t -65.15 135.95 27.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.152 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 25.2 t -84.87 -41.02 15.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.18 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 39.7 m -158.91 140.07 13.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.902 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . 0.612 ' HB3' HD13 ' A' ' 418' ' ' LEU . . . -149.36 132.11 15.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.122 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -157.28 135.3 10.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.933 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 85.3 t -91.98 146.85 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.124 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.889 -179.975 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 27.8 p . . . . . 0 C--O 1.231 0.132 0 CA-C-O 120.892 0.377 . . . . 0.0 110.913 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -161.99 150.74 15.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.919 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -141.98 176.27 22.15 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.544 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . 0.521 ' O ' HG23 ' A' ' 447' ' ' VAL . 39.8 t80 -117.03 156.81 26.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.948 0.404 . . . . 0.0 110.847 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 446' ' ' PHE . 76.2 t -161.03 153.9 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.109 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . 0.418 ' N ' HG12 ' A' ' 447' ' ' VAL . 3.2 m -151.57 142.39 22.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.865 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . 0.495 ' CE1' HD12 ' A' ' 403' ' ' LEU . 3.2 m-85 -107.01 -177.66 3.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.66 -17.19 56.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.838 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . 0.474 ' OD1' ' N ' ' A' ' 451' ' ' ASN . 3.7 p-10 -154.34 156.9 32.15 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.595 0.712 . . . . 0.0 110.852 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.52 -9.29 18.63 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.635 2.224 . . . . 0.0 112.323 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 99.6 t -83.14 -33.76 10.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.099 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 61.3 m -83.6 -38.71 21.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -54.92 -29.13 55.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.112 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 41.3 mm-40 -66.81 -49.99 64.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.911 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -38.93 -40.45 0.65 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.047 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . 0.559 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -70.32 -61.91 1.59 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.152 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . 0.437 ' O ' ' CB ' ' A' ' 463' ' ' ASN . 88.6 mt -42.2 -42.3 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 50.6 mm-40 -42.84 -66.33 0.38 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.917 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 30.2 t -79.63 -54.68 5.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.848 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . 0.709 ' HB3' HG21 ' A' ' 474' ' ' VAL . 6.9 mmt -40.85 -48.21 3.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.849 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . 0.437 ' CB ' ' O ' ' A' ' 459' ' ' ILE . 36.4 t-20 -55.97 107.56 0.36 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.843 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 87.65 22.8 41.74 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.48 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -69.03 114.15 7.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.753 0.311 . . . . 0.0 110.906 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 6.0 tm0? -72.14 104.63 3.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.935 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . 0.538 HG23 ' O ' ' A' ' 467' ' ' ILE . 17.3 tt -112.08 122.73 66.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.121 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 66.94 -94.38 0.24 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.488 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.12 -3.17 4.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.917 0.389 . . . . 0.0 110.948 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -125.48 -178.99 4.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.922 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -112.88 163.99 13.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.854 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . 0.535 HD23 ' O ' ' A' ' 407' ' ' HIS . 82.1 mt -109.33 155.75 20.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.916 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 26.6 ttmt -129.27 113.25 14.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.912 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . 0.709 HG21 ' HB3' ' A' ' 462' ' ' MET . 11.4 t -120.54 135.73 59.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.146 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 -156.99 140.33 15.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.875 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . 0.69 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.6 pp -80.96 125.35 30.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.938 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.529 ' HB2' ' CE1' ' A' ' 404' ' ' PHE . 15.3 ttmm . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.902 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.468 ' O ' ' CB ' ' A' ' 429' ' ' SER . 6.6 ptmm? . . . . . 0 C--O 1.23 0.063 0 CA-C-O 120.754 0.311 . . . . 0.0 110.91 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -132.01 -177.68 4.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -100.77 -147.2 20.49 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.501 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.77 161.18 36.85 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.669 2.246 . . . . 0.0 112.435 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -59.01 123.1 15.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 113.04 -27.57 9.49 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.576 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . 0.487 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.84 127.06 43.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.823 0.344 . . . . 0.0 111.112 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . 0.488 ' HB2' ' N ' ' A' ' 477' ' ' LYS . 0.7 OUTLIER -159.02 159.94 35.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.934 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . 0.567 HD23 HD11 ' A' ' 459' ' ' ILE . 17.6 mt -156.11 122.66 5.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.904 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . 0.482 ' CE1' ' CE1' ' A' ' 446' ' ' PHE . 22.8 m-85 -130.23 110.86 11.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . 0.625 HD12 ' N ' ' A' ' 405' ' ' ILE . 3.5 mp -91.1 134.13 30.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.176 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . 0.458 ' CD2' ' HD3' ' A' ' 473' ' ' LYS . 84.2 m-85 -126.19 -176.23 3.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.957 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 42.17 53.9 4.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.411 HD21 HG21 ' A' ' 405' ' ' ILE . 28.1 mt -98.38 143.07 25.64 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.591 0.71 . . . . 0.0 110.937 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.5 164.42 32.47 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.668 2.245 . . . . 0.0 112.397 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -62.78 -37.64 87.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.918 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -58.23 -35.04 71.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.833 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.472 ' CE1' HD11 ' A' ' 467' ' ' ILE . 5.2 m-85 -77.94 115.57 17.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.848 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -109.16 -138.79 8.36 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.474 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 414' ' ' ASP . 0.1 OUTLIER -79.17 -53.72 6.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.761 0.315 . . . . 0.0 110.856 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . 0.417 ' O ' ' C ' ' A' ' 416' ' ' ASP . 16.0 mp0 -60.98 -57.82 11.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 415' ' ' GLN . 70.9 m-20 -36.16 -50.52 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.855 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . 0.461 HD11 HG12 ' A' ' 405' ' ' ILE . 36.3 tp -57.74 -50.12 74.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.925 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 39.3 tp -56.73 -43.38 80.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -80.71 -10.76 59.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.936 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -82.29 -27.44 32.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.867 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . 0.425 ' C ' ' HD2' ' A' ' 423' ' ' PRO . 4.0 m-85 -107.14 -20.32 13.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.855 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . 0.575 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 0.4 OUTLIER -49.44 -46.3 77.96 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.56 0.695 . . . . 0.0 110.883 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 422' ' ' MET . 64.9 Cg_exo -47.96 -41.63 32.56 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.704 2.269 . . . . 0.0 112.376 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . 0.431 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 88.0 m-85 -67.27 -35.97 80.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.92 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 173.6 177.9 43.16 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.499 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -66.03 115.26 5.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.846 0.355 . . . . 0.0 110.877 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 87.4 t -85.12 131.08 35.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.073 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 53.6 t -83.83 -34.6 10.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.15 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 0.8 OUTLIER -149.2 143.86 26.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -160.91 119.49 2.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.066 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . 0.492 ' CG ' ' N ' ' A' ' 432' ' ' VAL . 32.7 tttp -159.47 163.17 35.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.939 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.492 ' N ' ' CG ' ' A' ' 431' ' ' LYS . 55.8 t -114.76 154.44 16.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.136 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . 0.563 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.1 m-85 . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.819 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 16.2 m . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.904 0.383 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . 0.563 ' CE1' ' HB2' ' A' ' 433' ' ' PHE . 1.8 p90 -161.94 139.67 8.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.93 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -133.7 172.07 21.76 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.512 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . 0.482 ' CE1' ' CE1' ' A' ' 404' ' ' PHE . 23.6 t80 -109.88 153.86 23.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.908 0.385 . . . . 0.0 110.894 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . 0.423 HG12 ' N ' ' A' ' 448' ' ' SER . 75.3 t -157.31 153.97 6.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.12 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . 0.423 ' N ' HG12 ' A' ' 447' ' ' VAL . 2.9 m -154.45 154.97 34.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.928 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . 0.46 ' CE1' HD12 ' A' ' 403' ' ' LEU . 4.7 m-85 -118.9 -175.17 2.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -85.05 -8.87 58.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.877 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -160.2 155.11 20.96 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.634 0.731 . . . . 0.0 110.942 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.78 -8.23 19.02 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.648 2.232 . . . . 0.0 112.41 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 60.0 t -82.14 -36.92 14.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.086 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 1.4 t -82.1 -42.01 19.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.855 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -52.36 -41.33 62.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.118 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -58.32 -46.57 85.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.942 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -43.47 -41.21 4.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.112 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . 0.431 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -62.99 -68.25 0.35 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . 0.567 HD11 HD23 ' A' ' 403' ' ' LEU . 77.5 mt -48.01 -43.28 10.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.086 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' ' 459' ' ' ILE . 23.6 mt-30 -37.76 -42.46 0.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 1.9 m -103.78 -56.3 2.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.852 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . 0.521 ' HB3' HG21 ' A' ' 474' ' ' VAL . 86.2 mmm -42.66 -42.84 3.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.96 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -42.55 100.26 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 83.24 31.35 28.43 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.488 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . 0.458 ' N ' ' O ' ' A' ' 462' ' ' MET . 58.3 t80 -64.79 117.12 7.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.787 0.327 . . . . 0.0 110.923 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 44.4 tp60 -74.26 105.39 5.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . 0.646 HG23 ' O ' ' A' ' 467' ' ' ILE . 16.4 tt -116.69 113.45 43.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.106 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 71.34 -104.12 1.37 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.465 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 469' ' ' MET . . . . . 0.4 ' O ' ' SD ' ' A' ' 469' ' ' MET . 5.8 tmm? -121.43 5.72 10.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.857 0.36 . . . . 0.0 110.846 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.73 -176.92 4.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.985 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -123.28 164.65 18.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.807 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . 0.458 HD12 ' HB3' ' A' ' 465' ' ' PHE . 60.2 mt -106.56 163.82 12.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.918 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . 0.458 ' HD3' ' CD2' ' A' ' 406' ' ' TYR . 11.8 tttt -138.43 104.99 5.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.934 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . 0.521 HG21 ' HB3' ' A' ' 462' ' ' MET . 5.3 t -110.78 139.07 36.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.092 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -157.22 145.89 19.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.876 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . 0.787 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.5 pp -92.08 123.99 35.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.488 ' N ' ' HB2' ' A' ' 402' ' ' ASN . 27.9 tttp . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.844 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.707 0.289 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -127.95 177.65 6.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.901 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -104.36 -147.31 16.85 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.535 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.57 151.61 32.81 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.709 2.273 . . . . 0.0 112.313 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -53.41 102.51 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.943 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 135.94 -28.71 2.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.466 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . 0.494 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.95 126.7 43.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.779 0.323 . . . . 0.0 111.106 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.5 OUTLIER -159.04 161.55 36.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.912 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . 0.562 HD12 ' CE1' ' A' ' 449' ' ' TYR . 17.9 mt -159.95 117.66 2.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.929 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . 0.73 ' CZ ' ' CD1' ' A' ' 446' ' ' PHE . 44.4 m-85 -126.39 115.42 19.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.887 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . 0.834 HD12 ' N ' ' A' ' 405' ' ' ILE . 1.2 mp -93.82 127.09 46.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.119 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . 0.484 ' CZ ' ' HB3' ' A' ' 404' ' ' PHE . 37.9 m-85 -120.19 151.99 38.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.964 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . 0.646 ' O ' HD23 ' A' ' 472' ' ' LEU . 15.5 m-70 73.47 54.44 0.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.885 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 26.0 mt -101.58 136.05 19.67 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.6 0.714 . . . . 0.0 110.966 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -47.73 -179.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.729 2.286 . . . . 0.0 112.329 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 35.7 tp60 -91.9 -38.79 12.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.933 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 25.0 pm0 -65.15 -13.19 57.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.881 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -80.29 135.49 36.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.901 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -116.41 -151.86 9.69 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.451 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.18 -56.53 4.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.736 0.303 . . . . 0.0 110.873 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . 0.453 ' O ' ' C ' ' A' ' 416' ' ' ASP . 9.2 mm-40 -56.88 -55.98 27.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.9 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 415' ' ' GLN . 63.6 m-20 -34.41 -59.06 0.46 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.845 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . 0.402 HD11 HG12 ' A' ' 405' ' ' ILE . 39.1 tp -46.64 -49.02 19.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . 0.464 ' HB3' ' NE2' ' A' ' 419' ' ' GLN . 52.2 tp -55.27 -55.33 32.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.916 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . 0.464 ' NE2' ' HB3' ' A' ' 418' ' ' LEU . 6.9 mp0 -60.45 -17.6 45.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.923 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 3.8 ttm -86.55 -26.48 24.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . 0.55 ' CZ ' HG12 ' A' ' 405' ' ' ILE . 10.8 m-85 -105.93 -10.14 16.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.9 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . 0.592 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 4.3 mtt -59.64 -45.59 98.6 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.581 0.705 . . . . 0.0 110.923 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.9 Cg_exo -47.98 -37.9 30.51 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.628 2.219 . . . . 0.0 112.362 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . 0.507 ' CE2' ' HA ' ' A' ' 458' ' ' ALA . 86.8 m-85 -67.19 -34.94 78.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.934 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 171.67 -156.82 26.66 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.488 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -92.0 92.77 8.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.841 0.353 . . . . 0.0 110.886 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.518 HG11 ' HB2' ' A' ' 430' ' ' ALA . 54.3 t -65.67 116.93 5.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.1 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 71.2 t -64.5 -43.18 96.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.126 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . 0.435 ' O ' ' CG1' ' A' ' 427' ' ' VAL . 93.2 p -137.34 146.83 45.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.82 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . 0.518 ' HB2' HG11 ' A' ' 427' ' ' VAL . . . -161.3 110.29 1.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.076 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . 0.418 ' C ' ' HD2' ' A' ' 431' ' ' LYS . 1.1 tmmm? -157.36 144.4 18.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.924 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 52.7 t -96.25 137.01 25.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.147 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . 0.403 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.2 m-85 . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . 0.482 ' O ' ' N ' ' A' ' 407' ' ' HIS . 31.4 p . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.832 0.349 . . . . 0.0 110.973 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . 0.403 ' CE1' ' HB2' ' A' ' 433' ' ' PHE . 12.0 p90 -162.2 141.5 9.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.852 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -132.65 171.16 21.73 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.454 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . 0.73 ' CD1' ' CZ ' ' A' ' 404' ' ' PHE . 30.6 t80 -111.24 153.16 26.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.911 0.386 . . . . 0.0 110.822 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . 0.467 HG13 ' CG1' ' A' ' 427' ' ' VAL . 59.5 t -159.06 146.64 7.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.099 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 1.2 t -148.74 148.89 30.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.835 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . 0.562 ' CE1' HD12 ' A' ' 403' ' ' LEU . 8.6 m-85 -112.11 -174.9 2.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.98 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -80.58 -21.21 41.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.904 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -152.99 155.73 32.25 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.613 0.72 . . . . 0.0 110.943 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . 0.452 ' N ' ' HB2' ' A' ' 401' ' ' ALA . 60.5 Cg_endo -74.28 -2.27 12.12 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.731 2.287 . . . . 0.0 112.356 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 93.2 t -86.19 -34.25 7.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.08 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 14.0 m -87.39 -39.65 15.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.823 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -52.99 -30.72 36.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.041 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -64.48 -45.95 85.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.876 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -40.31 -44.32 1.9 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.164 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . 0.507 ' HA ' ' CE2' ' A' ' 424' ' ' PHE . . . -61.36 -68.55 0.3 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.108 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . 0.428 ' O ' ' CB ' ' A' ' 463' ' ' ASN . 86.9 mt -43.04 -45.75 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.174 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 24.3 mm100 -39.34 -46.51 1.61 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.933 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 32.5 t -103.19 -56.56 2.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.883 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . 0.501 ' HB3' HG21 ' A' ' 474' ' ' VAL . 86.6 mmm -42.65 -43.26 3.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.892 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' A' ' 459' ' ' ILE . 14.4 t30 -44.74 110.19 0.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.866 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 74.38 33.33 56.62 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.59 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . 0.593 ' HB3' HD12 ' A' ' 472' ' ' LEU . 9.9 t80 -67.51 113.22 5.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.753 0.311 . . . . 0.0 110.913 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -70.36 109.18 4.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.904 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.7 tt -125.01 134.94 65.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.087 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 58.6 -102.33 0.26 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.434 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -124.33 -9.24 7.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.821 0.344 . . . . 0.0 110.878 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 8.9 pttm -120.57 179.2 4.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.88 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -112.09 164.37 13.24 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.909 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 407' ' ' HIS . 78.5 mt -107.0 158.39 17.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.886 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -131.97 102.52 5.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.825 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . 0.501 HG21 ' HB3' ' A' ' 462' ' ' MET . 15.3 t -110.18 125.54 67.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.138 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 39.9 tp60 -152.11 144.67 24.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . 0.617 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.6 pp -84.98 129.11 34.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.869 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.475 ' C ' ' O ' ' A' ' 476' ' ' LEU . 4.4 tptm . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.892 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.497 ' O ' ' CB ' ' A' ' 429' ' ' SER . 26.6 mtpt . . . . . 0 C--O 1.23 0.06 0 CA-C-O 120.783 0.325 . . . . 0.0 110.854 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -142.79 179.44 7.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.946 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -98.54 -147.37 22.04 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.53 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.56 155.77 40.43 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.672 2.248 . . . . 0.0 112.323 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -58.52 100.51 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 136.25 -28.75 2.88 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.479 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . 0.669 ' HB2' ' CA ' ' A' ' 452' ' ' PRO . . . -97.88 127.25 43.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.774 0.321 . . . . 0.0 111.151 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . 0.493 ' O ' ' CB ' ' A' ' 476' ' ' LEU . 16.9 m-80 -158.64 165.43 34.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.94 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . 0.523 HD12 ' CE1' ' A' ' 449' ' ' TYR . 50.7 mt -159.29 108.0 1.84 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.912 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . 0.535 ' C ' HD13 ' A' ' 405' ' ' ILE . 26.8 m-85 -109.94 120.32 42.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.87 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . 0.773 HD12 HG22 ' A' ' 474' ' ' VAL . 1.8 mm -91.04 133.92 31.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.074 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . 0.489 ' CZ ' ' HB3' ' A' ' 404' ' ' PHE . 13.9 m-85 -129.75 147.43 51.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.887 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . 0.66 ' O ' HD23 ' A' ' 472' ' ' LEU . 31.7 m-70 70.0 52.13 0.4 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.876 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.692 HD21 HG21 ' A' ' 405' ' ' ILE . 32.7 mt -93.65 139.65 22.85 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.585 0.707 . . . . 0.0 110.897 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -47.39 -179.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.64 2.227 . . . . 0.0 112.331 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -98.92 -24.84 14.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.949 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 7.7 pm0 -82.37 -12.75 57.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.461 ' CZ ' HD11 ' A' ' 467' ' ' ILE . 6.3 m-85 -76.55 147.55 37.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.893 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -127.03 -148.7 7.04 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.482 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -81.85 -54.72 5.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.816 0.341 . . . . 0.0 110.903 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . 0.466 ' O ' ' N ' ' A' ' 418' ' ' LEU . 7.3 mm100 -58.16 -58.53 8.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.935 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 415' ' ' GLN . 24.2 m-20 -37.3 -56.46 0.96 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.833 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . 0.548 HD11 HG13 ' A' ' 405' ' ' ILE . 48.5 tp -51.99 -37.24 52.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.943 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' A' ' 415' ' ' GLN . 23.9 tp -70.78 -50.77 32.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -63.88 -13.89 48.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.855 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 2.1 ttm -89.58 -32.79 16.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.943 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . 0.45 ' CE1' ' SD ' ' A' ' 462' ' ' MET . 6.2 m-85 -93.18 -17.8 23.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.873 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . 0.58 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 0.4 OUTLIER -57.28 -45.61 99.89 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.503 0.668 . . . . 0.0 110.825 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 422' ' ' MET . 64.7 Cg_exo -47.94 -37.79 29.95 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.68 2.253 . . . . 0.0 112.351 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -71.33 -35.56 71.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.901 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 176.06 -178.62 47.48 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.459 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -76.93 89.33 3.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.839 0.352 . . . . 0.0 110.945 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 70.3 t -56.69 143.57 10.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.112 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . 0.418 ' CG2' ' C ' ' A' ' 449' ' ' TYR . 99.4 t -95.25 -38.39 8.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.149 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 3.5 p -140.76 145.09 35.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.928 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -161.03 113.71 1.93 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.14 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.03 142.75 17.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.919 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 86.8 t -98.99 143.74 12.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.143 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . 0.534 ' CG ' ' CE1' ' A' ' 444' ' ' PHE . 3.1 m-85 . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 24.5 p . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.807 0.337 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . 0.534 ' CE1' ' CG ' ' A' ' 433' ' ' PHE . 4.6 p90 -162.15 143.48 10.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.829 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -137.22 179.07 18.46 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.539 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . 0.469 ' CD1' ' CZ ' ' A' ' 404' ' ' PHE . 66.0 t80 -122.89 141.1 52.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.906 0.384 . . . . 0.0 110.871 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . 0.42 HG13 ' O ' ' A' ' 429' ' ' SER . 84.5 t -146.12 149.44 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.102 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 1.3 t -147.95 144.94 28.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.83 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . 0.523 ' CE1' HD12 ' A' ' 403' ' ' LEU . 4.1 m-85 -104.84 -174.83 2.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.874 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -79.63 -22.48 43.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.797 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -147.37 155.46 46.07 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.596 0.712 . . . . 0.0 110.875 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . 0.669 ' CA ' ' HB2' ' A' ' 401' ' ' ALA . 59.7 Cg_endo -73.03 -0.36 8.95 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.713 2.275 . . . . 0.0 112.399 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 95.5 t -94.23 -37.05 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.149 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 50.6 m -78.63 -37.69 41.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.8 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -52.13 -30.13 25.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.054 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . 0.41 ' NE2' HD12 ' A' ' 459' ' ' ILE . 42.1 mm-40 -67.59 -51.59 48.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.855 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 456' ' ' GLN . . . -36.64 -42.35 0.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.124 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -69.0 -48.23 63.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.119 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . 0.443 ' O ' ' CB ' ' A' ' 463' ' ' ASN . 70.5 mt -55.39 -42.85 69.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.148 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -40.97 -53.08 3.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.925 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 27.8 t -93.08 -55.27 3.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.856 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . 0.573 ' HB3' HG21 ' A' ' 474' ' ' VAL . 6.3 mmt -43.53 -49.7 7.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.905 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' A' ' 459' ' ' ILE . 18.8 t-20 -48.45 114.7 1.01 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.878 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 65.88 33.86 86.93 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.492 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -75.9 109.04 9.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.795 0.331 . . . . 0.0 110.834 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -62.96 105.88 0.74 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.928 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . 0.588 HG23 ' O ' ' A' ' 467' ' ' ILE . 19.2 tt -111.05 116.99 53.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.189 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 65.85 -96.98 0.28 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.537 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 4.0 ttt -123.17 -13.0 7.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.792 0.329 . . . . 0.0 110.806 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 15.3 pttm -117.59 168.65 10.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.887 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -111.29 153.52 25.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.864 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . 0.66 HD23 ' O ' ' A' ' 407' ' ' HIS . 14.8 mt -104.21 161.61 13.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.977 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -134.57 104.74 6.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.928 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . 0.773 HG22 HD12 ' A' ' 405' ' ' ILE . 30.8 t -109.09 128.33 65.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.135 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -151.84 142.96 23.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.917 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . 0.615 HD12 ' C ' ' A' ' 476' ' ' LEU . 1.6 pp -80.13 135.24 36.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.973 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.53 ' HB2' ' CE1' ' A' ' 404' ' ' PHE . 22.8 ttpp . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.477 ' O ' ' CB ' ' A' ' 429' ' ' SER . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.088 0 CA-C-O 120.737 0.303 . . . . 0.0 110.906 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -137.2 179.31 6.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.935 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -94.81 -154.77 31.15 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.546 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.09 151.29 61.31 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.7 2.267 . . . . 0.0 112.294 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -49.58 97.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.913 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 136.43 -24.74 3.19 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.48 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . 0.481 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -98.18 126.93 43.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.843 0.354 . . . . 0.0 111.053 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . 0.481 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 22.1 m-80 -158.97 161.87 36.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . 0.637 HD12 ' CE1' ' A' ' 449' ' ' TYR . 47.5 mt -159.24 108.56 1.89 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.931 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . 0.489 ' CE1' ' CE1' ' A' ' 446' ' ' PHE . 20.1 m-85 -113.14 112.42 23.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.923 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . 0.689 HD12 ' N ' ' A' ' 405' ' ' ILE . 3.0 mp -90.83 137.44 21.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.093 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . 0.453 ' CD1' ' HB2' ' A' ' 444' ' ' PHE . 93.6 m-85 -129.47 169.74 14.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . 0.469 ' N ' ' O ' ' A' ' 443' ' ' CYS . 20.3 m-70 53.95 51.69 14.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.874 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.423 HD21 HG21 ' A' ' 405' ' ' ILE . 25.5 mt -93.9 134.35 26.31 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.594 0.711 . . . . 0.0 110.925 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -48.87 -175.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.659 2.24 . . . . 0.0 112.307 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -88.85 -41.43 12.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.957 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -62.5 -37.4 85.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.898 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -55.35 117.18 3.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.843 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . 0.461 ' O ' HG21 ' A' ' 432' ' ' VAL . . . -103.17 -138.45 9.91 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.552 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -89.98 -44.07 10.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.763 0.316 . . . . 0.0 110.871 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . 0.423 ' O ' ' N ' ' A' ' 418' ' ' LEU . 22.5 mp0 -70.06 -57.2 5.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 415' ' ' GLN . 32.9 m-20 -37.36 -56.77 0.95 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.838 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . 0.413 HD11 HG12 ' A' ' 405' ' ' ILE . 61.7 tp -52.33 -40.5 61.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.933 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' A' ' 415' ' ' GLN . 24.6 tp -69.61 -38.63 77.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -73.23 -17.51 61.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 4.8 ttp -88.9 -12.67 41.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.826 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . 0.517 ' CZ ' HG12 ' A' ' 405' ' ' ILE . 5.8 m-85 -111.79 -0.01 16.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.868 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . 0.576 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 4.5 mtt -71.82 -45.92 12.17 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.549 0.69 . . . . 0.0 110.848 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.1 Cg_exo -48.02 -36.84 28.81 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.762 2.308 . . . . 0.0 112.327 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . 0.501 ' CD1' ' HA ' ' A' ' 458' ' ' ALA . 97.2 m-85 -69.51 -36.02 76.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.833 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 171.7 -161.65 33.87 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.53 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -86.07 105.01 16.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.943 0.401 . . . . 0.0 110.896 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 93.8 t -74.13 130.0 36.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.126 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 76.2 t -85.99 -46.82 16.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.115 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 13.7 t -130.69 144.67 51.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.841 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -161.05 117.72 2.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.097 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . 0.425 ' C ' ' HD2' ' A' ' 431' ' ' LYS . 2.0 tmmm? -161.06 151.44 17.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.461 HG21 ' O ' ' A' ' 413' ' ' GLY . 82.0 t -108.62 137.96 37.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.138 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . 0.547 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.1 m-85 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . 0.469 ' O ' ' N ' ' A' ' 407' ' ' HIS . 23.0 p . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.867 0.365 . . . . 0.0 110.914 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . 0.547 ' CE1' ' HB2' ' A' ' 433' ' ' PHE . 6.0 p90 -161.97 138.42 8.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.88 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -136.2 175.46 20.9 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.475 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . 0.489 ' CE1' ' CE1' ' A' ' 404' ' ' PHE . 32.9 t80 -116.03 145.53 42.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.895 0.379 . . . . 0.0 110.857 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 69.3 t -151.44 151.31 12.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.117 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 3.8 m -148.0 153.53 39.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.866 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . 0.637 ' CE1' HD12 ' A' ' 403' ' ' LEU . 4.5 m-85 -115.01 -174.83 2.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.903 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -81.72 -17.54 47.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.869 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -156.44 154.71 27.64 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.672 0.748 . . . . 0.0 110.857 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.44 -6.14 18.29 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.723 2.282 . . . . 0.0 112.343 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 86.1 t -85.25 -33.39 7.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.063 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 61.7 m -85.76 -35.87 20.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.812 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -57.29 -23.8 50.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.095 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -67.33 -53.54 28.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.955 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -40.23 -43.29 1.66 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.152 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . 0.501 ' HA ' ' CD1' ' A' ' 424' ' ' PHE . . . -62.52 -52.29 64.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.124 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 55.5 mt -57.14 -44.16 82.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.132 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -40.94 -55.85 2.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 1.9 m -89.04 -56.1 3.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . 0.448 ' O ' ' N ' ' A' ' 465' ' ' PHE . 11.1 mmt -40.96 -63.7 0.64 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.86 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . 0.438 ' C ' ' O ' ' A' ' 462' ' ' MET . 37.9 t-20 -35.6 110.92 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.87 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 472' ' ' LEU . . . 67.86 38.43 89.19 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.504 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . 0.448 ' N ' ' O ' ' A' ' 462' ' ' MET . 25.0 t80 -78.59 116.06 18.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.826 0.346 . . . . 0.0 110.919 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 18.7 tp60 -63.07 104.28 0.55 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.874 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . 0.559 HG23 ' O ' ' A' ' 467' ' ' ILE . 20.0 tt -116.7 118.78 59.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.12 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 64.38 -106.37 1.42 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.449 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -113.31 -11.63 13.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.878 0.37 . . . . 0.0 110.857 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.64 178.41 5.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.864 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -110.1 170.28 8.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.91 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . 0.41 ' O ' ' N ' ' A' ' 464' ' ' GLY . 65.6 mt -114.09 150.07 34.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.88 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -124.61 107.93 11.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 33.0 t -119.05 137.14 54.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.149 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 48.0 tp60 -157.04 145.73 19.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.907 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . 0.709 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.5 pp -86.0 127.04 34.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.911 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.457 ' HB2' ' CE1' ' A' ' 404' ' ' PHE . 25.5 ttpt . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.853 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.418 ' O ' ' CB ' ' A' ' 429' ' ' SER . 6.6 ptmm? . . . . . 0 C--O 1.23 0.043 0 CA-C-O 120.835 0.35 . . . . 0.0 110.881 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . 0.413 ' CD ' ' O ' ' A' ' 397' ' ' GLY . 2.6 pp20? -126.72 -178.33 4.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.868 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . 0.413 ' O ' ' CD ' ' A' ' 396' ' ' GLU . . . -94.06 -146.42 20.14 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.511 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.71 152.05 37.09 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 122.747 2.298 . . . . 0.0 112.368 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -52.83 113.76 1.19 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.905 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 125.76 -28.19 5.0 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.529 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . 0.527 ' HB2' ' N ' ' A' ' 452' ' ' PRO . . . -97.93 127.16 43.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.84 0.352 . . . . 0.0 111.09 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.7 OUTLIER -158.6 160.76 36.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.852 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . 0.609 HD12 ' CE1' ' A' ' 449' ' ' TYR . 15.8 mt -156.29 117.76 3.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.909 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . 0.467 ' CE1' ' HB2' ' A' ' 477' ' ' LYS . 12.8 m-85 -125.6 113.04 16.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . 0.726 HD12 ' N ' ' A' ' 405' ' ' ILE . 1.8 mp -90.77 136.13 24.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.178 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -128.24 169.18 14.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.905 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . 0.43 ' N ' ' O ' ' A' ' 443' ' ' CYS . 30.2 m-70 54.23 53.44 10.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.874 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.601 HD21 HG21 ' A' ' 405' ' ' ILE . 35.4 mt -94.1 143.62 26.72 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.608 0.718 . . . . 0.0 110.929 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.601 ' HG2' ' CD1' ' A' ' 412' ' ' PHE . 61.4 Cg_endo -78.21 155.73 29.33 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.674 2.249 . . . . 0.0 112.309 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -60.03 -37.22 79.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.919 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -60.19 -19.87 56.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.865 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.601 ' CD1' ' HG2' ' A' ' 409' ' ' PRO . 4.2 m-85 -89.84 125.88 35.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.828 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -114.55 -141.86 7.75 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.475 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.78 -59.02 2.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.75 0.31 . . . . 0.0 110.892 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . 0.424 ' O ' ' C ' ' A' ' 416' ' ' ASP . 52.3 mm-40 -57.78 -56.49 21.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.906 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 415' ' ' GLN . 62.0 m-20 -36.42 -39.4 0.19 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.855 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 24.2 tp -71.33 -53.58 13.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.947 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . 0.466 ' O ' ' CG ' ' A' ' 422' ' ' MET . 29.6 tp -54.62 -41.19 69.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.878 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -79.78 -9.95 59.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.01 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -85.19 -35.91 21.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.874 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . 0.573 ' CE1' ' SD ' ' A' ' 462' ' ' MET . 5.3 m-85 -98.38 -22.28 16.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . 0.579 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 0.7 OUTLIER -50.35 -45.84 83.75 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.581 0.705 . . . . 0.0 110.889 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.4 Cg_exo -47.99 -41.79 32.62 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.627 2.218 . . . . 0.0 112.344 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -67.15 -34.39 77.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.902 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 170.5 -178.98 42.87 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.444 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -66.51 124.75 23.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.83 0.347 . . . . 0.0 110.877 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 58.7 t -98.08 118.53 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.143 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 40.5 t -61.98 -51.68 69.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.194 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 3.3 m -143.77 148.76 36.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.825 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -156.82 131.26 8.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.07 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . 0.476 ' CG ' ' N ' ' A' ' 432' ' ' VAL . 14.9 tttm -159.06 162.42 36.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.476 ' N ' ' CG ' ' A' ' 431' ' ' LYS . 69.6 t -121.32 144.41 30.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.145 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . 0.646 ' CG ' ' CE1' ' A' ' 444' ' ' PHE . 4.4 m-85 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.917 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . 0.43 ' O ' ' N ' ' A' ' 407' ' ' HIS . 60.7 m . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.812 0.339 . . . . 0.0 110.843 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . 0.646 ' CE1' ' CG ' ' A' ' 433' ' ' PHE . 12.0 p90 -162.13 148.34 13.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -143.77 178.44 21.85 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.485 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . 0.543 ' O ' HG23 ' A' ' 447' ' ' VAL . 26.1 t80 -117.45 155.01 30.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.949 0.404 . . . . 0.0 110.83 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 446' ' ' PHE . 71.4 t -161.35 150.57 4.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.126 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 84.6 p -149.69 141.81 24.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . 0.609 ' CE1' HD12 ' A' ' 403' ' ' LEU . 4.7 m-85 -106.07 -176.01 2.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.917 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.75 -10.57 59.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.883 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -166.91 160.36 11.23 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.592 0.71 . . . . 0.0 110.897 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . 0.527 ' N ' ' HB2' ' A' ' 401' ' ' ALA . 60.4 Cg_endo -74.76 -2.12 12.06 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.724 2.282 . . . . 0.0 112.316 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 92.8 t -85.11 -44.03 17.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.112 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 7.4 t -78.57 -34.8 46.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.838 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -59.35 -20.1 51.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.111 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' A' ' 457' ' ' ALA . 35.2 mm-40 -77.82 -53.92 6.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.936 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 456' ' ' GLN . . . -37.74 -44.42 0.73 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.11 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -64.58 -52.41 57.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.093 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 91.2 mt -52.8 -45.81 50.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.106 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -38.49 -58.52 1.02 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.863 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 30.0 t -87.71 -55.69 3.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . 0.746 ' HB3' HG21 ' A' ' 474' ' ' VAL . 8.6 mmt -39.02 -57.54 1.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.876 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -47.1 114.26 0.82 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 75.93 29.69 58.66 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.493 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -73.47 126.45 30.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.837 0.351 . . . . 0.0 110.886 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 25.3 tm0? -69.96 104.67 2.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.928 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 16.8 tt -119.98 138.41 50.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.148 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 46.68 -95.48 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.518 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 8.8 ptp -134.21 5.03 3.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.903 0.382 . . . . 0.0 110.932 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 15.4 pttm -130.7 174.36 10.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.958 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 42.6 mtm-85 -106.73 145.6 31.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.892 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 27.2 mt -89.26 149.43 23.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.925 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 27.6 ttpt -125.63 103.8 8.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.858 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . 0.746 HG21 ' HB3' ' A' ' 462' ' ' MET . 2.8 t -110.04 137.63 41.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.141 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -157.05 145.74 19.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.93 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . 0.784 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.5 pp -91.41 124.84 35.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.942 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.467 ' HB2' ' CE1' ' A' ' 404' ' ' PHE . 13.9 tttm . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.948 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.758 0.314 . . . . 0.0 110.933 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -136.29 -176.64 4.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -107.03 -143.17 10.96 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.459 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.13 151.89 44.74 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.666 2.244 . . . . 0.0 112.282 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -55.7 100.71 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.964 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 135.92 -25.78 3.19 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.486 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . 0.485 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -98.75 127.05 44.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.806 0.336 . . . . 0.0 111.103 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . 0.485 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 19.2 m-80 -158.86 167.89 28.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.93 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . 0.416 ' CD1' ' CE1' ' A' ' 449' ' ' TYR . 53.0 mt -158.66 124.6 4.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . 0.421 ' CZ ' ' HD3' ' A' ' 477' ' ' LYS . 28.8 m-85 -130.07 111.02 12.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.911 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . 0.627 HD12 ' N ' ' A' ' 405' ' ' ILE . 3.2 mp -91.68 132.31 36.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.131 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -122.21 158.1 30.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.903 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . 0.491 ' O ' ' CD2' ' A' ' 472' ' ' LEU . 53.8 m-70 67.06 55.03 0.72 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.848 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 37.4 mt -100.97 129.9 26.26 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.691 0.757 . . . . 0.0 110.898 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -48.11 -178.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.681 2.254 . . . . 0.0 112.32 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -87.74 -41.93 12.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.935 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -59.9 -36.27 76.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.927 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -57.56 128.98 39.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.88 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . 0.455 ' O ' HG21 ' A' ' 432' ' ' VAL . . . -116.08 -138.11 6.29 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.515 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -90.54 -59.22 2.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.732 0.301 . . . . 0.0 110.746 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -51.46 -53.25 39.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.821 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -42.46 -61.74 1.14 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.86 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 33.2 tp -42.44 -49.78 5.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.934 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . 0.408 ' CD1' ' HB ' ' A' ' 427' ' ' VAL . 52.9 tp -55.19 -58.67 6.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.949 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . 0.49 ' N ' ' OE1' ' A' ' 419' ' ' GLN . 0.8 OUTLIER -57.75 -21.36 40.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.913 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 4.2 ttm -82.21 -29.47 31.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.857 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . 0.528 ' CZ ' HG12 ' A' ' 405' ' ' ILE . 3.8 m-85 -106.9 4.29 27.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.856 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . 0.588 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 17.5 mtt -73.14 -45.64 8.13 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.588 0.709 . . . . 0.0 110.946 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.7 Cg_exo -47.97 -45.72 24.08 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.673 2.249 . . . . 0.0 112.36 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -61.46 -25.32 67.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 160.21 -177.61 36.59 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.469 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -73.78 100.12 3.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.874 0.369 . . . . 0.0 110.867 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.554 HG11 ' HB2' ' A' ' 430' ' ' ALA . 54.2 t -67.0 122.82 18.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.142 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 76.7 t -75.25 -35.97 35.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.103 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -144.74 143.91 30.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.828 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . 0.554 ' HB2' HG11 ' A' ' 427' ' ' VAL . . . -161.08 114.77 2.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.064 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . 0.419 ' C ' ' HD2' ' A' ' 431' ' ' LYS . 3.8 tmmm? -160.92 141.54 11.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.455 HG21 ' O ' ' A' ' 413' ' ' GLY . 58.6 t -90.8 139.5 17.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.192 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 -179.972 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . 0.434 ' O ' ' N ' ' A' ' 407' ' ' HIS . 27.3 p . . . . . 0 C--O 1.23 0.072 0 CA-C-O 120.805 0.336 . . . . 0.0 110.917 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -162.07 147.03 12.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.86 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -135.35 178.71 18.39 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.525 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . 0.437 ' O ' HG23 ' A' ' 447' ' ' VAL . 28.4 t80 -117.33 154.57 31.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.863 0.363 . . . . 0.0 110.883 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 448' ' ' SER . 72.2 t -158.53 155.96 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.116 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . 0.467 ' N ' HG12 ' A' ' 447' ' ' VAL . 3.8 m -154.38 154.06 32.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.828 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . 0.416 ' CE1' ' CD1' ' A' ' 403' ' ' LEU . 4.4 m-85 -118.43 -175.25 2.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.899 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.25 -12.53 59.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.86 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -157.61 156.36 28.59 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-O 121.659 0.742 . . . . 0.0 110.846 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . 0.423 ' N ' ' HB2' ' A' ' 401' ' ' ALA . 61.1 Cg_endo -75.45 0.21 9.36 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.648 2.232 . . . . 0.0 112.332 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 99.2 t -90.04 -38.84 11.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.134 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 31.2 m -79.34 -38.5 34.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.828 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -51.15 -42.92 61.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.069 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . 0.414 ' O ' ' C ' ' A' ' 457' ' ' ALA . 23.3 mm-40 -59.73 -51.27 70.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.917 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 456' ' ' GLN . . . -36.52 -41.94 0.32 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.083 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -64.43 -69.75 0.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.057 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . 0.548 HG12 HG12 ' A' ' 474' ' ' VAL . 82.5 mt -43.55 -42.56 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.119 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -39.68 -45.73 1.73 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 30.0 t -100.71 -56.29 2.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . 0.52 ' HB3' HG21 ' A' ' 474' ' ' VAL . 87.9 mmm -43.36 -33.15 0.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.881 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -53.01 103.14 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.873 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 83.49 30.77 29.26 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.565 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . 0.578 ' HB3' HD12 ' A' ' 472' ' ' LEU . 26.5 t80 -67.67 110.4 3.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.783 0.325 . . . . 0.0 110.886 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 9.8 tm0? -66.03 107.16 1.8 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.908 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . 0.432 HG21 HD21 ' A' ' 472' ' ' LEU . 17.0 tt -120.52 138.04 52.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.056 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 53.29 -96.44 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.449 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 2.4 ttt -131.89 -1.09 3.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.883 0.373 . . . . 0.0 110.895 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.35 174.68 8.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.891 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 54.5 mtm180 -105.22 172.64 6.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.84 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . 0.578 HD12 ' HB3' ' A' ' 465' ' ' PHE . 82.2 mt -121.24 156.09 33.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.95 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -134.13 108.45 8.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.863 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . 0.548 HG12 HG12 ' A' ' 459' ' ' ILE . 8.6 t -110.04 133.84 54.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.165 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . 0.444 ' HA ' HD13 ' A' ' 459' ' ' ILE . 26.1 mt-30 -156.97 139.1 14.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.946 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . 0.625 HD12 ' C ' ' A' ' 476' ' ' LEU . 1.6 pp -81.1 136.92 35.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.925 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.462 ' O ' HD12 ' A' ' 476' ' ' LEU . 21.7 tptt . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm . . . . . 0 N--CA 1.458 -0.056 0 CA-C-O 120.818 0.342 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.42 -176.76 3.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.946 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -110.73 -154.42 13.73 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.47 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -48.06 176.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.717 2.278 . . . . 0.0 112.263 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . 0.441 ' CD ' ' O ' ' A' ' 399' ' ' GLU . 0.2 OUTLIER -83.24 83.58 7.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.926 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 144.65 -14.77 2.0 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.468 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . 0.437 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -98.2 126.5 43.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.815 0.34 . . . . 0.0 111.145 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . 0.437 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 29.3 m-80 -159.41 162.45 35.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . 0.595 HD23 HD11 ' A' ' 459' ' ' ILE . 28.6 mt -159.78 109.18 1.82 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . 0.432 ' CE1' ' CD1' ' A' ' 446' ' ' PHE . 19.2 m-85 -112.63 114.81 27.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . 0.805 HG21 HD21 ' A' ' 408' ' ' LEU . 3.9 mp -90.87 135.72 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.113 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . 0.426 ' CD1' ' HB2' ' A' ' 444' ' ' PHE . 89.9 m-85 -130.22 168.25 17.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.952 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 32.6 m-70 61.4 48.68 5.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.805 HD21 HG21 ' A' ' 405' ' ' ILE . 38.0 mt -95.71 148.32 34.39 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.592 0.71 . . . . 0.0 110.914 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.598 ' HG2' ' CD1' ' A' ' 412' ' ' PHE . 59.9 Cg_endo -73.35 -169.77 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.699 2.266 . . . . 0.0 112.329 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -95.21 -38.01 10.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.932 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . 0.416 ' OE1' ' C ' ' A' ' 411' ' ' GLU . 0.3 OUTLIER -58.37 -32.45 68.58 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.922 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.598 ' CD1' ' HG2' ' A' ' 409' ' ' PRO . 4.1 m-85 -62.01 158.81 15.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -142.82 -140.74 3.76 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.547 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -88.65 -48.83 7.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.738 0.304 . . . . 0.0 110.876 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . 0.463 ' O ' ' N ' ' A' ' 418' ' ' LEU . 19.9 mp0 -64.43 -58.23 7.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.963 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 415' ' ' GLN . 35.9 m-20 -34.43 -56.6 0.52 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.899 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 24.3 tp -53.34 -43.42 67.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . 0.463 ' N ' ' O ' ' A' ' 415' ' ' GLN . 11.1 tp -65.04 -51.56 60.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.962 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -69.48 -9.85 55.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.951 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 2.8 ttm -89.79 -25.55 21.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.902 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . 0.444 ' CZ ' ' CG1' ' A' ' 405' ' ' ILE . 5.2 m-85 -104.57 -12.16 16.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.937 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . 0.577 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 7.6 mtt -57.38 -46.12 99.83 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.56 0.695 . . . . 0.0 110.823 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 422' ' ' MET . 64.5 Cg_exo -47.94 -39.63 32.48 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.71 2.273 . . . . 0.0 112.31 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . 0.574 ' CE2' ' HA ' ' A' ' 458' ' ' ALA . 73.4 m-85 -68.23 -35.67 78.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.905 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 172.16 -173.84 45.29 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.487 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.94 114.56 12.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.86 0.362 . . . . 0.0 110.905 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 98.2 t -84.79 124.4 39.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.153 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 17.1 t -70.93 -54.05 19.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.08 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 14.6 m -148.63 136.57 20.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.859 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -144.35 134.46 24.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.132 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . 0.423 ' CG ' ' N ' ' A' ' 432' ' ' VAL . 20.6 tttt -159.97 159.29 32.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.888 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.423 ' N ' ' CG ' ' A' ' 431' ' ' LYS . 38.8 t -111.03 144.64 18.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.165 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . 0.554 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 7.5 m-85 . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . 0.407 ' O ' ' SG ' ' A' ' 443' ' ' CYS . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.714 0.292 . . . . 0.0 110.819 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . 0.584 ' CD1' ' C ' ' A' ' 444' ' ' PHE . 1.1 p90 -161.71 145.65 12.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.876 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -139.25 179.16 18.94 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.534 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . 0.432 ' CD1' ' CE1' ' A' ' 404' ' ' PHE . 26.7 t80 -116.93 150.59 38.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.888 0.375 . . . . 0.0 110.875 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 21.0 t -153.91 143.15 13.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.117 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 99.8 p -139.05 141.85 38.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.865 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . 0.537 ' CE1' HD12 ' A' ' 403' ' ' LEU . 3.2 m-85 -108.92 175.18 5.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.912 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -69.59 -20.21 63.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.821 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -153.95 155.69 31.39 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.687 0.756 . . . . 0.0 110.836 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.91 -15.65 26.28 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.686 2.258 . . . . 0.0 112.319 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 97.3 t -74.74 -43.09 47.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.134 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 1.9 t -75.61 -41.95 53.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.886 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -47.76 -42.78 26.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.153 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -59.16 -46.44 88.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.925 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -37.75 -44.34 0.72 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.1 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . 0.574 ' HA ' ' CE2' ' A' ' 424' ' ' PHE . . . -64.28 -69.73 0.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.157 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . 0.595 HD11 HD23 ' A' ' 403' ' ' LEU . 93.9 mt -40.33 -47.43 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.167 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 459' ' ' ILE . 40.7 mt-30 -38.04 -51.7 1.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.89 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 17.4 t -93.94 -54.87 3.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.839 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . 0.463 ' O ' ' N ' ' A' ' 465' ' ' PHE . 77.5 mmm -43.7 -51.46 7.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.872 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 462' ' ' MET . 36.7 t-20 -38.17 105.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.921 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 472' ' ' LEU . . . 78.92 33.59 36.55 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.508 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . 0.463 ' N ' ' O ' ' A' ' 462' ' ' MET . 83.2 t80 -73.92 117.97 16.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.81 0.338 . . . . 0.0 110.907 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 5.2 tm0? -66.32 104.55 1.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.953 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 12.4 tt -117.65 139.33 45.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.114 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 49.54 -95.93 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.472 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 6.5 ptp -131.43 0.42 4.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.853 0.359 . . . . 0.0 110.914 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.7 172.93 11.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 48.2 mtt85 -100.91 167.32 10.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.887 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . 0.435 ' O ' ' N ' ' A' ' 464' ' ' GLY . 58.5 mt -114.81 152.98 31.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.005 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -130.69 106.62 8.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . 0.488 HG12 HG12 ' A' ' 459' ' ' ILE . 15.6 t -112.44 131.88 62.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.121 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -154.4 137.77 15.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . 0.626 HD12 ' C ' ' A' ' 476' ' ' LEU . 1.6 pp -79.5 132.84 36.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.856 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 476' ' ' LEU . 55.7 tttt . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.886 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.497 ' O ' ' CB ' ' A' ' 429' ' ' SER . 9.8 ptmt . . . . . 0 N--CA 1.458 -0.032 0 CA-C-O 120.727 0.299 . . . . 0.0 110.905 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -128.67 -175.73 3.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -100.48 -146.38 19.25 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.468 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.53 151.41 41.99 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.698 2.265 . . . . 0.0 112.314 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -51.46 104.01 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 130.58 -24.85 4.32 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.445 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . 0.494 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -98.02 126.98 43.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.341 . . . . 0.0 111.098 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 16.6 m-80 -158.98 164.29 35.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.874 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . 0.449 HD12 ' CE1' ' A' ' 449' ' ' TYR . 34.5 mt -158.05 124.83 4.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.917 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . 0.493 ' CZ ' ' CD1' ' A' ' 446' ' ' PHE . 35.5 m-85 -130.96 113.32 13.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.846 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . 0.657 HD12 ' N ' ' A' ' 405' ' ' ILE . 3.2 mp -90.75 136.09 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.122 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -127.74 159.77 33.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 28.8 m-70 60.14 54.99 3.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.855 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.526 HD21 HG21 ' A' ' 405' ' ' ILE . 19.3 mt -93.8 140.73 23.1 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.534 0.683 . . . . 0.0 110.943 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.565 ' HG2' ' CE1' ' A' ' 412' ' ' PHE . 77.6 Cg_exo -49.83 -173.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.67 2.247 . . . . 0.0 112.334 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -96.3 -35.62 11.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.953 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 25.3 pm0 -76.16 -13.77 60.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.858 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.565 ' CE1' ' HG2' ' A' ' 409' ' ' PRO . 5.3 m-85 -71.81 129.05 37.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -120.31 -152.93 9.04 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.44 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.48 -57.88 3.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.743 0.306 . . . . 0.0 110.886 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -54.9 -51.97 64.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.886 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -42.29 -58.57 2.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.833 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . 0.503 HD11 HG12 ' A' ' 405' ' ' ILE . 44.8 tp -54.19 -45.8 72.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.927 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 18.2 tp -54.72 -55.39 30.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.865 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -72.89 -9.29 58.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.882 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -82.68 -20.85 35.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -115.18 -12.22 11.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.878 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . 0.579 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 18.0 mtt -54.05 -45.84 98.9 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.611 0.719 . . . . 0.0 110.882 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.2 Cg_exo -48.05 -35.14 25.0 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.613 2.208 . . . . 0.0 112.335 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . 0.536 ' CZ ' ' SD ' ' A' ' 462' ' ' MET . 72.2 m-85 -73.89 -30.18 62.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 167.63 -171.87 42.3 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.502 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -77.91 98.77 5.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.888 0.375 . . . . 0.0 110.878 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.501 HG13 HG13 ' A' ' 447' ' ' VAL . 90.6 t -67.98 114.97 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.12 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 17.8 t -66.18 -45.54 89.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.121 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 30.8 t -135.87 144.58 45.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.821 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . 0.454 ' HB2' HG11 ' A' ' 427' ' ' VAL . . . -157.17 106.36 2.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.075 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . 0.42 ' C ' ' HD3' ' A' ' 431' ' ' LYS . 1.1 tmtp? -142.5 143.98 32.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.895 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 66.2 t -113.75 148.59 16.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.102 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . 0.41 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 2.9 m-85 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.934 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 30.4 p . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.818 0.342 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . 0.41 ' CE1' ' HB2' ' A' ' 433' ' ' PHE . 2.0 p90 -161.29 151.93 18.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.879 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -152.57 176.82 30.62 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.495 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . 0.502 ' O ' HG23 ' A' ' 447' ' ' VAL . 56.5 t80 -115.96 155.84 27.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.905 0.383 . . . . 0.0 110.885 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 446' ' ' PHE . 53.5 t -158.69 152.43 6.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.18 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 29.6 p -151.06 152.23 33.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.856 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . 0.544 ' HB2' ' HB2' ' A' ' 455' ' ' ALA . 4.5 m-85 -117.82 -177.51 3.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.895 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.48 -12.73 60.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . 0.459 ' OD1' ' N ' ' A' ' 451' ' ' ASN . 0.5 OUTLIER -159.25 159.99 28.66 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.627 0.727 . . . . 0.0 110.902 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . 0.405 ' N ' ' HB2' ' A' ' 401' ' ' ALA . 61.1 Cg_endo -75.23 -19.69 17.14 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.67 2.247 . . . . 0.0 112.379 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 60.3 t -72.94 -43.38 59.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.09 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 16.2 m -75.8 -44.7 39.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.873 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . 0.544 ' HB2' ' HB2' ' A' ' 449' ' ' TYR . . . -52.25 -34.88 48.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.152 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . 0.507 HE21 HD23 ' A' ' 476' ' ' LEU . 14.7 mm-40 -63.82 -44.35 93.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.904 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -41.8 -40.19 1.99 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.088 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . 0.478 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -62.39 -68.5 0.32 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.089 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . 0.444 ' O ' ' CB ' ' A' ' 463' ' ' ASN . 66.8 mt -45.71 -46.02 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.188 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -38.82 -50.48 1.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 2.8 m -97.12 -56.84 2.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.892 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . 0.536 ' SD ' ' CZ ' ' A' ' 424' ' ' PHE . 81.1 mmm -42.64 -45.44 4.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.853 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . 0.444 ' CB ' ' O ' ' A' ' 459' ' ' ILE . 9.5 t30 -43.89 108.19 0.11 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.869 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 78.32 30.49 49.85 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.466 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . 0.514 ' HB3' HD12 ' A' ' 472' ' ' LEU . 55.2 t80 -68.11 115.37 7.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.817 0.341 . . . . 0.0 110.894 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 18.6 tm0? -67.25 107.96 2.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.943 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . 0.469 HG23 ' O ' ' A' ' 467' ' ' ILE . 19.2 tt -126.22 126.31 69.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.108 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 64.26 -103.68 0.77 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.514 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 56.7 mtp -124.12 0.87 8.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.842 0.353 . . . . 0.0 110.9 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -131.18 -179.82 5.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.894 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 39.2 mtt-85 -112.68 164.39 13.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.881 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . 0.514 HD12 ' HB3' ' A' ' 465' ' ' PHE . 65.8 mt -103.09 152.34 21.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.9 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 17.9 tttm -130.31 99.94 5.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.885 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 3.2 t -108.82 140.63 26.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.169 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -157.07 147.48 21.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.921 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . 0.806 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.3 pp -94.25 127.21 39.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.923 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 476' ' ' LEU . 31.9 tttm . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.698 0.285 . . . . 0.0 110.931 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -138.95 174.67 10.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.864 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -98.0 -145.27 18.6 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.51 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.57 153.33 43.99 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.736 2.291 . . . . 0.0 112.358 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 15.1 tm-20 -54.98 110.64 0.69 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.899 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 129.22 -27.7 4.2 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.474 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . 0.491 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.94 126.77 43.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.774 0.321 . . . . 0.0 111.086 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.6 OUTLIER -158.99 160.32 35.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.861 -179.918 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . 0.622 HD23 HD11 ' A' ' 459' ' ' ILE . 38.7 mt -159.61 114.24 2.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.902 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . 0.641 ' CZ ' ' CD1' ' A' ' 446' ' ' PHE . 42.6 m-85 -122.23 111.91 17.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.9 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . 0.623 HD12 ' N ' ' A' ' 405' ' ' ILE . 3.6 mp -91.65 134.99 28.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.152 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -124.56 169.29 12.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.922 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 57.47 44.43 21.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.832 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.445 HD21 HG21 ' A' ' 405' ' ' ILE . 30.4 mt -91.09 134.55 29.83 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.625 0.726 . . . . 0.0 110.886 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -48.77 -179.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.683 2.255 . . . . 0.0 112.377 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -85.16 -46.06 11.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.9 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -58.88 -36.04 73.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.925 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.472 ' CZ ' HD11 ' A' ' 467' ' ' ILE . 7.9 m-85 -55.4 116.91 3.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.844 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -107.48 -151.88 17.44 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.436 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.96 -44.22 40.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.779 0.323 . . . . 0.0 110.877 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . 0.407 ' O ' ' C ' ' A' ' 416' ' ' ASP . 3.4 mp0 -62.88 -56.88 13.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.923 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . 0.407 ' C ' ' O ' ' A' ' 415' ' ' GLN . 36.3 m-20 -36.99 -64.92 0.33 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . 0.43 HD21 HD13 ' A' ' 405' ' ' ILE . 17.5 tp -42.73 -46.5 5.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.958 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . 0.453 ' O ' ' CG ' ' A' ' 422' ' ' MET . 14.9 tp -63.69 -37.41 87.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.913 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -80.44 -16.04 55.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.885 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 2.7 tpp -87.17 -30.43 21.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.881 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . 0.598 ' CE1' ' SD ' ' A' ' 462' ' ' MET . 4.6 m-85 -98.44 -25.55 14.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . 0.546 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 0.3 OUTLIER -45.23 -47.94 33.17 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.541 0.686 . . . . 0.0 110.926 179.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.546 ' CD ' ' N ' ' A' ' 422' ' ' MET . 63.9 Cg_exo -47.95 -46.12 22.84 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.722 2.281 . . . . 0.0 112.408 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . 0.44 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 90.1 m-85 -64.57 -33.96 77.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.854 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 169.03 163.58 23.31 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.541 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -56.46 118.47 4.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.863 0.363 . . . . 0.0 110.906 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.563 HG11 ' HB2' ' A' ' 430' ' ' ALA . 41.7 t -88.19 123.98 41.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.171 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 65.1 t -75.8 -36.11 32.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.09 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . 0.445 ' O ' HG13 ' A' ' 447' ' ' VAL . 0.7 OUTLIER -142.39 143.14 32.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.859 -179.856 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . 0.563 ' HB2' HG11 ' A' ' 427' ' ' VAL . . . -160.82 111.68 1.8 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.151 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -157.48 143.5 17.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.952 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 78.5 t -94.12 146.48 6.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.166 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . 0.456 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.4 m-30 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.798 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 26.8 p . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.865 0.364 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . 0.456 ' CE1' ' HB2' ' A' ' 433' ' ' PHE . 8.9 p90 -162.07 144.24 11.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.92 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -135.16 168.29 23.79 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.491 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . 0.641 ' CD1' ' CZ ' ' A' ' 404' ' ' PHE . 26.7 t80 -109.3 151.64 26.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.919 0.39 . . . . 0.0 110.913 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 429' ' ' SER . 23.0 t -155.42 144.81 12.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.104 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 1.8 m -143.22 141.06 30.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.896 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . 0.599 ' CE1' HD12 ' A' ' 403' ' ' LEU . 6.1 m-85 -107.43 176.61 5.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.913 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -72.01 -29.65 64.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.882 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -140.98 153.52 67.37 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.71 0.766 . . . . 0.0 110.871 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.39 0.12 8.46 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.716 2.277 . . . . 0.0 112.376 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 87.7 t -88.76 -37.66 10.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.131 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 22.9 t -78.88 -41.5 29.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.819 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -49.1 -37.0 20.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.177 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -62.25 -52.22 64.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.969 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -37.82 -45.67 0.86 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.106 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . 0.44 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -62.92 -62.96 1.37 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.108 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . 0.622 HD11 HD23 ' A' ' 403' ' ' LEU . 70.0 mt -47.43 -48.01 9.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.163 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . 0.436 ' C ' ' O ' ' A' ' 459' ' ' ILE . 49.7 mt-30 -34.35 -45.6 0.23 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.841 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 1.9 m -103.46 -56.27 2.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.882 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . 0.666 ' HB3' HG21 ' A' ' 474' ' ' VAL . 5.7 mmt -38.93 -45.74 1.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . 0.403 ' HB2' HG23 ' A' ' 459' ' ' ILE . 28.6 t-20 -59.8 89.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.904 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 114.16 -10.39 22.52 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.517 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -43.53 110.32 0.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.741 0.305 . . . . 0.0 110.945 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -63.22 105.75 0.77 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.863 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . 0.526 HG23 ' O ' ' A' ' 467' ' ' ILE . 15.4 tt -110.9 122.35 65.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.103 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 61.96 -100.42 0.29 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.568 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 9.7 mtt -120.13 -14.52 8.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.885 0.374 . . . . 0.0 110.842 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 31.2 pttt -117.16 179.47 4.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.933 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 50.1 mtt180 -107.23 173.44 6.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.863 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 94.4 mt -113.45 154.14 27.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -129.68 104.84 7.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.899 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . 0.666 HG21 ' HB3' ' A' ' 462' ' ' MET . 23.8 t -114.28 135.94 52.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.128 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 28.6 tp60 -157.06 143.63 18.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . 0.728 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.5 pp -86.9 125.37 33.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.916 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.467 ' O ' HD12 ' A' ' 476' ' ' LEU . 26.0 tttm . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.912 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.414 ' O ' ' CB ' ' A' ' 429' ' ' SER . 18.8 mtpp . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.774 0.321 . . . . 0.0 110.896 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -121.53 -177.44 3.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.85 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -103.74 -163.31 25.09 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.518 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . 0.401 ' HG2' ' O ' ' A' ' 450' ' ' ASP . 53.5 Cg_exo -49.45 157.84 2.0 Allowed 'Trans proline' 0 C--N 1.34 0.128 0 C-N-CA 122.683 2.255 . . . . 0.0 112.312 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -66.37 82.15 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.847 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 148.18 -18.2 1.36 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.495 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . 0.57 ' HB2' ' CA ' ' A' ' 452' ' ' PRO . . . -106.93 126.75 52.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.751 0.31 . . . . 0.0 111.08 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.3 OUTLIER -158.14 169.41 24.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.895 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . 0.578 HD12 ' CE1' ' A' ' 449' ' ' TYR . 16.3 mt -159.97 115.79 2.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.904 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . 0.545 ' CE1' ' CE1' ' A' ' 446' ' ' PHE . 25.3 m-85 -120.0 111.5 17.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.833 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . 0.676 HD12 ' N ' ' A' ' 405' ' ' ILE . 2.9 mp -91.01 136.01 25.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.16 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -124.41 177.81 5.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.834 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . 0.462 ' N ' ' CD2' ' A' ' 407' ' ' HIS . 4.2 m170 47.74 54.2 10.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.885 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 409' ' ' PRO . 30.5 mt -96.62 140.86 22.38 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.575 0.703 . . . . 0.0 110.929 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.561 ' HG2' ' CE1' ' A' ' 412' ' ' PHE . 77.0 Cg_exo -49.81 -173.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.691 2.261 . . . . 0.0 112.32 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -95.52 -29.58 14.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -78.67 -20.29 50.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.949 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.561 ' CE1' ' HG2' ' A' ' 409' ' ' PRO . 5.4 m-85 -64.91 128.49 35.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.799 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . 0.471 ' O ' HG21 ' A' ' 432' ' ' VAL . . . -117.68 -139.93 6.42 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.507 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -88.01 -36.82 16.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.833 0.349 . . . . 0.0 110.898 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . 0.437 ' O ' ' N ' ' A' ' 418' ' ' LEU . 19.8 mm-40 -71.36 -58.26 3.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.913 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -37.96 -49.38 1.25 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.882 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 53.0 tp -58.59 -40.96 84.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.914 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 415' ' ' GLN . 20.7 tp -64.93 -58.15 6.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.897 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -66.77 -8.95 31.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.925 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -87.69 -27.36 22.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.833 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . 0.492 ' CZ ' HG12 ' A' ' 405' ' ' ILE . 3.4 m-85 -110.32 6.61 22.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.827 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . 0.582 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 13.5 mtt -73.4 -45.76 7.66 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.549 0.69 . . . . 0.0 110.876 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 422' ' ' MET . 63.9 Cg_exo -47.96 -28.8 10.77 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.674 2.249 . . . . 0.0 112.418 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . 0.422 ' CE2' ' HA ' ' A' ' 458' ' ' ALA . 81.7 m-85 -76.7 -34.06 58.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.924 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 164.35 -163.63 36.21 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.488 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -72.68 134.77 45.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.889 0.376 . . . . 0.0 110.855 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 18.7 t -107.97 116.84 52.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.17 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . 0.526 HG12 ' OG ' ' A' ' 429' ' ' SER . 31.4 t -68.22 -55.34 16.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.181 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . 0.526 ' OG ' HG12 ' A' ' 428' ' ' VAL . 0.9 OUTLIER -136.75 148.61 47.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.854 -179.864 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -161.06 120.1 2.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.117 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -161.09 141.88 11.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.92 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.471 HG21 ' O ' ' A' ' 413' ' ' GLY . 84.0 t -86.99 153.91 3.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.159 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . 0.556 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.3 m-30 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.934 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 31.3 p . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.785 0.326 . . . . 0.0 110.866 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . 0.556 ' CE1' ' HB2' ' A' ' 433' ' ' PHE . 4.9 p90 -160.07 143.16 13.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -129.83 177.39 18.15 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.503 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . 0.545 ' CE1' ' CE1' ' A' ' 404' ' ' PHE . 20.2 t80 -119.35 152.67 36.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.956 0.408 . . . . 0.0 110.899 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 446' ' ' PHE . 77.9 t -159.03 153.75 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.063 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . 0.416 ' N ' HG12 ' A' ' 447' ' ' VAL . 79.0 p -151.53 144.35 24.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.857 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . 0.578 ' CE1' HD12 ' A' ' 403' ' ' LEU . 15.3 m-85 -107.84 -176.02 2.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.936 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . 0.401 ' O ' ' HG2' ' A' ' 398' ' ' PRO . 0.4 OUTLIER -79.75 -16.72 55.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.937 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -150.93 155.15 35.12 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.608 0.718 . . . . 0.0 110.863 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . 0.57 ' CA ' ' HB2' ' A' ' 401' ' ' ALA . 60.3 Cg_endo -73.95 -13.87 23.9 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.733 2.289 . . . . 0.0 112.378 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 37.2 t -78.89 -37.52 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.087 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 11.4 p -74.88 -50.95 15.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.887 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -40.84 -39.74 1.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.062 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . 0.4 ' O ' ' C ' ' A' ' 457' ' ' ALA . 45.6 mm-40 -56.66 -50.74 71.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.897 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 456' ' ' GLN . . . -36.91 -43.68 0.46 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.139 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . 0.422 ' HA ' ' CE2' ' A' ' 424' ' ' PHE . . . -62.81 -66.1 0.59 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.144 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . 0.443 ' O ' ' CB ' ' A' ' 463' ' ' ASN . 73.7 mt -46.94 -41.92 5.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.082 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -44.18 -49.14 9.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.9 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 45.2 t -98.12 -57.02 2.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.826 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . 0.404 ' O ' ' N ' ' A' ' 465' ' ' PHE . 91.8 mmm -40.9 -47.6 2.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.882 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' A' ' 459' ' ' ILE . 26.5 t-20 -44.78 106.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.914 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 82.74 27.06 43.5 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.477 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . 0.404 ' N ' ' O ' ' A' ' 462' ' ' MET . 10.9 t80 -66.59 117.59 8.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.81 0.338 . . . . 0.0 110.844 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 11.6 tm0? -64.8 118.09 8.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.911 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . 0.556 HG23 ' O ' ' A' ' 467' ' ' ILE . 14.4 tt -140.58 120.71 13.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.097 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 69.07 -104.26 1.23 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.487 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 24.6 ttp -131.25 12.53 5.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.841 0.353 . . . . 0.0 110.875 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -138.81 -179.15 5.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.89 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 57.9 mtm180 -108.48 163.13 13.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . 0.422 HD23 ' O ' ' A' ' 407' ' ' HIS . 53.7 mt -109.85 148.99 30.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.879 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -124.46 128.28 48.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.871 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . 0.429 HG12 HG12 ' A' ' 459' ' ' ILE . 32.5 t -133.95 133.81 56.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.09 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -157.13 136.34 11.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.905 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . 0.676 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.5 pp -79.19 128.61 33.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.937 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 476' ' ' LEU . 46.7 tttm . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.915 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.406 ' HB2' ' NZ ' ' A' ' 395' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.747 0.308 . . . . 0.0 110.919 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -142.74 -177.59 5.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.922 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -83.49 -147.01 7.2 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.521 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.9 151.53 40.14 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.721 2.28 . . . . 0.0 112.309 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -52.37 107.83 0.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.932 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 131.32 -28.57 3.6 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.463 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . 0.495 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.86 126.83 43.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.749 0.309 . . . . 0.0 111.07 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . 0.496 ' O ' ' CB ' ' A' ' 476' ' ' LEU . 0.6 OUTLIER -158.83 163.72 36.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.82 -179.932 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . 0.553 HD12 ' CE1' ' A' ' 449' ' ' TYR . 23.7 mt -160.35 108.03 1.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.899 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . 0.571 ' C ' HD13 ' A' ' 405' ' ' ILE . 5.3 m-85 -111.83 117.41 32.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.871 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . 0.826 HD12 HG22 ' A' ' 474' ' ' VAL . 1.4 mm -90.88 135.49 26.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.103 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . 0.452 ' C ' ' CD2' ' A' ' 407' ' ' HIS . 81.6 m-85 -126.57 148.89 49.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.932 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . 0.474 ' N ' ' O ' ' A' ' 443' ' ' CYS . 12.6 m-70 71.66 54.66 0.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.872 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 31.6 mt -100.38 132.49 22.42 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.637 0.732 . . . . 0.0 110.932 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -47.84 178.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.722 2.282 . . . . 0.0 112.376 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 18.9 tp60 -88.16 -39.09 14.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.938 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -60.18 -36.96 78.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -53.98 150.79 7.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -138.24 -145.34 4.82 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.494 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -79.72 -59.65 2.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.761 0.315 . . . . 0.0 110.934 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 -58.0 -53.76 54.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -38.89 -49.8 1.68 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.858 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . 0.4 HD21 ' CG2' ' A' ' 447' ' ' VAL . 40.8 tp -59.47 -49.41 77.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.903 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 54.9 tp -56.92 -56.01 27.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.925 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -60.24 -12.07 7.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.983 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 4.9 ttm -92.94 -23.59 18.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.904 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -109.97 6.6 23.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . 0.586 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 4.6 mtt -75.55 -45.78 4.29 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.622 0.725 . . . . 0.0 110.879 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.0 Cg_exo -47.97 -46.68 21.22 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.7 2.267 . . . . 0.0 112.325 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -59.4 -35.73 74.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.838 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 172.75 -171.9 44.67 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.501 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -81.53 102.59 10.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.842 0.353 . . . . 0.0 110.925 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 62.0 t -72.77 134.15 30.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.158 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . 0.562 HG12 ' OG ' ' A' ' 429' ' ' SER . 17.9 t -79.05 -48.5 21.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.107 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . 0.562 ' OG ' HG12 ' A' ' 428' ' ' VAL . 1.3 m -146.69 143.44 28.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.842 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -153.86 116.95 4.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.172 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -150.61 137.93 19.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.896 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.451 HG12 ' N ' ' A' ' 433' ' ' PHE . 57.8 t -87.3 155.25 3.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.105 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . 0.539 ' CG ' ' CE1' ' A' ' 444' ' ' PHE . 3.1 m-85 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . 0.474 ' O ' ' N ' ' A' ' 407' ' ' HIS . 26.6 p . . . . . 0 C--O 1.231 0.098 0 CA-C-O 120.843 0.354 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . 0.539 ' CE1' ' CG ' ' A' ' 433' ' ' PHE . 11.1 p90 -160.53 145.7 14.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.851 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -133.16 176.39 19.6 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.521 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -121.23 141.45 50.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.963 0.411 . . . . 0.0 110.818 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . 0.4 ' CG2' HD21 ' A' ' 417' ' ' LEU . 54.7 t -148.69 147.41 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.169 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 51.7 p -142.53 149.99 39.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.93 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . 0.553 ' CE1' HD12 ' A' ' 403' ' ' LEU . 3.3 m-85 -113.11 -174.87 2.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.945 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -81.32 -19.23 43.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.939 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -154.41 154.95 30.29 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.608 0.718 . . . . 0.0 110.898 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . 0.456 ' N ' ' HB2' ' A' ' 401' ' ' ALA . 61.4 Cg_endo -75.72 -10.12 19.98 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.721 2.281 . . . . 0.0 112.359 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 97.8 t -82.63 -29.28 8.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.154 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 68.1 m -90.86 -35.44 14.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.791 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -57.14 -35.22 69.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.041 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -61.1 -38.93 88.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.911 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -47.81 -39.39 18.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.12 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -64.38 -68.4 0.36 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.081 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . 0.52 HG12 HG12 ' A' ' 474' ' ' VAL . 95.2 mt -42.5 -45.32 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.206 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 -41.87 -45.28 3.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 2.9 t -101.47 -57.01 2.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.855 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . 0.41 ' O ' ' N ' ' A' ' 465' ' ' PHE . 91.8 mmm -43.77 -44.68 6.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.911 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 459' ' ' ILE . 19.4 t-20 -44.95 108.0 0.11 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 82.1 25.45 52.02 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.444 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . 0.507 ' HB3' HD12 ' A' ' 472' ' ' LEU . 18.0 t80 -64.34 109.25 1.85 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.809 0.337 . . . . 0.0 110.882 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 7.4 tm0? -63.12 114.79 3.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.875 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . 0.478 HG23 ' O ' ' A' ' 467' ' ' ILE . 17.9 tt -127.59 126.48 67.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.179 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 61.11 -96.79 0.11 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.467 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 33.0 ttp -129.44 -5.4 4.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.879 0.371 . . . . 0.0 110.896 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 15.6 pttm -121.45 176.23 5.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.871 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 28.1 mtm180 -108.56 169.3 8.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.925 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . 0.507 HD12 ' HB3' ' A' ' 465' ' ' PHE . 93.3 mt -115.54 158.32 22.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.904 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 33.8 tttp -137.76 107.54 6.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.928 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . 0.826 HG22 HD12 ' A' ' 405' ' ' ILE . 61.5 t -109.51 135.04 49.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.074 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -156.38 139.81 15.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . 0.631 HD12 ' C ' ' A' ' 476' ' ' LEU . 1.6 pp -83.5 129.91 34.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.563 ' HB2' ' CE1' ' A' ' 404' ' ' PHE . 59.2 tttt . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.933 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.421 ' O ' ' CB ' ' A' ' 429' ' ' SER . 13.8 ptpt . . . . . 0 N--CA 1.458 -0.064 0 CA-C-O 120.794 0.331 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . 0.474 ' HA ' ' CB ' ' A' ' 448' ' ' SER . 15.2 pt-20 -131.48 -176.44 4.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.916 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -99.82 -146.87 20.6 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.52 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.07 150.85 49.01 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.722 2.281 . . . . 0.0 112.358 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -50.89 97.93 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.874 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 137.61 -25.24 2.99 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.432 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . 0.486 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -98.21 126.84 43.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.836 0.35 . . . . 0.0 111.131 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 22.0 m-80 -159.17 161.29 36.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.903 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . 0.608 HD12 ' CE1' ' A' ' 449' ' ' TYR . 27.7 mt -159.76 113.8 2.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.944 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . 0.766 ' CZ ' ' CD1' ' A' ' 446' ' ' PHE . 46.6 m-85 -123.02 113.68 19.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . 0.645 HD11 ' CZ ' ' A' ' 421' ' ' PHE . 4.6 mp -90.97 136.89 22.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.097 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . 0.442 ' CD2' ' O ' ' A' ' 473' ' ' LYS . 10.9 m-85 -127.69 153.69 46.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.962 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 69.29 52.64 0.47 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.856 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 19.4 mt -96.13 131.85 27.99 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.594 0.712 . . . . 0.0 110.918 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -48.16 167.9 0.1 OUTLIER 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.678 2.252 . . . . 0.0 112.362 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -70.26 -44.06 69.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.977 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -61.46 -39.65 91.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -54.32 112.42 0.98 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.862 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -104.67 -140.15 10.3 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.475 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.51 -60.76 2.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.808 0.337 . . . . 0.0 110.897 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . 0.469 ' O ' ' N ' ' A' ' 418' ' ' LEU . 1.6 mp0 -53.72 -61.59 2.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 415' ' ' GLN . 35.3 m-20 -34.47 -58.76 0.48 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.841 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 66.2 tp -51.53 -41.83 61.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.9 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' A' ' 415' ' ' GLN . 12.7 tp -67.64 -56.03 10.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.939 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -56.74 -13.14 2.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.971 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 3.0 tpp -86.23 -31.18 21.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . 0.645 ' CZ ' HD11 ' A' ' 405' ' ' ILE . 5.2 m-85 -95.38 -26.66 15.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.838 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . 0.547 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 0.2 OUTLIER -46.14 -47.66 43.93 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.531 0.681 . . . . 0.0 110.846 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.547 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.2 Cg_exo -47.96 -42.99 31.12 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.717 2.278 . . . . 0.0 112.315 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . 0.408 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 64.6 m-85 -67.54 -35.06 78.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.878 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 172.08 -169.35 42.46 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.49 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -75.99 122.25 23.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.803 0.335 . . . . 0.0 110.921 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.495 HG11 ' HB2' ' A' ' 430' ' ' ALA . 84.1 t -95.15 115.23 33.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.191 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.4 -43.29 81.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.132 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 1.5 t -134.53 144.07 47.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . 0.495 ' HB2' HG11 ' A' ' 427' ' ' VAL . . . -161.07 107.11 1.41 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.139 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . 0.421 ' C ' ' HD2' ' A' ' 431' ' ' LYS . 0.1 OUTLIER -153.29 149.72 28.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 72.9 t -103.76 142.1 18.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.097 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . 0.51 ' CG ' ' CE1' ' A' ' 444' ' ' PHE . 3.1 m-85 . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.875 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 72.0 m . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.876 0.37 . . . . 0.0 110.822 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . 0.51 ' CE1' ' CG ' ' A' ' 433' ' ' PHE . 5.4 p90 -162.18 137.62 7.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.842 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -131.73 169.67 21.88 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.498 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . 0.766 ' CD1' ' CZ ' ' A' ' 404' ' ' PHE . 22.2 t80 -111.54 150.01 30.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.859 0.361 . . . . 0.0 110.918 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . 0.468 HG13 HG13 ' A' ' 427' ' ' VAL . 85.5 t -155.14 145.21 13.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.121 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . 0.474 ' CB ' ' HA ' ' A' ' 396' ' ' GLU . 1.9 m -144.42 140.85 29.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.91 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . 0.608 ' CE1' HD12 ' A' ' 403' ' ' LEU . 3.6 m-85 -102.94 179.79 4.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.942 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -75.82 -25.88 56.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.938 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -147.05 158.56 44.68 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.558 0.694 . . . . 0.0 110.912 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.65 -12.69 20.25 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.713 2.275 . . . . 0.0 112.3 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 92.4 t -77.37 -38.56 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.147 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 1.5 t -83.37 -39.61 20.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.882 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . 0.459 ' HB2' ' HB2' ' A' ' 449' ' ' TYR . . . -53.1 -43.23 66.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.076 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -59.08 -42.48 90.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.934 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -43.08 -38.84 2.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.126 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . 0.408 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -66.7 -61.74 1.81 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.121 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 67.1 mt -47.53 -45.45 10.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.115 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -37.68 -47.77 1.0 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 2.8 m -103.03 -56.98 2.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.899 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 88.4 mmm -39.72 -44.56 1.57 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.844 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -46.18 110.3 0.26 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.872 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 74.12 35.28 53.73 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.516 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . 0.417 ' CD1' ' C ' ' A' ' 465' ' ' PHE . 9.5 t80 -68.72 117.4 10.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.818 0.342 . . . . 0.0 110.905 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 11.2 tm0? -63.77 115.19 4.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.91 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 14.6 tt -138.11 132.94 43.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.094 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 51.25 -108.52 0.58 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.474 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 26.0 mtt -127.26 24.82 6.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.829 0.347 . . . . 0.0 110.844 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 7.8 pttt -142.43 -178.43 5.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.894 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 33.3 mtm-85 -125.13 121.91 35.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.911 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 45.0 mt -65.7 152.06 45.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.952 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . 0.442 ' O ' ' CD2' ' A' ' 406' ' ' TYR . 18.5 ttmm -132.6 100.49 4.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.88 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . 0.556 HG22 HG13 ' A' ' 405' ' ' ILE . 21.1 t -107.56 136.75 41.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.203 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -156.52 145.89 20.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.87 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . 0.786 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.4 pp -91.04 126.2 36.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 476' ' ' LEU . 16.9 ttpp . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.892 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.5 ' O ' ' CB ' ' A' ' 429' ' ' SER . 17.8 ptpt . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.778 0.323 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -109.71 -178.9 3.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.865 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -105.16 -155.45 22.52 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.555 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.13 157.58 8.25 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.729 2.286 . . . . 0.0 112.374 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -65.85 78.43 0.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.919 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 153.83 -16.69 0.63 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.456 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . 0.505 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -106.49 126.7 52.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.765 0.316 . . . . 0.0 111.111 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . 0.505 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.2 OUTLIER -158.15 168.91 25.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.884 -179.901 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . 0.497 HD12 ' CE1' ' A' ' 449' ' ' TYR . 27.7 mt -160.06 119.84 2.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.864 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . 0.535 ' CE1' ' HB2' ' A' ' 477' ' ' LYS . 15.0 m-85 -124.42 113.45 18.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . 0.567 HD12 ' N ' ' A' ' 405' ' ' ILE . 3.4 mp -91.15 133.95 31.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.151 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -125.75 162.27 25.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.935 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . 0.491 ' N ' ' O ' ' A' ' 443' ' ' CYS . 25.0 m-70 61.01 54.61 3.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.908 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.534 HD21 HG21 ' A' ' 405' ' ' ILE . 30.3 mt -99.87 144.91 29.24 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.668 0.747 . . . . 0.0 110.838 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.578 ' HG2' ' CD1' ' A' ' 412' ' ' PHE . 61.5 Cg_endo -76.47 164.96 29.92 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.711 2.274 . . . . 0.0 112.274 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -69.35 -38.63 78.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.918 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -54.46 -36.48 64.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.578 ' CD1' ' HG2' ' A' ' 409' ' ' PRO . 4.7 m-85 -67.65 138.64 56.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.934 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -123.48 -137.0 4.88 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.474 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -87.81 -56.97 3.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.772 0.32 . . . . 0.0 110.909 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . 0.444 ' O ' ' N ' ' A' ' 418' ' ' LEU . 26.9 mm-40 -58.4 -57.03 14.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.95 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' A' ' 415' ' ' GLN . 53.0 m-20 -34.87 -59.23 0.49 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.866 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . 0.403 HD11 HG12 ' A' ' 405' ' ' ILE . 51.5 tp -51.29 -42.63 61.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.906 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . 0.444 ' N ' ' O ' ' A' ' 415' ' ' GLN . 10.8 tp -65.84 -46.33 78.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.904 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -68.18 -16.24 63.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.973 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 2.0 ttt -85.35 -35.01 21.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.917 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . 0.468 ' CE1' ' SD ' ' A' ' 462' ' ' MET . 3.8 m-85 -92.69 -22.72 19.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.839 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . 0.574 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 0.3 OUTLIER -50.87 -45.62 87.24 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.563 0.697 . . . . 0.0 110.96 179.951 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.4 Cg_exo -47.98 -38.84 32.17 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.662 2.242 . . . . 0.0 112.372 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . 0.503 ' CE2' ' HA ' ' A' ' 458' ' ' ALA . 78.1 m-85 -70.88 -35.28 72.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.898 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 164.58 -178.96 39.59 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.523 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 -61.86 135.11 57.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.812 0.339 . . . . 0.0 110.834 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.436 HG11 ' HB2' ' A' ' 430' ' ' ALA . 24.2 t -111.47 124.83 68.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.117 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 19.1 t -69.64 -50.35 50.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.209 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . 0.5 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 4.5 t -137.69 148.7 45.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.826 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . 0.436 ' HB2' HG11 ' A' ' 427' ' ' VAL . . . -160.59 107.74 1.55 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.106 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -150.96 143.81 24.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 433' ' ' PHE . 99.3 t -94.43 152.49 3.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.048 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . 0.426 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.5 m-30 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.931 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . 0.491 ' O ' ' N ' ' A' ' 407' ' ' HIS . 30.3 p . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.806 0.336 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . 0.426 ' CE1' ' HB2' ' A' ' 433' ' ' PHE . 8.2 p90 -161.89 147.55 13.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.939 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -138.36 179.07 18.78 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.524 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . 0.503 ' O ' ' CG2' ' A' ' 447' ' ' VAL . 55.6 t80 -118.79 153.71 34.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.831 0.348 . . . . 0.0 110.936 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . 0.503 ' CG2' ' O ' ' A' ' 446' ' ' PHE . 94.3 t -161.02 153.56 4.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.176 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . 0.417 ' N ' HG12 ' A' ' 447' ' ' VAL . 65.7 p -153.12 148.39 26.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.876 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . 0.497 ' CE1' HD12 ' A' ' 403' ' ' LEU . 5.9 m-85 -110.43 -174.93 2.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.966 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -78.22 -25.55 47.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.817 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -146.87 158.28 45.73 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.66 0.743 . . . . 0.0 110.898 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . 0.414 ' N ' ' HB2' ' A' ' 401' ' ' ALA . 61.2 Cg_endo -75.5 0.24 9.33 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.714 2.276 . . . . 0.0 112.317 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 75.5 t -88.5 -36.03 8.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.146 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 71.3 m -83.63 -39.94 19.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.88 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -50.66 -33.31 21.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.1 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -69.15 -45.55 69.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -41.6 -44.49 3.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.089 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . 0.503 ' HA ' ' CE2' ' A' ' 424' ' ' PHE . . . -63.85 -64.3 0.93 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.086 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . 0.41 ' O ' ' C ' ' A' ' 460' ' ' GLN . 65.9 mt -41.46 -47.15 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.171 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 459' ' ' ILE . 14.4 mm100 -36.89 -60.33 0.63 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.94 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 13.3 t -87.0 -52.93 5.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.884 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . 0.468 ' SD ' ' CE1' ' A' ' 421' ' ' PHE . 7.5 mmt -40.43 -56.86 1.93 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -42.45 107.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.912 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 80.12 32.92 34.13 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.507 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -75.77 110.96 10.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.775 0.322 . . . . 0.0 110.891 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 12.6 tm0? -63.08 102.9 0.41 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.918 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . 0.521 HD11 ' CE1' ' A' ' 412' ' ' PHE . 16.1 tt -115.27 144.52 22.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.154 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 46.68 -95.94 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.498 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 4.6 tpt -130.22 -3.47 4.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.791 0.329 . . . . 0.0 110.869 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 11.7 pttm -125.26 -178.53 4.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.88 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 66.9 mtm-85 -108.25 172.38 6.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.843 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 82.8 mt -120.52 156.92 30.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.952 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 32.4 tttp -136.15 105.03 5.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.898 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . 0.433 HG22 HG13 ' A' ' 405' ' ' ILE . 12.1 t -113.76 133.2 60.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.171 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -155.23 138.2 15.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . 0.635 HD12 ' C ' ' A' ' 476' ' ' LEU . 1.6 pp -79.03 129.14 34.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.535 ' HB2' ' CE1' ' A' ' 404' ' ' PHE . 31.8 tttt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.909 179.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 4.1 ptmm? . . . . . 0 C--O 1.231 0.08 0 CA-C-O 120.821 0.343 . . . . 0.0 110.861 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -148.18 179.01 8.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -98.47 -146.0 19.76 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.491 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.19 155.05 46.99 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.648 2.232 . . . . 0.0 112.317 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -55.12 118.75 4.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.87 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 120.21 -27.4 6.7 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.527 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . 0.493 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.97 126.95 43.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.769 0.318 . . . . 0.0 111.06 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . 0.493 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.7 OUTLIER -158.87 165.02 35.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . 0.5 HD12 ' CE1' ' A' ' 449' ' ' TYR . 15.5 mt -159.34 122.04 3.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.941 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . 0.465 ' CE1' ' CD1' ' A' ' 446' ' ' PHE . 29.1 m-85 -128.94 111.56 13.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . 0.736 HG21 HD21 ' A' ' 408' ' ' LEU . 3.9 mp -91.17 135.2 27.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.155 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . 0.424 ' CD1' ' HB2' ' A' ' 444' ' ' PHE . 89.5 m-85 -125.74 163.25 23.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.986 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . 0.421 ' N ' ' O ' ' A' ' 443' ' ' CYS . 29.2 m-70 61.48 52.98 3.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.843 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.736 HD21 HG21 ' A' ' 405' ' ' ILE . 65.0 mt -92.24 128.92 43.13 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.571 0.7 . . . . 0.0 110.922 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -48.35 179.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.466 -0.126 0 C-N-CA 122.684 2.256 . . . . 0.0 112.33 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 23.8 tm0? -82.56 -41.28 19.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.899 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -65.75 -32.66 74.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.874 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.507 ' CE1' HD11 ' A' ' 467' ' ' ILE . 6.5 m-85 -59.88 138.72 57.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.899 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -137.05 -138.19 3.73 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.47 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -81.13 -61.09 2.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.704 0.288 . . . . 0.0 110.881 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -52.85 -53.72 44.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.954 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -41.36 -52.25 3.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.839 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 25.1 tp -55.44 -54.96 37.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.89 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . 0.41 ' O ' ' CG ' ' A' ' 422' ' ' MET . 55.8 tp -50.3 -45.3 54.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.924 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -77.89 -9.06 58.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 1.5 tpt -87.88 -27.35 22.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.796 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -110.1 -18.57 13.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.849 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . 0.576 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 0.2 OUTLIER -52.18 -46.14 93.8 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.599 0.714 . . . . 0.0 110.901 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 422' ' ' MET . 64.1 Cg_exo -47.97 -37.24 29.26 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.654 2.236 . . . . 0.0 112.39 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . 0.464 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 69.5 m-85 -71.41 -35.8 71.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.859 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 174.06 -171.47 44.55 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.426 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -75.27 116.26 15.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.818 0.342 . . . . 0.0 110.874 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.473 HG11 ' HB2' ' A' ' 430' ' ' ALA . 88.0 t -87.44 120.56 36.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.117 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 60.5 t -78.16 -43.6 27.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.127 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -132.73 139.17 47.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.833 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . 0.473 ' HB2' HG11 ' A' ' 427' ' ' VAL . . . -157.8 120.49 3.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.105 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . 0.45 ' CG ' ' N ' ' A' ' 432' ' ' VAL . 20.0 tttm -161.02 160.53 30.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.806 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.45 ' N ' ' CG ' ' A' ' 431' ' ' LYS . 41.0 t -119.18 140.2 43.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.172 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . 0.56 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.1 m-85 . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . 0.421 ' O ' ' N ' ' A' ' 407' ' ' HIS . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.142 0 CA-C-O 120.781 0.324 . . . . 0.0 110.918 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . 0.597 ' CD1' ' C ' ' A' ' 444' ' ' PHE . 0.9 OUTLIER -162.56 141.4 8.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.884 -179.854 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -135.6 175.66 20.62 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.48 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . 0.465 ' CD1' ' CE1' ' A' ' 404' ' ' PHE . 26.0 t80 -114.21 153.37 29.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.896 0.379 . . . . 0.0 110.873 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 446' ' ' PHE . 79.0 t -158.1 154.83 5.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.086 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . 0.431 ' N ' HG12 ' A' ' 447' ' ' VAL . 2.1 m -153.69 145.12 23.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.867 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . 0.5 ' CE1' HD12 ' A' ' 403' ' ' LEU . 4.2 m-85 -108.48 -174.72 2.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.934 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -78.5 -15.69 58.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.78 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . 0.451 ' OD1' ' N ' ' A' ' 451' ' ' ASN . 0.7 OUTLIER -158.69 160.17 29.41 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.598 0.713 . . . . 0.0 110.928 -179.918 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . 0.449 ' N ' ' HB2' ' A' ' 401' ' ' ALA . 60.9 Cg_endo -74.87 -18.13 19.34 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.674 2.249 . . . . 0.0 112.354 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 62.4 t -72.16 -42.78 66.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.105 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 41.8 m -80.8 -41.42 23.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.851 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . 0.458 ' HB2' ' HB2' ' A' ' 449' ' ' TYR . . . -50.51 -35.42 29.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.078 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' A' ' 457' ' ' ALA . 14.1 mm-40 -66.73 -44.75 80.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.918 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 456' ' ' GLN . . . -37.48 -43.18 0.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.085 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . 0.464 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -61.43 -69.44 0.24 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.147 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . 0.448 ' O ' ' C ' ' A' ' 460' ' ' GLN . 79.6 mt -44.13 -48.76 2.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.171 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 459' ' ' ILE . 35.9 mm-40 -34.62 -42.79 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.895 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 2.1 m -103.93 -56.53 2.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.848 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . 0.443 ' O ' ' N ' ' A' ' 465' ' ' PHE . 82.8 mmm -43.22 -46.51 6.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.881 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -41.56 104.19 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.903 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 80.22 31.61 37.77 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.502 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . 0.443 ' N ' ' O ' ' A' ' 462' ' ' MET . 66.2 t80 -71.93 117.24 13.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.862 0.363 . . . . 0.0 110.823 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 12.3 tm0? -66.01 107.04 1.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.883 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . 0.507 HD11 ' CE1' ' A' ' 412' ' ' PHE . 20.1 tt -116.66 145.31 22.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.166 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 40.45 -95.56 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.49 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 469' ' ' MET . . . . . 0.43 ' N ' ' O ' ' A' ' 467' ' ' ILE . 12.8 tmm? -126.77 -9.89 6.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.905 0.383 . . . . 0.0 110.874 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.68 174.97 6.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 40.1 mtt180 -104.79 167.65 9.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.915 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 65.1 mt -111.2 155.39 23.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.913 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -132.95 104.66 6.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.836 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 4.3 t -109.9 138.34 38.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.216 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 11.6 tt0 -156.86 139.77 15.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.98 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . 0.77 HD12 ' O ' ' A' ' 477' ' ' LYS . 1.5 pp -85.79 126.59 34.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.846 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.77 ' O ' HD12 ' A' ' 476' ' ' LEU . 11.3 tptm . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.912 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.498 ' O ' ' CB ' ' A' ' 429' ' ' SER . 7.8 mtpt . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.773 0.321 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -140.14 168.44 19.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.832 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -84.18 -152.93 16.05 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.444 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.05 157.76 46.42 Favored 'Trans proline' 0 N--CA 1.465 -0.188 0 C-N-CA 122.714 2.276 . . . . 0.0 112.39 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -55.42 110.46 0.7 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.858 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 127.77 -28.37 4.43 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.53 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . 0.501 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.94 127.14 43.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.781 0.324 . . . . 0.0 111.081 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . 0.501 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.6 OUTLIER -158.75 164.04 36.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.921 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . 0.595 HD12 ' CE1' ' A' ' 449' ' ' TYR . 20.1 mt -159.71 120.97 3.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . 0.538 ' CZ ' ' CD1' ' A' ' 446' ' ' PHE . 35.8 m-85 -126.59 111.16 14.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.939 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . 0.553 HD12 ' N ' ' A' ' 405' ' ' ILE . 4.0 mp -91.23 128.22 43.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.116 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . 0.413 ' C ' ' CD2' ' A' ' 407' ' ' HIS . 78.2 m-85 -122.11 151.84 40.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.94 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . 0.48 ' O ' ' CD2' ' A' ' 472' ' ' LEU . 15.8 m-70 72.9 47.8 0.2 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.85 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.536 HD21 HG21 ' A' ' 405' ' ' ILE . 31.2 mt -91.39 137.73 25.88 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.643 0.735 . . . . 0.0 110.924 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -47.91 177.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.662 2.241 . . . . 0.0 112.344 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -85.92 -46.13 10.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.916 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . 0.42 ' HG3' ' N ' ' A' ' 412' ' ' PHE . 12.7 pt-20 -58.54 -40.1 82.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.42 ' N ' ' HG3' ' A' ' 411' ' ' GLU . 7.9 m-85 -50.35 146.59 5.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . 0.401 ' O ' HG21 ' A' ' 432' ' ' VAL . . . -132.75 -139.21 4.22 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.444 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -86.12 -51.48 6.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.708 0.289 . . . . 0.0 110.795 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -61.79 -52.42 64.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.942 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -39.69 -59.92 1.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . 0.449 HD11 HG12 ' A' ' 405' ' ' ILE . 56.1 tp -49.67 -45.13 48.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.966 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 22.2 tp -62.95 -44.24 96.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.851 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -72.18 -9.73 58.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.87 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 6.2 ttm -93.89 -27.75 16.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.83 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . 0.443 ' CZ ' ' CG1' ' A' ' 405' ' ' ILE . 5.4 m-85 -101.25 -20.35 15.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.866 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . 0.579 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 3.1 mtt -49.7 -46.19 79.61 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.613 0.72 . . . . 0.0 110.911 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.3 Cg_exo -47.96 -45.68 24.17 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.705 2.27 . . . . 0.0 112.356 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . 0.538 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 86.6 m-85 -64.03 -30.17 71.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.933 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 168.71 170.05 32.88 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.519 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -66.31 94.02 0.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.841 0.353 . . . . 0.0 110.862 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 92.4 t -62.29 133.86 27.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.133 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 75.7 t -79.88 -48.17 20.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.159 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 44.5 t -136.45 148.3 47.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -161.21 114.01 1.91 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.116 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . 0.417 ' C ' ' HD2' ' A' ' 431' ' ' LYS . 2.0 tmmm? -154.99 142.47 19.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.925 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.401 HG21 ' O ' ' A' ' 413' ' ' GLY . 87.4 t -93.43 137.95 21.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.119 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . 0.463 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.3 m-85 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.884 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 83.6 m . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.797 0.332 . . . . 0.0 110.865 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . 0.463 ' CE1' ' HB2' ' A' ' 433' ' ' PHE . 4.6 p90 -162.07 138.84 8.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.859 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -132.55 169.31 22.39 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.509 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . 0.538 ' CD1' ' CZ ' ' A' ' 404' ' ' PHE . 61.4 t80 -106.33 154.26 21.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.925 0.393 . . . . 0.0 110.831 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . 0.425 HG23 ' C ' ' A' ' 446' ' ' PHE . 64.1 t -158.13 152.91 6.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.097 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . 0.416 ' N ' HG12 ' A' ' 447' ' ' VAL . 60.6 p -150.39 152.8 34.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.876 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . 0.595 ' CE1' HD12 ' A' ' 403' ' ' LEU . 5.1 m-85 -116.89 179.57 3.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.933 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . 0.446 ' CG ' ' OD1' ' A' ' 451' ' ' ASN . 0.6 OUTLIER -71.89 -28.91 63.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.868 179.858 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . 0.446 ' OD1' ' CG ' ' A' ' 450' ' ' ASP . 0.9 OUTLIER -146.64 155.92 48.72 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.659 0.742 . . . . 0.0 110.878 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.0 -12.6 28.41 Favored 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.71 2.273 . . . . 0.0 112.414 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 95.5 t -79.64 -33.13 14.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.187 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 78.3 p -84.0 -40.63 18.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.89 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -51.73 -40.4 60.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.159 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 53.0 mm-40 -57.08 -48.96 77.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.949 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -38.69 -40.58 0.62 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.119 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . 0.538 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -67.57 -63.99 0.95 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.1 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . 0.487 ' O ' ' CB ' ' A' ' 463' ' ' ASN . 81.0 mt -46.68 -44.24 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.17 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -41.63 -49.2 4.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.929 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 1.8 m -98.02 -57.13 2.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.82 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . 0.447 ' HB3' HG21 ' A' ' 474' ' ' VAL . 85.2 mmm -42.93 -38.55 2.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.825 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . 0.487 ' CB ' ' O ' ' A' ' 459' ' ' ILE . 15.1 t30 -49.12 106.0 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.904 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 78.3 32.16 44.13 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.5 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -70.79 105.26 3.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.796 0.332 . . . . 0.0 110.88 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -63.62 103.24 0.52 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . 0.486 HG23 ' O ' ' A' ' 467' ' ' ILE . 16.9 tt -113.0 122.26 66.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.175 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 70.56 -96.9 0.59 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.488 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 41.2 mtt -133.25 8.61 4.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.859 0.361 . . . . 0.0 110.881 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.3 175.46 9.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.856 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 71.6 mtt-85 -108.98 170.45 8.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.827 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . 0.48 ' CD2' ' O ' ' A' ' 407' ' ' HIS . 72.4 mt -121.97 157.87 30.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.925 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 33.5 tttp -128.56 101.36 6.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.911 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . 0.447 HG21 ' HB3' ' A' ' 462' ' ' MET . 16.6 t -106.49 127.4 61.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.111 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -151.86 147.16 26.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.923 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . 0.632 HD12 ' C ' ' A' ' 476' ' ' LEU . 1.6 pp -91.18 129.34 37.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.917 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.601 ' O ' HD12 ' A' ' 476' ' ' LEU . 38.3 tttt . . . . . 0 C--N 1.33 -0.256 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.91 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 429' ' ' SER . 22.4 ptmt . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.77 0.319 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . 0.605 ' OE2' ' CE2' ' A' ' 446' ' ' PHE . 6.1 mm-40 -129.87 179.72 5.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -117.2 -148.59 8.83 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.515 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -76.02 151.47 35.11 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.781 2.32 . . . . 0.0 112.32 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -56.44 108.89 0.53 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.902 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 128.61 -28.39 4.22 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.509 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . 0.563 ' HB2' ' CA ' ' A' ' 452' ' ' PRO . . . -97.86 126.98 43.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.826 0.346 . . . . 0.0 111.074 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . 0.505 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.6 OUTLIER -158.7 161.85 37.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.873 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . 0.54 HD12 ' CE1' ' A' ' 449' ' ' TYR . 38.4 mt -154.57 125.84 7.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.903 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . 0.58 ' CE1' ' HB2' ' A' ' 477' ' ' LYS . 27.8 m-85 -133.83 114.64 13.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . 0.673 HG12 HD11 ' A' ' 417' ' ' LEU . 3.0 mp -90.85 131.55 37.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.121 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . 0.472 ' CZ ' ' HB3' ' A' ' 404' ' ' PHE . 47.3 m-85 -125.31 171.12 10.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.976 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 45.8 m-70 53.67 50.98 15.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.869 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.636 HD11 ' CG2' ' A' ' 405' ' ' ILE . 46.6 mt -100.24 151.71 37.61 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.636 0.731 . . . . 0.0 110.928 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.512 ' HG2' ' CD1' ' A' ' 412' ' ' PHE . 57.4 Cg_endo -70.54 -168.31 0.3 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.689 2.259 . . . . 0.0 112.322 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -98.51 -37.91 9.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.872 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . 0.444 ' OE1' ' C ' ' A' ' 411' ' ' GLU . 0.2 OUTLIER -57.88 -38.33 75.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 -179.881 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . 0.512 ' CD1' ' HG2' ' A' ' 409' ' ' PRO . 6.5 m-85 -58.97 140.94 55.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.93 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -126.58 -134.19 3.98 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.471 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -87.99 -54.96 3.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.757 0.313 . . . . 0.0 110.837 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . 0.442 ' O ' ' C ' ' A' ' 416' ' ' ASP . 43.2 mm-40 -59.86 -60.64 3.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.852 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 415' ' ' GLN . 45.7 m-20 -34.47 -57.7 0.5 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.925 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . 0.673 HD11 HG12 ' A' ' 405' ' ' ILE . 67.6 tp -53.71 -44.35 69.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.838 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' A' ' 415' ' ' GLN . 29.7 tp -66.55 -61.67 1.86 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.87 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -51.84 -17.21 0.88 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 3.3 ttm -84.21 -35.91 23.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.825 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . 0.425 ' C ' ' HD2' ' A' ' 423' ' ' PRO . 4.0 m-85 -92.2 -17.86 24.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.88 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . 0.581 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 4.2 mtt -51.12 -45.81 88.71 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.54 0.686 . . . . 0.0 110.842 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 422' ' ' MET . 66.2 Cg_exo -48.03 -46.77 21.13 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.596 2.197 . . . . 0.0 112.34 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . 0.564 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 56.0 m-85 -60.14 -36.03 76.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.81 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 170.18 -179.57 42.32 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.476 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -69.17 109.72 4.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.88 0.371 . . . . 0.0 110.903 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 91.1 t -79.3 131.37 34.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.106 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . 0.442 HG12 ' HG3' ' A' ' 395' ' ' LYS . 55.2 t -84.36 -47.68 17.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.152 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . 0.492 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 23.3 t -129.57 144.4 51.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.814 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -160.44 111.09 1.83 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.118 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -159.04 135.1 8.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.856 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 80.0 t -90.05 142.5 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.162 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . 0.54 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.0 m-85 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 98.9 m . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.871 0.367 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . 0.54 ' CE1' ' HB2' ' A' ' 433' ' ' PHE . 3.7 p90 -162.28 139.93 8.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.868 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -131.09 175.86 19.31 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.503 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . 0.605 ' CE2' ' OE2' ' A' ' 396' ' ' GLU . 35.0 t80 -116.01 153.76 31.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.908 0.385 . . . . 0.0 110.857 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . 0.406 ' HB ' ' CB ' ' A' ' 403' ' ' LEU . 65.5 t -154.69 150.13 11.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.102 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 6.1 p -147.1 141.35 26.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . 0.54 ' CE1' HD12 ' A' ' 403' ' ' LEU . 3.8 m-85 -111.42 170.46 8.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.867 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -67.09 -25.65 66.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.803 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . 0.405 ' OD1' ' N ' ' A' ' 451' ' ' ASN . 2.0 p-10 -143.32 156.98 60.64 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.611 0.72 . . . . 0.0 110.896 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . 0.563 ' CA ' ' HB2' ' A' ' 401' ' ' ALA . 61.2 Cg_endo -75.39 -22.12 14.46 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.653 2.235 . . . . 0.0 112.377 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 98.3 t -72.82 -40.9 61.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.109 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 1.8 m -73.08 -42.65 62.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.81 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . 0.4 ' HB2' ' HB2' ' A' ' 449' ' ' TYR . . . -52.83 -42.67 65.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.097 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . 0.454 HE21 HD23 ' A' ' 476' ' ' LEU . 25.5 mm-40 -53.76 -44.86 70.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.867 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -43.63 -43.02 5.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.11 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . 0.564 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -58.18 -66.37 0.49 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.185 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . 0.454 ' O ' ' C ' ' A' ' 460' ' ' GLN . 58.8 mt -50.1 -48.94 23.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.121 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . 0.454 ' C ' ' O ' ' A' ' 459' ' ' ILE . 36.3 mt-30 -33.91 -43.24 0.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.93 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 34.1 t -102.55 -56.91 2.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . 0.427 ' O ' ' N ' ' A' ' 465' ' ' PHE . 80.6 mmm -44.36 -47.83 9.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.819 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -40.35 100.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.854 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 80.99 37.22 19.57 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.477 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . 0.427 ' N ' ' O ' ' A' ' 462' ' ' MET . 64.9 t80 -77.79 115.36 17.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.816 0.341 . . . . 0.0 110.899 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -64.28 102.88 0.57 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.952 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . 0.484 HG21 HD21 ' A' ' 472' ' ' LEU . 19.4 tt -112.94 144.95 19.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.153 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 42.45 -96.94 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.457 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 54.4 mtm -125.1 -7.77 7.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.863 0.363 . . . . 0.0 110.877 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.91 -177.96 3.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.907 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 68.0 mtt85 -112.2 168.4 9.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.867 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . 0.484 HD21 HG21 ' A' ' 467' ' ' ILE . 56.7 mt -111.22 158.35 19.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.912 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 21.4 ttmt -134.5 99.96 4.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 11.4 t -105.84 138.2 32.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.14 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -156.98 138.2 13.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.834 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . 0.697 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.6 pp -78.93 124.37 28.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.886 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.58 ' HB2' ' CE1' ' A' ' 404' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--N 1.328 -0.363 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.85 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 395' ' ' LYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 429' ' ' SER . 14.7 ptmt . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.786 0.327 . . . . 0.0 110.928 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -143.34 -178.38 5.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.901 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -100.08 -154.7 27.73 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.468 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.57 159.24 46.41 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.715 2.276 . . . . 0.0 112.349 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -54.51 116.38 2.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 120.33 -27.74 6.54 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.499 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 401' ' ' ALA . . . . . 0.488 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.91 127.18 43.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.858 0.361 . . . . 0.0 111.063 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 402' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.6 OUTLIER -158.73 160.0 35.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 -179.917 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 403' ' ' LEU . . . . . 0.467 HD12 ' CE1' ' A' ' 449' ' ' TYR . 23.1 mt -156.0 122.25 5.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.924 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 404' ' ' PHE . . . . . 0.522 ' CE1' ' HD3' ' A' ' 477' ' ' LYS . 36.6 m-85 -131.33 110.85 11.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.834 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 405' ' ' ILE . . . . . 0.682 HD12 ' N ' ' A' ' 405' ' ' ILE . 3.0 mp -91.18 136.76 23.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.116 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -131.2 165.69 22.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.956 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 407' ' ' HIS . . . . . 0.463 ' O ' HD23 ' A' ' 472' ' ' LEU . 22.0 m-70 58.96 53.22 5.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.891 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 408' ' ' LEU . . . . . 0.4 ' O ' ' O ' ' A' ' 409' ' ' PRO . 21.1 mt -94.83 138.35 22.17 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.613 0.721 . . . . 0.0 110.915 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 409' ' ' PRO . . . . . 0.4 ' O ' ' O ' ' A' ' 408' ' ' LEU . 76.1 Cg_exo -50.02 -172.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.671 2.247 . . . . 0.0 112.384 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -90.93 -43.03 10.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.876 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -62.52 -36.99 84.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -51.57 132.03 30.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.903 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 413' ' ' GLY . . . . . 0.511 ' O ' HG21 ' A' ' 432' ' ' VAL . . . -127.16 -130.91 3.42 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.536 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.56 -62.84 1.37 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.761 0.315 . . . . 0.0 110.836 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 415' ' ' GLN . . . . . 0.42 ' O ' ' C ' ' A' ' 416' ' ' ASP . 35.0 mm-40 -47.06 -58.03 4.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.948 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 416' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 415' ' ' GLN . 71.2 m-20 -36.0 -71.87 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 417' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 416' ' ' ASP . 26.2 tp -37.53 -53.26 1.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.966 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 27.5 tp -54.99 -46.61 75.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.944 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -75.33 -11.83 60.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.924 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 2.9 tpp -86.68 -28.3 23.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 421' ' ' PHE . . . . . 0.443 ' CE1' ' SD ' ' A' ' 462' ' ' MET . 6.0 m-85 -106.56 -11.27 15.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.936 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 422' ' ' MET . . . . . 0.583 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 1.6 mmt -60.59 -45.71 97.18 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.543 0.687 . . . . 0.0 110.852 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 423' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 422' ' ' MET . 66.5 Cg_exo -47.97 -48.44 16.31 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.706 2.271 . . . . 0.0 112.311 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -60.21 -35.15 74.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.865 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 175.79 -171.94 44.98 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.495 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -79.34 105.75 10.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.917 0.389 . . . . 0.0 110.919 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 427' ' ' VAL . . . . . 0.44 HG11 ' HB2' ' A' ' 430' ' ' ALA . 95.9 t -71.82 126.59 32.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.109 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 95.2 t -84.27 -38.31 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.081 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 429' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 1.0 OUTLIER -137.72 140.54 40.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.849 -179.841 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 430' ' ' ALA . . . . . 0.44 ' HB2' HG11 ' A' ' 427' ' ' VAL . . . -160.22 114.55 2.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.087 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -159.5 133.85 7.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 432' ' ' VAL . . . . . 0.511 HG21 ' O ' ' A' ' 413' ' ' GLY . 88.0 t -88.6 153.93 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.153 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 433' ' ' PHE . . . . . 0.436 ' N ' HG12 ' A' ' 432' ' ' VAL . 3.8 m-30 . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.863 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 443' ' ' CYS . . . . . 0.454 ' O ' ' N ' ' A' ' 407' ' ' HIS . 26.7 p . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.799 0.333 . . . . 0.0 110.839 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 444' ' ' PHE . . . . . 0.411 ' CE1' ' HB2' ' A' ' 433' ' ' PHE . 7.4 p90 -159.91 145.92 15.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -142.96 175.8 22.9 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.479 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 446' ' ' PHE . . . . . 0.549 ' O ' HG23 ' A' ' 447' ' ' VAL . 25.2 t80 -112.62 154.93 25.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.911 0.386 . . . . 0.0 110.92 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 447' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 446' ' ' PHE . 72.3 t -160.86 156.01 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.134 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 448' ' ' SER . . . . . 0.452 ' N ' HG12 ' A' ' 447' ' ' VAL . 2.4 m -155.89 152.68 28.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.864 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 449' ' ' TYR . . . . . 0.467 ' CE1' HD12 ' A' ' 403' ' ' LEU . 3.7 m-85 -115.63 -175.01 2.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.935 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -79.1 -24.0 43.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.817 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -147.98 158.34 42.16 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.627 0.727 . . . . 0.0 110.844 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.56 -2.13 12.01 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.645 2.23 . . . . 0.0 112.303 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 96.6 t -89.82 -39.85 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.089 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 10.6 t -74.76 -40.14 61.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.876 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -50.64 -32.97 20.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.172 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 456' ' ' GLN . . . . . 0.505 ' O ' ' N ' ' A' ' 458' ' ' ALA . 34.1 mm-40 -61.57 -60.34 3.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.918 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 457' ' ' ALA . . . . . 0.47 ' C ' ' HG2' ' A' ' 460' ' ' GLN . . . -35.89 -30.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.117 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 458' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 456' ' ' GLN . . . -81.53 -44.98 16.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.092 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 459' ' ' ILE . . . . . 0.488 ' N ' ' O ' ' A' ' 456' ' ' GLN . 26.0 mt -70.1 -48.42 62.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.113 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 460' ' ' GLN . . . . . 0.495 ' HG3' ' N ' ' A' ' 461' ' ' SER . 3.8 pt20 -37.01 -45.05 0.55 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.875 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 461' ' ' SER . . . . . 0.495 ' N ' ' HG3' ' A' ' 460' ' ' GLN . 2.0 m -93.94 -54.18 3.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.82 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 462' ' ' MET . . . . . 0.601 ' HB3' HG21 ' A' ' 474' ' ' VAL . 9.6 mmt -44.38 -57.49 3.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.85 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -38.16 97.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 464' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 462' ' ' MET . . . 84.43 34.82 15.65 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.517 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 465' ' ' PHE . . . . . 0.496 ' N ' ' O ' ' A' ' 462' ' ' MET . 48.6 t80 -71.98 125.92 28.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.823 0.344 . . . . 0.0 110.856 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 14.6 tm0? -70.73 117.18 11.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.945 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.6 tt -139.03 133.1 40.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.151 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 50.91 -103.0 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.465 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 11.4 mmm -132.53 25.58 4.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.805 0.336 . . . . 0.0 110.846 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -145.85 179.64 7.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.891 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 -120.32 122.3 40.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.877 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 472' ' ' LEU . . . . . 0.463 HD23 ' O ' ' A' ' 407' ' ' HIS . 52.8 mt -64.48 158.07 24.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.852 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -133.25 111.72 11.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.899 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 474' ' ' VAL . . . . . 0.601 HG21 ' HB3' ' A' ' 462' ' ' MET . 20.9 t -122.22 136.95 57.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.119 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 33.1 tp60 -157.14 141.6 16.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 476' ' ' LEU . . . . . 0.757 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.5 pp -85.01 125.05 32.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.961 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 477' ' ' LYS . . . . . 0.522 ' HD3' ' CE1' ' A' ' 404' ' ' PHE . 7.8 tptm . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.932 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.556 -0.217 . . . . 0.0 112.556 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 73.3 m 60.27 42.43 15.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.906 0.384 . . . . 0.0 110.861 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 66.4 m -81.22 146.76 30.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.791 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -146.88 169.66 27.95 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.451 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 3.1 m -152.83 133.53 13.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.862 0.363 . . . . 0.0 110.863 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 94.2 p -101.64 41.95 1.17 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.825 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -63.74 119.33 15.98 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.468 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . 0.443 HD22 ' HA ' ' A' ' 383' ' ' LEU . 0.6 OUTLIER -47.12 109.48 0.21 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.879 0.371 . . . . 0.0 110.914 -179.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . 0.425 HG22 ' HG3' ' A' ' 386' ' ' GLN . 24.5 m -118.65 138.78 52.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.094 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 12.1 mt-30 -93.91 41.29 1.08 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.918 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . 0.425 ' HG3' HG22 ' A' ' 384' ' ' THR . 72.3 mt-30 -103.37 93.71 5.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.923 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 26.8 t -110.7 95.0 5.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.875 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 33.5 mt -108.31 -54.75 5.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.123 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 92.78 60.54 1.2 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.657 -0.783 . . . . 0.0 112.466 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -112.56 -33.02 6.28 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.79 0.329 . . . . 0.0 111.068 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -48.18 110.01 0.29 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.108 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 85.7 57.13 2.23 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.491 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 75.3 m -147.58 130.7 16.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.834 0.349 . . . . 0.0 110.851 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 4.4 mm100 -88.57 36.47 0.8 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.911 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.491 ' O ' ' CB ' ' A' ' 429' ' ' SER . 26.6 mtpp -88.28 163.05 16.28 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.966 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -144.52 165.69 27.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.816 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -88.55 -146.43 12.49 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.448 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -75.44 154.1 40.22 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.647 2.231 . . . . 0.0 112.307 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -52.0 124.64 13.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.916 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 113.53 -27.28 9.48 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.505 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . 0.496 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.94 127.11 43.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.82 0.343 . . . . 0.0 111.11 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.7 OUTLIER -159.05 163.17 36.55 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.88 -179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . 0.493 HD12 ' CE1' ' A' ' 449' ' ' TYR . 24.1 mt -159.36 122.37 3.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.922 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . 0.615 ' CZ ' ' CD1' ' A' ' 446' ' ' PHE . 41.4 m-85 -129.78 114.81 16.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.907 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . 0.62 HG12 HD11 ' A' ' 417' ' ' LEU . 3.8 mp -90.9 134.0 30.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.1 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . 0.446 ' CD2' ' HD3' ' A' ' 473' ' ' LYS . 71.9 m-85 -129.4 166.36 19.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.902 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 59.0 50.5 8.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.83 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.493 HD21 HG21 ' A' ' 405' ' ' ILE . 32.8 mt -91.24 149.21 39.37 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.657 0.741 . . . . 0.0 110.935 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -78.31 169.86 19.45 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.634 2.223 . . . . 0.0 112.342 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -73.59 -31.14 63.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.43 -38.55 91.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.866 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.581 ' CE1' HD11 ' A' ' 467' ' ' ILE . 4.3 m-85 -70.22 148.01 49.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.826 -179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . 0.525 ' O ' HG21 ' A' ' 432' ' ' VAL . . . -135.25 -133.56 3.27 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.493 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -87.76 -61.9 1.61 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.753 0.311 . . . . 0.0 110.867 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . 0.415 ' O ' ' C ' ' A' ' 416' ' ' ASP . 11.5 mm-40 -54.33 -54.3 42.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.928 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . 0.415 ' C ' ' O ' ' A' ' 415' ' ' GLN . 67.0 m-20 -36.91 -60.94 0.58 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.774 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . 0.62 HD11 HG12 ' A' ' 405' ' ' ILE . 24.2 tp -46.52 -45.24 18.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.859 -179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . 0.451 HD13 ' HB3' ' A' ' 430' ' ' ALA . 27.1 tp -59.62 -54.99 40.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.939 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 67.1 mt-30 -68.41 -9.93 51.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.845 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -85.57 -30.57 23.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.859 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . 0.432 ' C ' ' HD2' ' A' ' 423' ' ' PRO . 4.0 m-85 -100.35 -20.9 15.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.864 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.569 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 3.6 mtt -48.85 -46.6 73.78 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.523 0.678 . . . . 0.0 110.787 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.569 ' CD ' ' N ' ' A' ' 422' ' ' MET . 64.3 Cg_exo -47.97 -38.49 31.45 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.663 2.242 . . . . 0.0 112.354 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . 0.517 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 82.0 m-85 -73.93 -31.91 63.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.909 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 171.6 -177.25 44.52 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.47 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -77.47 94.91 4.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.913 0.387 . . . . 0.0 110.913 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.425 HG22 ' CE1' ' A' ' 449' ' ' TYR . 86.5 t -64.57 127.96 26.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.148 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 79.5 t -78.84 -45.39 24.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.159 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . 0.491 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 8.5 p -128.99 144.7 51.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.89 -179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . 0.451 ' HB3' HD13 ' A' ' 418' ' ' LEU . . . -160.72 107.53 1.5 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.113 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . 0.482 ' CG ' ' N ' ' A' ' 432' ' ' VAL . 52.2 tttt -145.16 162.74 36.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.887 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.525 HG21 ' O ' ' A' ' 413' ' ' GLY . 18.5 t -124.52 148.12 28.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.138 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . 0.637 ' CG ' ' CE1' ' A' ' 444' ' ' PHE . 4.5 m-85 -92.61 153.75 18.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.849 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.7 HD13 ' HA ' ' A' ' 441' ' ' SER . 19.7 mm -125.43 140.76 47.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.119 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -67.46 148.93 50.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.866 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.65 3.19 54.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.915 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 73.8 mm-40 -119.2 -46.03 2.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.964 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 38.8 p -96.66 0.36 49.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.136 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 45.51 32.73 1.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.93 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.415 ' O ' ' C ' ' A' ' 441' ' ' SER . 57.4 mt -128.57 152.12 48.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.918 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . 0.7 ' HA ' HD13 ' A' ' 434' ' ' ILE . 7.4 t -35.9 136.75 0.25 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.863 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.574 ' HB3' ' CE2' ' A' ' 444' ' ' PHE . 67.5 mttt -77.47 8.6 4.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.948 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 22.6 m 67.0 26.76 8.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.916 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . 0.637 ' CE1' ' CG ' ' A' ' 433' ' ' PHE . 2.6 p90 -161.78 141.6 10.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.926 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -135.98 164.93 24.98 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.492 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . 0.615 ' CD1' ' CZ ' ' A' ' 404' ' ' PHE . 33.8 t80 -103.76 153.35 20.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.873 0.368 . . . . 0.0 110.913 -179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 446' ' ' PHE . 60.5 t -158.87 152.76 6.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.129 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 10.1 m -153.86 150.74 28.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.847 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . 0.493 ' CE1' HD12 ' A' ' 403' ' ' LEU . 3.9 m-85 -113.07 -175.14 2.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.862 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -80.61 -13.05 59.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.856 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -161.37 159.36 23.72 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.596 0.713 . . . . 0.0 110.817 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . 0.466 ' N ' ' HB2' ' A' ' 401' ' ' ALA . 61.1 Cg_endo -75.86 -7.11 18.15 Favored 'Trans proline' 0 N--CA 1.465 -0.187 0 C-N-CA 122.67 2.247 . . . . 0.0 112.362 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 58.9 t -81.3 -39.39 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.125 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 6.4 m -82.97 -40.7 19.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.89 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -53.1 -31.9 44.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.132 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -69.41 -43.72 72.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.951 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -43.84 -41.26 4.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.081 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . 0.517 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -64.29 -67.91 0.39 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.085 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . 0.527 HG23 ' HB2' ' A' ' 463' ' ' ASN . 87.1 mt -43.66 -45.95 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.114 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . 0.409 ' C ' ' O ' ' A' ' 459' ' ' ILE . 35.3 mt-30 -37.38 -47.42 0.85 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.869 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 2.8 m -101.58 -53.71 2.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.864 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . 0.459 ' SD ' ' CE1' ' A' ' 424' ' ' PHE . 84.3 mmm -44.85 -47.77 11.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.92 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . 0.527 ' HB2' HG23 ' A' ' 459' ' ' ILE . 27.2 t-20 -45.27 104.34 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 86.22 25.35 37.16 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.48 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . 0.413 ' N ' ' O ' ' A' ' 462' ' ' MET . 21.7 t80 -69.87 108.69 4.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.795 0.331 . . . . 0.0 110.931 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 12.4 tt0 -65.8 104.17 1.03 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.863 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . 0.581 HD11 ' CE1' ' A' ' 412' ' ' PHE . 19.8 tt -111.62 135.33 51.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.13 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 58.19 -93.01 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.463 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 59.9 mtp -133.57 -0.58 3.19 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.813 0.339 . . . . 0.0 110.875 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 21.1 pttp -127.88 -178.18 4.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.936 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 54.2 mtt85 -112.73 159.91 18.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.897 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 87.3 mt -103.0 157.54 16.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.894 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . 0.446 ' HD3' ' CD2' ' A' ' 406' ' ' TYR . 13.3 tttt -132.26 104.67 6.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.923 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 2.8 t -113.55 135.82 51.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.138 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -157.1 137.92 13.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.836 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . 0.666 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.6 pp -83.66 128.38 34.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.915 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 476' ' ' LEU . 10.7 tptm -34.37 112.79 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.875 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 71.2 ttt-85 -48.69 158.53 0.29 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.899 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 62.8 m -141.16 117.1 10.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.859 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 28.7 mtpt -69.83 -62.21 1.48 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.879 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -110.88 113.24 25.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.862 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -119.47 105.42 11.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.84 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 27.4 m -96.89 99.3 10.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.897 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -100.38 97.54 8.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.883 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 37.8 p -64.42 83.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.819 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -87.33 -147.1 11.56 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.498 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -76.35 131.16 12.52 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.697 2.265 . . . . 0.0 112.348 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 19.0 m -121.59 171.5 8.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.842 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 74.2 p 39.08 41.66 0.61 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.906 -179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.456 -179.992 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.348 0 N-CA-C 112.423 -0.271 . . . . 0.0 112.423 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 2.5 t -114.52 115.07 26.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.892 0.377 . . . . 0.0 110.828 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 9.2 t -102.7 124.41 48.18 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.852 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -134.79 -126.4 2.62 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.469 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 6.1 t -146.78 147.56 31.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.843 0.354 . . . . 0.0 110.888 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 13.5 t -106.3 156.8 18.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.829 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 137.9 177.72 15.45 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.459 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . 0.504 HD23 ' C ' ' A' ' 383' ' ' LEU . 6.9 tt -99.94 -58.22 1.96 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.863 0.363 . . . . 0.0 110.921 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 89.7 m -107.32 124.09 49.29 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.15 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . 0.426 ' O ' ' C ' ' A' ' 386' ' ' GLN . 36.9 mm-40 -81.01 -46.51 14.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.907 -179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 385' ' ' GLN . 41.2 tt0 -35.19 -57.73 0.57 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.895 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 77.6 p -71.76 118.33 14.47 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.85 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 17.8 mt -117.49 -50.77 4.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.192 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 58.39 63.97 4.75 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.499 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -109.76 -35.56 6.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.857 0.36 . . . . 0.0 111.124 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -54.57 98.33 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.148 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 107.3 -39.17 2.99 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.518 -179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 61.2 m -43.38 121.84 2.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.81 0.338 . . . . 0.0 110.848 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -96.04 33.79 1.66 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.956 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 31.8 mtmt -95.93 171.86 8.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.841 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -131.41 -178.3 4.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.868 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -98.14 -145.89 19.67 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.561 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.52 151.08 52.61 Favored 'Trans proline' 0 C--O 1.231 0.14 0 C-N-CA 122.697 2.265 . . . . 0.0 112.333 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -54.16 97.6 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.937 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 135.16 -22.95 3.53 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.462 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . 0.494 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -99.98 127.43 46.18 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.709 0.29 . . . . 0.0 111.166 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 18.6 m-80 -158.47 165.5 34.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.876 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . 0.716 HD23 HD11 ' A' ' 459' ' ' ILE . 22.4 mt -160.12 110.38 1.85 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.921 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . 0.584 ' CE1' ' HB2' ' A' ' 477' ' ' LYS . 26.2 m-85 -115.37 115.62 26.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.899 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . 0.572 HG21 HD21 ' A' ' 408' ' ' LEU . 4.0 mp -90.81 136.19 24.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.132 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . 0.54 ' CZ ' ' HB3' ' A' ' 404' ' ' PHE . 26.9 m-85 -130.49 167.53 18.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.945 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 59.79 50.14 7.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.858 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.572 HD21 HG21 ' A' ' 405' ' ' ILE . 38.3 mt -97.25 145.93 30.48 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.58 0.705 . . . . 0.0 110.957 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.487 ' HG2' ' CD1' ' A' ' 412' ' ' PHE . 61.5 Cg_endo -76.42 -177.51 3.77 Favored 'Trans proline' 0 C--N 1.341 0.134 0 C-N-CA 122.713 2.275 . . . . 0.0 112.308 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -84.44 -35.58 22.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.938 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -58.64 -33.39 70.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.938 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.517 ' CE1' HD11 ' A' ' 467' ' ' ILE . 3.4 m-85 -64.98 155.05 35.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.977 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -145.32 -148.08 4.75 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.493 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.35 -60.33 2.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.707 0.289 . . . . 0.0 110.805 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . 0.434 ' O ' ' C ' ' A' ' 416' ' ' ASP . 21.1 mp0 -54.27 -59.29 4.87 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.984 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 415' ' ' GLN . 35.3 m-20 -34.6 -61.19 0.4 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.831 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . 0.423 HD11 HD13 ' A' ' 405' ' ' ILE . 19.5 tp -47.84 -47.67 31.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.883 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 18.4 tp -62.38 -44.09 97.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 27.3 mm-40 -74.25 -17.42 60.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.878 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 2.5 ttt -83.94 -28.85 27.54 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.863 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . 0.438 ' C ' ' HD2' ' A' ' 423' ' ' PRO . 5.3 m-85 -102.93 -19.83 14.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.883 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.584 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 0.2 OUTLIER -49.97 -46.05 81.33 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.517 0.675 . . . . 0.0 110.827 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 422' ' ' MET . 66.7 Cg_exo -48.03 -48.97 14.93 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.69 2.26 . . . . 0.0 112.299 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . 0.503 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 81.5 m-85 -62.18 -31.79 72.35 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 175.35 173.58 41.22 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.52 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 20.5 m-80 -76.18 91.78 3.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.942 0.401 . . . . 0.0 110.886 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.518 HG11 ' HB2' ' A' ' 430' ' ' ALA . 72.4 t -56.33 128.62 16.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.127 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 31.3 t -73.16 -50.98 28.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.162 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 38.8 m -144.43 132.16 21.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.865 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . 0.518 ' HB2' HG11 ' A' ' 427' ' ' VAL . . . -140.78 129.86 23.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.097 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . 0.419 ' C ' ' HD3' ' A' ' 431' ' ' LYS . 0.2 OUTLIER -159.83 137.75 10.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.868 -180.0 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 72.2 t -93.7 151.37 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.128 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . 0.405 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 4.1 m-30 -82.55 153.46 25.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.912 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.508 HG22 ' N ' ' A' ' 435' ' ' ASP . 22.7 mm -131.8 158.77 43.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.081 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . 0.508 ' N ' HG22 ' A' ' 434' ' ' ILE . 22.1 t0 -103.87 149.63 24.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.856 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 1.7 tmtm? -92.91 -15.97 25.74 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.946 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -91.35 -45.08 8.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.889 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 30.8 p -95.02 -39.68 10.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.122 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 68.98 39.92 1.71 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.888 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 19.7 mt -128.49 134.28 48.67 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.886 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 8.4 p -38.37 105.87 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.874 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.584 ' HD3' ' CE1' ' A' ' 444' ' ' PHE . 17.9 mttm -52.02 -174.49 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.86 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 19.0 p -108.67 31.15 5.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.828 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . 0.584 ' CE1' ' HD3' ' A' ' 442' ' ' LYS . 7.0 p90 -162.1 141.9 9.88 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.908 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -139.25 179.08 19.04 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.475 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . 0.492 ' CE1' ' CE1' ' A' ' 404' ' ' PHE . 27.2 t80 -117.41 150.31 39.1 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.825 0.345 . . . . 0.0 110.958 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 96.6 t -155.32 144.61 12.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.127 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 51.6 p -139.81 146.34 39.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.838 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . 0.706 ' CE1' HD12 ' A' ' 403' ' ' LEU . 3.7 m-85 -111.86 174.67 5.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.87 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.63 -18.65 62.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.864 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . 0.482 ' OD1' ' N ' ' A' ' 451' ' ' ASN . 3.9 p-10 -152.01 155.1 33.36 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.642 0.734 . . . . 0.0 110.869 -179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . 0.448 ' N ' ' HB2' ' A' ' 401' ' ' ALA . 60.9 Cg_endo -75.41 -15.1 20.04 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.644 2.23 . . . . 0.0 112.347 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 85.7 t -77.72 -38.1 24.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.025 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 1.5 t -80.21 -35.86 35.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.762 -179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -56.43 -39.53 73.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.128 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 18.6 mm-40 -61.97 -42.59 99.3 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.912 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -42.63 -43.76 3.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.148 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . 0.503 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -64.02 -70.52 0.22 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.156 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . 0.716 HD11 HD23 ' A' ' 403' ' ' LEU . 84.6 mt -41.9 -44.78 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.161 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -39.54 -47.22 1.86 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.893 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 2.4 m -97.58 -54.31 3.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.863 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . 0.476 ' O ' ' N ' ' A' ' 465' ' ' PHE . 80.8 mmm -44.69 -57.39 3.71 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.847 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . 0.429 ' C ' ' O ' ' A' ' 462' ' ' MET . 9.8 t-20 -35.98 99.69 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.822 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 90.32 31.11 10.96 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.524 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . 0.476 ' N ' ' O ' ' A' ' 462' ' ' MET . 40.2 t80 -76.26 115.71 16.26 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.759 0.314 . . . . 0.0 110.883 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 50.5 tp60 -63.54 103.28 0.51 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.894 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . 0.517 HD11 ' CE1' ' A' ' 412' ' ' PHE . 18.8 tt -114.01 138.9 42.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.151 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 48.17 -96.87 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.457 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 27.3 mmm -125.14 -9.33 7.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.873 0.368 . . . . 0.0 110.861 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 14.6 pttm -121.03 178.98 4.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.894 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 62.0 mtm180 -110.42 151.61 27.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.888 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 68.5 mt -94.22 158.08 15.76 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.874 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 31.9 ttpt -137.43 108.53 6.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.884 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . 0.423 HG21 ' HB3' ' A' ' 462' ' ' MET . 2.9 t -110.02 140.34 29.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.129 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -157.17 141.01 16.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.907 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . 0.759 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.5 pp -85.19 125.65 33.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.939 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.584 ' HB2' ' CE1' ' A' ' 404' ' ' PHE . 32.9 ttpt -44.4 116.46 1.04 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.874 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 25.4 ttt180 -74.85 127.39 33.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.871 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 26.3 p -112.96 123.15 49.65 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.911 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.4 119.05 8.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.856 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -82.75 133.52 35.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.918 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -112.7 126.29 55.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.854 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 29.6 t -85.23 -61.47 1.76 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.829 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 30.1 mtmt -102.55 153.45 20.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.852 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 31.0 t -91.76 -57.22 2.82 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.918 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 74.75 74.37 0.88 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.549 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -79.96 29.54 0.5 Allowed 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.677 2.252 . . . . 0.0 112.339 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 83.1 p -132.86 177.66 7.47 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.874 -179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 3.9 m -45.86 -52.45 11.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.84 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.205 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.395 -179.934 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 N-CA-C 112.437 -0.265 . . . . 0.0 112.437 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 28.5 t 64.81 41.27 5.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.836 0.35 . . . . 0.0 110.848 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 4.4 t -117.12 103.75 10.53 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.827 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 129.28 45.28 0.18 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.498 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 15.9 m -95.0 95.21 8.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.907 0.384 . . . . 0.0 110.923 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 23.1 t -103.68 130.66 51.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.89 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -159.53 51.91 0.38 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.472 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 24.2 mt -100.32 85.36 2.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.87 0.367 . . . . 0.0 110.944 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 21.3 p -100.55 155.83 17.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.19 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.18 -48.93 2.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.965 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -144.1 118.15 9.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.895 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 2.1 t -103.4 105.57 15.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.855 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.408 ' N ' HD12 ' A' ' 388' ' ' ILE . 4.9 mp -107.04 133.35 51.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.151 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -135.16 59.07 0.67 Allowed Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.528 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . 0.63 ' O ' HD22 ' A' ' 418' ' ' LEU . . . -102.11 78.25 1.76 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.817 0.341 . . . . 0.0 111.109 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -129.29 120.78 26.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.161 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 93.99 -25.48 21.62 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.539 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 2.6 m -55.95 117.16 3.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.902 0.382 . . . . 0.0 110.801 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -86.2 30.82 0.66 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.97 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 33.3 mtmt -90.63 162.24 15.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.937 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -130.73 -178.33 4.75 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.84 180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -96.41 -155.09 30.62 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.5 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.25 151.73 43.88 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.618 2.212 . . . . 0.0 112.395 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -48.45 113.56 0.78 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.88 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 121.57 -28.53 5.94 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.512 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . 0.496 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.81 127.4 43.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.8 0.333 . . . . 0.0 111.127 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . 0.496 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.7 OUTLIER -158.42 161.96 37.54 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.947 -179.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . 0.495 HD12 ' CE1' ' A' ' 449' ' ' TYR . 19.8 mt -155.67 120.28 4.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.915 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . 0.529 ' CE1' ' HB2' ' A' ' 477' ' ' LYS . 25.3 m-85 -127.61 110.74 12.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.945 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . 0.635 HD12 ' N ' ' A' ' 405' ' ' ILE . 3.5 mp -91.84 136.31 24.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.127 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -127.28 174.63 8.8 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.894 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . 0.535 ' O ' HD23 ' A' ' 472' ' ' LEU . 20.2 m-70 51.04 50.29 19.41 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.919 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.424 HD11 ' CG2' ' A' ' 405' ' ' ILE . 19.7 mt -98.27 140.18 21.69 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.549 0.69 . . . . 0.0 110.982 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.411 ' O ' ' O ' ' A' ' 408' ' ' LEU . 73.1 Cg_exo -50.46 -171.25 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.651 2.234 . . . . 0.0 112.411 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -100.01 -24.77 14.53 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.97 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.11 -32.17 59.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.873 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -58.19 130.85 48.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.869 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -118.47 -144.88 7.65 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.51 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -80.86 -60.22 2.38 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.794 0.331 . . . . 0.0 110.847 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -53.84 -55.1 29.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.907 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 45.8 m-20 -42.23 -65.01 0.51 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.889 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 22.5 tp -42.86 -41.37 3.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.94 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . 0.63 HD22 ' O ' ' A' ' 390' ' ' ALA . 30.6 tp -65.35 -50.94 63.67 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.919 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 65.6 mt-30 -67.5 -9.0 38.15 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.925 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -86.43 -27.91 23.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.902 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . 0.597 ' CZ ' ' SD ' ' A' ' 462' ' ' MET . 10.6 m-85 -104.75 -12.48 16.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.909 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.575 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 6.1 mtt -54.22 -45.73 99.08 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.565 0.698 . . . . 0.0 110.877 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.0 Cg_exo -47.95 -40.79 33.08 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.611 2.207 . . . . 0.0 112.392 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . 0.559 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 86.7 m-85 -67.61 -36.01 80.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.806 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 178.34 -169.06 40.6 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.464 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -85.32 100.47 11.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.874 0.369 . . . . 0.0 110.911 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.551 HG11 HD12 ' A' ' 418' ' ' LEU . 74.7 t -65.15 135.95 27.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.152 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 25.2 t -84.87 -41.02 15.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.18 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 39.7 m -158.91 140.07 13.01 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.902 -179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . 0.612 ' HB3' HD13 ' A' ' 418' ' ' LEU . . . -149.36 132.11 15.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.122 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -157.28 135.3 10.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.933 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 85.3 t -91.98 146.85 5.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.124 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -75.85 142.26 42.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.889 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.403 ' C ' ' HE2' ' A' ' 442' ' ' LYS . 41.4 mt -132.01 148.8 32.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.137 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -83.11 144.03 30.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.891 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 40.8 mttp -95.38 5.79 50.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 20.7 mt-30 -113.18 -45.23 3.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.87 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 76.9 p -99.27 -28.32 13.37 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.137 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 52.8 t30 72.66 33.79 1.3 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.919 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 17.0 mt -116.67 114.42 24.02 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -42.65 117.46 1.04 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.912 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.452 ' HG2' ' CZ ' ' A' ' 444' ' ' PHE . 0.5 OUTLIER -53.72 -175.49 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.886 179.973 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 27.8 p -101.91 36.39 2.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.913 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . 0.452 ' CZ ' ' HG2' ' A' ' 442' ' ' LYS . 1.2 p90 -161.99 150.74 15.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.919 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -141.98 176.27 22.15 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.544 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . 0.521 ' O ' HG23 ' A' ' 447' ' ' VAL . 39.8 t80 -117.03 156.81 26.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.948 0.404 . . . . 0.0 110.847 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 446' ' ' PHE . 76.2 t -161.03 153.9 4.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.109 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . 0.418 ' N ' HG12 ' A' ' 447' ' ' VAL . 3.2 m -151.57 142.39 22.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.865 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . 0.495 ' CE1' HD12 ' A' ' 403' ' ' LEU . 3.2 m-85 -107.01 -177.66 3.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.934 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.66 -17.19 56.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.838 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . 0.474 ' OD1' ' N ' ' A' ' 451' ' ' ASN . 3.7 p-10 -154.34 156.9 32.15 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 121.595 0.712 . . . . 0.0 110.852 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -76.52 -9.29 18.63 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.635 2.224 . . . . 0.0 112.323 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 99.6 t -83.14 -33.76 10.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.099 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 61.3 m -83.6 -38.71 21.25 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.852 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -54.92 -29.13 55.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.112 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 41.3 mm-40 -66.81 -49.99 64.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.911 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -38.93 -40.45 0.65 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.047 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . 0.559 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -70.32 -61.91 1.59 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.152 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . 0.437 ' O ' ' CB ' ' A' ' 463' ' ' ASN . 88.6 mt -42.2 -42.3 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.097 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 50.6 mm-40 -42.84 -66.33 0.38 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.917 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 30.2 t -79.63 -54.68 5.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.848 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . 0.709 ' HB3' HG21 ' A' ' 474' ' ' VAL . 6.9 mmt -40.85 -48.21 3.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.849 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . 0.437 ' CB ' ' O ' ' A' ' 459' ' ' ILE . 36.4 t-20 -55.97 107.56 0.36 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.843 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 87.65 22.8 41.74 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.48 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 21.7 t80 -69.03 114.15 7.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.753 0.311 . . . . 0.0 110.906 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 6.0 tm0? -72.14 104.63 3.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.935 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . 0.538 HG23 ' O ' ' A' ' 467' ' ' ILE . 17.3 tt -112.08 122.73 66.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.121 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 66.94 -94.38 0.24 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.488 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.12 -3.17 4.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.917 0.389 . . . . 0.0 110.948 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 16.1 pttp -125.48 -178.99 4.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.922 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -112.88 163.99 13.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.854 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . 0.535 HD23 ' O ' ' A' ' 407' ' ' HIS . 82.1 mt -109.33 155.75 20.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.916 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 26.6 ttmt -129.27 113.25 14.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.912 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . 0.709 HG21 ' HB3' ' A' ' 462' ' ' MET . 11.4 t -120.54 135.73 59.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.146 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 54.7 tp60 -156.99 140.33 15.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.875 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . 0.69 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.6 pp -80.96 125.35 30.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.938 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.529 ' HB2' ' CE1' ' A' ' 404' ' ' PHE . 15.3 ttmm -39.54 104.01 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.902 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . 0.488 ' HD3' HD11 ' A' ' 476' ' ' LEU . 9.2 tpt180 -119.53 49.03 1.41 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.812 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 8.0 t -81.6 -45.0 16.45 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 5.0 ptpt -84.59 44.77 1.07 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.914 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -57.0 -61.87 2.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.907 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 14.9 t0 -170.48 129.06 0.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.866 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 9.6 t -116.73 158.11 24.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.857 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -98.6 176.83 5.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.87 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 3.1 m -85.7 48.55 1.61 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.854 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -102.72 -95.21 2.3 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.428 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -46.09 104.32 0.06 OUTLIER 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.736 2.29 . . . . 0.0 112.295 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 21.3 m -95.91 148.09 22.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.908 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 1.9 m -170.47 151.15 3.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.81 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.346 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.467 179.985 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.302 0 N-CA-C 112.461 -0.255 . . . . 0.0 112.461 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 74.2 m -123.86 145.2 49.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.84 0.352 . . . . 0.0 110.874 -179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 50.5 m -145.3 157.04 44.14 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.851 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 72.63 82.04 0.33 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.504 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 3.2 t -104.56 159.58 15.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.891 0.377 . . . . 0.0 110.875 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 32.3 t -168.57 121.99 0.86 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.888 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 127.13 114.18 1.85 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.475 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . 0.401 ' H ' HD23 ' A' ' 383' ' ' LEU . 1.6 pt? -56.76 141.35 44.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.87 0.367 . . . . 0.0 110.902 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 1.4 m -144.35 137.51 27.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.114 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 17.3 tp60 -72.93 -51.45 18.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.884 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 57.21 52.17 9.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.902 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . 0.404 ' C ' HD12 ' A' ' 388' ' ' ILE . 4.2 m -104.79 81.16 1.73 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.785 -179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.568 HG21 ' O ' ' A' ' 427' ' ' VAL . 3.4 mp -115.48 -38.81 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.108 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 38.91 80.03 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.504 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . 0.615 ' O ' ' HB3' ' A' ' 430' ' ' ALA . . . -104.94 78.84 1.45 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.87 0.367 . . . . 0.0 111.114 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -121.28 147.92 45.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.105 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 49.91 33.49 20.8 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.485 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.4 t -106.96 154.02 21.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.918 0.39 . . . . 0.0 110.823 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -122.46 47.72 1.88 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.9 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.468 ' O ' ' CB ' ' A' ' 429' ' ' SER . 6.6 ptmm? -120.66 163.81 17.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.91 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -132.01 -177.68 4.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.868 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -100.77 -147.2 20.49 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.501 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.77 161.18 36.85 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.669 2.246 . . . . 0.0 112.435 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -59.01 123.1 15.46 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 -179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 113.04 -27.57 9.49 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.576 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . 0.487 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.84 127.06 43.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.823 0.344 . . . . 0.0 111.112 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . 0.488 ' HB2' ' N ' ' A' ' 477' ' ' LYS . 0.7 OUTLIER -159.02 159.94 35.32 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.934 -179.887 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . 0.567 HD23 HD11 ' A' ' 459' ' ' ILE . 17.6 mt -156.11 122.66 5.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.904 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . 0.482 ' CE1' ' CE1' ' A' ' 446' ' ' PHE . 22.8 m-85 -130.23 110.86 11.88 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.874 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . 0.625 HD12 ' N ' ' A' ' 405' ' ' ILE . 3.5 mp -91.1 134.13 30.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.176 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . 0.458 ' CD2' ' HD3' ' A' ' 473' ' ' LYS . 84.2 m-85 -126.19 -176.23 3.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.957 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 42.17 53.9 4.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.411 HD21 HG21 ' A' ' 405' ' ' ILE . 28.1 mt -98.38 143.07 25.64 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.591 0.71 . . . . 0.0 110.937 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -75.5 164.42 32.47 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.668 2.245 . . . . 0.0 112.397 179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -62.78 -37.64 87.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.918 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -58.23 -35.04 71.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.833 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.472 ' CE1' HD11 ' A' ' 467' ' ' ILE . 5.2 m-85 -77.94 115.57 17.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.848 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -109.16 -138.79 8.36 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.474 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.49 ' N ' ' OD1' ' A' ' 414' ' ' ASP . 0.1 OUTLIER -79.17 -53.72 6.7 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.761 0.315 . . . . 0.0 110.856 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . 0.417 ' O ' ' C ' ' A' ' 416' ' ' ASP . 16.0 mp0 -60.98 -57.82 11.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 415' ' ' GLN . 70.9 m-20 -36.16 -50.52 0.72 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.855 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . 0.461 HD11 HG12 ' A' ' 405' ' ' ILE . 36.3 tp -57.74 -50.12 74.27 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.925 -179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . 0.401 HD13 ' HB3' ' A' ' 390' ' ' ALA . 39.3 tp -56.73 -43.38 80.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 26.6 mm-40 -80.71 -10.76 59.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.936 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -82.29 -27.44 32.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.867 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . 0.425 ' C ' ' HD2' ' A' ' 423' ' ' PRO . 4.0 m-85 -107.14 -20.32 13.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.855 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.575 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 0.4 OUTLIER -49.44 -46.3 77.96 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.56 0.695 . . . . 0.0 110.883 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 422' ' ' MET . 64.9 Cg_exo -47.96 -41.63 32.56 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.704 2.269 . . . . 0.0 112.376 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . 0.431 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 88.0 m-85 -67.27 -35.97 80.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.92 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 173.6 177.9 43.16 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.499 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -66.03 115.26 5.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.846 0.355 . . . . 0.0 110.877 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.568 ' O ' HG21 ' A' ' 388' ' ' ILE . 87.4 t -85.12 131.08 35.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.073 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 53.6 t -83.83 -34.6 10.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.15 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . 0.468 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 0.8 OUTLIER -149.2 143.86 26.2 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 390' ' ' ALA . . . -160.91 119.49 2.51 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.066 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . 0.492 ' CG ' ' N ' ' A' ' 432' ' ' VAL . 32.7 tttp -159.47 163.17 35.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.939 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.492 ' N ' ' CG ' ' A' ' 431' ' ' LYS . 55.8 t -114.76 154.44 16.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.136 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . 0.563 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.1 m-85 -99.8 143.72 29.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.819 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 21.5 mt -137.85 144.7 30.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.142 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -78.35 133.41 37.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.936 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.59 -6.79 46.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.946 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -98.1 -55.93 2.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.921 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 59.6 p -81.09 -27.11 35.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.152 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 63.61 41.43 7.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.895 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 7.9 mt -140.54 141.32 35.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.927 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 48.6 m -44.25 134.22 5.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.895 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.565 ' HB3' ' CE2' ' A' ' 444' ' ' PHE . 36.0 mttt -78.09 9.55 3.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.953 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 16.2 m 68.07 29.61 6.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.879 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . 0.565 ' CE2' ' HB3' ' A' ' 442' ' ' LYS . 1.8 p90 -161.94 139.67 8.78 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.93 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -133.7 172.07 21.76 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.512 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . 0.482 ' CE1' ' CE1' ' A' ' 404' ' ' PHE . 23.6 t80 -109.88 153.86 23.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.908 0.385 . . . . 0.0 110.894 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . 0.423 HG12 ' N ' ' A' ' 448' ' ' SER . 75.3 t -157.31 153.97 6.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.12 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . 0.423 ' N ' HG12 ' A' ' 447' ' ' VAL . 2.9 m -154.45 154.97 34.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.928 -179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . 0.46 ' CE1' HD12 ' A' ' 403' ' ' LEU . 4.7 m-85 -118.9 -175.17 2.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.886 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -85.05 -8.87 58.51 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.877 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -160.2 155.11 20.96 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.634 0.731 . . . . 0.0 110.942 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -75.78 -8.23 19.02 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.648 2.232 . . . . 0.0 112.41 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 60.0 t -82.14 -36.92 14.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.086 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 1.4 t -82.1 -42.01 19.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.855 -179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -52.36 -41.33 62.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.118 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 30.1 mm-40 -58.32 -46.57 85.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.942 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -43.47 -41.21 4.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.112 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . 0.431 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -62.99 -68.25 0.35 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.13 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . 0.567 HD11 HD23 ' A' ' 403' ' ' LEU . 77.5 mt -48.01 -43.28 10.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.086 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' ' 459' ' ' ILE . 23.6 mt-30 -37.76 -42.46 0.58 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 1.9 m -103.78 -56.3 2.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.852 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . 0.521 ' HB3' HG21 ' A' ' 474' ' ' VAL . 86.2 mmm -42.66 -42.84 3.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.96 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -42.55 100.26 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.875 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 83.24 31.35 28.43 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.488 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . 0.458 ' N ' ' O ' ' A' ' 462' ' ' MET . 58.3 t80 -64.79 117.12 7.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.787 0.327 . . . . 0.0 110.923 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 44.4 tp60 -74.26 105.39 5.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.862 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . 0.646 HG23 ' O ' ' A' ' 467' ' ' ILE . 16.4 tt -116.69 113.45 43.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.106 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 71.34 -104.12 1.37 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.465 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . 0.4 ' O ' ' SD ' ' A' ' 469' ' ' MET . 5.8 tmm? -121.43 5.72 10.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.857 0.36 . . . . 0.0 110.846 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.73 -176.92 4.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.985 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 43.3 mtt180 -123.28 164.65 18.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.807 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . 0.458 HD12 ' HB3' ' A' ' 465' ' ' PHE . 60.2 mt -106.56 163.82 12.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.918 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . 0.458 ' HD3' ' CD2' ' A' ' 406' ' ' TYR . 11.8 tttt -138.43 104.99 5.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.934 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . 0.521 HG21 ' HB3' ' A' ' 462' ' ' MET . 5.3 t -110.78 139.07 36.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.092 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -157.22 145.89 19.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.876 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . 0.787 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.5 pp -92.08 123.99 35.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.488 ' N ' ' HB2' ' A' ' 402' ' ' ASN . 27.9 tttp -40.66 111.73 0.23 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.844 179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -132.0 75.18 1.62 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.906 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 19.1 m -121.01 81.13 1.73 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.891 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.1 42.17 1.25 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.878 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 21.9 t-20 -63.9 -46.1 86.34 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.86 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -117.92 136.31 53.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.893 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 27.6 m -69.06 -45.36 70.56 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.849 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 31.3 tttm -84.39 155.0 22.49 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.907 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 67.0 m -80.41 -48.35 13.02 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.885 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 135.09 146.15 5.29 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.416 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -77.7 97.65 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.694 2.263 . . . . 0.0 112.325 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 489' ' ' SER . 1.9 t -152.59 159.72 43.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.844 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 488' ' ' SER . 2.4 m 35.31 50.0 0.5 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.835 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.497 179.986 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.335 0 N-CA-C 112.505 -0.238 . . . . 0.0 112.505 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 73.9 p -140.98 130.79 24.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.827 0.346 . . . . 0.0 110.78 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 22.9 t -69.75 140.36 53.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.85 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -87.35 91.06 1.71 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.55 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 3.5 t -117.51 134.07 55.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.886 0.374 . . . . 0.0 110.862 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 19.6 m -57.21 -47.12 82.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.868 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 53.25 62.05 6.36 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.472 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -58.44 169.77 0.84 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.853 0.359 . . . . 0.0 110.936 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 25.6 m -144.28 105.58 4.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.125 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 15.9 pt20 -66.37 -24.21 66.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.952 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -94.05 105.65 17.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.924 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 75.4 m -93.76 81.27 4.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.944 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 49.6 mm -72.87 135.7 27.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.153 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -69.97 110.91 3.53 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.502 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . 0.529 ' O ' ' HB3' ' A' ' 430' ' ' ALA . . . -73.07 77.47 1.22 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.772 0.32 . . . . 0.0 111.058 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -123.05 141.87 51.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.106 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 40.59 37.66 1.3 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.508 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.4 t -89.62 -25.95 21.02 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.761 0.315 . . . . 0.0 110.812 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 50.25 43.58 26.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.93 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 14.8 ptmt -121.68 164.54 17.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.95 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -127.95 177.65 6.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.901 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -104.36 -147.31 16.85 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.535 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.57 151.61 32.81 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.709 2.273 . . . . 0.0 112.313 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -53.41 102.51 0.06 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.943 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 135.94 -28.71 2.92 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.466 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . 0.494 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.95 126.7 43.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.779 0.323 . . . . 0.0 111.106 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.5 OUTLIER -159.04 161.55 36.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.912 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . 0.562 HD12 ' CE1' ' A' ' 449' ' ' TYR . 17.9 mt -159.95 117.66 2.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.929 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . 0.73 ' CZ ' ' CD1' ' A' ' 446' ' ' PHE . 44.4 m-85 -126.39 115.42 19.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.887 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . 0.834 HD12 ' N ' ' A' ' 405' ' ' ILE . 1.2 mp -93.82 127.09 46.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.119 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . 0.484 ' CZ ' ' HB3' ' A' ' 404' ' ' PHE . 37.9 m-85 -120.19 151.99 38.34 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.964 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . 0.646 ' O ' HD23 ' A' ' 472' ' ' LEU . 15.5 m-70 73.47 54.44 0.11 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.885 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 26.0 mt -101.58 136.05 19.67 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.6 0.714 . . . . 0.0 110.966 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -47.73 -179.04 0.01 OUTLIER 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.729 2.286 . . . . 0.0 112.329 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 35.7 tp60 -91.9 -38.79 12.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.933 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 25.0 pm0 -65.15 -13.19 57.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.881 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -80.29 135.49 36.24 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.901 -179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -116.41 -151.86 9.69 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.451 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -79.18 -56.53 4.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.736 0.303 . . . . 0.0 110.873 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . 0.453 ' O ' ' C ' ' A' ' 416' ' ' ASP . 9.2 mm-40 -56.88 -55.98 27.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.9 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 415' ' ' GLN . 63.6 m-20 -34.41 -59.06 0.46 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.845 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . 0.402 HD11 HG12 ' A' ' 405' ' ' ILE . 39.1 tp -46.64 -49.02 19.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.906 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . 0.464 ' HB3' ' NE2' ' A' ' 419' ' ' GLN . 52.2 tp -55.27 -55.33 32.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.916 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . 0.464 ' NE2' ' HB3' ' A' ' 418' ' ' LEU . 6.9 mp0 -60.45 -17.6 45.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.923 179.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 3.8 ttm -86.55 -26.48 24.49 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.899 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . 0.55 ' CZ ' HG12 ' A' ' 405' ' ' ILE . 10.8 m-85 -105.93 -10.14 16.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.9 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.592 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 4.3 mtt -59.64 -45.59 98.6 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.581 0.705 . . . . 0.0 110.923 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.9 Cg_exo -47.98 -37.9 30.51 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.628 2.219 . . . . 0.0 112.362 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . 0.507 ' CE2' ' HA ' ' A' ' 458' ' ' ALA . 86.8 m-85 -67.19 -34.94 78.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.934 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 171.67 -156.82 26.66 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.488 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 -92.0 92.77 8.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.841 0.353 . . . . 0.0 110.886 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.518 HG11 ' HB2' ' A' ' 430' ' ' ALA . 54.3 t -65.67 116.93 5.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.1 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 71.2 t -64.5 -43.18 96.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.126 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . 0.435 ' O ' ' CG1' ' A' ' 427' ' ' VAL . 93.2 p -137.34 146.83 45.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.82 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 390' ' ' ALA . . . -161.3 110.29 1.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.076 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . 0.418 ' C ' ' HD2' ' A' ' 431' ' ' LYS . 1.1 tmmm? -157.36 144.4 18.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.924 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 52.7 t -96.25 137.01 25.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.147 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . 0.403 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.2 m-85 -77.82 151.47 33.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.917 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.46 HG23 ' C ' ' A' ' 440' ' ' LEU . 45.8 mt -123.36 152.36 28.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.168 179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -84.73 132.2 34.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.937 179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 9.5 mtpt -75.01 -11.82 60.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.92 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 6.1 mm100 -95.59 -55.39 3.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.842 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 22.1 p -79.61 -32.13 41.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.125 -179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 38.2 t30 71.66 31.96 2.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.857 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.46 ' C ' HG23 ' A' ' 434' ' ' ILE . 10.1 mt -129.84 141.34 50.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 8.8 m -42.73 110.97 0.21 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.84 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.563 ' HD3' ' CE2' ' A' ' 444' ' ' PHE . 15.8 mttm -55.36 -174.96 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.902 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . 0.482 ' O ' ' N ' ' A' ' 407' ' ' HIS . 31.4 p -103.03 35.52 2.5 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.973 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . 0.563 ' CE2' ' HD3' ' A' ' 442' ' ' LYS . 12.0 p90 -162.2 141.5 9.51 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.852 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -132.65 171.16 21.73 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.454 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . 0.73 ' CD1' ' CZ ' ' A' ' 404' ' ' PHE . 30.6 t80 -111.24 153.16 26.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.911 0.386 . . . . 0.0 110.822 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . 0.467 HG13 ' CG1' ' A' ' 427' ' ' VAL . 59.5 t -159.06 146.64 7.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.099 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 1.2 t -148.74 148.89 30.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.835 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . 0.562 ' CE1' HD12 ' A' ' 403' ' ' LEU . 8.6 m-85 -112.11 -174.9 2.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.98 -179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -80.58 -21.21 41.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.904 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 20.2 p30 -152.99 155.73 32.25 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.613 0.72 . . . . 0.0 110.943 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . 0.452 ' N ' ' HB2' ' A' ' 401' ' ' ALA . 60.5 Cg_endo -74.28 -2.27 12.12 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.731 2.287 . . . . 0.0 112.356 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 93.2 t -86.19 -34.25 7.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.08 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 14.0 m -87.39 -39.65 15.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.823 -179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -52.99 -30.72 36.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.041 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 42.7 mm-40 -64.48 -45.95 85.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.876 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -40.31 -44.32 1.9 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.164 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . 0.507 ' HA ' ' CE2' ' A' ' 424' ' ' PHE . . . -61.36 -68.55 0.3 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.108 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . 0.428 ' O ' ' CB ' ' A' ' 463' ' ' ASN . 86.9 mt -43.04 -45.75 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.174 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 24.3 mm100 -39.34 -46.51 1.61 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.933 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 32.5 t -103.19 -56.56 2.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.883 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . 0.501 ' HB3' HG21 ' A' ' 474' ' ' VAL . 86.6 mmm -42.65 -43.26 3.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.892 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' A' ' 459' ' ' ILE . 14.4 t30 -44.74 110.19 0.21 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.866 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 74.38 33.33 56.62 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.59 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . 0.593 ' HB3' HD12 ' A' ' 472' ' ' LEU . 9.9 t80 -67.51 113.22 5.17 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.753 0.311 . . . . 0.0 110.913 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -70.36 109.18 4.59 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.904 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.7 tt -125.01 134.94 65.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.087 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 58.6 -102.33 0.26 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.434 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -124.33 -9.24 7.52 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.821 0.344 . . . . 0.0 110.878 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 8.9 pttm -120.57 179.2 4.4 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.88 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 80.3 mtt180 -112.09 164.37 13.24 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.909 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 407' ' ' HIS . 78.5 mt -107.0 158.39 17.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.886 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 19.5 tttt -131.97 102.52 5.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.825 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . 0.501 HG21 ' HB3' ' A' ' 462' ' ' MET . 15.3 t -110.18 125.54 67.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.138 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 39.9 tp60 -152.11 144.67 24.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.894 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . 0.617 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.6 pp -84.98 129.11 34.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.869 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.475 ' C ' ' O ' ' A' ' 476' ' ' LEU . 4.4 tptm -32.38 -70.82 0.06 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.892 179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . 0.585 ' N ' HD12 ' A' ' 476' ' ' LEU . 0.4 OUTLIER -151.23 142.1 22.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.878 -179.959 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . 0.443 ' N ' HD11 ' A' ' 476' ' ' LEU . 57.9 p -101.48 -52.81 3.14 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.875 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 31.1 pttt -125.57 93.03 3.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.955 179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -143.91 109.86 5.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.922 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -170.88 130.56 0.8 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.86 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 4.6 t -54.7 170.34 0.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.929 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 14.2 tptp -124.64 -54.5 1.65 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.904 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 49.4 m 64.04 42.55 5.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.872 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -144.47 68.58 0.42 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.499 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.15 -3.52 13.82 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.63 2.22 . . . . 0.0 112.286 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 33.4 m -108.8 106.05 15.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.843 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 2.5 m -89.36 82.06 6.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.861 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.27 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.455 179.933 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.337 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 37.9 m -146.58 176.83 9.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.905 0.383 . . . . 0.0 110.845 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 31.6 p -127.2 90.84 3.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.885 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 52.04 90.18 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.51 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 88.9 p -67.98 104.22 1.68 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.924 0.392 . . . . 0.0 110.856 -179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 80.0 p -46.2 165.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.904 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 53.28 82.73 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.475 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 4.3 pp -62.49 158.13 18.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.934 0.397 . . . . 0.0 110.848 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 54.7 p -127.71 100.62 6.03 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.099 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -85.67 41.06 0.88 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 5.5 mp0 -117.33 39.93 3.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.898 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 4.6 m -82.25 43.5 0.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.839 -179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 60.2 mt -39.27 133.65 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.109 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -130.87 47.46 1.02 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.45 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -98.46 -56.87 2.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.835 0.35 . . . . 0.0 111.108 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -38.77 127.52 1.55 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.075 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 86.98 -39.78 3.09 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.493 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 10.7 t -53.93 120.69 6.69 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.779 0.323 . . . . 0.0 110.901 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -92.11 26.46 2.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.883 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.497 ' O ' ' CB ' ' A' ' 429' ' ' SER . 26.6 mtpt -72.96 172.53 10.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.854 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -142.79 179.44 7.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.946 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -98.54 -147.37 22.04 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.53 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -75.56 155.77 40.43 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.672 2.248 . . . . 0.0 112.323 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -58.52 100.51 0.06 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 136.25 -28.75 2.88 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.479 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . 0.669 ' HB2' ' CA ' ' A' ' 452' ' ' PRO . . . -97.88 127.25 43.71 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.774 0.321 . . . . 0.0 111.151 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . 0.493 ' O ' ' CB ' ' A' ' 476' ' ' LEU . 16.9 m-80 -158.64 165.43 34.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.94 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . 0.523 HD12 ' CE1' ' A' ' 449' ' ' TYR . 50.7 mt -159.29 108.0 1.84 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.912 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . 0.535 ' C ' HD13 ' A' ' 405' ' ' ILE . 26.8 m-85 -109.94 120.32 42.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.87 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . 0.773 HD12 HG22 ' A' ' 474' ' ' VAL . 1.8 mm -91.04 133.92 31.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.074 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . 0.489 ' CZ ' ' HB3' ' A' ' 404' ' ' PHE . 13.9 m-85 -129.75 147.43 51.53 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.887 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . 0.66 ' O ' HD23 ' A' ' 472' ' ' LEU . 31.7 m-70 70.0 52.13 0.4 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.876 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.692 HD21 HG21 ' A' ' 405' ' ' ILE . 32.7 mt -93.65 139.65 22.85 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.585 0.707 . . . . 0.0 110.897 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -47.39 -179.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.64 2.227 . . . . 0.0 112.331 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -98.92 -24.84 14.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.949 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 7.7 pm0 -82.37 -12.75 57.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.877 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.461 ' CZ ' HD11 ' A' ' 467' ' ' ILE . 6.3 m-85 -76.55 147.55 37.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.893 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -127.03 -148.7 7.04 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.482 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -81.85 -54.72 5.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.816 0.341 . . . . 0.0 110.903 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . 0.466 ' O ' ' N ' ' A' ' 418' ' ' LEU . 7.3 mm100 -58.16 -58.53 8.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.935 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . 0.409 ' C ' ' O ' ' A' ' 415' ' ' GLN . 24.2 m-20 -37.3 -56.46 0.96 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.833 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . 0.548 HD11 HG13 ' A' ' 405' ' ' ILE . 48.5 tp -51.99 -37.24 52.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.943 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' A' ' 415' ' ' GLN . 23.9 tp -70.78 -50.77 32.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.905 179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 42.5 mm-40 -63.88 -13.89 48.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.855 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 2.1 ttm -89.58 -32.79 16.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.943 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . 0.45 ' CE1' ' SD ' ' A' ' 462' ' ' MET . 6.2 m-85 -93.18 -17.8 23.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.873 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.58 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 0.4 OUTLIER -57.28 -45.61 99.89 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.503 0.668 . . . . 0.0 110.825 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 422' ' ' MET . 64.7 Cg_exo -47.94 -37.79 29.95 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.68 2.253 . . . . 0.0 112.351 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -71.33 -35.56 71.25 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.901 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 176.06 -178.62 47.48 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.459 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -76.93 89.33 3.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.839 0.352 . . . . 0.0 110.945 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 70.3 t -56.69 143.57 10.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.112 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . 0.418 ' CG2' ' C ' ' A' ' 449' ' ' TYR . 99.4 t -95.25 -38.39 8.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.149 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 3.5 p -140.76 145.09 35.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.928 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -161.03 113.71 1.93 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.14 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -157.03 142.75 17.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.919 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 86.8 t -98.99 143.74 12.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.143 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . 0.534 ' CG ' ' CE1' ' A' ' 444' ' ' PHE . 3.1 m-85 -84.42 153.7 23.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.896 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.634 HG22 ' N ' ' A' ' 435' ' ' ASP . 69.3 mt -130.18 164.74 32.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.128 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . 0.634 ' N ' HG22 ' A' ' 434' ' ' ILE . 3.5 m-20 -102.45 151.47 22.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.88 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 16.3 mttp -89.6 -18.42 26.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.928 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -94.3 -52.65 4.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.917 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . 0.463 ' O ' ' ND2' ' A' ' 439' ' ' ASN . 58.2 p -82.1 -22.03 36.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.115 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . 0.463 ' ND2' ' O ' ' A' ' 438' ' ' THR . 10.6 p30 49.14 38.32 12.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.87 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.444 ' O ' ' C ' ' A' ' 441' ' ' SER . 57.5 mt -129.22 127.39 41.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.953 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . 0.444 ' C ' ' O ' ' A' ' 440' ' ' LEU . 7.9 t -34.35 107.29 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.568 ' HD3' ' CE2' ' A' ' 444' ' ' PHE . 39.6 mttt -51.54 -174.95 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.908 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 24.5 p -110.13 37.91 2.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.903 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . 0.568 ' CE2' ' HD3' ' A' ' 442' ' ' LYS . 4.6 p90 -162.15 143.48 10.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.829 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -137.22 179.07 18.46 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.539 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . 0.469 ' CD1' ' CZ ' ' A' ' 404' ' ' PHE . 66.0 t80 -122.89 141.1 52.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.906 0.384 . . . . 0.0 110.871 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . 0.42 HG13 ' O ' ' A' ' 429' ' ' SER . 84.5 t -146.12 149.44 16.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.102 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 1.3 t -147.95 144.94 28.36 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.83 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . 0.523 ' CE1' HD12 ' A' ' 403' ' ' LEU . 4.1 m-85 -104.84 -174.83 2.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.874 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 38.0 t0 -79.63 -22.48 43.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.797 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -147.37 155.46 46.07 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.596 0.712 . . . . 0.0 110.875 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . 0.669 ' CA ' ' HB2' ' A' ' 401' ' ' ALA . 59.7 Cg_endo -73.03 -0.36 8.95 Favored 'Trans proline' 0 N--CA 1.465 -0.191 0 C-N-CA 122.713 2.275 . . . . 0.0 112.399 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 95.5 t -94.23 -37.05 7.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.149 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 50.6 m -78.63 -37.69 41.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.8 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -52.13 -30.13 25.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.054 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . 0.41 ' NE2' HD12 ' A' ' 459' ' ' ILE . 42.1 mm-40 -67.59 -51.59 48.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.855 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 456' ' ' GLN . . . -36.64 -42.35 0.36 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.124 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -69.0 -48.23 63.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.119 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . 0.443 ' O ' ' CB ' ' A' ' 463' ' ' ASN . 70.5 mt -55.39 -42.85 69.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.148 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -40.97 -53.08 3.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.925 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 27.8 t -93.08 -55.27 3.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.856 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . 0.573 ' HB3' HG21 ' A' ' 474' ' ' VAL . 6.3 mmt -43.53 -49.7 7.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.905 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' A' ' 459' ' ' ILE . 18.8 t-20 -48.45 114.7 1.01 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.878 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 65.88 33.86 86.93 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.492 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 26.0 t80 -75.9 109.04 9.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.795 0.331 . . . . 0.0 110.834 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -62.96 105.88 0.74 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.928 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . 0.588 HG23 ' O ' ' A' ' 467' ' ' ILE . 19.2 tt -111.05 116.99 53.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.189 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 65.85 -96.98 0.28 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.537 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 4.0 ttt -123.17 -13.0 7.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.792 0.329 . . . . 0.0 110.806 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 15.3 pttm -117.59 168.65 10.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.887 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 89.6 mtt180 -111.29 153.52 25.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.864 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . 0.66 HD23 ' O ' ' A' ' 407' ' ' HIS . 14.8 mt -104.21 161.61 13.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.977 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm -134.57 104.74 6.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.928 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . 0.773 HG22 HD12 ' A' ' 405' ' ' ILE . 30.8 t -109.09 128.33 65.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.135 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -151.84 142.96 23.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.917 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . 0.615 HD12 ' C ' ' A' ' 476' ' ' LEU . 1.6 pp -80.13 135.24 36.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.973 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.53 ' HB2' ' CE1' ' A' ' 404' ' ' PHE . 22.8 ttpp -44.81 111.51 0.32 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 26.4 ttm-85 -90.34 86.8 6.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.904 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 11.8 t -82.1 104.3 12.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.824 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 12.8 pttp -103.22 40.77 1.34 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.875 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -107.1 87.07 2.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.843 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -117.79 83.73 2.05 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.907 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 15.1 m -85.2 96.81 9.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.786 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 9.8 tppt? -133.0 117.95 18.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.886 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 91.6 p -60.0 107.03 0.57 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.846 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 96.81 170.68 34.09 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.451 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -76.99 -42.01 0.34 Allowed 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.773 2.315 . . . . 0.0 112.323 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 3.7 m 44.03 42.25 4.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.886 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 4.7 m -38.37 154.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.829 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.37 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.48 179.988 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 3.4 m -52.48 155.49 2.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.786 0.327 . . . . 0.0 110.906 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 19.9 m -118.02 98.01 6.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.84 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -157.19 87.24 0.12 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.484 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 3.2 t -147.11 123.82 11.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.852 0.358 . . . . 0.0 110.904 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 13.1 t -99.96 89.16 3.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 -179.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -173.08 92.81 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.494 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 43.8 mt -94.99 115.09 26.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.914 0.388 . . . . 0.0 110.875 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 95.5 m -58.6 -67.17 0.38 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.157 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 18.4 mm-40 -130.67 167.09 19.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 40.4 tp60 -116.54 -46.31 2.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.882 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 4.4 t -123.35 94.48 4.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.769 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.593 ' H ' HD12 ' A' ' 388' ' ' ILE . 5.1 mp -74.54 -54.87 13.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.134 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 44.14 90.02 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.451 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -100.78 -49.02 4.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.713 0.292 . . . . 0.0 111.06 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -40.47 130.38 2.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.139 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 393' ' ' SER . . . 79.13 -50.2 3.66 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.487 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . 0.423 ' C ' ' O ' ' A' ' 392' ' ' GLY . 1.8 t -36.32 152.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.806 0.336 . . . . 0.0 110.897 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -124.33 48.97 1.85 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.874 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.477 ' O ' ' CB ' ' A' ' 429' ' ' SER . 0.1 OUTLIER -107.07 171.16 7.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.906 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -137.2 179.31 6.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.935 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -94.81 -154.77 31.15 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.546 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.09 151.29 61.31 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.7 2.267 . . . . 0.0 112.294 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 20.4 tp10 -49.58 97.2 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.913 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 136.43 -24.74 3.19 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.48 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . 0.481 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -98.18 126.93 43.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.843 0.354 . . . . 0.0 111.053 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . 0.481 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 22.1 m-80 -158.97 161.87 36.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . 0.637 HD12 ' CE1' ' A' ' 449' ' ' TYR . 47.5 mt -159.24 108.56 1.89 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.931 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . 0.489 ' CE1' ' CE1' ' A' ' 446' ' ' PHE . 20.1 m-85 -113.14 112.42 23.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.923 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . 0.689 HD12 ' N ' ' A' ' 405' ' ' ILE . 3.0 mp -90.83 137.44 21.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.093 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . 0.453 ' CD1' ' HB2' ' A' ' 444' ' ' PHE . 93.6 m-85 -129.47 169.74 14.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.915 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . 0.469 ' N ' ' O ' ' A' ' 443' ' ' CYS . 20.3 m-70 53.95 51.69 14.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.874 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.423 HD21 HG21 ' A' ' 405' ' ' ILE . 25.5 mt -93.9 134.35 26.31 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.594 0.711 . . . . 0.0 110.925 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -48.87 -175.89 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.659 2.24 . . . . 0.0 112.307 179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -88.85 -41.43 12.47 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.957 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -62.5 -37.4 85.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.898 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -55.35 117.18 3.32 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.843 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . 0.461 ' O ' HG21 ' A' ' 432' ' ' VAL . . . -103.17 -138.45 9.91 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.552 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -89.98 -44.07 10.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.763 0.316 . . . . 0.0 110.871 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . 0.423 ' O ' ' N ' ' A' ' 418' ' ' LEU . 22.5 mp0 -70.06 -57.2 5.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . 0.414 ' C ' ' O ' ' A' ' 415' ' ' GLN . 32.9 m-20 -37.36 -56.77 0.95 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.838 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . 0.413 HD11 HG12 ' A' ' 405' ' ' ILE . 61.7 tp -52.33 -40.5 61.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.933 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . 0.423 ' N ' ' O ' ' A' ' 415' ' ' GLN . 24.6 tp -69.61 -38.63 77.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 98.7 mt-30 -73.23 -17.51 61.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 4.8 ttp -88.9 -12.67 41.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.826 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . 0.517 ' CZ ' HG12 ' A' ' 405' ' ' ILE . 5.8 m-85 -111.79 -0.01 16.07 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.868 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.576 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 4.5 mtt -71.82 -45.92 12.17 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.549 0.69 . . . . 0.0 110.848 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.1 Cg_exo -48.02 -36.84 28.81 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.762 2.308 . . . . 0.0 112.327 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . 0.501 ' CD1' ' HA ' ' A' ' 458' ' ' ALA . 97.2 m-85 -69.51 -36.02 76.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.833 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 171.7 -161.65 33.87 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.53 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 10.7 m-20 -86.07 105.01 16.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.943 0.401 . . . . 0.0 110.896 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 93.8 t -74.13 130.0 36.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.126 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 76.2 t -85.99 -46.82 16.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.115 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . 0.477 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 13.7 t -130.69 144.67 51.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.841 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -161.05 117.72 2.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.097 179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . 0.425 ' C ' ' HD2' ' A' ' 431' ' ' LYS . 2.0 tmmm? -161.06 151.44 17.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.461 HG21 ' O ' ' A' ' 413' ' ' GLY . 82.0 t -108.62 137.96 37.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.138 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . 0.547 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.1 m-85 -79.51 153.0 29.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.544 HG22 ' N ' ' A' ' 435' ' ' ASP . 73.0 mt -131.11 159.91 42.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.152 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . 0.544 ' N ' HG22 ' A' ' 434' ' ' ILE . 4.1 m-20 -92.34 150.82 20.61 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.872 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 10.0 mptt -95.81 -17.17 21.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.95 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -95.39 -40.52 9.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.91 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . 0.47 ' HB ' HD12 ' A' ' 440' ' ' LEU . 73.3 p -96.3 -25.54 15.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.126 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 31.3 m120 55.1 42.26 30.94 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.878 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.47 HD12 ' HB ' ' A' ' 438' ' ' THR . 15.3 mt -128.99 123.55 32.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.925 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 440' ' ' LEU . 4.9 p -34.88 103.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.858 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.566 ' HD3' ' CE2' ' A' ' 444' ' ' PHE . 34.6 mttt -51.92 -174.9 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.844 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . 0.469 ' O ' ' N ' ' A' ' 407' ' ' HIS . 23.0 p -112.93 40.62 2.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.914 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . 0.566 ' CE2' ' HD3' ' A' ' 442' ' ' LYS . 6.0 p90 -161.97 138.42 8.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.88 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -136.2 175.46 20.9 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.475 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . 0.489 ' CE1' ' CE1' ' A' ' 404' ' ' PHE . 32.9 t80 -116.03 145.53 42.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.895 0.379 . . . . 0.0 110.857 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 69.3 t -151.44 151.31 12.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.117 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 3.8 m -148.0 153.53 39.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.866 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . 0.637 ' CE1' HD12 ' A' ' 403' ' ' LEU . 4.5 m-85 -115.01 -174.83 2.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.903 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -81.72 -17.54 47.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.869 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 22.8 p30 -156.44 154.71 27.64 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.672 0.748 . . . . 0.0 110.857 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.44 -6.14 18.29 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.723 2.282 . . . . 0.0 112.343 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 86.1 t -85.25 -33.39 7.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.063 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 61.7 m -85.76 -35.87 20.49 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.812 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -57.29 -23.8 50.84 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.095 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 39.1 mm-40 -67.33 -53.54 28.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.955 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -40.23 -43.29 1.66 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.152 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . 0.501 ' HA ' ' CD1' ' A' ' 424' ' ' PHE . . . -62.52 -52.29 64.05 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.124 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 55.5 mt -57.14 -44.16 82.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.132 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -40.94 -55.85 2.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 1.9 m -89.04 -56.1 3.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.853 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . 0.448 ' O ' ' N ' ' A' ' 465' ' ' PHE . 11.1 mmt -40.96 -63.7 0.64 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.86 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . 0.438 ' C ' ' O ' ' A' ' 462' ' ' MET . 37.9 t-20 -35.6 110.92 0.11 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.87 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 472' ' ' LEU . . . 67.86 38.43 89.19 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.504 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . 0.448 ' N ' ' O ' ' A' ' 462' ' ' MET . 25.0 t80 -78.59 116.06 18.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.826 0.346 . . . . 0.0 110.919 -179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 18.7 tp60 -63.07 104.28 0.55 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.874 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . 0.559 HG23 ' O ' ' A' ' 467' ' ' ILE . 20.0 tt -116.7 118.78 59.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.12 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 64.38 -106.37 1.42 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.449 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -113.31 -11.63 13.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.878 0.37 . . . . 0.0 110.857 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.64 178.41 5.02 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.864 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -110.1 170.28 8.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.91 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . 0.41 ' O ' ' N ' ' A' ' 464' ' ' GLY . 65.6 mt -114.09 150.07 34.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.88 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 26.8 ttpt -124.61 107.93 11.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.854 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 33.0 t -119.05 137.14 54.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.149 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 48.0 tp60 -157.04 145.73 19.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.907 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . 0.709 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.5 pp -86.0 127.04 34.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.911 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.457 ' HB2' ' CE1' ' A' ' 404' ' ' PHE . 25.5 ttpt -33.79 -72.39 0.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.853 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . 0.486 ' C ' ' CD1' ' A' ' 476' ' ' LEU . 8.2 mmt180 -146.35 151.03 36.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.821 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 3.8 t -125.39 76.37 1.55 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.828 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -46.43 -67.06 0.31 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.951 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -166.55 161.2 15.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -61.81 128.16 34.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.838 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 92.5 p -67.69 168.86 10.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.923 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.29 -56.86 3.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.927 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 9.4 t 46.08 40.76 7.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.871 -179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -76.18 -146.06 1.78 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.469 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -79.73 23.97 0.64 Allowed 'Trans proline' 0 N--CA 1.465 -0.156 0 C-N-CA 122.716 2.277 . . . . 0.0 112.405 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . 0.449 ' O ' ' C ' ' A' ' 489' ' ' SER . 67.0 m -135.56 138.64 43.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.864 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . 0.449 ' C ' ' O ' ' A' ' 488' ' ' SER . 68.3 p -34.85 -44.45 0.22 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.828 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.338 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.496 -179.97 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.377 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 33.0 m -87.51 145.33 26.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.881 0.372 . . . . 0.0 110.874 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 97.3 p -94.05 42.66 1.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.832 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 87.22 -75.68 2.14 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.417 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 36.3 t -46.49 135.1 8.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.877 0.37 . . . . 0.0 110.789 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 95.0 p -92.07 124.98 36.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.85 -179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -99.65 -62.1 0.83 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.476 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . 0.496 HD13 ' HA ' ' A' ' 383' ' ' LEU . 2.5 mm? -107.29 84.1 1.92 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.896 0.379 . . . . 0.0 110.911 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 15.0 t -118.78 37.83 3.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.143 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -41.94 101.45 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.892 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -118.72 87.78 2.8 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.914 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 80.1 p -94.79 89.61 5.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.882 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 41.3 mm -125.27 135.83 62.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.062 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -67.8 86.11 0.16 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.529 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -61.65 -44.31 97.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.808 0.337 . . . . 0.0 111.16 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -44.24 115.32 0.82 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.099 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 111.33 -47.76 1.01 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.474 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 2.2 m -45.81 130.15 9.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.842 0.353 . . . . 0.0 110.828 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -101.41 -12.66 18.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.877 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.418 ' O ' ' CB ' ' A' ' 429' ' ' SER . 6.6 ptmm? -55.48 161.61 1.9 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . 0.413 ' CD ' ' O ' ' A' ' 397' ' ' GLY . 2.6 pp20? -126.72 -178.33 4.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.868 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . 0.413 ' O ' ' CD ' ' A' ' 396' ' ' GLU . . . -94.06 -146.42 20.14 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.511 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.71 152.05 37.09 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 122.747 2.298 . . . . 0.0 112.368 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -52.83 113.76 1.19 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.905 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 125.76 -28.19 5.0 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.529 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . 0.527 ' HB2' ' N ' ' A' ' 452' ' ' PRO . . . -97.93 127.16 43.7 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.84 0.352 . . . . 0.0 111.09 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.7 OUTLIER -158.6 160.76 36.92 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.852 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . 0.609 HD12 ' CE1' ' A' ' 449' ' ' TYR . 15.8 mt -156.29 117.76 3.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.909 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . 0.467 ' CE1' ' HB2' ' A' ' 477' ' ' LYS . 12.8 m-85 -125.6 113.04 16.88 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.911 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . 0.726 HD12 ' N ' ' A' ' 405' ' ' ILE . 1.8 mp -90.77 136.13 24.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.178 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -128.24 169.18 14.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.905 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . 0.43 ' N ' ' O ' ' A' ' 443' ' ' CYS . 30.2 m-70 54.23 53.44 10.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.874 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.601 HD21 HG21 ' A' ' 405' ' ' ILE . 35.4 mt -94.1 143.62 26.72 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.608 0.718 . . . . 0.0 110.929 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.601 ' HG2' ' CD1' ' A' ' 412' ' ' PHE . 61.4 Cg_endo -78.21 155.73 29.33 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.674 2.249 . . . . 0.0 112.309 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -60.03 -37.22 79.15 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.919 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -60.19 -19.87 56.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.865 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.601 ' CD1' ' HG2' ' A' ' 409' ' ' PRO . 4.2 m-85 -89.84 125.88 35.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.828 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -114.55 -141.86 7.75 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.475 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.78 -59.02 2.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.75 0.31 . . . . 0.0 110.892 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . 0.424 ' O ' ' C ' ' A' ' 416' ' ' ASP . 52.3 mm-40 -57.78 -56.49 21.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.906 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . 0.424 ' C ' ' O ' ' A' ' 415' ' ' GLN . 62.0 m-20 -36.42 -39.4 0.19 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.855 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 24.2 tp -71.33 -53.58 13.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.947 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . 0.466 ' O ' ' CG ' ' A' ' 422' ' ' MET . 29.6 tp -54.62 -41.19 69.72 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.878 179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -79.78 -9.95 59.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.01 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -85.19 -35.91 21.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.874 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . 0.573 ' CE1' ' SD ' ' A' ' 462' ' ' MET . 5.3 m-85 -98.38 -22.28 16.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.579 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 0.7 OUTLIER -50.35 -45.84 83.75 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.581 0.705 . . . . 0.0 110.889 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.4 Cg_exo -47.99 -41.79 32.62 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.627 2.218 . . . . 0.0 112.344 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -67.15 -34.39 77.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.902 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 170.5 -178.98 42.87 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.444 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -66.51 124.75 23.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.83 0.347 . . . . 0.0 110.877 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 58.7 t -98.08 118.53 44.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.143 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 40.5 t -61.98 -51.68 69.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.194 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 3.3 m -143.77 148.76 36.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.825 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -156.82 131.26 8.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.07 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . 0.476 ' CG ' ' N ' ' A' ' 432' ' ' VAL . 14.9 tttm -159.06 162.42 36.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.476 ' N ' ' CG ' ' A' ' 431' ' ' LYS . 69.6 t -121.32 144.41 30.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.145 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . 0.646 ' CG ' ' CE1' ' A' ' 444' ' ' PHE . 4.4 m-85 -86.36 147.89 25.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.917 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 76.1 mt -119.3 138.22 50.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.116 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . 0.493 ' O ' ' N ' ' A' ' 439' ' ' ASN . 9.3 t0 -83.34 101.36 11.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.888 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . 0.405 ' HG3' ' N ' ' A' ' 437' ' ' GLN . 0.0 OUTLIER -50.8 -33.16 22.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.857 -179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . 0.405 ' N ' ' HG3' ' A' ' 436' ' ' LYS . 19.9 mm-40 -51.24 -42.12 60.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.92 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . 0.404 ' O ' ' C ' ' A' ' 439' ' ' ASN . 17.8 p -129.27 18.33 5.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.181 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . 0.493 ' N ' ' O ' ' A' ' 435' ' ' ASP . 2.3 m-80 37.71 38.54 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.862 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 20.4 mt -118.5 130.14 55.77 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.859 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 8.6 t -41.42 116.89 0.82 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.911 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.548 ' HD3' ' CE2' ' A' ' 444' ' ' PHE . 26.4 mttt -59.3 -174.74 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.876 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . 0.43 ' O ' ' N ' ' A' ' 407' ' ' HIS . 60.7 m -106.83 37.99 2.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.843 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . 0.646 ' CE1' ' CG ' ' A' ' 433' ' ' PHE . 12.0 p90 -162.13 148.34 13.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.883 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -143.77 178.44 21.85 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.485 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . 0.543 ' O ' HG23 ' A' ' 447' ' ' VAL . 26.1 t80 -117.45 155.01 30.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.949 0.404 . . . . 0.0 110.83 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 446' ' ' PHE . 71.4 t -161.35 150.57 4.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.126 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 84.6 p -149.69 141.81 24.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.844 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . 0.609 ' CE1' HD12 ' A' ' 403' ' ' LEU . 4.7 m-85 -106.07 -176.01 2.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.917 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.75 -10.57 59.61 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.883 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -166.91 160.36 11.23 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.592 0.71 . . . . 0.0 110.897 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . 0.527 ' N ' ' HB2' ' A' ' 401' ' ' ALA . 60.4 Cg_endo -74.76 -2.12 12.06 Favored 'Trans proline' 0 C--O 1.231 0.169 0 C-N-CA 122.724 2.282 . . . . 0.0 112.316 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 92.8 t -85.11 -44.03 17.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.112 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 7.4 t -78.57 -34.8 46.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.838 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -59.35 -20.1 51.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.111 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' A' ' 457' ' ' ALA . 35.2 mm-40 -77.82 -53.92 6.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.936 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 456' ' ' GLN . . . -37.74 -44.42 0.73 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.11 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -64.58 -52.41 57.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.093 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 91.2 mt -52.8 -45.81 50.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.106 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -38.49 -58.52 1.02 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.863 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 30.0 t -87.71 -55.69 3.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . 0.746 ' HB3' HG21 ' A' ' 474' ' ' VAL . 8.6 mmt -39.02 -57.54 1.25 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.876 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -47.1 114.26 0.82 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 75.93 29.69 58.66 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.493 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 35.5 t80 -73.47 126.45 30.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.837 0.351 . . . . 0.0 110.886 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 25.3 tm0? -69.96 104.67 2.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.928 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 16.8 tt -119.98 138.41 50.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.148 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 46.68 -95.48 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.518 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 8.8 ptp -134.21 5.03 3.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.903 0.382 . . . . 0.0 110.932 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 15.4 pttm -130.7 174.36 10.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.958 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 42.6 mtm-85 -106.73 145.6 31.84 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.892 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 27.2 mt -89.26 149.43 23.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.925 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 27.6 ttpt -125.63 103.8 8.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.858 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . 0.746 HG21 ' HB3' ' A' ' 462' ' ' MET . 2.8 t -110.04 137.63 41.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.141 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -157.05 145.74 19.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.93 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . 0.784 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.5 pp -91.41 124.84 35.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.942 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.467 ' HB2' ' CE1' ' A' ' 404' ' ' PHE . 13.9 tttm -34.97 105.18 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.948 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -90.07 148.98 22.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.869 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 51.7 m -136.89 162.57 32.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.828 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 36.1 tttm -63.46 -60.48 3.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.86 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 18.2 t30 -106.88 88.5 2.76 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.932 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -109.06 -53.06 2.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.867 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 3.6 t -97.92 -49.88 4.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.829 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 20.9 pttp -72.43 174.55 7.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.873 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 88.4 p -123.76 148.2 46.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.844 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -170.42 76.52 0.1 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.504 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -45.57 162.22 0.11 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.651 2.234 . . . . 0.0 112.403 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 5.7 t -50.22 124.52 10.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.831 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 74.5 p -73.26 141.11 47.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.888 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.282 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.451 -179.97 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 N-CA-C 112.506 -0.237 . . . . 0.0 112.506 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 26.3 p -83.39 121.76 27.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.96 0.409 . . . . 0.0 110.843 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 12.4 t -104.58 85.92 2.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.818 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 82.25 -130.33 9.63 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.453 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 1.6 t 58.78 40.86 22.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.837 0.351 . . . . 0.0 110.846 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 73.7 m -118.67 121.26 39.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.832 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 108.98 91.6 2.17 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.468 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . 0.641 ' H ' HD23 ' A' ' 383' ' ' LEU . 1.4 pt? -72.44 159.46 33.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.867 0.365 . . . . 0.0 110.896 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 9.0 t -170.77 132.45 0.9 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.195 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -148.76 152.81 37.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.936 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . 0.418 ' N ' ' CD ' ' A' ' 386' ' ' GLN . 2.9 mp0 -65.04 110.28 2.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.941 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 32.8 p -83.06 40.58 0.71 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.856 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 31.0 mt -108.99 99.91 9.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.117 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -71.08 117.74 7.01 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.477 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -90.15 -26.6 20.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.821 0.343 . . . . 0.0 111.089 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -43.62 119.27 1.61 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.052 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 393' ' ' SER . . . 94.63 -45.07 2.19 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.505 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 392' ' ' GLY . 5.3 p -35.87 126.42 0.71 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.866 0.365 . . . . 0.0 110.856 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -107.36 50.78 0.76 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.886 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.43 177.12 4.78 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.933 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -136.29 -176.64 4.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.894 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -107.03 -143.17 10.96 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.459 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -74.13 151.89 44.74 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.666 2.244 . . . . 0.0 112.282 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -55.7 100.71 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.964 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 135.92 -25.78 3.19 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.486 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . 0.485 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -98.75 127.05 44.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.806 0.336 . . . . 0.0 111.103 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . 0.485 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 19.2 m-80 -158.86 167.89 28.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.93 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . 0.416 ' CD1' ' CE1' ' A' ' 449' ' ' TYR . 53.0 mt -158.66 124.6 4.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.877 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . 0.421 ' CZ ' ' HD3' ' A' ' 477' ' ' LYS . 28.8 m-85 -130.07 111.02 12.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.911 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . 0.627 HD12 ' N ' ' A' ' 405' ' ' ILE . 3.2 mp -91.68 132.31 36.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.131 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -122.21 158.1 30.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.903 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . 0.491 ' O ' ' CD2' ' A' ' 472' ' ' LEU . 53.8 m-70 67.06 55.03 0.72 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.848 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 37.4 mt -100.97 129.9 26.26 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.691 0.757 . . . . 0.0 110.898 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -48.11 -178.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.681 2.254 . . . . 0.0 112.32 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -87.74 -41.93 12.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.935 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -59.9 -36.27 76.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.927 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -57.56 128.98 39.79 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.88 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . 0.455 ' O ' HG21 ' A' ' 432' ' ' VAL . . . -116.08 -138.11 6.29 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.515 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -90.54 -59.22 2.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.732 0.301 . . . . 0.0 110.746 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -51.46 -53.25 39.14 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.821 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -42.46 -61.74 1.14 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.86 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 33.2 tp -42.44 -49.78 5.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.934 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . 0.408 ' CD1' ' HB ' ' A' ' 427' ' ' VAL . 52.9 tp -55.19 -58.67 6.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.949 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . 0.49 ' N ' ' OE1' ' A' ' 419' ' ' GLN . 0.8 OUTLIER -57.75 -21.36 40.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.913 179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 4.2 ttm -82.21 -29.47 31.38 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.857 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . 0.528 ' CZ ' HG12 ' A' ' 405' ' ' ILE . 3.8 m-85 -106.9 4.29 27.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.856 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.588 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 17.5 mtt -73.14 -45.64 8.13 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.588 0.709 . . . . 0.0 110.946 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.7 Cg_exo -47.97 -45.72 24.08 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.673 2.249 . . . . 0.0 112.36 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -61.46 -25.32 67.16 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 160.21 -177.61 36.59 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.469 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -73.78 100.12 3.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.874 0.369 . . . . 0.0 110.867 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.554 HG11 ' HB2' ' A' ' 430' ' ' ALA . 54.2 t -67.0 122.82 18.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.142 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 76.7 t -75.25 -35.97 35.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.103 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -144.74 143.91 30.93 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.828 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . 0.554 ' HB2' HG11 ' A' ' 427' ' ' VAL . . . -161.08 114.77 2.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.064 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . 0.419 ' C ' ' HD2' ' A' ' 431' ' ' LYS . 3.8 tmmm? -160.92 141.54 11.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.881 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.455 HG21 ' O ' ' A' ' 413' ' ' GLY . 58.6 t -90.8 139.5 17.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.192 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -82.43 153.21 25.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.636 HG22 ' N ' ' A' ' 435' ' ' ASP . 67.1 mt -128.01 164.48 29.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.141 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . 0.636 ' N ' HG22 ' A' ' 434' ' ' ILE . 5.1 m-20 -98.09 152.1 19.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.91 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.08 -16.73 22.44 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.855 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 35.6 tp60 -96.04 -41.95 8.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.928 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 70.1 p -95.26 -25.36 16.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.105 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 34.8 m-20 56.76 33.6 23.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.86 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.436 ' O ' ' C ' ' A' ' 441' ' ' SER . 23.7 mt -121.01 126.67 50.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.944 179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . 0.436 ' C ' ' O ' ' A' ' 440' ' ' LEU . 1.5 m -35.39 102.64 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.839 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.563 ' HD3' ' CE2' ' A' ' 444' ' ' PHE . 25.2 mttm -47.38 174.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.837 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . 0.434 ' O ' ' N ' ' A' ' 407' ' ' HIS . 27.3 p -100.28 34.99 2.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.917 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . 0.563 ' CE2' ' HD3' ' A' ' 442' ' ' LYS . 7.4 p90 -162.07 147.03 12.79 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.86 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -135.35 178.71 18.39 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.525 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . 0.437 ' O ' HG23 ' A' ' 447' ' ' VAL . 28.4 t80 -117.33 154.57 31.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.863 0.363 . . . . 0.0 110.883 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 448' ' ' SER . 72.2 t -158.53 155.96 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.116 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . 0.467 ' N ' HG12 ' A' ' 447' ' ' VAL . 3.8 m -154.38 154.06 32.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.828 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . 0.416 ' CE1' ' CD1' ' A' ' 403' ' ' LEU . 4.4 m-85 -118.43 -175.25 2.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.899 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -81.25 -12.53 59.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.86 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -157.61 156.36 28.59 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-O 121.659 0.742 . . . . 0.0 110.846 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . 0.423 ' N ' ' HB2' ' A' ' 401' ' ' ALA . 61.1 Cg_endo -75.45 0.21 9.36 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.648 2.232 . . . . 0.0 112.332 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 99.2 t -90.04 -38.84 11.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.134 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 31.2 m -79.34 -38.5 34.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.828 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -51.15 -42.92 61.09 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.069 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . 0.414 ' O ' ' C ' ' A' ' 457' ' ' ALA . 23.3 mm-40 -59.73 -51.27 70.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.917 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 456' ' ' GLN . . . -36.52 -41.94 0.32 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.083 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -64.43 -69.75 0.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.057 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . 0.548 HG12 HG12 ' A' ' 474' ' ' VAL . 82.5 mt -43.55 -42.56 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.119 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 11.4 mm100 -39.68 -45.73 1.73 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.915 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 30.0 t -100.71 -56.29 2.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.905 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . 0.52 ' HB3' HG21 ' A' ' 474' ' ' VAL . 87.9 mmm -43.36 -33.15 0.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.881 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -53.01 103.14 0.06 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.873 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 83.49 30.77 29.26 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.565 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . 0.578 ' HB3' HD12 ' A' ' 472' ' ' LEU . 26.5 t80 -67.67 110.4 3.72 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.783 0.325 . . . . 0.0 110.886 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 9.8 tm0? -66.03 107.16 1.8 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.908 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . 0.432 HG21 HD21 ' A' ' 472' ' ' LEU . 17.0 tt -120.52 138.04 52.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.056 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 53.29 -96.44 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.449 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 2.4 ttt -131.89 -1.09 3.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.883 0.373 . . . . 0.0 110.895 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.35 174.68 8.4 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.891 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 54.5 mtm180 -105.22 172.64 6.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.84 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . 0.578 HD12 ' HB3' ' A' ' 465' ' ' PHE . 82.2 mt -121.24 156.09 33.22 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.95 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -134.13 108.45 8.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.863 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . 0.548 HG12 HG12 ' A' ' 459' ' ' ILE . 8.6 t -110.04 133.84 54.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.165 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . 0.444 ' HA ' HD13 ' A' ' 459' ' ' ILE . 26.1 mt-30 -156.97 139.1 14.56 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.946 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . 0.625 HD12 ' C ' ' A' ' 476' ' ' LEU . 1.6 pp -81.1 136.92 35.98 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.925 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.462 ' O ' HD12 ' A' ' 476' ' ' LEU . 21.7 tptt -34.01 107.48 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -97.3 179.34 4.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.89 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 45.4 m 59.27 48.69 9.93 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.872 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -72.52 89.64 1.29 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.978 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 4.6 m120 -61.81 138.71 58.36 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.934 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 11.5 t70 66.62 45.19 2.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.895 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 77.4 p -89.74 -42.49 11.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.882 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 45.4 pttt -112.85 136.74 52.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.95 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 2.9 m -131.7 130.48 42.05 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.835 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -176.21 97.45 0.11 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.431 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_exo -43.31 167.62 0.03 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.666 2.244 . . . . 0.0 112.349 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 3.5 m -55.23 -66.39 0.42 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.864 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 4.1 p -131.86 65.84 1.56 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.837 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.388 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.507 179.96 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.305 0 N-CA-C 112.483 -0.247 . . . . 0.0 112.483 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 11.2 m -82.0 169.69 16.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.844 0.354 . . . . 0.0 110.875 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 29.3 m -47.46 168.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.889 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -164.61 57.44 0.26 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.445 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 27.4 m -116.45 102.5 9.56 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.894 0.378 . . . . 0.0 110.836 -179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 3.3 m -98.4 138.07 36.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.903 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -104.8 106.88 2.79 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.492 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 6.5 mp -121.53 126.64 49.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.938 0.399 . . . . 0.0 110.871 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 45.8 p -133.42 172.39 12.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.165 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -77.91 -57.79 3.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.987 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -141.92 124.09 15.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.959 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 7.0 m -122.05 45.59 2.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.864 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 64.6 mt -108.65 -47.28 7.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.124 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . 43.9 67.94 0.95 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.513 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -72.69 -49.82 28.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.834 0.35 . . . . 0.0 111.141 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -39.92 119.93 1.07 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.091 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 81.13 53.95 3.74 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.51 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 3.2 m -140.16 135.97 33.0 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.817 0.341 . . . . 0.0 110.874 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -103.46 33.73 3.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.001 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 25.2 mtmm -98.27 160.4 14.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.42 -176.76 3.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.946 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -110.73 -154.42 13.73 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.47 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -48.06 176.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.717 2.278 . . . . 0.0 112.263 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . 0.441 ' CD ' ' O ' ' A' ' 399' ' ' GLU . 0.2 OUTLIER -83.24 83.58 7.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.926 179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 144.65 -14.77 2.0 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.468 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . 0.437 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -98.2 126.5 43.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.815 0.34 . . . . 0.0 111.145 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . 0.437 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 29.3 m-80 -159.41 162.45 35.74 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . 0.595 HD23 HD11 ' A' ' 459' ' ' ILE . 28.6 mt -159.78 109.18 1.82 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . 0.432 ' CE1' ' CD1' ' A' ' 446' ' ' PHE . 19.2 m-85 -112.63 114.81 27.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.888 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . 0.805 HG21 HD21 ' A' ' 408' ' ' LEU . 3.9 mp -90.87 135.72 25.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.113 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . 0.426 ' CD1' ' HB2' ' A' ' 444' ' ' PHE . 89.9 m-85 -130.22 168.25 17.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.952 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 32.6 m-70 61.4 48.68 5.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.887 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.805 HD21 HG21 ' A' ' 405' ' ' ILE . 38.0 mt -95.71 148.32 34.39 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.592 0.71 . . . . 0.0 110.914 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.598 ' HG2' ' CD1' ' A' ' 412' ' ' PHE . 59.9 Cg_endo -73.35 -169.77 0.57 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.699 2.266 . . . . 0.0 112.329 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -95.21 -38.01 10.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.932 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . 0.416 ' OE1' ' C ' ' A' ' 411' ' ' GLU . 0.3 OUTLIER -58.37 -32.45 68.58 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.922 -179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.598 ' CD1' ' HG2' ' A' ' 409' ' ' PRO . 4.1 m-85 -62.01 158.81 15.58 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.867 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -142.82 -140.74 3.76 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.547 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -88.65 -48.83 7.26 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.738 0.304 . . . . 0.0 110.876 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . 0.463 ' O ' ' N ' ' A' ' 418' ' ' LEU . 19.9 mp0 -64.43 -58.23 7.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.963 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 415' ' ' GLN . 35.9 m-20 -34.43 -56.6 0.52 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.899 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 24.3 tp -53.34 -43.42 67.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.857 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . 0.463 ' N ' ' O ' ' A' ' 415' ' ' GLN . 11.1 tp -65.04 -51.56 60.86 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.962 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 32.6 mm-40 -69.48 -9.85 55.52 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.951 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 2.8 ttm -89.79 -25.55 21.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.902 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . 0.444 ' CZ ' ' CG1' ' A' ' 405' ' ' ILE . 5.2 m-85 -104.57 -12.16 16.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.937 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.577 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 7.6 mtt -57.38 -46.12 99.83 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.56 0.695 . . . . 0.0 110.823 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 422' ' ' MET . 64.5 Cg_exo -47.94 -39.63 32.48 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.71 2.273 . . . . 0.0 112.31 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . 0.574 ' CE2' ' HA ' ' A' ' 458' ' ' ALA . 73.4 m-85 -68.23 -35.67 78.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.905 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 172.16 -173.84 45.29 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.487 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -73.94 114.56 12.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.86 0.362 . . . . 0.0 110.905 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 98.2 t -84.79 124.4 39.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.153 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 17.1 t -70.93 -54.05 19.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.08 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 14.6 m -148.63 136.57 20.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.859 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -144.35 134.46 24.15 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.132 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . 0.423 ' CG ' ' N ' ' A' ' 432' ' ' VAL . 20.6 tttt -159.97 159.29 32.02 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.888 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.423 ' N ' ' CG ' ' A' ' 431' ' ' LYS . 38.8 t -111.03 144.64 18.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.165 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . 0.554 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 7.5 m-85 -91.98 152.46 20.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.5 HG23 ' C ' ' A' ' 440' ' ' LEU . 64.2 mt -137.6 144.27 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.132 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -84.16 137.18 33.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.867 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.32 -30.0 61.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.881 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 28.8 tt0 -73.28 -49.54 27.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.905 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 25.6 p -85.65 -35.13 21.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.172 -179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 3.2 t30 71.85 31.02 2.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.824 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.5 ' C ' HG23 ' A' ' 434' ' ' ILE . 8.6 mt -135.95 153.08 51.53 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.893 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 440' ' ' LEU . 1.5 t -36.81 139.58 0.19 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.845 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.59 ' HB3' ' CE2' ' A' ' 444' ' ' PHE . 16.3 mtpt -86.56 20.29 2.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.852 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . 0.407 ' SG ' ' O ' ' A' ' 442' ' ' LYS . 0.9 OUTLIER 52.42 25.13 3.32 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.819 179.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . 0.59 ' CE2' ' HB3' ' A' ' 442' ' ' LYS . 1.1 p90 -161.71 145.65 12.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.876 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -139.25 179.16 18.94 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.534 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . 0.432 ' CD1' ' CE1' ' A' ' 404' ' ' PHE . 26.7 t80 -116.93 150.59 38.25 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.888 0.375 . . . . 0.0 110.875 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . . . . . . . . . 21.0 t -153.91 143.15 13.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.117 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 99.8 p -139.05 141.85 38.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.865 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . 0.537 ' CE1' HD12 ' A' ' 403' ' ' LEU . 3.2 m-85 -108.92 175.18 5.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.912 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -69.59 -20.21 63.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.821 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 1.4 p30 -153.95 155.69 31.39 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.687 0.756 . . . . 0.0 110.836 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -72.91 -15.65 26.28 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.686 2.258 . . . . 0.0 112.319 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 97.3 t -74.74 -43.09 47.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.134 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 1.9 t -75.61 -41.95 53.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.886 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -47.76 -42.78 26.45 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.153 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 17.5 mm-40 -59.16 -46.44 88.38 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.925 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -37.75 -44.34 0.72 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.1 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . 0.574 ' HA ' ' CE2' ' A' ' 424' ' ' PHE . . . -64.28 -69.73 0.27 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.157 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . 0.595 HD11 HD23 ' A' ' 403' ' ' LEU . 93.9 mt -40.33 -47.43 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.167 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 459' ' ' ILE . 40.7 mt-30 -38.04 -51.7 1.39 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.89 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 17.4 t -93.94 -54.87 3.43 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.839 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . 0.463 ' O ' ' N ' ' A' ' 465' ' ' PHE . 77.5 mmm -43.7 -51.46 7.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.872 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . 0.402 ' C ' ' O ' ' A' ' 462' ' ' MET . 36.7 t-20 -38.17 105.5 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.921 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 472' ' ' LEU . . . 78.92 33.59 36.55 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.508 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . 0.463 ' N ' ' O ' ' A' ' 462' ' ' MET . 83.2 t80 -73.92 117.97 16.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.81 0.338 . . . . 0.0 110.907 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 5.2 tm0? -66.32 104.55 1.23 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.953 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 12.4 tt -117.65 139.33 45.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.114 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 49.54 -95.93 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.472 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 6.5 ptp -131.43 0.42 4.06 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.853 0.359 . . . . 0.0 110.914 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.7 172.93 11.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.881 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 48.2 mtt85 -100.91 167.32 10.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.887 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . 0.435 ' O ' ' N ' ' A' ' 464' ' ' GLY . 58.5 mt -114.81 152.98 31.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.005 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -130.69 106.62 8.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . 0.488 HG12 HG12 ' A' ' 459' ' ' ILE . 15.6 t -112.44 131.88 62.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.121 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -154.4 137.77 15.82 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . 0.626 HD12 ' C ' ' A' ' 476' ' ' LEU . 1.6 pp -79.5 132.84 36.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.856 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 476' ' ' LEU . 55.7 tttt -35.92 102.16 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.886 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 32.8 ttt-85 -118.25 100.45 7.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.9 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 84.3 p -41.88 146.44 0.27 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.875 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -55.77 -51.87 65.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.861 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . 0.428 HD21 ' N ' ' A' ' 484' ' ' LYS . 0.4 OUTLIER -108.87 114.78 28.85 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.916 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . 0.418 ' OD1' ' C ' ' A' ' 482' ' ' ASP . 0.0 OUTLIER -93.03 -49.21 6.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.831 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 2.9 m -134.29 99.61 4.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.773 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . 0.428 ' N ' HD21 ' A' ' 481' ' ' ASN . 7.2 ptmm? -59.07 121.85 12.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.913 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 29.2 t -129.21 81.49 2.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.87 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 63.32 146.07 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.501 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -46.68 120.87 4.3 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.63 2.22 . . . . 0.0 112.379 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 64.2 p -73.28 145.72 45.89 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.884 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 41.2 p -89.06 123.0 32.95 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.832 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.261 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.44 -179.957 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 N-CA-C 112.547 -0.221 . . . . 0.0 112.547 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 8.8 t -77.49 129.54 35.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.857 0.36 . . . . 0.0 110.85 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 24.8 p -146.85 140.42 25.73 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.866 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -125.15 135.19 9.23 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.52 -179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 5.8 m -115.89 97.71 6.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.834 0.35 . . . . 0.0 110.857 -179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 8.5 t -104.17 41.08 1.35 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.902 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . 0.425 ' O ' ' C ' ' A' ' 383' ' ' LEU . . . 161.24 -106.28 0.28 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.444 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . 0.425 ' C ' ' O ' ' A' ' 382' ' ' GLY . 69.4 mt 36.04 39.37 0.08 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.929 0.395 . . . . 0.0 110.982 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 15.1 t -90.83 157.96 17.08 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.2 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 13.1 mm-40 -84.57 127.22 33.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.903 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -84.33 178.3 7.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.889 -179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . 0.481 ' C ' HD12 ' A' ' 388' ' ' ILE . 78.1 p -105.31 123.02 47.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.844 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.541 ' N ' HD12 ' A' ' 388' ' ' ILE . 3.2 mp -117.62 101.94 12.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.096 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -100.34 48.58 1.18 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.498 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -91.92 -28.43 17.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.812 0.339 . . . . 0.0 111.147 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -56.58 103.44 0.11 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.149 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 98.98 -39.34 2.77 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.442 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 14.9 m -46.92 123.06 4.81 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.827 0.346 . . . . 0.0 110.841 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -93.57 25.81 3.33 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.907 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.497 ' O ' ' CB ' ' A' ' 429' ' ' SER . 9.8 ptmt -82.64 163.23 21.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.905 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -128.67 -175.73 3.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -100.48 -146.38 19.25 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.758 -0.735 . . . . 0.0 112.468 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.53 151.41 41.99 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.698 2.265 . . . . 0.0 112.314 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -51.46 104.01 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 130.58 -24.85 4.32 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.445 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . 0.494 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -98.02 126.98 43.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.815 0.341 . . . . 0.0 111.098 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 16.6 m-80 -158.98 164.29 35.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.874 -179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . 0.449 HD12 ' CE1' ' A' ' 449' ' ' TYR . 34.5 mt -158.05 124.83 4.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.917 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . 0.493 ' CZ ' ' CD1' ' A' ' 446' ' ' PHE . 35.5 m-85 -130.96 113.32 13.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.846 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . 0.657 HD12 ' N ' ' A' ' 405' ' ' ILE . 3.2 mp -90.75 136.09 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.122 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 62.4 m-85 -127.74 159.77 33.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.908 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 28.8 m-70 60.14 54.99 3.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.855 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.526 HD21 HG21 ' A' ' 405' ' ' ILE . 19.3 mt -93.8 140.73 23.1 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.534 0.683 . . . . 0.0 110.943 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.565 ' HG2' ' CE1' ' A' ' 412' ' ' PHE . 77.6 Cg_exo -49.83 -173.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.67 2.247 . . . . 0.0 112.334 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -96.3 -35.62 11.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.953 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 25.3 pm0 -76.16 -13.77 60.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.858 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.565 ' CE1' ' HG2' ' A' ' 409' ' ' PRO . 5.3 m-85 -71.81 129.05 37.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.87 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -120.31 -152.93 9.04 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.44 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -72.48 -57.88 3.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.743 0.306 . . . . 0.0 110.886 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -54.9 -51.97 64.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.886 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -42.29 -58.57 2.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.833 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . 0.503 HD11 HG12 ' A' ' 405' ' ' ILE . 44.8 tp -54.19 -45.8 72.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.927 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 18.2 tp -54.72 -55.39 30.36 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.865 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -72.89 -9.29 58.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.882 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -82.68 -20.85 35.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.898 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -115.18 -12.22 11.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.878 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.579 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 18.0 mtt -54.05 -45.84 98.9 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.611 0.719 . . . . 0.0 110.882 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.2 Cg_exo -48.05 -35.14 25.0 Favored 'Trans proline' 0 C--O 1.232 0.179 0 C-N-CA 122.613 2.208 . . . . 0.0 112.335 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . 0.536 ' CZ ' ' SD ' ' A' ' 462' ' ' MET . 72.2 m-85 -73.89 -30.18 62.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 167.63 -171.87 42.3 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.502 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -77.91 98.77 5.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.888 0.375 . . . . 0.0 110.878 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.501 HG13 HG13 ' A' ' 447' ' ' VAL . 90.6 t -67.98 114.97 5.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.12 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 17.8 t -66.18 -45.54 89.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.121 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . 0.497 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 30.8 t -135.87 144.58 45.67 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.821 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . 0.454 ' HB2' HG11 ' A' ' 427' ' ' VAL . . . -157.17 106.36 2.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.075 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . 0.42 ' C ' ' HD3' ' A' ' 431' ' ' LYS . 1.1 tmtp? -142.5 143.98 32.78 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.895 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 66.2 t -113.75 148.59 16.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.102 179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . 0.453 ' C ' ' HG3' ' A' ' 442' ' ' LYS . 2.9 m-85 -84.11 144.51 28.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.934 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.605 HG22 ' N ' ' A' ' 435' ' ' ASP . 14.7 mt -129.09 165.66 28.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.114 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . 0.605 ' N ' HG22 ' A' ' 434' ' ' ILE . 5.9 t0 -106.52 131.53 53.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.83 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 14.7 ttmt -86.73 33.26 0.65 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.872 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -125.19 -42.27 2.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.889 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . 0.405 ' O ' ' CG ' ' A' ' 439' ' ' ASN . 51.1 p -128.85 14.29 6.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.069 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . 0.405 ' CG ' ' O ' ' A' ' 438' ' ' THR . 1.5 p-10 45.75 30.65 0.86 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.933 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 31.8 mt -96.81 120.8 37.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.878 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 1.9 m -52.37 122.2 8.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.453 ' HG3' ' C ' ' A' ' 433' ' ' PHE . 4.7 mmtp -53.04 -174.85 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.898 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 30.4 p -112.96 32.3 5.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.879 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . 0.41 ' CE1' ' HB2' ' A' ' 433' ' ' PHE . 2.0 p90 -161.29 151.93 18.0 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.879 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -152.57 176.82 30.62 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.495 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . 0.502 ' O ' HG23 ' A' ' 447' ' ' VAL . 56.5 t80 -115.96 155.84 27.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.905 0.383 . . . . 0.0 110.885 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 446' ' ' PHE . 53.5 t -158.69 152.43 6.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.18 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 29.6 p -151.06 152.23 33.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.856 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . 0.544 ' HB2' ' HB2' ' A' ' 455' ' ' ALA . 4.5 m-85 -117.82 -177.51 3.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.895 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.48 -12.73 60.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.857 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . 0.459 ' OD1' ' N ' ' A' ' 451' ' ' ASN . 0.5 OUTLIER -159.25 159.99 28.66 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.627 0.727 . . . . 0.0 110.902 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . 0.405 ' N ' ' HB2' ' A' ' 401' ' ' ALA . 61.1 Cg_endo -75.23 -19.69 17.14 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.67 2.247 . . . . 0.0 112.379 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 60.3 t -72.94 -43.38 59.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.09 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 16.2 m -75.8 -44.7 39.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.873 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . 0.544 ' HB2' ' HB2' ' A' ' 449' ' ' TYR . . . -52.25 -34.88 48.07 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.152 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . 0.507 HE21 HD23 ' A' ' 476' ' ' LEU . 14.7 mm-40 -63.82 -44.35 93.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.904 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -41.8 -40.19 1.99 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.088 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . 0.478 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -62.39 -68.5 0.32 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.089 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . 0.444 ' O ' ' CB ' ' A' ' 463' ' ' ASN . 66.8 mt -45.71 -46.02 4.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.188 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -38.82 -50.48 1.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.899 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 2.8 m -97.12 -56.84 2.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.892 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . 0.536 ' SD ' ' CZ ' ' A' ' 424' ' ' PHE . 81.1 mmm -42.64 -45.44 4.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.853 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . 0.444 ' CB ' ' O ' ' A' ' 459' ' ' ILE . 9.5 t30 -43.89 108.19 0.11 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.869 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 78.32 30.49 49.85 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.466 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . 0.514 ' HB3' HD12 ' A' ' 472' ' ' LEU . 55.2 t80 -68.11 115.37 7.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.817 0.341 . . . . 0.0 110.894 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 18.6 tm0? -67.25 107.96 2.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.943 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . 0.469 HG23 ' O ' ' A' ' 467' ' ' ILE . 19.2 tt -126.22 126.31 69.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.108 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 64.26 -103.68 0.77 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.514 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 56.7 mtp -124.12 0.87 8.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.842 0.353 . . . . 0.0 110.9 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -131.18 -179.82 5.57 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.894 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 39.2 mtt-85 -112.68 164.39 13.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.881 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . 0.514 HD12 ' HB3' ' A' ' 465' ' ' PHE . 65.8 mt -103.09 152.34 21.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.9 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 17.9 tttm -130.31 99.94 5.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.885 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 3.2 t -108.82 140.63 26.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.169 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -157.07 147.48 21.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.921 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . 0.806 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.3 pp -94.25 127.21 39.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.923 -179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 476' ' ' LEU . 31.9 tttm -35.25 110.6 0.1 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 12.4 ttt180 -114.63 -46.16 2.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.857 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 70.5 m -61.43 133.83 56.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.826 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 12.9 mmmt -63.26 149.42 45.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.899 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -50.61 -47.33 58.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.904 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.79 143.9 45.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.825 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 2.7 m -53.6 108.09 0.31 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.916 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 33.6 tttm -64.92 89.79 0.08 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.92 179.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 20.2 m -146.04 133.5 20.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -172.14 166.0 38.76 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.555 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.06 -49.3 0.11 Allowed 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 122.674 2.25 . . . . 0.0 112.34 -179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 92.6 p -101.77 169.89 8.52 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.862 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 10.3 t -108.11 83.48 1.79 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.875 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.444 179.956 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.313 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 4.3 m -160.26 132.51 6.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.925 0.393 . . . . 0.0 110.845 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 21.8 t -91.31 98.08 11.5 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.883 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -51.17 120.95 10.27 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.437 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 15.2 t -95.37 -55.19 3.13 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.882 0.373 . . . . 0.0 110.839 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 12.2 t -61.89 130.81 47.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.792 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . -151.82 119.15 0.95 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.471 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . 0.637 HD12 ' O ' ' A' ' 383' ' ' LEU . 4.2 pp -85.53 31.5 0.59 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.903 0.383 . . . . 0.0 110.891 -179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 50.5 m -120.51 108.83 14.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.065 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -90.73 -59.09 2.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.902 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -117.03 125.5 51.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 12.8 t -119.57 113.63 21.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.883 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 5.3 mp -102.02 103.58 15.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.135 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -37.29 118.13 0.53 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.491 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -118.69 38.47 3.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.749 0.309 . . . . 0.0 111.048 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -107.87 105.14 14.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.075 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 99.99 38.45 3.6 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.465 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 1.1 t -129.35 129.38 44.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.777 0.323 . . . . 0.0 110.843 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -93.32 53.76 1.97 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.861 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -111.7 166.59 11.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.931 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -138.95 174.67 10.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.864 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -98.0 -145.27 18.6 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.51 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -74.57 153.33 43.99 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.736 2.291 . . . . 0.0 112.358 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 15.1 tm-20 -54.98 110.64 0.69 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.899 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 129.22 -27.7 4.2 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.8 -0.715 . . . . 0.0 112.474 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . 0.491 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.94 126.77 43.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.774 0.321 . . . . 0.0 111.086 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.6 OUTLIER -158.99 160.32 35.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.861 -179.918 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . 0.622 HD23 HD11 ' A' ' 459' ' ' ILE . 38.7 mt -159.61 114.24 2.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.902 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . 0.641 ' CZ ' ' CD1' ' A' ' 446' ' ' PHE . 42.6 m-85 -122.23 111.91 17.52 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.9 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . 0.623 HD12 ' N ' ' A' ' 405' ' ' ILE . 3.6 mp -91.65 134.99 28.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.152 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -124.56 169.29 12.05 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.922 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 57.47 44.43 21.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.832 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.445 HD21 HG21 ' A' ' 405' ' ' ILE . 30.4 mt -91.09 134.55 29.83 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.625 0.726 . . . . 0.0 110.886 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -48.77 -179.55 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.683 2.255 . . . . 0.0 112.377 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 26.8 mt-30 -85.16 -46.06 11.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.9 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -58.88 -36.04 73.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.925 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.472 ' CZ ' HD11 ' A' ' 467' ' ' ILE . 7.9 m-85 -55.4 116.91 3.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.844 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -107.48 -151.88 17.44 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.436 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.96 -44.22 40.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.779 0.323 . . . . 0.0 110.877 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . 0.407 ' O ' ' C ' ' A' ' 416' ' ' ASP . 3.4 mp0 -62.88 -56.88 13.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.923 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . 0.407 ' C ' ' O ' ' A' ' 415' ' ' GLN . 36.3 m-20 -36.99 -64.92 0.33 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.885 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . 0.43 HD21 HD13 ' A' ' 405' ' ' ILE . 17.5 tp -42.73 -46.5 5.14 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.958 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . 0.453 ' O ' ' CG ' ' A' ' 422' ' ' MET . 14.9 tp -63.69 -37.41 87.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.913 179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -80.44 -16.04 55.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.885 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 2.7 tpp -87.17 -30.43 21.03 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.881 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . 0.598 ' CE1' ' SD ' ' A' ' 462' ' ' MET . 4.6 m-85 -98.44 -25.55 14.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.876 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.546 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 0.3 OUTLIER -45.23 -47.94 33.17 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.541 0.686 . . . . 0.0 110.926 179.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.546 ' CD ' ' N ' ' A' ' 422' ' ' MET . 63.9 Cg_exo -47.95 -46.12 22.84 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.722 2.281 . . . . 0.0 112.408 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . 0.44 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 90.1 m-85 -64.57 -33.96 77.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.854 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 169.03 163.58 23.31 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.541 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -56.46 118.47 4.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.863 0.363 . . . . 0.0 110.906 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.563 HG11 ' HB2' ' A' ' 430' ' ' ALA . 41.7 t -88.19 123.98 41.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.171 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 65.1 t -75.8 -36.11 32.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.09 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . 0.445 ' O ' HG13 ' A' ' 447' ' ' VAL . 0.7 OUTLIER -142.39 143.14 32.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.859 -179.856 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . 0.563 ' HB2' HG11 ' A' ' 427' ' ' VAL . . . -160.82 111.68 1.8 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.151 179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 7.0 tmtt? -157.48 143.5 17.61 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.952 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 78.5 t -94.12 146.48 6.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.166 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . 0.456 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.4 m-30 -87.72 154.05 20.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.798 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.471 HG22 ' N ' ' A' ' 435' ' ' ASP . 46.4 mt -128.39 156.08 40.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.177 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . 0.471 ' N ' HG22 ' A' ' 434' ' ' ILE . 6.3 t0 -91.22 144.72 25.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.88 179.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 13.6 ttmm -89.62 -10.2 46.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.92 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 6.6 mm100 -94.57 -45.4 7.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.849 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 70.5 p -94.8 -36.46 11.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.129 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 72.98 39.18 0.65 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.899 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.441 ' O ' ' C ' ' A' ' 441' ' ' SER . 21.2 mt -130.99 127.5 38.49 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.936 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . 0.441 ' C ' ' O ' ' A' ' 440' ' ' LEU . 15.0 m -34.53 106.79 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.846 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.561 ' HD3' ' CE2' ' A' ' 444' ' ' PHE . 17.1 mttm -51.61 -174.98 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.942 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 26.8 p -107.15 38.21 2.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.929 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . 0.561 ' CE2' ' HD3' ' A' ' 442' ' ' LYS . 8.9 p90 -162.07 144.24 11.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.92 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -135.16 168.29 23.79 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.491 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . 0.641 ' CD1' ' CZ ' ' A' ' 404' ' ' PHE . 26.7 t80 -109.3 151.64 26.32 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.919 0.39 . . . . 0.0 110.913 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . 0.445 HG13 ' O ' ' A' ' 429' ' ' SER . 23.0 t -155.42 144.81 12.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.104 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 1.8 m -143.22 141.06 30.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.896 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . 0.599 ' CE1' HD12 ' A' ' 403' ' ' LEU . 6.1 m-85 -107.43 176.61 5.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.913 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -72.01 -29.65 64.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.882 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 51.6 p-10 -140.98 153.52 67.37 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.71 0.766 . . . . 0.0 110.871 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -73.39 0.12 8.46 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.716 2.277 . . . . 0.0 112.376 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 87.7 t -88.76 -37.66 10.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.131 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 22.9 t -78.88 -41.5 29.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.819 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -49.1 -37.0 20.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.177 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -62.25 -52.22 64.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.969 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -37.82 -45.67 0.86 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.106 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . 0.44 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -62.92 -62.96 1.37 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.108 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . 0.622 HD11 HD23 ' A' ' 403' ' ' LEU . 70.0 mt -47.43 -48.01 9.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.163 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . 0.436 ' C ' ' O ' ' A' ' 459' ' ' ILE . 49.7 mt-30 -34.35 -45.6 0.23 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.841 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 1.9 m -103.46 -56.27 2.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.882 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . 0.666 ' HB3' HG21 ' A' ' 474' ' ' VAL . 5.7 mmt -38.93 -45.74 1.22 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.875 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . 0.403 ' HB2' HG23 ' A' ' 459' ' ' ILE . 28.6 t-20 -59.8 89.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.904 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 114.16 -10.39 22.52 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.517 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -43.53 110.32 0.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.741 0.305 . . . . 0.0 110.945 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -63.22 105.75 0.77 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.863 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . 0.526 HG23 ' O ' ' A' ' 467' ' ' ILE . 15.4 tt -110.9 122.35 65.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.103 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 61.96 -100.42 0.29 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.568 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 9.7 mtt -120.13 -14.52 8.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.885 0.374 . . . . 0.0 110.842 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 31.2 pttt -117.16 179.47 4.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.933 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 50.1 mtt180 -107.23 173.44 6.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.863 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 94.4 mt -113.45 154.14 27.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.889 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -129.68 104.84 7.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.899 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . 0.666 HG21 ' HB3' ' A' ' 462' ' ' MET . 23.8 t -114.28 135.94 52.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.128 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . 0.477 ' NE2' ' NH2' ' A' ' 478' ' ' ARG . 28.6 tp60 -157.06 143.63 18.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.93 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . 0.728 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.5 pp -86.9 125.37 33.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.916 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.467 ' O ' HD12 ' A' ' 476' ' ' LEU . 26.0 tttm -34.09 116.78 0.31 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.912 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . 0.477 ' NH2' ' NE2' ' A' ' 475' ' ' GLN . 32.1 mtt85 -81.4 122.92 28.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.823 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 83.9 p -105.42 150.75 24.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.825 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -121.57 148.61 44.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.868 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -135.66 133.34 38.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.867 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -119.13 127.25 53.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.833 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 1.3 t -171.83 166.65 6.43 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.804 -179.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 16.8 ttmm -160.68 137.44 8.87 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.926 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 3.3 m -100.47 114.1 27.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.893 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -130.11 95.48 0.35 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.476 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -45.08 136.86 10.22 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.74 2.294 . . . . 0.0 112.357 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 44.2 m -82.75 -46.99 12.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.818 -179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 8.5 m -73.06 111.89 8.59 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.879 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.251 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.492 -180.0 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.322 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 63.1 m -114.01 106.24 14.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.883 0.373 . . . . 0.0 110.892 -179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 3.6 m -93.1 115.02 27.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.843 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -178.19 44.13 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.493 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 83.7 p -67.11 135.21 53.23 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.928 0.394 . . . . 0.0 110.843 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 10.5 t -128.63 147.19 50.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.94 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 81.28 84.11 0.75 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.516 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -115.25 107.99 15.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.893 0.378 . . . . 0.0 110.954 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . 0.433 ' O ' ' C ' ' A' ' 385' ' ' GLN . 26.0 m -90.67 89.2 7.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.161 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . 0.433 ' C ' ' O ' ' A' ' 384' ' ' THR . 7.4 pt20 35.32 42.52 0.11 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.913 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 7.5 mm100 -88.31 85.7 6.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.826 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 42.7 p -121.02 95.32 4.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.89 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.509 ' N ' HD12 ' A' ' 388' ' ' ILE . 4.5 mp -96.59 98.09 7.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.154 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -79.04 72.87 2.41 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.518 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -101.24 84.25 2.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.854 0.359 . . . . 0.0 111.101 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -133.7 120.39 20.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.099 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.41 ' CA ' ' HB2' ' A' ' 431' ' ' LYS . . . 97.07 -45.62 1.78 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.493 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 19.1 m -39.29 114.75 0.43 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.845 0.355 . . . . 0.0 110.904 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.432 ' CD ' ' O ' ' A' ' 394' ' ' GLN . 11.2 tm0? -88.25 28.29 1.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.956 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.414 ' O ' ' CB ' ' A' ' 429' ' ' SER . 18.8 mtpp -88.84 165.42 14.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.896 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -121.53 -177.44 3.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.85 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -103.74 -163.31 25.09 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.518 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . 0.401 ' HG2' ' O ' ' A' ' 450' ' ' ASP . 53.5 Cg_exo -49.45 157.84 2.0 Allowed 'Trans proline' 0 C--N 1.34 0.128 0 C-N-CA 122.683 2.255 . . . . 0.0 112.312 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -66.37 82.15 0.09 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.847 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 148.18 -18.2 1.36 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.495 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . 0.57 ' HB2' ' CA ' ' A' ' 452' ' ' PRO . . . -106.93 126.75 52.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.751 0.31 . . . . 0.0 111.08 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . 0.511 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.3 OUTLIER -158.14 169.41 24.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.895 -179.929 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . 0.578 HD12 ' CE1' ' A' ' 449' ' ' TYR . 16.3 mt -159.97 115.79 2.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.904 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . 0.545 ' CE1' ' CE1' ' A' ' 446' ' ' PHE . 25.3 m-85 -120.0 111.5 17.98 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.833 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . 0.676 HD12 ' N ' ' A' ' 405' ' ' ILE . 2.9 mp -91.01 136.01 25.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.16 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 8.8 m-85 -124.41 177.81 5.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.834 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . 0.462 ' N ' ' CD2' ' A' ' 407' ' ' HIS . 4.2 m170 47.74 54.2 10.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.885 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.409 ' HA ' ' HD3' ' A' ' 409' ' ' PRO . 30.5 mt -96.62 140.86 22.38 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.575 0.703 . . . . 0.0 110.929 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.561 ' HG2' ' CE1' ' A' ' 412' ' ' PHE . 77.0 Cg_exo -49.81 -173.53 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.691 2.261 . . . . 0.0 112.32 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -95.52 -29.58 14.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.932 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -78.67 -20.29 50.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.949 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.561 ' CE1' ' HG2' ' A' ' 409' ' ' PRO . 5.4 m-85 -64.91 128.49 35.99 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.799 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . 0.471 ' O ' HG21 ' A' ' 432' ' ' VAL . . . -117.68 -139.93 6.42 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.507 179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -88.01 -36.82 16.8 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.833 0.349 . . . . 0.0 110.898 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . 0.437 ' O ' ' N ' ' A' ' 418' ' ' LEU . 19.8 mm-40 -71.36 -58.26 3.69 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.913 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -37.96 -49.38 1.25 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.882 179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 53.0 tp -58.59 -40.96 84.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.914 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . 0.437 ' N ' ' O ' ' A' ' 415' ' ' GLN . 20.7 tp -64.93 -58.15 6.9 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.897 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -66.77 -8.95 31.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.925 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -87.69 -27.36 22.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.833 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . 0.492 ' CZ ' HG12 ' A' ' 405' ' ' ILE . 3.4 m-85 -110.32 6.61 22.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.827 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.582 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 13.5 mtt -73.4 -45.76 7.66 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.549 0.69 . . . . 0.0 110.876 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.582 ' CD ' ' N ' ' A' ' 422' ' ' MET . 63.9 Cg_exo -47.96 -28.8 10.77 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.674 2.249 . . . . 0.0 112.418 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . 0.422 ' CE2' ' HA ' ' A' ' 458' ' ' ALA . 81.7 m-85 -76.7 -34.06 58.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.924 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 164.35 -163.63 36.21 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.488 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 12.7 m-80 -72.68 134.77 45.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.889 0.376 . . . . 0.0 110.855 -179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 18.7 t -107.97 116.84 52.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.17 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . 0.526 HG12 ' OG ' ' A' ' 429' ' ' SER . 31.4 t -68.22 -55.34 16.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.181 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . 0.526 ' OG ' HG12 ' A' ' 428' ' ' VAL . 0.9 OUTLIER -136.75 148.61 47.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.854 -179.864 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -161.06 120.1 2.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.117 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . 0.41 ' HB2' ' CA ' ' A' ' 392' ' ' GLY . 0.4 OUTLIER -161.09 141.88 11.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.92 179.948 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.471 HG21 ' O ' ' A' ' 413' ' ' GLY . 84.0 t -86.99 153.91 3.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.159 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . 0.556 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.3 m-30 -97.53 150.77 20.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.934 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.506 HG22 ' N ' ' A' ' 435' ' ' ASP . 43.0 mt -124.67 158.7 31.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.149 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . 0.506 ' N ' HG22 ' A' ' 434' ' ' ILE . 2.1 t70 -96.31 129.84 43.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.886 179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 25.0 tptt -77.52 6.66 6.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.909 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 11.1 tm0? -107.9 -51.86 2.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.89 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 16.2 p -91.61 -24.86 19.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.168 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 34.3 m120 65.25 36.98 6.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.855 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.437 ' O ' ' C ' ' A' ' 441' ' ' SER . 9.1 mt -130.94 125.92 34.7 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.953 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 440' ' ' LEU . 12.4 p -34.49 110.91 0.1 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.853 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.559 ' HD3' ' CE2' ' A' ' 444' ' ' PHE . 28.5 mttt -54.36 -174.81 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.917 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 31.3 p -106.22 36.66 2.51 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.866 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . 0.559 ' CE2' ' HD3' ' A' ' 442' ' ' LYS . 4.9 p90 -160.07 143.16 13.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.881 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -129.83 177.39 18.15 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.503 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . 0.545 ' CE1' ' CE1' ' A' ' 404' ' ' PHE . 20.2 t80 -119.35 152.67 36.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.956 0.408 . . . . 0.0 110.899 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 446' ' ' PHE . 77.9 t -159.03 153.75 5.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.063 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . 0.416 ' N ' HG12 ' A' ' 447' ' ' VAL . 79.0 p -151.53 144.35 24.42 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.857 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . 0.578 ' CE1' HD12 ' A' ' 403' ' ' LEU . 15.3 m-85 -107.84 -176.02 2.94 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.936 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . 0.401 ' O ' ' HG2' ' A' ' 398' ' ' PRO . 0.4 OUTLIER -79.75 -16.72 55.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.937 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -150.93 155.15 35.12 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.608 0.718 . . . . 0.0 110.863 -179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . 0.57 ' CA ' ' HB2' ' A' ' 401' ' ' ALA . 60.3 Cg_endo -73.95 -13.87 23.9 Favored 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.733 2.289 . . . . 0.0 112.378 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 37.2 t -78.89 -37.52 20.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.087 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 11.4 p -74.88 -50.95 15.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.887 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -40.84 -39.74 1.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.062 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . 0.4 ' O ' ' C ' ' A' ' 457' ' ' ALA . 45.6 mm-40 -56.66 -50.74 71.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.897 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . 0.4 ' C ' ' O ' ' A' ' 456' ' ' GLN . . . -36.91 -43.68 0.46 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.139 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . 0.422 ' HA ' ' CE2' ' A' ' 424' ' ' PHE . . . -62.81 -66.1 0.59 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.144 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . 0.443 ' O ' ' CB ' ' A' ' 463' ' ' ASN . 73.7 mt -46.94 -41.92 5.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.082 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 44.2 mm-40 -44.18 -49.14 9.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.9 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 45.2 t -98.12 -57.02 2.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.826 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . 0.404 ' O ' ' N ' ' A' ' 465' ' ' PHE . 91.8 mmm -40.9 -47.6 2.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.882 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' A' ' 459' ' ' ILE . 26.5 t-20 -44.78 106.17 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.914 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 82.74 27.06 43.5 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.477 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . 0.404 ' N ' ' O ' ' A' ' 462' ' ' MET . 10.9 t80 -66.59 117.59 8.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.81 0.338 . . . . 0.0 110.844 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 11.6 tm0? -64.8 118.09 8.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.911 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . 0.556 HG23 ' O ' ' A' ' 467' ' ' ILE . 14.4 tt -140.58 120.71 13.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.097 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 69.07 -104.26 1.23 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.487 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 24.6 ttp -131.25 12.53 5.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.841 0.353 . . . . 0.0 110.875 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -138.81 -179.15 5.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.89 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 57.9 mtm180 -108.48 163.13 13.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.898 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . 0.422 HD23 ' O ' ' A' ' 407' ' ' HIS . 53.7 mt -109.85 148.99 30.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.879 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 1.9 tppp? -124.46 128.28 48.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.871 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . 0.429 HG12 HG12 ' A' ' 459' ' ' ILE . 32.5 t -133.95 133.81 56.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.09 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -157.13 136.34 11.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.905 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . 0.676 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.5 pp -79.19 128.61 33.52 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.937 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.431 ' C ' ' O ' ' A' ' 476' ' ' LEU . 46.7 tttm -34.67 109.28 0.08 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.915 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . 0.464 ' HG3' ' N ' ' A' ' 479' ' ' SER . 14.6 tpp180 -41.36 150.19 0.1 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.834 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . 0.464 ' N ' ' HG3' ' A' ' 478' ' ' ARG . 5.0 t -147.38 157.3 43.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.821 -179.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . 0.412 ' O ' ' C ' ' A' ' 481' ' ' ASN . 24.9 mttp -98.23 -51.77 3.89 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.893 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 480' ' ' LYS . 16.7 m120 -37.12 115.63 0.4 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.91 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -79.21 -55.05 5.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 4.9 t -174.81 109.52 0.12 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.845 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 13.8 tmtt? -143.91 126.33 15.82 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.879 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 3.2 t -166.62 166.46 16.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.847 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 132.97 152.29 6.88 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.539 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -77.16 139.54 19.05 Favored 'Trans proline' 0 N--CA 1.465 -0.175 0 C-N-CA 122.597 2.198 . . . . 0.0 112.403 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 91.6 p -79.68 117.28 20.45 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.831 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 73.0 p -74.55 91.36 2.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.847 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.515 -179.926 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.317 0 N-CA-C 112.427 -0.269 . . . . 0.0 112.427 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 53.8 p -149.73 153.09 36.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.898 0.38 . . . . 0.0 110.876 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 20.4 m -112.06 157.92 20.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.877 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -68.41 113.5 5.37 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.44 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 48.3 m -155.36 169.2 24.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 110.819 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 2.6 m -134.18 164.34 27.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.911 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 137.53 72.51 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.553 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . 0.438 ' C ' HD12 ' A' ' 383' ' ' LEU . 3.5 pp -53.27 -33.04 51.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.837 0.351 . . . . 0.0 110.88 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 15.2 t -105.17 153.19 21.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.133 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -129.86 165.92 21.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.951 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -134.54 134.85 41.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.933 -179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 39.7 m -106.22 44.27 1.06 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.866 -179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 54.7 mt -98.92 119.27 46.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.166 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -89.04 108.9 3.51 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.471 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . 0.474 ' HB1' ' HA ' ' A' ' 429' ' ' SER . . . -101.1 70.88 1.37 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.805 0.336 . . . . 0.0 111.119 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . 0.402 ' HB1' ' CB ' ' A' ' 414' ' ' ASP . . . -106.47 -44.24 4.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.034 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . -120.41 39.38 2.46 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.695 -0.765 . . . . 0.0 112.521 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 52.3 m -97.34 125.03 41.69 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.825 0.345 . . . . 0.0 110.857 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -91.24 -9.88 43.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.848 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.406 ' HB2' ' NZ ' ' A' ' 395' ' ' LYS . 0.0 OUTLIER -68.21 170.7 8.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.919 179.948 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -142.74 -177.59 5.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.922 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -83.49 -147.01 7.2 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.521 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.9 151.53 40.14 Favored 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.721 2.28 . . . . 0.0 112.309 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 49.4 tt0 -52.37 107.83 0.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.932 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 131.32 -28.57 3.6 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.463 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . 0.495 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.86 126.83 43.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.749 0.309 . . . . 0.0 111.07 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . 0.496 ' O ' ' CB ' ' A' ' 476' ' ' LEU . 0.6 OUTLIER -158.83 163.72 36.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.82 -179.932 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . 0.553 HD12 ' CE1' ' A' ' 449' ' ' TYR . 23.7 mt -160.35 108.03 1.62 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.899 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . 0.571 ' C ' HD13 ' A' ' 405' ' ' ILE . 5.3 m-85 -111.83 117.41 32.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.871 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . 0.826 HD12 HG22 ' A' ' 474' ' ' VAL . 1.4 mm -90.88 135.49 26.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.103 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . 0.452 ' C ' ' CD2' ' A' ' 407' ' ' HIS . 81.6 m-85 -126.57 148.89 49.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.932 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . 0.474 ' N ' ' O ' ' A' ' 443' ' ' CYS . 12.6 m-70 71.66 54.66 0.2 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.872 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 31.6 mt -100.38 132.49 22.42 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 121.637 0.732 . . . . 0.0 110.932 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -47.84 178.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.722 2.282 . . . . 0.0 112.376 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . 0.453 ' NE2' ' HB3' ' A' ' 440' ' ' LEU . 18.9 tp60 -88.16 -39.09 14.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.938 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -60.18 -36.96 78.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -53.98 150.79 7.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.865 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -138.24 -145.34 4.82 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.494 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . 0.402 ' CB ' ' HB1' ' A' ' 391' ' ' ALA . 16.4 m-20 -79.72 -59.65 2.66 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.761 0.315 . . . . 0.0 110.934 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 -58.0 -53.76 54.6 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.916 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -38.89 -49.8 1.68 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.858 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . 0.4 HD21 ' CG2' ' A' ' 447' ' ' VAL . 40.8 tp -59.47 -49.41 77.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.903 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 54.9 tp -56.92 -56.01 27.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.925 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -60.24 -12.07 7.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.983 179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 4.9 ttm -92.94 -23.59 18.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.904 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -109.97 6.6 23.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.586 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 4.6 mtt -75.55 -45.78 4.29 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.622 0.725 . . . . 0.0 110.879 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.0 Cg_exo -47.97 -46.68 21.22 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.7 2.267 . . . . 0.0 112.325 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -59.4 -35.73 74.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.838 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 172.75 -171.9 44.67 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.501 -179.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -81.53 102.59 10.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.842 0.353 . . . . 0.0 110.925 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 62.0 t -72.77 134.15 30.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.158 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . 0.562 HG12 ' OG ' ' A' ' 429' ' ' SER . 17.9 t -79.05 -48.5 21.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.107 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . 0.562 ' OG ' HG12 ' A' ' 428' ' ' VAL . 1.3 m -146.69 143.44 28.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.842 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -153.86 116.95 4.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.172 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -150.61 137.93 19.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.896 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.451 HG12 ' N ' ' A' ' 433' ' ' PHE . 57.8 t -87.3 155.25 3.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.105 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . 0.539 ' CG ' ' CE1' ' A' ' 444' ' ' PHE . 3.1 m-85 -95.75 148.03 23.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.869 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.522 HG22 ' N ' ' A' ' 435' ' ' ASP . 30.7 mt -121.74 161.04 22.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.071 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . 0.522 ' N ' HG22 ' A' ' 434' ' ' ILE . 2.5 t70 -102.75 133.07 48.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.813 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 4.1 tppt? -80.07 0.16 33.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.963 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -99.23 -42.47 7.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.875 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 68.0 p -104.28 -21.84 13.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.183 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 68.3 m-20 64.45 39.25 7.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.938 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.453 ' HB3' ' NE2' ' A' ' 410' ' ' GLN . 22.4 mt -134.54 135.12 42.09 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.945 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 52.0 p -40.34 111.77 0.23 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.883 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.556 ' HD3' ' CE2' ' A' ' 444' ' ' PHE . 15.7 mttm -51.8 -175.23 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.876 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . 0.474 ' O ' ' N ' ' A' ' 407' ' ' HIS . 26.6 p -101.55 33.86 2.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.902 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . 0.556 ' CE2' ' HD3' ' A' ' 442' ' ' LYS . 11.1 p90 -160.53 145.7 14.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.851 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -133.16 176.39 19.6 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.521 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -121.23 141.45 50.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.963 0.411 . . . . 0.0 110.818 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . 0.4 ' CG2' HD21 ' A' ' 417' ' ' LEU . 54.7 t -148.69 147.41 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.169 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 51.7 p -142.53 149.99 39.85 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.93 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . 0.553 ' CE1' HD12 ' A' ' 403' ' ' LEU . 3.3 m-85 -113.11 -174.87 2.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.945 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 8.8 p30 -81.32 -19.23 43.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.939 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -154.41 154.95 30.29 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.608 0.718 . . . . 0.0 110.898 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . 0.456 ' N ' ' HB2' ' A' ' 401' ' ' ALA . 61.4 Cg_endo -75.72 -10.12 19.98 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.721 2.281 . . . . 0.0 112.359 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 97.8 t -82.63 -29.28 8.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.154 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 68.1 m -90.86 -35.44 14.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.791 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -57.14 -35.22 69.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.041 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 42.3 mm-40 -61.1 -38.93 88.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.911 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -47.81 -39.39 18.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.12 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . . . . . . . . . . . -64.38 -68.4 0.36 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.081 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . 0.52 HG12 HG12 ' A' ' 474' ' ' VAL . 95.2 mt -42.5 -45.32 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.206 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 66.7 mm-40 -41.87 -45.28 3.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.92 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 2.9 t -101.47 -57.01 2.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.855 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . 0.41 ' O ' ' N ' ' A' ' 465' ' ' PHE . 91.8 mmm -43.77 -44.68 6.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.911 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . 0.463 ' CB ' ' O ' ' A' ' 459' ' ' ILE . 19.4 t-20 -44.95 108.0 0.11 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.877 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 82.1 25.45 52.02 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.444 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . 0.507 ' HB3' HD12 ' A' ' 472' ' ' LEU . 18.0 t80 -64.34 109.25 1.85 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.809 0.337 . . . . 0.0 110.882 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 7.4 tm0? -63.12 114.79 3.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.875 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . 0.478 HG23 ' O ' ' A' ' 467' ' ' ILE . 17.9 tt -127.59 126.48 67.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.179 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 61.11 -96.79 0.11 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.467 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 33.0 ttp -129.44 -5.4 4.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.879 0.371 . . . . 0.0 110.896 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 15.6 pttm -121.45 176.23 5.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.871 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 28.1 mtm180 -108.56 169.3 8.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.925 179.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . 0.507 HD12 ' HB3' ' A' ' 465' ' ' PHE . 93.3 mt -115.54 158.32 22.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.904 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 33.8 tttp -137.76 107.54 6.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.928 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . 0.826 HG22 HD12 ' A' ' 405' ' ' ILE . 61.5 t -109.51 135.04 49.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.074 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 5.6 tp60 -156.38 139.81 15.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.871 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . 0.631 HD12 ' C ' ' A' ' 476' ' ' LEU . 1.6 pp -83.5 129.91 34.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.563 ' HB2' ' CE1' ' A' ' 404' ' ' PHE . 59.2 tttt -33.72 111.5 0.11 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.933 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . 0.452 ' O ' ' C ' ' A' ' 479' ' ' SER . 16.4 mmt180 -103.69 83.05 2.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.813 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . 0.452 ' C ' ' O ' ' A' ' 478' ' ' ARG . 23.0 m -34.53 -46.06 0.26 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.872 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.72 95.28 5.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.921 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -75.62 -52.66 10.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.943 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -59.05 -178.83 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.883 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 38.5 t -175.02 127.73 0.28 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.871 -179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 36.9 tttm -162.9 152.61 15.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.897 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 17.9 p -157.11 170.75 21.8 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.913 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -156.38 144.07 10.41 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.49 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -47.09 135.27 18.68 Favored 'Trans proline' 0 C--O 1.231 0.126 0 C-N-CA 122.631 2.22 . . . . 0.0 112.375 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 46.5 m -71.51 94.1 1.25 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.887 -179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 78.1 p -151.46 120.09 6.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.861 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.309 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.493 -179.971 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 N-CA-C 112.469 -0.253 . . . . 0.0 112.469 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 68.1 m -147.61 137.66 22.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.8 0.333 . . . . 0.0 110.912 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 88.4 p -120.85 160.5 23.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.791 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -111.49 -101.54 2.6 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.545 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 77.8 p -148.94 122.09 8.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.844 0.354 . . . . 0.0 110.851 -179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 15.7 m -102.65 160.39 14.62 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . 0.545 ' O ' HG23 ' A' ' 384' ' ' THR . . . 39.51 -110.03 0.14 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.56 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 11.7 mt 46.88 48.64 15.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.901 0.382 . . . . 0.0 110.897 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . 0.545 HG23 ' O ' ' A' ' 382' ' ' GLY . 74.9 p -121.11 115.77 23.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.129 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -82.58 -58.55 2.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.009 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 20.6 mp0 -117.66 101.97 8.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.917 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 3.6 t -88.4 51.35 2.16 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.845 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 41.6 mm -55.18 127.57 14.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.161 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -120.47 81.55 0.34 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.458 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . 0.422 ' O ' ' C ' ' A' ' 391' ' ' ALA . . . -64.33 -54.86 26.34 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.828 0.346 . . . . 0.0 111.17 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . 0.437 ' CB ' ' OE1' ' A' ' 415' ' ' GLN . . . -35.9 120.61 0.62 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.131 179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 83.52 52.22 3.81 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.455 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 56.6 m -137.91 129.51 28.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.764 0.316 . . . . 0.0 110.901 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . 0.448 ' HG2' ' HZ1' ' A' ' 431' ' ' LYS . 0.0 OUTLIER -101.59 72.13 1.37 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.882 -179.925 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.421 ' O ' ' CB ' ' A' ' 429' ' ' SER . 13.8 ptpt -141.07 163.64 32.42 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.9 179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . 0.474 ' HA ' ' CB ' ' A' ' 448' ' ' SER . 15.2 pt-20 -131.48 -176.44 4.03 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.916 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -99.82 -146.87 20.6 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.52 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -73.07 150.85 49.01 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.722 2.281 . . . . 0.0 112.358 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -50.89 97.93 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.874 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 137.61 -25.24 2.99 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.432 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . 0.486 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -98.21 126.84 43.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.836 0.35 . . . . 0.0 111.131 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . 0.486 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 22.0 m-80 -159.17 161.29 36.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.903 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . 0.608 HD12 ' CE1' ' A' ' 449' ' ' TYR . 27.7 mt -159.76 113.8 2.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.944 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . 0.766 ' CZ ' ' CD1' ' A' ' 446' ' ' PHE . 46.6 m-85 -123.02 113.68 19.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . 0.645 HD11 ' CZ ' ' A' ' 421' ' ' PHE . 4.6 mp -90.97 136.89 22.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.097 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . 0.442 ' CD2' ' O ' ' A' ' 473' ' ' LYS . 10.9 m-85 -127.69 153.69 46.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.962 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 51.4 m-70 69.29 52.64 0.47 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.856 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . . . . . . . . . 19.4 mt -96.13 131.85 27.99 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.594 0.712 . . . . 0.0 110.918 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -48.16 167.9 0.1 OUTLIER 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.678 2.252 . . . . 0.0 112.362 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 13.9 tt0 -70.26 -44.06 69.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.977 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -61.46 -39.65 91.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.919 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -54.32 112.42 0.98 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.862 -179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -104.67 -140.15 10.3 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.475 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -80.51 -60.76 2.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.808 0.337 . . . . 0.0 110.897 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . 0.469 ' O ' ' N ' ' A' ' 418' ' ' LEU . 1.6 mp0 -53.72 -61.59 2.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.893 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 415' ' ' GLN . 35.3 m-20 -34.47 -58.76 0.48 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.841 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 66.2 tp -51.53 -41.83 61.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.9 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . 0.469 ' N ' ' O ' ' A' ' 415' ' ' GLN . 12.7 tp -67.64 -56.03 10.95 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.939 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 85.2 mm-40 -56.74 -13.14 2.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.971 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 3.0 tpp -86.23 -31.18 21.83 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.893 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . 0.645 ' CZ ' HD11 ' A' ' 405' ' ' ILE . 5.2 m-85 -95.38 -26.66 15.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.838 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.547 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 0.2 OUTLIER -46.14 -47.66 43.93 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.531 0.681 . . . . 0.0 110.846 179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.547 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.2 Cg_exo -47.96 -42.99 31.12 Favored 'Trans proline' 0 C--O 1.231 0.155 0 C-N-CA 122.717 2.278 . . . . 0.0 112.315 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . 0.408 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 64.6 m-85 -67.54 -35.06 78.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.878 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 172.08 -169.35 42.46 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.49 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -75.99 122.25 23.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.803 0.335 . . . . 0.0 110.921 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.495 HG11 ' HB2' ' A' ' 430' ' ' ALA . 84.1 t -95.15 115.23 33.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.191 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 54.1 t -69.4 -43.29 81.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.132 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 1.5 t -134.53 144.07 47.79 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.845 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . 0.495 ' HB2' HG11 ' A' ' 427' ' ' VAL . . . -161.07 107.11 1.41 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.139 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . 0.448 ' HZ1' ' HG2' ' A' ' 394' ' ' GLN . 0.1 OUTLIER -153.29 149.72 28.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 72.9 t -103.76 142.1 18.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.097 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . 0.51 ' CG ' ' CE1' ' A' ' 444' ' ' PHE . 3.1 m-85 -81.88 153.0 26.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.875 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.48 ' N ' ' HD2' ' A' ' 442' ' ' LYS . 69.4 mt -128.1 155.53 39.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.062 -179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . 0.461 ' N ' HG22 ' A' ' 434' ' ' ILE . 3.6 m-20 -87.54 152.1 22.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.881 179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.58 -23.73 15.38 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -88.14 -28.13 21.45 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.958 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . 0.425 ' HB ' HD12 ' A' ' 440' ' ' LEU . 75.5 p -109.22 -34.88 6.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.135 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 67.75 42.32 2.02 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.934 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' A' ' 441' ' ' SER . 10.1 mt -132.17 127.17 35.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . 0.432 ' C ' ' O ' ' A' ' 440' ' ' LEU . 36.6 p -34.87 106.03 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.852 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.555 ' HD3' ' CE2' ' A' ' 444' ' ' PHE . 19.3 mttm -51.69 -174.9 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.836 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 72.0 m -110.43 38.15 2.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.822 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . 0.555 ' CE2' ' HD3' ' A' ' 442' ' ' LYS . 5.4 p90 -162.18 137.62 7.31 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.842 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -131.73 169.67 21.88 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.739 -0.744 . . . . 0.0 112.498 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . 0.766 ' CD1' ' CZ ' ' A' ' 404' ' ' PHE . 22.2 t80 -111.54 150.01 30.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.859 0.361 . . . . 0.0 110.918 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . 0.468 HG13 HG13 ' A' ' 427' ' ' VAL . 85.5 t -155.14 145.21 13.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.121 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . 0.474 ' CB ' ' HA ' ' A' ' 396' ' ' GLU . 1.9 m -144.42 140.85 29.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.91 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . 0.608 ' CE1' HD12 ' A' ' 403' ' ' LEU . 3.6 m-85 -102.94 179.79 4.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.942 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -75.82 -25.88 56.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.938 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -147.05 158.56 44.68 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.558 0.694 . . . . 0.0 110.912 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.65 -12.69 20.25 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.713 2.275 . . . . 0.0 112.3 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 92.4 t -77.37 -38.56 26.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.147 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 1.5 t -83.37 -39.61 20.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.882 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . 0.459 ' HB2' ' HB2' ' A' ' 449' ' ' TYR . . . -53.1 -43.23 66.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.076 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 14.6 mm-40 -59.08 -42.48 90.51 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.934 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -43.08 -38.84 2.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.126 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . 0.408 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -66.7 -61.74 1.81 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.121 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . . . . . . . . . 67.1 mt -47.53 -45.45 10.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.115 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -37.68 -47.77 1.0 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.877 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 2.8 m -103.03 -56.98 2.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.899 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . . . . . . . . . 88.4 mmm -39.72 -44.56 1.57 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.844 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -46.18 110.3 0.26 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.872 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 74.12 35.28 53.73 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.516 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . 0.417 ' CD1' ' C ' ' A' ' 465' ' ' PHE . 9.5 t80 -68.72 117.4 10.38 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.818 0.342 . . . . 0.0 110.905 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 11.2 tm0? -63.77 115.19 4.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.91 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 14.6 tt -138.11 132.94 43.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.094 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 51.25 -108.52 0.58 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.474 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 26.0 mtt -127.26 24.82 6.25 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.829 0.347 . . . . 0.0 110.844 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 7.8 pttt -142.43 -178.43 5.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.894 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 33.3 mtm-85 -125.13 121.91 35.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.911 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 45.0 mt -65.7 152.06 45.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.952 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . 0.442 ' O ' ' CD2' ' A' ' 406' ' ' TYR . 18.5 ttmm -132.6 100.49 4.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.88 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . 0.556 HG22 HG13 ' A' ' 405' ' ' ILE . 21.1 t -107.56 136.75 41.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.203 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -156.52 145.89 20.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.87 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . 0.786 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.4 pp -91.04 126.2 36.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 476' ' ' LEU . 16.9 ttpp -34.47 115.53 0.26 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.892 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . 0.468 ' HD2' ' CB ' ' A' ' 481' ' ' ASN . 13.5 tpp180 -81.15 94.47 6.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.854 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 65.3 m -111.72 109.88 19.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 -179.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 45.3 mtmt 40.69 41.47 1.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.875 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . 0.468 ' CB ' ' HD2' ' A' ' 478' ' ' ARG . 20.6 t-20 -52.98 -59.2 4.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.873 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -99.41 97.83 8.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 57.5 p -85.31 116.77 23.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.877 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 15.2 ttmm -161.01 124.42 3.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.978 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 90.3 p -107.54 130.28 54.88 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.913 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -85.27 147.78 22.64 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.449 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -45.61 121.22 3.85 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.662 2.241 . . . . 0.0 112.358 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 6.2 t -68.59 168.68 12.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.827 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 69.7 m -93.42 -44.0 8.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.854 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.334 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.506 -179.959 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 53.7 m -105.88 -58.23 1.94 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.875 0.369 . . . . 0.0 110.882 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 82.7 p -65.97 143.55 57.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.801 -179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . 162.4 -73.21 0.2 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.475 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 59.7 p -174.07 151.28 1.69 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.814 0.34 . . . . 0.0 110.923 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 12.2 p -116.66 -28.14 6.47 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.814 -179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 78.6 135.22 0.97 Allowed Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.506 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 7.4 mp -109.6 -63.09 1.41 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.913 0.387 . . . . 0.0 110.945 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . 0.492 ' O ' HG22 ' A' ' 384' ' ' THR . 13.8 m 52.77 44.36 30.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.09 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 14.3 tp60 -90.84 -46.01 8.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.886 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 19.8 tt0 -103.08 123.15 46.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.92 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 74.1 m -115.33 46.24 1.51 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.796 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 68.5 mt -116.74 102.78 14.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.129 179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -108.51 114.0 3.97 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.529 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . 0.699 ' HB3' HD13 ' A' ' 418' ' ' LEU . . . -81.96 88.5 6.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.731 0.3 . . . . 0.0 111.099 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -136.69 115.51 12.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.142 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.448 ' O ' ' C ' ' A' ' 393' ' ' SER . . . 98.77 -49.45 1.28 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.464 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . 0.448 ' C ' ' O ' ' A' ' 392' ' ' GLY . 3.3 m -34.72 145.18 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.759 0.314 . . . . 0.0 110.914 -179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -123.75 38.34 4.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.912 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.5 ' O ' ' CB ' ' A' ' 429' ' ' SER . 17.8 ptpt -103.66 157.31 17.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.856 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -109.71 -178.9 3.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.865 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -105.16 -155.45 22.52 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.555 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.13 157.58 8.25 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.729 2.286 . . . . 0.0 112.374 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -65.85 78.43 0.08 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.919 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 153.83 -16.69 0.63 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.456 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . 0.505 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -106.49 126.7 52.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.765 0.316 . . . . 0.0 111.111 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . 0.505 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.2 OUTLIER -158.15 168.91 25.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.884 -179.901 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . 0.497 HD12 ' CE1' ' A' ' 449' ' ' TYR . 27.7 mt -160.06 119.84 2.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.864 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . 0.535 ' CE1' ' HB2' ' A' ' 477' ' ' LYS . 15.0 m-85 -124.42 113.45 18.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.898 179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . 0.567 HD12 ' N ' ' A' ' 405' ' ' ILE . 3.4 mp -91.15 133.95 31.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.151 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -125.75 162.27 25.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.935 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . 0.491 ' N ' ' O ' ' A' ' 443' ' ' CYS . 25.0 m-70 61.01 54.61 3.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.908 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.534 HD21 HG21 ' A' ' 405' ' ' ILE . 30.3 mt -99.87 144.91 29.24 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.668 0.747 . . . . 0.0 110.838 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.578 ' HG2' ' CD1' ' A' ' 412' ' ' PHE . 61.5 Cg_endo -76.47 164.96 29.92 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.711 2.274 . . . . 0.0 112.274 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -69.35 -38.63 78.22 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.918 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -54.46 -36.48 64.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.578 ' CD1' ' HG2' ' A' ' 409' ' ' PRO . 4.7 m-85 -67.65 138.64 56.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.934 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -123.48 -137.0 4.88 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.474 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -87.81 -56.97 3.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.772 0.32 . . . . 0.0 110.909 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . 0.444 ' O ' ' N ' ' A' ' 418' ' ' LEU . 26.9 mm-40 -58.4 -57.03 14.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.95 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . 0.438 ' C ' ' O ' ' A' ' 415' ' ' GLN . 53.0 m-20 -34.87 -59.23 0.49 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.866 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . 0.403 HD11 HG12 ' A' ' 405' ' ' ILE . 51.5 tp -51.29 -42.63 61.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.906 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . 0.699 HD13 ' HB3' ' A' ' 390' ' ' ALA . 10.8 tp -65.84 -46.33 78.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.904 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -68.18 -16.24 63.91 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.973 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 2.0 ttt -85.35 -35.01 21.69 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.917 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . 0.468 ' CE1' ' SD ' ' A' ' 462' ' ' MET . 3.8 m-85 -92.69 -22.72 19.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.839 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.574 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 0.3 OUTLIER -50.87 -45.62 87.24 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.563 0.697 . . . . 0.0 110.96 179.951 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.4 Cg_exo -47.98 -38.84 32.17 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.662 2.242 . . . . 0.0 112.372 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . 0.503 ' CE2' ' HA ' ' A' ' 458' ' ' ALA . 78.1 m-85 -70.88 -35.28 72.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.898 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 164.58 -178.96 39.59 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.523 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 17.0 m-20 -61.86 135.11 57.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.812 0.339 . . . . 0.0 110.834 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.436 HG11 ' HB2' ' A' ' 430' ' ' ALA . 24.2 t -111.47 124.83 68.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.117 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 19.1 t -69.64 -50.35 50.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.209 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . 0.5 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 4.5 t -137.69 148.7 45.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.826 -179.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . 0.436 ' HB2' HG11 ' A' ' 427' ' ' VAL . . . -160.59 107.74 1.55 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.106 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 3.0 tmtt? -150.96 143.81 24.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.898 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.405 HG12 ' N ' ' A' ' 433' ' ' PHE . 99.3 t -94.43 152.49 3.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.048 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . 0.426 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.5 m-30 -89.68 154.06 20.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.931 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.48 ' N ' ' HD2' ' A' ' 442' ' ' LYS . 71.4 mt -136.48 152.0 28.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.15 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . 0.402 ' N ' HG22 ' A' ' 434' ' ' ILE . 3.9 m-20 -86.35 144.51 27.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.861 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 43.0 mttt -94.4 -8.4 38.8 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.85 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -99.98 -28.79 12.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.896 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 46.0 p -112.74 -28.87 7.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.162 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 66.28 31.37 8.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.918 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 47.9 mt -116.7 124.58 50.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.959 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 5.8 p -37.85 110.06 0.12 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.881 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.562 ' HD3' ' CE1' ' A' ' 444' ' ' PHE . 37.1 mttt -52.21 -174.95 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.942 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . 0.491 ' O ' ' N ' ' A' ' 407' ' ' HIS . 30.3 p -110.13 33.72 4.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.943 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . 0.562 ' CE1' ' HD3' ' A' ' 442' ' ' LYS . 8.2 p90 -161.89 147.55 13.37 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.939 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -138.36 179.07 18.78 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.524 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . 0.503 ' O ' ' CG2' ' A' ' 447' ' ' VAL . 55.6 t80 -118.79 153.71 34.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.831 0.348 . . . . 0.0 110.936 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . 0.503 ' CG2' ' O ' ' A' ' 446' ' ' PHE . 94.3 t -161.02 153.56 4.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.176 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . 0.417 ' N ' HG12 ' A' ' 447' ' ' VAL . 65.7 p -153.12 148.39 26.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.876 -179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . 0.497 ' CE1' HD12 ' A' ' 403' ' ' LEU . 5.9 m-85 -110.43 -174.93 2.6 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.966 -179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -78.22 -25.55 47.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.817 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 4.6 p30 -146.87 158.28 45.73 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.66 0.743 . . . . 0.0 110.898 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . 0.414 ' N ' ' HB2' ' A' ' 401' ' ' ALA . 61.2 Cg_endo -75.5 0.24 9.33 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.714 2.276 . . . . 0.0 112.317 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 75.5 t -88.5 -36.03 8.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.146 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 71.3 m -83.63 -39.94 19.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.88 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -50.66 -33.31 21.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.1 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 13.7 mm-40 -69.15 -45.55 69.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.895 -179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -41.6 -44.49 3.07 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.089 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . 0.503 ' HA ' ' CE2' ' A' ' 424' ' ' PHE . . . -63.85 -64.3 0.93 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.086 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . 0.41 ' O ' ' C ' ' A' ' 460' ' ' GLN . 65.9 mt -41.46 -47.15 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.171 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 459' ' ' ILE . 14.4 mm100 -36.89 -60.33 0.63 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.94 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 13.3 t -87.0 -52.93 5.16 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.884 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . 0.468 ' SD ' ' CE1' ' A' ' 421' ' ' PHE . 7.5 mmt -40.43 -56.86 1.93 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.902 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -42.45 107.27 0.08 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.912 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 80.12 32.92 34.13 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.507 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -75.77 110.96 10.63 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.775 0.322 . . . . 0.0 110.891 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 12.6 tm0? -63.08 102.9 0.41 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.918 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . 0.521 HD11 ' CE1' ' A' ' 412' ' ' PHE . 16.1 tt -115.27 144.52 22.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.154 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 46.68 -95.94 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.498 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 4.6 tpt -130.22 -3.47 4.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.791 0.329 . . . . 0.0 110.869 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 11.7 pttm -125.26 -178.53 4.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.88 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 66.9 mtm-85 -108.25 172.38 6.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.843 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 82.8 mt -120.52 156.92 30.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.952 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 32.4 tttp -136.15 105.03 5.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.898 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . 0.433 HG22 HG13 ' A' ' 405' ' ' ILE . 12.1 t -113.76 133.2 60.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.171 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -155.23 138.2 15.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.9 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . 0.635 HD12 ' C ' ' A' ' 476' ' ' LEU . 1.6 pp -79.03 129.14 34.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.896 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.535 ' HB2' ' CE1' ' A' ' 404' ' ' PHE . 31.8 tttt -34.04 99.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.909 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 28.1 ttm-85 -97.62 139.35 33.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.866 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 16.8 m -105.92 -61.89 1.44 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.797 -179.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -115.46 157.43 24.0 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.9 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -125.63 -47.92 1.68 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.823 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 24.8 p-10 -92.64 165.75 12.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.897 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . 0.417 ' O ' ' C ' ' A' ' 484' ' ' LYS . 2.7 t 40.96 40.18 0.97 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.905 -179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . 0.417 ' C ' ' O ' ' A' ' 483' ' ' SER . 8.6 tptm -36.54 -53.88 0.87 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.884 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 70.3 m -144.9 145.79 31.73 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.885 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -144.16 147.57 18.9 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.588 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -45.58 109.63 0.2 Allowed 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.704 2.269 . . . . 0.0 112.365 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 44.5 m -71.37 165.54 23.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.811 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 55.9 p -164.37 155.44 15.4 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.361 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.519 179.995 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 15.2 m -142.05 159.47 42.16 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.896 0.379 . . . . 0.0 110.884 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 80.3 p -158.22 140.28 14.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 -179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -166.31 66.36 0.2 Allowed Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.393 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 2.0 t -115.64 118.46 33.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.792 0.329 . . . . 0.0 110.849 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 62.0 p -102.65 80.03 1.87 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.823 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 49.03 -177.83 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.478 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -85.37 176.79 8.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.91 0.386 . . . . 0.0 110.903 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 6.9 t -108.76 -39.33 5.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.155 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 74.5 mt-30 -155.09 128.74 8.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.861 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 21.7 tm0? -61.0 -53.35 58.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.944 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 5.0 m -103.36 125.18 49.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.868 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . . . . . . . . . 5.3 mp -98.2 119.13 45.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.172 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -60.33 96.94 0.1 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.476 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -122.77 -49.61 1.98 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.778 0.323 . . . . 0.0 111.1 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -45.43 101.18 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.13 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 85.89 35.0 11.86 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.5 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 2.2 t -121.68 121.58 37.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.849 0.357 . . . . 0.0 110.828 -179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 5.2 mp0 -89.22 60.2 5.22 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.905 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . . . . . . . . . 4.1 ptmm? -126.12 176.24 7.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.861 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -148.18 179.01 8.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -98.47 -146.0 19.76 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.491 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.19 155.05 46.99 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.648 2.232 . . . . 0.0 112.317 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -55.12 118.75 4.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.87 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 120.21 -27.4 6.7 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.527 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . 0.493 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.97 126.95 43.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.769 0.318 . . . . 0.0 111.06 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . 0.493 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.7 OUTLIER -158.87 165.02 35.15 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.955 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . 0.5 HD12 ' CE1' ' A' ' 449' ' ' TYR . 15.5 mt -159.34 122.04 3.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.941 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . 0.465 ' CE1' ' CD1' ' A' ' 446' ' ' PHE . 29.1 m-85 -128.94 111.56 13.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.893 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . 0.736 HG21 HD21 ' A' ' 408' ' ' LEU . 3.9 mp -91.17 135.2 27.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.155 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . 0.424 ' CD1' ' HB2' ' A' ' 444' ' ' PHE . 89.5 m-85 -125.74 163.25 23.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.986 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . 0.421 ' N ' ' O ' ' A' ' 443' ' ' CYS . 29.2 m-70 61.48 52.98 3.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.843 179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.736 HD21 HG21 ' A' ' 405' ' ' ILE . 65.0 mt -92.24 128.92 43.13 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.571 0.7 . . . . 0.0 110.922 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -48.35 179.73 0.01 OUTLIER 'Trans proline' 0 N--CA 1.466 -0.126 0 C-N-CA 122.684 2.256 . . . . 0.0 112.33 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 23.8 tm0? -82.56 -41.28 19.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.899 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -65.75 -32.66 74.33 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.874 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.507 ' CE1' HD11 ' A' ' 467' ' ' ILE . 6.5 m-85 -59.88 138.72 57.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.899 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -137.05 -138.19 3.73 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.47 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -81.13 -61.09 2.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.704 0.288 . . . . 0.0 110.881 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -52.85 -53.72 44.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.954 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -41.36 -52.25 3.55 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.839 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . . . . . . . . . 25.1 tp -55.44 -54.96 37.3 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.89 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . 0.41 ' O ' ' CG ' ' A' ' 422' ' ' MET . 55.8 tp -50.3 -45.3 54.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.924 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -77.89 -9.06 58.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.89 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 1.5 tpt -87.88 -27.35 22.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.796 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -110.1 -18.57 13.31 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.849 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.576 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 0.2 OUTLIER -52.18 -46.14 93.8 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.599 0.714 . . . . 0.0 110.901 179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.576 ' CD ' ' N ' ' A' ' 422' ' ' MET . 64.1 Cg_exo -47.97 -37.24 29.26 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.654 2.236 . . . . 0.0 112.39 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . 0.464 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 69.5 m-85 -71.41 -35.8 71.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.859 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 174.06 -171.47 44.55 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.426 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -75.27 116.26 15.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.818 0.342 . . . . 0.0 110.874 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.473 HG11 ' HB2' ' A' ' 430' ' ' ALA . 88.0 t -87.44 120.56 36.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.117 179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 60.5 t -78.16 -43.6 27.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.127 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -132.73 139.17 47.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.833 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . 0.473 ' HB2' HG11 ' A' ' 427' ' ' VAL . . . -157.8 120.49 3.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.105 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . 0.45 ' CG ' ' N ' ' A' ' 432' ' ' VAL . 20.0 tttm -161.02 160.53 30.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.806 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.45 ' N ' ' CG ' ' A' ' 431' ' ' LYS . 41.0 t -119.18 140.2 43.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.172 179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . 0.56 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.1 m-85 -83.27 151.78 25.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.9 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . . . . . . . . . 84.3 mt -138.14 150.97 24.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.042 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -90.62 128.66 36.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.888 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 6.5 tppt? -72.08 -3.75 24.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.906 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 95.0 mm-40 -99.66 -47.43 5.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.89 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 27.5 p -92.4 -20.57 20.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.102 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 60.18 33.38 21.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.996 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 441' ' ' SER . 10.0 mt -135.22 145.37 47.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.925 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . 0.408 ' C ' ' O ' ' A' ' 440' ' ' LEU . 24.3 p -36.91 140.53 0.16 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.888 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.603 ' HB3' ' CE2' ' A' ' 444' ' ' PHE . 18.6 mttp -84.24 21.85 1.33 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.912 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . 0.421 ' O ' ' N ' ' A' ' 407' ' ' HIS . 0.8 OUTLIER 53.56 25.03 4.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.918 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . 0.603 ' CE2' ' HB3' ' A' ' 442' ' ' LYS . 0.9 OUTLIER -162.56 141.4 8.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.884 -179.854 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -135.6 175.66 20.62 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.48 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . 0.465 ' CD1' ' CE1' ' A' ' 404' ' ' PHE . 26.0 t80 -114.21 153.37 29.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.896 0.379 . . . . 0.0 110.873 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . 0.447 HG23 ' O ' ' A' ' 446' ' ' PHE . 79.0 t -158.1 154.83 5.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.086 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . 0.431 ' N ' HG12 ' A' ' 447' ' ' VAL . 2.1 m -153.69 145.12 23.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.867 -179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . 0.5 ' CE1' HD12 ' A' ' 403' ' ' LEU . 4.2 m-85 -108.48 -174.72 2.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.934 -179.869 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -78.5 -15.69 58.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.78 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . 0.451 ' OD1' ' N ' ' A' ' 451' ' ' ASN . 0.7 OUTLIER -158.69 160.17 29.41 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.598 0.713 . . . . 0.0 110.928 -179.918 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . 0.449 ' N ' ' HB2' ' A' ' 401' ' ' ALA . 60.9 Cg_endo -74.87 -18.13 19.34 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.674 2.249 . . . . 0.0 112.354 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 62.4 t -72.16 -42.78 66.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.105 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 41.8 m -80.8 -41.42 23.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.851 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . 0.458 ' HB2' ' HB2' ' A' ' 449' ' ' TYR . . . -50.51 -35.42 29.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.078 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . 0.401 ' O ' ' C ' ' A' ' 457' ' ' ALA . 14.1 mm-40 -66.73 -44.75 80.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.918 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . 0.401 ' C ' ' O ' ' A' ' 456' ' ' GLN . . . -37.48 -43.18 0.57 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.085 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . 0.464 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -61.43 -69.44 0.24 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.147 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . 0.448 ' O ' ' C ' ' A' ' 460' ' ' GLN . 79.6 mt -44.13 -48.76 2.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.171 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . 0.448 ' C ' ' O ' ' A' ' 459' ' ' ILE . 35.9 mm-40 -34.62 -42.79 0.16 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.895 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 2.1 m -103.93 -56.53 2.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.848 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . 0.443 ' O ' ' N ' ' A' ' 465' ' ' PHE . 82.8 mmm -43.22 -46.51 6.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.881 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -41.56 104.19 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.903 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 80.22 31.61 37.77 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.502 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . 0.443 ' N ' ' O ' ' A' ' 462' ' ' MET . 66.2 t80 -71.93 117.24 13.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.862 0.363 . . . . 0.0 110.823 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 12.3 tm0? -66.01 107.04 1.75 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.883 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . 0.507 HD11 ' CE1' ' A' ' 412' ' ' PHE . 20.1 tt -116.66 145.31 22.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.166 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 40.45 -95.56 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.49 179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . 0.43 ' N ' ' O ' ' A' ' 467' ' ' ILE . 12.8 tmm? -126.77 -9.89 6.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.905 0.383 . . . . 0.0 110.874 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -120.68 174.97 6.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 40.1 mtt180 -104.79 167.65 9.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.915 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . . . . . . . . . 65.1 mt -111.2 155.39 23.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.913 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 25.3 ttpt -132.95 104.66 6.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.836 179.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 4.3 t -109.9 138.34 38.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.216 179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . 0.444 ' NE2' ' HD2' ' A' ' 478' ' ' ARG . 11.6 tt0 -156.86 139.77 15.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.98 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . 0.77 HD12 ' O ' ' A' ' 477' ' ' LYS . 1.5 pp -85.79 126.59 34.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.846 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.77 ' O ' HD12 ' A' ' 476' ' ' LEU . 11.3 tptm -34.14 133.76 0.21 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.912 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . 0.444 ' HD2' ' NE2' ' A' ' 475' ' ' GLN . 0.0 OUTLIER -126.32 151.84 47.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.861 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 2.2 m -160.73 154.55 22.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.882 -179.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt -115.91 79.68 1.34 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.935 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -136.07 115.34 12.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.964 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -166.36 115.64 0.93 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.895 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 2.4 p -116.4 -9.84 11.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 -179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -128.55 -70.03 0.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.894 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 2.0 m -160.42 169.21 23.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.849 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -130.43 96.88 0.37 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.486 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -74.18 90.74 0.97 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.649 2.233 . . . . 0.0 112.367 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 3.0 t -97.32 97.73 9.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.853 -179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 31.1 p -166.27 160.95 16.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.906 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.274 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.477 179.998 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.391 0 N-CA-C 112.494 -0.242 . . . . 0.0 112.494 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 59.5 m -109.91 158.66 17.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.893 0.378 . . . . 0.0 110.856 -179.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 58.3 m -99.98 164.31 12.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.875 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -138.46 -109.62 0.89 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.538 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 3.1 m -130.03 116.13 18.11 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.863 0.363 . . . . 0.0 110.863 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 70.5 p -136.17 168.36 19.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.845 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 84.06 108.9 0.58 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.469 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 16.7 tp -80.51 91.02 5.71 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.887 0.375 . . . . 0.0 110.914 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 36.3 p -108.38 158.55 17.41 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.181 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -104.5 122.39 45.45 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.947 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -95.68 103.97 15.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.916 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 56.7 m -124.95 41.46 3.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.867 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.569 ' H ' HD12 ' A' ' 388' ' ' ILE . 5.1 mp -75.88 133.98 30.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.119 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -114.73 101.53 1.08 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.533 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -84.44 -30.96 24.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.785 0.326 . . . . 0.0 111.113 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -51.72 135.27 29.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.157 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.411 ' O ' ' C ' ' A' ' 393' ' ' SER . . . 81.66 -51.71 4.46 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.483 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . 0.411 ' C ' ' O ' ' A' ' 392' ' ' GLY . 27.8 m -37.32 124.62 0.99 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.819 0.342 . . . . 0.0 110.878 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -101.65 27.29 6.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.903 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.498 ' O ' ' CB ' ' A' ' 429' ' ' SER . 7.8 mtpt -81.49 170.46 15.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.9 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -140.14 168.44 19.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.832 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -84.18 -152.93 16.05 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.444 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -74.05 157.76 46.42 Favored 'Trans proline' 0 N--CA 1.465 -0.188 0 C-N-CA 122.714 2.276 . . . . 0.0 112.39 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -55.42 110.46 0.7 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.858 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 127.77 -28.37 4.43 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.53 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . 0.501 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.94 127.14 43.7 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.781 0.324 . . . . 0.0 111.081 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . 0.501 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.6 OUTLIER -158.75 164.04 36.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.921 -179.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . 0.595 HD12 ' CE1' ' A' ' 449' ' ' TYR . 20.1 mt -159.71 120.97 3.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.905 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . 0.538 ' CZ ' ' CD1' ' A' ' 446' ' ' PHE . 35.8 m-85 -126.59 111.16 14.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.939 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . 0.553 HD12 ' N ' ' A' ' 405' ' ' ILE . 4.0 mp -91.23 128.22 43.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.116 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . 0.413 ' C ' ' CD2' ' A' ' 407' ' ' HIS . 78.2 m-85 -122.11 151.84 40.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.94 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . 0.48 ' O ' ' CD2' ' A' ' 472' ' ' LEU . 15.8 m-70 72.9 47.8 0.2 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.85 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.536 HD21 HG21 ' A' ' 405' ' ' ILE . 31.2 mt -91.39 137.73 25.88 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-O 121.643 0.735 . . . . 0.0 110.924 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -47.91 177.87 0.01 OUTLIER 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.662 2.241 . . . . 0.0 112.344 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -85.92 -46.13 10.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.916 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . 0.42 ' HG3' ' N ' ' A' ' 412' ' ' PHE . 12.7 pt-20 -58.54 -40.1 82.05 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.833 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.42 ' N ' ' HG3' ' A' ' 411' ' ' GLU . 7.9 m-85 -50.35 146.59 5.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.879 -179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . 0.401 ' O ' HG21 ' A' ' 432' ' ' VAL . . . -132.75 -139.21 4.22 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.444 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -86.12 -51.48 6.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.708 0.289 . . . . 0.0 110.795 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -61.79 -52.42 64.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.942 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -39.69 -59.92 1.06 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.868 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . 0.449 HD11 HG12 ' A' ' 405' ' ' ILE . 56.1 tp -49.67 -45.13 48.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.966 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 22.2 tp -62.95 -44.24 96.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.851 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -72.18 -9.73 58.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.87 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 6.2 ttm -93.89 -27.75 16.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.83 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . 0.443 ' CZ ' ' CG1' ' A' ' 405' ' ' ILE . 5.4 m-85 -101.25 -20.35 15.29 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.866 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.579 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 3.1 mtt -49.7 -46.19 79.61 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.613 0.72 . . . . 0.0 110.911 179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 422' ' ' MET . 65.3 Cg_exo -47.96 -45.68 24.17 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.705 2.27 . . . . 0.0 112.356 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . 0.538 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 86.6 m-85 -64.03 -30.17 71.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.933 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 168.71 170.05 32.88 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.519 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 11.7 m-80 -66.31 94.02 0.24 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.841 0.353 . . . . 0.0 110.862 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 92.4 t -62.29 133.86 27.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.133 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 75.7 t -79.88 -48.17 20.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.159 179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 44.5 t -136.45 148.3 47.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -161.21 114.01 1.91 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.116 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . 0.417 ' C ' ' HD2' ' A' ' 431' ' ' LYS . 2.0 tmmm? -154.99 142.47 19.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.925 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.401 HG21 ' O ' ' A' ' 413' ' ' GLY . 87.4 t -93.43 137.95 21.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.119 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . 0.463 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.3 m-85 -79.22 153.97 29.57 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.884 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.526 HG22 ' N ' ' A' ' 435' ' ' ASP . 77.2 mt -123.81 158.49 29.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.098 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . 0.526 ' N ' HG22 ' A' ' 434' ' ' ILE . 7.0 t0 -87.94 138.89 31.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.782 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.04 -2.48 58.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.903 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 15.2 mm-40 -106.95 -52.4 2.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.893 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 30.8 p -88.38 -20.55 25.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.124 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 59.96 38.55 20.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.827 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 74.7 mt -127.87 132.17 49.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.965 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . . . . . . . . . 49.2 p -39.92 107.28 0.07 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.882 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.546 ' HD3' ' CE2' ' A' ' 444' ' ' PHE . 14.5 mttm -52.78 -176.21 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.903 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 83.6 m -106.83 37.99 2.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.865 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . 0.546 ' CE2' ' HD3' ' A' ' 442' ' ' LYS . 4.6 p90 -162.07 138.84 8.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.859 -179.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -132.55 169.31 22.39 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.509 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . 0.538 ' CD1' ' CZ ' ' A' ' 404' ' ' PHE . 61.4 t80 -106.33 154.26 21.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.925 0.393 . . . . 0.0 110.831 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . 0.425 HG23 ' C ' ' A' ' 446' ' ' PHE . 64.1 t -158.13 152.91 6.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.097 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . 0.416 ' N ' HG12 ' A' ' 447' ' ' VAL . 60.6 p -150.39 152.8 34.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.876 -179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . 0.595 ' CE1' HD12 ' A' ' 403' ' ' LEU . 5.1 m-85 -116.89 179.57 3.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.933 -179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . 0.446 ' CG ' ' OD1' ' A' ' 451' ' ' ASN . 0.6 OUTLIER -71.89 -28.91 63.82 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.868 179.858 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . 0.446 ' OD1' ' CG ' ' A' ' 450' ' ' ASP . 0.9 OUTLIER -146.64 155.92 48.72 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.659 0.742 . . . . 0.0 110.878 -179.953 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -72.0 -12.6 28.41 Favored 'Trans proline' 0 C--O 1.231 0.141 0 C-N-CA 122.71 2.273 . . . . 0.0 112.414 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 95.5 t -79.64 -33.13 14.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.187 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 78.3 p -84.0 -40.63 18.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.89 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -51.73 -40.4 60.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.159 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . . . . . . . . . 53.0 mm-40 -57.08 -48.96 77.33 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.949 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -38.69 -40.58 0.62 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.119 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . 0.538 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -67.57 -63.99 0.95 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.1 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . 0.487 ' O ' ' CB ' ' A' ' 463' ' ' ASN . 81.0 mt -46.68 -44.24 6.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.17 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -41.63 -49.2 4.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.929 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 1.8 m -98.02 -57.13 2.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.82 -179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . 0.447 ' HB3' HG21 ' A' ' 474' ' ' VAL . 85.2 mmm -42.93 -38.55 2.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.825 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . 0.487 ' CB ' ' O ' ' A' ' 459' ' ' ILE . 15.1 t30 -49.12 106.0 0.09 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.904 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 78.3 32.16 44.13 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.5 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -70.79 105.26 3.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.796 0.332 . . . . 0.0 110.88 -179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -63.62 103.24 0.52 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . 0.486 HG23 ' O ' ' A' ' 467' ' ' ILE . 16.9 tt -113.0 122.26 66.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.175 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 70.56 -96.9 0.59 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.488 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 41.2 mtt -133.25 8.61 4.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.859 0.361 . . . . 0.0 110.881 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.3 175.46 9.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.856 179.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 71.6 mtt-85 -108.98 170.45 8.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.827 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . 0.48 ' CD2' ' O ' ' A' ' 407' ' ' HIS . 72.4 mt -121.97 157.87 30.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.925 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 33.5 tttp -128.56 101.36 6.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.911 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . 0.447 HG21 ' HB3' ' A' ' 462' ' ' MET . 16.6 t -106.49 127.4 61.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.111 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -151.86 147.16 26.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.923 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . 0.632 HD12 ' C ' ' A' ' 476' ' ' LEU . 1.6 pp -91.18 129.34 37.19 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.917 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.601 ' O ' HD12 ' A' ' 476' ' ' LEU . 38.3 tttt -34.34 121.33 0.48 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.91 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 12.2 mmt180 -119.01 170.28 9.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.924 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 5.7 t 58.97 42.34 19.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.999 0.428 . . . . 0.0 110.872 -179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 21.2 tttt -98.67 -51.47 3.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.948 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -124.84 130.04 51.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.932 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.55 146.32 43.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.858 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 7.7 t -103.48 152.31 21.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.822 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -44.0 163.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.95 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 18.5 m -143.05 121.82 12.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.865 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 136.69 138.73 3.83 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.528 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_endo -79.17 118.83 4.09 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.751 2.301 . . . . 0.0 112.334 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 27.5 t -77.82 -59.92 2.58 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.839 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 7.6 t -110.33 -57.28 2.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.869 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.269 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.428 -179.979 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.373 0 N-CA-C 112.493 -0.243 . . . . 0.0 112.493 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 88.3 p -172.78 157.79 3.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.878 0.37 . . . . 0.0 110.854 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 13.8 t -122.7 120.34 33.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.903 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -163.69 164.15 36.16 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.728 -0.749 . . . . 0.0 112.461 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 30.9 t -75.76 93.13 3.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.885 0.374 . . . . 0.0 110.873 -179.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 68.3 m -89.99 96.49 10.7 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.882 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 59.46 -148.46 41.19 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.501 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . . . . . . . . . 5.0 mp 58.42 43.58 19.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.88 0.372 . . . . 0.0 110.874 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 92.4 m -97.37 133.15 42.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.137 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -113.26 -46.84 3.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.921 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 24.7 pt20 -93.54 126.54 38.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.932 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 23.0 t -128.81 85.03 2.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.777 -179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.509 ' H ' HD12 ' A' ' 388' ' ' ILE . 5.1 mp -66.34 140.54 19.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.094 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -54.24 113.24 3.17 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.498 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -111.31 -37.73 5.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.733 0.301 . . . . 0.0 111.072 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -59.42 112.08 1.62 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.069 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 393' ' ' SER . . . 96.95 -30.21 9.36 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.453 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . 0.437 ' C ' ' O ' ' A' ' 392' ' ' GLY . 46.9 t -34.85 -47.98 0.37 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.834 0.349 . . . . 0.0 110.913 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 68.84 44.33 1.11 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.947 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.492 ' O ' ' CB ' ' A' ' 429' ' ' SER . 22.4 ptmt -105.71 174.18 5.99 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.892 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . 0.605 ' OE2' ' CE2' ' A' ' 446' ' ' PHE . 6.1 mm-40 -129.87 179.72 5.69 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.892 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -117.2 -148.59 8.83 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.515 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -76.02 151.47 35.11 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.781 2.32 . . . . 0.0 112.32 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -56.44 108.89 0.53 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.902 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 128.61 -28.39 4.22 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.509 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . 0.563 ' HB2' ' CA ' ' A' ' 452' ' ' PRO . . . -97.86 126.98 43.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.826 0.346 . . . . 0.0 111.074 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . 0.505 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.6 OUTLIER -158.7 161.85 37.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.873 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . 0.54 HD12 ' CE1' ' A' ' 449' ' ' TYR . 38.4 mt -154.57 125.84 7.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.903 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . 0.58 ' CE1' ' HB2' ' A' ' 477' ' ' LYS . 27.8 m-85 -133.83 114.64 13.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.919 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . 0.673 HG12 HD11 ' A' ' 417' ' ' LEU . 3.0 mp -90.85 131.55 37.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.121 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . 0.472 ' CZ ' ' HB3' ' A' ' 404' ' ' PHE . 47.3 m-85 -125.31 171.12 10.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.976 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . . . . . . . . . 45.8 m-70 53.67 50.98 15.92 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.869 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.636 HD11 ' CG2' ' A' ' 405' ' ' ILE . 46.6 mt -100.24 151.71 37.61 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.636 0.731 . . . . 0.0 110.928 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.512 ' HG2' ' CD1' ' A' ' 412' ' ' PHE . 57.4 Cg_endo -70.54 -168.31 0.3 Allowed 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.689 2.259 . . . . 0.0 112.322 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -98.51 -37.91 9.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.872 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . 0.444 ' OE1' ' C ' ' A' ' 411' ' ' GLU . 0.2 OUTLIER -57.88 -38.33 75.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 -179.881 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . 0.512 ' CD1' ' HG2' ' A' ' 409' ' ' PRO . 6.5 m-85 -58.97 140.94 55.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.93 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . . . . . . . . . . . -126.58 -134.19 3.98 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.471 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -87.99 -54.96 3.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.757 0.313 . . . . 0.0 110.837 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . 0.442 ' O ' ' C ' ' A' ' 416' ' ' ASP . 43.2 mm-40 -59.86 -60.64 3.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.852 -179.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . 0.442 ' C ' ' O ' ' A' ' 415' ' ' GLN . 45.7 m-20 -34.47 -57.7 0.5 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.925 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . 0.673 HD11 HG12 ' A' ' 405' ' ' ILE . 67.6 tp -53.71 -44.35 69.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.838 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . 0.429 ' N ' ' O ' ' A' ' 415' ' ' GLN . 29.7 tp -66.55 -61.67 1.86 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.87 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -51.84 -17.21 0.88 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.904 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 3.3 ttm -84.21 -35.91 23.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.825 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . 0.425 ' C ' ' HD2' ' A' ' 423' ' ' PRO . 4.0 m-85 -92.2 -17.86 24.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.88 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.581 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 4.2 mtt -51.12 -45.81 88.71 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.54 0.686 . . . . 0.0 110.842 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 422' ' ' MET . 66.2 Cg_exo -48.03 -46.77 21.13 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.596 2.197 . . . . 0.0 112.34 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . 0.564 ' CD2' ' HA ' ' A' ' 458' ' ' ALA . 56.0 m-85 -60.14 -36.03 76.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.81 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 170.18 -179.57 42.32 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.476 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -69.17 109.72 4.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.88 0.371 . . . . 0.0 110.903 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . . . . . . . . . 91.1 t -79.3 131.37 34.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.106 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . 0.442 HG12 ' HG3' ' A' ' 395' ' ' LYS . 55.2 t -84.36 -47.68 17.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.152 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . 0.492 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 23.3 t -129.57 144.4 51.25 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.814 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . . . . . . . . . . . -160.44 111.09 1.83 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.118 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -159.04 135.1 8.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.856 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . . . . . . . . . 80.0 t -90.05 142.5 12.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.162 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . 0.54 ' HB2' ' CE1' ' A' ' 444' ' ' PHE . 3.0 m-85 -83.84 144.48 29.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.432 HG23 ' C ' ' A' ' 440' ' ' LEU . 21.0 mt -138.08 149.89 24.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.12 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -82.48 151.94 26.3 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.83 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 1.6 tmmm? -82.05 -30.96 31.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -77.57 -58.98 2.97 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.88 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 44.3 p -72.05 -42.86 65.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.205 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 5.6 t30 74.97 36.1 0.57 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . 0.444 ' O ' ' C ' ' A' ' 441' ' ' SER . 5.7 mt -139.27 138.39 36.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.921 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . 0.444 ' C ' ' O ' ' A' ' 440' ' ' LEU . 52.7 m -34.35 137.29 0.12 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.863 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.487 ' CB ' ' CE2' ' A' ' 444' ' ' PHE . 84.8 mttt -83.41 20.62 1.3 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.884 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . . . . . . . . . 98.9 m 62.76 27.41 16.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.884 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . 0.54 ' CE1' ' HB2' ' A' ' 433' ' ' PHE . 3.7 p90 -162.28 139.93 8.49 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.868 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -131.09 175.86 19.31 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.503 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . 0.605 ' CE2' ' OE2' ' A' ' 396' ' ' GLU . 35.0 t80 -116.01 153.76 31.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.908 0.385 . . . . 0.0 110.857 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . 0.406 ' HB ' ' CB ' ' A' ' 403' ' ' LEU . 65.5 t -154.69 150.13 11.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.102 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . . . . . . . . . 6.1 p -147.1 141.35 26.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.894 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . 0.54 ' CE1' HD12 ' A' ' 403' ' ' LEU . 3.8 m-85 -111.42 170.46 8.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.867 -179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -67.09 -25.65 66.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.803 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . 0.405 ' OD1' ' N ' ' A' ' 451' ' ' ASN . 2.0 p-10 -143.32 156.98 60.64 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.611 0.72 . . . . 0.0 110.896 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . 0.563 ' CA ' ' HB2' ' A' ' 401' ' ' ALA . 61.2 Cg_endo -75.39 -22.12 14.46 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.653 2.235 . . . . 0.0 112.377 179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 98.3 t -72.82 -40.9 61.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.109 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 1.8 m -73.08 -42.65 62.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.81 -179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . 0.4 ' HB2' ' HB2' ' A' ' 449' ' ' TYR . . . -52.83 -42.67 65.37 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.097 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . 0.454 HE21 HD23 ' A' ' 476' ' ' LEU . 25.5 mm-40 -53.76 -44.86 70.36 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.867 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . . . . . . . . . . . -43.63 -43.02 5.53 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.11 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . 0.564 ' HA ' ' CD2' ' A' ' 424' ' ' PHE . . . -58.18 -66.37 0.49 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.185 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . 0.454 ' O ' ' C ' ' A' ' 460' ' ' GLN . 58.8 mt -50.1 -48.94 23.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.121 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . 0.454 ' C ' ' O ' ' A' ' 459' ' ' ILE . 36.3 mt-30 -33.91 -43.24 0.14 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.93 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . . . . . . . . . 34.1 t -102.55 -56.91 2.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 -179.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . 0.427 ' O ' ' N ' ' A' ' 465' ' ' PHE . 80.6 mmm -44.36 -47.83 9.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.819 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -40.35 100.8 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.854 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . . . . . . . . . . . 80.99 37.22 19.57 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.477 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . 0.427 ' N ' ' O ' ' A' ' 462' ' ' MET . 64.9 t80 -77.79 115.36 17.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.816 0.341 . . . . 0.0 110.899 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -64.28 102.88 0.57 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.952 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . 0.484 HG21 HD21 ' A' ' 472' ' ' LEU . 19.4 tt -112.94 144.95 19.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.153 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 42.45 -96.94 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.457 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 54.4 mtm -125.1 -7.77 7.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.863 0.363 . . . . 0.0 110.877 -179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.91 -177.96 3.91 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.907 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 68.0 mtt85 -112.2 168.4 9.64 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.867 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . 0.484 HD21 HG21 ' A' ' 467' ' ' ILE . 56.7 mt -111.22 158.35 19.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.912 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 21.4 ttmt -134.5 99.96 4.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.901 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . . . . . . . . . 11.4 t -105.84 138.2 32.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.14 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . 0.446 ' OE1' ' NH1' ' A' ' 478' ' ' ARG . 37.5 tt0 -156.98 138.2 13.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.834 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . 0.697 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.6 pp -78.93 124.37 28.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.886 -179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.58 ' HB2' ' CE1' ' A' ' 404' ' ' PHE . 0.3 OUTLIER -61.26 117.21 5.31 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.85 179.828 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . 0.446 ' NH1' ' OE1' ' A' ' 475' ' ' GLN . 4.0 mpt_? -74.23 139.46 44.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.892 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 95.1 p -50.1 135.1 21.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.884 -179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.11 176.86 11.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.932 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -135.97 137.09 40.93 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.894 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -129.72 -56.53 1.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.868 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 94.0 p -166.0 112.55 0.88 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.79 -179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 5.3 tmtm? -121.1 125.82 48.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.87 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 43.5 t -141.65 156.45 45.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.893 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . -96.56 134.25 11.73 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.471 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -78.06 120.93 5.16 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.741 2.294 . . . . 0.0 112.341 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 80.6 p -93.52 89.26 6.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.789 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 25.0 p 44.02 41.98 4.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.843 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.354 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.459 179.993 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 376' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.256 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 377' ' ' SER . . . . . . . . . . . . . 44.8 p -94.18 138.82 31.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.848 0.356 . . . . 0.0 110.891 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 378' ' ' SER . . . . . . . . . . . . . 55.5 p -73.33 175.42 6.91 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.874 -179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 379' ' ' GLY . . . . . . . . . . . . . . . -161.83 148.23 15.43 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.547 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' SER . . . . . . . . . . . . . 25.4 t -116.63 91.96 3.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.926 0.394 . . . . 0.0 110.8 -179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' SER . . . . . . . . . . . . . 19.6 m -96.96 99.59 11.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.862 -179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' GLY . . . . . . . . . . . . . . . 47.17 -127.53 11.88 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.499 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' LEU . . . . . 0.616 ' O ' HD23 ' A' ' 383' ' ' LEU . 1.8 tt 64.01 41.29 6.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.855 0.36 . . . . 0.0 110.956 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' THR . . . . . . . . . . . . . 70.0 p -136.83 157.28 47.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.139 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -102.37 116.11 31.95 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.923 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -151.74 136.02 16.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.925 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' SER . . . . . . . . . . . . . 17.7 m -122.85 91.75 3.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.842 -179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' ILE . . . . . 0.559 ' N ' HD12 ' A' ' 388' ' ' ILE . 4.0 mp -119.74 135.01 61.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.115 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' GLY . . . . . . . . . . . . . . . -61.51 118.09 13.69 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.498 179.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' ALA . . . . . . . . . . . . . . . -110.74 31.54 5.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.839 0.352 . . . . 0.0 111.145 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -90.98 132.83 35.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.05 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' GLY . . . . . . . . . . . . . . . 83.83 -41.12 2.93 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.459 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' SER . . . . . . . . . . . . . 11.4 m -43.98 114.2 0.63 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.837 0.351 . . . . 0.0 110.916 -179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -87.15 42.64 1.04 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.936 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' LYS . . . . . 0.478 ' O ' ' CB ' ' A' ' 429' ' ' SER . 14.7 ptmt -102.38 176.76 5.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.928 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -143.34 -178.38 5.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.901 179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' GLY . . . . . . . . . . . . . . . -100.08 -154.7 27.73 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.468 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.57 159.24 46.41 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.715 2.276 . . . . 0.0 112.349 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -54.51 116.38 2.63 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 120.33 -27.74 6.54 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.499 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' ALA . . . . . 0.488 ' O ' ' ND2' ' A' ' 402' ' ' ASN . . . -97.91 127.18 43.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.858 0.361 . . . . 0.0 111.063 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 402' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' A' ' 401' ' ' ALA . 0.6 OUTLIER -158.73 160.0 35.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.885 -179.917 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 403' ' ' LEU . . . . . 0.467 HD12 ' CE1' ' A' ' 449' ' ' TYR . 23.1 mt -156.0 122.25 5.09 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.924 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 404' ' ' PHE . . . . . 0.522 ' CE1' ' HD3' ' A' ' 477' ' ' LYS . 36.6 m-85 -131.33 110.85 11.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.834 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 405' ' ' ILE . . . . . 0.682 HD12 ' N ' ' A' ' 405' ' ' ILE . 3.0 mp -91.18 136.76 23.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.116 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 406' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -131.2 165.69 22.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.956 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 407' ' ' HIS . . . . . 0.463 ' O ' HD23 ' A' ' 472' ' ' LEU . 22.0 m-70 58.96 53.22 5.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.891 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 408' ' ' LEU . . . . . 0.4 ' O ' ' O ' ' A' ' 409' ' ' PRO . 21.1 mt -94.83 138.35 22.17 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.613 0.721 . . . . 0.0 110.915 -179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 409' ' ' PRO . . . . . 0.4 ' O ' ' O ' ' A' ' 408' ' ' LEU . 76.1 Cg_exo -50.02 -172.31 0.0 OUTLIER 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.671 2.247 . . . . 0.0 112.384 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -90.93 -43.03 10.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.876 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 411' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -62.52 -36.99 84.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 412' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -51.57 132.03 30.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.903 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 413' ' ' GLY . . . . . 0.511 ' O ' HG21 ' A' ' 432' ' ' VAL . . . -127.16 -130.91 3.42 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.536 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 414' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.56 -62.84 1.37 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.761 0.315 . . . . 0.0 110.836 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 415' ' ' GLN . . . . . 0.42 ' O ' ' C ' ' A' ' 416' ' ' ASP . 35.0 mm-40 -47.06 -58.03 4.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.948 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 416' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' A' ' 415' ' ' GLN . 71.2 m-20 -36.0 -71.87 0.06 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 417' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 416' ' ' ASP . 26.2 tp -37.53 -53.26 1.18 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.966 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 418' ' ' LEU . . . . . . . . . . . . . 27.5 tp -54.99 -46.61 75.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.944 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 419' ' ' GLN . . . . . . . . . . . . . 37.2 mm-40 -75.33 -11.83 60.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.924 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 420' ' ' MET . . . . . . . . . . . . . 2.9 tpp -86.68 -28.3 23.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 421' ' ' PHE . . . . . 0.443 ' CE1' ' SD ' ' A' ' 462' ' ' MET . 6.0 m-85 -106.56 -11.27 15.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.936 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 422' ' ' MET . . . . . 0.583 ' N ' ' CD ' ' A' ' 423' ' ' PRO . 1.6 mmt -60.59 -45.71 97.18 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.543 0.687 . . . . 0.0 110.852 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 423' ' ' PRO . . . . . 0.583 ' CD ' ' N ' ' A' ' 422' ' ' MET . 66.5 Cg_exo -47.97 -48.44 16.31 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.706 2.271 . . . . 0.0 112.311 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 424' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -60.21 -35.15 74.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.865 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 425' ' ' GLY . . . . . . . . . . . . . . . 175.79 -171.94 44.98 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.495 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 426' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -79.34 105.75 10.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.917 0.389 . . . . 0.0 110.919 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 427' ' ' VAL . . . . . 0.44 HG11 ' HB2' ' A' ' 430' ' ' ALA . 95.9 t -71.82 126.59 32.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.109 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 428' ' ' VAL . . . . . . . . . . . . . 95.2 t -84.27 -38.31 13.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.081 179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . 0.478 ' CB ' ' O ' ' A' ' 395' ' ' LYS . 1.0 OUTLIER -137.72 140.54 40.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.849 -179.841 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 430' ' ' ALA . . . . . 0.44 ' HB2' HG11 ' A' ' 427' ' ' VAL . . . -160.22 114.55 2.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.087 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 431' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -159.5 133.85 7.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 432' ' ' VAL . . . . . 0.511 HG21 ' O ' ' A' ' 413' ' ' GLY . 88.0 t -88.6 153.93 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.153 179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 433' ' ' PHE . . . . . 0.436 ' N ' HG12 ' A' ' 432' ' ' VAL . 3.8 m-30 -88.01 153.98 20.85 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.863 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 434' ' ' ILE . . . . . 0.476 HD13 ' HA ' ' A' ' 441' ' ' SER . 21.3 mm -132.98 141.89 43.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.122 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 435' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -85.33 147.88 26.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.92 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 436' ' ' LYS . . . . . . . . . . . . . 18.2 tptp -92.13 -5.24 53.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.932 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 437' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -98.37 -46.21 5.87 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.865 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 438' ' ' THR . . . . . . . . . . . . . 30.4 p -97.21 -21.59 17.2 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.128 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 439' ' ' ASN . . . . . . . . . . . . . 58.1 t30 55.06 44.88 27.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.865 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 440' ' ' LEU . . . . . . . . . . . . . 55.3 mt -130.36 160.41 34.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.897 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 441' ' ' SER . . . . . 0.476 ' HA ' HD13 ' A' ' 434' ' ' ILE . 10.3 p -61.94 104.86 0.5 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.913 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 442' ' ' LYS . . . . . 0.562 ' HD3' ' CE1' ' A' ' 444' ' ' PHE . 20.6 mttt -52.46 -174.79 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.834 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 443' ' ' CYS . . . . . 0.454 ' O ' ' N ' ' A' ' 407' ' ' HIS . 26.7 p -110.27 30.63 6.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.839 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 444' ' ' PHE . . . . . 0.562 ' CE1' ' HD3' ' A' ' 442' ' ' LYS . 7.4 p90 -159.91 145.92 15.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 445' ' ' GLY . . . . . . . . . . . . . . . -142.96 175.8 22.9 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.479 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 446' ' ' PHE . . . . . 0.549 ' O ' HG23 ' A' ' 447' ' ' VAL . 25.2 t80 -112.62 154.93 25.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.911 0.386 . . . . 0.0 110.92 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 447' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 446' ' ' PHE . 72.3 t -160.86 156.01 3.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.134 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 448' ' ' SER . . . . . 0.452 ' N ' HG12 ' A' ' 447' ' ' VAL . 2.4 m -155.89 152.68 28.59 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.864 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 449' ' ' TYR . . . . . 0.467 ' CE1' HD12 ' A' ' 403' ' ' LEU . 3.7 m-85 -115.63 -175.01 2.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.935 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 450' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -79.1 -24.0 43.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.817 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 451' ' ' ASN . . . . . . . . . . . . . 1.5 p30 -147.98 158.34 42.16 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.627 0.727 . . . . 0.0 110.844 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 452' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.56 -2.13 12.01 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.645 2.23 . . . . 0.0 112.303 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 453' ' ' VAL . . . . . . . . . . . . . 96.6 t -89.82 -39.85 12.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.089 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 454' ' ' SER . . . . . . . . . . . . . 10.6 t -74.76 -40.14 61.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.876 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 455' ' ' ALA . . . . . . . . . . . . . . . -50.64 -32.97 20.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.172 179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 456' ' ' GLN . . . . . 0.505 ' O ' ' N ' ' A' ' 458' ' ' ALA . 34.1 mm-40 -61.57 -60.34 3.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.918 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 457' ' ' ALA . . . . . 0.47 ' C ' ' HG2' ' A' ' 460' ' ' GLN . . . -35.89 -30.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.117 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 458' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 456' ' ' GLN . . . -81.53 -44.98 16.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.092 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 459' ' ' ILE . . . . . 0.488 ' N ' ' O ' ' A' ' 456' ' ' GLN . 26.0 mt -70.1 -48.42 62.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.113 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 460' ' ' GLN . . . . . 0.495 ' HG3' ' N ' ' A' ' 461' ' ' SER . 3.8 pt20 -37.01 -45.05 0.55 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.875 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 461' ' ' SER . . . . . 0.495 ' N ' ' HG3' ' A' ' 460' ' ' GLN . 2.0 m -93.94 -54.18 3.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.82 -179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 462' ' ' MET . . . . . 0.601 ' HB3' HG21 ' A' ' 474' ' ' VAL . 9.6 mmt -44.38 -57.49 3.49 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.85 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 463' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -38.16 97.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.876 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 464' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 462' ' ' MET . . . 84.43 34.82 15.65 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.517 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 465' ' ' PHE . . . . . 0.496 ' N ' ' O ' ' A' ' 462' ' ' MET . 48.6 t80 -71.98 125.92 28.44 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.823 0.344 . . . . 0.0 110.856 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 466' ' ' GLN . . . . . . . . . . . . . 14.6 tm0? -70.73 117.18 11.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.945 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 467' ' ' ILE . . . . . . . . . . . . . 13.6 tt -139.03 133.1 40.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.151 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 468' ' ' GLY . . . . . . . . . . . . . . . 50.91 -103.0 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.465 179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 469' ' ' MET . . . . . . . . . . . . . 11.4 mmm -132.53 25.58 4.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.805 0.336 . . . . 0.0 110.846 -179.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 46.7 pttt -145.85 179.64 7.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.891 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 73.9 mtm180 -120.32 122.3 40.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.877 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 472' ' ' LEU . . . . . 0.463 HD23 ' O ' ' A' ' 407' ' ' HIS . 52.8 mt -64.48 158.07 24.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.852 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -133.25 111.72 11.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.899 179.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 474' ' ' VAL . . . . . 0.601 HG21 ' HB3' ' A' ' 462' ' ' MET . 20.9 t -122.22 136.95 57.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.119 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 475' ' ' GLN . . . . . . . . . . . . . 33.1 tp60 -157.14 141.6 16.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.854 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 476' ' ' LEU . . . . . 0.757 ' O ' HD12 ' A' ' 476' ' ' LEU . 1.5 pp -85.01 125.05 32.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.961 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 477' ' ' LYS . . . . . 0.522 ' HD3' ' CE1' ' A' ' 404' ' ' PHE . 7.8 tptm -34.18 109.07 0.07 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.932 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 478' ' ' ARG . . . . . . . . . . . . . 46.3 mtt180 -74.4 98.82 3.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.922 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 479' ' ' SER . . . . . . . . . . . . . 80.8 p -112.45 110.71 21.06 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.887 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 480' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -99.26 40.78 1.19 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.895 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 481' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -84.57 42.19 0.89 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.886 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 482' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -83.81 86.45 7.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.878 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 483' ' ' SER . . . . . . . . . . . . . 22.5 t -115.15 42.85 2.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.813 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 484' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -132.2 95.33 3.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.833 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 485' ' ' SER . . . . . . . . . . . . . 19.3 m -83.48 102.37 12.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.801 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 486' ' ' GLY . . . . . . . . . . . . . . . 113.91 96.46 2.18 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.483 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 487' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -74.62 136.01 20.65 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.66 2.24 . . . . 0.0 112.337 -179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 488' ' ' SER . . . . . . . . . . . . . 14.9 t -108.14 109.73 21.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.871 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 489' ' ' SER . . . . . . . . . . . . . 7.0 t -108.59 89.1 2.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.882 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 490' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.266 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.526 -179.936 . . . . . . . . 0 0 . 1 stop_ save_